data_2l6x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l6x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 175.6 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 -73.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -31.63 54.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -71.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -48.17 81.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -51.23 -42.88 61.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.96 -50.81 27.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.17 -51.66 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -64.37 -48.74 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.34 -49.07 65.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -46.92 83.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -59.0 -38.76 79.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -68.09 -45.56 83.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 m -62.31 -50.54 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.53 -52.53 54.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -53.58 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -47.16 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -29.01 68.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.0 m -72.81 -48.87 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.8 m -65.66 -40.3 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.87 -51.34 41.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.37 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.05 -51.33 13.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.62 -31.13 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -79.22 -7.06 57.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.38 -27.26 55.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.26 -12.54 27.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -102.39 36.69 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.03 158.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.8 147.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.27 -52.87 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.18 -21.82 60.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -87.73 6.97 32.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -51.33 -50.75 58.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -36.17 56.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.153 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -47.8 73.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.19 -27.5 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -67.77 -53.6 25.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -71.73 -44.91 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -66.32 -40.56 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -35.29 58.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.07 -49.19 65.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.48 -44.11 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.082 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.1 m -67.26 -35.26 79.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.95 -42.68 59.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 mt -68.48 -41.67 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.63 83.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -61.1 -51.95 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.56 -50.41 74.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -59.25 -61.43 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -51.5 -49.7 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -53.15 30.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -58.72 -48.74 80.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.3 mmt -55.83 -54.84 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -51.41 -55.16 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.04 -45.87 56.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.7 -35.68 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 111.136 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -59.75 -51.6 69.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.3 tp -74.51 -26.13 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -50.15 -48.61 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.9 p -111.43 -39.25 4.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 122.36 -13.66 8.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.46 127.03 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.7 161.28 35.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.643 0.735 . . . . 0.0 110.859 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 99.96 0.79 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.358 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 p -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -50.6 -33.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -71.57 -51.92 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -63.74 -33.55 75.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -53.79 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.57 -37.94 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -47.88 80.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 0.0 109.31 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -64.82 -41.67 95.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.8 tp -75.15 -16.58 60.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 tt -99.36 -16.8 18.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.5 p -100.12 -29.17 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.51 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -60.0 -58.63 17.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.675 0.75 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.75 -24.82 29.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.71 2.273 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 mt -76.51 -52.45 9.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.08 -38.52 91.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -70.55 -57.94 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.9 t -52.05 -49.83 62.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -55.48 33.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -51.11 -50.75 58.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -68.53 -30.54 69.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -60.23 -63.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.64 -37.53 79.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.54 -50.45 71.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.01 59.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.69 -23.62 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -27.65 68.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -117.81 -45.84 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -179.61 -78.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -154.74 157.34 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -106.8 124.29 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.31 -5.53 81.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -50.5 -28.15 7.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.82 -39.78 59.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -64.95 -52.68 55.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -49.94 74.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -48.32 76.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -58.58 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.3 -51.95 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.63 74.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -45.35 91.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -49.67 76.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.8 -51.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -35.89 80.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -51.01 71.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.62 -46.89 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.71 -39.51 84.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -51.99 8.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.56 -55.75 30.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.95 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.3 mmt -69.29 -47.9 63.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.63 -31.7 53.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -47.48 -46.77 27.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.6 -27.1 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.48 20.33 30.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.8 pt -75.52 -40.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.876 0.37 . . . . 0.0 111.157 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -156.39 132.52 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 165.11 -20.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.75 -43.0 80.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.618 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 4.9 t-105 -66.78 -54.82 19.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.532 0.682 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.71 -16.96 38.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.319 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.17 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.085 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.4 -37.72 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.6 -65.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.5 pt -50.68 -44.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.133 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.15 61.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.22 -50.5 69.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.913 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.15 -50.34 73.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.26 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -65.21 -55.14 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.1 t -52.75 -50.15 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -39.88 94.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.84 -58.7 6.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.49 -32.17 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -53.24 -55.91 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -76.65 -35.29 58.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 tp -60.52 -40.25 90.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -21.58 26.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -110.44 20.01 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.815 0.34 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.56 163.19 21.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.699 0.761 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.64 27.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.27 -48.39 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.38 -41.78 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -65.78 -33.43 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.6 m -70.57 -46.89 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.48 94.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.17 -51.77 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -56.48 -49.94 73.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 20.6 p -61.91 -38.48 88.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -62.31 -51.95 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.7 ttp -61.5 -38.62 87.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -49.04 79.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.3 mm -65.21 -48.49 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.6 mm -52.58 -45.93 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.1 mt -64.95 -51.33 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.2 -57.5 11.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -56.51 -59.21 11.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.5 -34.01 56.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.92 -23.7 44.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.1 mt -78.37 -32.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.557 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 6.8 t80 -48.38 -56.23 15.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.76 -23.65 30.57 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.697 2.264 . . . . 0.0 112.379 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.19 -45.24 83.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.01 -39.03 10.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -53.22 -48.59 68.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.923 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.07 -32.77 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -13.38 61.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -131.6 5.01 5.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 -179.811 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.71 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.5 mp -52.78 -63.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -33.64 39.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.9 -54.47 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -61.12 -52.12 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.17 -58.46 6.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.2 -42.51 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.71 -52.56 63.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -37.92 83.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.04 -45.0 94.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.75 -52.14 64.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.61 -32.05 73.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -66.18 -49.61 66.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.33 -25.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -80.47 2.55 24.76 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-O 126.738 3.161 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -131.59 -51.57 0.99 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.111 -3.493 . . . . 0.0 112.761 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.33 -64.53 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.16 -1.837 . . . . 0.0 111.101 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.91 -36.0 35.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -51.56 -56.04 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.65 65.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.99 -47.36 85.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.8 mm -71.42 -50.77 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.5 mm -53.19 -40.92 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -74.71 -41.97 59.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -60.55 -42.54 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.02 -35.12 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.76 72.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.76 -37.9 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -70.27 -37.8 74.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -77.04 -46.29 24.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.9 t -51.95 -62.3 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 170.7 12.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.18 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.64 -39.62 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -62.36 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -48.05 80.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -52.79 -46.27 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.41 -51.44 16.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.11 -50.53 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 t -66.18 -49.89 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -52.35 -49.13 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -63.79 -47.33 81.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.07 -38.2 78.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.79 -45.21 81.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 m -61.88 -51.59 67.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.92 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.087 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.18 -55.43 35.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.33 -39.72 64.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.45 -56.02 24.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -24.15 67.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -51.85 21.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.3 t -69.58 -39.48 77.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.05 -49.32 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.53 -45.06 76.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -64.54 -30.47 71.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -75.04 -51.78 12.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.83 -36.12 76.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.37 -9.26 59.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -29.08 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.15 -11.66 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.17 24.6 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.51 156.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.27 148.65 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -55.56 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -20.7 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -88.58 -15.33 35.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -51.68 -50.38 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 p -61.13 -50.34 73.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.178 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -35.53 72.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.36 72.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -53.96 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.8 m -64.5 -51.29 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.4 t -68.1 -38.16 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -36.38 68.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.79 -50.01 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -64.69 -48.45 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -62.54 -33.56 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.03 -69.56 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 pt -45.4 -41.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.41 69.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -52.77 -55.24 24.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -56.69 -46.15 81.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.56 -38.77 88.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -68.93 -68.53 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -45.28 -42.9 10.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.03 -49.01 71.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.7 mmm -59.61 -48.99 79.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -56.21 22.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.26 -43.56 75.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.46 -27.67 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 111.081 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -69.93 -53.35 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -26.05 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -50.08 -47.62 53.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.2 p -108.12 -39.06 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.93 -56.34 0.74 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.62 126.82 53.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.48 161.01 37.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 78.79 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.353 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 m -54.02 -25.66 22.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.8 p -48.14 -32.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -69.56 -52.39 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -59.89 -45.03 93.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -60.34 -52.0 67.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.55 -27.69 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.52 -68.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 109.275 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -53.84 -32.78 54.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -32.76 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -84.03 -14.9 49.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.9 p -99.42 -32.69 11.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -46.49 -59.41 5.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.0 Cg_endo -69.75 -23.33 30.95 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -53.97 11.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.93 -37.5 70.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.67 -51.38 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.139 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.04 -47.73 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -58.03 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -51.21 -52.16 47.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.66 -30.49 71.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -66.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.56 -37.83 67.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.12 -51.4 61.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.58 63.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.14 -22.54 11.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.06 68.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -120.1 -48.3 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.17 -73.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -155.17 157.21 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.37 123.6 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.0 -6.09 81.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.5 t -50.62 -28.95 9.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.95 -39.42 94.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -52.31 64.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -62.14 -34.05 75.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.05 -46.31 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.95 -58.18 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.0 t -55.19 -50.09 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.45 94.68 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 t -59.85 -48.05 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -52.97 63.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.31 -46.23 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -30.68 68.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -50.17 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.1 m -67.07 -39.12 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.31 -37.15 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.36 -51.9 19.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -64.35 -54.92 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 21.7 tpp -60.79 -43.08 98.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.79 -32.44 82.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.53 -28.53 8.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.35 -26.79 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.58 44.02 50.93 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 65.1 mt -84.97 -54.56 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -130.36 136.61 49.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . -149.75 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.65 81.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.08 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.61 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.03 -52.92 15.08 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.75 -9.86 27.16 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.73 -53.91 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -30.39 58.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.24 -66.48 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 24.3 mt -61.37 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.137 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.05 68.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.9 t -58.66 -49.59 76.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.26 -48.52 68.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.15 90.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -60.69 -56.42 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.25 -45.9 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.76 -41.29 99.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -57.85 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.2 mt -63.87 -37.95 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -52.94 -54.21 38.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -74.79 -48.71 23.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -51.36 -60.07 3.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -58.01 -20.29 37.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.17 17.96 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.742 0.306 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.64 162.99 24.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.667 0.746 . . . . 0.0 110.879 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -16.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.97 37.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.91 -47.03 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -38.29 86.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -66.82 -48.42 68.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.83 86.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -51.53 61.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.74 -41.03 73.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.9 p -72.29 -32.23 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -52.21 58.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.43 76.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -50.96 69.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.3 pt -69.38 -33.46 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mm -61.26 -53.19 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 17.9 pt -67.33 -36.75 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.89 -60.97 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.72 97.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -61.63 -32.37 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -81.05 -27.52 35.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.3 mt -80.96 -31.03 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.597 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.8 t80 -48.36 -54.19 27.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.732 0.777 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.75 -21.91 32.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 0.0 112.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.19 -44.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.5 -37.38 14.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.497 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.95 -36.37 72.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.39 -49.4 73.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 t -73.24 -13.93 61.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -96.79 -21.48 21.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 18.1 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 -179.826 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.888 0.375 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.19 -23.67 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.73 -62.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -25.61 61.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.81 -58.81 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.02 -43.32 95.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -53.93 -58.49 7.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 34.9 mm -59.47 -44.39 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.61 -47.81 78.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.73 -43.9 82.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.4 tt -57.01 -49.64 75.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.2 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -56.43 -27.93 58.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -73.08 -46.91 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.88 -25.43 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.88 2.26 31.28 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 126.686 3.136 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -130.74 -58.3 1.03 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 117.109 -3.494 . . . . 0.0 112.71 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 45.4 mm -62.11 -64.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.08 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -38.21 50.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.57 -56.63 12.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.22 90.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.2 -44.17 96.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.312 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.7 mm -67.65 -47.18 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.01 -40.9 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -71.94 -41.08 68.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -62.95 -43.88 97.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.87 -32.5 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.21 62.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 62.3 t -76.36 -33.22 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -75.88 -39.7 55.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.1 -42.84 55.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 t -52.05 -58.92 5.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.38 -177.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.5 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -54.23 -36.23 63.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -55.78 -69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -46.67 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.5 m -51.68 -45.78 63.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.62 -50.49 36.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.1 t -54.36 -54.51 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.072 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -60.45 -49.97 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -52.44 -49.23 64.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -44.52 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -36.68 84.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.02 -51.51 59.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 m -62.83 -46.36 88.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.71 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.151 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.42 56.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.58 -54.42 27.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -54.22 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.72 62.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -66.18 -28.17 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -72.33 -50.15 29.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.73 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -70.43 -51.69 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -63.41 -30.96 72.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -74.03 -51.25 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.32 -31.47 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.74 -4.88 53.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -55.78 -26.37 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.25 -10.67 22.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -95.49 24.6 5.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.95 158.61 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.195 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 157.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.59 -55.9 11.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -61.4 -19.87 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -88.96 -6.81 56.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -50.81 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 p -68.13 -39.07 82.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -37.12 75.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -33.7 76.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -54.89 8.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 m -63.54 -53.53 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -39.53 90.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.15 -32.7 69.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.79 -47.64 62.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.69 -45.32 84.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 m -69.51 -35.32 75.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.45 -45.97 65.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.59 -48.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.91 97.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.94 -52.47 65.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -56.99 -50.27 73.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -56.59 -53.68 54.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.79 -53.21 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.97 -53.83 18.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -56.55 -43.46 79.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -51.95 67.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' A' ' 224' ' ' ASN . 0.0 OUTLIER -53.56 -55.46 25.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.9 -46.33 60.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.51 -27.83 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.344 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -67.59 -54.83 16.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.2 tp -73.59 -24.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -46.77 -47.92 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 t -123.04 -39.11 2.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.158 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.55 -38.48 1.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.56 127.12 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p -138.61 160.25 64.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 97.59 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.7 2.266 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -69.58 -26.81 64.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.5 t -50.73 -46.65 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -38.31 90.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -64.08 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -36.41 70.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.7 mt -63.73 -66.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -33.37 59.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.533 1.146 . . . . 0.0 109.305 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -55.95 -63.17 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -10.47 59.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.87 -15.18 30.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . 81.9 p -112.62 -36.24 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.483 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -46.67 -59.43 5.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.689 0.756 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.77 -18.68 36.82 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.4 mm? -77.51 -53.92 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -50.44 64.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.02 -56.08 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.0 t -58.54 -40.0 81.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -65.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.0 -50.16 48.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -60.1 -32.21 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.23 -62.22 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.3 mp -50.77 -41.97 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -41.4 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.2 -15.68 61.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.36 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.086 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.4 -18.15 61.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 t -119.34 -49.38 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.179 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.63 -78.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.64 163.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.05 118.09 35.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.29 -14.96 81.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.512 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.3 m -54.53 -23.99 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.868 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.41 -37.58 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -73.42 -42.04 62.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -64.18 -50.32 68.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -36.08 82.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -48.08 80.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.918 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.79 -58.91 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.08 -52.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.79 -49.19 76.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.4 m -53.67 -45.87 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.62 -50.54 72.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.36 -45.68 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -41.03 89.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -53.18 57.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -67.14 -50.87 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.93 -44.14 63.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.32 -52.47 8.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -53.5 -57.66 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.1 mmt -69.99 -32.56 70.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.57 78.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.43 -27.85 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -103.09 -28.16 12.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.48 20.75 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.472 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.116 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.49 122.35 45.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 176.4 -29.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.97 87.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.508 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -70.22 -58.33 5.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.79 -6.26 18.18 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -65.14 -44.18 89.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.95 -63.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.0 mt -58.36 -51.72 67.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -54.55 -49.07 62.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.465 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.4 t -56.54 -51.1 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -49.34 65.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.53 83.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -67.42 -56.69 8.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -53.82 -52.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.141 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -59.83 -44.67 93.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.2 mmm -50.73 -56.59 11.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.29 -38.87 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -51.25 56.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.19 -52.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.7 mp -50.31 -59.09 4.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -20.93 27.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -106.12 17.69 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.08 161.76 52.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.636 0.731 . . . . 0.0 110.839 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -22.0 32.84 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.85 -43.16 47.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.73 -46.26 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.67 -36.51 84.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.2 t -71.16 -49.71 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.88 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -50.61 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -53.58 -56.96 12.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.7 t -60.32 -41.98 94.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -51.51 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.13 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -50.35 68.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -39.5 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.082 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.17 -56.57 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.15 -48.46 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -49.83 -56.34 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.44 -59.72 10.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -54.44 -31.36 55.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.48 -22.89 43.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.4 mt -78.92 -32.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.592 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 23.8 t80 -49.93 -54.5 31.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.682 0.753 . . . . 0.0 110.914 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.7 Cg_endo -69.77 -25.03 28.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.682 2.255 . . . . 0.0 112.384 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.51 -37.73 65.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.12 -28.88 39.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.458 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.41 -33.76 21.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.59 -28.03 12.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.7 p -47.83 -32.4 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 136.58 44.03 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.883 0.373 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.09 68.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.09 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.5 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.11 -26.98 65.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.67 -59.01 5.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -65.7 -34.7 78.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.36 -58.11 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 86.6 mt -58.82 -49.04 84.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.41 -54.54 45.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.401 ' HB2' ' HG3' ' A' ' 80' ' ' ARG . 7.5 t-20 -60.84 -32.55 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.54 -49.25 74.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.72 -49.06 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -46.78 87.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -59.09 -44.18 91.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.1 t -72.91 -25.59 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -93.9 2.1 56.22 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.738 3.161 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -120.94 -60.36 1.66 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.095 -3.503 . . . . 0.0 112.751 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 44.8 mm -67.64 -64.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.177 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -34.52 60.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -56.64 -56.56 19.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.42 -34.4 87.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -41.07 87.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.1 mm -68.46 -50.1 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.6 mm -61.61 -37.73 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -74.78 -41.96 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.67 -44.3 93.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.59 -41.38 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.08 91.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.45 -34.77 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -69.87 -40.92 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.14 -41.36 42.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 29.7 t -51.39 -46.68 62.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.823 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 168.43 15.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.096 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.9 t -52.03 -31.18 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.59 -63.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -47.96 80.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -51.21 -47.71 62.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.13 -51.55 38.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.24 -56.19 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 111.148 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -48.78 78.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -52.05 -39.93 60.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -71.37 -40.0 70.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.67 -44.34 86.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.02 -35.83 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.5 m -71.03 -54.19 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.46 -44.9 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.27 69.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tt -55.3 -42.36 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.4 tp -64.42 -56.1 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -38.15 74.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.2 t -67.56 -48.96 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -63.82 -46.55 84.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.92 -46.61 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.26 -48.85 66.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -61.39 -28.85 69.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -75.66 -50.33 15.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.02 -33.19 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -79.23 -6.56 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -59.47 -27.76 66.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.62 -13.7 27.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.69 39.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.89 160.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 t -48.87 143.11 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.22 57.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 -25.06 61.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -91.85 13.25 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -49.69 -50.26 44.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.3 p -76.84 -30.26 56.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -44.06 72.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.84 -28.94 67.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -53.34 20.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.69 -46.83 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -66.62 -39.0 88.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.06 -36.22 60.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.17 -49.83 58.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 104' ' ' LEU . 7.7 p -65.67 -44.78 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.4 m -67.62 -36.14 80.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.71 -41.57 74.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.461 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 mt -66.95 -50.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.95 85.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.079 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.53 -54.85 40.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -46.7 85.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -59.11 -63.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.17 -55.29 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -57.5 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -40.46 82.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.4 mmt -59.91 -56.51 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -55.36 19.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -47.85 57.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.08 -37.22 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.169 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -59.78 -48.12 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.29 -25.93 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.52 -48.12 38.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -115.01 -39.36 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.164 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.64 -14.41 5.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -135.34 141.49 45.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.27 162.08 33.88 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.697 0.761 . . . . 0.0 110.826 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.32 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -66.78 -25.6 66.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -65.7 -53.19 44.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -62.31 -30.79 71.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -65.38 -56.44 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.91 -32.73 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.63 -61.99 2.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.147 . . . . 0.0 109.293 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -61.02 -35.72 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.7 tp -73.91 -17.15 61.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.42 -16.5 16.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.0 m -100.41 -35.41 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.52 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -55.51 -57.83 18.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.729 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.77 -20.97 34.07 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HB3' HG22 ' A' ' 68' ' ' VAL . 3.9 mp -78.56 -53.7 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.48 -45.3 93.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -63.14 -42.16 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.16 -41.34 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -54.44 46.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.34 -52.38 65.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -57.38 -49.92 74.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -50.69 72.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 mt -50.77 -46.34 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.62 -28.2 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.01 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.04 -10.85 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.67 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -71.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.75 -75.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.21 141.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.25 98.45 5.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.02 77.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -48.02 -34.72 9.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mt -50.95 -53.23 34.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -65.13 -53.44 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -50.68 52.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -33.3 75.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.12 -51.39 61.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.75 -60.85 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.56 -45.17 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.25 -46.67 94.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 m -58.26 -57.1 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.22 -52.13 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.8 t -53.13 -47.4 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -44.98 90.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.0 -57.62 12.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -53.2 -51.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.98 -36.65 79.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -55.96 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.942 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.1 mtt -53.13 -37.8 62.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.87 -30.16 58.08 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -40.26 -52.98 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -27.47 8.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.5 15.65 47.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 pt -98.19 -36.4 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.13 137.91 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 172.12 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.69 98.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CE3' ' HA ' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -71.01 -60.58 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.511 0.672 . . . . 0.0 110.932 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.75 -1.63 8.79 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 147' ' ' ALA . . . -62.2 -50.49 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.64 -45.96 70.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -61.11 -59.09 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.54 -47.09 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.96 -49.55 77.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 50.3 t -57.11 -51.47 69.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.26 -49.18 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.07 92.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -62.17 -56.38 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.09 -50.11 77.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -55.16 -44.54 75.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -58.02 10.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.21 -33.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -61.02 -52.16 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.66 -31.57 63.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.4 mp -67.15 -52.27 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -57.6 -20.95 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.02 18.12 21.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.797 0.332 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.22 162.37 54.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.01 31.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.16 30.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.68 -41.39 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -65.7 -36.96 85.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.7 p -70.07 -49.45 50.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.83 96.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.7 -51.1 64.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -53.91 -51.81 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -61.66 -37.11 82.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -51.19 70.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -35.6 81.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -50.94 70.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -33.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.84 -50.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.27 -49.31 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.95 -58.58 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.26 -58.44 14.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -54.66 -30.98 56.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.02 -23.04 44.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.075 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 16.9 mt -80.01 -32.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.4 t80 -48.57 -54.01 30.57 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.76 -23.03 31.24 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.315 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.9 t -71.66 -36.5 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.98 -34.88 20.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.511 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -40.21 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.9 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -64.4 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.51 -27.86 7.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 144.82 57.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 33.9 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.937 -179.802 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.38 -23.8 58.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.8 mt -55.24 -63.34 1.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -58.67 -33.56 70.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.63 -55.94 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.04 -36.87 85.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -63.49 -53.63 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 19.8 mt -59.49 -48.09 88.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -57.09 12.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.52 -44.69 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -39.83 92.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.46 27.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -29.31 69.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.64 -58.5 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.44 -30.67 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -78.05 -25.33 47.7 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.679 3.133 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -76.9 -30.39 56.14 Favored 'General case' 0 N--CA 1.423 -1.79 0 O-C-N 117.114 -3.491 . . . . 0.0 112.778 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.95 -38.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.146 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.1 mt -55.78 -34.07 64.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -57.54 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.68 -34.97 79.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.47 -39.41 85.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.762 0.315 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.8 -50.03 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.16 -35.61 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -77.59 -47.25 19.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -56.81 -42.66 79.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.4 p -74.35 -39.97 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.72 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.27 -38.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -42.46 99.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.03 -49.22 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.2 t -58.43 -33.37 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 179.4 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -63.27 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -51.67 60.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -50.52 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.56 -48.26 81.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.9 m -50.77 -47.55 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.01 32.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.1 t -53.55 -56.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 0.0 111.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -45.8 90.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -51.92 -44.12 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -46.24 68.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -41.04 88.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.95 -49.3 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.8 m -60.2 -41.41 92.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.43 -52.17 55.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.071 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -55.17 29.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 tp -53.17 -46.48 68.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.98 -56.1 26.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.971 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.41 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.1 t -68.3 -29.29 68.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 m -72.34 -49.1 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.15 -41.47 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.45 -50.5 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.2 -26.74 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -72.43 -50.06 29.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.41 -34.57 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -80.14 -9.99 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -52.72 -29.0 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.99 -4.82 13.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.83 29.63 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.34 -171.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.05 164.11 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.92 -54.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -25.66 64.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -83.51 -17.2 42.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.41 -49.68 53.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.94 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.5 p -76.61 -43.91 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 t -53.03 -44.44 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -31.61 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.6 m -73.85 -54.77 7.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.3 m -62.33 -50.39 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.1 t -70.14 -40.46 74.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.8 -34.77 78.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.466 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.13 -49.63 55.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -62.74 -47.25 93.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.154 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.8 p -62.96 -36.67 84.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.65 -66.66 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.473 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -47.46 -36.84 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.03 -49.41 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -59.23 -49.48 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -62.07 -51.99 65.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -59.0 -43.41 91.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.82 -69.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -48.19 -35.96 12.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -65.87 -75.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.5 mtt -53.55 -57.35 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.48 -56.79 16.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.06 -51.21 41.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.52 -52.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -50.71 -55.44 16.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.73 -30.38 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.99 -21.23 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -112.46 -21.5 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 63.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -139.49 149.97 44.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 p -115.15 79.97 6.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 0.0 110.924 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 73.07 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -70.06 -36.21 74.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.98 -43.9 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -72.42 -32.57 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -78.26 -47.17 18.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.46 -37.09 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.82 -50.98 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.55 -36.17 73.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.289 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -75.39 -50.08 16.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.05 -11.06 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 tp -103.13 -34.02 9.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.4 m -85.36 -37.96 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 t -50.71 -53.31 48.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.625 0.726 . . . . 0.0 111.121 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.73 -25.1 29.09 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -75.84 -52.54 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -41.15 93.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.78 -34.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.8 t -69.53 -53.48 18.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -58.25 -45.66 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -59.45 -49.78 76.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -33.58 74.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -61.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.6 tp -56.51 -39.91 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.39 -42.32 96.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.89 -18.51 58.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.44 -20.2 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.103 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.45 -78.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.89 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -168.23 131.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.49 11.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.25 -5.5 66.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -29.64 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.854 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -61.75 -34.74 76.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -49.66 60.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -62.6 -50.36 71.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -61.53 -36.74 81.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -44.51 86.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -58.33 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -56.29 -38.77 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 -42.72 94.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.518 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.2 t -63.46 -45.05 92.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.62 -52.63 60.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.21 -47.24 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -58.0 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 m -68.75 -39.23 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -56.48 -43.82 80.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.06 -50.11 8.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -55.06 31.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -47.82 75.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.59 -33.13 62.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.16 -23.96 24.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.86 -27.27 9.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.66 49.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -37.3 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.7 137.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 173.73 -27.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.124 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.9 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.572 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.7 t-105 -65.66 -55.49 23.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.55 0.691 . . . . 0.0 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.75 -20.77 34.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.653 2.235 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.06 6.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -69.58 -42.92 73.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.9 -67.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.5 pt -51.65 -44.83 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.93 -48.89 77.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.1 m -61.21 -50.71 71.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.884 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -50.42 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.81 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -67.28 -57.5 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.7 -40.26 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -68.2 -45.33 73.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.968 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.1 tpt -53.88 -52.92 58.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -63.6 -53.1 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -49.81 -33.31 16.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -53.68 8.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.12 -11.13 60.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -16.38 57.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.03 14.6 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.502 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.336 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.6 163.62 22.15 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 0.0 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -27.14 26.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.59 -45.26 31.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.1 t -60.49 -47.72 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.29 -35.54 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -43.97 78.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.6 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.04 -46.82 73.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.973 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -49.3 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -64.92 -32.75 74.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -52.58 56.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.0 ptm -63.52 -35.52 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.02 -48.21 79.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.2 mm -65.23 -54.45 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.0 mm -50.71 -53.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.84 -51.67 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -53.67 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.01 -62.72 5.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -53.62 -30.61 43.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.8 -26.3 54.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.07 -30.89 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.3 t80 -45.5 -56.19 10.29 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.674 0.75 . . . . 0.0 110.917 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.3 Cg_endo -69.7 -23.16 31.39 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.657 2.238 . . . . 0.0 112.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.48 -45.2 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.95 -46.34 5.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.59 -48.57 71.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.918 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -49.95 -54.28 20.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.3 t -73.09 -14.21 61.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -92.41 -13.1 57.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.936 -179.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.01 65.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.88 -52.28 64.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -35.66 41.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.16 -44.63 59.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -55.47 -51.65 66.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.71 -48.87 67.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.8 mt -54.38 -44.49 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -65.82 -52.98 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -56.85 -39.24 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.07 -49.15 71.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.23 -55.09 37.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -63.26 -32.66 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -60.91 -55.67 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.09 -24.94 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -77.87 0.91 22.15 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 126.729 3.157 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -135.16 -63.75 0.67 Allowed 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 117.144 -3.473 . . . . 0.0 112.756 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.0 -63.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.173 -1.831 . . . . 0.0 111.142 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -34.23 33.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -56.51 -56.74 17.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.72 -42.6 97.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.3 tt -52.53 -49.77 64.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.3 mm -69.28 -36.18 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 20.1 mt -52.9 -57.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -74.02 -29.51 61.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -54.51 -55.99 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.41 -42.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.72 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.84 -44.71 85.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -57.67 -44.82 86.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.11 -27.66 54.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.7 t -50.85 -34.45 27.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.35 -177.21 3.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.18 -55.56 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.9 m -53.11 -42.87 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -53.79 47.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.04 -48.88 78.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 m -49.85 -48.96 50.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.47 -51.53 47.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.12 -56.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.8 t -57.05 -48.68 77.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -51.76 -42.18 62.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -39.74 78.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -65.24 -44.54 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.47 -33.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.0 m -69.72 -51.87 30.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.29 -48.36 80.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.27 70.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -55.69 -43.22 76.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.35 -57.9 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.82 62.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.5 p -68.83 -34.69 75.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.8 m -67.15 -52.74 37.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.09 -42.05 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.22 -52.73 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.79 -31.7 68.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -77.62 -51.48 10.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.01 -44.16 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -79.89 -4.58 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' ' CH2' ' A' ' 239' ' ' TRP . 1.2 tmt_? -55.29 -26.05 37.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.91 -3.31 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -106.02 42.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 m -112.47 -170.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -84.58 156.22 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.35 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -20.55 56.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -96.18 3.96 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.38 -51.85 50.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.6 p -78.47 -33.15 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB2' HD12 ' A' ' 112' ' ' ILE . 43.3 t -54.8 -42.94 72.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.8 -29.0 69.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.5 m -71.23 -53.62 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -70.64 -49.37 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -67.86 -37.97 82.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 -34.35 63.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.57 -50.06 48.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.61 -45.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -69.52 -34.3 74.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.67 -45.73 74.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.88 -48.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.59 91.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -62.77 -54.62 36.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.05 -50.52 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -57.32 -49.61 75.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 227' ' ' ASP . 0.0 OUTLIER -59.95 -45.85 91.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.9 ttp -53.57 -47.06 70.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -30.72 67.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.8 mmt -66.84 -58.15 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.69 -49.61 75.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.9 -32.26 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -62.23 -51.0 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.02 -25.59 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.4 -48.79 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 t -121.84 -39.34 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.14 18.6 3.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 127.01 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.823 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.53 160.9 37.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 0.0 110.866 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 97.82 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.736 2.291 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.5 t -69.51 -25.38 64.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.76 -37.05 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -70.14 -53.15 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.29 73.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -67.73 -55.92 11.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 pt -65.55 -30.91 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -48.07 71.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -61.32 -41.47 97.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.908 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.6 tp -76.81 -21.23 55.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.1 -11.41 30.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.965 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.2 p -109.55 -38.93 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.51 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -47.96 -58.47 7.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.23 36.42 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.24 -52.77 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.3 -51.81 58.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.0 tt -55.52 -39.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 41.4 t -67.53 -50.49 58.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.37 -57.98 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -52.52 -52.25 55.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.68 -30.85 71.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.42 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 61' ' ' SER . 0.0 OUTLIER -55.54 -35.65 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.116 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.48 -35.94 73.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.84 -21.65 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.2 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.74 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -64.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 176.47 -66.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.85 166.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.15 96.99 5.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 -11.51 84.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -25.34 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.98 -42.57 49.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.61 -43.32 59.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -59.47 -51.7 68.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -37.21 85.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.86 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.85 -58.2 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.84 -51.79 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.39 97.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.3 m -63.9 -40.36 96.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -55.69 12.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.08 -35.76 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -70.75 -43.13 69.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.9 -52.84 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.59 -50.95 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.07 -38.89 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.17 -52.52 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -51.87 -57.71 8.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.9 mtt -71.56 -31.37 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -63.17 -28.49 72.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.54 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 141' ' ' GLY . 10.4 tt0 -34.54 -55.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.49 -30.97 6.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 -4.03 20.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 pt -108.92 3.51 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.1 132.48 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.72 47.66 14.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.6 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.081 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.586 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.0 t-105 -57.98 -54.23 57.66 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.73 -17.34 37.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -63.9 -36.65 84.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 mt -62.27 -53.49 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.21 -48.91 13.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.08 -49.63 73.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.97 -49.4 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.88 -35.54 81.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -67.73 -57.31 6.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.73 -44.59 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.27 -47.07 85.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -58.34 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.82 -31.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -58.63 -49.39 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.31 -40.59 64.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.57 -13.91 61.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 -23.78 53.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.87 18.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.488 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.807 0.337 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.11 164.31 22.01 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -27.68 26.25 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.323 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.49 -40.9 48.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.57 -45.88 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.89 -35.37 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 m -69.86 -45.59 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -66.81 -52.13 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.52 -41.23 84.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 p -64.03 -44.92 91.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 3.6 tpt -59.35 -52.8 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 ttp -61.3 -35.91 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.69 -40.38 92.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.9 mt -66.5 -53.68 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.1 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.1 -46.44 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.27 -48.7 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.87 -58.96 5.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.68 18.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -53.27 -31.37 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.41 -29.15 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -76.53 -31.09 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.6 t80 -47.38 -57.36 9.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.648 0.737 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.81 -20.87 34.03 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 0.0 112.38 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.1 -44.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.7 -33.01 28.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -32.83 35.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 0.0 110.972 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.428 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 2.0 t80 -49.22 -30.9 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 13.1 t -51.54 -28.53 13.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -144.34 14.69 2.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.941 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.08 -40.29 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.46 -51.83 61.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -60.19 -40.03 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.49 -56.97 14.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -57.47 -36.18 71.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.75 -58.93 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.02 -48.87 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.173 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.01 -37.76 88.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.78 -39.25 80.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.61 -52.8 55.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . 0.403 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 43.3 t0 -63.61 -40.66 97.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -57.74 -52.68 64.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.1 m -72.12 -24.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.28 0.64 13.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 126.696 3.141 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -134.32 -45.29 0.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 O-C-N 117.093 -3.504 . . . . 0.0 112.756 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.65 -65.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.135 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.06 -37.15 32.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.07 -56.36 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 -35.15 86.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -49.09 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.3 mm -65.91 -45.89 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.32 -30.98 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 51' ' ' ARG . 4.8 m0 -74.75 -42.82 57.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -42.4 95.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.27 -40.14 77.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.74 -52.35 18.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.48 -46.77 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -65.25 -50.77 64.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.88 -31.4 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.9 t -58.5 -48.54 80.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.781 0.324 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.13 -177.12 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.47 -72.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.13 -32.64 36.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -62.15 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.23 80.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -52.81 -45.9 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.77 -51.47 19.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.0 t -52.7 -51.51 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.338 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.0 t -64.76 -49.31 71.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -53.25 -47.63 68.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -47.48 80.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -40.6 88.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.0 t -67.99 -39.37 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.7 m -65.0 -53.01 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.71 85.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.75 -55.68 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -33.45 69.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.92 -54.04 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.94 68.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.5 m -72.41 -52.31 16.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 t -66.21 -37.04 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.7 -50.6 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.84 -43.85 78.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -64.51 -31.64 72.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.22 -52.09 13.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.92 -39.64 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -79.8 -7.54 58.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -55.64 -26.66 45.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -104.56 -9.36 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -96.15 30.72 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.09 -170.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.32 159.86 30.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.02 -55.21 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -21.82 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -88.5 -4.33 58.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -51.15 -49.68 60.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -42.99 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -47.3 66.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.5 m -70.56 -53.54 15.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.03 -46.88 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -68.77 -39.28 80.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.77 -37.65 66.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.99 -48.08 66.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.9 t -64.74 -51.61 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.56 -48.79 64.68 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mt -64.71 -50.14 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.87 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.84 -56.15 24.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.72 -45.92 77.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -57.77 -44.89 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.34 -54.77 41.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.872 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -50.2 30.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -27.14 64.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.2 tpt -67.58 -58.67 4.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -36.79 81.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.82 -45.09 93.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.1 -36.2 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -65.51 -46.52 79.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -26.12 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -47.92 -48.03 32.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 p -115.37 -39.65 3.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -21.85 4.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.21 134.84 45.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.05 160.93 38.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.879 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.88 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.27 -26.14 62.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -49.44 -36.82 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -67.38 -51.77 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -62.57 -55.29 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -52.33 -49.15 64.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.97 -35.05 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.96 -64.48 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -51.83 -37.58 52.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tp -75.63 -27.41 58.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -87.67 -10.89 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.3 m -106.17 -25.55 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -56.05 -59.5 11.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.721 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.81 -39.68 6.13 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.319 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.95 -53.37 55.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.03 -48.72 79.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.82 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.65 -53.48 51.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -53.49 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -49.7 -51.06 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.89 -33.53 70.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.88 -66.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.81 -36.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.7 -33.37 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.04 -24.06 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.82 -23.01 16.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.3 -65.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.2 m -64.34 -74.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -170.76 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 m -153.12 131.26 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.85 99.91 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.98 -6.82 83.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.3 m -51.0 -25.64 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.39 -45.35 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -48.76 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.42 -50.49 73.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.0 -36.63 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.87 -46.87 79.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mt -65.4 -58.08 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -55.53 -51.16 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.73 -51.31 57.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.0 t -53.41 -47.48 69.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -52.23 66.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.08 -45.46 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 2.6 mtt -68.4 -34.98 77.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.81 -52.72 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -53.58 -41.5 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.07 25.63 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.6 -55.92 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 mmt -65.44 -50.78 64.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.897 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.26 -31.2 59.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.23 -27.88 10.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.51 -27.52 17.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.91 11.71 55.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.2 mt -89.33 -54.81 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.148 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.86 141.39 42.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 176.02 -25.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.64 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.092 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.486 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -68.92 -60.05 4.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.565 0.698 . . . . 0.0 110.916 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.73 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.345 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.7 -50.86 69.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -77.49 -30.14 52.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.9 mt -63.7 -62.86 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.78 -37.04 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.82 -43.61 91.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.0 t -63.55 -46.97 83.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.838 0.352 . . . . 0.0 110.834 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -49.84 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.26 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.076 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -55.96 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.77 -43.56 95.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.16 -43.19 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -52.4 61.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 53.7 mt -63.93 -49.6 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -48.74 -38.67 22.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.02 -48.66 28.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.27 -10.69 59.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.24 -15.68 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.47 17.4 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.464 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.822 0.344 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.2 163.56 31.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -25.96 28.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.02 -46.02 31.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.33 -47.82 91.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -36.61 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -68.21 -45.22 73.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.85 87.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -68.28 -49.45 60.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -37.31 78.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 p -72.03 -39.68 68.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -52.96 61.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -66.22 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -60.18 -50.25 74.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -33.81 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.69 -43.94 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 80.7 mt -69.71 -51.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.66 -55.72 17.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.58 -57.34 18.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 25.6 m0 -53.12 -31.95 44.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.21 52.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.03 -30.42 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.518 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -44.74 -58.0 6.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.733 0.777 . . . . 0.0 110.949 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.72 -20.58 34.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 93.1 t -71.52 -44.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.49 -34.59 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.62 -57.09 12.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -30.93 71.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.84 -26.82 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.54 -42.55 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.393 . . . . 0.0 110.936 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.67 81.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.082 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.17 -51.54 67.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -56.24 21.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -51.0 71.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -50.72 -58.48 5.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 90.4 mt -53.72 -43.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.1 -48.05 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -36.82 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -49.58 76.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.0 66.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.69 -30.46 70.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.71 -46.18 59.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . 0.403 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 34.2 m -71.73 -23.33 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -95.09 2.94 55.26 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-O 126.697 3.141 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -60.18 1.48 Allowed 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 117.131 -3.481 . . . . 0.0 112.74 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.47 -64.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.138 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.2 OUTLIER -48.59 -32.94 8.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.36 -55.54 33.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.08 -34.43 88.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -42.65 87.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.9 mm -66.72 -47.61 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.91 -40.82 88.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -70.5 -39.33 74.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -68.72 -47.08 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 9.2 p -67.05 -33.01 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -76.94 -51.44 11.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.88 -34.06 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -76.22 -54.57 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.78 -38.78 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 81.5 p -55.1 -35.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -179.04 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.13 -71.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -30.54 45.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.52 -70.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.83 -43.03 63.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.8 m -60.42 -40.95 92.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.16 -54.22 21.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.82 -40.8 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -64.58 -49.73 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -55.19 -44.71 75.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -46.91 82.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -39.78 91.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.44 -48.75 83.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -57.71 -50.06 74.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.05 71.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.99 -52.07 67.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -52.3 -47.3 66.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -49.9 75.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.12 75.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.4 t -69.35 -37.49 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -46.01 71.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.5 m -66.69 -41.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -69.08 -51.54 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -61.86 -33.41 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.45 -47.61 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.44 -29.77 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -73.93 -10.77 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -56.11 -26.81 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -12.73 17.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -106.24 42.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.7 160.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.7 t -49.98 148.67 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 -48.73 65.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -58.88 -23.03 60.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -88.02 7.36 31.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -49.64 -50.08 44.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -36.36 58.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -52.6 -42.38 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.29 -28.98 67.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.7 m -72.45 -52.21 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.19 -50.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -69.16 -36.7 77.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.95 -41.43 93.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -70.84 -47.43 59.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.8 -55.36 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 m -68.37 -26.82 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.173 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.88 -51.45 24.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.6 pt -64.2 -39.64 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.95 72.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -61.0 -57.93 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -47.56 85.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -55.14 -47.51 74.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -48.94 79.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -51.34 48.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -58.71 -53.38 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.2 mmt -54.71 -47.52 73.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -53.1 -56.07 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.5 -33.78 73.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.56 -47.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -61.71 -45.07 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.6 tp -73.63 -25.19 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -48.25 33.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.4 p -136.61 -39.81 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.57 -15.37 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 127.02 53.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.46 160.79 52.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.75 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 90.09 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -69.42 -32.55 71.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 m -50.93 -45.87 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -46.78 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -47.12 77.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -65.41 -39.89 92.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.81 -57.52 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -33.18 69.87 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t-105 -60.09 -58.75 7.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.06 -13.11 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 tt -91.6 -16.6 26.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -110.76 -31.5 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.491 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -51.16 -59.51 7.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.613 0.721 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.6 Cg_endo -69.79 -35.5 12.44 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.91 -38.95 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -48.69 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mm -64.9 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.1 t -64.31 -55.33 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.83 -58.47 6.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -50.02 -54.56 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -61.16 -31.07 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.25 -67.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 46.3 mm -50.86 -40.72 20.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -35.36 76.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.91 59.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.79 -23.28 11.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.78 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -122.09 -6.57 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.33 51.93 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 p 179.8 112.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -119.76 97.71 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.32 -5.73 87.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.18 -23.44 8.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.89 -42.86 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -73.14 -37.41 66.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -53.25 41.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -34.15 77.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -47.09 74.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.41 -59.81 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.92 -33.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.1 -47.75 57.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.3 m -65.35 -38.6 90.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.383 . . . . 0.0 110.844 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -52.15 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.88 -51.81 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.7 ptm -62.98 -33.67 75.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.98 -56.2 21.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.886 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.62 -53.16 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.22 -37.12 71.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.5 -52.27 40.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -48.71 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.5 ttp -62.74 -34.38 77.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.81 -30.98 55.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.55 -48.0 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.77 -26.68 8.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 52.81 26.38 25.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.88 -37.38 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 111.129 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.408 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -131.06 -170.73 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 77.14 -4.97 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.93 -43.14 62.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.553 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.2 t-105 -64.52 -55.62 28.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.73 -19.01 36.84 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.36 57.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -58.54 -39.42 80.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.37 -64.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.3 pt -51.69 -41.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.87 -50.03 32.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -56.82 -55.95 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 110.911 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 mt -54.72 -48.13 72.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.9 91.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.098 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -67.02 -56.87 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -52.96 -45.79 52.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.159 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -62.97 -45.08 94.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -58.47 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.4 mp -66.99 -32.04 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -55.82 -54.54 43.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -42.57 63.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.49 -15.49 62.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -22.58 43.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.37 19.09 19.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.795 0.331 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 164.1 17.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -22.87 31.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.313 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.54 -42.45 42.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.64 78.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.7 t -70.36 -46.87 63.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -66.92 -52.07 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.27 -54.88 40.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 63.9 p -58.83 -40.76 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -52.87 62.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.82 -32.68 74.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.33 -49.27 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -35.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.131 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.76 -48.18 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.12 -50.74 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -51.51 -55.26 19.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.57 10.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -53.35 -31.34 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.44 -27.28 46.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -75.0 -32.05 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.525 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.4 t80 -47.89 -57.72 9.49 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.8 -26.49 27.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.364 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.85 -37.62 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.49 -40.78 12.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.48 -33.13 43.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -27.28 10.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 14.1 t -49.8 -27.96 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 -179.809 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.36 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.075 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tp -53.0 -61.85 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.93 -37.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.01 -42.4 94.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.58 -46.76 81.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.27 -57.79 11.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 35.3 mm -53.11 -48.01 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.24 -36.38 83.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -70.28 -42.45 72.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -51.46 68.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.97 -52.24 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -58.71 -37.6 76.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.34 -58.22 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.5 m -61.08 -25.62 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.68 1.23 20.52 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 126.69 3.138 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -130.0 -60.28 1.03 Allowed 'General case' 0 N--CA 1.423 -1.793 0 O-C-N 117.116 -3.49 . . . . 0.0 112.754 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.8 mp -60.97 -63.71 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.104 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.74 -40.54 69.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -52.78 -58.77 5.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.02 91.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.75 -48.96 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.7 -49.64 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 45.9 mm -57.7 -52.43 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -57.91 -43.47 86.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -55.46 -42.9 74.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.86 -49.54 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -56.62 -51.34 69.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.96 -31.69 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -60.74 -53.62 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -35.72 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -43.43 65.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.345 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.75 178.35 8.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -70.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -54.95 -42.17 72.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.91 -57.0 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -47.9 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -51.13 -47.42 62.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.51 36.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.98 -56.22 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.147 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t -58.6 -48.82 79.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -51.95 -39.7 59.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.48 -41.05 69.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.22 -44.31 92.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -36.09 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.9 m -69.67 -53.4 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.86 -46.54 89.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.8 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.97 -47.54 77.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.18 -54.41 47.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.79 71.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 m -72.13 -41.51 67.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -41.19 94.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.01 -37.89 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.02 -53.26 52.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.98 -47.95 75.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.21 -48.25 68.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.14 -29.76 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -79.9 -7.12 58.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -27.09 29.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -113.49 -4.04 13.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -94.73 8.99 40.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 m -104.27 -171.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -77.87 158.36 29.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.76 -55.19 28.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.49 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -87.77 -14.03 40.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -51.36 -49.73 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -36.1 69.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 p -56.92 -45.31 82.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.836 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.42 -27.14 66.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -71.0 -53.49 14.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 m -72.02 -47.27 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 p -68.77 -38.68 80.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.3 -33.82 58.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.89 -46.65 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.98 -44.07 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -70.54 -34.04 71.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.83 37.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -36.83 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.43 62.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.99 -48.81 78.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -64.36 -51.87 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -57.05 -52.68 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.64 -65.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -51.43 -32.88 28.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -61.07 -67.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.5 mmt -67.86 -59.58 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -50.91 -40.21 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.17 -57.62 4.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -53.77 -35.6 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.101 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -76.33 -58.5 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tp -56.83 -24.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -54.59 -27.16 37.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 t -107.95 -21.6 12.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.77 -109.56 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -123.53 142.5 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.25 161.99 38.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.69 0.757 . . . . 0.0 110.859 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 136.54 33.36 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 0.0 112.358 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -69.9 -29.96 67.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.7 m -58.78 -45.75 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -69.93 -53.36 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -56.02 -47.96 76.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -57.26 -55.3 36.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.5 mt -62.35 -29.88 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -61.37 -61.61 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 109.24 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.46 -31.27 71.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -22.72 61.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.929 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.2 tt -101.26 -18.82 15.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.8 m -94.79 -33.04 13.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -57.78 -56.76 31.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.602 0.715 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.81 -26.23 27.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.54 -54.0 7.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 pp -65.04 -39.47 93.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.94 -43.9 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.0 t -61.76 -52.75 62.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.67 54.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.82 -45.84 64.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -44.91 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -50.29 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 40.8 mm -59.93 -59.44 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.73 -22.09 44.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.22 -44.47 46.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.29 -17.97 33.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.07 62.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 -67.63 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -161.43 -75.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -151.77 135.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -103.69 100.05 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.52 -8.51 59.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -52.17 -25.44 9.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -63.52 -34.64 78.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -47.02 81.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -69.0 -44.76 72.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -64.41 -37.3 87.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.65 -47.66 62.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.49 -58.8 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.0 -51.57 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.36 -43.1 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.7 t -66.88 -36.6 82.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mt -64.08 -54.3 36.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -60.12 -39.68 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -45.87 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.7 -49.63 83.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -66.69 -33.17 75.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.17 -52.07 15.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -65.22 -52.18 56.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 mmt -66.0 -44.6 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.66 -32.56 84.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -46.82 -52.69 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.89 16.33 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.44 50.16 42.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.511 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.46 -18.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.96 132.1 54.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.87 -162.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.99 -25.64 48.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.598 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.3 m95 -66.42 -53.64 29.21 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.79 -12.35 32.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.35 -47.09 29.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.32 -34.38 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.95 -57.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.61 -47.74 85.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.21 -42.75 93.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.482 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.56 -50.93 63.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -55.87 -48.62 75.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.88 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -55.72 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.16 -48.92 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.11 -41.65 97.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -55.89 -59.28 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.18 -31.67 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.39 -52.57 64.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -73.72 -34.58 64.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.23 -18.94 62.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.66 -35.22 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.21 18.85 14.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.796 0.331 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.22 163.21 24.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -18.37 36.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.58 -47.76 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.3 t -62.27 -47.06 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -34.33 73.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -70.26 -45.18 66.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.6 95.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -48.85 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.67 -56.19 24.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -59.08 -40.46 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -58.74 -52.36 66.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.1 ttp -61.02 -36.66 80.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -48.32 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.15 -44.99 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.102 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.28 -46.88 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.41 -49.7 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.17 -57.14 10.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -59.37 -58.83 12.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -52.7 -31.48 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.26 -30.05 54.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.3 mt -74.31 -31.03 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.515 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -45.87 -58.53 6.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.4 Cg_endo -69.74 -21.38 33.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.312 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.83 -44.67 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.81 -30.78 28.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -53.16 -57.96 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -31.05 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -27.21 11.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.155 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.99 -7.04 5.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.7 t80 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 -179.852 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.36 67.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -62.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -51.96 -36.42 49.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.76 -52.09 65.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.84 -42.01 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -55.46 27.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 84.4 mt -60.46 -48.76 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.15 -57.89 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -40.54 74.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -50.4 71.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.22 -54.83 38.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.55 -35.95 82.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -61.79 -53.08 60.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.9 -24.83 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -24.55 63.91 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 126.68 3.133 . . . . 0.0 110.83 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -112.91 -10.16 13.56 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 117.117 -3.489 . . . . 0.0 112.789 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.3 mm -91.97 -61.57 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.147 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.52 -35.49 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -54.72 -57.59 10.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.56 -42.76 87.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 12.4 tp -51.76 -50.98 59.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.914 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.54 -37.01 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 4.0 mm -52.22 -57.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -74.09 -29.39 61.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -53.74 -56.77 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.61 -43.62 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -55.87 -51.45 67.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.133 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.28 -41.93 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -54.06 -51.17 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -29.58 54.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.4 t -51.13 -30.84 17.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.24 164.01 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.69 -65.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -52.46 -44.53 65.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -56.22 -61.58 2.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -51.94 -42.81 63.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.1 m -60.65 -41.29 94.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.58 -54.19 24.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.16 -40.24 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -64.8 -49.59 70.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -56.16 -44.26 79.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.56 -47.8 80.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.23 -40.82 91.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 -49.12 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 m -57.75 -47.08 83.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.33 78.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.13 -47.85 80.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.094 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -60.78 -39.09 87.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.96 -56.83 15.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.52 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -69.7 -33.1 72.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.0 m -72.67 -45.68 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.37 -43.18 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.23 -49.11 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -63.71 -32.03 73.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -75.35 -52.3 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.77 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.06 -0.62 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -26.51 60.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.79 -19.3 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 22.52 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 243' ' ' VAL . 0.5 OUTLIER -94.75 174.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.63 150.44 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.86 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -79.17 -26.56 42.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -87.13 -6.23 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -51.58 -50.46 60.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.7 p -77.83 -35.68 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -59.43 -42.48 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.1 -30.21 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -55.65 5.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -57.79 -51.8 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.89 57.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.63 92.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.86 -47.18 60.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -58.53 -56.43 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -63.55 -39.31 94.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.65 -68.95 1.46 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -33.97 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.43 59.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -58.81 -48.77 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -50.57 71.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -55.8 -60.88 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -54.2 -58.77 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.9 -33.35 36.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -65.58 -69.15 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.71 -57.37 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -55.31 -52.22 64.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.435 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -59.57 -47.6 90.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.458 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 t -61.37 -46.65 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.106 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -56.48 11.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 tp -58.81 -26.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -21.65 47.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 p -114.2 -30.62 6.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.46 -110.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -98.56 -176.08 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.769 0.319 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -115.78 155.68 47.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.679 0.752 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 121.51 8.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -69.69 -35.87 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.99 -44.71 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.149 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -71.39 -44.27 65.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -64.45 -48.16 76.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -59.86 -52.78 63.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.96 -30.01 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.66 -57.44 11.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 109.297 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -69.82 -30.67 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.12 -19.39 59.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -101.01 -31.73 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.8 p -79.83 -39.62 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -50.83 -56.61 18.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.79 -38.48 7.67 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.315 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.5 -51.99 67.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.11 -41.99 85.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.93 -48.62 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.099 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.22 -57.53 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -52.07 -40.54 61.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -66.37 -50.18 64.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -35.38 65.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.58 -61.19 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.9 pt -55.68 -36.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.78 -50.8 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.61 67.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.05 -11.11 60.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.119 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.1 -29.67 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 -67.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -174.84 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 m -151.54 142.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.37 108.14 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.81 -5.49 69.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -50.22 -27.98 6.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.903 0.382 . . . . 0.0 110.811 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 -41.0 96.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.83 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -48.31 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -60.28 -34.99 74.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 tp -68.33 -48.8 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.92 -56.73 18.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.96 -43.1 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.04 -41.27 94.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.446 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -35.16 71.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -53.84 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.5 m -58.16 -43.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -28.99 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -50.33 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.7 m -70.3 -41.22 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -61.92 -38.92 90.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 -50.5 9.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -63.24 -50.53 69.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 mmt -65.49 -52.68 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.77 -32.61 74.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.72 -30.21 13.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.53 -27.28 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.76 9.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.92 8.82 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -169.29 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.32 107.59 18.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.55 59.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.3 t-105 -52.85 -57.8 14.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.59 0.71 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.76 -19.24 36.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.329 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.22 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.26 -40.88 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.67 -41.59 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.8 mt -59.12 -57.17 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.55 94.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 39.0 t -63.39 -57.36 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.2 mt -53.52 -50.5 65.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.35 77.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -55.25 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.3 t -55.66 -51.61 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -35.59 75.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.6 mmt -61.62 -59.86 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.39 -36.4 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.34 -36.37 82.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.05 -38.82 61.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.11 -11.14 57.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.33 -25.41 48.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.38 18.35 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.79 0.329 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.2 164.02 15.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 0.0 110.857 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.58 33.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.56 -44.48 34.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.067 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.52 -48.05 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -58.13 -36.99 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.2 m -68.2 -45.21 74.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.855 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.43 91.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.68 -51.8 52.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -45.2 75.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.9 p -66.22 -38.24 87.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -50.5 73.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.03 -34.48 76.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -59.54 -49.54 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 22.0 pt -70.53 -36.72 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 mm -63.0 -48.77 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.06 -51.91 49.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.1 -56.08 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.93 -58.48 14.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -54.21 -31.88 54.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.18 -24.64 43.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -78.93 -31.96 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.9 t80 -48.16 -55.42 18.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.71 -24.92 29.38 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.26 -43.18 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -84.07 -27.74 36.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -46.07 65.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.899 0.38 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -31.39 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -23.0 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -118.86 -26.35 2.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.1 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 -179.845 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -39.02 57.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.39 -62.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -53.35 -42.51 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -53.64 54.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -58.18 -42.31 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.37 -58.82 6.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.26 -47.92 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -58.07 -39.64 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -70.5 -46.24 64.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -51.27 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.59 -50.85 70.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.3 -28.08 69.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.66 -48.96 19.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.34 -23.15 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -90.9 3.11 55.44 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-O 126.72 3.152 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -129.96 -64.88 0.85 Allowed 'General case' 0 N--CA 1.424 -1.769 0 O-C-N 117.128 -3.483 . . . . 0.0 112.782 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 42.8 mm -55.86 -62.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.136 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -32.65 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.68 -55.77 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.81 -36.13 58.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -51.54 69.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.329 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.1 mm -68.85 -49.6 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 21.5 mm -56.87 -32.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -76.01 -47.52 24.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -57.19 -40.84 78.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 9.4 p -74.21 -40.47 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.7 86.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.401 HG22 HG21 ' A' ' 54' ' ' VAL . 43.7 t -78.54 -48.19 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -60.11 -37.56 80.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -76.95 -45.99 25.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 20.7 t -55.64 -72.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.841 0.353 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.55 175.53 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.2 -75.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -34.38 64.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -64.11 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -48.11 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -51.58 -43.78 62.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.166 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.64 -50.47 30.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.8 t -52.04 -51.14 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 111.176 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -49.88 69.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -53.28 -47.04 69.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -48.02 75.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.59 -41.86 86.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.75 -43.94 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 m -60.67 -53.28 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.79 74.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.84 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tp -53.03 -45.16 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.7 tp -64.1 -54.12 38.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.84 73.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -70.38 -34.54 72.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.6 m -72.76 -49.29 31.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.88 -39.53 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -69.46 -52.12 29.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.59 -31.79 72.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -74.62 -52.16 12.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.92 -38.81 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.72 -6.33 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -55.11 -26.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -99.99 -12.84 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 40.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -116.48 160.42 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -47.79 152.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 -54.52 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -20.51 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.88 7.84 25.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -50.27 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -37.47 55.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 p -53.48 -37.08 62.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.03 -34.62 78.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -71.08 -47.69 56.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 t -70.21 -58.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -63.69 -41.42 98.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.58 91.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.25 -52.07 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -65.46 -26.45 67.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.3 -55.03 17.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.537 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.58 -42.47 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.52 96.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.87 -52.49 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -44.19 72.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.0 -54.75 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -41.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.5 ttp -59.85 -46.01 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -70.07 -30.79 68.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -63.87 -59.81 4.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -41.86 97.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.86 -49.03 73.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.1 -43.69 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -52.78 -51.47 60.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.08 -26.37 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -49.01 -48.0 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.0 p -146.33 -40.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.52 57.09 0.13 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.34 127.03 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 p -113.26 75.1 2.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.739 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 93.17 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -51.22 -35.14 35.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.88 -43.8 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -68.09 -48.05 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -51.58 63.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -56.72 -55.55 32.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.96 -34.81 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.76 -68.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -57.48 -35.63 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.18 -18.27 62.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.2 tt -100.29 -23.08 14.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 p -91.72 -32.44 15.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.571 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.9 t -57.73 -55.52 44.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.662 0.744 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.77 -38.37 7.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 0.0 112.36 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.51 -52.91 61.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.93 -40.98 99.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.05 -38.46 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.1 t -63.15 -62.53 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -49.09 67.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.32 -50.36 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -39.64 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -51.47 69.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.51 -52.75 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -21.97 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.36 -40.35 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.02 14.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.1 -54.69 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -53.8 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -164.96 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.3 m -143.51 150.25 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.3 122.69 36.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.71 -2.61 70.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.9 p -47.53 -31.28 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.96 -52.02 61.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -59.74 -48.64 80.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -61.1 -33.51 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.41 -48.16 68.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.22 -53.13 60.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.77 -48.01 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -39.31 97.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.528 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -65.82 -39.1 90.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.49 -53.38 35.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.71 -36.08 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -70.51 -39.83 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.8 t -64.69 -47.0 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -57.35 -42.3 81.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.36 21.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -56.12 -51.08 69.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.923 0.392 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -31.6 69.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.15 78.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -48.36 -33.08 8.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.94 -27.33 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.11 18.3 40.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.431 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 pt -93.69 -34.74 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.93 119.28 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 151' ' ' ALA . . . 172.73 -55.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -42.12 -34.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.53 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -85.33 -64.82 0.22 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.568 0.699 . . . . 0.0 110.892 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.72 -54.74 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . -43.22 -38.49 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.41 -51.42 69.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.36 -40.1 77.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 77.8 mt -60.72 -50.96 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.3 94.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 47.3 t -55.81 -51.17 68.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 110.904 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.05 -49.75 76.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.14 71.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.75 -54.93 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.0 t -53.05 -43.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.92 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -47.82 73.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.17 -40.39 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.81 -50.62 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.99 -43.92 56.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.34 -40.45 78.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -57.73 -20.57 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.87 18.34 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 -179.919 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.769 0.318 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.81 162.07 54.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 0.0 110.871 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.85 10.06 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.68 -42.47 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.5 t -67.13 -41.72 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -66.11 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.2 t -72.53 -48.65 38.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.61 96.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.53 -52.24 54.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -54.68 -50.32 68.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 75.5 p -60.66 -39.92 90.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -52.02 67.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -35.76 81.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -49.1 78.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.11 -48.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -50.97 -48.16 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.32 -44.85 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.163 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -59.32 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.25 -55.74 24.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.5 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -51.18 -33.8 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.763 0.316 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.42 -30.36 42.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.8 mt -67.74 -32.11 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -51.88 -60.55 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.74 . . . . 0.0 110.939 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.74 -24.51 29.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.671 2.247 . . . . 0.0 112.344 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.8 t -75.23 -33.77 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.03 -36.62 17.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -32.74 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -67.14 -30.67 70.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 p -47.79 -31.68 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.77 56.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.3 t80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.775 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.857 0.361 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.81 -27.23 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.0 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -52.29 -34.79 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mp -62.18 -56.03 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -58.23 -39.16 78.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.38 -51.46 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 27.1 mt -59.65 -45.25 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -56.63 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -38.53 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.14 -51.31 68.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.26 36.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.66 -45.54 93.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -51.34 -54.86 22.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.6 -24.7 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -82.56 1.42 38.1 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.745 3.164 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -130.28 -63.1 0.91 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.083 -3.51 . . . . 0.0 112.751 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.8 mp -56.48 -63.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.109 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -33.69 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.74 -53.82 52.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.86 -36.71 87.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.93 -40.19 83.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.41 -49.73 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 11.8 tt -63.44 -33.88 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -75.52 -42.88 51.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.96 -40.79 98.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.74 -37.89 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.64 -41.36 68.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 86.4 t -73.39 -35.92 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -74.69 -35.7 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -76.75 -35.33 57.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 85.3 p -51.21 -49.16 61.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.871 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -178.25 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -61.69 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.32 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.33 -74.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -47.23 84.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.1 m -52.37 -45.04 65.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.186 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.65 -51.91 33.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 t -53.84 -55.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 111.132 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.1 p -58.52 -49.96 75.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.92 -39.33 58.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -70.14 -43.4 71.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -44.88 94.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.57 -34.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.087 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.3 m -68.18 -54.3 18.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.71 88.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.94 -55.14 18.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -32.76 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.51 -57.75 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 t -70.2 -37.9 75.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.2 m -67.73 -46.39 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.85 -41.55 92.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.26 -51.09 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -62.87 -28.67 70.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -74.34 -49.18 23.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.09 -30.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.209 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.54 -6.03 56.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -59.88 -26.75 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -96.61 -9.8 28.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -108.38 42.34 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.74 159.25 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.4 t -50.12 139.58 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.69 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -23.88 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -90.05 11.29 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -49.94 -50.06 47.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.76 -38.92 53.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -43.57 67.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.83 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -68.69 -53.72 20.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -70.98 -45.79 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 t -66.7 -39.42 88.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.79 -34.71 59.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.73 -48.26 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.54 -44.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.7 m -69.0 -34.52 75.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.46 51.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.68 -46.79 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.75 91.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -58.02 -56.34 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -49.98 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -56.73 -44.99 82.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -59.26 5.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.3 ttm -47.17 -41.76 18.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.99 -40.41 78.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.01 -58.03 6.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.486 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -57.03 -42.82 81.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -63.37 -42.46 99.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.56 -30.01 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -71.99 -41.83 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 tt -76.62 -30.8 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -80.95 -49.79 10.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 m -79.17 -38.45 35.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -23.11 35.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -148.14 126.79 12.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.833 0.349 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 161.16 36.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.897 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 99.14 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.704 2.27 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.2 p -64.28 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 m -50.38 -35.13 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.23 -49.99 57.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -57.74 -45.74 85.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.79 -55.1 33.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.5 mt -61.28 -26.37 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.17 -67.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.107 . . . . 0.0 109.301 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -51.86 -33.2 35.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 tp -74.6 -38.55 62.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.22 -5.28 59.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.946 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 m -107.56 -39.43 5.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -44.61 -58.91 4.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.6 0.714 . . . . 0.0 111.159 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.74 -19.53 36.08 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.67 -51.69 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.05 -35.88 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.1 -50.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.72 -47.63 80.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -56.62 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -51.47 -51.09 57.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -65.53 -35.09 79.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.0 -66.95 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.931 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.22 -45.25 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.05 -44.69 83.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.67 -15.85 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.72 -23.37 11.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -22.73 62.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.6 t -128.17 -47.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -179.45 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.06 161.86 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.24 125.53 42.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.89 -11.02 84.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -50.56 -31.91 17.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.19 -38.64 83.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -45.31 93.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -62.15 -50.51 71.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -35.39 80.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -63.06 -48.51 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -57.59 8.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.92 -46.86 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.53 99.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.1 t -62.88 -39.62 95.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -47.02 61.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.8 t -56.73 -51.44 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -32.22 72.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -48.93 79.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.1 t -71.48 -40.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.32 -43.18 98.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.24 34.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.17 -56.0 13.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.21 -32.84 74.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.78 -29.65 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.448 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -55.31 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.34 -27.4 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.07 39.59 5.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tt -47.37 -33.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptm -108.58 -170.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.35 -174.4 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.93 -20.34 56.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.542 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -61.41 -56.75 30.66 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.535 0.683 . . . . 0.0 110.89 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.1 Cg_endo -69.73 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.16 32.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.61 -35.77 82.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.3 mt -58.23 -51.7 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.22 -45.78 95.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.0 99.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.499 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 12.5 m -63.9 -50.59 68.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -49.64 76.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.19 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -62.53 -55.98 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.25 -47.94 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.34 -40.14 89.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 10.7 ttm -60.95 -56.37 21.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.8 -32.33 51.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -50.89 68.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -73.87 -25.34 59.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.43 -43.33 40.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -57.54 -23.59 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.12 17.19 23.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.489 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.828 0.347 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.26 162.99 20.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.866 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.16 22.84 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.344 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -46.77 28.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.84 -43.61 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -35.1 79.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.5 t -69.8 -47.28 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.59 97.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.047 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -65.88 -50.83 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -56.02 -55.49 32.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.5 m -58.88 -37.75 77.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.9 tpt -60.0 -48.74 80.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.26 77.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -50.71 70.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -35.2 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.93 -48.34 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 65.5 mt -64.85 -47.76 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.81 -59.16 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.41 -56.99 22.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -53.71 -32.11 50.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.94 -26.31 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.106 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 18.4 mt -76.8 -28.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -42.7 -57.13 5.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.669 0.747 . . . . 0.0 110.954 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.6 Cg_endo -69.79 -82.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 20.5 m -33.7 -42.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -65.24 -57.79 10.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.01 -19.91 21.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.92 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -47.05 -26.98 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 t -49.53 -28.28 5.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.78 -27.63 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.09 -51.97 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -61.39 -40.94 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.52 -42.84 93.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.63 -47.17 73.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.06 -58.75 5.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.14 -40.77 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.139 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -62.61 -42.39 99.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -63.89 -46.2 85.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.03 17.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.11 -27.21 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.52 -54.92 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.2 -23.55 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -69.75 -33.62 72.68 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 126.739 3.161 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -103.58 -8.72 19.8 Favored 'General case' 0 N--CA 1.424 -1.773 0 O-C-N 117.11 -3.494 . . . . 0.0 112.747 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.3 -63.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.137 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.5 tp -53.82 -31.09 47.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.54 -56.25 23.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.93 83.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 -39.39 85.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.0 mm -70.25 -50.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.44 -35.79 71.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -76.84 -45.74 27.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.21 -42.11 85.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.4 p -74.67 -38.23 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.9 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.27 -40.79 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.9 -39.11 93.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.88 -48.65 17.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.2 t -59.78 -68.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.96 178.39 8.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.77 -75.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -33.67 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -56.51 21.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -47.71 83.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.5 p -51.04 -47.05 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.113 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.79 -50.87 32.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.0 t -52.78 -55.67 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -60.83 -48.13 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -53.83 -41.56 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -47.24 68.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.08 -43.64 98.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.6 t -66.62 -41.41 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -62.63 -43.12 99.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.69 49.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.42 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 tt -53.14 -50.13 65.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.09 -55.73 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.75 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -72.02 -44.51 63.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -59.69 -47.28 86.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.11 -42.83 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.08 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.95 -52.17 65.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.22 -47.76 82.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -74.95 -38.7 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 87.9 mt-10 -81.16 2.67 26.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.71 66.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -97.2 -3.05 41.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -110.31 23.73 13.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.44 -170.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 153.7 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.59 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -21.68 55.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -88.93 10.43 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -51.01 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 p -77.88 -26.0 48.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -54.76 -43.27 72.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.7 -27.66 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -64.49 -53.68 44.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.53 -51.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 t -60.86 -35.48 76.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -42.27 63.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.66 -50.18 72.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -43.48 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.146 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.6 m -67.33 -36.66 81.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.82 -46.93 88.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.11 -48.42 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.98 84.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -53.31 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.86 -41.99 68.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -66.98 -59.66 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -42.02 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.06 -46.54 87.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -61.87 -60.11 4.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -32.96 63.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.31 -33.57 87.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.83 -38.47 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -71.6 -45.24 62.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 tp -72.2 -26.01 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.59 -47.79 49.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -143.28 -39.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.69 36.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -153.6 127.37 8.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.24 160.07 50.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.699 0.761 . . . . 0.0 110.822 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 101.44 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 m -69.3 -31.58 70.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.39 -51.19 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -51.72 57.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -48.63 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.69 -55.42 34.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.9 mt -55.49 -36.59 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -52.79 61.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -59.8 -43.19 94.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.97 -20.92 61.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.38 -17.43 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.8 p -96.77 -25.47 15.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.6 t -57.15 -56.87 29.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.618 0.723 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.78 -27.61 26.17 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.91 -47.25 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -51.05 62.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.2 mm -58.49 -56.05 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.33 -34.56 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.18 -65.56 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.92 -52.29 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -56.91 -44.93 82.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.43 -59.49 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.5 mm -51.93 -42.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -27.99 67.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.59 -25.97 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.57 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.96 -20.07 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.53 -73.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 170.1 -76.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.3 146.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.99 96.1 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.16 -3.48 89.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -48.8 -36.39 16.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -48.83 28.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -70.14 -50.02 44.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.68 -52.95 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.74 -47.55 74.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.71 -59.97 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.6 m -58.37 -33.65 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.41 -46.99 65.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.542 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -65.65 -49.36 68.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.835 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.69 -52.83 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.78 -41.88 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -64.42 -44.89 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.45 -57.78 11.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.3 t -53.14 -52.06 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.89 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.95 8.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -56.46 19.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -30.84 68.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -64.01 -30.29 77.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLY . 2.8 tt0 -35.7 -59.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 110.894 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.13 -30.47 4.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.89 -13.3 44.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.08 5.69 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.24 144.68 32.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 61.94 32.29 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.97 96.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -69.88 -58.52 5.31 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 110.925 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.5 Cg_endo -69.68 -5.12 15.39 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.329 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.02 -49.97 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.22 -45.76 79.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mp -61.57 -43.37 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.2 mt -65.61 -55.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.71 98.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.94 -52.53 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.61 -49.78 67.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.21 77.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -67.08 -54.69 19.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.95 -49.47 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -61.13 -43.06 99.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.44 -58.61 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -65.47 -31.9 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -58.93 -47.58 84.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -41.99 63.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.32 -16.73 63.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -56.53 -25.84 53.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.71 19.01 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.512 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.798 0.333 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.12 163.08 24.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -20.08 35.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.357 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.51 -52.77 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.74 -48.82 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -58.28 -37.53 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -65.38 -47.15 77.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.12 88.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.22 -51.66 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -49.22 73.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -63.85 -32.38 73.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -35.34 75.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 5.1 ttp -74.96 -36.08 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -40.89 69.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.1 tp -71.09 -44.02 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.92 -37.92 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.5 mt -69.1 -49.5 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -51.69 68.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.67 9.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.73 -34.6 59.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.34 -24.56 46.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.26 -32.28 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.544 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 2.8 t80 -48.44 -57.22 11.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.669 0.747 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.8 -25.35 28.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.651 2.234 . . . . 0.0 112.313 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.6 -40.57 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.95 -43.4 8.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.94 -31.2 60.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -49.99 -32.69 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.4 t -51.33 -27.88 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -0.26 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.899 0.381 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.79 86.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.95 -63.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -56.38 -42.03 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.56 -49.28 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.42 -42.27 98.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.18 -58.0 10.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 37.3 mm -53.9 -46.98 64.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -60.46 -48.14 83.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.19 -38.99 93.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.69 -51.38 69.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.06 -55.21 36.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.16 -40.7 77.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.98 -40.99 99.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.2 t -71.98 -26.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -97.85 1.74 48.54 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 126.749 3.166 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -116.48 -63.92 1.38 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.049 -3.532 . . . . 0.0 112.776 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.81 -64.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.143 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -39.66 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.912 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.35 -58.83 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.24 93.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.28 -44.46 92.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.958 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -47.89 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 32.0 mm -54.85 -50.93 57.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.15 -29.64 64.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.62 -54.23 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.14 -40.36 36.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.44 56.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.89 -47.51 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -58.69 -43.69 90.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.03 -41.3 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.5 p -50.83 -35.14 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.332 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.02 160.94 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.93 -42.22 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -58.19 -36.85 73.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -61.36 -60.51 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.401 ' HB2' HD21 ' A' ' 217' ' ' LEU . 1.5 m-85 -61.15 -48.19 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -51.57 -47.31 63.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.81 -51.73 28.21 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.67 -55.33 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.03 -48.61 80.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -52.32 -45.57 65.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.46 83.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.01 -39.25 91.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.51 -52.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -62.49 -45.73 91.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.79 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.18 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tt -51.12 -52.83 39.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 tp -55.29 -53.34 57.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.74 -40.62 66.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -69.2 -32.17 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -73.06 -46.81 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.57 -42.89 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.159 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -68.24 -49.79 58.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.55 -27.63 69.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -74.42 -49.55 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.26 -38.27 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -79.58 -7.45 58.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -56.54 -26.85 56.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.41 -11.05 21.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.19 38.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 243' ' ' VAL . 5.2 p -113.24 162.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.32 149.21 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.61 -55.58 12.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -60.51 -22.99 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -88.78 8.75 27.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.73 -50.37 55.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -73.76 -34.49 64.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.207 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -50.73 -45.04 58.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.01 -30.12 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -55.51 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.8 m -67.88 -51.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -65.06 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.95 68.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -70.12 -47.63 60.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.24 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.9 p -71.79 -33.12 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -49.25 54.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.1 tt -67.64 -43.39 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.78 93.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -63.06 -57.78 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -53.74 -50.07 66.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.92 -47.38 74.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -44.13 97.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -51.02 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -62.32 -48.75 78.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -57.32 12.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -51.58 -54.59 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -39.54 54.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.33 -43.85 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -57.06 -52.28 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.67 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -48.37 40.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.6 p -139.0 -39.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.53 -6.78 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -122.56 127.14 49.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.82 160.35 41.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.676 0.75 . . . . 0.0 110.848 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 86.65 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -56.66 -33.35 66.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -61.55 -34.4 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -51.35 68.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -67.59 -34.68 77.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -55.09 32.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.93 -43.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -33.01 73.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -68.86 -50.29 51.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.42 -13.3 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -95.82 -25.34 16.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.6 m -95.33 -35.8 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.518 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -50.12 -58.07 10.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.661 0.743 . . . . 0.0 111.178 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.8 -35.68 12.09 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.676 2.25 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.48 -43.38 98.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -46.14 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.62 -41.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 32.9 m -68.25 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.4 -52.37 22.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.88 -51.61 68.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.83 -36.67 48.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -62.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.4 pt -52.89 -38.75 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -51.43 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.83 -18.85 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.71 -23.68 30.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.16 86.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t 179.15 -48.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.28 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.68 167.77 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.22 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.14 -3.03 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 m -50.59 -20.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.3 -33.18 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -67.46 -44.66 78.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -65.3 -45.33 84.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -37.53 87.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.16 -43.05 79.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.46 -56.35 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.0 p -58.49 -39.59 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.2 -46.4 87.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -41.69 97.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.908 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.84 -52.41 63.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 82.0 t -54.92 -46.01 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -27.14 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -45.71 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.27 -35.52 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -70.42 -38.72 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.32 -43.68 19.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.529 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -67.63 -51.86 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.97 -35.46 74.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.27 -32.7 57.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.535 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.65 -32.1 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.0 -26.06 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.81 22.99 12.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.58 0.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.29 -170.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -154.99 162.7 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.71 61.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.505 ' CE3' ' HA ' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -70.49 -59.57 3.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.535 0.683 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.1 Cg_endo -69.75 -14.05 35.58 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.55 -37.27 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.09 -37.81 88.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -60.53 -53.15 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.26 -50.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.33 -49.07 82.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.02 -50.0 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.47 -45.62 84.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.05 83.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -64.64 -55.24 21.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.23 -46.88 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -37.02 86.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 10.7 mtp -59.43 -53.59 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.99 -42.87 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -54.01 -44.4 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -74.65 -57.67 3.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.5 mt -51.5 -58.45 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.12 -20.1 23.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.27 19.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 -179.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.822 0.344 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 160.59 62.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -24.26 30.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.66 2.24 . . . . 0.0 112.356 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.2 52.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.86 -43.29 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -35.67 81.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.2 m -71.28 -47.5 56.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.87 94.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.85 -52.79 39.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -52.46 -54.1 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 43.7 p -58.14 -45.63 87.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -44.41 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 17.5 ttp -72.43 -29.97 64.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -40.32 69.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -72.67 -44.45 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.16 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.447 ' N ' HG22 ' A' ' 192' ' ' ILE . 6.5 tt -65.28 -40.99 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.13 -49.38 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -52.41 -58.15 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.29 -57.76 18.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -54.28 -32.07 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.79 -23.87 44.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.8 mt -77.12 -32.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.6 OUTLIER -48.85 -55.8 18.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 110.94 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.82 -21.7 32.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.246 . . . . 0.0 112.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 50.2 t -71.07 -43.66 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.34 -40.93 10.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.482 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.67 -57.4 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.52 -32.56 72.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.16 -25.86 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.36 -7.54 5.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 -179.847 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.55 70.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 28' ' ' TYR . 10.9 mp -55.28 -63.31 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -54.21 -37.54 64.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -54.74 43.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -57.58 -48.76 78.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.94 -58.09 10.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.87 -46.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.1 -48.98 79.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -61.28 -41.05 96.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 tp -61.21 -48.8 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.51 -55.28 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.91 -27.02 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -66.72 -55.71 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.43 -25.53 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -68.96 -8.25 42.82 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.68 3.133 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -129.85 -59.98 1.05 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 117.107 -3.496 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.26 -63.22 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.102 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -30.65 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -55.47 32.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.29 -37.09 93.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.42 -37.54 80.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.4 mm -69.43 -49.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.32 -35.58 74.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -75.95 -43.99 42.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.63 -42.2 92.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 10.3 p -74.07 -38.28 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.49 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.8 t -75.36 -40.78 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -66.96 -36.11 81.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -76.83 -44.03 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.5 t -51.74 -45.27 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.82 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.82 -177.1 6.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.33 -72.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.75 -28.84 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.69 -73.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -43.76 63.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.2 m -61.01 -39.28 89.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -52.92 22.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -39.02 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -67.63 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.33 -42.68 78.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -46.9 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.86 -41.95 96.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.06 -43.28 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.132 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -59.5 -49.2 78.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.09 92.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.68 -55.48 23.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.84 -31.94 73.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.92 -53.4 46.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -34.55 78.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.61 -39.55 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 p -67.24 -43.52 81.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.7 m -68.5 -38.51 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.15 -49.04 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.72 -30.29 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.87 -50.17 63.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.75 -33.45 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -79.65 -14.52 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -36.86 69.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.48 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.18 42.33 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -114.51 -170.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.66 155.37 40.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.51 -50.93 65.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -24.73 62.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -96.82 -4.33 40.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -51.57 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -35.02 53.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -50.73 -41.66 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 mt -64.61 -33.16 75.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -68.65 -54.19 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.38 -57.01 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.53 89.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.57 -44.69 77.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.933 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.99 -55.25 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -33.1 75.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.23 -47.66 70.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.62 -46.9 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.83 88.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -64.65 -54.04 38.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -45.49 80.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -59.7 -53.19 60.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -39.23 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -57.54 -55.2 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -53.04 62.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.6 mmt -54.42 -47.89 72.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -55.34 -56.68 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -34.0 73.75 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.24 -33.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.34 . . . . 0.0 111.077 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -73.84 -40.7 63.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.85 -26.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -87.52 -49.94 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 -39.67 26.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -12.72 56.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -152.97 130.16 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.29 162.01 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.706 0.765 . . . . 0.0 110.857 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 103.29 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -69.43 -26.67 64.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -42.21 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.172 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -48.38 67.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -57.67 -51.43 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.29 -50.62 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.08 -53.92 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -34.01 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.108 . . . . 0.0 109.336 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.6 -59.58 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.59 -11.37 60.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.85 -17.12 25.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . 81.7 p -110.95 -39.39 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.508 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -43.79 -58.49 4.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.79 -21.12 33.81 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.311 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.2 mm? -75.71 -54.37 7.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -49.55 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.77 -58.59 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.3 t -59.33 -34.38 72.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.41 -63.33 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -50.47 -51.09 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -61.66 -40.01 93.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.8 tp -57.67 -66.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -50.53 -34.56 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.158 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.58 -39.5 73.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.87 -14.82 59.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -17.07 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -24.64 60.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -119.26 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER 164.87 -78.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.13 134.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.89 97.46 4.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.26 -6.05 85.97 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -33.49 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.82 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -41.71 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.95 -37.47 64.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -51.54 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -35.33 79.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.64 -49.79 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.17 -59.68 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.65 -46.98 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.67 -49.61 76.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -53.73 -46.2 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -42.04 96.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.51 -55.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.96 68.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -58.17 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.6 -41.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -62.38 -38.66 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.07 -51.31 18.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.6 -56.91 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.89 -32.69 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.22 -29.51 72.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -38.12 -55.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.97 -31.47 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.32 -9.36 20.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 pt -107.44 8.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.116 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.05 119.88 39.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 44.38 53.94 6.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -53.28 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.612 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.3 t90 -52.83 -53.25 56.7 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.555 0.693 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.7 -17.2 37.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.256 . . . . 0.0 112.379 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.69 58.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -29.33 69.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.62 -51.64 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.82 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.47 -46.9 23.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.71 -45.75 92.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.832 0.348 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.71 -49.58 74.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.77 -29.89 70.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . 0.416 ' CD1' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -67.3 -57.48 6.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.02 -41.79 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.25 -45.86 89.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.2 mmt -57.05 -54.9 41.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 159' ' ' TRP . 2.1 mp -64.56 -37.32 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.83 -36.97 86.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.56 -39.5 62.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.54 -14.51 58.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.93 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.18 -27.42 33.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.12 21.1 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.34 163.15 47.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.644 0.735 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.35 27.79 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.244 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.75 -39.88 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.34 -43.99 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.144 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -67.44 -32.98 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.0 m -71.77 -49.11 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.94 99.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.1 -44.76 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -58.08 -56.79 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.1 m -58.19 -48.22 81.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -52.0 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -32.63 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -49.25 77.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.72 -47.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.55 -49.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.37 -48.15 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -59.93 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.0 -54.61 33.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -53.23 -30.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.304 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -80.05 -28.95 39.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.51 -30.77 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 24.5 t80 -48.03 -54.37 25.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.686 0.755 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.76 -22.46 32.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 80.7 t -69.27 -44.31 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.81 -32.35 27.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.36 -45.92 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.09 -53.87 24.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 t -72.47 -14.17 61.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -89.69 -19.75 46.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.902 -179.784 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.48 -21.11 62.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -59.74 4.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -52.03 -37.91 55.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.35 -33.44 67.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.15 -48.82 64.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.53 -38.78 81.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 40.4 mt -66.68 -47.14 84.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.85 -43.27 96.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.47 -45.67 91.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -55.68 30.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.54 -37.56 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -62.14 -46.62 88.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.02 -25.15 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.137 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -92.14 2.35 56.64 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 126.704 3.145 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -124.07 -63.33 1.22 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.121 -3.487 . . . . 0.0 112.743 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.9 mm -61.59 -64.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.165 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -36.65 48.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -57.83 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.76 -42.42 93.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.31 -49.54 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.1 mm -69.07 -36.16 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 15.8 mt -52.39 -57.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.9 p-90 -73.67 -30.14 62.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -56.96 -52.19 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.08 -44.05 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.68 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.29 -43.42 98.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -46.92 74.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -74.21 -29.24 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.2 t -51.55 -33.24 31.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.78 172.14 13.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.47 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.73 -25.86 42.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.84 -68.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -48.54 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.3 m -52.8 -44.34 66.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.27 -51.61 31.72 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.62 -55.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.45 -46.38 88.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -52.68 -43.74 65.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.21 -45.59 72.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -37.27 84.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.1 -52.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.9 m -61.73 -47.48 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.95 71.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -52.18 17.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.83 -42.37 90.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.8 m -71.67 -36.18 70.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -74.81 -45.2 44.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.28 -38.84 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -71.9 -49.63 36.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -63.6 -34.34 77.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -70.72 -52.24 22.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.36 -35.63 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -79.92 -22.38 42.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -54.23 -44.66 71.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.97 -3.95 50.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -106.32 12.01 30.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.4 m -94.35 -170.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.27 158.28 33.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -51.45 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.068 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -62.4 -34.29 76.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -83.7 -10.87 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -51.02 -50.58 58.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.29 -41.53 40.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -46.95 72.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -27.32 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.3 m -71.18 -53.61 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -70.21 -45.5 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -69.56 -41.03 76.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.33 -33.4 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.46 -48.37 56.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -65.06 -47.78 86.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.1 p -63.73 -38.11 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.02 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -35.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 111.108 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.41 53.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.37 -46.53 69.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -67.73 -45.8 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -58.36 -45.22 88.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -72.94 -57.74 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -37.36 23.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -74.01 -55.4 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -57.84 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -48.76 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.41 -48.74 53.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.37 -53.23 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.155 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -53.31 -55.93 20.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.33 -34.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -57.59 -22.02 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.4 m -99.41 -38.36 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.38 35.52 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.4 -177.42 3.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.869 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.6 t -147.77 75.39 11.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.653 0.74 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.05 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -38.58 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.98 -44.57 99.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -73.01 -47.28 46.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -50.54 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.29 -55.96 27.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.97 -27.18 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -66.42 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.298 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -60.53 -30.04 69.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -74.72 -30.55 61.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.58 -18.89 28.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.5 m -94.81 -39.62 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -43.55 -58.46 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.78 -18.91 36.66 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 tp -77.21 -54.0 7.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.52 -47.38 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 mm -54.81 -46.79 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 48.6 t -69.07 -42.2 76.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -54.45 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -58.79 -50.97 71.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -64.06 -28.54 69.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -56.07 12.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.03 -36.37 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -70.81 -55.27 8.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.39 -12.47 61.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.7 -24.64 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -28.35 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -9.03 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.4 t30 66.12 50.35 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.57 107.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -119.61 97.82 5.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.75 -35.89 27.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -49.85 -31.85 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tp -54.03 -50.72 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.53 85.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.02 -50.5 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -34.11 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.78 -47.97 70.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -58.87 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.9 -52.82 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.93 -42.59 86.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 m -63.55 -40.05 96.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -63.06 -56.15 19.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.82 -35.64 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -40.51 82.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -43.92 88.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.88 -47.89 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.42 -40.78 97.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.66 -49.4 64.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -52.99 62.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.4 ptp -59.15 -33.74 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.17 -31.7 57.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -29.88 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.871 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.4 -27.4 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 5.32 62.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.89 -35.07 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.323 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -135.15 133.91 39.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . -160.59 -45.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -46.3 74.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.611 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.73 -52.82 13.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.561 0.696 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.3 Cg_endo -69.8 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.334 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.75 -52.41 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -77.44 -34.15 54.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.35 -65.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.85 -44.6 99.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.59 86.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.43 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.63 -47.82 66.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.49 94.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -60.24 -55.37 34.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.77 -50.11 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -39.49 87.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -58.08 10.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.77 -38.92 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.59 -49.5 67.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.82 -54.68 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.1 mp -50.46 -59.82 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.79 -20.56 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.0 17.81 23.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.819 0.342 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.04 161.78 51.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.7 0.762 . . . . 0.0 110.839 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -26.03 28.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -44.19 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.62 -42.46 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -66.21 -39.17 89.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.1 t -70.05 -49.38 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.78 97.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -65.46 -47.85 74.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.22 -44.39 83.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.4 m -69.64 -35.11 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -53.02 46.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 14.5 ptm -64.11 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.88 -47.76 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.65 -39.5 85.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.2 mt -57.8 -57.58 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 pt -60.5 -38.68 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -56.29 -59.47 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.56 -52.95 49.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -55.4 -36.73 66.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.796 0.331 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.6 -24.72 49.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 200' ' ' TYR . 19.6 mt -79.08 -26.97 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.524 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.5 t80 -32.7 -57.76 0.48 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.697 0.761 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.77 -65.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . 0.474 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 57.3 t -36.51 -42.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -77.14 -57.86 3.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.81 -21.68 7.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.858 0.361 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.58 -28.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 96.7 m -49.34 -29.45 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.14 18.02 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.918 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.71 57.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 78.8 mt -55.99 -63.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -52.79 -31.48 38.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -57.39 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.26 -58.63 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.21 -48.84 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -57.05 -49.14 76.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -60.34 -40.38 90.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.57 -48.9 78.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.45 -55.16 38.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.17 -27.54 69.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -67.44 -56.58 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.0 m -72.57 -25.02 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.92 -10.32 37.69 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-O 126.701 3.143 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -131.31 -56.24 1.02 Allowed 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 117.102 -3.499 . . . . 0.0 112.773 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 44.3 mm -53.8 -64.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.115 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -41.21 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.08 -57.3 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.65 -41.11 99.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.3 -48.96 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.7 mm -69.68 -36.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.4 mt -53.0 -58.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -73.71 -29.63 62.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -54.87 -55.06 34.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.32 -44.8 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -56.58 -53.17 60.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.47 -41.76 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -54.18 27.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 -34.73 69.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t -51.82 -68.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 -179.834 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.816 0.341 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.4 168.51 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.37 -60.35 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -52.56 -43.91 65.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -54.53 -52.35 62.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -47.57 84.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -51.22 -47.01 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.8 -50.58 34.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.505 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.58 -55.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.351 . . . . 0.0 111.117 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -61.12 -47.18 87.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -53.22 -45.25 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -46.21 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.04 -40.24 92.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.4 -48.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.9 p -61.11 -46.5 90.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.9 -51.87 67.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.93 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.68 -33.66 64.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 tp -68.44 -56.34 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.8 72.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -71.25 -43.11 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.5 m -65.2 -47.09 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.25 -39.39 82.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.21 -49.81 63.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -67.18 -31.26 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.61 -48.91 58.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.5 -37.25 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -79.51 -10.57 59.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -27.78 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.02 -5.79 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -100.81 29.41 4.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.58 -171.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.52 160.12 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.11 86.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -45.59 86.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -81.88 -1.64 48.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -50.94 -52.33 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.0 p -77.56 -35.33 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.161 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.2 p -60.31 -31.85 70.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -34.2 74.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -56.39 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.74 -52.28 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.4 p -69.2 -36.6 77.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.7 -34.6 78.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.7 -47.29 60.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.85 -44.69 98.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -71.65 -39.14 70.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.164 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.24 -45.22 95.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.451 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.64 -47.85 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 -44.59 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -58.38 -53.41 58.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -57.0 -47.39 80.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -60.15 -61.38 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.15 -54.32 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 -58.14 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -38.04 76.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -57.1 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -53.46 44.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.39 -53.15 33.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.02 -39.15 82.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.79 -51.95 64.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tp -73.63 -25.83 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.1 -47.93 34.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 -38.78 4.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.14 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.42 126.53 52.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.7 162.22 32.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.613 0.721 . . . . 0.0 110.861 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 101.92 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.2 m -69.1 -26.02 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.7 t -48.04 -41.73 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 -44.82 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -67.2 -58.28 5.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.4 mm -63.5 -62.53 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.66 -33.35 54.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.553 1.158 . . . . 0.0 109.277 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.13 -65.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 -9.88 59.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tt -91.42 -18.83 23.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -105.61 -39.05 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 4.0 t -44.28 -55.03 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.658 0.742 . . . . 0.0 111.128 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -23.25 31.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.252 . . . . 0.0 112.361 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt -75.83 -54.63 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mm -57.65 -37.81 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.63 -56.37 16.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -51.68 -46.62 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.42 -43.62 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -32.61 74.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -56.81 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.5 tp -56.81 -40.3 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.82 -43.33 68.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.58 62.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.38 -16.36 45.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.3 -14.37 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.079 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.28 -74.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 176.78 -33.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 p -170.68 145.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.65 145.43 42.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -5.04 82.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -39.09 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -54.17 29.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.928 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -52.09 -50.1 62.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -31.48 72.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.61 -49.7 74.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.61 -59.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.77 -49.39 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.57 -48.71 83.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 m -53.43 -44.13 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.84 -48.12 72.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 85.2 t -51.93 -54.41 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -64.8 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -58.52 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.03 -51.72 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -51.96 -37.18 52.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.66 14.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -55.8 28.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 110.926 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -32.57 74.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.04 70.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.92 -32.86 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -28.58 7.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.53 26.37 10.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.2 pp -94.86 -34.9 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.096 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.74 142.45 27.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 171.73 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.72 -35.29 70.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -69.48 -61.46 3.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.3 Cg_endo -69.79 -6.72 19.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.271 . . . . 0.0 112.303 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.73 70.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.55 -38.29 89.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.03 -65.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.58 -38.05 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -48.91 56.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.23 -44.02 92.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -50.47 72.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.89 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -55.45 25.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.5 t -58.41 -47.05 89.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.35 -46.17 89.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -52.15 -58.66 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.09 -32.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -53.49 -54.52 36.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.19 -40.2 62.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.2 tp -61.64 -24.94 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -25.32 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.74 18.72 15.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.494 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.7 165.12 36.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.729 0.776 . . . . 0.0 110.827 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.57 16.4 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.3 54.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.42 -44.2 77.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.72 -39.94 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -68.18 -50.06 56.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.99 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -45.1 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.68 -56.31 23.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -43.61 89.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -56.86 -47.42 80.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.42 -32.56 74.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.8 -51.27 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -37.95 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.096 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.2 -46.17 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.57 -49.58 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -51.23 -58.96 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.4 -58.52 13.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -52.77 -31.09 36.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.402 ' C ' ' HD2' ' A' ' 201' ' ' PRO . . . -81.18 -24.11 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.26 -34.26 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 16.6 t80 -51.95 -55.57 29.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.663 0.744 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.72 -28.99 24.79 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.368 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.5 -27.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.84 -46.75 6.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -37.32 45.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -48.81 -28.21 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.9 p -47.36 -30.54 3.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 134.08 49.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 26.5 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.813 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -30.67 16.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.29 -30.13 71.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.6 -58.59 7.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -65.69 -37.32 86.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -55.87 24.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 48.1 mt -61.4 -47.64 92.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -59.8 -56.63 19.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -49.03 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.39 -39.2 82.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -55.33 24.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.09 -28.12 69.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -70.97 -52.81 17.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 m -72.06 -24.42 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -77.49 0.81 21.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-O 126.692 3.139 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.21 -59.63 0.87 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 117.122 -3.486 . . . . 0.0 112.75 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.08 -64.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.148 174.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -42.8 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.01 -58.45 6.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 -40.64 94.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -44.06 81.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -48.18 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 27.5 mm -54.34 -50.09 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -72.02 -30.7 65.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -58.61 -53.74 54.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.52 -42.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -60.21 -55.01 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.72 -48.31 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.141 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -35.44 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -71.6 -37.66 70.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.6 p -50.22 -40.8 48.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -177.11 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.88 -74.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m -51.97 -32.07 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -58.44 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -48.33 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 m -49.87 -47.31 51.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.0 -50.54 39.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.0 t -51.33 -55.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.8 p -60.77 -48.31 82.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.2 -48.39 65.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -46.22 88.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.62 -38.19 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.94 -52.34 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 m -58.79 -54.24 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.66 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.57 69.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.43 -42.43 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.36 -56.17 10.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.45 -39.14 64.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 m -69.89 -43.43 71.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -60.42 -49.06 79.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.53 -36.1 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.14 -57.07 10.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.21 -45.88 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -54.14 -52.02 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.9 -29.85 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -79.32 -6.21 56.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -27.39 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.79 -10.67 47.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 31.87 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.82 154.02 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.1 142.06 2.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.83 74.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -23.86 61.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -88.6 6.56 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -53.57 -50.13 66.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -33.53 61.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -40.52 96.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.0 -26.75 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -70.93 -49.91 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.59 -45.17 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 t -70.47 -39.32 74.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.25 64.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.38 -51.06 60.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.857 0.361 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.22 -51.9 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -63.66 -37.55 87.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.22 -37.05 93.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 mt -71.6 -45.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.23 98.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 231' ' ' LYS . 43.6 t80 -64.97 -57.08 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -55.02 -51.89 64.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.22 -42.07 94.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -57.96 -71.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.3 ttp -52.26 -32.16 35.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -57.66 -68.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.913 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.4 ' HA ' HG13 ' A' ' 82' ' ' VAL . 21.2 mtt -74.81 -58.28 3.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -39.81 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.91 -57.51 4.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.4 HG13 ' HA ' ' A' ' 79' ' ' MET . 5.8 p -53.72 -35.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 220' ' ' ASN . 8.3 tp -54.52 -26.89 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.29 -20.92 58.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -103.28 -38.24 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.19 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.71 -175.11 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.88 37.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.708 0.766 . . . . 0.0 110.847 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 84.44 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 t -60.07 -37.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.91 -52.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -51.05 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -34.38 74.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.11 -57.86 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -30.38 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.6 -66.83 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -31.6 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.5 tp -77.23 -21.83 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.9 tt -99.47 -16.38 18.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.9 p -98.35 -32.6 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -57.55 -59.33 13.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.85 35.61 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.375 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.42 -51.98 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 pp -67.43 -40.82 85.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.8 mm -66.66 -49.88 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.26 -40.83 97.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -59.71 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -51.11 -50.84 58.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -64.41 -37.1 86.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -55.7 -63.87 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 mm -57.9 -44.69 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.92 -47.28 77.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.22 -15.68 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.37 -20.17 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.87 -26.63 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -123.48 -45.61 2.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 179.91 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -151.56 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.08 151.64 48.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.35 -2.47 73.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.21 -31.37 5.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.887 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.79 -40.52 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -49.93 25.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -58.22 -51.74 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.68 80.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 tp -62.25 -47.03 86.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.62 -58.72 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 m -55.31 -36.05 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.92 -45.57 72.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.5 t -63.01 -39.09 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.828 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -53.85 37.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.68 -43.44 79.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -36.4 82.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -47.24 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.02 -48.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.32 -41.08 83.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.01 -51.67 8.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.13 -57.32 10.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.8 mmt -68.34 -46.13 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.81 55.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -45.57 -36.56 4.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.911 0.386 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.95 -27.45 8.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.084 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.09 27.37 5.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.488 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -104.71 -37.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.437 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -128.31 -168.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.538 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 79.28 0.42 2.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.114 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -42.61 71.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -70.11 -57.05 6.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.536 0.684 . . . . 0.0 110.93 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.77 -7.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.717 2.278 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.0 81.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.49 -39.25 91.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.83 -58.93 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -35.25 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.06 -49.31 16.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.7 t -57.36 -50.63 72.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -50.11 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.58 94.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -61.55 -55.68 28.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.3 t -53.5 -48.07 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.66 -39.78 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.8 mtt -58.62 -58.22 9.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.24 -30.88 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -58.26 -54.68 44.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -33.72 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.63 -13.99 60.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -21.22 24.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.85 21.62 14.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.791 0.329 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.63 162.73 51.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.659 0.742 . . . . 0.0 110.854 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -30.83 21.52 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.5 -47.53 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.115 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.6 t -67.31 -44.6 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.01 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 t -66.62 -49.26 66.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.2 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.29 -51.66 68.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.4 -54.71 43.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 31.9 m -55.33 -36.51 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.174 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -51.92 62.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.5 ttp -59.8 -37.53 79.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 -49.53 74.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -69.34 -53.45 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.2 mt -49.78 -50.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.44 -49.79 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -53.21 -48.86 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 199' ' ' ILE . . . -62.06 -49.58 73.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.61 -28.43 69.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.84 -45.04 19.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.438 HG12 ' HA2' ' A' ' 196' ' ' GLY . 21.0 pt -71.85 -29.46 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.499 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.7 t80 -45.59 -59.36 4.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.662 2.241 . . . . 0.0 112.343 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.38 -43.88 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.142 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.32 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -59.49 -24.57 63.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 110.899 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 70.6 t80 -54.47 -33.2 59.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 t -66.26 -13.75 60.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.38 -4.79 6.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.407 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.0 110.937 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.904 0.383 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.33 70.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.8 -52.1 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -35.8 81.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.54 -58.63 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . 0.476 ' HB2' HG23 ' A' ' 84' ' ' ILE . 1.2 p-10 -63.74 -35.99 82.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.07 -54.23 41.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 23.3 mt -59.48 -48.13 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -57.63 10.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -55.33 -39.86 70.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.83 -47.75 82.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.23 37.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.069 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -36.49 83.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.43 -40.8 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.37 -42.66 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -72.78 -5.08 35.52 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 126.718 3.151 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . 2.3 mmtm -113.05 -27.07 8.18 Favored 'General case' 0 N--CA 1.424 -1.761 0 O-C-N 117.119 -3.488 . . . . 0.0 112.773 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.63 -63.44 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.14 174.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.4 tp -49.08 -31.55 8.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.52 -56.71 18.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.95 -39.76 89.16 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.97 -38.97 93.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.59 -47.43 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.48 -49.25 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -69.85 -38.21 76.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -58.42 -53.85 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.15 -37.13 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.27 77.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.27 -41.49 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -63.24 -39.57 94.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -77.52 -48.34 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.3 t -52.39 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.822 0.344 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.01 157.89 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.04 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -31.06 61.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -66.44 -68.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -49.71 -52.07 34.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 t -61.82 -31.87 72.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.23 -55.51 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -57.0 -44.35 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.148 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -64.37 -46.94 81.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.91 -40.14 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -47.5 69.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -43.98 97.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.2 -43.99 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.5 m -61.59 -42.66 99.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.13 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -51.9 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.42 -39.03 75.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.19 -55.57 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.81 75.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -50.66 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.7 p -61.39 -40.4 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.48 -48.05 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.92 -46.35 75.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.18 -28.72 69.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -74.66 -45.5 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.55 -42.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.01 -4.01 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -26.38 62.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.03 -3.98 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.07 42.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.01 -170.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -66.27 152.94 43.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.62 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -27.81 64.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -91.69 1.6 57.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -51.11 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -31.29 53.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 p -55.29 -43.58 74.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -29.67 69.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -54.82 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.91 -50.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -70.12 -35.56 74.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.4 84.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.27 -47.92 59.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.54 -55.24 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 m -65.13 -37.52 87.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.29 99.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.478 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.51 -42.99 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 111.172 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.89 82.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -63.98 -54.56 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -52.82 -51.19 61.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -63.92 -59.33 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -49.0 -62.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -38.31 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.21 -70.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -59.67 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -53.47 -55.95 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.94 -54.6 27.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.59 -54.86 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.329 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -54.18 -55.67 25.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.7 -26.52 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -21.28 50.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -38.33 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.08 31.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.52 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.77 -176.17 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 p -146.12 77.51 11.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.663 0.744 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 72.55 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.673 2.249 . . . . 0.0 112.328 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -69.87 -41.39 74.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.7 m -54.56 -52.43 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -71.1 -44.61 65.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -55.46 -58.5 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -40.22 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.05 -63.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.02 -33.29 70.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -60.58 -58.72 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.07 -11.99 60.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.3 tt -90.96 -21.04 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.1 p -107.81 -34.36 6.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.486 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -47.57 -60.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.69 -30.46 22.54 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.27 . . . . 0.0 112.374 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.88 -55.55 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.48 -43.01 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.36 -50.64 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 16.3 t -64.41 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -65.27 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.42 -50.21 60.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.48 -37.46 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.17 -66.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -50.75 -37.53 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.36 -39.82 77.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.43 -14.27 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.43 -14.67 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.02 -24.89 68.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -120.42 -70.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 117' ' ' THR . 2.1 m-20 165.24 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.46 138.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.02 96.94 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.99 85.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.0 p -48.78 -35.85 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.2 mp -49.48 -42.64 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -68.26 -53.68 22.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -52.09 64.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -36.14 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.31 -50.52 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.5 -60.13 2.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.58 -47.12 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.25 98.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.4 m -66.53 -55.26 16.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -53.81 43.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.55 -45.09 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -61.92 -42.04 98.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.55 -57.82 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.67 -52.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -40.78 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.37 -51.46 52.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -60.44 -56.83 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -34.62 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.91 -29.19 59.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -39.79 -48.88 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.66 -28.95 7.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.78 17.02 33.29 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.54 -55.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.45 138.35 48.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 174.07 -27.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.63 -31.64 48.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -74.54 -63.07 0.85 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.544 0.688 . . . . 0.0 110.881 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.71 -6.16 17.91 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.75 -49.63 74.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.95 -31.13 68.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.99 -61.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -62.71 -38.96 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.194 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.43 93.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.489 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.94 -48.23 74.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -50.29 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -66.64 -57.89 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.36 -41.11 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.79 -47.09 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.23 -52.59 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.9 mt -63.13 -53.07 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -47.39 -35.59 8.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.96 -49.53 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.6 -16.39 61.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -116.69 18.42 14.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.933 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.856 0.36 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.417 ' CB ' ' HD2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -110.67 166.42 10.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.64 0.734 . . . . 0.0 110.849 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 179' ' ' SER . 53.9 Cg_endo -69.74 -36.79 10.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.79 -43.68 35.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.02 -46.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.01 -36.47 83.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 m -68.67 -47.24 67.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.89 95.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -43.77 78.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.05 -49.35 78.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.6 m -65.16 -38.66 91.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -42.31 96.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.9 ttp -71.7 -34.97 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -63.97 -50.89 66.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.86 -38.33 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 8.1 mm -64.1 -47.56 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 62.3 mt -64.41 -52.95 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -52.34 -54.51 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.04 21.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -53.95 -36.32 62.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.67 -20.81 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.8 mt -82.01 -31.86 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -48.35 -54.09 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.666 0.746 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.2 Cg_endo -69.7 -20.86 34.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.83 -43.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.57 -38.27 17.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.39 -29.36 23.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -49.0 -30.75 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.2 t -51.16 -24.64 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.1 22.24 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.855 0.36 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.65 -36.79 69.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.53 -63.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.39 -43.25 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -45.27 81.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -65.31 -44.66 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.98 -53.63 52.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 36.3 mm -57.15 -45.75 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -63.95 -54.64 31.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.37 -47.61 78.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -50.48 71.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.95 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -27.92 69.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -67.88 -56.43 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -24.95 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -80.4 2.78 23.63 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.68 3.133 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -131.18 -51.22 1.02 Allowed 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 117.158 -3.464 . . . . 0.0 112.753 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.83 -63.67 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.12 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.99 -36.55 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -56.1 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.39 -33.69 85.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.08 -41.32 86.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.6 mm -67.77 -50.01 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.7 mm -63.67 -36.52 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -74.1 -41.82 61.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -69.64 -40.98 76.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.56 -36.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.21 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.3 -36.5 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -75.61 -50.6 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -58.54 -41.79 86.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -54.51 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.82 163.53 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.39 -65.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.43 -30.91 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.97 -67.83 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -44.04 65.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.7 p -60.13 -38.73 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.15 -54.56 13.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -55.93 -41.43 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.8 m -66.44 -48.43 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.02 -42.59 72.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -47.85 68.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 -42.62 96.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.91 -50.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.098 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -55.36 -43.39 75.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.33 -52.04 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -54.34 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -51.16 -52.84 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -54.27 -48.64 70.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.48 -36.02 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -70.88 -34.93 72.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -70.78 -45.08 65.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -65.87 -42.83 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -68.74 -48.62 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -64.6 -29.87 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -74.95 -50.36 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.73 -41.03 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -79.73 -6.22 56.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -57.4 -26.67 61.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -93.22 -10.71 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -100.63 28.78 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.98 161.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.79 149.93 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.87 -55.88 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -23.86 59.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -90.43 11.64 20.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -62.25 -50.46 71.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -34.26 73.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.179 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -43.2 62.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.18 -29.53 70.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.4 m -70.14 -54.53 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.62 -49.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -67.12 -36.87 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.67 -36.79 83.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.535 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tp -70.58 -49.97 42.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.4 p -66.08 -46.32 88.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.3 m -71.51 -29.95 65.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.04 -52.01 30.58 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -68.69 -37.19 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 71' ' ' ILE . . . -68.54 -42.09 78.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.75 -56.59 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.831 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -56.28 -50.21 72.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -60.78 -62.6 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -49.84 -51.27 41.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -53.69 27.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -56.78 -46.21 81.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -57.12 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.44 -56.59 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.69 58.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.29 -28.12 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -70.29 -47.32 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.6 tt -73.35 -24.96 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.32 -47.78 18.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.8 p -122.5 -39.23 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.21 -23.33 4.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -122.7 129.12 51.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.2 161.03 40.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 110.878 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 104.07 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -26.41 64.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 m -51.38 -41.29 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.093 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.83 -52.03 53.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -60.03 -37.72 80.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.08 -48.78 74.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.64 -50.25 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.85 -39.69 95.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -61.03 -49.45 77.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -16.53 60.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.02 -14.74 25.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.6 p -108.17 -29.48 8.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.492 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -54.88 -59.64 10.13 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.634 0.73 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.71 -35.55 12.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.315 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.4 -52.34 54.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.63 -50.57 73.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.4 mm -57.69 -58.64 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.98 -33.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.97 -68.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -50.5 -50.72 52.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.35 -43.98 83.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.25 -66.71 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -31.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.65 -42.09 67.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.2 -14.37 59.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.52 -17.31 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.41 -24.05 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -121.87 -69.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' THR . 1.7 m-20 165.77 -76.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -47.23 135.01 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.11 98.27 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.29 74.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -47.87 -33.5 7.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -48.26 -43.38 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.38 -53.26 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -52.27 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -37.34 86.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.81 -50.85 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -59.76 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.03 -49.56 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.3 59.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 t -52.49 -57.21 10.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -53.04 44.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.53 -44.56 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt -64.25 -38.14 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.3 -58.72 7.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -57.14 -43.0 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.62 -47.3 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.55 -52.23 47.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -58.71 -55.21 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.92 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -58.37 -32.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.3 -30.18 59.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -41.61 -52.8 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.18 -28.48 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.73 16.95 48.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.5 pt -100.58 -37.27 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.63 139.82 47.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 170.4 -14.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.84 91.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.581 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.7 m95 -69.12 -55.83 9.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.687 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 149' ' ' TRP . 54.4 Cg_endo -69.76 -16.88 37.77 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.733 2.289 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.21 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -77.7 -28.49 51.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.0 mt -66.88 -64.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.29 -36.39 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.1 93.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.444 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.6 t -63.65 -46.77 84.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.71 -47.35 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.65 91.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -61.06 -55.82 28.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.5 t -58.88 -46.85 90.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.41 -43.28 99.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 mmm -57.35 -49.32 76.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.59 -52.65 54.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -36.5 38.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.68 -58.76 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -55.77 27.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -22.05 26.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.04 18.47 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.473 -179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.786 0.327 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.52 162.32 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.664 0.745 . . . . 0.0 110.898 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -28.57 25.19 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.304 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.32 -41.44 56.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.8 -43.32 97.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.49 -32.59 72.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 t -69.8 -45.14 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.831 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.8 80.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -64.96 -51.39 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.947 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -61.86 -56.23 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.6 m -53.02 -44.18 67.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -52.38 65.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -54.78 -39.34 68.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.93 -52.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.5 tt -52.7 -45.95 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.5 pt -69.58 -38.12 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -56.84 -58.32 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.97 -48.84 77.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.535 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -58.21 -33.11 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.03 -25.2 43.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 24.6 mt -80.34 -31.11 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -47.75 -54.5 22.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.693 0.758 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.72 -23.13 31.32 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.695 2.263 . . . . 0.0 112.386 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.9 t -69.56 -44.32 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.91 -35.11 22.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -52.7 -29.44 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -48.76 -30.28 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.9 t -50.5 -28.07 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.21 21.7 0.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.79 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.27 65.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -51.77 57.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.14 -41.56 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -58.46 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -36.27 69.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -60.19 -57.92 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.51 -48.62 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.4 -51.54 69.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -60.04 -38.82 83.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.24 -51.22 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.21 86.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.78 -39.31 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.33 -24.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.11 2.51 53.27 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.671 3.129 . . . . 0.0 110.84 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -121.51 -45.37 2.31 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 117.121 -3.487 . . . . 0.0 112.76 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.34 -65.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.08 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -36.22 44.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -55.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.29 -35.25 91.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -42.32 85.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.1 mm -65.72 -50.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.84 -34.45 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -74.41 -44.27 52.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -60.32 -41.95 94.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.67 -36.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.86 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -38.58 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -71.61 -35.83 70.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -76.85 -36.81 56.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.4 t -50.93 -54.88 20.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.817 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.99 146.56 10.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.448 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.05 -99.45 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.9 71.75 1.05 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.92 89.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.2 mt -145.7 150.7 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 175.6 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.73 -73.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -31.63 54.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.43 -71.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -48.17 81.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -51.23 -42.88 61.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.96 -50.81 27.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.7 t -51.17 -51.66 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.0 t -64.37 -48.74 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.34 -49.07 65.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -46.92 83.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -59.0 -38.76 79.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.1 t -68.09 -45.56 83.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 m -62.31 -50.54 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.53 -52.53 54.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -53.58 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -47.16 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -29.01 68.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.0 m -72.81 -48.87 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.8 m -65.66 -40.3 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.87 -51.34 41.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -63.37 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.05 -51.33 13.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.0 t -67.62 -31.13 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -79.22 -7.06 57.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.38 -27.26 55.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.26 -12.54 27.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -102.39 36.69 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.03 158.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.8 147.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.27 -52.87 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.18 -21.82 60.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -87.73 6.97 32.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -51.33 -50.75 58.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -36.17 56.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.153 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.92 -47.8 73.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.19 -27.5 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -67.77 -53.6 25.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -71.73 -44.91 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 t -66.32 -40.56 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -35.29 58.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.07 -49.19 65.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.48 -44.11 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.082 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.1 m -67.26 -35.26 79.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.95 -42.68 59.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 mt -68.48 -41.67 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.87 -43.63 83.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -61.1 -51.95 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.56 -50.41 74.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -59.25 -61.43 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -51.5 -49.7 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -53.15 30.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -58.72 -48.74 80.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.3 mmt -55.83 -54.84 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -51.41 -55.16 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.04 -45.87 56.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.6 t -66.7 -35.68 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 111.136 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -59.75 -51.6 69.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.3 tp -74.51 -26.13 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -50.15 -48.61 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.9 p -111.43 -39.25 4.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 122.36 -13.66 8.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.46 127.03 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.7 161.28 35.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.643 0.735 . . . . 0.0 110.859 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 99.96 0.79 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.358 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 p -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -50.6 -33.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -71.57 -51.92 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -63.74 -33.55 75.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -53.79 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.57 -37.94 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -47.88 80.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 0.0 109.31 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 14.5 t90 -64.82 -41.67 95.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.916 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.8 tp -75.15 -16.58 60.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.4 tt -99.36 -16.8 18.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.5 p -100.12 -29.17 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.51 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -60.0 -58.63 17.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.675 0.75 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.75 -24.82 29.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.71 2.273 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.5 mt -76.51 -52.45 9.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.08 -38.52 91.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 26.1 mm -70.55 -57.94 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.9 t -52.05 -49.83 62.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -55.48 33.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -51.11 -50.75 58.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -68.53 -30.54 69.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -60.23 -63.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.64 -37.53 79.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.54 -50.45 71.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.97 -14.01 59.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.69 -23.62 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -27.65 68.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -117.81 -45.84 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -179.61 -78.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -154.74 157.34 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -106.8 124.29 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.31 -5.53 81.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -50.5 -28.15 7.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 21.4 tp -51.82 -39.78 59.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -64.95 -52.68 55.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -49.94 74.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.32 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -48.32 76.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -58.58 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.3 -51.95 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.63 74.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -45.35 91.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.47 -49.67 76.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.8 -51.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -35.89 80.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -51.01 71.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.7 t -64.62 -46.89 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.71 -39.51 84.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -51.99 8.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.56 -55.75 30.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.95 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 16.3 mmt -69.29 -47.9 63.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.63 -31.7 53.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -47.48 -46.77 27.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.6 -27.1 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.48 20.33 30.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.8 pt -75.52 -40.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.876 0.37 . . . . 0.0 111.157 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -156.39 132.52 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.51 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 165.11 -20.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.75 -43.0 80.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.618 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 4.9 t-105 -66.78 -54.82 19.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.532 0.682 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.71 -16.96 38.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.319 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.7 -33.17 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.085 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.4 -37.72 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.6 -65.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.5 pt -50.68 -44.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.133 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.15 61.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 49.1 t -55.22 -50.5 69.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.913 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.15 -50.34 73.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.26 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -65.21 -55.14 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.1 t -52.75 -50.15 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -39.88 94.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.84 -58.7 6.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.9 mp -68.49 -32.17 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -53.24 -55.91 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -76.65 -35.29 58.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 tp -60.52 -40.25 90.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -21.58 26.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -110.44 20.01 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -47.96 164.88 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.19 1.15 42.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.16 -58.61 7.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -76.85 -17.55 58.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.9 t -70.42 -23.78 62.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -45.56 -57.2 4.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.77 -57.45 2.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 176.53 -71.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.88 5.65 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.71 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.56 163.19 21.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.699 0.761 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.64 27.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.27 -48.39 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.38 -41.78 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -65.78 -33.43 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.6 m -70.57 -46.89 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.48 94.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.17 -51.77 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -56.48 -49.94 73.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 20.6 p -61.91 -38.48 88.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -62.31 -51.95 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.7 ttp -61.5 -38.62 87.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -49.04 79.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.3 mm -65.21 -48.49 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.6 mm -52.58 -45.93 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 32.1 mt -64.95 -51.33 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.2 -57.5 11.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -56.51 -59.21 11.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.5 -34.01 56.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.92 -23.7 44.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.108 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.1 mt -78.37 -32.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.557 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 6.8 t80 -48.38 -56.23 15.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.76 -23.65 30.57 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.697 2.264 . . . . 0.0 112.379 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.19 -45.24 83.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.01 -39.03 10.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -53.22 -48.59 68.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.923 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.07 -32.77 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -13.38 61.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -131.6 5.01 5.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -88.88 -53.48 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 32.3 mt -100.78 -41.1 7.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.975 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 31.4 ttp -116.44 164.6 14.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.36 -61.55 0.38 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.87 34.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.836 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.38 46.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 104.89 60.31 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 17.9 t -84.07 132.55 34.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 110.854 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.71 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.5 mp -52.78 -63.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.925 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -33.64 39.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.9 -54.47 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -61.12 -52.12 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.17 -58.46 6.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.6 mt -54.2 -42.51 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.71 -52.56 63.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -37.92 83.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.1 tp -63.04 -45.0 94.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.75 -52.14 64.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.61 -32.05 73.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -66.18 -49.61 66.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.33 -25.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -80.47 2.55 24.76 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-O 126.738 3.161 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.2 mmtm -131.59 -51.57 0.99 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.111 -3.493 . . . . 0.0 112.761 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.33 -64.53 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.16 -1.837 . . . . 0.0 111.101 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.91 -36.0 35.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.9 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -51.56 -56.04 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.65 65.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.99 -47.36 85.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.8 mm -71.42 -50.77 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.5 mm -53.19 -40.92 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 17.9 t90 -74.71 -41.97 59.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -60.55 -42.54 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.02 -35.12 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.76 72.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.76 -37.9 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -70.27 -37.8 74.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -77.04 -46.29 24.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.9 t -51.95 -62.3 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.92 93.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -151.39 158.84 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -107.57 160.52 26.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 111.116 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 148.02 64.11 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 154.44 107.94 0.3 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.161 -0.799 . . . . 0.0 112.455 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.479 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.786 0.327 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.0 179.21 22.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.22 132.77 3.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.68 123.0 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 110.61 4.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp -99.02 170.13 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 170.7 12.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.18 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.64 -39.62 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -62.36 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -48.05 80.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -52.79 -46.27 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.41 -51.44 16.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.11 -50.53 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 111.164 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 t -66.18 -49.89 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -52.35 -49.13 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -63.79 -47.33 81.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.07 -38.2 78.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 98.7 t -68.79 -45.21 81.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 m -61.88 -51.59 67.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.92 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.087 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.18 -55.43 35.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 tt -53.33 -39.72 64.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.45 -56.02 24.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -24.15 67.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.36 -51.85 21.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.3 t -69.58 -39.48 77.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 82.0 t -65.05 -49.32 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.53 -45.06 76.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -64.54 -30.47 71.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -75.04 -51.78 12.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.83 -36.12 76.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.37 -9.26 59.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -29.08 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.15 -11.66 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.17 24.6 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.9 p -112.51 156.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.27 148.65 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -55.56 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -20.7 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -88.58 -15.33 35.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -51.68 -50.38 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.6 p -61.13 -50.34 73.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.178 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -35.53 72.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -32.36 72.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -53.96 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.8 m -64.5 -51.29 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.4 t -68.1 -38.16 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -36.38 68.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.79 -50.01 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -64.69 -48.45 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -62.54 -33.56 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.03 -69.56 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 pt -45.4 -41.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.36 -49.41 69.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -52.77 -55.24 24.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -56.69 -46.15 81.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.56 -38.77 88.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -68.93 -68.53 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -45.28 -42.9 10.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -65.03 -49.01 71.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.7 mmm -59.61 -48.99 79.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -56.21 22.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.26 -43.56 75.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.7 t -69.46 -27.67 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 111.081 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -69.93 -53.35 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.89 -26.05 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -50.08 -47.62 53.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.2 p -108.12 -39.06 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.93 -56.34 0.74 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.62 126.82 53.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.48 161.01 37.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 78.79 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.353 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 m -54.02 -25.66 22.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.8 p -48.14 -32.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -69.56 -52.39 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -59.89 -45.03 93.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -60.34 -52.0 67.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.55 -27.69 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.52 -68.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 109.275 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 11.1 t-105 -53.84 -32.78 54.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.23 -32.76 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.953 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -84.03 -14.9 49.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.9 p -99.42 -32.69 11.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -46.49 -59.41 5.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.0 Cg_endo -69.75 -23.33 30.95 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.63 -53.97 11.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -71.93 -37.5 70.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.9 mt -62.67 -51.38 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.139 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.04 -47.73 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -58.03 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -51.21 -52.16 47.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.66 -30.49 71.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -66.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.4 mm -58.56 -37.83 67.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.2 tp -65.12 -51.4 61.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.6 -16.58 63.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.14 -22.54 11.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.06 68.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -120.1 -48.3 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.17 -73.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 m -155.17 157.21 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.37 123.6 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.0 -6.09 81.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.5 t -50.62 -28.95 9.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.95 -39.42 94.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -52.31 64.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -62.14 -34.05 75.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.05 -46.31 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.95 -58.18 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 52.0 t -55.19 -50.09 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.45 94.68 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 t -59.85 -48.05 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -52.97 63.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.31 -46.23 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -30.68 68.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -50.17 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.1 m -67.07 -39.12 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.31 -37.15 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.36 -51.9 19.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -64.35 -54.92 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 21.7 tpp -60.79 -43.08 98.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.79 -32.44 82.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.53 -28.53 8.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.35 -26.79 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.58 44.02 50.93 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 65.1 mt -84.97 -54.56 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -130.36 136.61 49.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . -149.75 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.89 -45.65 81.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.08 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.61 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.03 -52.92 15.08 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.75 -9.86 27.16 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.73 -53.91 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -30.39 58.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 39.9 mt -64.24 -66.48 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 24.3 mt -61.37 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.137 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.05 68.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.9 t -58.66 -49.59 76.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.26 -48.52 68.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.15 90.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -60.69 -56.42 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.25 -45.9 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.76 -41.29 99.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -57.85 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.2 mt -63.87 -37.95 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -52.94 -54.21 38.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -74.79 -48.71 23.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -51.36 -60.07 3.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -58.01 -20.29 37.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.17 17.96 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.36 -154.75 31.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 0.78 49.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.869 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.98 -70.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.449 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -24.11 45.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.7 m -77.18 -23.68 51.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -57.46 -19.43 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 t -83.01 7.56 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.28 -65.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -119.85 -29.4 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.27 -166.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.64 162.99 24.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.667 0.746 . . . . 0.0 110.879 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -16.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.97 37.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.91 -47.03 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -38.29 86.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -66.82 -48.42 68.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.83 86.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -51.53 61.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.74 -41.03 73.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 9.9 p -72.29 -32.23 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -52.21 58.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.43 76.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -50.96 69.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 24.3 pt -69.38 -33.46 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mm -61.26 -53.19 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 17.9 pt -67.33 -36.75 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.89 -60.97 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.72 97.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -61.63 -32.37 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -81.05 -27.52 35.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.3 mt -80.96 -31.03 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.597 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.8 t80 -48.36 -54.19 27.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.732 0.777 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.75 -21.91 32.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 0.0 112.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.4 t -70.19 -44.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.5 -37.38 14.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.497 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -57.95 -36.37 72.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -63.39 -49.4 73.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 t -73.24 -13.93 61.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -96.79 -21.48 21.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -106.94 -51.26 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.54 39.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 8.8 ttt -65.48 91.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 51.74 31.36 30.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.8 t70 63.44 33.44 13.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.828 0.347 . . . . 0.0 110.815 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.95 21.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.449 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -68.84 125.07 18.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.64 160.54 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.845 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.19 -23.67 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.73 -62.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -25.61 61.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.81 -58.81 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.02 -43.32 95.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -53.93 -58.49 7.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 34.9 mm -59.47 -44.39 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.61 -47.81 78.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.73 -43.9 82.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.4 tt -57.01 -49.64 75.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.92 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.2 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -56.43 -27.93 58.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -73.08 -46.91 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.88 -25.43 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.88 2.26 31.28 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 126.686 3.136 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.5 mmtm -130.74 -58.3 1.03 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 117.109 -3.494 . . . . 0.0 112.71 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 45.4 mm -62.11 -64.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.08 174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -38.21 50.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.57 -56.63 12.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.22 90.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.2 -44.17 96.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.312 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.7 mm -67.65 -47.18 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.01 -40.9 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -71.94 -41.08 68.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -62.95 -43.88 97.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.87 -32.5 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.21 62.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 62.3 t -76.36 -33.22 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -75.88 -39.7 55.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.1 -42.84 55.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 t -52.05 -58.92 5.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.95 95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -76.9 -44.43 31.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . 63.48 160.43 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.106 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 95.57 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.695 2.263 . . . . 0.0 112.39 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.75 93.13 2.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.196 -0.78 . . . . 0.0 112.531 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.433 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.9 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.838 0.351 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -134.93 173.26 21.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.3 -35.8 0.4 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.456 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.44 114.94 3.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.494 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 t0 57.78 82.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.06 167.02 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.38 -177.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.5 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -54.23 -36.23 63.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -55.78 -69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -46.67 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.5 m -51.68 -45.78 63.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.62 -50.49 36.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.1 t -54.36 -54.51 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.072 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -60.45 -49.97 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -52.44 -49.23 64.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -44.52 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -36.68 84.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.02 -51.51 59.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 m -62.83 -46.36 88.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.71 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.151 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.42 56.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 tt -51.58 -54.42 27.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.44 -54.22 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.72 62.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -66.18 -28.17 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -72.33 -50.15 29.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.4 m -65.73 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -70.43 -51.69 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -63.41 -30.96 72.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -74.03 -51.25 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.32 -31.47 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.74 -4.88 53.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -55.78 -26.37 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.25 -10.67 22.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -95.49 24.6 5.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.95 158.61 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.195 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.03 157.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.59 -55.9 11.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -61.4 -19.87 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 40.7 m95 -88.96 -6.81 56.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -50.81 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 p -68.13 -39.07 82.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -37.12 75.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.26 -33.7 76.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -54.89 8.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 m -63.54 -53.53 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.09 -39.53 90.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.15 -32.7 69.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.79 -47.64 62.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.69 -45.32 84.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 m -69.51 -35.32 75.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.45 -45.97 65.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.59 -48.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.44 -41.91 97.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -59.94 -52.47 65.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -56.99 -50.27 73.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -56.59 -53.68 54.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.79 -53.21 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.97 -53.83 18.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -56.55 -43.46 79.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -51.95 67.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.401 ' HG3' ' HB2' ' A' ' 224' ' ' ASN . 0.0 OUTLIER -53.56 -55.46 25.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.9 -46.33 60.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.0 t -67.51 -27.83 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.344 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -67.59 -54.83 16.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.2 tp -73.59 -24.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -46.77 -47.92 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 t -123.04 -39.11 2.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.158 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.55 -38.48 1.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.56 127.12 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p -138.61 160.25 64.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 97.59 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.7 2.266 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -69.58 -26.81 64.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 68.5 t -50.73 -46.65 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -38.31 90.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -64.08 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -36.41 70.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.7 mt -63.73 -66.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.51 -33.37 59.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.533 1.146 . . . . 0.0 109.305 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -55.95 -63.17 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.26 -10.47 59.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.918 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.87 -15.18 30.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . 81.9 p -112.62 -36.24 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.483 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -46.67 -59.43 5.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.689 0.756 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.77 -18.68 36.82 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.4 mm? -77.51 -53.92 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.1 -50.44 64.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.5 mm -55.02 -56.08 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.0 t -58.54 -40.0 81.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -65.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.0 -50.16 48.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -60.1 -32.21 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.23 -62.22 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.3 mp -50.77 -41.97 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.36 -41.4 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.2 -15.68 61.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.36 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.086 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.4 -18.15 61.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 t -119.34 -49.38 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.179 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.63 -78.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.64 163.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -104.05 118.09 35.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.29 -14.96 81.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.512 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.3 m -54.53 -23.99 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.868 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.41 -37.58 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -73.42 -42.04 62.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -64.18 -50.32 68.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -36.08 82.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.912 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -48.08 80.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.918 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.79 -58.91 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 60.1 t -54.08 -52.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.79 -49.19 76.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.4 m -53.67 -45.87 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.62 -50.54 72.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.8 t -51.36 -45.68 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.6 -41.03 89.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.56 -53.18 57.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -67.14 -50.87 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.93 -44.14 63.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.32 -52.47 8.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -53.5 -57.66 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.1 mmt -69.99 -32.56 70.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.57 78.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.43 -27.85 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -103.09 -28.16 12.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.48 20.75 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.472 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.116 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.49 122.35 45.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 176.4 -29.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.97 87.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.508 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -70.22 -58.33 5.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.79 -6.26 18.18 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -65.14 -44.18 89.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.95 -63.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 52.0 mt -58.36 -51.72 67.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -54.55 -49.07 62.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.465 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.4 t -56.54 -51.1 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -49.34 65.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.53 83.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -67.42 -56.69 8.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 25.7 t -53.82 -52.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.141 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -59.83 -44.67 93.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.2 mmm -50.73 -56.59 11.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.29 -38.87 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -51.25 56.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.19 -52.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.7 mp -50.31 -59.09 4.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.04 -20.93 27.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -106.12 17.69 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -65.45 125.26 28.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.03 -0.55 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.847 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.54 -28.03 28.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -31.6 59.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.4 t -55.36 -25.82 37.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.16 -33.24 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.1 m -117.08 -10.49 10.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 75.2 -58.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.8 t -98.16 -8.94 26.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.75 -166.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.08 161.76 52.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.636 0.731 . . . . 0.0 110.839 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -22.0 32.84 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.85 -43.16 47.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.73 -46.26 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.67 -36.51 84.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.2 t -71.16 -49.71 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.93 -37.88 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -50.61 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -53.58 -56.96 12.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 6.7 t -60.32 -41.98 94.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -51.51 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.13 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -50.35 68.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -39.5 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.082 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.17 -56.57 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 54.4 mt -60.15 -48.46 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -49.83 -56.34 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.44 -59.72 10.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -54.44 -31.36 55.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.48 -22.89 43.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.4 mt -78.92 -32.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.592 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 23.8 t80 -49.93 -54.5 31.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.682 0.753 . . . . 0.0 110.914 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.7 Cg_endo -69.77 -25.03 28.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.682 2.255 . . . . 0.0 112.384 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.6 t -71.51 -37.73 65.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.12 -28.88 39.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.458 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.41 -33.76 21.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.59 -28.03 12.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.7 p -47.83 -32.4 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 136.58 44.03 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.36 -19.77 62.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 2.9 mt -92.59 -36.31 13.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 44.9 mtm -77.23 -172.86 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 67.72 62.49 4.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 13.1 t0 62.2 36.37 14.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.89 26.63 66.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.68 101.95 1.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.482 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.4 t -65.57 126.89 29.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.857 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.01 -42.09 68.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.09 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.5 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.11 -26.98 65.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.67 -59.01 5.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -65.7 -34.7 78.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.36 -58.11 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 86.6 mt -58.82 -49.04 84.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.41 -54.54 45.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.401 ' HB2' ' HG3' ' A' ' 80' ' ' ARG . 7.5 t-20 -60.84 -32.55 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 26.0 tp -63.54 -49.25 74.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.72 -49.06 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -46.78 87.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -59.09 -44.18 91.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 99.1 t -72.91 -25.59 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -93.9 2.1 56.22 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.738 3.161 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -120.94 -60.36 1.66 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.095 -3.503 . . . . 0.0 112.751 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 44.8 mm -67.64 -64.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.177 174.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -34.52 60.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -56.64 -56.56 19.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.42 -34.4 87.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -41.07 87.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.1 mm -68.46 -50.1 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.6 mm -61.61 -37.73 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -74.78 -41.96 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.67 -44.3 93.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.59 -41.38 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.59 -39.08 91.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.45 -34.77 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -69.87 -40.92 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.14 -41.36 42.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 29.7 t -51.39 -46.68 62.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.71 92.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.823 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 110.03 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -115.36 160.48 34.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.584 0.707 . . . . 0.0 111.115 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 -35.98 11.53 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -151.38 137.79 6.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.507 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.408 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.819 0.342 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.45 -174.12 45.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.06 -173.25 13.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.85 -166.53 31.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.62 -70.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.86 148.57 27.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 168.43 15.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.096 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.9 t -52.03 -31.18 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.59 -63.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -47.96 80.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -51.21 -47.71 62.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.13 -51.55 38.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.3 t -53.24 -56.19 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 111.148 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -48.78 78.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -52.05 -39.93 60.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -71.37 -40.0 70.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.67 -44.34 86.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -70.02 -35.83 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.5 m -71.03 -54.19 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.46 -44.9 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.89 -50.27 69.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tt -55.3 -42.36 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.4 tp -64.42 -56.1 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -38.15 74.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.2 t -67.56 -48.96 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -63.82 -46.55 84.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.92 -46.61 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.26 -48.85 66.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -61.39 -28.85 69.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -75.66 -50.33 15.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.02 -33.19 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -79.23 -6.56 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -59.47 -27.76 66.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.62 -13.7 27.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.69 39.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.89 160.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.0 t -48.87 143.11 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.22 57.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 -25.06 61.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -91.85 13.25 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -49.69 -50.26 44.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.3 p -76.84 -30.26 56.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -44.06 72.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.84 -28.94 67.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -53.34 20.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 m -70.69 -46.83 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -66.62 -39.0 88.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.06 -36.22 60.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.17 -49.83 58.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 104' ' ' LEU . 7.7 p -65.67 -44.78 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 96.4 m -67.62 -36.14 80.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.71 -41.57 74.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.461 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 mt -66.95 -50.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.11 -36.95 85.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.079 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.53 -54.85 40.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -46.7 85.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -59.11 -63.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.17 -55.29 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -57.5 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.34 -40.46 82.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.4 mmt -59.91 -56.51 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -55.36 19.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -47.85 57.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.08 -37.22 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.169 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -59.78 -48.12 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.29 -25.93 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.52 -48.12 38.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -115.01 -39.36 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.164 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.64 -14.41 5.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -135.34 141.49 45.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.27 162.08 33.88 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.697 0.761 . . . . 0.0 110.826 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.32 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -66.78 -25.6 66.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -65.7 -53.19 44.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -62.31 -30.79 71.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -65.38 -56.44 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.91 -32.73 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.63 -61.99 2.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.147 . . . . 0.0 109.293 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -61.02 -35.72 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.7 tp -73.91 -17.15 61.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.42 -16.5 16.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.0 m -100.41 -35.41 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.52 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -55.51 -57.83 18.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.729 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.77 -20.97 34.07 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HB3' HG22 ' A' ' 68' ' ' VAL . 3.9 mp -78.56 -53.7 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.48 -45.3 93.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 10.6 tt -63.14 -42.16 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.1 t -69.16 -41.34 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -54.44 46.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.34 -52.38 65.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -57.38 -49.92 74.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.93 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -57.9 -50.69 72.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 mt -50.77 -46.34 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.62 -28.2 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.22 -19.01 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.04 -10.85 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.67 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -71.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.75 -75.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -48.21 141.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.25 98.45 5.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.02 77.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -48.02 -34.72 9.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mt -50.95 -53.23 34.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -65.13 -53.44 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -50.68 52.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -33.3 75.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.12 -51.39 61.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.75 -60.85 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 65.1 t -54.56 -45.17 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.25 -46.67 94.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 m -58.26 -57.1 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.22 -52.13 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 68.8 t -53.13 -47.4 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.03 -44.98 90.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.0 -57.62 12.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.9 t -53.2 -51.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.98 -36.65 79.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -55.96 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.942 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.1 mtt -53.13 -37.8 62.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.87 -30.16 58.08 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -40.26 -52.98 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -27.47 8.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.5 15.65 47.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 pt -98.19 -36.4 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.13 137.91 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 172.12 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.69 98.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CE3' ' HA ' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -71.01 -60.58 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.511 0.672 . . . . 0.0 110.932 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.75 -1.63 8.79 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 147' ' ' ALA . . . -62.2 -50.49 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.64 -45.96 70.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.6 mp -61.11 -59.09 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.54 -47.09 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.96 -49.55 77.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 50.3 t -57.11 -51.47 69.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.892 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.26 -49.18 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.07 92.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -62.17 -56.38 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.09 -50.11 77.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -55.16 -44.54 75.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -58.02 10.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.21 -33.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -61.02 -52.16 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.66 -31.57 63.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.4 mp -67.15 -52.27 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -57.6 -20.95 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.02 18.12 21.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.8 120.04 20.57 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -0.29 26.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.399 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.89 -27.25 28.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.523 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -72.27 -31.12 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 m -55.68 -26.08 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.09 -36.21 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.98 -15.04 10.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.35 -58.64 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.4 p -93.74 -12.78 28.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.6 -166.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.22 162.37 54.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.01 31.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.16 30.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.68 -41.39 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -65.7 -36.96 85.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.7 p -70.07 -49.45 50.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.83 96.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.7 -51.1 64.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -53.91 -51.81 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -61.66 -37.11 82.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -51.19 70.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -35.6 81.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -50.94 70.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -33.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.84 -50.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 58.4 mt -64.27 -49.31 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.95 -58.58 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.26 -58.44 14.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -54.66 -30.98 56.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.02 -23.04 44.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.075 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 16.9 mt -80.01 -32.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.4 t80 -48.57 -54.01 30.57 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.76 -23.03 31.24 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.315 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 75.9 t -71.66 -36.5 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.98 -34.88 20.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.511 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -40.21 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.9 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -64.4 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.51 -27.86 7.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 144.82 57.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -102.07 -20.87 14.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.937 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.26 -28.12 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -62.36 -178.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.23 -57.55 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.51 -39.76 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -22.75 75.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -131.78 93.88 0.29 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.16 160.36 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.38 -23.8 58.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.8 mt -55.24 -63.34 1.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -58.67 -33.56 70.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.63 -55.94 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.04 -36.87 85.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -63.49 -53.63 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 19.8 mt -59.49 -48.09 88.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -57.09 12.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.52 -44.69 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -39.83 92.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.46 27.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -29.31 69.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.64 -58.5 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.44 -30.67 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -78.05 -25.33 47.7 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.679 3.133 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -76.9 -30.39 56.14 Favored 'General case' 0 N--CA 1.423 -1.79 0 O-C-N 117.114 -3.491 . . . . 0.0 112.778 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.95 -38.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.146 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.1 mt -55.78 -34.07 64.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.39 -57.54 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.68 -34.97 79.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.47 -39.41 85.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.762 0.315 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.8 -50.03 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.16 -35.61 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 37.7 t90 -77.59 -47.25 19.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -56.81 -42.66 79.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.4 p -74.35 -39.97 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.41 -39.72 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.27 -38.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -42.46 99.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.03 -49.22 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.2 t -58.43 -33.37 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.31 -75.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -163.44 130.51 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -149.04 73.56 10.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.711 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 118.32 5.61 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 70.63 -149.54 46.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.121 -0.821 . . . . 0.0 112.482 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 102.94 1.58 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.494 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.49 -121.42 1.29 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.52 111.51 3.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -56.9 4.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -61.24 141.66 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 179.4 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -63.27 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -51.67 60.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -50.52 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.56 -48.26 81.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.9 m -50.77 -47.55 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.01 32.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.1 t -53.55 -56.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 0.0 111.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.55 -45.8 90.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -51.92 -44.12 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -46.24 68.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -41.04 88.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.1 t -67.95 -49.3 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.8 m -60.2 -41.41 92.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.43 -52.17 55.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.071 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -55.17 29.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 tp -53.17 -46.48 68.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.98 -56.1 26.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.971 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.41 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.1 t -68.3 -29.29 68.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 m -72.34 -49.1 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.15 -41.47 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -67.45 -50.5 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.2 -26.74 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -72.43 -50.06 29.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.41 -34.57 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -80.14 -9.99 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -52.72 -29.0 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.99 -4.82 13.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.83 29.63 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.34 -171.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.05 164.11 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.92 -54.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -25.66 64.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -83.51 -17.2 42.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.41 -49.68 53.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.94 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.5 p -76.61 -43.91 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.0 t -53.03 -44.44 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -31.61 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.6 m -73.85 -54.77 7.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.3 m -62.33 -50.39 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.1 t -70.14 -40.46 74.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.8 -34.77 78.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.466 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.13 -49.63 55.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -62.74 -47.25 93.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.154 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.8 p -62.96 -36.67 84.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.65 -66.66 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.473 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -47.46 -36.84 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.03 -49.41 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -59.23 -49.48 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -62.07 -51.99 65.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -59.0 -43.41 91.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.82 -69.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -48.19 -35.96 12.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -65.87 -75.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.5 mtt -53.55 -57.35 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.48 -56.79 16.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.06 -51.21 41.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.52 -52.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -50.71 -55.44 16.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.73 -30.38 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.99 -21.23 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -112.46 -21.5 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 63.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -139.49 149.97 44.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 p -115.15 79.97 6.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 0.0 110.924 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 73.07 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -70.06 -36.21 74.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.98 -43.9 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -72.42 -32.57 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -78.26 -47.17 18.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.46 -37.09 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.82 -50.98 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.55 -36.17 73.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.289 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -75.39 -50.08 16.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.05 -11.06 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 tp -103.13 -34.02 9.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.4 m -85.36 -37.96 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.198 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 t -50.71 -53.31 48.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.625 0.726 . . . . 0.0 111.121 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.73 -25.1 29.09 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -75.84 -52.54 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -41.15 93.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 13.0 tt -66.78 -34.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.8 t -69.53 -53.48 18.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -58.25 -45.66 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -59.45 -49.78 76.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -33.58 74.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -61.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.6 tp -56.51 -39.91 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tt -64.39 -42.32 96.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.89 -18.51 58.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.44 -20.2 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.103 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.45 -78.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.89 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.1 p -168.23 131.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -110.34 102.49 11.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.25 -5.5 66.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -29.64 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.854 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -61.75 -34.74 76.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -49.66 60.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -62.6 -50.36 71.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -61.53 -36.74 81.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -44.51 86.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -58.33 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 28.9 m -56.29 -38.77 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 -42.72 94.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.518 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.2 t -63.46 -45.05 92.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.62 -52.63 60.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.21 -47.24 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.04 -58.0 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 19.0 m -68.75 -39.23 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -56.48 -43.82 80.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.06 -50.11 8.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -55.06 31.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -65.23 -47.82 75.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.59 -33.13 62.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.16 -23.96 24.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.86 -27.27 9.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.66 49.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -37.3 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.7 137.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.432 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 173.73 -27.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.124 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.9 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.572 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.7 t-105 -65.66 -55.49 23.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.55 0.691 . . . . 0.0 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.75 -20.77 34.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.653 2.235 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -49.55 -29.06 6.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.089 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -69.58 -42.92 73.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.9 -67.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 6.5 pt -51.65 -44.83 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.93 -48.89 77.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.1 m -61.21 -50.71 71.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.884 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -50.42 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.81 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -67.28 -57.5 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 91.0 t -61.7 -40.26 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -68.2 -45.33 73.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.968 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 8.1 tpt -53.88 -52.92 58.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 50.5 mt -63.6 -53.1 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -49.81 -33.31 16.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -53.68 8.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.5 pp -70.12 -11.13 60.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.81 -16.38 57.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.03 14.6 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.78 -158.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -66.16 -17.03 64.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.856 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.8 -21.16 67.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -74.03 -51.54 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -27.52 48.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.29 -20.2 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.075 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 14.0 m -53.14 -34.05 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.837 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.6 9.38 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -117.88 -21.28 8.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -111.92 -167.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.6 163.62 22.15 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 0.0 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -27.14 26.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.59 -45.26 31.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 51.1 t -60.49 -47.72 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.29 -35.54 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -43.97 78.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.6 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -67.04 -46.82 73.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.973 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -49.3 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -64.92 -32.75 74.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -52.58 56.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.0 ptm -63.52 -35.52 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.02 -48.21 79.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 31.2 mm -65.23 -54.45 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.14 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.0 mm -50.71 -53.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 76.9 mt -56.84 -51.67 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -53.67 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.01 -62.72 5.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -53.62 -30.61 43.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.8 -26.3 54.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.07 -30.89 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.3 t80 -45.5 -56.19 10.29 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.674 0.75 . . . . 0.0 110.917 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.3 Cg_endo -69.7 -23.16 31.39 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.657 2.238 . . . . 0.0 112.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 88.7 t -68.48 -45.2 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.95 -46.34 5.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.59 -48.57 71.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.918 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -49.95 -54.28 20.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.3 t -73.09 -14.21 61.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -92.41 -13.1 57.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.87 -51.04 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.936 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 29.0 mt -95.28 40.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -168.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -99.31 -37.68 3.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.59 47.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -165.05 25.09 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -96.45 98.09 2.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -179.23 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.01 65.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.88 -52.28 64.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -51.54 -35.66 41.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.16 -44.63 59.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -55.47 -51.65 66.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.71 -48.87 67.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 28.8 mt -54.38 -44.49 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -65.82 -52.98 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -56.85 -39.24 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.07 -49.15 71.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.23 -55.09 37.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -63.26 -32.66 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -60.91 -55.67 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.09 -24.94 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -77.87 0.91 22.15 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 126.729 3.157 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -135.16 -63.75 0.67 Allowed 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 117.144 -3.473 . . . . 0.0 112.756 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 48.8 mm -51.0 -63.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.173 -1.831 . . . . 0.0 111.142 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.41 -34.23 33.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -56.51 -56.74 17.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.72 -42.6 97.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.3 tt -52.53 -49.77 64.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.3 mm -69.28 -36.18 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 20.1 mt -52.9 -57.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.5 p-90 -74.02 -29.51 61.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -54.51 -55.99 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -77.41 -42.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -57.35 -52.72 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.088 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 97.2 t -67.84 -44.71 85.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -57.67 -44.82 86.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.11 -27.66 54.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.7 t -50.85 -34.45 27.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.5 t 51.7 30.43 6.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -146.07 175.59 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -142.63 160.36 54.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.594 0.711 . . . . 0.0 111.11 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 154.45 67.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 112.14 41.57 1.06 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.509 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.76 176.46 22.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.05 163.13 9.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.527 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -177.39 40.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.73 140.83 56.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -135.36 167.73 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.35 -177.21 3.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.18 -55.56 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.9 m -53.11 -42.87 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.72 -53.79 47.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.04 -48.88 78.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 m -49.85 -48.96 50.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.47 -51.53 47.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.9 t -51.12 -56.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.8 t -57.05 -48.68 77.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -51.76 -42.18 62.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -39.74 78.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -65.24 -44.54 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.47 -33.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.0 m -69.72 -51.87 30.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.29 -48.36 80.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.27 70.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -55.69 -43.22 76.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.35 -57.9 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.82 62.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.5 p -68.83 -34.69 75.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.8 m -67.15 -52.74 37.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.6 m -62.09 -42.05 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.22 -52.73 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.79 -31.7 68.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -77.62 -51.48 10.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.01 -44.16 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -79.89 -4.58 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' ' CH2' ' A' ' 239' ' ' TRP . 1.2 tmt_? -55.29 -26.05 37.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.91 -3.31 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -106.02 42.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.5 m -112.47 -170.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -84.58 156.22 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.35 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -20.55 56.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -96.18 3.96 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.38 -51.85 50.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.6 p -78.47 -33.15 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB2' HD12 ' A' ' 112' ' ' ILE . 43.3 t -54.8 -42.94 72.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.0 mp -65.8 -29.0 69.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.5 m -71.23 -53.62 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -70.64 -49.37 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -67.86 -37.97 82.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 -34.35 63.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.57 -50.06 48.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.61 -45.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.4 m -69.52 -34.3 74.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.67 -45.73 74.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.88 -48.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -39.59 91.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -62.77 -54.62 36.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.05 -50.52 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -57.32 -49.61 75.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CE1' ' HB3' ' A' ' 227' ' ' ASP . 0.0 OUTLIER -59.95 -45.85 91.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.9 ttp -53.57 -47.06 70.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.78 -30.72 67.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.8 mmt -66.84 -58.15 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.69 -49.61 75.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.2 t -66.9 -32.26 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 111.119 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -62.23 -51.0 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.02 -25.59 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.4 -48.79 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 t -121.84 -39.34 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.14 18.6 3.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 127.01 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.823 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.53 160.9 37.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 0.0 110.866 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 97.82 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.736 2.291 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.5 t -69.51 -25.38 64.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.76 -37.05 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -70.14 -53.15 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.29 73.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -67.73 -55.92 11.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 pt -65.55 -30.91 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.33 -48.07 71.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -61.32 -41.47 97.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.908 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.6 tp -76.81 -21.23 55.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.1 -11.41 30.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.965 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.2 p -109.55 -38.93 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.51 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -47.96 -58.47 7.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.23 36.42 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.24 -52.77 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -65.3 -51.81 58.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 6.0 tt -55.52 -39.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 41.4 t -67.53 -50.49 58.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.37 -57.98 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -52.52 -52.25 55.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.68 -30.85 71.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.42 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 61' ' ' SER . 0.0 OUTLIER -55.54 -35.65 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.116 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.48 -35.94 73.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.84 -21.65 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.2 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.74 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -64.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 176.47 -66.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.85 166.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -118.15 96.99 5.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 -11.51 84.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -25.34 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.98 -42.57 49.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.61 -43.32 59.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -59.47 -51.7 68.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -37.21 85.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.86 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.85 -58.2 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.84 -51.79 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.39 97.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.3 m -63.9 -40.36 96.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -55.69 12.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.08 -35.76 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -70.75 -43.13 69.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.9 -52.84 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.4 t -61.59 -50.95 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.07 -38.89 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.17 -52.52 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -51.87 -57.71 8.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.9 mtt -71.56 -31.37 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -63.17 -28.49 72.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.54 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 141' ' ' GLY . 10.4 tt0 -34.54 -55.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.49 -30.97 6.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 -4.03 20.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 pt -108.92 3.51 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.1 132.48 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.72 47.66 14.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.6 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.081 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.586 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.0 t-105 -57.98 -54.23 57.66 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.73 -17.34 37.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.49 68.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -63.9 -36.65 84.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 mt -62.27 -53.49 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.21 -48.91 13.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.08 -49.63 73.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.97 -49.4 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.88 -35.54 81.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -67.73 -57.31 6.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.5 t -55.73 -44.59 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.27 -47.07 85.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -58.34 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.82 -31.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -58.63 -49.39 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.31 -40.59 64.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.57 -13.91 61.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 -23.78 53.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.87 18.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.39 -162.25 0.26 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.488 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -22.93 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.913 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -65.86 -45.95 85.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.43 -60.0 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.97 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 p -65.36 -25.88 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -64.57 -14.31 57.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 32.0 t -56.85 -21.68 31.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -142.6 -40.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.6 p -71.28 -9.39 58.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -121.7 -166.0 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.075 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.11 164.31 22.01 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -27.68 26.25 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.323 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.49 -40.9 48.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.57 -45.88 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.89 -35.37 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 m -69.86 -45.59 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -66.81 -52.13 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.52 -41.23 84.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 p -64.03 -44.92 91.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 3.6 tpt -59.35 -52.8 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 ttp -61.3 -35.91 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.69 -40.38 92.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 10.9 mt -66.5 -53.68 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.1 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 67.1 mt -56.1 -46.44 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.27 -48.7 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.87 -58.96 5.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.68 18.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -53.27 -31.37 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.41 -29.15 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.2 mt -76.53 -31.09 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.6 t80 -47.38 -57.36 9.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.648 0.737 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.81 -20.87 34.03 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 0.0 112.38 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.1 -44.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.7 -33.01 28.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -52.02 -32.83 35.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 0.0 110.972 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.428 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 2.0 t80 -49.22 -30.9 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 13.1 t -51.54 -28.53 13.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -144.34 14.69 2.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -68.48 -42.48 78.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.941 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.8 mt -127.18 11.95 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 60.2 mtm -129.63 -173.07 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.29 34.33 40.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.0 t70 62.04 43.82 8.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.35 -21.42 44.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.18 166.15 12.07 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -119.04 146.42 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.08 -40.29 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.46 -51.83 61.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 20.9 m-20 -60.19 -40.03 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.49 -56.97 14.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -57.47 -36.18 71.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.75 -58.93 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.8 mt -54.02 -48.87 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.173 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.01 -37.76 88.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.78 -39.25 80.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.61 -52.8 55.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . 0.403 ' HB3' ' CE1' ' A' ' 76' ' ' TYR . 43.3 t0 -63.61 -40.66 97.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -57.74 -52.68 64.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.1 m -72.12 -24.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.28 0.64 13.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 126.696 3.141 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -134.32 -45.29 0.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 O-C-N 117.093 -3.504 . . . . 0.0 112.756 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.65 -65.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.135 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.06 -37.15 32.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.07 -56.36 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 -35.15 86.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -49.09 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.3 mm -65.91 -45.89 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.32 -30.98 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . 0.409 ' CH2' ' HA ' ' A' ' 51' ' ' ARG . 4.8 m0 -74.75 -42.82 57.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -42.4 95.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 10.2 p -70.27 -40.14 77.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.74 -52.35 18.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 71.6 t -57.48 -46.77 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -65.25 -50.77 64.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.88 -31.4 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.9 t -58.5 -48.54 80.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.5 t 62.13 63.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -130.32 43.11 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -146.09 71.79 13.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.594 0.711 . . . . 0.0 111.077 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -17.23 37.52 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.348 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -132.4 -46.12 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.515 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 mmm . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.63 -166.44 37.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.81 -132.06 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.77 78.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.38 94.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.48 168.32 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.13 -177.12 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.47 -72.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.13 -32.64 36.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -62.15 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -58.18 -48.23 80.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.951 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -52.81 -45.9 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.77 -51.47 19.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.0 t -52.7 -51.51 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.338 . . . . 0.0 111.128 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.0 t -64.76 -49.31 71.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -53.25 -47.63 68.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -47.48 80.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -40.6 88.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 86.0 t -67.99 -39.37 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.7 m -65.0 -53.01 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.71 85.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.75 -55.68 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.42 -33.45 69.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 48.5 tp -68.92 -54.04 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.94 68.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.5 m -72.41 -52.31 16.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 t -66.21 -37.04 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.7 -50.6 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.84 -43.85 78.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -64.51 -31.64 72.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.22 -52.09 13.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.92 -39.64 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -79.8 -7.54 58.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -55.64 -26.66 45.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -104.56 -9.36 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -96.15 30.72 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.09 -170.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.32 159.86 30.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.02 -55.21 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -21.82 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -88.5 -4.33 58.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -51.15 -49.68 60.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -42.99 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.46 -47.3 66.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.4 tp -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.5 m -70.56 -53.54 15.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.3 m -72.03 -46.88 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -68.77 -39.28 80.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.77 -37.65 66.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.99 -48.08 66.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.9 t -64.74 -51.61 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.56 -48.79 64.68 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mt -64.71 -50.14 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.87 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -60.84 -56.15 24.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.72 -45.92 77.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -57.77 -44.89 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.34 -54.77 41.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.872 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -50.2 30.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -27.14 64.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.2 tpt -67.58 -58.67 4.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -36.79 81.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.82 -45.09 93.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.1 -36.2 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -65.51 -46.52 79.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -26.12 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -47.92 -48.03 32.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 p -115.37 -39.65 3.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -21.85 4.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.21 134.84 45.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.05 160.93 38.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.879 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.88 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.27 -26.14 62.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.2 t -49.44 -36.82 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -67.38 -51.77 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -62.57 -55.29 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -52.33 -49.15 64.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.6 mt -65.97 -35.05 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.96 -64.48 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 10.5 t-105 -51.83 -37.58 52.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.962 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tp -75.63 -27.41 58.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -87.67 -10.89 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.3 m -106.17 -25.55 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.493 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -56.05 -59.5 11.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.721 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.81 -39.68 6.13 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.319 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.95 -53.37 55.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.03 -48.72 79.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 68.8 mt -61.82 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.65 -53.48 51.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -53.49 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -49.7 -51.06 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.89 -33.53 70.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.88 -66.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 mm -54.81 -36.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.7 -33.37 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.04 -24.06 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.82 -23.01 16.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.3 -65.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.2 m -64.34 -74.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -170.76 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.6 m -153.12 131.26 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.85 99.91 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.98 -6.82 83.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.3 m -51.0 -25.64 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.39 -45.35 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -48.76 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -58.42 -50.49 73.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.0 -36.63 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.87 -46.87 79.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mt -65.4 -58.08 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.6 t -55.53 -51.16 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.73 -51.31 57.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.0 t -53.41 -47.48 69.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -52.23 66.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.5 t -53.08 -45.46 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 2.6 mtt -68.4 -34.98 77.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.44 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.81 -52.72 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -53.58 -41.5 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.07 25.63 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.6 -55.92 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 mmt -65.44 -50.78 64.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.897 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.26 -31.2 59.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.23 -27.88 10.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -92.51 -27.52 17.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.91 11.71 55.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.2 mt -89.33 -54.81 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.148 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.86 141.39 42.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 176.02 -25.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.78 -36.64 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.092 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.486 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -68.92 -60.05 4.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.565 0.698 . . . . 0.0 110.916 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.73 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.345 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.7 -50.86 69.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -77.49 -30.14 52.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.9 mt -63.7 -62.86 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.78 -37.04 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.82 -43.61 91.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.0 t -63.55 -46.97 83.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.838 0.352 . . . . 0.0 110.834 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -49.84 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.26 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.076 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -66.26 -55.96 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.77 -43.56 95.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.16 -43.19 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -52.4 61.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 53.7 mt -63.93 -49.6 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -48.74 -38.67 22.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.02 -48.66 28.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.27 -10.69 59.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.24 -15.68 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.47 17.4 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -79.96 -165.53 31.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -84.93 -5.48 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -69.4 -55.26 10.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.463 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.29 -33.6 75.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.7 p -78.12 -25.25 47.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.71 7.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.07 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 16.0 p -59.64 -18.71 43.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.73 -40.29 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.5 t -89.89 13.43 14.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.188 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -152.51 -166.39 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.2 163.56 31.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -25.96 28.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.02 -46.02 31.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.33 -47.82 91.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -36.61 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -68.21 -45.22 73.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.85 87.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -68.28 -49.45 60.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -37.31 78.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 3.1 p -72.03 -39.68 68.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -52.96 61.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -66.22 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -60.18 -50.25 74.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -33.81 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.2 mp -64.69 -43.94 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 80.7 mt -69.71 -51.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.66 -55.72 17.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.58 -57.34 18.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 25.6 m0 -53.12 -31.95 44.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.44 -28.21 52.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.2 mt -75.03 -30.42 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.518 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -44.74 -58.0 6.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.733 0.777 . . . . 0.0 110.949 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.72 -20.58 34.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 93.1 t -71.52 -44.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.49 -34.59 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.62 -57.09 12.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -30.93 71.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -50.84 -26.82 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.54 -42.55 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.12 -22.33 66.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.393 . . . . 0.0 110.936 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -120.24 39.81 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -169.54 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -97.18 17.34 59.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -132.6 -59.14 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 -16.57 1.07 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 74.71 164.85 12.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.7 t -121.87 174.64 6.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.67 81.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.082 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.1 pp -56.17 -51.54 67.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -56.24 21.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -51.0 71.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -50.72 -58.48 5.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 90.4 mt -53.72 -43.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.1 -48.05 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -36.82 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -49.58 76.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.08 -51.0 66.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.69 -30.46 70.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.71 -46.18 59.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . 0.403 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 34.2 m -71.73 -23.33 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -95.09 2.94 55.26 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-O 126.697 3.141 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -60.18 1.48 Allowed 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 117.131 -3.481 . . . . 0.0 112.74 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 18.7 mm -66.47 -64.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.138 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.2 OUTLIER -48.59 -32.94 8.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -58.36 -55.54 33.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.08 -34.43 88.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -42.65 87.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.9 mm -66.72 -47.61 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 84.3 mt -65.91 -40.82 88.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -70.5 -39.33 74.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -68.72 -47.08 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 9.2 p -67.05 -33.01 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -76.94 -51.44 11.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.2 t -62.88 -34.06 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -76.22 -54.57 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.78 -38.78 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 81.5 p -55.1 -35.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.7 t -52.02 114.71 1.39 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -160.85 -68.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.458 ' CB ' ' CD ' ' A' ' 250' ' ' PRO . . . -179.26 -61.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 249' ' ' ALA . 54.3 Cg_endo -69.75 158.4 57.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -98.31 -70.89 1.0 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.459 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.495 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.91 -150.94 6.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.75 -19.24 66.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.48 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.7 41.66 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.16 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.77 -172.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -179.04 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.13 -71.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -30.54 45.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.52 -70.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -51.83 -43.03 63.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.8 m -60.42 -40.95 92.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.16 -54.22 21.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.82 -40.8 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.0 m -64.58 -49.73 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -55.19 -44.71 75.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -46.91 82.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -39.78 91.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.2 t -64.44 -48.75 83.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -57.71 -50.06 74.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.05 71.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.99 -52.07 67.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -52.3 -47.3 66.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.57 -49.9 75.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.12 75.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.4 t -69.35 -37.49 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -46.01 71.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.5 m -66.69 -41.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -69.08 -51.54 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -61.86 -33.41 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.45 -47.61 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.3 t -70.44 -29.77 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -73.93 -10.77 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -56.11 -26.81 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -12.73 17.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -106.24 42.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -127.7 160.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.7 t -49.98 148.67 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 -48.73 65.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -58.88 -23.03 60.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -88.02 7.36 31.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -49.64 -50.08 44.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -36.36 58.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -52.6 -42.38 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.29 -28.98 67.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.7 m -72.45 -52.21 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.19 -50.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.5 m -69.16 -36.7 77.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.95 -41.43 93.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 mt -70.84 -47.43 59.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.8 -55.36 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 m -68.37 -26.82 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.173 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.88 -51.45 24.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.6 pt -64.2 -39.64 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.19 -37.95 72.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -61.0 -57.93 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -47.56 85.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -55.14 -47.51 74.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -48.94 79.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.55 -51.34 48.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -58.71 -53.38 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.2 mmt -54.71 -47.52 73.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -53.1 -56.07 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.5 -33.78 73.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.2 t -67.56 -47.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.157 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -61.71 -45.07 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.6 tp -73.63 -25.19 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -48.25 33.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.4 p -136.61 -39.81 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.57 -15.37 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 127.02 53.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.46 160.79 52.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.75 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 90.09 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -69.42 -32.55 71.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.3 m -50.93 -45.87 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.54 -46.78 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -47.12 77.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -65.41 -39.89 92.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.81 -57.52 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -33.18 69.87 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.1 t-105 -60.09 -58.75 7.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.928 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.06 -13.11 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 tt -91.6 -16.6 26.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 25.5 m -110.76 -31.5 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.491 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -51.16 -59.51 7.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.613 0.721 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.6 Cg_endo -69.79 -35.5 12.44 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.91 -38.95 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -48.69 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mm -64.9 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.1 t -64.31 -55.33 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.83 -58.47 6.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -50.02 -54.56 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -61.16 -31.07 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.25 -67.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 46.3 mm -50.86 -40.72 20.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -35.36 76.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.91 59.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.79 -23.28 11.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.78 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -122.09 -6.57 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.33 51.93 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.1 p 179.8 112.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -119.76 97.71 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.32 -5.73 87.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.18 -23.44 8.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.89 -42.86 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -73.14 -37.41 66.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -53.25 41.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -34.15 77.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -47.09 74.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.41 -59.81 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.92 -33.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.1 -47.75 57.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.3 m -65.35 -38.6 90.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.383 . . . . 0.0 110.844 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -52.15 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.88 -51.81 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.7 ptm -62.98 -33.67 75.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.98 -56.2 21.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.886 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.7 t -60.62 -53.16 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.22 -37.12 71.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.5 -52.27 40.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -48.71 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.5 ttp -62.74 -34.38 77.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.81 -30.98 55.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.55 -48.0 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.77 -26.68 8.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 52.81 26.38 25.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.88 -37.38 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 111.129 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.408 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -131.06 -170.73 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 77.14 -4.97 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.93 -43.14 62.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.553 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.2 t-105 -64.52 -55.62 28.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.73 -19.01 36.84 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -50.79 -42.36 57.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.102 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -58.54 -39.42 80.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.37 -64.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.3 pt -51.69 -41.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.87 -50.03 32.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -56.82 -55.95 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 110.911 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 mt -54.72 -48.13 72.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.9 91.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.098 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -67.02 -56.87 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -52.96 -45.79 52.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.159 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -62.97 -45.08 94.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -58.47 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.4 mp -66.99 -32.04 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -55.82 -54.54 43.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -42.57 63.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.49 -15.49 62.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -57.38 -22.58 43.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.37 19.09 19.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.48 -163.41 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.21 -22.72 42.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 110.898 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.09 76.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.457 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -53.32 56.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -26.32 48.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -68.19 -11.62 59.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.47 -29.49 70.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -139.03 9.45 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -126.88 2.45 6.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.21 -165.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 164.1 17.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -22.87 31.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.313 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.54 -42.45 42.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.64 78.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.7 t -70.36 -46.87 63.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -66.92 -52.07 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.27 -54.88 40.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 63.9 p -58.83 -40.76 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.15 -52.87 62.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.82 -32.68 74.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.33 -49.27 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -35.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.131 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.76 -48.18 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.12 -50.74 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -51.51 -55.26 19.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.21 -59.57 10.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -53.35 -31.34 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.44 -27.28 46.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -75.0 -32.05 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.525 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.4 t80 -47.89 -57.72 9.49 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.8 -26.49 27.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.364 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.85 -37.62 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.49 -40.78 12.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.48 -33.13 43.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -27.28 10.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 14.1 t -49.8 -27.96 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -57.65 -32.86 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 13.5 mt -129.58 15.63 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 20.4 ttp -83.11 81.87 8.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.01 -15.17 40.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.19 15.65 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -178.9 42.45 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -49.56 163.54 0.6 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.78 146.81 44.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.36 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.075 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 10.2 tp -53.0 -61.85 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.93 -37.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.01 -42.4 94.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.58 -46.76 81.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.27 -57.79 11.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 35.3 mm -53.11 -48.01 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.24 -36.38 83.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -70.28 -42.45 72.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -51.46 68.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.97 -52.24 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -58.71 -37.6 76.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -64.34 -58.22 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.5 m -61.08 -25.62 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.68 1.23 20.52 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 126.69 3.138 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -130.0 -60.28 1.03 Allowed 'General case' 0 N--CA 1.423 -1.793 0 O-C-N 117.116 -3.49 . . . . 0.0 112.754 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.8 mp -60.97 -63.71 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.104 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.74 -40.54 69.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -52.78 -58.77 5.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.02 91.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.75 -48.96 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 43.3 mm -65.7 -49.64 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 45.9 mm -57.7 -52.43 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -57.91 -43.47 86.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -55.46 -42.9 74.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.6 t -63.86 -49.54 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -56.62 -51.34 69.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.1 t -67.96 -31.69 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -60.74 -53.62 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -35.72 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -43.43 65.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.0 t 59.7 -174.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -57.02 134.42 55.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -152.74 160.51 31.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 166.3 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.347 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.85 160.05 29.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.106 -0.83 . . . . 0.0 112.453 -179.901 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.799 0.333 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.04 -131.62 1.46 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.5 172.34 23.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.77 43.83 5.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -176.87 43.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.92 166.85 17.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.75 178.35 8.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -70.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -54.95 -42.17 72.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -51.91 -57.0 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -47.9 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -51.13 -47.42 62.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.51 36.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.98 -56.22 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.147 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t -58.6 -48.82 79.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -51.95 -39.7 59.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.48 -41.05 69.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.22 -44.31 92.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -36.09 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.9 m -69.67 -53.4 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.86 -46.54 89.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.8 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 tp -55.97 -47.54 77.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.18 -54.41 47.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.79 71.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 m -72.13 -41.51 67.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -41.19 94.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.01 -37.89 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.02 -53.26 52.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.98 -47.95 75.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.21 -48.25 68.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.14 -29.76 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -79.9 -7.12 58.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -27.09 29.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -113.49 -4.04 13.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -94.73 8.99 40.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.6 m -104.27 -171.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -77.87 158.36 29.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.76 -55.19 28.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.49 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -87.77 -14.03 40.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -51.36 -49.73 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -36.1 69.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.2 p -56.92 -45.31 82.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.836 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.42 -27.14 66.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -71.0 -53.49 14.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.2 m -72.02 -47.27 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 p -68.77 -38.68 80.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.3 -33.82 58.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.89 -46.65 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.98 -44.07 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 97.3 m -70.54 -34.04 71.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.83 37.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -36.83 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.43 62.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -61.99 -48.81 78.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -64.36 -51.87 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -57.05 -52.68 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.64 -65.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -51.43 -32.88 28.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -61.07 -67.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.5 mmt -67.86 -59.58 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -50.91 -40.21 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.17 -57.62 4.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.8 p -53.77 -35.6 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.101 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -76.33 -58.5 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.5 tp -56.83 -24.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -54.59 -27.16 37.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 t -107.95 -21.6 12.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.77 -109.56 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -123.53 142.5 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.25 161.99 38.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.69 0.757 . . . . 0.0 110.859 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 136.54 33.36 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 0.0 112.358 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -69.9 -29.96 67.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.7 m -58.78 -45.75 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -69.93 -53.36 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -56.02 -47.96 76.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -57.26 -55.3 36.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.5 mt -62.35 -29.88 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -61.37 -61.61 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 109.24 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.46 -31.27 71.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.21 -22.72 61.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.929 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.2 tt -101.26 -18.82 15.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 35.8 m -94.79 -33.04 13.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -57.78 -56.76 31.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.602 0.715 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.81 -26.23 27.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -75.54 -54.0 7.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 pp -65.04 -39.47 93.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 17.4 mm -65.94 -43.9 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.0 t -61.76 -52.75 62.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.67 54.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.82 -45.84 64.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -44.91 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -50.29 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 40.8 mm -59.93 -59.44 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.73 -22.09 44.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.22 -44.47 46.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.29 -17.97 33.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.48 -39.07 62.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 -67.63 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -161.43 -75.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -151.77 135.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -103.69 100.05 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.52 -8.51 59.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -52.17 -25.44 9.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -63.52 -34.64 78.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -47.02 81.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -69.0 -44.76 72.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -64.41 -37.3 87.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.65 -47.66 62.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.49 -58.8 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.0 -51.57 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.36 -43.1 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.7 t -66.88 -36.6 82.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mt -64.08 -54.3 36.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -60.12 -39.68 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.06 -45.87 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.7 -49.63 83.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -66.69 -33.17 75.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.17 -52.07 15.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -65.22 -52.18 56.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 mmt -66.0 -44.6 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.66 -32.56 84.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -46.82 -52.69 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.89 16.33 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.44 50.16 42.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.511 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.6 mt -83.46 -18.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.96 132.1 54.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.87 -162.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.99 -25.64 48.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.598 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.3 m95 -66.42 -53.64 29.21 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.79 -12.35 32.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.35 -47.09 29.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.32 -34.38 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.95 -57.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.6 mt -65.61 -47.74 85.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.21 -42.75 93.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.482 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.56 -50.93 63.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -55.87 -48.62 75.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.88 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -55.72 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.16 -48.92 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.11 -41.65 97.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -55.89 -59.28 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.7 mp -66.18 -31.67 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.39 -52.57 64.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -73.72 -34.58 64.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.23 -18.94 62.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -65.66 -35.22 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.21 18.85 14.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.68 -156.87 0.14 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.99 -12.85 61.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.2 15.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -77.16 -38.1 52.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.5 t -58.69 -53.45 58.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -75.39 -11.15 59.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 t -52.98 -20.24 3.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.31 -58.47 4.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 12.92 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.5 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.22 163.21 24.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -18.37 36.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.58 -47.76 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.3 t -62.27 -47.06 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -34.33 73.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -70.26 -45.18 66.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.6 95.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.88 -48.85 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.67 -56.19 24.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -59.08 -40.46 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -58.74 -52.36 66.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.1 ttp -61.02 -36.66 80.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -48.32 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.9 mm -64.15 -44.99 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.102 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 69.3 mt -55.28 -46.88 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.41 -49.7 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.17 -57.14 10.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -59.37 -58.83 12.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -52.7 -31.48 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.26 -30.05 54.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.3 mt -74.31 -31.03 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.515 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -45.87 -58.53 6.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.4 Cg_endo -69.74 -21.38 33.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.312 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.83 -44.67 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.81 -30.78 28.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -53.16 -57.96 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -31.05 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -51.74 -27.21 11.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.155 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.99 -7.04 5.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -101.86 -14.65 17.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.71 33.4 4.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.84 -170.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.46 51.74 0.85 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.14 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.26 48.85 3.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.456 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -109.37 50.82 0.75 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.493 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 159.41 26.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.36 67.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -62.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -51.96 -36.42 49.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.76 -52.09 65.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.84 -42.01 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -62.29 -55.46 27.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 84.4 mt -60.46 -48.76 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.15 -57.89 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -40.54 74.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -50.4 71.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.22 -54.83 38.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.55 -35.95 82.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -61.79 -53.08 60.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 8.6 p -71.9 -24.83 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -24.55 63.91 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 126.68 3.133 . . . . 0.0 110.83 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -112.91 -10.16 13.56 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 117.117 -3.489 . . . . 0.0 112.789 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.3 mm -91.97 -61.57 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.147 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.52 -35.49 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -54.72 -57.59 10.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.56 -42.76 87.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 12.4 tp -51.76 -50.98 59.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.914 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 3.2 mm -68.54 -37.01 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 4.0 mm -52.22 -57.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 -74.09 -29.39 61.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -53.74 -56.77 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.61 -43.62 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -55.87 -51.45 67.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.133 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 99.2 t -70.28 -41.93 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -54.06 -51.17 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -29.58 54.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.4 t -51.13 -30.84 17.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.48 -75.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -175.91 89.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -58.42 160.44 9.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.563 0.697 . . . . 0.0 111.128 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -47.89 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 172.17 -81.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.501 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.32 -166.25 12.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.05 173.39 21.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.49 162.54 36.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.483 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.12 118.54 4.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mt -140.85 164.63 29.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.24 164.01 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.69 -65.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -52.46 -44.53 65.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -56.22 -61.58 2.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -51.94 -42.81 63.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.1 m -60.65 -41.29 94.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.58 -54.19 24.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.16 -40.24 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.9 p -64.8 -49.59 70.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -56.16 -44.26 79.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.56 -47.8 80.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.23 -40.82 91.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.47 -49.12 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 m -57.75 -47.08 83.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.33 78.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.13 -47.85 80.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.094 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -60.78 -39.09 87.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.96 -56.83 15.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.52 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -69.7 -33.1 72.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.0 m -72.67 -45.68 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.37 -43.18 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.23 -49.11 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -63.71 -32.03 73.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -75.35 -52.3 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.8 t -64.77 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.06 -0.62 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -26.51 60.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.79 -19.3 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 22.52 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG21 HG22 ' A' ' 243' ' ' VAL . 0.5 OUTLIER -94.75 174.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.63 150.44 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.86 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -79.17 -26.56 42.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -87.13 -6.23 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -51.58 -50.46 60.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.7 p -77.83 -35.68 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -59.43 -42.48 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.1 -30.21 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -55.65 5.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -57.79 -51.8 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.89 57.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.63 92.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.86 -47.18 60.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -58.53 -56.43 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -63.55 -39.31 94.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.65 -68.95 1.46 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -33.97 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 111.127 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.97 -52.43 59.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -58.81 -48.77 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.1 -50.57 71.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -55.8 -60.88 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -54.2 -58.77 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.9 -33.35 36.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -65.58 -69.15 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.71 -57.37 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.435 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -55.31 -52.22 64.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.435 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -59.57 -47.6 90.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.458 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 t -61.37 -46.65 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.106 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -56.48 11.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.8 tp -58.81 -26.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -21.65 47.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 p -114.2 -30.62 6.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.46 -110.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -98.56 -176.08 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.769 0.319 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -115.78 155.68 47.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.679 0.752 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 121.51 8.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -69.69 -35.87 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.99 -44.71 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.149 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -71.39 -44.27 65.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -64.45 -48.16 76.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -59.86 -52.78 63.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.96 -30.01 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -61.66 -57.44 11.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 109.297 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -69.82 -30.67 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -75.12 -19.39 59.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -101.01 -31.73 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 55.8 p -79.83 -39.62 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -50.83 -56.61 18.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.79 -38.48 7.67 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.315 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.5 -51.99 67.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.11 -41.99 85.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.8 mt -59.93 -48.62 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.099 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.3 t -62.22 -57.53 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -52.07 -40.54 61.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -66.37 -50.18 64.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -35.38 65.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.58 -61.19 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.9 pt -55.68 -36.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.78 -50.8 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.61 67.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.05 -11.11 60.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.119 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.1 -29.67 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 -67.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -174.84 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 m -151.54 142.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.37 108.14 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.81 -5.49 69.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -50.22 -27.98 6.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.903 0.382 . . . . 0.0 110.811 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.62 -41.0 96.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -58.83 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -48.31 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -60.28 -34.99 74.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 tp -68.33 -48.8 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.92 -56.73 18.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.96 -43.1 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -58.04 -41.27 94.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.446 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -35.16 71.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -53.84 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.5 m -58.16 -43.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -28.99 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.11 -50.33 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.7 m -70.3 -41.22 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -61.92 -38.92 90.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 -50.5 9.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -63.24 -50.53 69.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 14.1 mmt -65.49 -52.68 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.77 -32.61 74.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.72 -30.21 13.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.53 -27.28 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.76 9.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.3 pp -103.92 8.82 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -169.29 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.32 107.59 18.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.33 -22.55 59.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.3 t-105 -52.85 -57.8 14.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.59 0.71 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.76 -19.24 36.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.329 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.22 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.26 -40.88 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mt -60.67 -41.59 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.086 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.8 mt -59.12 -57.17 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.55 94.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 39.0 t -63.39 -57.36 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 35.2 mt -53.52 -50.5 65.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.35 77.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -64.53 -55.25 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.3 t -55.66 -51.61 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -35.59 75.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.6 mmt -61.62 -59.86 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.8 mp -58.39 -36.4 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.34 -36.37 82.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.05 -38.82 61.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.11 -11.14 57.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.33 -25.41 48.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.38 18.35 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.88 -130.39 1.51 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.66 -12.69 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.933 0.397 . . . . 0.0 110.909 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.01 -77.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -68.43 -25.03 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.885 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -70.89 -25.86 62.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -65.19 -14.48 60.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.088 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 10.34 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -94.34 -76.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 t -120.14 -14.6 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.19 -166.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.115 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.2 164.02 15.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 0.0 110.857 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.58 33.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.56 -44.48 34.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.067 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.52 -48.05 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -58.13 -36.99 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.2 m -68.2 -45.21 74.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.855 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.55 -39.43 91.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.68 -51.8 52.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -45.2 75.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.9 p -66.22 -38.24 87.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -50.5 73.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.03 -34.48 76.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -59.54 -49.54 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 22.0 pt -70.53 -36.72 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 mm -63.0 -48.77 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 55.7 mt -67.06 -51.91 49.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.1 -56.08 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.93 -58.48 14.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -54.21 -31.88 54.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.18 -24.64 43.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -78.93 -31.96 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.9 t80 -48.16 -55.42 18.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.71 -24.92 29.38 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.26 -43.18 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -84.07 -27.74 36.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.504 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -46.07 65.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.899 0.38 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -31.39 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -23.0 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -118.86 -26.35 2.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -76.4 -50.56 13.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.46 -23.59 61.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.2 tpp -75.8 -169.44 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.28 6.63 81.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -24.03 35.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.83 64.59 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 52.14 73.89 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 171.84 13.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -39.02 57.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.39 -62.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -53.35 -42.51 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -53.64 54.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -58.18 -42.31 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.37 -58.82 6.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 47.4 mm -59.26 -47.92 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -58.07 -39.64 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -70.5 -46.24 64.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -51.27 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.59 -50.85 70.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.3 -28.08 69.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.66 -48.96 19.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.34 -23.15 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -90.9 3.11 55.44 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-O 126.72 3.152 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -129.96 -64.88 0.85 Allowed 'General case' 0 N--CA 1.424 -1.769 0 O-C-N 117.128 -3.483 . . . . 0.0 112.782 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 42.8 mm -55.86 -62.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.136 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -32.65 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -52.68 -55.77 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.81 -36.13 58.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -51.54 69.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.329 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.1 mm -68.85 -49.6 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 21.5 mm -56.87 -32.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 20.1 t90 -76.01 -47.52 24.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -57.19 -40.84 78.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 9.4 p -74.21 -40.47 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.7 86.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.401 HG22 HG21 ' A' ' 54' ' ' VAL . 43.7 t -78.54 -48.19 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -60.11 -37.56 80.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -76.95 -45.99 25.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 20.7 t -55.64 -72.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.5 t 58.39 44.45 18.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -158.42 94.67 1.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -87.54 160.39 47.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.521 0.677 . . . . 0.0 111.15 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -43.93 2.38 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.677 2.251 . . . . 0.0 112.363 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 136.71 38.64 0.15 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.482 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.442 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.778 0.323 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.88 81.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.05 -114.07 4.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.449 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.07 -149.15 38.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -86.9 131.24 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.49 124.51 51.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.55 175.53 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.2 -75.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -34.38 64.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.41 -64.11 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -48.11 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.6 m -51.58 -43.78 62.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.166 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.64 -50.47 30.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.8 t -52.04 -51.14 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 111.176 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.74 -49.88 69.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -53.28 -47.04 69.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -48.02 75.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.59 -41.86 86.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.75 -43.94 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 m -60.67 -53.28 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.79 74.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.84 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tp -53.03 -45.16 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 18.7 tp -64.1 -54.12 38.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.84 73.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -70.38 -34.54 72.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.6 m -72.76 -49.29 31.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.9 m -65.88 -39.53 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -69.46 -52.12 29.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.59 -31.79 72.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -74.62 -52.16 12.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.92 -38.81 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.72 -6.33 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -55.11 -26.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -99.99 -12.84 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 40.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -116.48 160.42 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 t -47.79 152.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 -54.52 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -20.51 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.88 7.84 25.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -50.27 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -37.47 55.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.6 p -53.48 -37.08 62.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.03 -34.62 78.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.92 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -71.08 -47.69 56.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 t -70.21 -58.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -63.69 -41.42 98.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.58 91.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.0 t -59.25 -52.07 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -65.46 -26.45 67.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.3 -55.03 17.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.537 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.58 -42.47 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.108 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.52 96.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -60.87 -52.49 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -44.19 72.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.0 -54.75 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -41.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.5 ttp -59.85 -46.01 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -70.07 -30.79 68.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -63.87 -59.81 4.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -41.86 97.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.86 -49.03 73.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.1 -43.69 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -52.78 -51.47 60.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.4 mm -73.08 -26.37 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -49.01 -48.0 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.0 p -146.33 -40.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.52 57.09 0.13 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.34 127.03 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 p -113.26 75.1 2.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.739 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 93.17 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -51.22 -35.14 35.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.88 -43.8 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -68.09 -48.05 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -51.58 63.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -56.72 -55.55 32.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.96 -34.81 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.76 -68.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 25.3 m0 -57.48 -35.63 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.18 -18.27 62.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.2 tt -100.29 -23.08 14.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 21.9 p -91.72 -32.44 15.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.571 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.9 t -57.73 -55.52 44.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.662 0.744 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.77 -38.37 7.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 0.0 112.36 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.51 -52.91 61.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.93 -40.98 99.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 70.5 mt -67.05 -38.46 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.1 t -63.15 -62.53 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.39 -49.09 67.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -52.32 -50.36 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -39.64 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -51.47 69.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 mm -58.51 -52.75 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -21.97 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.36 -40.35 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.02 14.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.1 -54.69 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -53.8 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -164.96 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.3 m -143.51 150.25 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.3 122.69 36.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.71 -2.61 70.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.9 p -47.53 -31.28 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -53.96 -52.02 61.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -59.74 -48.64 80.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -61.1 -33.51 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.41 -48.16 68.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.22 -53.13 60.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 61.0 t -58.77 -48.01 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -39.31 97.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.528 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -65.82 -39.1 90.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.49 -53.38 35.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.71 -36.08 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -70.51 -39.83 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 66.8 t -64.69 -47.0 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -57.35 -42.3 81.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.36 21.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -56.12 -51.08 69.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.923 0.392 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -31.6 69.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.15 78.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -48.36 -33.08 8.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.94 -27.33 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.11 18.3 40.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.431 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 pt -93.69 -34.74 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.93 119.28 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 151' ' ' ALA . . . 172.73 -55.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -42.12 -34.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.53 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -85.33 -64.82 0.22 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.568 0.699 . . . . 0.0 110.892 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.72 -54.74 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . -43.22 -38.49 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.41 -51.42 69.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 2.9 mp -70.36 -40.1 77.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 77.8 mt -60.72 -50.96 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.3 94.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 47.3 t -55.81 -51.17 68.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 110.904 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.05 -49.75 76.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.14 71.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.75 -54.93 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.0 t -53.05 -43.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.92 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -47.82 73.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.17 -40.39 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.81 -50.62 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.99 -43.92 56.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 34.9 tp -57.34 -40.45 78.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -57.73 -20.57 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.87 18.34 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -50.72 124.96 21.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -73.4 -3.97 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -57.38 -62.27 6.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -76.69 -25.09 53.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -72.85 -26.15 61.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.2 -45.03 72.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.87 -15.3 61.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.01 -59.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 79.7 p -95.96 -8.17 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.82 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.81 162.07 54.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 0.0 110.871 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.85 10.06 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.68 -42.47 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 48.5 t -67.13 -41.72 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -66.11 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.2 t -72.53 -48.65 38.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.61 96.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -65.53 -52.24 54.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -54.68 -50.32 68.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 75.5 p -60.66 -39.92 90.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -52.02 67.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -35.76 81.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -49.1 78.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.11 -48.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -50.97 -48.16 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 73.9 mt -65.32 -44.85 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.163 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -59.32 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.25 -55.74 24.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.5 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -51.18 -33.8 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.763 0.316 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.42 -30.36 42.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.8 mt -67.74 -32.11 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -51.88 -60.55 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.74 . . . . 0.0 110.939 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.74 -24.51 29.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.671 2.247 . . . . 0.0 112.344 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 29.8 t -75.23 -33.77 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.03 -36.62 17.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -32.74 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -67.14 -30.67 70.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.3 p -47.79 -31.68 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.77 56.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -89.85 -23.4 21.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.33 -14.28 9.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -171.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 22.18 4.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.38 -38.35 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -145.4 60.35 0.49 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.99 24.5 5.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.61 175.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 0.0 110.867 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.81 -27.23 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.0 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -52.29 -34.79 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mp -62.18 -56.03 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -58.23 -39.16 78.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.38 -51.46 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 27.1 mt -59.65 -45.25 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -56.63 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -38.53 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.14 -51.31 68.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.26 36.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.66 -45.54 93.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -51.34 -54.86 22.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.6 -24.7 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -82.56 1.42 38.1 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.745 3.164 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -130.28 -63.1 0.91 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.083 -3.51 . . . . 0.0 112.751 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.8 mp -56.48 -63.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.109 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 -33.69 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.74 -53.82 52.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.86 -36.71 87.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.93 -40.19 83.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.41 -49.73 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 11.8 tt -63.44 -33.88 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -75.52 -42.88 51.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.96 -40.79 98.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.74 -37.89 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.64 -41.36 68.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 86.4 t -73.39 -35.92 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -74.69 -35.7 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -76.75 -35.33 57.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 85.3 p -51.21 -49.16 61.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.9 t -164.72 -58.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -159.17 163.89 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -149.47 73.75 9.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.575 0.702 . . . . 0.0 111.132 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -41.79 4.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 142.32 -101.32 0.27 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.143 -0.81 . . . . 0.0 112.467 -179.888 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.508 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.815 0.341 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.24 124.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.442 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.7 -94.33 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.56 128.58 2.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.45 -59.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.94 156.16 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -178.25 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -61.69 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.32 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.33 -74.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -47.23 84.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.1 m -52.37 -45.04 65.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.186 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.65 -51.91 33.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.5 t -53.84 -55.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 111.132 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.1 p -58.52 -49.96 75.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.92 -39.33 58.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -70.14 -43.4 71.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -44.88 94.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -69.57 -34.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.087 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.3 m -68.18 -54.3 18.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.71 88.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.94 -55.14 18.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.65 -32.76 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.1 mp -66.51 -57.75 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 t -70.2 -37.9 75.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.2 m -67.73 -46.39 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.85 -41.55 92.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.26 -51.09 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -62.87 -28.67 70.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -74.34 -49.18 23.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.09 -30.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.209 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.54 -6.03 56.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -59.88 -26.75 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -96.61 -9.8 28.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -108.38 42.34 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.74 159.25 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.4 t -50.12 139.58 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.69 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -23.88 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -90.05 11.29 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -49.94 -50.06 47.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.76 -38.92 53.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.16 -43.57 67.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.83 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -68.69 -53.72 20.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 m -70.98 -45.79 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.6 t -66.7 -39.42 88.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.79 -34.71 59.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.73 -48.26 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.54 -44.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.7 m -69.0 -34.52 75.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.46 51.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.68 -46.79 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.75 91.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -58.02 -56.34 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -49.98 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -56.73 -44.99 82.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -59.26 5.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.3 ttm -47.17 -41.76 18.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -68.99 -40.41 78.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.01 -58.03 6.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.486 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -57.03 -42.82 81.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -63.37 -42.46 99.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.56 -30.01 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -71.99 -41.83 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 tt -76.62 -30.8 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.118 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -80.95 -49.79 10.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 m -79.17 -38.45 35.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -23.11 35.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -148.14 126.79 12.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.833 0.349 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 161.16 36.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.897 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 99.14 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.704 2.27 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.2 p -64.28 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 m -50.38 -35.13 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.23 -49.99 57.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -57.74 -45.74 85.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.79 -55.1 33.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.5 mt -61.28 -26.37 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.17 -67.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.107 . . . . 0.0 109.301 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -51.86 -33.2 35.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.6 tp -74.6 -38.55 62.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.22 -5.28 59.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.946 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.3 m -107.56 -39.43 5.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -44.61 -58.91 4.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.6 0.714 . . . . 0.0 111.159 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.74 -19.53 36.08 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.67 -51.69 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.05 -35.88 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.1 -50.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.72 -47.63 80.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -56.62 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -51.47 -51.09 57.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -65.53 -35.09 79.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.0 -66.95 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.931 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 49.7 mm -56.22 -45.25 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.3 tp -57.05 -44.69 83.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.67 -15.85 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.092 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.72 -23.37 11.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -22.73 62.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.6 t -128.17 -47.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -179.45 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -155.06 161.86 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.24 125.53 42.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.89 -11.02 84.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -50.56 -31.91 17.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.19 -38.64 83.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -45.31 93.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.9 mttm -62.15 -50.51 71.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.65 -35.39 80.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 tp -63.06 -48.51 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -57.59 8.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 49.3 t -54.92 -46.86 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.53 99.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.1 t -62.88 -39.62 95.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -47.02 61.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 97.8 t -56.73 -51.44 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -32.22 72.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -48.93 79.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.1 t -71.48 -40.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.4 ' HB2' H163 ' A' ' 301' ' ' RET . 7.8 t80 -63.32 -43.18 98.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.24 34.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.17 -56.0 13.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.21 -32.84 74.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.78 -29.65 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.448 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -55.31 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.34 -27.4 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.07 39.59 5.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tt -47.37 -33.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptm -108.58 -170.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.35 -174.4 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.93 -20.34 56.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.542 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -61.41 -56.75 30.66 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.535 0.683 . . . . 0.0 110.89 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.1 Cg_endo -69.73 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.16 32.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.61 -35.77 82.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.3 mt -58.23 -51.7 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.22 -45.78 95.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.0 99.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.499 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 12.5 m -63.9 -50.59 68.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -49.64 76.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.19 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -62.53 -55.98 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.25 -47.94 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.34 -40.14 89.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 10.7 ttm -60.95 -56.37 21.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.8 -32.33 51.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -50.89 68.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -73.87 -25.34 59.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.43 -43.33 40.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -57.54 -23.59 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.12 17.19 23.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.7 133.6 39.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -78.3 -0.35 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.32 -41.34 39.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -76.67 -26.28 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.9 m -56.46 -24.81 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -47.93 -47.68 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.078 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 69.8 m -117.17 -1.49 11.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 74.94 -59.03 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.65 -10.89 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.187 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.86 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.076 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.26 162.99 20.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.866 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.16 22.84 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.344 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -46.77 28.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.84 -43.61 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -35.1 79.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.5 t -69.8 -47.28 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.59 97.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.047 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -65.88 -50.83 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -56.02 -55.49 32.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.5 m -58.88 -37.75 77.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.9 tpt -60.0 -48.74 80.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.26 77.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -50.71 70.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -35.2 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.93 -48.34 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 65.5 mt -64.85 -47.76 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.81 -59.16 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.41 -56.99 22.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -53.71 -32.11 50.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.94 -26.31 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.106 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 18.4 mt -76.8 -28.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -42.7 -57.13 5.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.669 0.747 . . . . 0.0 110.954 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.6 Cg_endo -69.79 -82.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 20.5 m -33.7 -42.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -65.24 -57.79 10.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -57.01 -19.91 21.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.92 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -47.05 -26.98 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 t -49.53 -28.28 5.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.59 -27.24 48.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 16.2 mt -127.43 -53.71 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.98 87.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -88.9 -15.55 59.27 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -52.48 -29.43 24.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -115.76 -17.78 6.32 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -104.59 77.34 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -179.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.78 -27.63 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.09 -51.97 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -61.39 -40.94 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.52 -42.84 93.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -66.63 -47.17 73.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -53.06 -58.75 5.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.14 -40.77 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.139 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -62.61 -42.39 99.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -63.89 -46.2 85.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.03 17.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.11 -27.21 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.52 -54.92 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.9 p -68.2 -23.55 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -69.75 -33.62 72.68 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 126.739 3.161 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -103.58 -8.72 19.8 Favored 'General case' 0 N--CA 1.424 -1.773 0 O-C-N 117.11 -3.494 . . . . 0.0 112.747 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.3 -63.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.137 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 7.5 tp -53.82 -31.09 47.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.54 -56.25 23.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.93 83.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 -39.39 85.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.0 mm -70.25 -50.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.2 mm -62.44 -35.79 71.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -76.84 -45.74 27.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.21 -42.11 85.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.4 p -74.67 -38.23 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.9 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.27 -40.79 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.164 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.9 -39.11 93.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.88 -48.65 17.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.2 t -59.78 -68.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.44 -75.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -107.26 158.19 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -104.43 160.37 26.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.122 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -18.27 37.07 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.88 45.27 5.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.487 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.512 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.9 mtp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.23 154.67 7.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.88 -143.17 8.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.23 176.08 46.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.539 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.81 124.11 27.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.31 158.69 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.96 178.39 8.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.77 -75.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -33.67 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.8 -56.51 21.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -47.71 83.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 30.5 p -51.04 -47.05 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.113 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.79 -50.87 32.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 93.0 t -52.78 -55.67 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -60.83 -48.13 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -53.83 -41.56 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -47.24 68.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.08 -43.64 98.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 94.6 t -66.62 -41.41 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -62.63 -43.12 99.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.69 49.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.42 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 tt -53.14 -50.13 65.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.09 -55.73 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.75 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -72.02 -44.51 63.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.2 p -59.69 -47.28 86.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.7 m -67.11 -42.83 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.08 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.95 -52.17 65.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.22 -47.76 82.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -74.95 -38.7 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 87.9 mt-10 -81.16 2.67 26.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.71 66.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -97.2 -3.05 41.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -110.31 23.73 13.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.44 -170.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 153.7 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.59 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -21.68 55.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -88.93 10.43 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -51.01 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 p -77.88 -26.0 48.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -54.76 -43.27 72.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.7 -27.66 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -64.49 -53.68 44.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.53 -51.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 t -60.86 -35.48 76.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -42.27 63.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.66 -50.18 72.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.42 -43.48 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.146 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 98.6 m -67.33 -36.66 81.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.82 -46.93 88.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.11 -48.42 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.98 84.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -53.31 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.86 -41.99 68.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -66.98 -59.66 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -42.02 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.06 -46.54 87.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -61.87 -60.11 4.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -32.96 63.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -65.31 -33.57 87.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.1 t -68.83 -38.47 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -71.6 -45.24 62.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.1 tp -72.2 -26.01 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.59 -47.79 49.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -143.28 -39.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.69 36.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -153.6 127.37 8.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.24 160.07 50.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.699 0.761 . . . . 0.0 110.822 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 101.44 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 m -69.3 -31.58 70.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.39 -51.19 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -51.72 57.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -48.63 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.69 -55.42 34.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.9 mt -55.49 -36.59 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -52.79 61.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.297 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -59.8 -43.19 94.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.97 -20.92 61.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.38 -17.43 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 71.8 p -96.77 -25.47 15.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.536 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.6 t -57.15 -56.87 29.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.618 0.723 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.78 -27.61 26.17 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.91 -47.25 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -51.05 62.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 36.2 mm -58.49 -56.05 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.33 -34.56 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.18 -65.56 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.92 -52.29 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -56.91 -44.93 82.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.43 -59.49 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.5 mm -51.93 -42.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -27.99 67.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.59 -25.97 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.57 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.96 -20.07 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.53 -73.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 170.1 -76.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.3 146.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.99 96.1 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.16 -3.48 89.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -48.8 -36.39 16.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -48.83 28.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -70.14 -50.02 44.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.68 -52.95 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.74 -47.55 74.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.71 -59.97 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 16.6 m -58.37 -33.65 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.41 -46.99 65.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.542 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -65.65 -49.36 68.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.835 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.69 -52.83 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -59.78 -41.88 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -64.42 -44.89 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.4 tt -60.45 -57.78 11.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.3 t -53.14 -52.06 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.89 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.95 8.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -56.46 19.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -30.84 68.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -64.01 -30.29 77.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLY . 2.8 tt0 -35.7 -59.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 110.894 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.13 -30.47 4.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.89 -13.3 44.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.08 5.69 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.24 144.68 32.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 61.94 32.29 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.97 96.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -69.88 -58.52 5.31 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 110.925 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.5 Cg_endo -69.68 -5.12 15.39 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.329 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.02 -49.97 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.22 -45.76 79.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.7 mp -61.57 -43.37 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.2 mt -65.61 -55.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.71 98.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.94 -52.53 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.61 -49.78 67.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.03 -34.21 77.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -67.08 -54.69 19.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 99.3 t -57.95 -49.47 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -61.13 -43.06 99.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.9 mtm -55.44 -58.61 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 85.1 mt -65.47 -31.9 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -58.93 -47.58 84.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -41.99 63.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.32 -16.73 63.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -56.53 -25.84 53.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.71 19.01 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -64.72 -153.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -69.53 -11.07 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.907 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -79.78 -40.61 14.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -56.92 -61.34 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.4 p -63.28 -25.26 68.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -59.09 -19.38 43.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 41.9 t -51.41 -30.07 18.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -39.28 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 p -71.52 -9.07 57.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.84 -166.63 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.12 163.08 24.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -20.08 35.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.357 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.51 -52.77 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.74 -48.82 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.173 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -58.28 -37.53 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -65.38 -47.15 77.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.12 88.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.22 -51.66 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -49.22 73.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -63.85 -32.38 73.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.67 -35.34 75.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 5.1 ttp -74.96 -36.08 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -40.89 69.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 7.1 tp -71.09 -44.02 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.1 tt -65.92 -37.92 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 45.5 mt -69.1 -49.5 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -51.69 68.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.67 9.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.73 -34.6 59.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.34 -24.56 46.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.26 -32.28 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.544 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 2.8 t80 -48.44 -57.22 11.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.669 0.747 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.8 -25.35 28.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.651 2.234 . . . . 0.0 112.313 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 40.9 t -68.6 -40.57 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.115 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.95 -43.4 8.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -54.94 -31.2 60.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.935 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -49.99 -32.69 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.4 t -51.33 -27.88 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -0.26 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.53 -50.33 10.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -113.76 24.69 11.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -169.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -94.15 19.07 55.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.13 -25.55 11.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.58 76.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 68.14 128.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 168.76 11.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 110.851 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.79 86.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.95 -63.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -56.38 -42.03 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 9.8 tp -55.56 -49.28 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.42 -42.27 98.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.18 -58.0 10.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 37.3 mm -53.9 -46.98 64.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -60.46 -48.14 83.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.19 -38.99 93.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.69 -51.38 69.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.06 -55.21 36.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.16 -40.7 77.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.98 -40.99 99.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 88.2 t -71.98 -26.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -97.85 1.74 48.54 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 126.749 3.166 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -116.48 -63.92 1.38 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.049 -3.532 . . . . 0.0 112.776 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.81 -64.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.143 174.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -39.66 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.912 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.35 -58.83 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.24 93.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.28 -44.46 92.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.958 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -47.89 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 32.0 mm -54.85 -50.93 57.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -72.15 -29.64 64.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.62 -54.23 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.5 p -76.14 -40.36 36.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -61.35 -53.44 56.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 94.4 t -65.89 -47.51 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -58.69 -43.69 90.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.03 -41.3 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.5 p -50.83 -35.14 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.22 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -115.31 159.34 21.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -165.38 72.63 1.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.549 0.69 . . . . 0.0 111.079 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 90.99 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.358 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.92 -113.87 4.09 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.172 -0.793 . . . . 0.0 112.508 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 CA--C 1.526 0.041 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.37 -177.51 42.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.511 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.17 175.02 47.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.29 113.69 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.552 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 55.57 -175.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.23 111.53 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.02 160.94 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.93 -42.22 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -58.19 -36.85 73.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -61.36 -60.51 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.401 ' HB2' HD21 ' A' ' 217' ' ' LEU . 1.5 m-85 -61.15 -48.19 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -51.57 -47.31 63.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.81 -51.73 28.21 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.2 t -54.67 -55.33 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.03 -48.61 80.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -52.32 -45.57 65.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.46 83.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.01 -39.25 91.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.51 -52.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -62.49 -45.73 91.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.79 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.18 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 tt -51.12 -52.83 39.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 21.2 tp -55.29 -53.34 57.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.74 -40.62 66.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -69.2 -32.17 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -73.06 -46.81 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.57 -42.89 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.159 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -68.24 -49.79 58.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.55 -27.63 69.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -74.42 -49.55 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.6 t -71.26 -38.27 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -79.58 -7.45 58.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -56.54 -26.85 56.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.41 -11.05 21.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.19 38.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 243' ' ' VAL . 5.2 p -113.24 162.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.32 149.21 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.61 -55.58 12.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -60.51 -22.99 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -88.78 8.75 27.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.73 -50.37 55.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -73.76 -34.49 64.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.207 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m -50.73 -45.04 58.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.01 -30.12 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 -55.51 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.8 m -67.88 -51.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -65.06 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.95 68.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -70.12 -47.63 60.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.6 p -65.24 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 68.9 p -71.79 -33.12 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -49.25 54.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.1 tt -67.64 -43.39 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.09 -39.78 93.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -63.06 -57.78 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -53.74 -50.07 66.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.92 -47.38 74.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -44.13 97.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -51.02 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -62.32 -48.75 78.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -57.32 12.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -51.58 -54.59 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -39.54 54.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -67.33 -43.85 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -57.06 -52.28 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -25.67 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -48.37 40.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.6 p -139.0 -39.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.53 -6.78 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -122.56 127.14 49.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.82 160.35 41.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.676 0.75 . . . . 0.0 110.848 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 86.65 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -56.66 -33.35 66.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -61.55 -34.4 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -51.35 68.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -67.59 -34.68 77.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -55.09 32.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.93 -43.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -33.01 73.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -68.86 -50.29 51.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.42 -13.3 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -95.82 -25.34 16.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 62.6 m -95.33 -35.8 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.518 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -50.12 -58.07 10.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.661 0.743 . . . . 0.0 111.178 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.8 -35.68 12.09 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.676 2.25 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.9 mt -62.48 -43.38 98.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -46.14 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.62 -41.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 32.9 m -68.25 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.4 -52.37 22.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -57.88 -51.61 68.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -51.83 -36.67 48.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -62.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.4 pt -52.89 -38.75 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -51.43 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.83 -18.85 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.71 -23.68 30.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.16 86.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t 179.15 -48.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.28 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.68 167.77 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 111.22 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.14 -3.03 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 m -50.59 -20.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.3 -33.18 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -67.46 -44.66 78.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -65.3 -45.33 84.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -37.53 87.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.16 -43.05 79.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.46 -56.35 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 12.0 p -58.49 -39.59 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -65.2 -46.4 87.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.448 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -41.69 97.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.908 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.84 -52.41 63.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 82.0 t -54.92 -46.01 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -27.14 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -45.71 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.0 m -73.27 -35.52 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -70.42 -38.72 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.32 -43.68 19.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.529 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -67.63 -51.86 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.97 -35.46 74.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.27 -32.7 57.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.535 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.65 -32.1 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.0 -26.06 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.81 22.99 12.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.58 0.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.29 -170.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -154.99 162.7 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.71 61.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.505 ' CE3' ' HA ' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -70.49 -59.57 3.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.535 0.683 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.1 Cg_endo -69.75 -14.05 35.58 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.55 -37.27 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.09 -37.81 88.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.3 mp -60.53 -53.15 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.26 -50.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.33 -49.07 82.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.02 -50.0 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.47 -45.62 84.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.05 83.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -64.64 -55.24 21.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.23 -46.88 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -37.02 86.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 10.7 mtp -59.43 -53.59 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.99 -42.87 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -54.01 -44.4 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -74.65 -57.67 3.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.5 mt -51.5 -58.45 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.12 -20.1 23.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.27 19.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.63 -170.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.86 -3.67 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.93 20.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -64.81 -40.42 95.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -31.17 46.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -71.85 -9.11 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.081 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 14.3 p -50.22 -25.04 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -50.21 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.91 11.37 39.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -51.6 168.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.15 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 160.59 62.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -24.26 30.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.66 2.24 . . . . 0.0 112.356 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.2 52.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.86 -43.29 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -35.67 81.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.2 m -71.28 -47.5 56.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -60.39 -41.87 94.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.85 -52.79 39.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -52.46 -54.1 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 43.7 p -58.14 -45.63 87.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -44.41 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 17.5 ttp -72.43 -29.97 64.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -40.32 69.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -72.67 -44.45 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.16 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.447 ' N ' HG22 ' A' ' 192' ' ' ILE . 6.5 tt -65.28 -40.99 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 44.4 mt -69.13 -49.38 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -52.41 -58.15 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.29 -57.76 18.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -54.28 -32.07 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.927 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.79 -23.87 44.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 11.8 mt -77.12 -32.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.6 OUTLIER -48.85 -55.8 18.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 110.94 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.82 -21.7 32.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.246 . . . . 0.0 112.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 50.2 t -71.07 -43.66 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.34 -40.93 10.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.482 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.67 -57.4 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.52 -32.56 72.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.16 -25.86 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.36 -7.54 5.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -78.6 -51.11 10.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.97 38.69 3.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -167.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -51.76 -74.3 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -175.63 38.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -112.45 -1.09 26.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -57.87 99.28 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.95 173.03 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.55 70.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 28' ' ' TYR . 10.9 mp -55.28 -63.31 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -54.21 -37.54 64.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -54.74 43.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -57.58 -48.76 78.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -58.94 -58.09 10.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 45.5 mt -54.87 -46.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.1 -48.98 79.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -61.28 -41.05 96.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 tp -61.21 -48.8 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.51 -55.28 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.91 -27.02 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -66.72 -55.71 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.43 -25.53 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -68.96 -8.25 42.82 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.68 3.133 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -129.85 -59.98 1.05 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 117.107 -3.496 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 50.0 mm -51.26 -63.22 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.102 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.82 -30.65 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -55.47 32.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.29 -37.09 93.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.42 -37.54 80.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.4 mm -69.43 -49.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.32 -35.58 74.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 17.0 t90 -75.95 -43.99 42.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.63 -42.2 92.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 10.3 p -74.07 -38.28 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.49 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.8 t -75.36 -40.78 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -66.96 -36.11 81.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -76.83 -44.03 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.5 t -51.74 -45.27 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.2 t 63.42 179.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.82 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -64.51 138.48 58.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -170.61 160.45 5.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 111.104 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -174.63 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.61 -169.76 41.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.481 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.441 -179.907 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.432 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.8 mtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.871 0.367 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.8 -132.28 6.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.26 68.99 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.47 89.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -147.39 -43.02 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.67 -176.18 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.82 -177.1 6.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.33 -72.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.75 -28.84 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.69 -73.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -43.76 63.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 96.2 m -61.01 -39.28 89.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -52.92 22.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -39.02 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 t -67.63 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.33 -42.68 78.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -46.9 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.86 -41.95 96.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.06 -43.28 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.132 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -59.5 -49.2 78.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.09 92.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.68 -55.48 23.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.84 -31.94 73.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.92 -53.4 46.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -34.55 78.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.61 -39.55 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.0 p -67.24 -43.52 81.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.7 m -68.5 -38.51 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.15 -49.04 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.72 -30.29 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.87 -50.17 63.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p -73.75 -33.45 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -79.65 -14.52 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -36.86 69.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.48 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.18 42.33 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 m -114.51 -170.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.66 155.37 40.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.51 -50.93 65.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -24.73 62.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -96.82 -4.33 40.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -51.57 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 t -77.62 -35.02 53.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 p -50.73 -41.66 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 mt -64.61 -33.16 75.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -68.65 -54.19 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.38 -57.01 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.53 89.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.57 -44.69 77.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.933 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.99 -55.25 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -33.1 75.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.23 -47.66 70.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.62 -46.9 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.22 -37.83 88.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -64.65 -54.04 38.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -45.49 80.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -59.7 -53.19 60.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -39.23 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -57.54 -55.2 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -53.04 62.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.6 mmt -54.42 -47.89 72.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -55.34 -56.68 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -34.0 73.75 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.1 t -70.24 -33.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.34 . . . . 0.0 111.077 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -73.84 -40.7 63.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.85 -26.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -87.52 -49.94 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 -39.67 26.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -12.72 56.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -152.97 130.16 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.29 162.01 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.706 0.765 . . . . 0.0 110.857 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 103.29 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -69.43 -26.67 64.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -42.21 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.172 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -48.38 67.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -57.67 -51.43 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.29 -50.62 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.08 -53.92 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.67 -34.01 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.108 . . . . 0.0 109.336 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.6 -59.58 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.59 -11.37 60.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.85 -17.12 25.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.426 ' HA ' ' HB2' ' A' ' 104' ' ' LEU . 81.7 p -110.95 -39.39 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.508 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -43.79 -58.49 4.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.79 -21.12 33.81 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.311 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.2 mm? -75.71 -54.37 7.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -49.55 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.77 -58.59 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.3 t -59.33 -34.38 72.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.41 -63.33 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -50.47 -51.09 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -61.66 -40.01 93.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.8 tp -57.67 -66.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -50.53 -34.56 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.158 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.58 -39.5 73.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.87 -14.82 59.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -17.07 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -24.64 60.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -119.26 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER 164.87 -78.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.13 134.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.89 97.46 4.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.26 -6.05 85.97 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -33.49 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.82 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -41.71 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.95 -37.47 64.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.95 -51.54 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -35.33 79.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.64 -49.79 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.17 -59.68 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.65 -46.98 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.67 -49.61 76.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -53.73 -46.2 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.32 -42.04 96.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.51 -55.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.96 68.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.77 -58.17 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.6 -41.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -62.38 -38.66 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.07 -51.31 18.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.6 -56.91 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.89 -32.69 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.22 -29.51 72.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -38.12 -55.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.97 -31.47 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.32 -9.36 20.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 pt -107.44 8.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.116 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.05 119.88 39.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 44.38 53.94 6.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.55 -53.28 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.088 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.612 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.3 t90 -52.83 -53.25 56.7 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.555 0.693 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.7 -17.2 37.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.256 . . . . 0.0 112.379 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -53.23 -34.69 58.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -29.33 69.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.62 -51.64 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.82 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.47 -46.9 23.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.1 t -61.71 -45.75 92.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.832 0.348 . . . . 0.0 110.875 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.71 -49.58 74.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.77 -29.89 70.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . 0.416 ' CD1' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -67.3 -57.48 6.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.7 m -60.02 -41.79 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.25 -45.86 89.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.2 mmt -57.05 -54.9 41.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 159' ' ' TRP . 2.1 mp -64.56 -37.32 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.83 -36.97 86.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.56 -39.5 62.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.54 -14.51 58.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.93 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.18 -27.42 33.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.12 21.1 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -42.23 132.22 4.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -78.35 1.0 23.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.27 -40.05 29.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.09 -28.95 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.5 m -60.43 -24.87 65.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.4 -30.49 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.27 -13.7 16.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 75.02 -59.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 82.7 p -92.02 -11.66 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 48.12 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.34 163.15 47.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.644 0.735 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.35 27.79 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.244 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.75 -39.88 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 71.2 t -68.34 -43.99 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.144 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -67.44 -32.98 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.0 m -71.77 -49.11 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.94 99.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.1 -44.76 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -58.08 -56.79 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.1 m -58.19 -48.22 81.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -52.0 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -32.63 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -49.25 77.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.4 mp -67.72 -47.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.55 -49.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.37 -48.15 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -59.93 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.0 -54.61 33.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -53.23 -30.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.304 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -80.05 -28.95 39.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.51 -30.77 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 24.5 t80 -48.03 -54.37 25.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.686 0.755 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.76 -22.46 32.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 80.7 t -69.27 -44.31 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.81 -32.35 27.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.36 -45.92 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.918 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.09 -53.87 24.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 t -72.47 -14.17 61.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -89.69 -19.75 46.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -111.44 -50.88 2.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 86.0 mt -93.87 39.94 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.52 -171.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -83.0 -18.06 65.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.79 -53.07 2.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.361 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 169.24 -27.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.61 137.75 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 96.0 p -121.91 178.62 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.48 -21.11 62.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -59.74 4.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -52.03 -37.91 55.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.35 -33.44 67.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.15 -48.82 64.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.3 pp -68.53 -38.78 81.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 40.4 mt -66.68 -47.14 84.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -63.85 -43.27 96.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.47 -45.67 91.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -55.68 30.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.54 -37.56 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -62.14 -46.62 88.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 96.7 t -73.02 -25.15 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.137 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -92.14 2.35 56.64 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 126.704 3.145 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -124.07 -63.33 1.22 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.121 -3.487 . . . . 0.0 112.743 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.9 mm -61.59 -64.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.165 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -36.65 48.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -57.83 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.76 -42.42 93.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.31 -49.54 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.1 mm -69.07 -36.16 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 15.8 mt -52.39 -57.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.9 p-90 -73.67 -30.14 62.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -56.96 -52.19 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.4 p -75.08 -44.05 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -60.05 -55.68 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.085 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.29 -43.42 98.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -46.92 74.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -74.21 -29.24 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.2 t -51.55 -33.24 31.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.47 -74.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -161.22 137.13 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -171.44 71.61 0.5 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.613 0.72 . . . . 0.0 111.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 101.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 173.46 -141.13 5.92 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.531 -179.887 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.418 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.34 84.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.92 -140.12 5.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.66 -160.83 47.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.01 -42.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.7 mt -139.78 141.68 36.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.78 172.14 13.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.47 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.73 -25.86 42.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.84 -68.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -63.7 -48.54 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.3 m -52.8 -44.34 66.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.27 -51.61 31.72 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.62 -55.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.45 -46.38 88.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -52.68 -43.74 65.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.21 -45.59 72.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -37.27 84.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.7 t -69.1 -52.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.9 m -61.73 -47.48 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.95 71.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -52.18 17.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.83 -42.37 90.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.75 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.8 m -71.67 -36.18 70.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -74.81 -45.2 44.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -67.28 -38.84 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -71.9 -49.63 36.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -63.6 -34.34 77.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -70.72 -52.24 22.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -66.36 -35.63 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -79.92 -22.38 42.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -54.23 -44.66 71.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.97 -3.95 50.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -106.32 12.01 30.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.4 m -94.35 -170.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.27 158.28 33.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -51.45 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.068 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -62.4 -34.29 76.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -83.7 -10.87 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -51.02 -50.58 58.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.29 -41.53 40.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -46.95 72.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -27.32 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.3 m -71.18 -53.61 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -70.21 -45.5 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -69.56 -41.03 76.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.33 -33.4 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.46 -48.37 56.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -65.06 -47.78 86.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 67.1 p -63.73 -38.11 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.02 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -48.03 -35.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 111.108 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.41 53.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -53.37 -46.53 69.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -67.73 -45.8 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -58.36 -45.22 88.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -72.94 -57.74 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -37.36 23.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -74.01 -55.4 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -57.84 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -48.76 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.41 -48.74 53.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.37 -53.23 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.155 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -53.31 -55.93 20.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.4 mm -61.33 -34.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -57.59 -22.02 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.4 m -99.41 -38.36 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.38 35.52 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -112.4 -177.42 3.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.869 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.6 t -147.77 75.39 11.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.653 0.74 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.05 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -38.58 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.98 -44.57 99.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -73.01 -47.28 46.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -50.54 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.29 -55.96 27.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.97 -27.18 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -66.42 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.298 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -60.53 -30.04 69.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -74.72 -30.55 61.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.58 -18.89 28.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.5 m -94.81 -39.62 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.514 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -43.55 -58.46 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.78 -18.91 36.66 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 tp -77.21 -54.0 7.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.52 -47.38 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 mm -54.81 -46.79 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 48.6 t -69.07 -42.2 76.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -54.45 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -58.79 -50.97 71.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -64.06 -28.54 69.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.84 -56.07 12.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.0 mm -65.03 -36.37 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -70.81 -55.27 8.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.39 -12.47 61.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.7 -24.64 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -28.35 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -9.03 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.4 t30 66.12 50.35 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.57 107.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -119.61 97.82 5.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.75 -35.89 27.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -49.85 -31.85 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.1 tp -54.03 -50.72 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.53 85.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.02 -50.5 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -65.82 -34.11 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tt -66.78 -47.97 70.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -58.87 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.9 -52.82 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.93 -42.59 86.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 m -63.55 -40.05 96.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -63.06 -56.15 19.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.82 -35.64 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -40.51 82.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.49 -43.92 88.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.88 -47.89 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -62.42 -40.78 97.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.66 -49.4 64.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -52.99 62.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 20.4 ptp -59.15 -33.74 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.17 -31.7 57.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -29.88 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.871 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.4 -27.4 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 5.32 62.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.89 -35.07 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.323 . . . . 0.0 111.13 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptt? -135.15 133.91 39.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . -160.59 -45.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.03 -46.3 74.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.611 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.73 -52.82 13.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.561 0.696 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.3 Cg_endo -69.8 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.334 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.75 -52.41 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -77.44 -34.15 54.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 36.2 mt -59.35 -65.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 28.1 mm -62.85 -44.6 99.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.59 86.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.43 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.63 -47.82 66.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.49 94.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -60.24 -55.37 34.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.77 -50.11 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -39.49 87.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -57.98 -58.08 10.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.77 -38.92 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.59 -49.5 67.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.82 -54.68 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 6.1 mp -50.46 -59.82 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.79 -20.56 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.0 17.81 23.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -68.63 118.27 8.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.24 -0.74 26.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.877 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.05 -37.77 46.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.468 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.75 -27.89 69.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -55.16 -26.2 37.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.11 -39.3 55.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.25 -11.86 14.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.29 -58.65 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 t -100.06 -7.64 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.58 -166.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.04 161.78 51.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.7 0.762 . . . . 0.0 110.839 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -26.03 28.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -44.19 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.62 -42.46 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -66.21 -39.17 89.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.1 t -70.05 -49.38 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.78 97.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -65.46 -47.85 74.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.22 -44.39 83.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.4 m -69.64 -35.11 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -53.02 46.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 14.5 ptm -64.11 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.88 -47.76 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 28.3 mm -65.65 -39.5 85.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.2 mt -57.8 -57.58 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 pt -60.5 -38.68 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -56.29 -59.47 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.56 -52.95 49.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -55.4 -36.73 66.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.796 0.331 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.6 -24.72 49.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 200' ' ' TYR . 19.6 mt -79.08 -26.97 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.524 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.5 t80 -32.7 -57.76 0.48 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.697 0.761 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.77 -65.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . 0.474 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 57.3 t -36.51 -42.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -77.14 -57.86 3.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -53.81 -21.68 7.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.858 0.361 . . . . 0.0 110.886 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.58 -28.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 96.7 m -49.34 -29.45 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.14 18.02 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.28 -23.08 46.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.918 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.4 tp -129.36 -53.92 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.51 -175.14 3.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 125.89 38.12 0.48 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.2 68.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.61 25.62 70.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 55.51 82.56 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.518 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.9 p -72.58 135.55 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.71 57.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 78.8 mt -55.99 -63.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -52.79 -31.48 38.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -57.39 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.26 -58.63 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 39.5 mm -60.21 -48.84 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -57.05 -49.14 76.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -60.34 -40.38 90.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.57 -48.9 78.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.45 -55.16 38.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.17 -27.54 69.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -67.44 -56.58 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.0 m -72.57 -25.02 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.92 -10.32 37.69 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-O 126.701 3.143 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -131.31 -56.24 1.02 Allowed 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 117.102 -3.499 . . . . 0.0 112.773 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 44.3 mm -53.8 -64.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.115 174.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -41.21 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.08 -57.3 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.65 -41.11 99.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.3 -48.96 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 4.7 mm -69.68 -36.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 39.4 mt -53.0 -58.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 15.9 p-90 -73.71 -29.63 62.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -54.87 -55.06 34.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.32 -44.8 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -56.58 -53.17 60.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.47 -41.76 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -54.18 27.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 -34.73 69.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t -51.82 -68.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 t -174.66 96.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -53.88 172.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -123.75 160.49 51.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.615 0.721 . . . . 0.0 111.106 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 80.3 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.656 2.237 . . . . 0.0 112.411 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 159.99 -58.64 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.489 -179.902 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.43 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mtm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.81 0.338 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.27 130.57 1.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.9 -73.52 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.69 46.51 2.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.495 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -175.02 77.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.54 -169.98 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.4 168.51 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -51.37 -60.35 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -52.56 -43.91 65.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -54.53 -52.35 62.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -47.57 84.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -51.22 -47.01 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.8 -50.58 34.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.505 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.3 t -53.58 -55.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.351 . . . . 0.0 111.117 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -61.12 -47.18 87.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -53.22 -45.25 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -46.21 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.04 -40.24 92.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.4 -48.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.9 p -61.11 -46.5 90.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.9 -51.87 67.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.93 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.68 -33.66 64.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.7 tp -68.44 -56.34 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.8 72.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -71.25 -43.11 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.5 m -65.2 -47.09 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.25 -39.39 82.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.21 -49.81 63.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -67.18 -31.26 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.61 -48.91 58.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.5 -37.25 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -79.51 -10.57 59.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -27.78 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.02 -5.79 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -100.81 29.41 4.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.58 -171.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.52 160.12 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.11 86.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -45.59 86.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -81.88 -1.64 48.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -50.94 -52.33 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.0 p -77.56 -35.33 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.161 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.2 p -60.31 -31.85 70.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.12 -34.2 74.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -56.39 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 m -59.74 -52.28 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.4 p -69.2 -36.6 77.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.7 -34.6 78.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -70.7 -47.29 60.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 p -63.85 -44.69 98.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 70.0 p -71.65 -39.14 70.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.164 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.24 -45.22 95.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.451 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.64 -47.85 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 -44.59 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -58.38 -53.41 58.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -57.0 -47.39 80.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -60.15 -61.38 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.15 -54.32 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 -58.14 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -58.33 -38.04 76.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -57.1 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -53.46 44.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.39 -53.15 33.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.02 -39.15 82.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.79 -51.95 64.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 9.6 tp -73.63 -25.83 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.1 -47.93 34.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 -38.78 4.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.14 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.42 126.53 52.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.7 162.22 32.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.613 0.721 . . . . 0.0 110.861 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 101.92 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.2 m -69.1 -26.02 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.7 t -48.04 -41.73 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 -44.82 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -67.2 -58.28 5.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.4 mm -63.5 -62.53 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.66 -33.35 54.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.553 1.158 . . . . 0.0 109.277 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -58.13 -65.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.09 -9.88 59.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 tt -91.42 -18.83 23.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -105.61 -39.05 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.578 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 4.0 t -44.28 -55.03 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.658 0.742 . . . . 0.0 111.128 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -23.25 31.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.252 . . . . 0.0 112.361 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.2 mt -75.83 -54.63 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 35.4 mm -57.65 -37.81 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.63 -56.37 16.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -51.68 -46.62 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.42 -43.62 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -32.61 74.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -56.81 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.5 tp -56.81 -40.3 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.82 -43.33 68.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.51 -18.58 62.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.38 -16.36 45.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.3 -14.37 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.079 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.28 -74.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 176.78 -33.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 p -170.68 145.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.65 145.43 42.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -5.04 82.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -39.09 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -54.17 29.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.928 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.6 ttpt -52.09 -50.1 62.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -66.28 -31.48 72.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.61 -49.7 74.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.61 -59.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.77 -49.39 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.57 -48.71 83.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 m -53.43 -44.13 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.84 -48.12 72.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 85.2 t -51.93 -54.41 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -64.8 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.11 -58.52 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.7 t -62.03 -51.72 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -51.96 -37.18 52.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.66 14.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -55.8 28.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 110.926 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -32.57 74.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.04 70.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.92 -32.86 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -28.58 7.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.53 26.37 10.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.2 pp -94.86 -34.9 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.096 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.74 142.45 27.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 171.73 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -57.72 -35.29 70.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -69.48 -61.46 3.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.477 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.3 Cg_endo -69.79 -6.72 19.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.271 . . . . 0.0 112.303 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.73 70.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.55 -38.29 89.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.2 mp -65.03 -65.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.3 pt -57.58 -38.05 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -48.91 56.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.23 -44.02 92.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -50.47 72.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.89 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -55.45 25.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 82.5 t -58.41 -47.05 89.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.35 -46.17 89.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -52.15 -58.66 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.8 mp -68.09 -32.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -53.49 -54.52 36.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.19 -40.2 62.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.2 tp -61.64 -24.94 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -25.32 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.74 18.72 15.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -108.82 -13.45 18.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -85.25 -46.92 10.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -82.93 -41.66 8.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.58 -7.32 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.333 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -54.13 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -97.22 -66.66 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 78.1 m -123.02 -65.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -173.33 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.9 t -112.04 -10.55 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.179 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.92 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.7 165.12 36.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.729 0.776 . . . . 0.0 110.827 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.57 16.4 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.3 54.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.42 -44.2 77.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.72 -39.94 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -68.18 -50.06 56.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -58.21 -39.99 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -45.1 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.68 -56.31 23.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -43.61 89.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -56.86 -47.42 80.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 35.7 ttp -65.42 -32.56 74.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.8 -51.27 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -37.95 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.096 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.2 -46.17 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.57 -49.58 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -51.23 -58.96 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.4 -58.52 13.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -52.77 -31.09 36.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.402 ' C ' ' HD2' ' A' ' 201' ' ' PRO . . . -81.18 -24.11 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.26 -34.26 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 16.6 t80 -51.95 -55.57 29.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.663 0.744 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.72 -28.99 24.79 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.368 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 38.9 t -72.5 -27.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.84 -46.75 6.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -37.32 45.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -48.81 -28.21 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.9 p -47.36 -30.54 3.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 134.08 49.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -63.25 -15.97 58.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.57 25.83 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.56 -25.31 49.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.508 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -98.93 18.81 16.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.361 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.02 51.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 92.6 107.56 1.72 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.519 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -60.69 125.2 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -30.67 16.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.82 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.29 -30.13 71.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.6 -58.59 7.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -65.69 -37.32 86.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.23 -55.87 24.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 48.1 mt -61.4 -47.64 92.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -59.8 -56.63 19.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -49.03 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.4 tp -59.39 -39.2 82.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -55.33 24.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.09 -28.12 69.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -70.97 -52.81 17.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 m -72.06 -24.42 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -77.49 0.81 21.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-O 126.692 3.139 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.21 -59.63 0.87 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 117.122 -3.486 . . . . 0.0 112.75 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 48.1 mm -58.08 -64.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.148 174.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.13 -42.8 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.945 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.01 -58.45 6.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 -40.64 94.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -44.06 81.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -68.59 -48.18 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 27.5 mm -54.34 -50.09 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -72.02 -30.7 65.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -58.61 -53.74 54.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 7.3 p -75.52 -42.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -60.21 -55.01 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.72 -48.31 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.141 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -35.44 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -71.6 -37.66 70.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.6 p -50.22 -40.8 48.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.93 -172.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.19 84.58 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -174.65 70.09 0.3 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.134 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 89.53 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 155.03 164.19 12.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.51 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.59 108.22 0.26 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.43 -48.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.515 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.06 78.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.491 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -174.59 63.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.86 170.19 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -177.11 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.88 -74.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m -51.97 -32.07 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -58.44 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.836 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -48.33 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 m -49.87 -47.31 51.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.0 -50.54 39.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.0 t -51.33 -55.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 0.0 111.169 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.8 p -60.77 -48.31 82.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.2 -48.39 65.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -46.22 88.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.62 -38.19 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.5 t -65.94 -52.34 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 m -58.79 -54.24 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.66 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.57 69.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 tp -54.43 -42.43 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.1 tp -67.36 -56.17 10.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.45 -39.14 64.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 m -69.89 -43.43 71.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -60.42 -49.06 79.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.53 -36.1 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.14 -57.07 10.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.21 -45.88 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -54.14 -52.02 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.9 -29.85 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -79.32 -6.21 56.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.7 -27.39 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.79 -10.67 47.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 31.87 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.4 p -120.82 154.02 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.1 142.06 2.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.83 74.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -23.86 61.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 26.2 m95 -88.6 6.56 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -53.57 -50.13 66.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.25 -33.53 61.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -40.52 96.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -77.0 -26.75 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -70.93 -49.91 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.59 -45.17 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.2 t -70.47 -39.32 74.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.25 64.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.38 -51.06 60.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.857 0.361 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 75.3 t -61.22 -51.9 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -63.66 -37.55 87.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.22 -37.05 93.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 mt -71.6 -45.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.72 -43.23 98.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 231' ' ' LYS . 43.6 t80 -64.97 -57.08 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -55.02 -51.89 64.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.22 -42.07 94.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -57.96 -71.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.3 ttp -52.26 -32.16 35.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -57.66 -68.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.913 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.4 ' HA ' HG13 ' A' ' 82' ' ' VAL . 21.2 mtt -74.81 -58.28 3.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -39.81 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.91 -57.51 4.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.4 HG13 ' HA ' ' A' ' 79' ' ' MET . 5.8 p -53.72 -35.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 220' ' ' ASN . 8.3 tp -54.52 -26.89 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.29 -20.92 58.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -103.28 -38.24 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.19 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.71 -175.11 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.88 37.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.708 0.766 . . . . 0.0 110.847 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 84.44 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 t -60.07 -37.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.91 -52.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -51.05 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -34.38 74.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.11 -57.86 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -30.38 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.6 -66.83 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.311 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -31.6 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.5 tp -77.23 -21.83 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.9 tt -99.47 -16.38 18.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.9 p -98.35 -32.6 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.487 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -57.55 -59.33 13.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.85 35.61 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.375 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.42 -51.98 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 pp -67.43 -40.82 85.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.8 mm -66.66 -49.88 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.26 -40.83 97.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.14 -59.71 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -51.11 -50.84 58.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -64.41 -37.1 86.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -55.7 -63.87 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 48.7 mm -57.9 -44.69 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -55.92 -47.28 77.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.22 -15.68 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.37 -20.17 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.87 -26.63 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -123.48 -45.61 2.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 179.91 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.3 m -151.56 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.08 151.64 48.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.35 -2.47 73.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.21 -31.37 5.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.887 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.79 -40.52 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -49.93 25.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -58.22 -51.74 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.68 80.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 tp -62.25 -47.03 86.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.62 -58.72 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.0 m -55.31 -36.05 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.112 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.92 -45.57 72.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.5 t -63.01 -39.09 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.828 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -53.85 37.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.68 -43.44 79.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -36.4 82.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.4 -47.24 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.02 -48.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.32 -41.08 83.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.01 -51.67 8.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.13 -57.32 10.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.8 mmt -68.34 -46.13 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.81 55.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -45.57 -36.56 4.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.911 0.386 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.95 -27.45 8.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.084 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.09 27.37 5.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.488 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -104.71 -37.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.437 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -128.31 -168.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.538 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 79.28 0.42 2.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.114 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.41 -42.61 71.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.543 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -70.11 -57.05 6.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.536 0.684 . . . . 0.0 110.93 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.77 -7.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.717 2.278 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -57.98 -48.0 81.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.49 -39.25 91.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 mt -66.83 -58.93 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -35.25 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.06 -49.31 16.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.7 t -57.36 -50.63 72.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -50.11 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.58 94.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -61.55 -55.68 28.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.3 t -53.5 -48.07 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.66 -39.78 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 27.8 mtt -58.62 -58.22 9.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.24 -30.88 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -58.26 -54.68 44.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -33.72 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.5 tp -74.63 -13.99 60.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -56.47 -21.22 24.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.85 21.62 14.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -38.4 137.71 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -72.31 -5.0 33.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.901 0.382 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.08 -41.42 37.92 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -77.69 -36.31 51.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 p -68.55 -25.14 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.28 -30.96 12.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 -8.78 13.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 75.06 -59.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 -8.52 30.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.73 -166.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.63 162.73 51.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.659 0.742 . . . . 0.0 110.854 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -30.83 21.52 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.5 -47.53 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.115 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 84.6 t -67.31 -44.6 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.01 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 t -66.62 -49.26 66.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.2 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.29 -51.66 68.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.4 -54.71 43.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 31.9 m -55.33 -36.51 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.174 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -51.92 62.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.5 ttp -59.8 -37.53 79.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 -49.53 74.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -69.34 -53.45 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.2 mt -49.78 -50.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.44 -49.79 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -53.21 -48.86 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 199' ' ' ILE . . . -62.06 -49.58 73.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.61 -28.43 69.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.84 -45.04 19.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.438 HG12 ' HA2' ' A' ' 196' ' ' GLY . 21.0 pt -71.85 -29.46 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.499 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.7 t80 -45.59 -59.36 4.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.662 2.241 . . . . 0.0 112.343 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 74.3 t -68.38 -43.88 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.142 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.32 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -59.49 -24.57 63.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 110.899 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . 0.407 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 70.6 t80 -54.47 -33.2 59.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.2 t -66.26 -13.75 60.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.38 -4.79 6.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.407 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.2 OUTLIER -64.99 -51.22 62.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.0 110.937 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.88 -54.49 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -168.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 166.05 42.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.7 31.44 7.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 110.879 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.16 23.55 9.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 68.13 84.4 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.35 122.15 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.832 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.33 70.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.8 -52.1 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -35.8 81.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.54 -58.63 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . 0.476 ' HB2' HG23 ' A' ' 84' ' ' ILE . 1.2 p-10 -63.74 -35.99 82.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.07 -54.23 41.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 23.3 mt -59.48 -48.13 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -57.63 10.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -55.33 -39.86 70.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.83 -47.75 82.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.23 37.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.069 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -36.49 83.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.43 -40.8 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.37 -42.66 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -72.78 -5.08 35.52 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 126.718 3.151 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 73' ' ' PHE . 2.3 mmtm -113.05 -27.07 8.18 Favored 'General case' 0 N--CA 1.424 -1.761 0 O-C-N 117.119 -3.488 . . . . 0.0 112.773 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.8 mm -91.63 -63.44 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.14 174.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 6.4 tp -49.08 -31.55 8.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.52 -56.71 18.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.95 -39.76 89.16 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.97 -38.97 93.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.59 -47.43 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.3 mt -55.48 -49.25 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -69.85 -38.21 76.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -58.42 -53.85 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.15 -37.13 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.27 77.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.27 -41.49 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -63.24 -39.57 94.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -77.52 -48.34 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.3 t -52.39 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.3 t 57.22 43.41 23.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -129.71 -176.59 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.462 ' CB ' ' CD ' ' A' ' 250' ' ' PRO . . . -179.08 -61.41 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 0.0 111.074 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 249' ' ' ALA . 53.4 Cg_endo -69.78 111.44 2.81 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 153.26 154.34 6.7 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.54 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.7 ttp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.853 0.359 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.61 -158.57 3.53 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -121.62 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.25 41.09 22.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.473 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.99 117.74 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.13 139.04 54.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.01 157.89 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.04 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -31.06 61.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -66.44 -68.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -49.71 -52.07 34.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.6 t -61.82 -31.87 72.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.23 -55.51 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m -57.0 -44.35 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.148 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -64.37 -46.94 81.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.91 -40.14 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -47.5 69.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -43.98 97.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.2 -43.99 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.5 m -61.59 -42.66 99.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.13 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -51.9 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -57.42 -39.03 75.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.19 -55.57 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.81 75.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -50.66 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.7 p -61.39 -40.4 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.48 -48.05 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.92 -46.35 75.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.18 -28.72 69.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -74.66 -45.5 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.55 -42.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.01 -4.01 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -26.38 62.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.03 -3.98 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.07 42.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 m -115.01 -170.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -66.27 152.94 43.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.62 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -27.81 64.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -91.69 1.6 57.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -51.11 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -31.29 53.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.4 p -55.29 -43.58 74.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -29.67 69.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -54.82 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -62.91 -50.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -70.12 -35.56 74.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.4 84.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.27 -47.92 59.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.54 -55.24 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 m -65.13 -37.52 87.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.29 99.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.478 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.51 -42.99 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 111.172 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.41 -47.89 82.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -63.98 -54.56 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -52.82 -51.19 61.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -63.92 -59.33 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -49.0 -62.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -38.31 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -65.21 -70.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -59.67 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -53.47 -55.95 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.94 -54.6 27.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.59 -54.86 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.329 . . . . 0.0 111.156 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -54.18 -55.67 25.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.6 mm -59.7 -26.52 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -21.28 50.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -38.33 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.08 31.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.52 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.77 -176.17 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 p -146.12 77.51 11.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.663 0.744 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 72.55 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.673 2.249 . . . . 0.0 112.328 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -69.87 -41.39 74.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.7 m -54.56 -52.43 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -71.1 -44.61 65.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -55.46 -58.5 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -40.22 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 mt -59.05 -63.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.15 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.02 -33.29 70.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 17.4 t-105 -60.58 -58.72 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -75.07 -11.99 60.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.3 tt -90.96 -21.04 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.1 p -107.81 -34.36 6.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.486 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -47.57 -60.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.69 -30.46 22.54 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.27 . . . . 0.0 112.374 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.88 -55.55 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.48 -43.01 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.36 -50.64 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 16.3 t -64.41 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -65.27 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.42 -50.21 60.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.48 -37.46 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.17 -66.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -50.75 -37.53 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.36 -39.82 77.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.43 -14.27 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.43 -14.67 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.02 -24.89 68.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -120.42 -70.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 117' ' ' THR . 2.1 m-20 165.24 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.46 138.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.02 96.94 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.99 85.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.0 p -48.78 -35.85 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.2 mp -49.48 -42.64 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -68.26 -53.68 22.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -52.09 64.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -36.14 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.31 -50.52 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.5 -60.13 2.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 89.9 t -56.58 -47.12 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.25 98.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.4 m -66.53 -55.26 16.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -53.81 43.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.55 -45.09 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.135 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -61.92 -42.04 98.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.55 -57.82 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.67 -52.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -40.78 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.37 -51.46 52.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -60.44 -56.83 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -34.62 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.91 -29.19 59.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -39.79 -48.88 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.66 -28.95 7.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.78 17.02 33.29 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 12.9 mt -93.54 -55.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.123 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.45 138.35 48.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 174.07 -27.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.63 -31.64 48.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -74.54 -63.07 0.85 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.544 0.688 . . . . 0.0 110.881 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.71 -6.16 17.91 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.75 -49.63 74.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.95 -31.13 68.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.99 -61.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -62.71 -38.96 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.194 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.43 93.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.489 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.94 -48.23 74.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -50.29 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -66.64 -57.89 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.8 t -61.36 -41.11 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.79 -47.09 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.23 -52.59 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.9 mt -63.13 -53.07 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.17 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -47.39 -35.59 8.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.96 -49.53 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -72.6 -16.39 61.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -116.69 18.42 14.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.53 13.34 6.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.61 -47.37 10.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -84.78 -41.45 7.68 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.33 -6.6 53.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -52.95 25.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -96.64 -66.68 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 7.6 m -123.21 -65.09 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -168.04 -38.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.74 1.16 17.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 48.34 -167.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.417 ' CB ' ' HD2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -110.67 166.42 10.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.64 0.734 . . . . 0.0 110.849 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 179' ' ' SER . 53.9 Cg_endo -69.74 -36.79 10.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.79 -43.68 35.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 76.6 t -68.02 -46.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.01 -36.47 83.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 m -68.67 -47.24 67.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.89 95.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -43.77 78.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.05 -49.35 78.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.6 m -65.16 -38.66 91.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -42.31 96.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.9 ttp -71.7 -34.97 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -63.97 -50.89 66.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.2 pp -70.86 -38.33 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 8.1 mm -64.1 -47.56 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 62.3 mt -64.41 -52.95 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -52.34 -54.51 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.04 21.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -53.95 -36.32 62.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.67 -20.81 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.8 mt -82.01 -31.86 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -48.35 -54.09 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.666 0.746 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.2 Cg_endo -69.7 -20.86 34.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.83 -43.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -80.57 -38.27 17.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.39 -29.36 23.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -49.0 -30.75 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 15.2 t -51.16 -24.64 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.184 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.1 22.24 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -46.39 -36.99 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.75 -37.48 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.4 ttp -60.12 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 67.22 40.93 92.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.464 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.52 26.35 12.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.832 0.348 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.78 24.42 9.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.443 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 109.75 102.32 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 135.72 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 0.0 110.879 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.65 -36.79 69.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.53 -63.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.39 -43.25 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -45.27 81.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -65.31 -44.66 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.98 -53.63 52.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 36.3 mm -57.15 -45.75 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -63.95 -54.64 31.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.37 -47.61 78.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -50.48 71.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.95 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -27.92 69.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -67.88 -56.43 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -24.95 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -80.4 2.78 23.63 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.68 3.133 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -131.18 -51.22 1.02 Allowed 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 117.158 -3.464 . . . . 0.0 112.753 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.9 mp -63.83 -63.67 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.12 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 5.9 tp -48.99 -36.55 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -56.1 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.39 -33.69 85.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.08 -41.32 86.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 19.6 mm -67.77 -50.01 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 24.7 mm -63.67 -36.52 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -74.1 -41.82 61.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -69.64 -40.98 76.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.56 -36.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.21 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.3 -36.5 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -75.61 -50.6 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -58.54 -41.79 86.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -54.51 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.14 -179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -125.34 149.71 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -137.05 160.46 65.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.613 0.72 . . . . 0.0 111.094 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -35.17 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -139.12 93.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.459 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.45 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.4 174.9 21.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.3 24.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.471 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.78 170.86 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.517 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.05 -72.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.56 103.68 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.82 163.53 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.39 -65.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.43 -30.91 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.97 -67.83 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -52.43 -44.04 65.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.7 p -60.13 -38.73 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.15 -54.56 13.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -55.93 -41.43 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.8 m -66.44 -48.43 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.02 -42.59 72.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -47.85 68.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 -42.62 96.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 91.8 t -63.91 -50.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.098 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -55.36 -43.39 75.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.33 -52.04 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -54.34 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.1 mp -51.16 -52.84 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -54.27 -48.64 70.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.48 -36.02 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.3 p -70.88 -34.93 72.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -70.78 -45.08 65.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -65.87 -42.83 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -68.74 -48.62 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -64.6 -29.87 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -74.95 -50.36 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -65.73 -41.03 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -79.73 -6.22 56.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.0 ttt180 -57.4 -26.67 61.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -93.22 -10.71 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -100.63 28.78 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -107.98 161.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.79 149.93 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.87 -55.88 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -23.86 59.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -90.43 11.64 20.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -62.25 -50.46 71.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -34.26 73.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.179 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -43.2 62.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mp -65.18 -29.53 70.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.4 m -70.14 -54.53 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.62 -49.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -67.12 -36.87 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.67 -36.79 83.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.535 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tp -70.58 -49.97 42.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.4 p -66.08 -46.32 88.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 52.3 m -71.51 -29.95 65.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.04 -52.01 30.58 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.413 ' CG2' ' N ' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -68.69 -37.19 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 71' ' ' ILE . . . -68.54 -42.09 78.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.75 -56.59 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.831 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -56.28 -50.21 72.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -60.78 -62.6 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -49.84 -51.27 41.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -53.69 27.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -56.78 -46.21 81.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -57.12 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.44 -56.59 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.69 58.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -62.29 -28.12 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 111.157 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -70.29 -47.32 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.6 tt -73.35 -24.96 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.32 -47.78 18.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.8 p -122.5 -39.23 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.21 -23.33 4.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -122.7 129.12 51.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.2 161.03 40.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 110.878 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 104.07 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -26.41 64.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 m -51.38 -41.29 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.093 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.83 -52.03 53.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -60.03 -37.72 80.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.08 -48.78 74.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.64 -50.25 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -62.85 -39.69 95.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -61.03 -49.45 77.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.917 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -16.53 60.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.02 -14.74 25.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 72.6 p -108.17 -29.48 8.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.492 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -54.88 -59.64 10.13 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.634 0.73 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.71 -35.55 12.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.315 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.2 mt -65.4 -52.34 54.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.63 -50.57 73.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 27.4 mm -57.69 -58.64 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.98 -33.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.97 -68.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -50.5 -50.72 52.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.35 -43.98 83.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.25 -66.71 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -31.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.65 -42.09 67.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.2 -14.37 59.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.52 -17.31 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.41 -24.05 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -121.87 -69.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' THR . 1.7 m-20 165.77 -76.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -47.23 135.01 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.11 98.27 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.29 74.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -47.87 -33.5 7.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -48.26 -43.38 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.38 -53.26 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -52.27 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -37.34 86.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.81 -50.85 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -59.76 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 67.5 t -53.03 -49.56 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.3 59.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 t -52.49 -57.21 10.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -53.04 44.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.6 t -56.53 -44.56 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 14.8 mtt -64.25 -38.14 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.3 -58.72 7.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -57.14 -43.0 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.62 -47.3 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.55 -52.23 47.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -58.71 -55.21 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.92 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -58.37 -32.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.3 -30.18 59.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -41.61 -52.8 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.18 -28.48 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.73 16.95 48.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.5 pt -100.58 -37.27 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.63 139.82 47.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.492 ' HA ' ' HG2' ' A' ' 150' ' ' PRO . . . 170.4 -14.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.36 -38.84 91.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.581 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.7 m95 -69.12 -55.83 9.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.687 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 149' ' ' TRP . 54.4 Cg_endo -69.76 -16.88 37.77 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.733 2.289 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -52.52 -53.21 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -77.7 -28.49 51.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 46.0 mt -66.88 -64.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.073 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.1 pt -63.29 -36.39 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.1 93.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.444 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.6 t -63.65 -46.77 84.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.71 -47.35 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.65 91.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -61.06 -55.82 28.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.5 t -58.88 -46.85 90.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.41 -43.28 99.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.9 mmm -57.35 -49.32 76.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 81.5 mt -63.59 -52.65 54.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -36.5 38.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.68 -58.76 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.14 -55.77 27.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -56.14 -22.05 26.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.04 18.47 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -87.09 -155.23 27.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.473 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.35 -17.76 64.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.37 -31.23 34.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -49.59 73.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.9 t -77.95 -25.69 48.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -55.45 -23.55 26.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 18.6 p -52.25 -26.88 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -126.18 -33.47 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.1 p -89.65 12.7 16.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -145.68 -167.18 2.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.119 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.52 162.32 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.664 0.745 . . . . 0.0 110.898 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -28.57 25.19 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.304 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.32 -41.44 56.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 98.6 t -63.8 -43.32 97.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.131 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.49 -32.59 72.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 t -69.8 -45.14 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.831 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.8 80.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -64.96 -51.39 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.947 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -61.86 -56.23 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.6 m -53.02 -44.18 67.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -52.38 65.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -54.78 -39.34 68.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.93 -52.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.5 tt -52.7 -45.95 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.5 pt -69.58 -38.12 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -56.84 -58.32 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.97 -48.84 77.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.535 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -58.21 -33.11 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -79.03 -25.2 43.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 24.6 mt -80.34 -31.11 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -47.75 -54.5 22.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.693 0.758 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.72 -23.13 31.32 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.695 2.263 . . . . 0.0 112.386 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' VAL . . . . . . . . . . . . . 73.9 t -69.56 -44.32 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -81.91 -35.11 22.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -52.7 -29.44 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -48.76 -30.28 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 8.9 t -50.5 -28.07 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.21 21.7 0.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -54.53 -26.06 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.06 -46.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.925 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 3.4 mtm -51.6 121.66 6.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.88 43.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -63.23 -60.97 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.95 83.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.482 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -93.67 39.08 3.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.3 m -61.34 -179.9 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.27 65.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -51.77 57.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -61.14 -41.56 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -58.46 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -36.27 69.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -60.19 -57.92 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 42.3 mm -55.51 -48.62 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.4 -51.54 69.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -60.04 -38.82 83.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.24 -51.22 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.75 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.21 86.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.78 -39.31 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 95.6 t -74.33 -24.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.11 2.51 53.27 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.671 3.129 . . . . 0.0 110.84 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -121.51 -45.37 2.31 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 117.121 -3.487 . . . . 0.0 112.76 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.34 -65.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.08 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -36.22 44.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -55.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.29 -35.25 91.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -42.32 85.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.1 mm -65.72 -50.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.84 -34.45 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -74.41 -44.27 52.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -60.32 -41.95 94.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.6 p -72.67 -36.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.86 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 61.4 t -74.8 -38.58 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -71.61 -35.83 70.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -76.85 -36.81 56.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.4 t -50.93 -54.88 20.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 m 72.23 -69.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.26 66.36 3.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.457 ' N ' ' HD2' ' A' ' 250' ' ' PRO . . . -68.31 -60.86 4.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.555 0.693 . . . . 0.0 111.082 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 249' ' ' ALA . 53.6 Cg_endo -69.76 134.58 28.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.379 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.35 140.46 9.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.536 -179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.416 H183 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 27' ' ' ASP . 16.2 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 175.6 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -55.73 -73.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -31.63 54.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -58.43 -71.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.564 ' HB2' HD23 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -58.39 -48.17 81.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -51.23 -42.88 61.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.96 -50.81 27.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 27' ' ' ASP . 57.7 t -51.17 -51.66 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 t -64.37 -48.74 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.34 -49.07 65.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -46.92 83.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -59.0 -38.76 79.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 32' ' ' SER . 84.1 t -68.09 -45.56 83.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 m -62.31 -50.54 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 tt -52.53 -52.53 54.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.8 -53.58 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -47.16 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -29.01 68.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.0 m -72.81 -48.87 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.8 m -65.66 -40.3 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.87 -51.34 41.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 48.8 t80 -63.37 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.05 -51.33 13.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 45' ' ' VAL . 90.0 t -67.62 -31.13 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -79.22 -7.06 57.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.38 -27.26 55.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.26 -12.54 27.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -102.39 36.69 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.672 ' HA ' HG22 ' A' ' 243' ' ' VAL . 8.2 p -120.03 158.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -47.8 147.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.27 -52.87 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.18 -21.82 60.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -87.73 6.97 32.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -51.33 -50.75 58.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -77.06 -36.17 56.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.153 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.509 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -54.92 -47.8 73.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -72.19 -27.5 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -67.77 -53.6 25.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 68' ' ' VAL . 29.8 m -71.73 -44.91 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 64' ' ' VAL . 4.2 t -66.32 -40.56 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -35.29 58.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.07 -49.19 65.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.7 p -68.48 -44.11 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.082 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.448 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.1 m -67.26 -35.26 79.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.95 -42.68 59.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 mt -68.48 -41.67 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -66.87 -43.63 83.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 232' ' ' ILE . 30.6 t80 -61.1 -51.95 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.56 -50.41 74.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -59.25 -61.43 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -51.5 -49.7 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -53.15 30.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 82' ' ' VAL . 18.8 t80 -58.72 -48.74 80.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.3 mmt -55.83 -54.84 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -51.41 -55.16 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.04 -45.87 56.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 78' ' ' TYR . 58.6 t -66.7 -35.68 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -59.75 -51.6 69.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.3 tp -74.51 -26.13 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -50.15 -48.61 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.9 p -111.43 -39.25 4.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 122.36 -13.66 8.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.46 127.03 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.7 161.28 35.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.643 0.735 . . . . 0.0 110.859 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 99.96 0.79 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.358 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 p -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -50.6 -33.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -71.57 -51.92 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -63.74 -33.55 75.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -53.79 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.57 -37.94 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 101' ' ' THR . 0.8 OUTLIER -63.25 -47.88 80.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 0.0 109.31 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.606 ' CD1' HG23 ' A' ' 102' ' ' VAL . 14.5 t90 -64.82 -41.67 95.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.8 tp -75.15 -16.58 60.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.551 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.4 tt -99.36 -16.8 18.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 72' ' ' ALA . 40.5 p -100.12 -29.17 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.606 HG23 ' CD1' ' A' ' 98' ' ' TRP . 2.2 t -60.0 -58.63 17.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.675 0.75 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.75 -24.82 29.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.71 2.273 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 100' ' ' LEU . 8.5 mt -76.51 -52.45 9.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.743 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.8 pp -64.08 -38.52 91.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.789 HD12 ' HD3' ' A' ' 126' ' ' LYS . 26.1 mm -70.55 -57.94 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.521 ' HB2' HD13 ' A' ' 123' ' ' LEU . 35.9 t -52.05 -49.83 62.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -55.48 33.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -51.11 -50.75 58.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.682 ' HB3' ' HB3' ' A' ' 120' ' ' ALA . 18.4 m-85 -68.53 -30.54 69.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -60.23 -63.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 61' ' ' SER . 39.4 mm -62.64 -37.53 79.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.062 HD11 HG13 ' A' ' 182' ' ' VAL . 4.9 tp -62.54 -50.45 71.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -76.97 -14.01 59.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.69 -23.62 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -27.65 68.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -117.81 -45.84 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -179.61 -78.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -154.74 157.34 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -106.8 124.29 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.31 -5.53 81.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -50.5 -28.15 7.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 107' ' ' CYS . 21.4 tp -51.82 -39.78 59.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -64.95 -52.68 55.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -49.94 74.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HD3' HD12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -64.32 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -48.32 76.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -58.58 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.856 HG11 ' HG3' ' A' ' 162' ' ' MET . 48.1 t -56.3 -51.95 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.63 74.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -45.35 91.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -60.47 -49.67 76.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 129' ' ' VAL . 39.6 t -54.8 -51.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.452 ' HE1' ' HA ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -62.53 -35.89 80.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -58.94 -51.01 71.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD12 ' A' ' 154' ' ' ILE . 80.7 t -64.62 -46.89 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.71 -39.51 84.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -51.99 8.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.56 -55.75 30.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.95 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.609 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 16.3 mmt -69.29 -47.9 63.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.63 -31.7 53.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -47.48 -46.77 27.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.6 -27.1 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.48 20.33 30.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.8 pt -75.52 -40.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.876 0.37 . . . . 0.0 111.157 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.64 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -156.39 132.52 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 146' ' ' MET . . . 165.11 -20.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.677 ' HB3' ' CE1' ' A' ' 208' ' ' TYR . . . -67.75 -43.0 80.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.638 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 4.9 t-105 -66.78 -54.82 19.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.532 0.682 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.71 -16.96 38.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.319 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.7 -33.17 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.4 -37.72 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.6 -65.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 136' ' ' VAL . 6.5 pt -50.68 -44.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.15 61.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.721 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.1 t -55.22 -50.5 69.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.15 -50.34 73.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.26 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.532 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.6 t90 -65.21 -55.14 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 156' ' ' CYS . 33.1 t -52.75 -50.15 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -39.88 94.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.856 ' HG3' HG11 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -54.84 -58.7 6.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.9 mp -68.49 -32.17 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -53.24 -55.91 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -76.65 -35.29 58.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 tp -60.52 -40.25 90.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -21.58 26.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -110.44 20.01 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.815 0.34 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.56 163.19 21.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.699 0.761 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.64 27.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.27 -48.39 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 1.062 HG13 HD11 ' A' ' 113' ' ' LEU . 85.4 t -63.38 -41.78 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -65.78 -33.43 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.6 m -70.57 -46.89 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.48 94.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.17 -51.77 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -56.48 -49.94 73.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 20.6 p -61.91 -38.48 88.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.622 ' SD ' HD11 ' A' ' 238' ' ' ILE . 5.1 tpt -62.31 -51.95 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.628 ' CE ' HG23 ' A' ' 163' ' ' ILE . 2.7 ttp -61.5 -38.62 87.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -49.04 79.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.3 mm -65.21 -48.49 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.6 mm -52.58 -45.93 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.525 HG23 ' NE1' ' A' ' 159' ' ' TRP . 32.1 mt -64.95 -51.33 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.2 -57.5 11.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -56.51 -59.21 11.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.5 -34.01 56.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.92 -23.7 44.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.108 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.1 mt -78.37 -32.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 6.8 t80 -48.38 -56.23 15.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.76 -23.65 30.57 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.697 2.264 . . . . 0.0 112.379 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.19 -45.24 83.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.01 -39.03 10.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -53.22 -48.59 68.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.923 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.07 -32.77 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.5 OUTLIER -67.23 -13.38 61.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -131.6 5.01 5.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.71 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.5 mp -52.78 -63.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -33.64 39.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.9 -54.47 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.4 t30 -61.12 -52.12 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 32' ' ' SER . 2.2 tm? -52.17 -58.46 6.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 221' ' ' LEU . 96.6 mt -54.2 -42.51 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.71 -52.56 63.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -37.92 83.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.1 tp -63.04 -45.0 94.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.75 -52.14 64.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.61 -32.05 73.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -66.18 -49.61 66.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 233' ' ' LEU . 53.7 t -73.33 -25.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -80.47 2.55 24.76 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-O 126.738 3.161 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.677 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 5.2 mmtm -131.59 -51.57 0.99 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.111 -3.493 . . . . 0.0 112.761 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.3 mm -65.33 -64.53 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.16 -1.837 . . . . 0.0 111.101 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.442 ' HB2' HG13 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -50.91 -36.0 35.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.9 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -51.56 -56.04 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.65 65.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.99 -47.36 85.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.8 mm -71.42 -50.77 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.622 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.5 mm -53.19 -40.92 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.648 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.9 t90 -74.71 -41.97 59.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -60.55 -42.54 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.02 -35.12 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.76 72.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' VAL . 60.7 t -79.76 -37.9 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -70.27 -37.8 74.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -77.04 -46.29 24.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.9 t -51.95 -62.3 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 170.7 12.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.18 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.64 -39.62 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -53.71 -62.36 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -48.05 80.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -52.79 -46.27 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.41 -51.44 16.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.5 t -52.11 -50.53 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 111.164 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 36' ' ' VAL . 17.9 t -66.18 -49.89 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -52.35 -49.13 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -63.79 -47.33 81.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.07 -38.2 78.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 32' ' ' SER . 98.7 t -68.79 -45.21 81.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 m -61.88 -51.59 67.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.92 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.087 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -59.18 -55.43 35.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD13 ' HE1' ' A' ' 77' ' ' MET . 5.0 tt -53.33 -39.72 64.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 45' ' ' VAL . 51.6 tp -61.45 -56.02 24.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -24.15 67.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.683 ' OG ' HD12 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -71.36 -51.85 21.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.3 t -69.58 -39.48 77.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 41' ' ' LEU . 82.0 t -65.05 -49.32 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.53 -45.06 76.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -64.54 -30.47 71.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -75.04 -51.78 12.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.83 -36.12 76.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.37 -9.26 59.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.42 -29.08 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.15 -11.66 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.17 24.6 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.801 ' HA ' HG22 ' A' ' 243' ' ' VAL . 7.9 p -112.51 156.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 148.65 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -55.56 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -20.7 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -88.58 -15.33 35.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -51.68 -50.38 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 64' ' ' VAL . 7.6 p -61.13 -50.34 73.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.41 ' OG ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.53 -35.53 72.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -68.71 -32.36 72.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -53.96 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 68' ' ' VAL . 14.8 m -64.5 -51.29 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.523 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.4 t -68.1 -38.16 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -36.38 68.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.79 -50.01 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -64.69 -48.45 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' VAL . 5.1 t -62.54 -33.56 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.03 -69.56 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 pt -45.4 -41.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -65.36 -49.41 69.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.734 ' CE2' HD11 ' A' ' 232' ' ' ILE . 23.5 t80 -52.77 -55.24 24.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -56.69 -46.15 81.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.56 -38.77 88.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -68.93 -68.53 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.435 ' HE1' HD13 ' A' ' 40' ' ' LEU . 3.2 ppp? -45.28 -42.9 10.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.7 t80 -65.03 -49.01 71.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.7 mmm -59.61 -48.99 79.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -56.21 22.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.26 -43.56 75.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.7 t -69.46 -27.67 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 111.081 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -69.93 -53.35 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -72.89 -26.05 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -50.08 -47.62 53.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.2 p -108.12 -39.06 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.93 -56.34 0.74 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.62 126.82 53.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.48 161.01 37.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 78.79 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.353 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 m -54.02 -25.66 22.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 96' ' ' ILE . 14.8 p -48.14 -32.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -69.56 -52.39 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -59.89 -45.03 93.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.437 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 35.8 t80 -60.34 -52.0 67.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.578 ' CD1' HG22 ' A' ' 92' ' ' VAL . 76.7 mt -63.55 -27.69 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.52 -68.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 109.275 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.599 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.1 t-105 -53.84 -32.78 54.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 1.0 OUTLIER -75.23 -32.76 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.953 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.1 tt -84.03 -14.9 49.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HB2' ' A' ' 72' ' ' ALA . 55.9 p -99.42 -32.69 11.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 98' ' ' TRP . 2.1 t -46.49 -59.41 5.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.0 Cg_endo -69.75 -23.33 30.95 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -71.63 -53.97 11.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.499 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.9 pp -71.93 -37.5 70.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 102' ' ' VAL . 21.9 mt -62.67 -51.38 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.04 -47.73 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -58.03 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HE1' HD22 ' A' ' 113' ' ' LEU . 19.6 t80 -51.21 -52.16 47.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.66 -30.49 71.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -66.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.41 HG21 ' OG ' ' A' ' 61' ' ' SER . 43.4 mm -58.56 -37.83 67.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 HG13 ' A' ' 182' ' ' VAL . 11.2 tp -65.12 -51.4 61.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -69.6 -16.58 63.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -54.14 -22.54 11.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -59.8 -30.06 68.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -120.1 -48.3 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 178.17 -73.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.2 m -155.17 157.21 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.37 123.6 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.0 -6.09 81.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.5 t -50.62 -28.95 9.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.95 -39.42 94.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -52.31 64.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -62.14 -34.05 75.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.05 -46.31 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.95 -58.18 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 133' ' ' VAL . 52.0 t -55.19 -50.09 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.45 94.68 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 t -59.85 -48.05 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -52.97 63.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' VAL . 47.4 t -52.31 -46.23 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -30.68 68.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -65.71 -50.17 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 154' ' ' ILE . 21.1 m -67.07 -39.12 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.31 -37.15 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.36 -51.9 19.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -64.35 -54.92 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 21.7 tpp -60.79 -43.08 98.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.79 -32.44 82.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.53 -28.53 8.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.35 -26.79 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.58 44.02 50.93 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 65.1 mt -84.97 -54.56 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -130.36 136.61 49.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -149.75 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' A' ' 205' ' ' PHE . . . -65.89 -45.65 81.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.08 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.618 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.03 -52.92 15.08 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.69 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.75 -9.86 27.16 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -60.73 -53.91 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -30.39 58.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 150' ' ' PRO . 39.9 mt -64.24 -66.48 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.645 HD13 HG21 ' A' ' 136' ' ' VAL . 24.3 mt -61.37 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.05 68.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.9 t -58.66 -49.59 76.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.26 -48.52 68.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.15 90.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -60.69 -56.42 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.25 -45.9 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.76 -41.29 99.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -57.85 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.2 mt -63.87 -37.95 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -52.94 -54.21 38.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -74.79 -48.71 23.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -51.36 -60.07 3.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -58.01 -20.29 37.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.17 17.96 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.742 0.306 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.64 162.99 24.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.667 0.746 . . . . 0.0 110.879 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -16.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.97 37.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.705 HG13 HD11 ' A' ' 113' ' ' LEU . 87.3 t -65.91 -47.03 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -38.29 86.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -66.82 -48.42 68.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.83 86.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -51.53 61.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.74 -41.03 73.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' ILE . 9.9 p -72.29 -32.23 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -64.74 -52.21 58.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.43 76.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -50.96 69.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 237' ' ' ILE . 24.3 pt -69.38 -33.46 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.536 HD11 ' HE1' ' A' ' 189' ' ' MET . 5.5 mm -61.26 -53.19 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 17.9 pt -67.33 -36.75 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.89 -60.97 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.72 97.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -61.63 -32.37 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.05 -27.52 35.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.3 mt -80.96 -31.03 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.8 t80 -48.36 -54.19 27.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.732 0.777 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.75 -21.91 32.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 0.0 112.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.4 t -70.19 -44.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.41 ' C ' HG21 ' A' ' 222' ' ' ILE . . . -82.5 -37.38 14.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.497 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.416 ' N ' HG21 ' A' ' 222' ' ' ILE . 71.6 t80 -57.95 -36.37 72.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.897 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 148' ' ' ALA . 13.9 t80 -63.39 -49.4 73.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 t -73.24 -13.93 61.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -96.79 -21.48 21.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 18.1 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 -179.826 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.888 0.375 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.19 -23.67 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.73 -62.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -58.01 -25.61 61.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.81 -58.81 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.02 -43.32 95.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -53.93 -58.49 7.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 221' ' ' LEU . 34.9 mm -59.47 -44.39 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.61 -47.81 78.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -66.73 -43.9 82.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 229' ' ' VAL . 4.4 tt -57.01 -49.64 75.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.92 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.2 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -56.43 -27.93 58.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.2 t80 -73.08 -46.91 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 225' ' ' LEU . 21.2 t -73.88 -25.43 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.88 2.26 31.28 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 126.686 3.136 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 3.5 mmtm -130.74 -58.3 1.03 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 117.109 -3.494 . . . . 0.0 112.71 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.734 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.4 mm -62.11 -64.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.08 174.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -38.21 50.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.57 -56.63 12.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.22 90.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.2 -44.17 96.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.312 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 192' ' ' ILE . 4.7 mm -67.65 -47.18 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.01 -40.9 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.63 ' O ' HG23 ' A' ' 243' ' ' VAL . 13.3 t90 -71.94 -41.08 68.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -62.95 -43.88 97.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.87 -32.5 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.21 62.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 54' ' ' VAL . 62.3 t -76.36 -33.22 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -75.88 -39.7 55.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.1 -42.84 55.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 t -52.05 -58.92 5.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.38 -177.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.5 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -54.23 -36.23 63.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 61.4 m-20 -55.78 -69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.755 ' HB3' HD12 ' A' ' 217' ' ' LEU . 0.3 OUTLIER -60.5 -46.67 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.5 m -51.68 -45.78 63.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.62 -50.49 36.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' ASP . 80.1 t -54.36 -54.51 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.5 t -60.45 -49.97 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -52.44 -49.23 64.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -44.52 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -36.68 84.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 32' ' ' SER . 89.2 t -66.02 -51.51 59.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 m -62.83 -46.36 88.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.71 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.151 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.42 56.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 tt -51.58 -54.42 27.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -56.44 -54.22 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.72 62.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -66.18 -28.17 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -72.33 -50.15 29.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 49' ' ' VAL . 23.4 m -65.73 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -70.43 -51.69 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -63.41 -30.96 72.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -74.03 -51.25 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.8 t -68.32 -31.47 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.74 -4.88 53.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -55.78 -26.37 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.25 -10.67 22.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -95.49 24.6 5.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 62' ' ' LEU . 8.6 p -111.95 158.61 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.195 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -48.03 157.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.59 -55.9 11.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -61.4 -19.87 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 40.7 m95 -88.96 -6.81 56.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -50.81 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 64' ' ' VAL . 56.2 p -68.13 -39.07 82.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.737 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.57 -37.12 75.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.26 -33.7 76.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -54.89 8.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 112' ' ' ILE . 10.6 m -63.54 -53.53 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.536 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -66.09 -39.53 90.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.15 -32.7 69.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.79 -47.64 62.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.2 p -67.69 -45.32 84.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.476 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 m -69.51 -35.32 75.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.45 -45.97 65.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.59 -48.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.847 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.44 -41.91 97.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 25.2 t80 -59.94 -52.47 65.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -56.99 -50.27 73.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -56.59 -53.68 54.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.79 -53.21 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.97 -53.83 18.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.3 t80 -56.55 -43.46 79.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -51.95 67.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.498 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -53.56 -55.46 25.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.9 -46.33 60.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.0 t -67.51 -27.83 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.344 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -67.59 -54.83 16.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.512 ' CD1' ' HB1' ' A' ' 216' ' ' ALA . 11.2 tp -73.59 -24.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -46.77 -47.92 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 t -123.04 -39.11 2.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.158 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.55 -38.48 1.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.56 127.12 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p -138.61 160.25 64.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 97.59 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.7 2.266 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -69.58 -26.81 64.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.498 HG12 ' CD1' ' A' ' 96' ' ' ILE . 68.5 t -50.73 -46.65 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -38.31 90.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -64.08 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -36.41 70.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 92' ' ' VAL . 39.7 mt -63.73 -66.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 101' ' ' THR . 0.1 OUTLIER -54.51 -33.37 59.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.533 1.146 . . . . 0.0 109.305 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -55.95 -63.17 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' SD ' ' A' ' 134' ' ' MET . 0.3 OUTLIER -76.26 -10.47 59.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.918 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.87 -15.18 30.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.847 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.9 p -112.62 -36.24 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.495 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -46.67 -59.43 5.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.689 0.756 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.77 -18.68 36.82 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 68' ' ' VAL . 2.4 mm? -77.51 -53.92 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HA ' HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -66.1 -50.44 64.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 126' ' ' LYS . 35.5 mm -55.02 -56.08 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.0 t -58.54 -40.0 81.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -56.35 -65.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.691 ' CE2' HD12 ' A' ' 238' ' ' ILE . 43.9 t80 -50.0 -50.16 48.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 13.0 m-85 -60.1 -32.21 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.23 -62.22 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.737 HG21 ' CB ' ' A' ' 61' ' ' SER . 2.3 mp -50.77 -41.97 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 HG13 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -69.36 -41.4 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . . . -72.2 -15.68 61.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.36 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.086 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.4 -18.15 61.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 t -119.34 -49.38 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.179 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.63 -78.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.64 163.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 114' ' ' ALA . . . -104.05 118.09 35.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.29 -14.96 81.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.512 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.3 m -54.53 -23.99 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.868 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.41 -37.58 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -73.42 -42.04 62.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 129' ' ' VAL . 34.1 mttm -64.18 -50.32 68.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.88 -36.08 82.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.912 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -48.08 80.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.918 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.79 -58.91 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 133' ' ' VAL . 60.1 t -54.08 -52.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.79 -49.19 76.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.4 m -53.67 -45.87 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.62 -50.54 72.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 129' ' ' VAL . 62.8 t -51.36 -45.68 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.599 ' SD ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.6 -41.03 89.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -54.56 -53.18 57.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 154' ' ' ILE . 42.0 t -67.14 -50.87 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.93 -44.14 63.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.32 -52.47 8.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -53.5 -57.66 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.1 mmt -69.99 -32.56 70.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.57 78.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.43 -27.85 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -103.09 -28.16 12.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.48 20.75 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.472 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.116 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.459 ' HE3' ' HG3' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -115.49 122.35 45.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.4 -29.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.97 87.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -70.22 -58.33 5.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.79 -6.26 18.18 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -65.14 -44.18 89.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.6 mp -58.95 -63.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.856 HD13 HG11 ' A' ' 136' ' ' VAL . 52.0 mt -58.36 -51.72 67.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -54.55 -49.07 62.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.465 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.537 ' O ' HG23 ' A' ' 160' ' ' VAL . 40.4 t -56.54 -51.1 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -49.34 65.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.53 83.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.573 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.6 t90 -67.42 -56.69 8.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 156' ' ' CYS . 25.7 t -53.82 -52.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -59.83 -44.67 93.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.542 ' O ' HD13 ' A' ' 166' ' ' LEU . 6.2 mmm -50.73 -56.59 11.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 194' ' ' ILE . 1.6 mp -62.29 -38.87 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -51.25 56.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.19 -52.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 162' ' ' MET . 8.7 mp -50.31 -59.09 4.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -57.04 -20.93 27.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -106.12 17.69 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.08 161.76 52.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.636 0.731 . . . . 0.0 110.839 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -22.0 32.84 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.85 -43.16 47.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.651 HG13 HD12 ' A' ' 113' ' ' LEU . 17.9 t -70.73 -46.26 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.67 -36.51 84.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.706 ' O ' HG22 ' A' ' 188' ' ' THR . 32.2 t -71.16 -49.71 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.486 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -59.93 -37.88 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -50.61 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -53.58 -56.96 12.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 184' ' ' SER . 6.7 t -60.32 -41.98 94.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.463 ' HG3' HD11 ' A' ' 238' ' ' ILE . 0.4 OUTLIER -57.65 -51.51 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.443 ' HG2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.13 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -50.35 68.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -70.01 -39.5 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.17 -56.57 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 163' ' ' ILE . 54.4 mt -60.15 -48.46 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -49.83 -56.34 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.44 -59.72 10.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -54.44 -31.36 55.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.48 -22.89 43.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.104 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.4 mt -78.92 -32.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 151' ' ' ALA . 23.8 t80 -49.93 -54.5 31.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.682 0.753 . . . . 0.0 110.914 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.7 Cg_endo -69.77 -25.03 28.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.682 2.255 . . . . 0.0 112.384 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.6 t -71.51 -37.73 65.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.12 -28.88 39.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.41 -33.76 21.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.59 -28.03 12.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.7 p -47.83 -32.4 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 136.58 44.03 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.752 ' CE1' HD12 ' A' ' 222' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.883 0.373 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB1' ' CD1' ' A' ' 84' ' ' ILE . . . -54.01 -42.09 68.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 28' ' ' TYR . 4.2 mm? -53.5 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.11 -26.98 65.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.682 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -62.67 -59.01 5.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -34.7 78.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 221' ' ' LEU . 2.9 tm? -62.36 -58.11 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.752 HD12 ' CE1' ' A' ' 208' ' ' TYR . 86.6 mt -58.82 -49.04 84.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.41 -54.54 45.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -60.84 -32.55 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 229' ' ' VAL . 26.0 tp -63.54 -49.25 74.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.72 -49.06 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -46.78 87.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -59.09 -44.18 91.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.826 HG13 HD13 ' A' ' 233' ' ' LEU . 99.1 t -72.91 -25.59 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -93.9 2.1 56.22 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.738 3.161 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -120.94 -60.36 1.66 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.095 -3.503 . . . . 0.0 112.751 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.8 mm -67.64 -64.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.177 174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.826 HD13 HG13 ' A' ' 229' ' ' VAL . 0.3 OUTLIER -54.09 -34.52 60.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -56.64 -56.56 19.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.42 -34.4 87.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -41.07 87.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.526 HD12 ' OG1' ' A' ' 188' ' ' THR . 1.1 mm -68.46 -50.1 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.691 HD12 ' CE2' ' A' ' 109' ' ' PHE . 39.6 mm -61.61 -37.73 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.604 ' O ' HG23 ' A' ' 243' ' ' VAL . 14.7 t90 -74.78 -41.96 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.67 -44.3 93.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.503 ' HB ' HG21 ' A' ' 188' ' ' THR . 8.1 p -70.59 -41.38 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.417 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.59 -39.08 91.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.774 HG22 ' HA ' ' A' ' 54' ' ' VAL . 87.8 t -78.45 -34.77 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -69.87 -40.92 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.14 -41.36 42.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 29.7 t -51.39 -46.68 62.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.823 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' A' ' 27' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 168.43 15.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.096 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.9 t -52.03 -31.18 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -58.59 -63.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.563 ' CE2' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.98 -47.96 80.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -51.21 -47.71 62.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.13 -51.55 38.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 97.3 t -53.24 -56.19 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 111.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -48.78 78.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -52.05 -39.93 60.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -71.37 -40.0 70.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.67 -44.34 86.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG23 ' CE2' ' A' ' 228' ' ' PHE . 13.2 p -70.02 -35.83 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.5 m -71.03 -54.19 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.46 -44.9 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 228' ' ' PHE . . . -63.89 -50.27 69.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' CE2' ' A' ' 73' ' ' PHE . 2.1 tt -55.3 -42.36 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.4 tp -64.42 -56.1 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -38.15 74.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.516 ' OG ' HD12 ' A' ' 232' ' ' ILE . 3.2 t -67.56 -48.96 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -63.82 -46.55 84.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' LEU . 88.8 t -60.92 -46.61 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.26 -48.85 66.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -61.39 -28.85 69.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -75.66 -50.33 15.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.02 -33.19 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -79.23 -6.56 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -59.47 -27.76 66.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.62 -13.7 27.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.69 39.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.774 HG21 HD21 ' A' ' 62' ' ' LEU . 8.5 p -117.89 160.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 54' ' ' VAL . 26.0 t -48.87 143.11 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.22 57.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 -25.06 61.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -91.85 13.25 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -49.69 -50.26 44.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.3 p -76.84 -30.26 56.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -44.06 72.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.774 HD21 HG21 ' A' ' 54' ' ' VAL . 3.9 mm? -67.84 -28.94 67.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -53.34 20.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 21.8 m -70.69 -46.83 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.1 t -66.62 -39.0 88.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.06 -36.22 60.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.17 -49.83 58.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -65.67 -44.78 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' VAL . 96.4 m -67.62 -36.14 80.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.71 -41.57 74.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.461 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 mt -66.95 -50.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -65.11 -36.95 85.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.079 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CE2' HD12 ' A' ' 40' ' ' LEU . 57.9 t80 -60.53 -54.85 40.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -46.7 85.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -59.11 -63.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.17 -55.29 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -57.5 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.34 -40.46 82.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.4 mmt -59.91 -56.51 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -55.36 19.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -47.85 57.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 78' ' ' TYR . 94.4 t -64.08 -37.22 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -59.78 -48.12 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.6 tp -74.29 -25.93 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.52 -48.12 38.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -115.01 -39.36 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.164 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.64 -14.41 5.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -135.34 141.49 45.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.27 162.08 33.88 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.697 0.761 . . . . 0.0 110.826 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.32 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -66.78 -25.6 66.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -65.7 -53.19 44.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -62.31 -30.79 71.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -65.38 -56.44 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.91 -32.73 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.63 -61.99 2.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.147 . . . . 0.0 109.293 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 133' ' ' VAL . 5.2 t90 -61.02 -35.72 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 134' ' ' MET . 64.7 tp -73.91 -17.15 61.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 104' ' ' LEU . 1.2 tt -102.42 -16.5 16.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.66 HG23 HG22 ' A' ' 68' ' ' VAL . 6.0 m -100.41 -35.41 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 133' ' ' VAL . 2.4 t -55.51 -57.83 18.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.729 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.77 -20.97 34.07 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 68' ' ' VAL . 3.9 mp -78.56 -53.7 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 101' ' ' THR . 3.6 pp -62.48 -45.3 93.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 105' ' ' LEU . 10.6 tt -63.14 -42.16 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.47 ' N ' HG23 ' A' ' 106' ' ' ILE . 42.1 t -69.16 -41.34 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -54.44 46.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.34 -52.38 65.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.575 ' HA ' HD23 ' A' ' 113' ' ' LEU . 6.7 m-85 -57.38 -49.92 74.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.93 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 111' ' ' LEU . 1.9 tm? -57.9 -50.69 72.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 mt -50.77 -46.34 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -70.62 -28.2 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' VAL . . . -78.22 -19.01 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.04 -10.85 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.67 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -71.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.75 -75.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 7.1 p -48.21 141.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.25 98.45 5.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.02 77.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -48.02 -34.72 9.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mt -50.95 -53.23 34.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -65.13 -53.44 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -50.68 52.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -33.3 75.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.12 -51.39 61.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.75 -60.85 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.1 t -54.56 -45.17 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.25 -46.67 94.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 m -58.26 -57.1 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -51.22 -52.13 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 102' ' ' VAL . 68.8 t -53.13 -47.4 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.417 ' HB2' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -64.03 -44.98 90.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.0 -57.62 12.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 132' ' ' LEU . 43.9 t -53.2 -51.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.98 -36.65 79.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -55.96 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.942 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.1 mtt -53.13 -37.8 62.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.87 -30.16 58.08 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -40.26 -52.98 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -27.47 8.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.5 15.65 47.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 pt -98.19 -36.4 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.13 137.91 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.774 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 172.12 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.759 ' HB1' ' CE1' ' A' ' 204' ' ' TYR . . . -63.24 -40.69 98.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -71.01 -60.58 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.511 0.672 . . . . 0.0 110.932 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 147' ' ' ALA . 53.9 Cg_endo -69.75 -1.63 8.79 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.2 -50.49 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.64 -45.96 70.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.6 mp -61.11 -59.09 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.54 -47.09 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.96 -49.55 77.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.3 t -57.11 -51.47 69.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.892 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.26 -49.18 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.07 92.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.566 ' NE1' HG23 ' A' ' 194' ' ' ILE . 3.5 t90 -62.17 -56.38 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.6 t -57.09 -50.11 77.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -55.16 -44.54 75.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -59.18 -58.02 10.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.89 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.564 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -59.21 -33.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -61.02 -52.16 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.66 -31.57 63.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 162' ' ' MET . 6.4 mp -67.15 -52.27 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.416 ' CE3' ' HE1' ' A' ' 190' ' ' MET . 2.6 t-105 -57.6 -20.95 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.02 18.12 21.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.797 0.332 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.22 162.37 54.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.01 31.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.16 30.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 113' ' ' LEU . 89.2 t -68.68 -41.39 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -65.7 -36.96 85.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.516 ' C ' HG21 ' A' ' 241' ' ' VAL . 59.7 p -70.07 -49.45 50.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -60.72 -41.83 96.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.7 -51.1 64.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -53.91 -51.81 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 237' ' ' ILE . 1.4 m -61.66 -37.11 82.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.603 ' CG ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.96 -51.19 70.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.564 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -64.13 -35.6 81.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -50.94 70.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -33.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.84 -50.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.566 HG23 ' NE1' ' A' ' 159' ' ' TRP . 58.4 mt -64.27 -49.31 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.95 -58.58 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -57.26 -58.44 14.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -54.66 -30.98 56.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.02 -23.04 44.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA2' ' A' ' 196' ' ' GLY . 16.9 mt -80.01 -32.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.688 ' HE1' ' HB1' ' A' ' 151' ' ' ALA . 13.4 t80 -48.57 -54.01 30.57 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.76 -23.03 31.24 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.315 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 75.9 t -71.66 -36.5 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' THR . . . -82.98 -34.88 20.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.511 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.759 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -51.59 -40.21 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.9 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -64.4 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -50.51 -27.86 7.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 144.82 57.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.466 ' CD2' HD13 ' A' ' 219' ' ' LEU . 33.9 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.937 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.38 -23.8 58.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.8 mt -55.24 -63.34 1.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -58.67 -33.56 70.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 208' ' ' TYR . 3.5 tp -59.63 -55.94 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.433 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.5 t30 -64.04 -36.87 85.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.535 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.4 tm? -63.49 -53.63 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 221' ' ' LEU . 19.8 mt -59.49 -48.09 88.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -57.09 12.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.52 -44.69 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -61.46 -39.83 92.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.46 27.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -29.31 69.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.676 ' CE2' HG23 ' A' ' 36' ' ' VAL . 44.3 t80 -71.64 -58.5 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 225' ' ' LEU . 9.1 p -62.44 -30.67 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -78.05 -25.33 47.7 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.679 3.133 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -76.9 -30.39 56.14 Favored 'General case' 0 N--CA 1.423 -1.79 0 O-C-N 117.114 -3.491 . . . . 0.0 112.778 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.516 HD12 ' OG ' ' A' ' 43' ' ' SER . 47.6 mm -86.95 -38.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.146 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.1 mt -55.78 -34.07 64.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -61.39 -57.54 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.68 -34.97 79.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.47 -39.41 85.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.762 0.315 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 188' ' ' THR . 5.0 mm -70.8 -50.03 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.603 HD11 ' CG ' ' A' ' 189' ' ' MET . 40.0 mm -62.16 -35.61 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.668 ' O ' HG23 ' A' ' 243' ' ' VAL . 37.7 t90 -77.59 -47.25 19.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -56.81 -42.66 79.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.4 p -74.35 -39.97 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.415 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.41 -39.72 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 54' ' ' VAL . 43.9 t -78.27 -38.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -42.46 99.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.03 -49.22 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.2 t -58.43 -33.37 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 179.4 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -63.27 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -51.67 60.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -51.89 -50.52 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.56 -48.26 81.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.9 m -50.77 -47.55 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.01 32.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.1 t -53.55 -56.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -59.55 -45.8 90.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -51.92 -44.12 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -46.24 68.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -41.04 88.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 32' ' ' SER . 87.1 t -67.95 -49.3 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.8 m -60.2 -41.41 92.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.43 -52.17 55.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.071 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -55.17 29.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 tp -53.17 -46.48 68.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.98 -56.1 26.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.971 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.41 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.1 t -68.3 -29.29 68.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 m -72.34 -49.1 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 46' ' ' PHE . 20.0 m -65.15 -41.47 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -67.45 -50.5 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.2 -26.74 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -72.43 -50.06 29.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.41 -34.57 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.712 ' O ' HG13 ' A' ' 54' ' ' VAL . 81.6 mt-10 -80.14 -9.99 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -52.72 -29.0 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.99 -4.82 13.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.83 29.63 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 243' ' ' VAL . 12.6 m -114.34 -171.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.05 164.11 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.92 -54.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -25.66 64.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.465 ' CG ' ' HB1' ' A' ' 242' ' ' ALA . 61.7 m95 -83.51 -17.2 42.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.41 -49.68 53.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.94 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 64' ' ' VAL . 4.5 p -76.61 -43.91 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB2' HD13 ' A' ' 112' ' ' ILE . 5.0 t -53.03 -44.44 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -66.13 -31.61 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.6 m -73.85 -54.77 7.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 60' ' ' THR . 12.3 m -62.33 -50.39 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 64' ' ' VAL . 7.1 t -70.14 -40.46 74.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.8 -34.77 78.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.466 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.13 -49.63 55.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -62.74 -47.25 93.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.491 ' N ' HG13 ' A' ' 68' ' ' VAL . 51.8 p -62.96 -36.67 84.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.65 -66.66 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.473 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -47.46 -36.84 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -72.03 -49.41 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 232' ' ' ILE . 13.2 t80 -59.23 -49.48 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -62.07 -51.99 65.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -59.0 -43.41 91.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.82 -69.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -48.19 -35.96 12.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 82' ' ' VAL . 72.3 t80 -65.87 -75.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.5 mtt -53.55 -57.35 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.48 -56.79 16.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.06 -51.21 41.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.9 t -61.52 -52.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.403 ' O ' HG22 ' A' ' 86' ' ' THR . 1.1 m-90 -50.71 -55.44 16.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.73 -30.38 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.99 -21.23 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 83' ' ' TRP . 11.1 t -112.46 -21.5 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 63.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -139.49 149.97 44.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 p -115.15 79.97 6.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 0.0 110.924 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 73.07 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -70.06 -36.21 74.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 29.0 m -69.98 -43.9 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 25.7 m-85 -72.42 -32.57 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -78.26 -47.17 18.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.46 -37.09 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.82 -50.98 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.55 -36.17 73.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.289 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CE2' HG21 ' A' ' 102' ' ' VAL . 9.5 t-105 -75.39 -50.08 16.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.05 -11.06 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 tp -103.13 -34.02 9.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.42 HG21 ' CB ' ' A' ' 72' ' ' ALA . 91.4 m -85.36 -37.96 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 t -50.71 -53.31 48.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.625 0.726 . . . . 0.0 111.121 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.73 -25.1 29.09 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 68' ' ' VAL . 28.2 mt -75.84 -52.54 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.53 -41.15 93.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.676 ' N ' HD23 ' A' ' 105' ' ' LEU . 13.0 tt -66.78 -34.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.8 t -69.53 -53.48 18.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -58.25 -45.66 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.719 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 5.8 t80 -59.45 -49.78 76.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.481 ' HD1' ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -61.98 -33.58 74.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -61.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 61' ' ' SER . 5.6 tp -56.51 -39.91 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 186' ' ' TYR . 3.3 tt -64.39 -42.32 96.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -76.89 -18.51 58.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.44 -20.2 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.103 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 182' ' ' VAL . . . -101.45 -78.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -48.18 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' HG23 ' A' ' 117' ' ' THR . 1.1 m-20 174.89 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.1 p -168.23 131.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.481 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -110.34 102.49 11.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.25 -5.5 66.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -29.64 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.854 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 120' ' ' ALA . 1.8 pt? -61.75 -34.74 76.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -49.66 60.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.7 mttt -62.6 -50.36 71.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' HD12 ' A' ' 106' ' ' ILE . 6.5 mttt -61.53 -36.74 81.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -44.51 86.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -58.33 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 162' ' ' MET . 28.9 m -56.29 -38.77 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 -42.72 94.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.518 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.2 t -63.46 -45.05 92.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.62 -52.63 60.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 129' ' ' VAL . 75.3 t -54.21 -47.24 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.04 -58.0 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.806 HG13 HD23 ' A' ' 135' ' ' LEU . 19.0 m -68.75 -39.23 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.407 ' HD1' HG23 ' A' ' 136' ' ' VAL . 4.4 m-30 -56.48 -43.82 80.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.06 -50.11 8.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -55.06 31.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.792 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -65.23 -47.82 75.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.59 -33.13 62.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.16 -23.96 24.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.86 -27.27 9.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.66 49.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -37.3 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.506 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -170.7 137.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.792 ' HB2' ' HB3' ' A' ' 140' ' ' MET . . . 173.73 -27.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.124 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.9 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.582 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.7 t-105 -65.66 -55.49 23.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.55 0.691 . . . . 0.0 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.798 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.6 Cg_endo -69.75 -20.77 34.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.653 2.235 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.55 -29.06 6.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -69.58 -42.92 73.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 150' ' ' PRO . 5.1 mt -62.9 -67.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 136' ' ' VAL . 6.5 pt -51.65 -44.83 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.93 -48.89 77.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.1 m -61.21 -50.71 71.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.884 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -50.42 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.81 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.496 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.9 t90 -67.28 -57.5 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.496 HG23 ' CE3' ' A' ' 159' ' ' TRP . 91.0 t -61.7 -40.26 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -68.2 -45.33 73.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.968 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.633 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.1 tpt -53.88 -52.92 58.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.712 HG22 ' CE3' ' A' ' 167' ' ' TRP . 50.5 mt -63.6 -53.1 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -49.81 -33.31 16.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -53.68 8.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.5 pp -70.12 -11.13 60.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.712 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -62.81 -16.38 57.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.03 14.6 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.502 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.336 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.6 163.62 22.15 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 0.0 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -27.14 26.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.59 -45.26 31.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 116' ' ' ALA . 51.1 t -60.49 -47.72 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.29 -35.54 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -43.97 78.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.6 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.812 ' CD2' HD11 ' A' ' 113' ' ' LEU . 11.8 t80 -67.04 -46.82 73.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.973 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -49.3 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -64.92 -32.75 74.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.466 ' HE1' HG13 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -64.81 -52.58 56.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.0 ptm -63.52 -35.52 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.02 -48.21 79.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.566 HD12 HD12 ' A' ' 233' ' ' LEU . 31.2 mm -65.23 -54.45 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.14 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 234' ' ' PHE . 34.0 mm -50.71 -53.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.544 HD13 HD13 ' A' ' 163' ' ' ILE . 76.9 mt -56.84 -51.67 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -53.67 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.01 -62.72 5.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -53.62 -30.61 43.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -76.8 -26.3 54.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.07 -30.89 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.3 t80 -45.5 -56.19 10.29 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.674 0.75 . . . . 0.0 110.917 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.3 Cg_endo -69.7 -23.16 31.39 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.657 2.238 . . . . 0.0 112.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 198' ' ' ALA . 88.7 t -68.48 -45.2 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.95 -46.34 5.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.59 -48.57 71.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.918 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -49.95 -54.28 20.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.3 t -73.09 -14.21 61.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -92.41 -13.1 57.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.936 -179.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.01 65.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.88 -52.28 64.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.555 ' HA ' HD21 ' A' ' 221' ' ' LEU . 0.2 OUTLIER -51.54 -35.66 41.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.16 -44.63 59.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -55.47 -51.65 66.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 218' ' ' ASN . 1.2 pp -66.71 -48.87 67.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 221' ' ' LEU . 28.8 mt -54.38 -44.49 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -65.82 -52.98 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -56.85 -39.24 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.07 -49.15 71.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.23 -55.09 37.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -63.26 -32.66 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -60.91 -55.67 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 233' ' ' LEU . 21.5 t -72.09 -24.94 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -77.87 0.91 22.15 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 126.729 3.157 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -135.16 -63.75 0.67 Allowed 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 117.144 -3.473 . . . . 0.0 112.756 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.8 mm -51.0 -63.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.173 -1.831 . . . . 0.0 111.142 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -51.41 -34.23 33.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 193' ' ' ILE . 6.1 t80 -56.51 -56.74 17.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -64.72 -42.6 97.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.3 tt -52.53 -49.77 64.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.3 mm -69.28 -36.18 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.703 HD12 ' HA2' ' A' ' 235' ' ' GLY . 20.1 mt -52.9 -57.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.816 ' HB3' HD21 ' A' ' 62' ' ' LEU . 16.5 p-90 -74.02 -29.51 61.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -54.51 -55.99 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 242' ' ' ALA . 8.9 p -77.41 -42.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB1' ' CG ' ' A' ' 58' ' ' TRP . . . -57.35 -52.72 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 54' ' ' VAL . 97.2 t -67.84 -44.71 85.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -57.67 -44.82 86.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.11 -27.66 54.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.7 t -50.85 -34.45 27.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.35 -177.21 3.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.18 -55.56 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.9 m -53.11 -42.87 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.72 -53.79 47.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.545 ' CG ' HD13 ' A' ' 217' ' ' LEU . 2.9 m-85 -62.04 -48.88 78.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 m -49.85 -48.96 50.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.47 -51.53 47.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.9 t -51.12 -56.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.8 t -57.05 -48.68 77.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -51.76 -42.18 62.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -39.74 78.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -65.24 -44.54 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 ' NH1' ' A' ' 80' ' ' ARG . 12.6 p -70.47 -33.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.0 m -69.72 -51.87 30.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.29 -48.36 80.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -60.4 -51.27 70.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 73' ' ' PHE . 2.3 tm? -55.69 -43.22 76.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.35 -57.9 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.82 62.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.5 p -68.83 -34.69 75.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.8 m -67.15 -52.74 37.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.6 m -62.09 -42.05 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.425 ' N ' HG23 ' A' ' 45' ' ' VAL . 12.2 t80 -68.22 -52.73 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.79 -31.7 68.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -77.62 -51.48 10.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 45' ' ' VAL . 77.0 t -62.01 -44.16 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.585 ' O ' HG13 ' A' ' 54' ' ' VAL . 23.5 tt0 -79.89 -4.58 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' ' CH2' ' A' ' 239' ' ' TRP . 1.2 tmt_? -55.29 -26.05 37.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.91 -3.31 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -106.02 42.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.958 HG11 HD21 ' A' ' 62' ' ' LEU . 9.5 m -112.47 -170.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -84.58 156.22 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.35 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -20.55 56.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -96.18 3.96 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.38 -51.85 50.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.6 p -78.47 -33.15 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -54.8 -42.94 72.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.958 HD21 HG11 ' A' ' 54' ' ' VAL . 7.0 mp -65.8 -29.0 69.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.5 m -71.23 -53.62 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 68' ' ' VAL . 16.9 m -70.64 -49.37 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.5 t -67.86 -37.97 82.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 -34.35 63.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.57 -50.06 48.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.1 p -67.61 -45.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.471 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.4 m -69.52 -34.3 74.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.67 -45.73 74.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.88 -48.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.32 -39.59 91.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.743 ' CE1' HD11 ' A' ' 232' ' ' ILE . 5.9 t80 -62.77 -54.62 36.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.05 -50.52 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -57.32 -49.61 75.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -45.85 91.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.9 ttp -53.57 -47.06 70.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.459 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -70.78 -30.72 67.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.8 mmt -66.84 -58.15 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.69 -49.61 75.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.2 t -66.9 -32.26 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 111.119 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -62.23 -51.0 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.02 -25.59 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.4 -48.79 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 t -121.84 -39.34 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.14 18.6 3.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 127.01 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.823 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.53 160.9 37.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 0.0 110.866 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 97.82 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.736 2.291 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.5 t -69.51 -25.38 64.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 96' ' ' ILE . 7.2 p -67.76 -37.05 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -70.14 -53.15 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.29 73.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -67.73 -55.92 11.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 92' ' ' VAL . 21.2 pt -65.55 -30.91 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -66.33 -48.07 71.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 102' ' ' VAL . 16.6 t90 -61.32 -41.47 97.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD13 ' HE2' ' A' ' 134' ' ' MET . 24.6 tp -76.81 -21.23 55.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.588 ' O ' HD13 ' A' ' 104' ' ' LEU . 7.8 tt -94.1 -11.41 30.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.965 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 72' ' ' ALA . 62.2 p -109.55 -38.93 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' ILE . 2.1 t -47.96 -58.47 7.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.23 36.42 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 100' ' ' LEU . 4.9 mp -78.24 -52.77 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HA ' HG11 ' A' ' 68' ' ' VAL . 1.1 pp -65.3 -51.81 58.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt -55.52 -39.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.431 ' N ' HG23 ' A' ' 106' ' ' ILE . 41.4 t -67.53 -50.49 58.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.37 -57.98 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -52.52 -52.25 55.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.68 -30.85 71.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.42 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.54 -35.65 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.615 HD21 HG13 ' A' ' 182' ' ' VAL . 3.4 tm? -70.48 -35.94 73.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.5 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -74.84 -21.65 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.2 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.74 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -64.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 176.47 -66.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.449 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 m -116.85 166.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -118.15 96.99 5.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 -11.51 84.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -25.34 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.98 -42.57 49.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.61 -43.32 59.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 166' ' ' LEU . 11.2 mttt -59.47 -51.7 68.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -66.09 -37.21 85.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.86 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.85 -58.2 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 162' ' ' MET . 93.9 t -51.84 -51.79 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.39 97.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.3 m -63.9 -40.36 96.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -55.69 12.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.08 -35.76 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.542 ' HE2' HD13 ' A' ' 99' ' ' LEU . 6.4 tmm? -70.75 -43.13 69.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -59.9 -52.84 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.601 ' N ' HD23 ' A' ' 135' ' ' LEU . 43.4 t -61.59 -50.95 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.07 -38.89 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.17 -52.52 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -51.87 -57.71 8.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.9 mtt -71.56 -31.37 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -63.17 -28.49 72.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.54 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 141' ' ' GLY . 10.4 tt0 -34.54 -55.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.49 -30.97 6.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 -4.03 20.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 pt -108.92 3.51 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.518 ' HE3' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -107.1 132.48 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 46.72 47.66 14.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.6 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.081 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.603 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.0 t-105 -57.98 -54.23 57.66 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.729 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -17.34 37.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.96 -33.49 68.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -63.9 -36.65 84.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 150' ' ' PRO . 12.0 mt -62.27 -53.49 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.21 -48.91 13.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.08 -49.63 73.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.97 -49.4 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.88 -35.54 81.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.596 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.7 t90 -67.73 -57.31 6.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' CE3' ' A' ' 159' ' ' TRP . 76.5 t -55.73 -44.59 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.27 -47.07 85.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.791 ' HG3' HG22 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.45 -58.34 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.2 mp -64.82 -31.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -58.63 -49.39 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.31 -40.59 64.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 125' ' ' LYS . 7.5 tt -71.57 -13.91 61.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 -23.78 53.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.87 18.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.488 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.807 0.337 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.11 164.31 22.01 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -27.68 26.25 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.323 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.49 -40.9 48.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.615 HG13 HD21 ' A' ' 113' ' ' LEU . 38.9 t -65.57 -45.88 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.89 -35.37 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 m -69.86 -45.59 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -66.81 -52.13 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.52 -41.23 84.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 p -64.03 -44.92 91.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.745 ' CE ' HD11 ' A' ' 193' ' ' ILE . 3.6 tpt -59.35 -52.8 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 ttp -61.3 -35.91 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.69 -40.38 92.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.757 HD11 ' CG2' ' A' ' 237' ' ' ILE . 10.9 mt -66.5 -53.68 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.745 HD11 ' CE ' ' A' ' 189' ' ' MET . 67.1 mt -56.1 -46.44 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.27 -48.7 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.87 -58.96 5.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.437 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.43 -57.68 18.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -53.27 -31.37 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.677 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.41 -29.15 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.437 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.2 mt -76.53 -31.09 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.6 t80 -47.38 -57.36 9.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.648 0.737 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.81 -20.87 34.03 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 0.0 112.38 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 198' ' ' ALA . 53.0 t -72.1 -44.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.7 -33.01 28.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.711 ' HA ' HD13 ' A' ' 222' ' ' ILE . 0.1 OUTLIER -52.02 -32.83 35.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 2.0 t80 -49.22 -30.9 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 203' ' ' GLY . 13.1 t -51.54 -28.53 13.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -144.34 14.69 2.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.941 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.08 -40.29 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.545 HD13 ' CG ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -64.46 -51.83 61.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.432 ' N ' HD12 ' A' ' 217' ' ' LEU . 20.9 m-20 -60.19 -40.03 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 220' ' ' ASN . 3.3 tt -61.49 -56.97 14.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.564 ' N ' HD23 ' A' ' 219' ' ' LEU . 7.1 t-20 -57.47 -36.18 71.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.75 -58.93 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 204' ' ' TYR . 10.8 mt -54.02 -48.87 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.173 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.01 -37.76 88.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.78 -39.25 80.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.61 -52.8 55.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.61 -40.66 97.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 232' ' ' ILE . 42.4 t80 -57.74 -52.68 64.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.1 m -72.12 -24.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.28 0.64 13.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 126.696 3.141 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -134.32 -45.29 0.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 O-C-N 117.093 -3.504 . . . . 0.0 112.756 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.743 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.7 mp -75.65 -65.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.135 174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.06 -37.15 32.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 192' ' ' ILE . 1.9 t80 -54.07 -56.36 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 -35.15 86.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -49.09 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.757 ' CG2' HD11 ' A' ' 192' ' ' ILE . 1.3 mm -65.91 -45.89 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.32 -30.98 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.557 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.8 m0 -74.75 -42.82 57.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -42.4 95.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 242' ' ' ALA . 10.2 p -70.27 -40.14 77.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -71.74 -52.35 18.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 54' ' ' VAL . 71.6 t -57.48 -46.77 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -65.25 -50.77 64.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.88 -31.4 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.9 t -58.5 -48.54 80.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.822 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.781 0.324 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.13 -177.12 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.601 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -58.47 -72.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.13 -32.64 36.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.3 -62.15 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -58.18 -48.23 80.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.951 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -52.81 -45.9 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.77 -51.47 19.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 27' ' ' ASP . 89.0 t -52.7 -51.51 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.338 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 36' ' ' VAL . 26.0 t -64.76 -49.31 71.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -53.25 -47.63 68.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -47.48 80.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -40.6 88.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 32' ' ' SER . 86.0 t -67.99 -39.37 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.7 m -65.0 -53.01 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.71 85.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.75 -55.68 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' C ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.42 -33.45 69.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 45' ' ' VAL . 48.5 tp -68.92 -54.04 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.94 68.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' HD12 ' A' ' 232' ' ' ILE . 71.5 m -72.41 -52.31 16.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 t -66.21 -37.04 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 41' ' ' LEU . 60.3 t -66.7 -50.6 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.84 -43.85 78.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -64.51 -31.64 72.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.22 -52.09 13.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' VAL . 57.3 t -65.92 -39.64 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 54' ' ' VAL . 69.0 mt-10 -79.8 -7.54 58.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -55.64 -26.66 45.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -104.56 -9.36 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -96.15 30.72 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.826 HG11 HD22 ' A' ' 62' ' ' LEU . 4.6 m -110.09 -170.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -76.32 159.86 30.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.02 -55.21 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -21.82 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -88.5 -4.33 58.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -51.15 -49.68 60.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -42.99 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -52.46 -47.3 66.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG11 ' A' ' 54' ' ' VAL . 8.4 tp -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.5 m -70.56 -53.54 15.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' VAL . 26.3 m -72.03 -46.88 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.3 t -68.77 -39.28 80.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.77 -37.65 66.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.99 -48.08 66.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 101' ' ' THR . 72.9 t -64.74 -51.61 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.56 -48.79 64.68 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mt -64.71 -50.14 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.533 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -60.33 -36.87 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.782 ' CE2' HD11 ' A' ' 232' ' ' ILE . 18.7 t80 -60.84 -56.15 24.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.72 -45.92 77.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -57.77 -44.89 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.34 -54.77 41.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.872 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -50.2 30.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.551 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.19 -27.14 64.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.2 tpt -67.58 -58.67 4.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -36.79 81.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.82 -45.09 93.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.1 t -69.1 -36.2 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CZ3' HG23 ' A' ' 91' ' ' THR . 2.7 t-105 -65.51 -46.52 79.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -26.12 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -47.92 -48.03 32.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 p -115.37 -39.65 3.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -21.85 4.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.21 134.84 45.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.05 160.93 38.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.879 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.88 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.473 HG23 ' CZ3' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -58.27 -26.14 62.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 96' ' ' ILE . 41.2 t -49.44 -36.82 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -67.38 -51.77 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -62.57 -55.29 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -52.33 -49.15 64.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.63 HD12 HG12 ' A' ' 92' ' ' VAL . 64.6 mt -65.97 -35.05 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.96 -64.48 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' VAL . 10.5 t-105 -51.83 -37.58 52.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.962 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tp -75.63 -27.41 58.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -87.67 -10.89 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.669 HG23 HG12 ' A' ' 68' ' ' VAL . 6.3 m -106.17 -25.55 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.699 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.3 t -56.05 -59.5 11.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.721 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.81 -39.68 6.13 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.319 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.95 -53.37 55.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD11 ' CE2' ' A' ' 234' ' ' PHE . 1.7 tm? -62.03 -48.72 79.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 110' ' ' TYR . 68.8 mt -61.82 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 123' ' ' LEU . 49.2 t -53.65 -53.48 51.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -53.49 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -49.7 -51.06 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.443 ' CE2' HG23 ' A' ' 106' ' ' ILE . 7.9 m-30 -58.89 -33.53 70.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.88 -66.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 61' ' ' SER . 48.7 mm -54.81 -36.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 113' ' ' LEU . 3.2 tm? -70.7 -33.37 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -77.04 -24.06 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.82 -23.01 16.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -84.3 -65.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.2 m -64.34 -74.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -170.76 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 5.6 m -153.12 131.26 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.85 99.91 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.98 -6.82 83.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.3 m -51.0 -25.64 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 0.4 OUTLIER -51.39 -45.35 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -48.76 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.2 mttt -58.42 -50.49 73.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.0 -36.63 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 127' ' ' LEU . 3.1 tm? -64.87 -46.87 79.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mt -65.4 -58.08 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.737 ' CG1' ' HB1' ' A' ' 158' ' ' ALA . 61.6 t -55.53 -51.16 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.73 -51.31 57.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.0 t -53.41 -47.48 69.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -52.23 66.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 129' ' ' VAL . 44.5 t -53.08 -45.46 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.699 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 mtt -68.4 -34.98 77.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -60.44 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.6 t -70.81 -52.72 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -53.58 -41.5 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.07 25.63 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.6 -55.92 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 mmt -65.44 -50.78 64.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.897 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.26 -31.2 59.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.23 -27.88 10.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 1.119 ' HB1' HD12 ' A' ' 145' ' ' ILE . . . -92.51 -27.52 17.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.91 11.71 55.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 1.119 HD12 ' HB1' ' A' ' 143' ' ' ALA . 5.2 mt -89.33 -54.81 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.148 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -136.86 141.39 42.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.02 -25.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -58.78 -36.64 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.499 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -68.92 -60.05 4.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.565 0.698 . . . . 0.0 110.916 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.757 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.345 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.7 -50.86 69.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -77.49 -30.14 52.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.9 mt -63.7 -62.86 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.78 -37.04 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.82 -43.61 91.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.0 t -63.55 -46.97 83.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.838 0.352 . . . . 0.0 110.834 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -49.84 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.737 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -65.98 -31.26 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.26 -55.96 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 159' ' ' TRP . 84.8 t -60.77 -43.56 95.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.16 -43.19 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -52.4 61.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.69 HG22 ' CE3' ' A' ' 167' ' ' TRP . 53.7 mt -63.93 -49.6 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -48.74 -38.67 22.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.02 -48.66 28.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.27 -10.69 59.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.69 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -71.24 -15.68 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.47 17.4 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.464 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.822 0.344 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.2 163.56 31.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -25.96 28.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.02 -46.02 31.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.435 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.1 t -62.33 -47.82 91.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -36.61 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -68.21 -45.22 73.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.85 87.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -68.28 -49.45 60.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -37.31 78.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.499 HG21 HG21 ' A' ' 241' ' ' VAL . 3.1 p -72.03 -39.68 68.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -62.25 -52.96 61.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -66.22 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -60.18 -50.25 74.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -33.81 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 189' ' ' MET . 1.2 mp -64.69 -43.94 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 163' ' ' ILE . 80.7 mt -69.71 -51.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.66 -55.72 17.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -61.58 -57.34 18.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.521 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 25.6 m0 -53.12 -31.95 44.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.44 -28.21 52.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 14.2 mt -75.03 -30.42 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -44.74 -58.0 6.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.733 0.777 . . . . 0.0 110.949 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.72 -20.58 34.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 198' ' ' ALA . 93.1 t -71.52 -44.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.49 -34.59 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.62 -57.09 12.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -30.93 71.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -50.84 -26.82 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.54 -42.55 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.776 ' CE2' HD21 ' A' ' 219' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.393 . . . . 0.0 110.936 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.67 81.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.082 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 25' ' ' ALA . 1.1 pp -56.17 -51.54 67.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 217' ' ' LEU . 1.9 t30 -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.776 HD21 ' CE2' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -62.01 -56.24 21.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -51.0 71.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -50.72 -58.48 5.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.53 ' N ' HD13 ' A' ' 221' ' ' LEU . 90.4 mt -53.72 -43.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.1 -48.05 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -36.82 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -49.58 76.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 200' ' ' TYR . . . -64.08 -51.0 66.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.69 -30.46 70.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.71 -46.18 59.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 34.2 m -71.73 -23.33 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -95.09 2.94 55.26 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-O 126.697 3.141 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -60.18 1.48 Allowed 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 117.131 -3.481 . . . . 0.0 112.74 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.782 HD11 ' CE2' ' A' ' 73' ' ' PHE . 18.7 mm -66.47 -64.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.138 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.2 OUTLIER -48.59 -32.94 8.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 238' ' ' ILE . 14.1 t80 -58.36 -55.54 33.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.08 -34.43 88.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -42.65 87.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.9 mm -66.72 -47.61 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 234' ' ' PHE . 84.3 mt -65.91 -40.82 88.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 23.8 t90 -70.5 -39.33 74.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -68.72 -47.08 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 188' ' ' THR . 9.2 p -67.05 -33.01 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -76.94 -51.44 11.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 54' ' ' VAL . 72.2 t -62.88 -34.06 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -76.22 -54.57 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.78 -38.78 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 81.5 p -55.1 -35.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -179.04 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -77.13 -71.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -30.54 45.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.52 -70.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.455 ' HB3' HD21 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -51.83 -43.03 63.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 84' ' ' ILE . 18.8 m -60.42 -40.95 92.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.16 -54.22 21.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.82 -40.8 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 74.0 m -64.58 -49.73 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -55.19 -44.71 75.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -46.91 82.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -39.78 91.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -64.44 -48.75 83.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -57.71 -50.06 74.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.05 71.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -57.99 -52.07 67.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.486 HD13 ' HG3' ' A' ' 77' ' ' MET . 1.3 tt -52.3 -47.3 66.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.57 -49.9 75.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.12 75.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.4 t -69.35 -37.49 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -46.01 71.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.5 m -66.69 -41.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.0 m-85 -69.08 -51.54 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -61.86 -33.41 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.45 -47.61 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' VAL . 86.3 t -70.44 -29.77 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -73.93 -10.77 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -56.11 -26.81 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -12.73 17.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -106.24 42.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.6 p -127.7 160.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 12.7 t -49.98 148.67 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 -48.73 65.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -58.88 -23.03 60.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CE2' ' HB2' ' A' ' 242' ' ' ALA . 45.1 m95 -88.02 7.36 31.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -49.64 -50.08 44.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -36.36 58.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' HG21 ' A' ' 112' ' ' ILE . 8.1 t -52.6 -42.38 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.596 HD21 HG21 ' A' ' 54' ' ' VAL . 4.3 mm? -68.29 -28.98 67.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.7 m -72.45 -52.21 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 17.2 m -67.19 -50.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' HG23 ' A' ' 64' ' ' VAL . 36.5 m -69.16 -36.7 77.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.95 -41.43 93.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 71' ' ' ILE . 31.7 mt -70.84 -47.43 59.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.664 HG12 HG23 ' A' ' 101' ' ' THR . 61.1 t -65.8 -55.36 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.494 HG23 ' HD2' ' A' ' 231' ' ' LYS . 9.7 m -68.37 -26.82 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.173 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.88 -51.45 24.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 67' ' ' LEU . 17.6 pt -64.2 -39.64 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.734 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -71.19 -37.95 72.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 232' ' ' ILE . 8.8 t80 -61.0 -57.93 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -47.56 85.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -55.14 -47.51 74.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -48.94 79.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -50.55 -51.34 48.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.0 t80 -58.71 -53.38 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.2 mmt -54.71 -47.52 73.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -53.1 -56.07 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.5 -33.78 73.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 78' ' ' TYR . 98.2 t -67.56 -47.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.157 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -61.71 -45.07 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 29' ' ' THR . 10.6 tp -73.63 -25.19 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -48.25 33.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.4 p -136.61 -39.81 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.57 -15.37 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 127.02 53.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.46 160.79 52.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.75 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 90.09 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -69.42 -32.55 71.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' PHE . 12.3 m -50.93 -45.87 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -69.54 -46.78 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -47.12 77.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -65.41 -39.89 92.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.81 -57.52 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -33.18 69.87 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.414 ' CE3' HG23 ' A' ' 102' ' ' VAL . 25.1 t-105 -60.09 -58.75 7.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.06 -13.11 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.584 ' O ' HD22 ' A' ' 104' ' ' LEU . 6.3 tt -91.6 -16.6 26.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.734 HG21 ' CB ' ' A' ' 72' ' ' ALA . 25.5 m -110.76 -31.5 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -51.16 -59.51 7.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.613 0.721 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.6 Cg_endo -69.79 -35.5 12.44 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 100' ' ' LEU . 8.9 mp -64.91 -38.95 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -48.69 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mm -64.9 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.1 t -64.31 -55.33 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.83 -58.47 6.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.661 ' CE1' HD12 ' A' ' 238' ' ' ILE . 79.8 t80 -50.02 -54.56 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.541 ' HD2' ' HG ' ' A' ' 122' ' ' SER . 6.1 m-85 -61.16 -31.07 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.25 -67.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 61' ' ' SER . 46.3 mm -50.86 -40.72 20.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.802 HD12 HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -68.81 -35.36 76.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -77.73 -14.91 59.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.79 -23.28 11.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.78 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -122.09 -6.57 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.33 51.93 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 119' ' ' VAL . 3.1 p 179.8 112.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.76 97.71 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.32 -5.73 87.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.541 ' HG ' ' HD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -53.18 -23.44 8.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.89 -42.86 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -73.14 -37.41 66.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.67 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -65.95 -53.25 41.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -34.15 77.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -47.09 74.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.41 -59.81 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 125' ' ' LYS . 8.1 p -58.92 -33.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.1 -47.75 57.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.3 m -65.35 -38.6 90.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.383 . . . . 0.0 110.844 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -52.15 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 129' ' ' VAL . 77.9 t -56.88 -51.81 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.7 ptm -62.98 -33.67 75.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.98 -56.2 21.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.886 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 135' ' ' LEU . 71.7 t -60.62 -53.16 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.22 -37.12 71.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.5 -52.27 40.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -48.71 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.5 ttp -62.74 -34.38 77.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.81 -30.98 55.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.55 -48.0 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.77 -26.68 8.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 52.81 26.38 25.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.88 -37.38 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 111.129 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.838 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -131.06 -170.73 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.838 ' HB2' ' HE2' ' A' ' 146' ' ' MET . . . 77.14 -4.97 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.93 -43.14 62.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.2 t-105 -64.52 -55.62 28.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.73 -19.01 36.84 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -50.79 -42.36 57.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -58.54 -39.42 80.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.37 -64.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 151' ' ' ALA . 9.3 pt -51.69 -41.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.87 -50.03 32.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -56.82 -55.95 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 110.911 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 mt -54.72 -48.13 72.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.9 91.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.098 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.579 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.2 t90 -67.02 -56.87 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.48 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.2 t -52.96 -45.79 52.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.159 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -62.97 -45.08 94.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -58.47 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.579 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.4 mp -66.99 -32.04 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -55.82 -54.54 43.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -42.57 63.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.49 -15.49 62.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.442 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -57.38 -22.58 43.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.37 19.09 19.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.795 0.331 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 164.1 17.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -22.87 31.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.313 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 245' ' ' GLU . . . -76.54 -42.45 42.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.802 HG13 HD12 ' A' ' 113' ' ' LEU . 54.3 t -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.64 78.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 188' ' ' THR . 41.7 t -70.36 -46.87 63.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 241' ' ' VAL . . . -62.89 -40.02 96.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -66.92 -52.07 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.27 -54.88 40.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.564 ' OG1' HG21 ' A' ' 241' ' ' VAL . 63.9 p -58.83 -40.76 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.421 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -56.15 -52.87 62.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.82 -32.68 74.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.33 -49.27 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -35.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.131 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 194' ' ' ILE . 1.3 mp -63.76 -48.18 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 159' ' ' TRP . 97.0 mt -69.12 -50.74 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -51.51 -55.26 19.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.402 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -60.21 -59.57 10.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -53.35 -31.34 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.44 -27.28 46.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.7 mt -75.0 -32.05 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.4 t80 -47.89 -57.72 9.49 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.8 -26.49 27.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.364 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 198' ' ' ALA . 52.3 t -70.85 -37.62 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.49 -40.78 12.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.48 -33.13 43.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -27.28 10.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 203' ' ' GLY . 14.1 t -49.8 -27.96 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 -179.809 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.36 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.075 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 25' ' ' ALA . 10.2 tp -53.0 -61.85 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.93 -37.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.01 -42.4 94.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.493 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.5 t-20 -64.58 -46.76 81.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 221' ' ' LEU . 3.4 tm? -60.27 -57.79 11.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 35.3 mm -53.11 -48.01 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.24 -36.38 83.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -70.28 -42.45 72.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -51.46 68.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.97 -52.24 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -58.71 -37.6 76.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 232' ' ' ILE . 39.2 t80 -64.34 -58.22 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.5 m -61.08 -25.62 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.68 1.23 20.52 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 126.69 3.138 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HD2' HG23 ' A' ' 69' ' ' THR . 21.3 mmtm -130.0 -60.28 1.03 Allowed 'General case' 0 N--CA 1.423 -1.793 0 O-C-N 117.116 -3.49 . . . . 0.0 112.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -60.97 -63.71 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.104 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.74 -40.54 69.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -52.78 -58.77 5.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.02 91.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.75 -48.96 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 241' ' ' VAL . 43.3 mm -65.7 -49.64 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 109' ' ' PHE . 45.9 mm -57.7 -52.43 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.654 ' O ' HG23 ' A' ' 243' ' ' VAL . 7.9 t90 -57.91 -43.47 86.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -55.46 -42.9 74.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 237' ' ' ILE . 14.6 t -63.86 -49.54 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' A' ' 58' ' ' TRP . . . -56.62 -51.34 69.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' VAL . 8.1 t -67.96 -31.69 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -60.74 -53.62 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 181' ' ' ALA . 0.9 OUTLIER -71.51 -35.72 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -43.43 65.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.345 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.75 178.35 8.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -70.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -54.95 -42.17 72.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 t0 -51.91 -57.0 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -47.9 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.549 ' OG1' HD11 ' A' ' 217' ' ' LEU . 23.9 m -51.13 -47.42 62.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.163 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.51 36.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 27' ' ' ASP . 92.2 t -52.98 -56.22 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.147 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t -58.6 -48.82 79.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -51.95 -39.7 59.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.48 -41.05 69.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.22 -44.31 92.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -36.09 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.9 m -69.67 -53.4 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.86 -46.54 89.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.8 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.62 HD13 ' HE2' ' A' ' 73' ' ' PHE . 4.6 tp -55.97 -47.54 77.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.18 -54.41 47.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.79 71.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 m -72.13 -41.51 67.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -41.19 94.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 49' ' ' VAL . 27.2 m -72.01 -37.89 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.02 -53.26 52.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.98 -47.95 75.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.21 -48.25 68.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 45' ' ' VAL . 95.6 t -74.14 -29.76 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.761 ' O ' HG13 ' A' ' 54' ' ' VAL . 45.8 mm-40 -79.9 -7.12 58.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -27.09 29.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -113.49 -4.04 13.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -94.73 8.99 40.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.6 m -104.27 -171.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -77.87 158.36 29.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.76 -55.19 28.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.49 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 73.6 m95 -87.77 -14.03 40.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -51.36 -49.73 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -36.1 69.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.746 ' HB2' HG21 ' A' ' 112' ' ' ILE . 2.2 p -56.92 -45.31 82.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.836 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.42 -27.14 66.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -71.0 -53.49 14.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 68' ' ' VAL . 23.2 m -72.02 -47.27 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.511 ' N ' HG23 ' A' ' 64' ' ' VAL . 11.4 p -68.77 -38.68 80.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.3 -33.82 58.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.89 -46.65 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -69.98 -44.07 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.454 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.3 m -70.54 -34.04 71.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.83 37.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -36.83 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.43 62.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.62 ' HE2' HD13 ' A' ' 40' ' ' LEU . 4.1 t80 -61.99 -48.81 78.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -64.36 -51.87 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -57.05 -52.68 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.64 -65.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -51.43 -32.88 28.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -61.07 -67.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.44 ' HA ' HG12 ' A' ' 82' ' ' VAL . 2.5 mmt -67.86 -59.58 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -50.91 -40.21 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.17 -57.62 4.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 79' ' ' MET . 4.8 p -53.77 -35.6 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . 0.8 OUTLIER -76.33 -58.5 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 88' ' ' ASP . 2.5 tp -56.83 -24.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -54.59 -27.16 37.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 83' ' ' TRP . 10.1 t -107.95 -21.6 12.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.77 -109.56 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 11.8 p-10 -123.53 142.5 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.25 161.99 38.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.69 0.757 . . . . 0.0 110.859 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 93' ' ' PHE . 54.3 Cg_endo -69.72 136.54 33.36 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 0.0 112.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -69.9 -29.96 67.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 93' ' ' PHE . 6.7 m -58.78 -45.75 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 92' ' ' VAL . 43.4 m-85 -69.93 -53.36 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -56.02 -47.96 76.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 18.8 t80 -57.26 -55.3 36.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.5 mt -62.35 -29.88 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -61.37 -61.61 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 109.24 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.46 -31.27 71.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.43 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 0.7 OUTLIER -72.21 -22.72 61.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.929 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 104' ' ' LEU . 4.2 tt -101.26 -18.82 15.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.803 HG22 HD23 ' A' ' 105' ' ' LEU . 35.8 m -94.79 -33.04 13.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -57.78 -56.76 31.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.602 0.715 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.81 -26.23 27.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.4 mm? -75.54 -54.0 7.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 101' ' ' THR . 3.3 pp -65.04 -39.47 93.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.4 mm -65.94 -43.9 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.0 t -61.76 -52.75 62.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.67 54.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.82 -45.84 64.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.97 -44.91 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -50.29 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 61' ' ' SER . 40.8 mm -59.93 -59.44 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.73 -22.09 44.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.22 -44.47 46.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.29 -17.97 33.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 182' ' ' VAL . . . -74.48 -39.07 62.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 -67.63 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' OD1' HG22 ' A' ' 119' ' ' VAL . 7.7 t-20 -161.43 -75.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.528 HG22 ' OD1' ' A' ' 118' ' ' ASN . 6.3 m -151.77 135.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB1' ' OH ' ' A' ' 186' ' ' TYR . . . -103.69 100.05 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.52 -8.51 59.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -52.17 -25.44 9.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 110' ' ' TYR . 1.7 pt? -63.52 -34.64 78.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -47.02 81.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -69.0 -44.76 72.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -64.41 -37.3 87.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.65 -47.66 62.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.49 -58.8 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 162' ' ' MET . 92.6 t -58.0 -51.57 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.36 -43.1 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.7 t -66.88 -36.6 82.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 136' ' ' VAL . 4.5 mt -64.08 -54.3 36.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -60.12 -39.68 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -67.06 -45.87 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 HD13 ' A' ' 154' ' ' ILE . 95.5 t -60.7 -49.63 83.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -66.69 -33.17 75.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.17 -52.07 15.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -65.22 -52.18 56.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 mmt -66.0 -44.6 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.66 -32.56 84.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -46.82 -52.69 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 145' ' ' ILE . . . -111.89 16.33 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.44 50.16 42.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.511 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 143' ' ' ALA . 2.6 mt -83.46 -18.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.96 132.1 54.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.87 -162.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.681 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -77.99 -25.64 48.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.614 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.3 m95 -66.42 -53.64 29.21 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.79 -12.35 32.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.35 -47.09 29.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.32 -34.38 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.3 mt -58.95 -57.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.77 HD13 HG11 ' A' ' 136' ' ' VAL . 60.6 mt -65.61 -47.74 85.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.21 -42.75 93.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.482 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.56 -50.93 63.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -55.87 -48.62 75.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.88 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.535 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -60.09 -55.72 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.5 t -57.16 -48.92 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.11 -41.65 97.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.78 ' HB2' HG11 ' A' ' 129' ' ' VAL . 1.7 tmt? -55.89 -59.28 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.535 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.7 mp -66.18 -31.67 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.39 -52.57 64.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -73.72 -34.58 64.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.23 -18.94 62.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.404 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -65.66 -35.22 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.21 18.85 14.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.796 0.331 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.22 163.21 24.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -18.37 36.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.58 -47.76 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.509 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 17.3 t -62.27 -47.06 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -34.33 73.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB3' HG21 ' A' ' 241' ' ' VAL . 1.3 m -70.26 -45.18 66.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.6 95.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.587 ' OH ' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -67.88 -48.85 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.67 -56.19 24.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -59.08 -40.46 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -58.74 -52.36 66.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.1 ttp -61.02 -36.66 80.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -48.32 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.833 HG23 HD13 ' A' ' 233' ' ' LEU . 46.9 mm -64.15 -44.99 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.454 HG21 ' HE1' ' A' ' 162' ' ' MET . 69.3 mt -55.28 -46.88 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HG12 ' A' ' 163' ' ' ILE . 92.6 mt -64.41 -49.7 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.17 -57.14 10.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -59.37 -58.83 12.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -52.7 -31.48 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.26 -30.05 54.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.466 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.3 mt -74.31 -31.03 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -45.87 -58.53 6.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.4 Cg_endo -69.74 -21.38 33.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.312 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.9 t -70.83 -44.67 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.81 -30.78 28.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -53.16 -57.96 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -31.05 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -51.74 -27.21 11.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.155 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.99 -7.04 5.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 17.7 t80 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.36 67.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.549 HD11 ' OG1' ' A' ' 29' ' ' THR . 0.2 OUTLIER -58.15 -62.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -51.96 -36.42 49.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.76 -52.09 65.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.84 -42.01 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.4 tm? -62.29 -55.46 27.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 221' ' ' LEU . 84.4 mt -60.46 -48.76 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.15 -57.89 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -40.54 74.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -50.4 71.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.22 -54.83 38.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.55 -35.95 82.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -61.79 -53.08 60.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 233' ' ' LEU . 8.6 p -71.9 -24.83 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -69.35 -24.55 63.91 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 126.68 3.133 . . . . 0.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 1.6 mttm -112.91 -10.16 13.56 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 117.117 -3.489 . . . . 0.0 112.789 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.3 mm -91.97 -61.57 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.147 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.833 HD13 HG23 ' A' ' 192' ' ' ILE . 0.7 OUTLIER -50.52 -35.49 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -54.72 -57.59 10.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.56 -42.76 87.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HE1' ' A' ' 239' ' ' TRP . 12.4 tp -51.76 -50.98 59.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 241' ' ' VAL . 3.2 mm -68.54 -37.01 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.452 HG23 ' CZ3' ' A' ' 58' ' ' TRP . 4.0 mm -52.22 -57.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.502 ' HE1' HD12 ' A' ' 236' ' ' LEU . 16.0 p-90 -74.09 -29.39 61.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -53.74 -56.77 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.7 p -77.61 -43.62 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -55.87 -51.45 67.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.786 HG22 ' HA ' ' A' ' 54' ' ' VAL . 99.2 t -70.28 -41.93 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -54.06 -51.17 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -29.58 54.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.4 t -51.13 -30.84 17.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.24 164.01 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 217' ' ' LEU . . . -76.69 -65.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -52.46 -44.53 65.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -56.22 -61.58 2.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -51.94 -42.81 63.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.1 m -60.65 -41.29 94.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.58 -54.19 24.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.16 -40.24 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 76.9 p -64.8 -49.59 70.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -56.16 -44.26 79.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.56 -47.8 80.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.23 -40.82 91.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -63.47 -49.12 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 m -57.75 -47.08 83.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.33 78.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.13 -47.85 80.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.094 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.58 HD21 ' NE1' ' A' ' 74' ' ' TRP . 14.4 tp -60.78 -39.09 87.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.96 -56.83 15.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.52 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -69.7 -33.1 72.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.559 HG21 ' HH2' ' A' ' 74' ' ' TRP . 95.0 m -72.67 -45.68 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.3 p -65.37 -43.18 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -68.23 -49.11 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.859 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -63.71 -32.03 73.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -75.35 -52.3 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 45' ' ' VAL . 85.8 t -64.77 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.06 -0.62 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -74.04 -26.51 60.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.79 -19.3 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 22.52 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.123 HG21 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -94.75 174.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -53.63 150.44 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.86 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -79.17 -26.56 42.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HH2' ' HB1' ' A' ' 185' ' ' ALA . 59.4 m95 -87.13 -6.23 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -51.58 -50.46 60.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 64' ' ' VAL . 17.7 p -77.83 -35.68 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -59.43 -42.48 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.123 HD13 HG21 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -65.1 -30.21 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -55.65 5.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 68' ' ' VAL . 13.9 m -57.79 -51.8 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.534 ' N ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -70.77 -47.89 57.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.63 92.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.86 -47.18 60.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' VAL . 56.8 t -58.53 -56.43 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -63.55 -39.31 94.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.65 -68.95 1.46 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.442 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -50.12 -33.97 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 111.127 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 101' ' ' THR . . . -63.97 -52.43 59.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 40' ' ' LEU . 46.9 t80 -58.81 -48.77 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.58 ' NE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -62.1 -50.57 71.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -55.8 -60.88 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -54.2 -58.77 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.9 -33.35 36.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.3 m-85 -65.58 -69.15 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.71 -57.37 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -55.31 -52.22 64.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.471 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -59.57 -47.6 90.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.458 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 78' ' ' TYR . 27.1 t -61.37 -46.65 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -56.48 11.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 87' ' ' GLY . 6.8 tp -58.81 -26.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -21.65 47.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 p -114.2 -30.62 6.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 84' ' ' ILE . . . -164.46 -110.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -98.56 -176.08 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.769 0.319 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -115.78 155.68 47.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.679 0.752 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 121.51 8.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -69.69 -35.87 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 93' ' ' PHE . 7.3 p -66.99 -44.71 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.149 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.463 ' N ' HG13 ' A' ' 92' ' ' VAL . 4.7 m-85 -71.39 -44.27 65.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -64.45 -48.16 76.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -59.86 -52.78 63.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 92' ' ' VAL . 63.7 mt -65.96 -30.01 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 101' ' ' THR . 2.9 t70 -61.66 -57.44 11.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 109.297 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.428 ' HA ' ' HG1' ' A' ' 101' ' ' THR . 27.1 m0 -69.82 -30.67 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.878 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -75.12 -19.39 59.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -101.01 -31.73 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.538 HG21 ' HB1' ' A' ' 72' ' ' ALA . 55.8 p -79.83 -39.62 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.549 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -50.83 -56.61 18.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.79 -38.48 7.67 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.315 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.5 -51.99 67.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.4 tm? -67.11 -41.99 85.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.657 HG23 ' HA ' ' A' ' 123' ' ' LEU . 49.8 mt -59.93 -48.62 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.099 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.511 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.3 t -62.22 -57.53 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -52.07 -40.54 61.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -66.37 -50.18 64.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -35.38 65.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.58 -61.19 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.9 pt -55.68 -36.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 120' ' ' ALA . 1.4 tm? -71.78 -50.8 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.61 67.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.05 -11.11 60.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.119 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 182' ' ' VAL . . . -92.1 -29.67 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 -67.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -174.84 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 m -151.54 142.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 113' ' ' LEU . . . -126.37 108.14 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.81 -5.49 69.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -50.22 -27.98 6.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.903 0.382 . . . . 0.0 110.811 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -64.62 -41.0 96.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.625 ' N ' HD23 ' A' ' 123' ' ' LEU . 2.4 t80 -58.83 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.645 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -63.16 -48.31 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -60.28 -34.99 74.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 tp -68.33 -48.8 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.92 -56.73 18.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 133' ' ' VAL . 7.4 p -58.96 -43.1 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.445 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -58.04 -41.27 94.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.446 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 134' ' ' MET . 0.1 OUTLIER -71.07 -35.16 71.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -53.84 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 129' ' ' VAL . 26.5 m -58.16 -43.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.44 ' N ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -71.77 -28.99 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -66.11 -50.33 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.686 HG13 HD23 ' A' ' 135' ' ' LEU . 30.7 m -70.3 -41.22 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.422 ' N ' HG23 ' A' ' 136' ' ' VAL . 35.4 t80 -61.92 -38.92 90.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 -50.5 9.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -63.24 -50.53 69.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.548 ' HB3' ' HE2' ' A' ' 146' ' ' MET . 14.1 mmt -65.49 -52.68 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.77 -32.61 74.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.72 -30.21 13.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 145' ' ' ILE . . . -112.53 -27.28 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.76 9.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 143' ' ' ALA . 1.3 pp -103.92 8.82 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.548 ' HE2' ' HB3' ' A' ' 140' ' ' MET . 0.1 OUTLIER -100.63 -169.29 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.32 107.59 18.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 208' ' ' TYR . . . -74.33 -22.55 59.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.3 t-105 -52.85 -57.8 14.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.59 0.71 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.0 Cg_endo -69.76 -19.24 36.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.329 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.22 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.26 -40.88 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mt -60.67 -41.59 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.8 mt -59.12 -57.17 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.55 94.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 39.0 t -63.39 -57.36 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 153' ' ' ILE . 35.2 mt -53.52 -50.5 65.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.35 77.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.581 ' HE1' HG23 ' A' ' 194' ' ' ILE . 0.4 OUTLIER -64.53 -55.25 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG23 ' CE3' ' A' ' 159' ' ' TRP . 89.3 t -55.66 -51.61 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -35.59 75.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.6 mmt -61.62 -59.86 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.8 mp -58.39 -36.4 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.34 -36.37 82.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.05 -38.82 61.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -84.11 -11.14 57.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.483 ' CE3' HG22 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -56.33 -25.41 48.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.38 18.35 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.79 0.329 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.2 164.02 15.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 0.0 110.857 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.58 33.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.56 -44.48 34.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.067 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.967 HG22 ' HB1' ' A' ' 116' ' ' ALA . 16.9 t -62.52 -48.05 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -58.13 -36.99 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.2 m -68.2 -45.21 74.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.855 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.42 ' HB1' ' HH2' ' A' ' 58' ' ' TRP . . . -61.55 -39.43 91.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.68 -51.8 52.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -45.2 75.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.9 p -66.22 -38.24 87.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.827 ' HG2' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -59.2 -50.5 73.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.03 -34.48 76.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -59.54 -49.54 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 234' ' ' PHE . 22.0 pt -70.53 -36.72 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.413 HD11 ' HE2' ' A' ' 234' ' ' PHE . 13.6 mm -63.0 -48.77 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.581 HG23 ' HE1' ' A' ' 159' ' ' TRP . 55.7 mt -67.06 -51.91 49.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.1 -56.08 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.93 -58.48 14.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -54.21 -31.88 54.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.18 -24.64 43.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -78.93 -31.96 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.9 t80 -48.16 -55.42 18.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.71 -24.92 29.38 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.9 t -67.26 -43.18 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.634 ' O ' HG22 ' A' ' 206' ' ' THR . . . -84.07 -27.74 36.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -46.07 65.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.899 0.38 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -31.39 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -53.68 -23.0 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -118.86 -26.35 2.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 148' ' ' ALA . 29.1 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -39.02 57.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.555 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 81.3 mt -61.39 -62.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -53.35 -42.51 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -53.64 54.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.4 ' HB2' HG12 ' A' ' 84' ' ' ILE . 2.4 t30 -58.18 -42.31 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.37 -58.82 6.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.629 HD12 ' HA3' ' A' ' 203' ' ' GLY . 47.4 mm -59.26 -47.92 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -58.07 -39.64 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 36' ' ' VAL . 1.8 t-20 -70.5 -46.24 64.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -51.27 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.59 -50.85 70.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.3 -28.08 69.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.66 -48.96 19.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.34 -23.15 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -90.9 3.11 55.44 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-O 126.72 3.152 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -129.96 -64.88 0.85 Allowed 'General case' 0 N--CA 1.424 -1.769 0 O-C-N 117.128 -3.483 . . . . 0.0 112.782 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 73' ' ' PHE . 42.8 mm -55.86 -62.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.136 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -32.65 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.713 ' HA ' HD12 ' A' ' 192' ' ' ILE . 3.3 t80 -52.68 -55.77 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.81 -36.13 58.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -51.54 69.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.329 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 241' ' ' VAL . 1.1 mm -68.85 -49.6 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.827 HD11 ' HG2' ' A' ' 189' ' ' MET . 21.5 mm -56.87 -32.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.695 ' O ' HG23 ' A' ' 243' ' ' VAL . 20.1 t90 -76.01 -47.52 24.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -57.19 -40.84 78.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 237' ' ' ILE . 9.4 p -74.21 -40.47 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.98 -37.7 86.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 54' ' ' VAL . 43.7 t -78.54 -48.19 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -60.11 -37.56 80.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -76.95 -45.99 25.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 20.7 t -55.64 -72.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.841 0.353 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.55 175.53 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -52.2 -75.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -34.38 64.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -55.41 -64.11 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -59.66 -48.11 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 84' ' ' ILE . 96.6 m -51.58 -43.78 62.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.64 -50.47 30.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 27' ' ' ASP . 91.8 t -52.04 -51.14 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -64.74 -49.88 69.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -53.28 -47.04 69.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -48.02 75.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.59 -41.86 86.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 32' ' ' SER . 84.2 t -65.75 -43.94 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 m -60.67 -53.28 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.79 74.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.84 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 tp -53.03 -45.16 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 45' ' ' VAL . 18.7 tp -64.1 -54.12 38.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.84 73.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -70.38 -34.54 72.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.6 m -72.76 -49.29 31.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 41' ' ' LEU . 29.9 m -65.88 -39.53 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -69.46 -52.12 29.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.59 -31.79 72.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -74.62 -52.16 12.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.3 t -64.92 -38.81 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.72 -6.33 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -55.11 -26.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -99.99 -12.84 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 40.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.077 HG21 HD21 ' A' ' 62' ' ' LEU . 9.6 p -116.48 160.42 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.434 ' N ' HG22 ' A' ' 54' ' ' VAL . 1.6 t -47.79 152.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 -54.52 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -20.51 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.88 7.84 25.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -50.27 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -37.47 55.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.572 ' CB ' HD12 ' A' ' 112' ' ' ILE . 54.6 p -53.48 -37.08 62.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.077 HD21 HG21 ' A' ' 54' ' ' VAL . 2.9 mm? -65.03 -34.62 78.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -71.08 -47.69 56.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' A' ' 108' ' ' GLU . 17.7 t -70.21 -58.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -63.69 -41.42 98.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.58 91.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.879 HG22 HD12 ' A' ' 104' ' ' LEU . 5.0 t -59.25 -52.07 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -65.46 -26.45 67.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.3 -55.03 17.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.537 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 72' ' ' ALA . 12.1 tt -66.58 -42.47 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.108 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -61.7 -44.52 96.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 40' ' ' LEU . 20.3 t80 -60.87 -52.49 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -44.19 72.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.0 -54.75 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -41.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.5 ttp -59.85 -46.01 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t80 -70.07 -30.79 68.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -63.87 -59.81 4.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.574 HH11 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.48 -41.86 97.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.86 -49.03 73.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 78' ' ' TYR . 74.7 t -64.1 -43.69 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -52.78 -51.47 60.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.729 HG21 HG23 ' A' ' 29' ' ' THR . 30.4 mm -73.08 -26.37 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -49.01 -48.0 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.0 p -146.33 -40.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.52 57.09 0.13 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.34 127.03 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 p -113.26 75.1 2.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.739 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 93.17 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -51.22 -35.14 35.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.88 -43.8 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -68.09 -48.05 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -51.58 63.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -56.72 -55.55 32.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.96 -34.81 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -57.76 -68.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.326 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.3 m0 -57.48 -35.63 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -71.18 -18.27 62.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 104' ' ' LEU . 8.2 tt -100.29 -23.08 14.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 97' ' ' ASP . 21.9 p -91.72 -32.44 15.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.583 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.9 t -57.73 -55.52 44.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.662 0.744 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.77 -38.37 7.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 0.0 112.36 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.879 HD12 HG22 ' A' ' 68' ' ' VAL . 2.6 mm? -62.51 -52.91 61.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.527 ' HA ' HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -62.93 -40.98 99.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 123' ' ' LEU . 70.5 mt -67.05 -38.46 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.502 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.1 t -63.15 -62.53 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.716 ' HB3' HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -53.39 -49.09 67.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 113' ' ' LEU . 12.9 t80 -52.32 -50.36 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -39.64 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -51.47 69.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD12 ' CB ' ' A' ' 61' ' ' SER . 6.3 mm -58.51 -52.75 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -64.46 -21.97 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.36 -40.35 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.02 14.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -54.1 -54.69 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -53.8 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -164.96 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.547 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 11.3 m -143.51 150.25 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.3 122.69 36.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.71 -2.61 70.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.9 p -47.53 -31.28 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -61.13 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.897 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.64 ' N ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -53.96 -52.02 61.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -59.74 -48.64 80.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.418 ' C ' HD13 ' A' ' 106' ' ' ILE . 5.7 mmmm -61.1 -33.51 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.41 -48.16 68.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 132' ' ' LEU . 1.2 tt -61.22 -53.13 60.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 162' ' ' MET . 61.0 t -58.77 -48.01 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -39.31 97.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.528 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -65.82 -39.1 90.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 128' ' ' LEU . 1.2 mm? -66.49 -53.38 35.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.71 -36.08 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.562 ' HE2' HD23 ' A' ' 99' ' ' LEU . 11.4 tmm? -70.51 -39.83 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 66.8 t -64.69 -47.0 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -57.35 -42.3 81.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.36 21.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -56.12 -51.08 69.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.923 0.392 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -31.6 69.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.15 78.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -48.36 -33.08 8.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.94 -27.33 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.11 18.3 40.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.431 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 pt -93.69 -34.74 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.519 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -124.93 119.28 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . 172.73 -55.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.554 ' HB1' ' HE2' ' A' ' 204' ' ' TYR . . . -42.12 -34.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.726 ' O ' HD12 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -85.33 -64.82 0.22 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.568 0.699 . . . . 0.0 110.892 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.72 -54.74 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . -43.22 -38.49 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.41 -51.42 69.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 149' ' ' TRP . 2.9 mp -70.36 -40.1 77.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 77.8 mt -60.72 -50.96 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.3 94.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 160' ' ' VAL . 47.3 t -55.81 -51.17 68.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 110.904 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.05 -49.75 76.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.14 71.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -64.75 -54.93 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 156' ' ' CYS . 32.0 t -53.05 -43.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.92 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.469 ' CE ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -54.76 -47.82 73.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.6 mp -65.17 -40.39 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.81 -50.62 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.99 -43.92 56.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.469 HD22 ' CE ' ' A' ' 162' ' ' MET . 34.9 tp -57.34 -40.45 78.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -57.73 -20.57 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.87 18.34 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 -179.919 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.769 0.318 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.81 162.07 54.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 0.0 110.871 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.85 10.06 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.68 -42.47 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.5 t -67.13 -41.72 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -66.11 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 188' ' ' THR . 1.2 t -72.53 -48.65 38.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.61 96.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 113' ' ' LEU . 45.5 t80 -65.53 -52.24 54.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -54.68 -50.32 68.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 184' ' ' SER . 75.5 p -60.66 -39.92 90.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.415 ' HE2' ' HB ' ' A' ' 238' ' ' ILE . 0.0 OUTLIER -58.05 -52.02 67.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.44 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -63.37 -35.76 81.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -49.1 78.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.11 -48.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -50.97 -48.16 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.542 HG23 ' NE1' ' A' ' 159' ' ' TRP . 73.9 mt -65.32 -44.85 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -59.32 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -63.25 -55.74 24.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.5 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -51.18 -33.8 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.763 0.316 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.42 -30.36 42.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.8 mt -67.74 -32.11 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.484 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -51.88 -60.55 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.74 . . . . 0.0 110.939 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.74 -24.51 29.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.671 2.247 . . . . 0.0 112.344 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 198' ' ' ALA . 29.8 t -75.23 -33.77 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.03 -36.62 17.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HE2' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.29 -32.74 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -67.14 -30.67 70.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 203' ' ' GLY . 32.3 p -47.79 -31.68 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.77 56.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.3 t80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.775 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.857 0.361 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.81 -27.23 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 28' ' ' TYR . 13.1 mt -59.0 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -52.29 -34.79 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mp -62.18 -56.03 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 84' ' ' ILE . 1.9 t30 -58.23 -39.16 78.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.545 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.4 tm? -60.38 -51.46 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 221' ' ' LEU . 27.1 mt -59.65 -45.25 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -56.63 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -38.53 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.14 -51.31 68.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.26 36.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.66 -45.54 93.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.554 ' CD2' HD13 ' A' ' 232' ' ' ILE . 41.6 t80 -51.34 -54.86 22.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 40.6 t -70.6 -24.7 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -82.56 1.42 38.1 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.745 3.164 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.524 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 8.2 mmtm -130.28 -63.1 0.91 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.083 -3.51 . . . . 0.0 112.751 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.8 mp -56.48 -63.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.109 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.1 OUTLIER -55.92 -33.69 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.74 -53.82 52.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.86 -36.71 87.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.93 -40.19 83.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.41 -49.73 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.415 ' HB ' ' HE2' ' A' ' 189' ' ' MET . 11.8 tt -63.44 -33.88 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.607 ' O ' HG23 ' A' ' 243' ' ' VAL . 16.0 t90 -75.52 -42.88 51.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.96 -40.79 98.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.74 -37.89 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.64 -41.36 68.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 54' ' ' VAL . 86.4 t -73.39 -35.92 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -74.69 -35.7 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -76.75 -35.33 57.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 85.3 p -51.21 -49.16 61.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.871 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -178.25 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -61.69 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.32 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.8 m-20 -58.33 -74.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -47.23 84.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.1 m -52.37 -45.04 65.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.186 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.65 -51.91 33.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 27' ' ' ASP . 34.5 t -53.84 -55.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.59 ' CB ' HD23 ' A' ' 221' ' ' LEU . 99.1 p -58.52 -49.96 75.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.92 -39.33 58.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -70.14 -43.4 71.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -44.88 94.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.433 HG11 HH12 ' A' ' 80' ' ' ARG . 33.2 m -69.57 -34.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.087 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 41' ' ' LEU . 27.3 m -68.18 -54.3 18.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.71 88.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.94 -55.14 18.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.65 -32.76 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 37' ' ' THR . 4.1 mp -66.51 -57.75 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 t -70.2 -37.9 75.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.2 m -67.73 -46.39 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.85 -41.55 92.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.26 -51.09 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -62.87 -28.67 70.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -74.34 -49.18 23.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.09 -30.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.209 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.54 -6.03 56.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -59.88 -26.75 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -96.61 -9.8 28.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -108.38 42.34 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.9 p -120.74 159.25 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 54' ' ' VAL . 16.4 t -50.12 139.58 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.69 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -23.88 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -90.05 11.29 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -49.94 -50.06 47.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.76 -38.92 53.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.495 ' CA ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -53.16 -43.57 67.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.83 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -68.69 -53.72 20.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 26.0 m -70.98 -45.79 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 64' ' ' VAL . 6.6 t -66.7 -39.42 88.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.79 -34.71 59.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.73 -48.26 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.905 HG23 HD23 ' A' ' 104' ' ' LEU . 7.7 p -68.54 -44.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.46 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.7 m -69.0 -34.52 75.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.46 51.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.68 -46.79 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.95 -44.75 91.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -58.02 -56.34 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -49.98 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -56.73 -44.99 82.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -59.26 5.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.3 ttm -47.17 -41.76 18.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.542 ' O ' HG23 ' A' ' 82' ' ' VAL . 88.4 t80 -68.99 -40.41 78.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.01 -58.03 6.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -57.03 -42.82 81.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -63.37 -42.46 99.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 78' ' ' TYR . 47.1 t -69.56 -30.01 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -71.99 -41.83 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 220' ' ' ASN . 12.7 tt -76.62 -30.8 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -80.95 -49.79 10.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 m -79.17 -38.45 35.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -23.11 35.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -148.14 126.79 12.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.833 0.349 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 161.16 36.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.897 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 99.14 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.704 2.27 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.2 p -64.28 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 m -50.38 -35.13 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.23 -49.99 57.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -57.74 -45.74 85.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.79 -55.1 33.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.5 mt -61.28 -26.37 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.17 -67.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.107 . . . . 0.0 109.301 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.514 ' O ' HG23 ' A' ' 102' ' ' VAL . 13.0 t90 -51.86 -33.2 35.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.681 HD13 ' CE ' ' A' ' 134' ' ' MET . 9.6 tp -74.6 -38.55 62.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 100' ' ' LEU . 6.3 tt -84.22 -5.28 59.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.019 HG22 HD23 ' A' ' 105' ' ' LEU . 30.3 m -107.56 -39.43 5.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.52 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -44.61 -58.91 4.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.6 0.714 . . . . 0.0 111.159 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 127' ' ' LEU . 53.9 Cg_endo -69.74 -19.53 36.08 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.905 HD23 HG23 ' A' ' 68' ' ' VAL . 51.6 tp -75.67 -51.69 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.019 HD23 HG22 ' A' ' 101' ' ' THR . 1.7 pp -71.05 -35.88 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.1 -50.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.72 -47.63 80.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -61.52 -56.62 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 238' ' ' ILE . 59.6 t80 -51.47 -51.09 57.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -65.53 -35.09 79.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.0 -66.95 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.931 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.495 HG21 ' CA ' ' A' ' 61' ' ' SER . 49.7 mm -56.22 -45.25 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.07 HD11 HG13 ' A' ' 182' ' ' VAL . 7.3 tp -57.05 -44.69 83.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.67 -15.85 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.092 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -53.72 -23.37 11.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -22.73 62.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.6 t -128.17 -47.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' VAL . 2.9 m-20 -179.45 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.3 m -155.06 161.86 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.24 125.53 42.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.89 -11.02 84.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -50.56 -31.91 17.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.19 -38.64 83.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -45.31 93.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.9 mttm -62.15 -50.51 71.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HD2' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -64.65 -35.39 80.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 103' ' ' PRO . 3.9 tp -63.06 -48.51 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -57.59 8.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 133' ' ' VAL . 49.3 t -54.92 -46.86 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.53 99.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.1 t -62.88 -39.62 95.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -47.02 61.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 129' ' ' VAL . 97.8 t -56.73 -51.44 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.681 ' CE ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -68.3 -32.22 72.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -60.59 -48.93 79.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.632 ' N ' HD23 ' A' ' 135' ' ' LEU . 97.1 t -71.48 -40.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.32 -43.18 98.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.24 34.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.17 -56.0 13.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.21 -32.84 74.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.78 -29.65 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.448 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -55.31 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.34 -27.4 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.07 39.59 5.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tt -47.37 -33.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptm -108.58 -170.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.35 -174.4 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 208' ' ' TYR . . . -76.93 -20.34 56.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -61.41 -56.75 30.66 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.535 0.683 . . . . 0.0 110.89 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.859 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.73 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.16 32.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.61 -35.77 82.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 150' ' ' PRO . 49.3 mt -58.23 -51.7 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.22 -45.78 95.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.0 99.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.499 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.5 m -63.9 -50.59 68.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -49.64 76.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.19 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.543 ' NE1' HG23 ' A' ' 194' ' ' ILE . 2.2 t90 -62.53 -55.98 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.9 t -56.25 -47.94 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.34 -40.14 89.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.585 ' HB2' HG11 ' A' ' 129' ' ' VAL . 10.7 ttm -60.95 -56.37 21.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.525 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -60.8 -32.33 51.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' TYR . . . . . 0.439 ' HD2' HG12 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -63.39 -50.89 68.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -73.87 -25.34 59.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' HD2' ' A' ' 126' ' ' LYS . 3.0 mm? -76.43 -43.33 40.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -57.54 -23.59 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.12 17.19 23.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.489 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.828 0.347 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.26 162.99 20.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.866 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.16 22.84 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.344 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -46.77 28.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 1.07 HG13 HD11 ' A' ' 113' ' ' LEU . 96.3 t -65.84 -43.61 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -35.1 79.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.5 t -69.8 -47.28 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.59 97.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.047 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -65.88 -50.83 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -56.02 -55.49 32.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.633 HG22 HG23 ' A' ' 237' ' ' ILE . 2.5 m -58.88 -37.75 77.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.9 tpt -60.0 -48.74 80.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.525 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -66.19 -34.26 77.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -50.71 70.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.54 HG12 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.79 -35.2 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.126 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.93 -48.34 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 65.5 mt -64.85 -47.76 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.81 -59.16 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.41 -56.99 22.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -53.71 -32.11 50.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 202' ' ' VAL . . . -77.94 -26.31 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.106 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 18.4 mt -76.8 -28.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -42.7 -57.13 5.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.669 0.747 . . . . 0.0 110.954 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.6 Cg_endo -69.79 -82.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 198' ' ' ALA . 20.5 m -33.7 -42.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 202' ' ' VAL . . . -65.24 -57.79 10.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.745 ' OH ' HD22 ' A' ' 219' ' ' LEU . 6.6 t80 -57.01 -19.91 21.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.92 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -47.05 -26.98 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 t -49.53 -28.28 5.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.416 ' HB2' ' HB1' ' A' ' 148' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.78 -27.63 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 218' ' ' ASN . 0.9 OUTLIER -59.09 -51.97 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.421 ' O ' HG22 ' A' ' 222' ' ' ILE . 4.0 t-20 -61.39 -40.94 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.745 HD22 ' OH ' ' A' ' 204' ' ' TYR . 20.3 mt -59.52 -42.84 93.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.598 ' CB ' HD12 ' A' ' 84' ' ' ILE . 23.6 m120 -66.63 -47.17 73.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.59 HD23 ' CB ' ' A' ' 32' ' ' SER . 1.9 tm? -53.06 -58.75 5.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 204' ' ' TYR . 1.0 OUTLIER -57.14 -40.77 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.139 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.42 ' N ' HG23 ' A' ' 222' ' ' ILE . 30.9 t80 -62.61 -42.39 99.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -63.89 -46.2 85.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.03 17.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.11 -27.21 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.52 -54.92 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 225' ' ' LEU . 7.9 p -68.2 -23.55 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -69.75 -33.62 72.68 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 126.739 3.161 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.1 mmtm -103.58 -8.72 19.8 Favored 'General case' 0 N--CA 1.424 -1.773 0 O-C-N 117.11 -3.494 . . . . 0.0 112.747 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.3 -63.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.137 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 192' ' ' ILE . 7.5 tp -53.82 -31.09 47.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.54 -56.25 23.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.93 83.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 -39.39 85.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.633 HG23 HG22 ' A' ' 188' ' ' THR . 4.0 mm -70.25 -50.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.464 HD12 ' CE1' ' A' ' 109' ' ' PHE . 42.2 mm -62.44 -35.79 71.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 243' ' ' VAL . 29.5 t90 -76.84 -45.74 27.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.21 -42.11 85.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 237' ' ' ILE . 14.4 p -74.67 -38.23 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.9 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 54' ' ' VAL . 53.6 t -78.27 -40.79 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.9 -39.11 93.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.88 -48.65 17.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.2 t -59.78 -68.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.96 178.39 8.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' THR . . . -57.77 -75.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -33.67 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.671 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -58.8 -56.51 21.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -47.71 83.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.936 HG22 HD11 ' A' ' 84' ' ' ILE . 30.5 p -51.04 -47.05 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.113 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.79 -50.87 32.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 27' ' ' ASP . 93.0 t -52.78 -55.67 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.8 t -60.83 -48.13 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -53.83 -41.56 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -47.24 68.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.08 -43.64 98.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' SER . 94.6 t -66.62 -41.41 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -62.63 -43.12 99.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.69 49.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.42 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 44' ' ' THR . 4.0 tt -53.14 -50.13 65.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.09 -55.73 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.75 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 232' ' ' ILE . 22.0 m -72.02 -44.51 63.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 40' ' ' LEU . 31.2 p -59.69 -47.28 86.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 46' ' ' PHE . 29.7 m -67.11 -42.83 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.441 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -55.95 -52.17 65.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.22 -47.76 82.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -74.95 -38.7 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 87.9 mt-10 -81.16 2.67 26.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.71 66.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -97.2 -3.05 41.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.31 23.73 13.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 62' ' ' LEU . 3.5 m -93.44 -170.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 153.7 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.59 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -21.68 55.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -88.93 10.43 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -51.01 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 p -77.88 -26.0 48.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -54.76 -43.27 72.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 54' ' ' VAL . 4.6 mp -74.7 -27.66 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -64.49 -53.68 44.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 44.7 t -71.53 -51.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 t -60.86 -35.48 76.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -42.27 63.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.66 -50.18 72.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -63.42 -43.48 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 68' ' ' VAL . 98.6 m -67.33 -36.66 81.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.82 -46.93 88.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.11 -48.42 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -58.64 -40.98 84.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -61.31 -53.31 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.86 -41.99 68.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -66.98 -59.66 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -42.02 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.06 -46.54 87.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t80 -61.87 -60.11 4.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -32.96 63.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -65.31 -33.57 87.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 78' ' ' TYR . 87.1 t -68.83 -38.47 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -71.6 -45.24 62.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.936 HD11 HG22 ' A' ' 29' ' ' THR . 10.1 tp -72.2 -26.01 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.59 -47.79 49.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -143.28 -39.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.69 36.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 31.7 m-20 -153.6 127.37 8.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.24 160.07 50.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.699 0.761 . . . . 0.0 110.822 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 101.44 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 m -69.3 -31.58 70.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.39 -51.19 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -51.72 57.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -48.63 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.69 -55.42 34.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.9 mt -55.49 -36.59 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -62.88 -52.79 61.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.297 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.443 ' O ' HG23 ' A' ' 102' ' ' VAL . 8.3 t-105 -59.8 -43.19 94.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.97 -20.92 61.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.38 -17.43 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.784 HG21 ' HB2' ' A' ' 72' ' ' ALA . 71.8 p -96.77 -25.47 15.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 133' ' ' VAL . 2.6 t -57.15 -56.87 29.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.618 0.723 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.78 -27.61 26.17 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.91 -47.25 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' A' ' 234' ' ' PHE . 0.9 OUTLIER -65.57 -51.05 62.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.657 HG13 HG21 ' A' ' 129' ' ' VAL . 36.2 mm -58.49 -56.05 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.33 -34.56 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.18 -65.56 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.92 -52.29 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -56.91 -44.93 82.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.43 -59.49 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.5 mm -51.93 -42.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 HG12 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -67.9 -27.99 67.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.59 -25.97 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.57 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.96 -20.07 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -122.53 -73.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 117' ' ' THR . 2.0 m-20 170.1 -76.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.3 146.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.99 96.1 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.16 -3.48 89.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -48.8 -36.39 16.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -48.83 28.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -70.14 -50.02 44.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -51.68 -52.95 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.74 -47.55 74.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.71 -59.97 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.657 HG21 HG13 ' A' ' 106' ' ' ILE . 16.6 m -58.37 -33.65 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -67.41 -46.99 65.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.542 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -65.65 -49.36 68.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.835 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.69 -52.83 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 102' ' ' VAL . 53.5 t -59.78 -41.88 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -64.42 -44.89 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 136' ' ' VAL . 3.4 tt -60.45 -57.78 11.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.578 ' N ' HD23 ' A' ' 135' ' ' LEU . 86.3 t -53.14 -52.06 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.89 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.95 8.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -56.46 19.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -30.84 68.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -64.01 -30.29 77.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLY . 2.8 tt0 -35.7 -59.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 110.894 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.13 -30.47 4.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.89 -13.3 44.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.08 5.69 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.24 144.68 32.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.651 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 61.94 32.29 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.97 96.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -69.88 -58.52 5.31 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 110.925 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.5 Cg_endo -69.68 -5.12 15.39 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.329 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.02 -49.97 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.22 -45.76 79.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.7 mp -61.57 -43.37 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.2 mt -65.61 -55.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.71 98.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.94 -52.53 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 153' ' ' ILE . 2.9 mm? -53.61 -49.78 67.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HB1' ' HE2' ' A' ' 162' ' ' MET . . . -65.03 -34.21 77.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.456 ' HZ2' HG23 ' A' ' 194' ' ' ILE . 1.9 t90 -67.08 -54.69 19.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' CE3' ' A' ' 159' ' ' TRP . 99.3 t -57.95 -49.47 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -61.13 -43.06 99.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.489 ' HE2' ' HB1' ' A' ' 158' ' ' ALA . 15.9 mtm -55.44 -58.61 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 194' ' ' ILE . 85.1 mt -65.47 -31.9 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -58.93 -47.58 84.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -41.99 63.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.32 -16.73 63.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -56.53 -25.84 53.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.71 19.01 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.512 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.798 0.333 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.12 163.08 24.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -20.08 35.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.357 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.51 -52.77 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.629 HG12 HD12 ' A' ' 113' ' ' LEU . 19.1 t -60.74 -48.82 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.173 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -58.28 -37.53 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -65.38 -47.15 77.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.12 88.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.22 -51.66 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -49.22 73.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.71 ' CG2' HD12 ' A' ' 237' ' ' ILE . 1.4 m -63.85 -32.38 73.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.681 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.1 OUTLIER -69.67 -35.34 75.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.45 ' HA ' HG22 ' A' ' 193' ' ' ILE . 5.1 ttp -74.96 -36.08 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -40.89 69.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 188' ' ' THR . 7.1 tp -71.09 -44.02 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 192' ' ' ILE . 16.1 tt -65.92 -37.92 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 163' ' ' ILE . 45.5 mt -69.1 -49.5 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -51.69 68.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.67 9.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.73 -34.6 59.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.34 -24.56 46.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.26 -32.28 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.557 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 2.8 t80 -48.44 -57.22 11.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.669 0.747 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.8 -25.35 28.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.651 2.234 . . . . 0.0 112.313 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.6 -40.57 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.115 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.95 -43.4 8.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.61 ' OH ' HD13 ' A' ' 219' ' ' LEU . 1.5 t80 -54.94 -31.2 60.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -49.99 -32.69 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 203' ' ' GLY . 11.4 t -51.33 -27.88 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -0.26 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.899 0.381 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.79 86.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.592 HD21 ' HB1' ' A' ' 25' ' ' ALA . 2.4 mt -60.95 -63.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -56.38 -42.03 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.61 HD13 ' OH ' ' A' ' 204' ' ' TYR . 9.8 tp -55.56 -49.28 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.42 -42.27 98.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.18 -58.0 10.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.404 HG21 ' CD2' ' A' ' 204' ' ' TYR . 37.3 mm -53.9 -46.98 64.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -60.46 -48.14 83.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.19 -38.99 93.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.9 OUTLIER -60.69 -51.38 69.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.06 -55.21 36.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.16 -40.7 77.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.655 ' CD2' HD13 ' A' ' 232' ' ' ILE . 27.0 t80 -62.98 -40.99 99.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 225' ' ' LEU . 88.2 t -71.98 -26.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -97.85 1.74 48.54 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 126.749 3.166 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.663 ' CE ' ' HB1' ' A' ' 72' ' ' ALA . 13.3 mmtm -116.48 -63.92 1.38 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.049 -3.532 . . . . 0.0 112.776 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.1 mp -66.81 -64.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.143 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -39.66 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.912 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -51.35 -58.83 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.24 93.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.28 -44.46 92.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.958 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.71 HD12 ' CG2' ' A' ' 188' ' ' THR . 0.8 OUTLIER -67.34 -47.89 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.681 HD11 ' SD ' ' A' ' 189' ' ' MET . 32.0 mm -54.85 -50.93 57.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.501 ' CZ3' HD12 ' A' ' 62' ' ' LEU . 4.4 m95 -72.15 -29.64 64.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.62 -54.23 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.5 p -76.14 -40.36 36.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.411 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -61.35 -53.44 56.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 54' ' ' VAL . 94.4 t -65.89 -47.51 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -58.69 -43.69 90.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.03 -41.3 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.5 p -50.83 -35.14 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.332 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.488 ' C ' HD21 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -70.02 160.94 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -51.93 -42.22 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -58.19 -36.85 73.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.4 m-20 -61.36 -60.51 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.446 ' CD1' HD23 ' A' ' 217' ' ' LEU . 1.5 m-85 -61.15 -48.19 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -51.57 -47.31 63.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.81 -51.73 28.21 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 27' ' ' ASP . 96.2 t -54.67 -55.33 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -59.03 -48.61 80.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -52.32 -45.57 65.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.46 83.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.01 -39.25 91.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 97.6 t -65.51 -52.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -62.49 -45.73 91.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.79 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -61.46 -54.18 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' CZ ' ' A' ' 73' ' ' PHE . 3.0 tt -51.12 -52.83 39.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.542 ' N ' HD23 ' A' ' 40' ' ' LEU . 21.2 tp -55.29 -53.34 57.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.74 -40.62 66.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -69.2 -32.17 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -73.06 -46.81 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 46' ' ' PHE . 17.7 m -64.57 -42.89 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.24 -49.79 58.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 64.5 t80 -64.55 -27.63 69.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -74.42 -49.55 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.6 t -71.26 -38.27 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -79.58 -7.45 58.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -56.54 -26.85 56.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.41 -11.05 21.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.19 38.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 62' ' ' LEU . 5.2 p -113.24 162.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.411 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -48.32 149.21 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.61 -55.58 12.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -60.51 -22.99 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -88.78 8.75 27.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.73 -50.37 55.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -73.76 -34.49 64.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.207 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.787 ' HA ' HG21 ' A' ' 112' ' ' ILE . 19.8 m -50.73 -45.04 58.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.01 -30.12 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.539 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -70.83 -55.51 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.175 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 65' ' ' SER . 12.8 m -67.88 -51.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.112 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 64' ' ' VAL . 8.6 t -65.06 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.95 68.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' ILE . 4.0 mp -70.12 -47.63 60.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' THR . 6.6 p -65.24 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' VAL . 68.9 p -71.79 -33.12 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -49.25 54.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 7.1 tt -67.64 -43.39 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.699 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -65.09 -39.78 93.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.769 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 27.3 t80 -63.06 -57.78 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -53.74 -50.07 66.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.92 -47.38 74.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -44.13 97.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -51.02 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 82' ' ' VAL . 24.5 t80 -62.32 -48.75 78.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -57.32 12.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -51.58 -54.59 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -39.54 54.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.1 t -67.33 -43.85 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -57.06 -52.28 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.29 -25.67 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -48.37 40.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.6 p -139.0 -39.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.53 -6.78 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -122.56 127.14 49.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.82 160.35 41.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.676 0.75 . . . . 0.0 110.848 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 86.65 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -56.66 -33.35 66.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -61.55 -34.4 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -51.35 68.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -67.59 -34.68 77.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -55.09 32.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.93 -43.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -33.01 73.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -68.86 -50.29 51.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.42 -13.3 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 tt -95.82 -25.34 16.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.606 HG21 ' CB ' ' A' ' 72' ' ' ALA . 62.6 m -95.33 -35.8 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.531 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -50.12 -58.07 10.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.661 0.743 . . . . 0.0 111.178 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.8 -35.68 12.09 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.676 2.25 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 100' ' ' LEU . 9.9 mt -62.48 -43.38 98.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -46.14 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 102' ' ' VAL . 1.5 mp -63.62 -41.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 32.9 m -68.25 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.4 -52.37 22.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.609 ' CE1' HD23 ' A' ' 113' ' ' LEU . 54.5 t80 -57.88 -51.61 68.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.465 ' HB2' HD13 ' A' ' 123' ' ' LEU . 2.2 t80 -51.83 -36.67 48.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -62.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.787 HG21 ' HA ' ' A' ' 61' ' ' SER . 21.4 pt -52.89 -38.75 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' CE1' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -71.19 -51.43 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.83 -18.85 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.71 -23.68 30.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.16 86.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t 179.15 -48.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.28 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -87.68 167.77 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.422 ' HB1' ' HA3' ' A' ' 169' ' ' GLY . . . -62.98 111.22 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.14 -3.03 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 m -50.59 -20.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.491 ' HB2' HG23 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -47.3 -33.18 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -67.46 -44.66 78.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.63 ' O ' HG12 ' A' ' 129' ' ' VAL . 14.6 mptt -65.3 -45.33 84.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -37.53 87.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 128' ' ' LEU . 1.2 tt -68.16 -43.05 79.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 127' ' ' LEU . 1.2 mt -66.46 -56.35 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 133' ' ' VAL . 12.0 p -58.49 -39.59 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -65.2 -46.4 87.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.448 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -41.69 97.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.908 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.84 -52.41 63.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 129' ' ' VAL . 82.0 t -54.92 -46.01 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -27.14 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -67.8 -45.71 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 135' ' ' LEU . 11.0 m -73.27 -35.52 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.51 ' HE1' HD12 ' A' ' 154' ' ' ILE . 12.7 m-30 -70.42 -38.72 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.32 -43.68 19.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.529 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -67.63 -51.86 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.97 -35.46 74.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.27 -32.7 57.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.535 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.65 -32.1 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.0 -26.06 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.81 22.99 12.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 145' ' ' ILE . 11.0 mt -80.58 0.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -108.29 -170.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 150' ' ' PRO . . . -154.99 162.7 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 208' ' ' TYR . . . -71.77 -21.71 61.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.539 ' O ' HD12 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -70.49 -59.57 3.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.535 0.683 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.75 -14.05 35.58 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.55 -37.27 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.09 -37.81 88.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.3 mp -60.53 -53.15 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.51 HD12 ' HE1' ' A' ' 137' ' ' PHE . 88.4 mt -59.26 -50.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.33 -49.07 82.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.02 -50.0 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.47 -45.62 84.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.05 83.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.632 ' HE1' HD11 ' A' ' 163' ' ' ILE . 8.7 t90 -64.64 -55.24 21.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.23 -46.88 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -37.02 86.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.466 ' O ' HD12 ' A' ' 166' ' ' LEU . 10.7 mtp -59.43 -53.59 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.632 HD11 ' HE1' ' A' ' 159' ' ' TRP . 91.2 mt -63.99 -42.87 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -54.01 -44.4 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -74.65 -57.67 3.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 162' ' ' MET . 5.5 mt -51.5 -58.45 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.45 ' HE3' HG23 ' A' ' 163' ' ' ILE . 1.1 t-105 -57.12 -20.1 23.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.27 19.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 120' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.822 0.344 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 160.59 62.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -24.26 30.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.66 2.24 . . . . 0.0 112.356 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.2 52.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' A' ' 113' ' ' LEU . 60.2 t -66.86 -43.29 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -35.67 81.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 188' ' ' THR . 70.2 m -71.28 -47.5 56.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.585 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -60.39 -41.87 94.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.85 -52.79 39.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -52.46 -54.1 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 184' ' ' SER . 43.7 p -58.14 -45.63 87.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -44.41 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.519 ' HA ' HG22 ' A' ' 193' ' ' ILE . 17.5 ttp -72.43 -29.97 64.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -40.32 69.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -72.67 -44.45 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.16 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 190' ' ' MET . 6.5 tt -65.28 -40.99 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 193' ' ' ILE . 44.4 mt -69.13 -49.38 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -52.41 -58.15 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.29 -57.76 18.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TRP . . . . . 0.466 ' CZ2' HD11 ' A' ' 193' ' ' ILE . 34.3 m0 -54.28 -32.07 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.79 -23.87 44.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 196' ' ' GLY . 11.8 mt -77.12 -32.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.6 OUTLIER -48.85 -55.8 18.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 110.94 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.82 -21.7 32.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.246 . . . . 0.0 112.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 198' ' ' ALA . 50.2 t -71.07 -43.66 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.34 -40.93 10.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.482 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.67 -57.4 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.52 -32.56 72.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -52.16 -25.86 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.36 -7.54 5.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.445 ' CG ' ' HB2' ' A' ' 148' ' ' ALA . 4.3 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.55 70.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.9 mp -55.28 -63.31 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -54.21 -37.54 64.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -54.74 43.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -57.58 -48.76 78.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.3 tm? -58.94 -58.09 10.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 221' ' ' LEU . 45.5 mt -54.87 -46.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.1 -48.98 79.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -61.28 -41.05 96.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 tp -61.21 -48.8 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.51 -55.28 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.91 -27.02 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' PHE . . . . . 0.429 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.9 t80 -66.72 -55.71 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.43 -25.53 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -68.96 -8.25 42.82 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.68 3.133 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.699 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 14.2 mmtm -129.85 -59.98 1.05 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 117.107 -3.496 . . . . 0.0 112.798 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 50.0 mm -51.26 -63.22 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.102 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.551 HD23 HG12 ' A' ' 237' ' ' ILE . 0.3 OUTLIER -54.82 -30.65 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -55.47 32.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.29 -37.09 93.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.42 -37.54 80.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.551 HG12 HD23 ' A' ' 233' ' ' LEU . 1.4 mm -69.43 -49.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.32 -35.58 74.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.0 t90 -75.95 -43.99 42.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.63 -42.2 92.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 185' ' ' ALA . 10.3 p -74.07 -38.28 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.49 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.8 t -75.36 -40.78 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -66.96 -36.11 81.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -76.83 -44.03 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.5 t -51.74 -45.27 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.82 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.82 -177.1 6.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.33 -72.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.75 -28.84 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.69 -73.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -43.76 63.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 84' ' ' ILE . 96.2 m -61.01 -39.28 89.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -52.92 22.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -39.02 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.2 t -67.63 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.33 -42.68 78.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -46.9 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.86 -41.95 96.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 32' ' ' SER . 92.5 t -67.06 -43.28 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -59.5 -49.2 78.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.09 92.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.68 -55.48 23.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD13 ' HZ ' ' A' ' 73' ' ' PHE . 1.3 pp -62.84 -31.94 73.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.92 -53.4 46.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -34.55 78.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.61 -39.55 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 40' ' ' LEU . 14.0 p -67.24 -43.52 81.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 49' ' ' VAL . 27.7 m -68.5 -38.51 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.15 -49.04 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.72 -30.29 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.87 -50.17 63.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 45' ' ' VAL . 12.4 p -73.75 -33.45 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.1 tp10 -79.65 -14.52 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -36.86 69.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.48 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.18 42.33 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 62' ' ' LEU . 14.2 m -114.51 -170.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.66 155.37 40.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.51 -50.93 65.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -24.73 62.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.439 ' HZ3' HG23 ' A' ' 238' ' ' ILE . 62.5 m95 -96.82 -4.33 40.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -51.57 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 112' ' ' ILE . 5.3 t -77.62 -35.02 53.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.594 ' CA ' HD13 ' A' ' 112' ' ' ILE . 1.3 p -50.73 -41.66 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 54' ' ' VAL . 12.5 mt -64.61 -33.16 75.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -68.65 -54.19 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.38 -57.01 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.53 89.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.57 -44.69 77.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.933 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.99 -55.25 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -33.1 75.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.23 -47.66 70.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.62 -46.9 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.22 -37.83 88.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -64.65 -54.04 38.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -45.49 80.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -59.7 -53.19 60.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -39.23 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -57.54 -55.2 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.658 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -59.31 -53.04 62.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.6 mmt -54.42 -47.89 72.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -55.34 -56.68 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -58.48 -34.0 73.75 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.511 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 78' ' ' TYR . 75.1 t -70.24 -33.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.34 . . . . 0.0 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -73.84 -40.7 63.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.553 HD13 ' CB ' ' A' ' 220' ' ' ASN . 9.7 tp -76.85 -26.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -87.52 -49.94 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 -39.67 26.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -12.72 56.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -152.97 130.16 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.29 162.01 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.706 0.765 . . . . 0.0 110.857 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 103.29 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -69.43 -26.67 64.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -42.21 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.172 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -48.38 67.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -57.67 -51.43 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.29 -50.62 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.08 -53.92 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 101' ' ' THR . 0.6 OUTLIER -57.67 -34.01 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.108 . . . . 0.0 109.336 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.6 -59.58 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.59 -11.37 60.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 100' ' ' LEU . 8.6 tt -91.85 -17.12 25.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.705 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.7 p -110.95 -39.39 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -43.79 -58.49 4.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.79 -21.12 33.81 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.311 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.2 mm? -75.71 -54.37 7.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -49.55 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.77 -58.59 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.3 t -59.33 -34.38 72.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.41 -63.33 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -50.47 -51.09 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -61.66 -40.01 93.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.8 tp -57.67 -66.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 60' ' ' THR . 0.6 OUTLIER -50.53 -34.56 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.158 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 182' ' ' VAL . 5.3 tp -70.58 -39.5 73.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.87 -14.82 59.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -17.07 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -24.64 60.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -119.26 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER 164.87 -78.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.13 134.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.89 97.46 4.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.26 -6.05 85.97 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -33.49 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.82 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -41.71 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.95 -37.47 64.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -64.95 -51.54 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -35.33 79.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.64 -49.79 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.17 -59.68 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 133' ' ' VAL . 58.8 t -52.65 -46.98 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.67 -49.61 76.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -53.73 -46.2 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.413 HD13 HD22 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -64.32 -42.04 96.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 129' ' ' VAL . 74.4 t -59.51 -55.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.96 68.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 136' ' ' VAL . 1.0 OUTLIER -64.77 -58.17 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 135' ' ' LEU . 42.7 t -66.6 -41.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -62.38 -38.66 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.07 -51.31 18.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.6 -56.91 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.89 -32.69 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.22 -29.51 72.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -38.12 -55.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.97 -31.47 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.32 -9.36 20.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 pt -107.44 8.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.116 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.66 ' CE ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -102.05 119.88 39.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' CE ' ' A' ' 146' ' ' MET . . . 44.38 53.94 6.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -73.55 -53.28 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.622 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.3 t90 -52.83 -53.25 56.7 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.555 0.693 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 147' ' ' ALA . 53.7 Cg_endo -69.7 -17.2 37.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.256 . . . . 0.0 112.379 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 148' ' ' ALA . . . -53.23 -34.69 58.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -29.33 69.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.62 -51.64 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.82 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.47 -46.9 23.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 36.1 t -61.71 -45.75 92.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.832 0.348 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.71 -49.58 74.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.77 -29.89 70.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.699 ' CE3' HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -67.3 -57.48 6.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.699 HG13 ' CE3' ' A' ' 159' ' ' TRP . 18.7 m -60.02 -41.79 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.25 -45.86 89.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.65 ' SD ' HG22 ' A' ' 129' ' ' VAL . 13.2 mmt -57.05 -54.9 41.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 194' ' ' ILE . 2.1 mp -64.56 -37.32 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.83 -36.97 86.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.56 -39.5 62.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -80.54 -14.51 58.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.93 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.18 -27.42 33.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.12 21.1 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.34 163.15 47.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.644 0.735 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.35 27.79 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.244 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.75 -39.88 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 1.037 HG13 HD11 ' A' ' 113' ' ' LEU . 71.2 t -68.34 -43.99 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -67.44 -32.98 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.0 m -71.77 -49.11 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.94 99.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.1 -44.76 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -58.08 -56.79 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.1 m -58.19 -48.22 81.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -52.0 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -32.63 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -49.25 77.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 237' ' ' ILE . 2.4 mp -67.72 -47.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.55 -49.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.584 HD11 HG21 ' A' ' 163' ' ' ILE . 87.3 mt -65.37 -48.15 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -59.93 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.0 -54.61 33.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -53.23 -30.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.304 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -80.05 -28.95 39.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.51 -30.77 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 24.5 t80 -48.03 -54.37 25.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.686 0.755 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.76 -22.46 32.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 198' ' ' ALA . 80.7 t -69.27 -44.31 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.81 -32.35 27.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.482 ' HA ' HD13 ' A' ' 222' ' ' ILE . 60.2 t80 -58.36 -45.92 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.918 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.09 -53.87 24.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 t -72.47 -14.17 61.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -89.69 -19.75 46.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.902 -179.784 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.48 -21.11 62.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -59.74 4.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.425 ' O ' HD12 ' A' ' 222' ' ' ILE . 14.0 m-20 -52.03 -37.91 55.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.35 -33.44 67.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.553 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.6 m120 -68.15 -48.82 64.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 221' ' ' LEU . 2.3 pp -68.53 -38.78 81.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 204' ' ' TYR . 40.4 mt -66.68 -47.14 84.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.422 HD21 HG21 ' A' ' 36' ' ' VAL . 39.4 t30 -63.85 -43.27 96.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.7 tp -62.47 -45.67 91.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -55.68 30.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.54 -37.56 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -62.14 -46.62 88.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 1.041 HG13 HD13 ' A' ' 233' ' ' LEU . 96.7 t -73.02 -25.15 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -92.14 2.35 56.64 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 126.704 3.145 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -124.07 -63.33 1.22 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.121 -3.487 . . . . 0.0 112.743 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 43.9 mm -61.59 -64.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.165 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 1.041 HD13 HG13 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -51.75 -36.65 48.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -57.83 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -66.76 -42.42 93.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.31 -49.54 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 241' ' ' VAL . 5.1 mm -69.07 -36.16 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.705 HD12 ' HA2' ' A' ' 235' ' ' GLY . 15.8 mt -52.39 -57.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.9 p-90 -73.67 -30.14 62.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.404 HD22 HD13 ' A' ' 237' ' ' ILE . 37.0 t30 -56.96 -52.19 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.4 p -75.08 -44.05 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.05 -55.68 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 54' ' ' VAL . 74.1 t -62.29 -43.42 98.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -46.92 74.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -74.21 -29.24 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.2 t -51.55 -33.24 31.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 28' ' ' TYR . 16.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.78 172.14 13.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -54.77 -65.47 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.73 -25.86 42.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -59.84 -68.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB2' HD22 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -63.7 -48.54 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.3 m -52.8 -44.34 66.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.27 -51.61 31.72 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 71.1 t -54.62 -55.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -59.45 -46.38 88.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -52.68 -43.74 65.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.21 -45.59 72.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -37.27 84.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 32' ' ' SER . 89.7 t -69.1 -52.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.9 m -61.73 -47.48 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.95 71.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -52.18 17.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 45' ' ' VAL . 5.5 tp -65.83 -42.37 90.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 45' ' ' VAL . . . -64.75 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.8 m -71.67 -36.18 70.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -74.81 -45.2 44.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 41' ' ' LEU . 12.3 p -67.28 -38.84 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -71.9 -49.63 36.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 45.6 t80 -63.6 -34.34 77.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -70.72 -52.24 22.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 45' ' ' VAL . 91.1 t -66.36 -35.63 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.631 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.4 tp10 -79.92 -22.38 42.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.642 ' O ' HG22 ' A' ' 54' ' ' VAL . 3.9 mtp180 -54.23 -44.66 71.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.97 -3.95 50.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -106.32 12.01 30.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 51' ' ' ARG . 8.4 m -94.35 -170.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.27 158.28 33.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -51.45 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.068 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -62.4 -34.29 76.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.466 ' CD1' ' HB1' ' A' ' 242' ' ' ALA . 95.6 m95 -83.7 -10.87 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -51.02 -50.58 58.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -77.29 -41.53 40.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.427 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -54.26 -46.95 72.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.747 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -70.79 -27.32 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.3 m -71.18 -53.61 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 68' ' ' VAL . 25.6 m -70.21 -45.5 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.0 t -69.56 -41.03 76.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.33 -33.4 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.46 -48.37 56.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.8 p -65.06 -47.78 86.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.51 ' N ' HG13 ' A' ' 68' ' ' VAL . 67.1 p -63.73 -38.11 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.02 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -48.03 -35.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 111.108 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -69.73 -49.41 53.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CE2' HD11 ' A' ' 232' ' ' ILE . 5.5 t80 -53.37 -46.53 69.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -67.73 -45.8 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -58.36 -45.22 88.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -72.94 -57.74 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -37.36 23.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.9 t80 -74.01 -55.4 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -57.84 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -66.55 -48.76 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.41 -48.74 53.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.9 t -66.37 -53.23 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -53.31 -55.93 20.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 88' ' ' ASP . 40.4 mm -61.33 -34.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -57.59 -22.02 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.4 m -99.41 -38.36 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.38 35.52 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.612 ' O ' HD13 ' A' ' 84' ' ' ILE . 2.3 m-20 -112.4 -177.42 3.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.6 t -147.77 75.39 11.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.653 0.74 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.05 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -38.58 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 19.7 m -62.98 -44.57 99.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 7.6 m-85 -73.01 -47.28 46.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -50.54 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.29 -55.96 27.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.97 -27.18 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -66.42 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.298 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.477 ' O ' HG23 ' A' ' 102' ' ' VAL . 12.2 t-105 -60.53 -30.04 69.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -74.72 -30.55 61.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.58 -18.89 28.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.106 HG22 HD23 ' A' ' 105' ' ' LEU . 3.5 m -94.81 -39.62 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.643 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.1 t -43.55 -58.46 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.78 -18.91 36.66 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 68' ' ' VAL . 6.7 tp -77.21 -54.0 7.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.106 HD23 HG22 ' A' ' 101' ' ' THR . 1.0 OUTLIER -72.52 -47.38 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 mm -54.81 -46.79 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.443 ' HA ' HD13 ' A' ' 123' ' ' LEU . 48.6 t -69.07 -42.2 76.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -54.45 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -58.79 -50.97 71.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 6.6 m-85 -64.06 -28.54 69.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -66.84 -56.07 12.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.513 HD13 HD23 ' A' ' 111' ' ' LEU . 48.0 mm -65.03 -36.37 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 182' ' ' VAL . 9.5 tp -70.81 -55.27 8.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -71.39 -12.47 61.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 111' ' ' LEU . . . -51.7 -24.64 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -28.35 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -9.03 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 119' ' ' VAL . 36.4 t30 66.12 50.35 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -172.57 107.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.61 97.82 5.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.75 -35.89 27.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -49.85 -31.85 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 107' ' ' CYS . 8.1 tp -54.03 -50.72 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.53 85.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.02 -50.5 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' NZ ' HD13 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -65.82 -34.11 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 103' ' ' PRO . 2.1 tt -66.78 -47.97 70.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -58.87 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.9 -52.82 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.93 -42.59 86.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 m -63.55 -40.05 96.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -63.06 -56.15 19.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 154' ' ' ILE . 7.1 p -57.82 -35.64 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.643 ' CE ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -68.06 -40.51 82.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -65.49 -43.92 88.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.71 HG12 ' CE ' ' A' ' 140' ' ' MET . 60.2 t -64.88 -47.89 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . 0.415 ' HD2' HG22 ' A' ' 133' ' ' VAL . 2.9 m-85 -62.42 -40.78 97.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.66 -49.4 64.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -52.99 62.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' MET . . . . . 0.71 ' CE ' HG12 ' A' ' 136' ' ' VAL . 20.4 ptp -59.15 -33.74 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.17 -31.7 57.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -29.88 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.871 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.4 -27.4 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 5.32 62.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.0 pp -63.89 -35.07 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.323 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.541 ' HB3' HD12 ' A' ' 145' ' ' ILE . 4.0 ptt? -135.15 133.91 39.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -160.59 -45.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -67.03 -46.3 74.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.628 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.73 -52.82 13.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.561 0.696 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.699 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.8 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.334 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -61.75 -52.41 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -77.44 -34.15 54.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 150' ' ' PRO . 36.2 mt -59.35 -65.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.672 HG22 HG23 ' A' ' 133' ' ' VAL . 28.1 mm -62.85 -44.6 99.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.59 86.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.8 t -60.43 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.63 -47.82 66.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.49 94.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -60.24 -55.37 34.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 156' ' ' CYS . 22.8 t -57.77 -50.11 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -39.49 87.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.564 ' SD ' HD22 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -57.98 -58.08 10.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.77 -38.92 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.59 -49.5 67.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.82 -54.68 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 190' ' ' MET . 6.1 mp -50.46 -59.82 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.79 -20.56 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.0 17.81 23.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.819 0.342 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.04 161.78 51.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.7 0.762 . . . . 0.0 110.839 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -26.03 28.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -44.19 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.859 HG13 HD11 ' A' ' 113' ' ' LEU . 91.5 t -71.62 -42.46 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -66.21 -39.17 89.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.1 t -70.05 -49.38 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.78 97.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -65.46 -47.85 74.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.22 -44.39 83.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 237' ' ' ILE . 2.4 m -69.64 -35.11 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.472 ' HE3' ' N ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.73 -53.02 46.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.582 ' HB3' HD23 ' A' ' 166' ' ' LEU . 14.5 ptm -64.11 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.88 -47.76 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HG21 ' A' ' 237' ' ' ILE . 28.3 mm -65.65 -39.5 85.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.555 ' CG2' ' HE3' ' A' ' 162' ' ' MET . 42.2 mt -57.8 -57.58 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 pt -60.5 -38.68 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 199' ' ' ILE . 5.4 t80 -56.29 -59.47 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.56 -52.95 49.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -55.4 -36.73 66.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.796 0.331 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.6 -24.72 49.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 200' ' ' TYR . 19.6 mt -79.08 -26.97 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.54 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.5 t80 -32.7 -57.76 0.48 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.697 0.761 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.77 -65.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 57.3 t -36.51 -42.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -77.14 -57.86 3.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 222' ' ' ILE . 10.0 t80 -53.81 -21.68 7.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.858 0.361 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.58 -28.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 96.7 m -49.34 -29.45 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.14 18.02 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.605 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.918 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.71 57.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 25' ' ' ALA . 78.8 mt -55.99 -63.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -52.79 -31.48 38.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -57.39 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 221' ' ' LEU . 3.3 tm? -61.26 -58.63 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 204' ' ' TYR . 39.5 mm -60.21 -48.84 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -57.05 -49.14 76.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -60.34 -40.38 90.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.57 -48.9 78.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.45 -55.16 38.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.17 -27.54 69.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -67.44 -56.58 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.0 m -72.57 -25.02 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.92 -10.32 37.69 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-O 126.701 3.143 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -131.31 -56.24 1.02 Allowed 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 117.102 -3.499 . . . . 0.0 112.773 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.3 mm -53.8 -64.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.115 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -41.21 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.08 -57.3 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -62.65 -41.11 99.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.3 -48.96 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.7 mm -69.68 -36.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.752 HD12 ' HA2' ' A' ' 235' ' ' GLY . 39.4 mt -53.0 -58.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.747 ' HB3' HD21 ' A' ' 62' ' ' LEU . 15.9 p-90 -73.71 -29.63 62.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 237' ' ' ILE . 7.3 t-20 -54.87 -55.06 34.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.1 p -76.32 -44.8 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.474 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -56.58 -53.17 60.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 54' ' ' VAL . 85.1 t -67.47 -41.76 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -54.18 27.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 -34.73 69.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t -51.82 -68.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 -179.834 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.816 0.341 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.4 168.51 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -51.37 -60.35 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -52.56 -43.91 65.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.7 m-20 -54.53 -52.35 62.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.711 ' CD1' HD23 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -61.84 -47.57 84.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -51.22 -47.01 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.8 -50.58 34.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.505 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.3 t -53.58 -55.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.351 . . . . 0.0 111.117 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.2 t -61.12 -47.18 87.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -53.22 -45.25 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -46.21 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.04 -40.24 92.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 32' ' ' SER . 93.1 t -66.4 -48.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.9 p -61.11 -46.5 90.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.9 -51.87 67.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.93 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 73' ' ' PHE . 1.8 tt -55.68 -33.66 64.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 62.7 tp -68.44 -56.34 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.8 72.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -71.25 -43.11 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.5 m -65.2 -47.09 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 41' ' ' LEU . 7.2 p -67.25 -39.39 82.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.21 -49.81 63.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -67.18 -31.26 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.61 -48.91 58.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 45' ' ' VAL . 73.2 t -73.5 -37.25 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 tt0 -79.51 -10.57 59.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -27.78 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.02 -5.79 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -100.81 29.41 4.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 62' ' ' LEU . 17.6 m -108.58 -171.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.42 ' HG ' ' HD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -77.52 160.12 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.11 86.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -45.59 86.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 67.4 m95 -81.88 -1.64 48.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -50.94 -52.33 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.0 p -77.56 -35.33 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.161 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 112' ' ' ILE . 10.2 p -60.31 -31.85 70.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.12 -34.2 74.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -73.29 -56.39 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' THR . 6.0 m -59.74 -52.28 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 64' ' ' VAL . 9.4 p -69.2 -36.6 77.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.7 -34.6 78.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 63' ' ' THR . 6.0 mp -70.7 -47.29 60.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 104' ' ' LEU . 5.1 p -63.85 -44.69 98.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 p -71.65 -39.14 70.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.164 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.24 -45.22 95.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.451 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.64 -47.85 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.67 -44.59 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 16.1 t80 -58.38 -53.41 58.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -57.0 -47.39 80.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -60.15 -61.38 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.15 -54.32 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 -58.14 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -58.33 -38.04 76.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -57.1 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -53.46 44.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.39 -53.15 33.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 78' ' ' TYR . 78.3 t -62.02 -39.15 82.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.79 -51.95 64.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.054 HD11 ' HB1' ' A' ' 216' ' ' ALA . 9.6 tp -73.63 -25.83 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.1 -47.93 34.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 -38.78 4.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.14 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.42 126.53 52.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.7 162.22 32.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.613 0.721 . . . . 0.0 110.861 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 101.92 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.2 m -69.1 -26.02 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.7 t -48.04 -41.73 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 -44.82 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -67.2 -58.28 5.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.549 ' O ' HD23 ' A' ' 99' ' ' LEU . 8.4 mm -63.5 -62.53 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -53.66 -33.35 54.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.553 1.158 . . . . 0.0 109.277 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.423 ' HD1' HG23 ' A' ' 102' ' ' VAL . 4.5 t90 -58.13 -65.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -73.09 -9.88 59.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 99' ' ' LEU . 3.5 tt -91.42 -18.83 23.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.735 HG21 ' HB2' ' A' ' 72' ' ' ALA . 68.6 p -105.61 -39.05 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 4.0 t -44.28 -55.03 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.658 0.742 . . . . 0.0 111.128 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -23.25 31.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.252 . . . . 0.0 112.361 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 68' ' ' VAL . 20.2 mt -75.83 -54.63 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.682 HG21 ' CB ' ' A' ' 126' ' ' LYS . 35.4 mm -57.65 -37.81 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.63 -56.37 16.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -51.68 -46.62 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.42 -43.62 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.598 ' CD2' HD23 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -63.44 -32.61 74.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -56.81 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 61' ' ' SER . 5.5 tp -56.81 -40.3 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.135 HD12 HG13 ' A' ' 182' ' ' VAL . 3.2 mm? -70.82 -43.33 68.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -70.51 -18.58 62.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.38 -16.36 45.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 182' ' ' VAL . . . -92.3 -14.37 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -126.28 -74.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.451 ' H ' HG23 ' A' ' 117' ' ' THR . 0.4 OUTLIER 176.78 -33.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.454 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.6 p -170.68 145.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -115.65 145.43 42.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -5.04 82.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -39.09 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -51.5 -54.17 29.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.586 ' NZ ' HD22 ' A' ' 166' ' ' LEU . 20.6 ttpt -52.09 -50.1 62.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.682 ' CB ' HG21 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -66.28 -31.48 72.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.61 -49.7 74.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.61 -59.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.798 HG21 ' HG3' ' A' ' 162' ' ' MET . 50.6 t -53.77 -49.39 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.57 -48.71 83.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 m -53.43 -44.13 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.84 -48.12 72.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 129' ' ' VAL . 85.2 t -51.93 -54.41 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -64.8 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -56.11 -58.52 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.78 HG11 ' CD1' ' A' ' 154' ' ' ILE . 65.7 t -62.03 -51.72 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -51.96 -37.18 52.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.66 14.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -55.8 28.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 110.926 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -32.57 74.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.04 70.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.92 -32.86 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -28.58 7.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.53 26.37 10.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.2 pp -94.86 -34.9 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.096 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.739 ' HB3' HD12 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -146.74 142.45 27.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 171.73 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -57.72 -35.29 70.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -69.48 -61.46 3.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HA ' HD13 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.79 -6.72 19.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.271 . . . . 0.0 112.303 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -65.78 -48.73 70.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.55 -38.29 89.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.2 mp -65.03 -65.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.78 ' CD1' HG11 ' A' ' 136' ' ' VAL . 5.3 pt -57.58 -38.05 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -48.91 56.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.23 -44.02 92.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -50.47 72.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.89 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.565 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -62.94 -55.45 25.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CE3' ' A' ' 159' ' ' TRP . 82.5 t -58.41 -47.05 89.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.35 -46.17 89.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.798 ' HG3' HG21 ' A' ' 129' ' ' VAL . 9.3 tmm? -52.15 -58.66 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 194' ' ' ILE . 2.8 mp -68.09 -32.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -53.49 -54.52 36.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.19 -40.2 62.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.586 HD22 ' NZ ' ' A' ' 125' ' ' LYS . 28.2 tp -61.64 -24.94 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.439 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -58.9 -25.32 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.74 18.72 15.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.494 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.7 165.12 36.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.729 0.776 . . . . 0.0 110.827 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.57 16.4 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.3 54.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 1.135 HG13 HD12 ' A' ' 113' ' ' LEU . 96.7 t -70.42 -44.2 77.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.72 -39.94 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -68.18 -50.06 56.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -58.21 -39.99 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -45.1 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.68 -56.31 23.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' THR . . . . . 1.026 HG22 HD12 ' A' ' 237' ' ' ILE . 0.2 OUTLIER -58.67 -43.61 89.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -56.86 -47.42 80.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.494 ' SD ' HG23 ' A' ' 163' ' ' ILE . 35.7 ttp -65.42 -32.56 74.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.8 -51.27 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.63 -37.95 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.096 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.2 -46.17 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.595 HD11 HG12 ' A' ' 163' ' ' ILE . 87.2 mt -65.57 -49.58 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -51.23 -58.96 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.4 -58.52 13.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -52.77 -31.09 36.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.18 -24.11 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.26 -34.26 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 16.6 t80 -51.95 -55.57 29.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.663 0.744 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.72 -28.99 24.79 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.368 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 198' ' ' ALA . 38.9 t -72.5 -27.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 206' ' ' THR . . . -81.84 -46.75 6.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -37.32 45.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -48.81 -28.21 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.9 p -47.36 -30.54 3.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 134.08 49.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 26.5 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -51.09 -30.67 16.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.711 HD23 ' CD1' ' A' ' 28' ' ' TYR . 9.8 mp -61.82 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.29 -30.13 71.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LEU . . . . . 0.412 HD11 ' OH ' ' A' ' 208' ' ' TYR . 1.5 tt -60.6 -58.59 7.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -65.69 -37.32 86.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 221' ' ' LEU . 2.9 tm? -62.23 -55.87 24.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 48.1 mt -61.4 -47.64 92.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -59.8 -56.63 19.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -58.05 -49.03 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 229' ' ' VAL . 6.4 tp -59.39 -39.2 82.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -55.33 24.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.09 -28.12 69.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -70.97 -52.81 17.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 225' ' ' LEU . 17.7 m -72.06 -24.42 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -77.49 0.81 21.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-O 126.692 3.139 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.21 -59.63 0.87 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 117.122 -3.486 . . . . 0.0 112.75 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.1 mm -58.08 -64.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.148 174.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.445 HD12 HG13 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -52.13 -42.8 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.945 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.01 -58.45 6.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 -40.64 94.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -44.06 81.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 1.026 HD12 HG22 ' A' ' 188' ' ' THR . 0.9 OUTLIER -68.59 -48.18 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 27.5 mm -54.34 -50.09 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.448 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.9 m95 -72.02 -30.7 65.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -58.61 -53.74 54.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 185' ' ' ALA . 7.3 p -75.52 -42.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.21 -55.01 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.486 ' CG2' HG12 ' A' ' 54' ' ' VAL . 93.9 t -63.72 -48.31 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -35.44 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -71.6 -37.66 70.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.6 p -50.22 -40.8 48.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -177.11 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -73.88 -74.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m -51.97 -32.07 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -59.1 -58.44 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.836 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -48.33 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 m -49.87 -47.31 51.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.0 -50.54 39.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.0 t -51.33 -55.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 p -60.77 -48.31 82.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.2 -48.39 65.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -46.22 88.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.62 -38.19 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' SER . 85.5 t -65.94 -52.34 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 m -58.79 -54.24 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.66 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.57 69.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD13 ' HE2' ' A' ' 73' ' ' PHE . 7.8 tp -54.43 -42.43 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 45' ' ' VAL . 11.1 tp -67.36 -56.17 10.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.45 -39.14 64.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 m -69.89 -43.43 71.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -60.42 -49.06 79.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 49' ' ' VAL . 28.1 m -69.53 -36.1 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.14 -57.07 10.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 44.2 t80 -62.21 -45.88 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -54.14 -52.02 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 45' ' ' VAL . 88.6 t -70.9 -29.85 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -79.32 -6.21 56.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.7 -27.39 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.79 -10.67 47.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 31.87 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.4 p -120.82 154.02 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.1 142.06 2.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.83 74.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -23.86 61.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.624 ' HB3' HD23 ' A' ' 62' ' ' LEU . 26.2 m95 -88.6 6.56 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.953 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -53.57 -50.13 66.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -75.25 -33.53 61.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.5 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -63.92 -40.52 96.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 3.7 mm? -77.0 -26.75 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -70.93 -49.91 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 60' ' ' THR . 30.6 m -73.59 -45.17 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 9.2 t -70.47 -39.32 74.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.25 64.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.38 -51.06 60.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.857 0.361 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 105' ' ' LEU . 75.3 t -61.22 -51.9 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -63.66 -37.55 87.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.22 -37.05 93.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 mt -71.6 -45.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 101' ' ' THR . . . -60.72 -43.23 98.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 232' ' ' ILE . 43.6 t80 -64.97 -57.08 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -55.02 -51.89 64.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.22 -42.07 94.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -57.96 -71.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.3 ttp -52.26 -32.16 35.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -57.66 -68.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.913 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.455 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.2 mtt -74.81 -58.28 3.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -39.81 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -74.91 -57.51 4.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 79' ' ' MET . 5.8 p -53.72 -35.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 220' ' ' ASN . 8.3 tp -54.52 -26.89 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.29 -20.92 58.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -103.28 -38.24 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.19 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.71 -175.11 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.88 37.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.708 0.766 . . . . 0.0 110.847 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 84.44 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 t -60.07 -37.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.91 -52.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -51.05 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -34.38 74.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.11 -57.86 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -30.38 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 101' ' ' THR . 5.1 t70 -63.6 -66.83 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.311 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -31.6 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.474 HD22 ' SD ' ' A' ' 134' ' ' MET . 30.5 tp -77.23 -21.83 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HD23 ' A' ' 104' ' ' LEU . 3.9 tt -99.47 -16.38 18.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' ASP . 40.9 p -98.35 -32.6 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.499 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -57.55 -59.33 13.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.85 35.61 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.375 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.2 mm? -79.42 -51.98 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 101' ' ' THR . 3.7 pp -67.43 -40.82 85.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 126' ' ' LYS . 24.8 mm -66.66 -49.88 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.26 -40.83 97.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' OE2' HD13 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.14 -59.71 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -51.11 -50.84 58.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -64.41 -37.1 86.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -55.7 -63.87 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.5 HG21 ' N ' ' A' ' 61' ' ' SER . 48.7 mm -57.9 -44.69 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.749 HD21 HG13 ' A' ' 182' ' ' VAL . 2.8 tm? -55.92 -47.28 77.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.22 -15.68 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -55.37 -20.17 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.87 -26.63 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -123.48 -45.61 2.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.717 ' OD1' HG22 ' A' ' 119' ' ' VAL . 3.4 t-20 179.91 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.717 HG22 ' OD1' ' A' ' 118' ' ' ASN . 18.3 m -151.56 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -127.08 151.64 48.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.35 -2.47 73.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.21 -31.37 5.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.887 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.79 -40.52 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -49.93 25.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.588 ' CG ' HD13 ' A' ' 166' ' ' LEU . 3.9 mptt -58.22 -51.74 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.581 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -62.67 -35.68 80.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 tp -62.25 -47.03 86.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.62 -58.72 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 133' ' ' VAL . 6.0 m -55.31 -36.05 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.112 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.92 -45.57 72.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.5 t -63.01 -39.09 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.828 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -53.85 37.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 129' ' ' VAL . 59.6 t -56.68 -43.44 79.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -67.04 -36.4 82.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -61.4 -47.24 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.61 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.3 t -67.02 -48.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.32 -41.08 83.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.01 -51.67 8.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.13 -57.32 10.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.8 mmt -68.34 -46.13 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.81 55.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -45.57 -36.56 4.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.911 0.386 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.95 -27.45 8.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.084 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.09 27.37 5.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.488 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -104.71 -37.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.692 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -128.31 -168.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 79.28 0.42 2.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.114 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 208' ' ' TYR . . . -70.41 -42.61 71.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.555 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -70.11 -57.05 6.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.536 0.684 . . . . 0.0 110.93 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.77 -7.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.717 2.278 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.98 -48.0 81.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.49 -39.25 91.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 150' ' ' PRO . 7.6 mt -66.83 -58.93 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -35.25 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.06 -49.31 16.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.7 t -57.36 -50.63 72.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -50.11 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.58 94.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.592 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -61.55 -55.68 28.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' CE3' ' A' ' 159' ' ' TRP . 73.3 t -53.5 -48.07 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.66 -39.78 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.642 ' HG2' HG12 ' A' ' 129' ' ' VAL . 27.8 mtt -58.62 -58.22 9.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.3 mp -67.24 -30.88 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -58.26 -54.68 44.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -33.72 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' ' 125' ' ' LYS . 21.5 tp -74.63 -13.99 60.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.435 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -56.47 -21.22 24.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.85 21.62 14.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.791 0.329 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.63 162.73 51.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.659 0.742 . . . . 0.0 110.854 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -30.83 21.52 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.5 -47.53 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.115 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.749 HG13 HD21 ' A' ' 113' ' ' LEU . 84.6 t -67.31 -44.6 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.01 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 t -66.62 -49.26 66.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.476 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.78 -42.2 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.29 -51.66 68.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.4 -54.71 43.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 31.9 m -55.33 -36.51 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.174 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.402 ' HE2' ' HA ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -63.71 -51.92 62.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.5 ttp -59.8 -37.53 79.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 -49.53 74.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -69.34 -53.45 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.2 mt -49.78 -50.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 91.3 mt -62.44 -49.79 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 199' ' ' ILE . 50.6 t80 -53.21 -48.86 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA2' HG12 ' A' ' 199' ' ' ILE . . . -62.06 -49.58 73.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.61 -28.43 69.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.84 -45.04 19.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 195' ' ' PHE . 21.0 pt -71.85 -29.46 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.7 t80 -45.59 -59.36 4.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.662 2.241 . . . . 0.0 112.343 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 198' ' ' ALA . 74.3 t -68.38 -43.88 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.67 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.99 -41.32 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.507 ' HA ' HG21 ' A' ' 222' ' ' ILE . 3.3 t80 -59.49 -24.57 63.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PHE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 70.6 t80 -54.47 -33.2 59.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 203' ' ' GLY . 6.2 t -66.26 -13.75 60.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.38 -4.79 6.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.594 ' CD1' ' HB1' ' A' ' 148' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.0 110.937 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.904 0.383 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.33 70.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -59.8 -52.1 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -35.8 81.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.54 -58.63 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 84' ' ' ILE . 1.2 p-10 -63.74 -35.99 82.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.531 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.3 tm? -63.07 -54.23 41.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 204' ' ' TYR . 23.3 mt -59.48 -48.13 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' TYR . . . . . 0.486 ' HD2' ' HH ' ' A' ' 204' ' ' TYR . 0.2 OUTLIER -62.14 -57.63 10.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -55.33 -39.86 70.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 229' ' ' VAL . 22.2 tp -62.83 -47.75 82.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.23 37.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.069 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -36.49 83.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.43 -40.8 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' LEU . 94.0 t -72.37 -42.66 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -72.78 -5.08 35.52 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 126.718 3.151 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -113.05 -27.07 8.18 Favored 'General case' 0 N--CA 1.424 -1.761 0 O-C-N 117.119 -3.488 . . . . 0.0 112.773 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 73' ' ' PHE . 31.8 mm -91.63 -63.44 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.14 174.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 233' ' ' LEU . 6.4 tp -49.08 -31.55 8.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.531 ' CZ ' HD11 ' A' ' 238' ' ' ILE . 71.6 t80 -57.52 -56.71 18.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.95 -39.76 89.16 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.97 -38.97 93.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.59 -47.43 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.531 HD11 ' CZ ' ' A' ' 234' ' ' PHE . 24.3 mt -55.48 -49.25 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 243' ' ' VAL . 3.4 t90 -69.85 -38.21 76.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -58.42 -53.85 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.7 p -65.15 -37.13 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.27 77.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 54' ' ' VAL . 98.9 t -81.27 -41.49 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -63.24 -39.57 94.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -77.52 -48.34 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.3 t -52.39 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.822 0.344 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.01 157.89 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -55.04 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -31.06 61.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -66.44 -68.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.779 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -49.71 -52.07 34.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 25' ' ' ALA . 5.6 t -61.82 -31.87 72.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.23 -55.51 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 32' ' ' SER . 15.4 m -57.0 -44.35 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 36' ' ' VAL . 35.0 t -64.37 -46.94 81.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.91 -40.14 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -47.5 69.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -43.98 97.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 32' ' ' SER . 93.2 t -63.2 -43.99 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.5 m -61.59 -42.66 99.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.13 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -51.9 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 232' ' ' ILE . 3.1 tm? -57.42 -39.03 75.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 tm? -61.19 -55.57 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.81 75.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -50.66 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.7 p -61.39 -40.4 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' LEU . 74.2 t -64.48 -48.05 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.92 -46.35 75.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 38.8 t80 -65.18 -28.72 69.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -74.66 -45.5 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' VAL . 61.1 t -73.55 -42.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.01 -4.01 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -26.38 62.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.03 -3.98 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.07 42.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.792 ' HA ' HG22 ' A' ' 243' ' ' VAL . 3.5 m -115.01 -170.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -66.27 152.94 43.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.62 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -27.81 64.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.471 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 58.3 m95 -91.69 1.6 57.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -51.11 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.473 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -77.56 -31.29 53.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 112' ' ' ILE . 5.4 p -55.29 -43.58 74.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 4.2 mm? -67.37 -29.67 69.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -54.82 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 65' ' ' SER . 15.5 m -62.91 -50.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 64' ' ' VAL . 1.1 p -70.12 -35.56 74.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.4 84.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.27 -47.92 59.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.54 -55.24 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 m -65.13 -37.52 87.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.29 99.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.478 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.51 -42.99 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 111.172 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.569 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -58.41 -47.89 82.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -63.98 -54.56 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -52.82 -51.19 61.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -63.92 -59.33 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -49.0 -62.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -38.31 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 82' ' ' VAL . 29.6 t80 -65.21 -70.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -59.67 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.478 HH21 HD11 ' A' ' 84' ' ' ILE . 2.1 tpm_? -53.47 -55.95 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.94 -54.6 27.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.0 t -56.59 -54.86 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.329 . . . . 0.0 111.156 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -54.18 -55.67 25.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HH21 ' A' ' 80' ' ' ARG . 41.6 mm -59.7 -26.52 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -21.28 50.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -38.33 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.08 31.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.52 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.77 -176.17 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 p -146.12 77.51 11.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.663 0.744 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 72.55 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.673 2.249 . . . . 0.0 112.328 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -69.87 -41.39 74.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 93' ' ' PHE . 4.7 m -54.56 -52.43 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.502 ' H ' HG23 ' A' ' 92' ' ' VAL . 34.5 m-85 -71.1 -44.61 65.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -55.46 -58.5 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -40.22 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 97' ' ' ASP . 21.6 mt -59.05 -63.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 101' ' ' THR . 18.6 t70 -59.02 -33.29 70.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.567 ' HE1' HG12 ' A' ' 133' ' ' VAL . 17.4 t-105 -60.58 -58.72 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.5 tm? -75.07 -11.99 60.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 100' ' ' LEU . 9.3 tt -90.96 -21.04 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.569 HG21 ' CB ' ' A' ' 72' ' ' ALA . 65.1 p -107.81 -34.36 6.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 t -47.57 -60.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.69 -30.46 22.54 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.27 . . . . 0.0 112.374 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 100' ' ' LEU . 3.1 mm? -64.88 -55.55 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.48 -43.01 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.36 -50.64 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 16.3 t -64.41 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -65.27 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.42 -50.21 60.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.48 -37.46 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.17 -66.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' N ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -50.75 -37.53 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.969 HD21 HG13 ' A' ' 182' ' ' VAL . 3.3 tm? -69.36 -39.82 77.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.43 -14.27 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.43 -14.67 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.02 -24.89 68.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -120.42 -70.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 117' ' ' THR . 2.1 m-20 165.24 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.46 138.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.02 96.94 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.99 85.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.0 p -48.78 -35.85 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.2 mp -49.48 -42.64 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -68.26 -53.68 22.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -52.09 64.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -36.14 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.31 -50.52 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.5 -60.13 2.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 89.9 t -56.58 -47.12 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.25 98.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.4 m -66.53 -55.26 16.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -53.81 43.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 129' ' ' VAL . 64.2 t -57.55 -45.09 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -61.92 -42.04 98.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 136' ' ' VAL . 2.1 tt -60.55 -57.82 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.627 ' CG1' HD12 ' A' ' 154' ' ' ILE . 48.5 t -52.67 -52.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -40.78 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.37 -51.46 52.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -60.44 -56.83 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -34.62 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.91 -29.19 59.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -39.79 -48.88 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' HG13 ' A' ' 145' ' ' ILE . . . -111.66 -28.95 7.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.78 17.02 33.29 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.403 HG13 ' HB1' ' A' ' 143' ' ' ALA . 12.9 mt -93.54 -55.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.123 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -111.45 138.35 48.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 174.07 -27.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.63 -31.64 48.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -74.54 -63.07 0.85 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.544 0.688 . . . . 0.0 110.881 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.71 -6.16 17.91 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.75 -49.63 74.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.95 -31.13 68.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mp -68.99 -61.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.627 HD12 ' CG1' ' A' ' 136' ' ' VAL . 1.3 pt -62.71 -38.96 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.194 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.43 93.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.489 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.94 -48.23 74.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -50.29 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.428 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.4 t90 -66.64 -57.89 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.428 HG23 ' CE3' ' A' ' 159' ' ' TRP . 59.8 t -61.36 -41.11 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.79 -47.09 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.23 -52.59 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.679 HG22 ' CE3' ' A' ' 167' ' ' TRP . 48.9 mt -63.13 -53.07 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -47.39 -35.59 8.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.96 -49.53 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -72.6 -16.39 61.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -116.69 18.42 14.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.933 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.856 0.36 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -110.67 166.42 10.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.64 0.734 . . . . 0.0 110.849 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 179' ' ' SER . 53.9 Cg_endo -69.74 -36.79 10.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.79 -43.68 35.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.969 HG13 HD21 ' A' ' 113' ' ' LEU . 76.6 t -68.02 -46.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.01 -36.47 83.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 m -68.67 -47.24 67.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.54 -39.89 95.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -43.77 78.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.05 -49.35 78.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.6 m -65.16 -38.66 91.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -64.22 -42.31 96.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.9 ttp -71.7 -34.97 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -63.97 -50.89 66.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.72 HG21 ' CD1' ' A' ' 237' ' ' ILE . 2.2 pp -70.86 -38.33 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 8.1 mm -64.1 -47.56 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.517 HD13 HD13 ' A' ' 163' ' ' ILE . 62.3 mt -64.41 -52.95 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -52.34 -54.51 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.04 21.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -53.95 -36.32 62.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.67 -20.81 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.8 mt -82.01 -31.86 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -48.35 -54.09 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.666 0.746 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.2 Cg_endo -69.7 -20.86 34.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 198' ' ' ALA . 76.7 t -72.83 -43.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.57 -38.27 17.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.708 ' CD2' HG21 ' A' ' 222' ' ' ILE . 0.6 OUTLIER -52.39 -29.36 23.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -49.0 -30.75 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 203' ' ' GLY . 15.2 t -51.16 -24.64 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.1 22.24 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.855 0.36 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.65 -36.79 69.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 28' ' ' TYR . 17.0 mt -62.53 -63.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.39 -43.25 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -45.27 81.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -65.31 -44.66 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.98 -53.63 52.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.708 HG21 ' CD2' ' A' ' 204' ' ' TYR . 36.3 mm -57.15 -45.75 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -63.95 -54.64 31.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.37 -47.61 78.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -50.48 71.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.95 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -27.92 69.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -67.88 -56.43 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -24.95 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -80.4 2.78 23.63 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.68 3.133 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -131.18 -51.22 1.02 Allowed 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 117.158 -3.464 . . . . 0.0 112.753 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 40' ' ' LEU . 1.9 mp -63.83 -63.67 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.12 174.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 232' ' ' ILE . 5.9 tp -48.99 -36.55 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -56.1 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.39 -33.69 85.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.08 -41.32 86.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.72 ' CD1' HG21 ' A' ' 192' ' ' ILE . 19.6 mm -67.77 -50.01 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.524 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.7 mm -63.67 -36.52 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 24.8 t90 -74.1 -41.82 61.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -69.64 -40.98 76.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 185' ' ' ALA . 9.9 p -70.56 -36.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.21 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.5 t -66.3 -36.5 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -75.61 -50.6 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -58.54 -41.79 86.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -54.51 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.82 163.53 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 29' ' ' THR . . . -67.39 -65.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.43 -30.91 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.97 -67.83 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.688 ' CD2' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -52.43 -44.04 65.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.88 HG22 HD11 ' A' ' 84' ' ' ILE . 34.7 p -60.13 -38.73 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.15 -54.56 13.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -55.93 -41.43 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.633 ' O ' HG23 ' A' ' 36' ' ' VAL . 52.8 m -66.44 -48.43 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.02 -42.59 72.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -47.85 68.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 -42.62 96.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.698 HG12 HD22 ' A' ' 40' ' ' LEU . 91.8 t -63.91 -50.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -55.36 -43.39 75.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.33 -52.04 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -54.34 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.698 HD22 HG12 ' A' ' 36' ' ' VAL . 4.1 mp -51.16 -52.84 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -54.27 -48.64 70.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.48 -36.02 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.696 ' OG ' HD12 ' A' ' 232' ' ' ILE . 6.3 p -70.88 -34.93 72.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -70.78 -45.08 65.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.9 m -65.87 -42.83 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.74 -48.62 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -64.6 -29.87 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -74.95 -50.36 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 45' ' ' VAL . 94.0 t -65.73 -41.03 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -79.73 -6.22 56.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.486 ' CG ' HD22 ' A' ' 62' ' ' LEU . 12.0 ttt180 -57.4 -26.67 61.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -93.22 -10.71 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 243' ' ' VAL . 1.3 tpt180 -100.63 28.78 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.041 HG11 HD11 ' A' ' 62' ' ' LEU . 9.4 p -107.98 161.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.439 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -48.79 149.93 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.87 -55.88 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -23.86 59.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.744 ' CZ3' HD11 ' A' ' 238' ' ' ILE . 59.9 m95 -90.43 11.64 20.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -62.25 -50.46 71.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -34.26 73.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.179 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -43.2 62.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.041 HD11 HG11 ' A' ' 54' ' ' VAL . 2.6 mp -65.18 -29.53 70.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.4 m -70.14 -54.53 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 68' ' ' VAL . 12.6 m -69.62 -49.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.5 p -67.12 -36.87 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.67 -36.79 83.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.535 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tp -70.58 -49.97 42.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.4 p -66.08 -46.32 88.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.481 ' N ' HG13 ' A' ' 68' ' ' VAL . 52.3 m -71.51 -29.95 65.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.04 -52.01 30.58 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.497 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -68.69 -37.19 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -68.54 -42.09 78.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.75 -56.59 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.831 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -56.28 -50.21 72.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -60.78 -62.6 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -49.84 -51.27 41.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -53.69 27.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 4.7 m-85 -56.78 -46.21 81.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -57.12 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.44 -56.59 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.69 58.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.6 t -62.29 -28.12 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 111.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -70.29 -47.32 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.88 HD11 HG22 ' A' ' 29' ' ' THR . 1.6 tt -73.35 -24.96 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.32 -47.78 18.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.8 p -122.5 -39.23 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.21 -23.33 4.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -122.7 129.12 51.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.2 161.03 40.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 110.878 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 104.07 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -26.41 64.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 m -51.38 -41.29 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.093 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.83 -52.03 53.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -60.03 -37.72 80.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.08 -48.78 74.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.64 -50.25 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 3.9 t70 -62.85 -39.69 95.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.1 t-105 -61.03 -49.45 77.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.451 HD12 ' CG ' ' A' ' 134' ' ' MET . 1.0 OUTLIER -75.55 -16.53 60.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 tt -94.02 -14.74 25.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 72' ' ' ALA . 72.6 p -108.17 -29.48 8.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -54.88 -59.64 10.13 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.634 0.73 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.71 -35.55 12.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.315 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 100' ' ' LEU . 6.2 mt -65.4 -52.34 54.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 106' ' ' ILE . 1.5 tt -60.63 -50.57 73.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.574 ' N ' HD23 ' A' ' 105' ' ' LEU . 27.4 mm -57.69 -58.64 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.98 -33.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.97 -68.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -50.5 -50.72 52.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.35 -43.98 83.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.25 -66.71 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -31.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 113' ' ' LEU . 2.9 tm? -71.65 -42.09 67.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.2 -14.37 59.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.52 -17.31 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.41 -24.05 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -121.87 -69.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' THR . 1.7 m-20 165.77 -76.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -47.23 135.01 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.11 98.27 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.29 74.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -47.87 -33.5 7.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -48.26 -43.38 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.38 -53.26 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -52.91 -52.27 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -37.34 86.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.81 -50.85 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -59.76 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.5 t -53.03 -49.56 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.3 59.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 t -52.49 -57.21 10.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -53.04 44.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 129' ' ' VAL . 98.6 t -56.53 -44.56 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.451 ' CG ' HD12 ' A' ' 99' ' ' LEU . 14.8 mtt -64.25 -38.14 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.3 -58.72 7.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 154' ' ' ILE . 15.6 m -57.14 -43.0 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.62 -47.3 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.55 -52.23 47.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -58.71 -55.21 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.92 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -58.37 -32.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.3 -30.18 59.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -41.61 -52.8 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.18 -28.48 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.73 16.95 48.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.5 pt -100.58 -37.27 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.63 139.82 47.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 170.4 -14.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -65.36 -38.84 91.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.7 m95 -69.12 -55.83 9.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.687 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.4 Cg_endo -69.76 -16.88 37.77 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.733 2.289 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -52.52 -53.21 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -77.7 -28.49 51.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 150' ' ' PRO . 46.0 mt -66.88 -64.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.073 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 136' ' ' VAL . 1.1 pt -63.29 -36.39 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.1 93.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.444 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.6 t -63.65 -46.77 84.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.71 -47.35 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.65 91.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 163' ' ' ILE . 11.0 t90 -61.06 -55.82 28.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 156' ' ' CYS . 43.5 t -58.88 -46.85 90.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.41 -43.28 99.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.698 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.9 mmm -57.35 -49.32 76.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.629 HD11 ' NE1' ' A' ' 159' ' ' TRP . 81.5 mt -63.59 -52.65 54.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -36.5 38.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.68 -58.76 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 162' ' ' MET . 0.5 OUTLIER -55.14 -55.77 27.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.433 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -56.14 -22.05 26.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.04 18.47 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.473 -179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.786 0.327 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.52 162.32 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.664 0.745 . . . . 0.0 110.898 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -28.57 25.19 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.304 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.32 -41.44 56.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 113' ' ' LEU . 98.6 t -63.8 -43.32 97.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.49 -32.59 72.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 t -69.8 -45.14 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.831 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -68.45 -40.8 80.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.537 ' CZ ' HD23 ' A' ' 166' ' ' LEU . 32.8 t80 -64.96 -51.39 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -61.86 -56.23 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.6 m -53.02 -44.18 67.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -59.9 -52.38 65.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.656 ' HG3' HD13 ' A' ' 166' ' ' LEU . 3.5 tmm? -54.78 -39.34 68.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.93 -52.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 194' ' ' ILE . 9.5 tt -52.7 -45.95 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 190' ' ' MET . 21.5 pt -69.58 -38.12 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' A' ' 199' ' ' ILE . 23.6 t80 -56.84 -58.32 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.97 -48.84 77.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.535 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -58.21 -33.11 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.03 -25.2 43.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.664 HD11 ' CE1' ' A' ' 195' ' ' PHE . 24.6 mt -80.34 -31.11 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.599 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -47.75 -54.5 22.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.693 0.758 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.72 -23.13 31.32 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.695 2.263 . . . . 0.0 112.386 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 198' ' ' ALA . 73.9 t -69.56 -44.32 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.91 -35.11 22.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.421 ' HB2' HG21 ' A' ' 222' ' ' ILE . 11.7 t80 -52.7 -29.44 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -48.76 -30.28 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 203' ' ' GLY . 8.9 t -50.5 -28.07 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.21 21.7 0.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.639 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 1.1 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.27 65.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -65.43 -51.77 57.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ASN . . . . . 0.43 ' N ' HD12 ' A' ' 217' ' ' LEU . 2.0 t-20 -61.14 -41.56 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -58.46 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -36.27 69.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -60.19 -57.92 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 200' ' ' TYR . 42.3 mm -55.51 -48.62 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.4 -51.54 69.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -60.04 -38.82 83.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -59.24 -51.22 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 200' ' ' TYR . . . -59.75 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.21 86.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.78 -39.31 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 225' ' ' LEU . 95.6 t -74.33 -24.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.11 2.51 53.27 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.671 3.129 . . . . 0.0 110.84 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.7 mmtm -121.51 -45.37 2.31 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 117.121 -3.487 . . . . 0.0 112.76 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.696 HD12 ' OG ' ' A' ' 43' ' ' SER . 46.5 mm -84.34 -65.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.08 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -36.22 44.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -55.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.29 -35.25 91.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -42.32 85.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 238' ' ' ILE . 1.1 mm -65.72 -50.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ILE . . . . . 0.744 HD11 ' CZ3' ' A' ' 58' ' ' TRP . 9.0 tp -62.84 -34.45 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' TRP . . . . . 0.709 ' O ' HG23 ' A' ' 243' ' ' VAL . 10.2 t90 -74.41 -44.27 52.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -60.32 -41.95 94.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 185' ' ' ALA . 13.6 p -72.67 -36.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.86 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 54' ' ' VAL . 61.4 t -74.8 -38.58 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -71.61 -35.83 70.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -76.85 -36.81 56.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.4 t -50.93 -54.88 20.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.817 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.99 146.56 10.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.448 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.05 -99.45 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.9 71.75 1.05 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.92 89.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 27' ' ' ASP . 16.2 mt -145.7 150.7 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 175.6 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -55.73 -73.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -31.63 54.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -58.43 -71.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.564 ' HB2' HD23 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -58.39 -48.17 81.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -51.23 -42.88 61.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.96 -50.81 27.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 27' ' ' ASP . 57.7 t -51.17 -51.66 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 t -64.37 -48.74 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.34 -49.07 65.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -46.92 83.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -59.0 -38.76 79.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 32' ' ' SER . 84.1 t -68.09 -45.56 83.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 m -62.31 -50.54 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 tt -52.53 -52.53 54.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.8 -53.58 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -47.16 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -29.01 68.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.0 m -72.81 -48.87 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.8 m -65.66 -40.3 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.87 -51.34 41.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 48.8 t80 -63.37 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.05 -51.33 13.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 45' ' ' VAL . 90.0 t -67.62 -31.13 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -79.22 -7.06 57.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.38 -27.26 55.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.26 -12.54 27.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -102.39 36.69 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.672 ' HA ' HG22 ' A' ' 243' ' ' VAL . 8.2 p -120.03 158.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -47.8 147.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.27 -52.87 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.18 -21.82 60.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -87.73 6.97 32.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -51.33 -50.75 58.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -77.06 -36.17 56.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.153 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.509 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -54.92 -47.8 73.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -72.19 -27.5 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -67.77 -53.6 25.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 68' ' ' VAL . 29.8 m -71.73 -44.91 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 64' ' ' VAL . 4.2 t -66.32 -40.56 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -35.29 58.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.07 -49.19 65.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.7 p -68.48 -44.11 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.082 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.448 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.1 m -67.26 -35.26 79.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.95 -42.68 59.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 mt -68.48 -41.67 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -66.87 -43.63 83.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 232' ' ' ILE . 30.6 t80 -61.1 -51.95 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.56 -50.41 74.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -59.25 -61.43 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -51.5 -49.7 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -53.15 30.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 82' ' ' VAL . 18.8 t80 -58.72 -48.74 80.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.3 mmt -55.83 -54.84 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -51.41 -55.16 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.04 -45.87 56.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 78' ' ' TYR . 58.6 t -66.7 -35.68 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -59.75 -51.6 69.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.3 tp -74.51 -26.13 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -50.15 -48.61 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.9 p -111.43 -39.25 4.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 122.36 -13.66 8.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.46 127.03 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.7 161.28 35.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.643 0.735 . . . . 0.0 110.859 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 99.96 0.79 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.358 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 p -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -50.6 -33.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -71.57 -51.92 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -63.74 -33.55 75.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -53.79 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.57 -37.94 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 101' ' ' THR . 0.8 OUTLIER -63.25 -47.88 80.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 0.0 109.31 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.606 ' CD1' HG23 ' A' ' 102' ' ' VAL . 14.5 t90 -64.82 -41.67 95.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.8 tp -75.15 -16.58 60.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.551 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.4 tt -99.36 -16.8 18.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 72' ' ' ALA . 40.5 p -100.12 -29.17 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.606 HG23 ' CD1' ' A' ' 98' ' ' TRP . 2.2 t -60.0 -58.63 17.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.675 0.75 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.75 -24.82 29.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.71 2.273 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 100' ' ' LEU . 8.5 mt -76.51 -52.45 9.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.743 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.8 pp -64.08 -38.52 91.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.789 HD12 ' HD3' ' A' ' 126' ' ' LYS . 26.1 mm -70.55 -57.94 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.521 ' HB2' HD13 ' A' ' 123' ' ' LEU . 35.9 t -52.05 -49.83 62.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -55.48 33.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -51.11 -50.75 58.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.682 ' HB3' ' HB3' ' A' ' 120' ' ' ALA . 18.4 m-85 -68.53 -30.54 69.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -60.23 -63.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 61' ' ' SER . 39.4 mm -62.64 -37.53 79.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.062 HD11 HG13 ' A' ' 182' ' ' VAL . 4.9 tp -62.54 -50.45 71.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -76.97 -14.01 59.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.69 -23.62 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -27.65 68.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -117.81 -45.84 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -179.61 -78.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -154.74 157.34 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -106.8 124.29 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.31 -5.53 81.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -50.5 -28.15 7.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 107' ' ' CYS . 21.4 tp -51.82 -39.78 59.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -64.95 -52.68 55.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -49.94 74.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HD3' HD12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -64.32 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -48.32 76.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -58.58 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.856 HG11 ' HG3' ' A' ' 162' ' ' MET . 48.1 t -56.3 -51.95 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.63 74.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -45.35 91.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -60.47 -49.67 76.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 129' ' ' VAL . 39.6 t -54.8 -51.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.452 ' HE1' ' HA ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -62.53 -35.89 80.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -58.94 -51.01 71.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD12 ' A' ' 154' ' ' ILE . 80.7 t -64.62 -46.89 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.547 ' HB2' H162 ' A' ' 301' ' ' RET . 76.1 t80 -59.71 -39.51 84.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -51.99 8.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.56 -55.75 30.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.95 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.609 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 16.3 mmt -69.29 -47.9 63.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.63 -31.7 53.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -47.48 -46.77 27.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.6 -27.1 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.48 20.33 30.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.8 pt -75.52 -40.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.876 0.37 . . . . 0.0 111.157 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.64 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -156.39 132.52 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 146' ' ' MET . . . 165.11 -20.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.677 ' HB3' ' CE1' ' A' ' 208' ' ' TYR . . . -67.75 -43.0 80.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.638 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 4.9 t-105 -66.78 -54.82 19.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.532 0.682 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.71 -16.96 38.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.319 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.7 -33.17 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.4 -37.72 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.6 -65.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 136' ' ' VAL . 6.5 pt -50.68 -44.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.409 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -65.66 -49.15 61.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.721 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.1 t -55.22 -50.5 69.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.15 -50.34 73.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.26 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.532 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.6 t90 -65.21 -55.14 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 156' ' ' CYS . 33.1 t -52.75 -50.15 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -39.88 94.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.856 ' HG3' HG11 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -54.84 -58.7 6.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.9 mp -68.49 -32.17 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -53.24 -55.91 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -76.65 -35.29 58.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 tp -60.52 -40.25 90.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -21.58 26.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -110.44 20.01 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -47.96 164.88 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.19 1.15 42.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.16 -58.61 7.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -76.85 -17.55 58.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.9 t -70.42 -23.78 62.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -45.56 -57.2 4.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.77 -57.45 2.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 176.53 -71.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.88 5.65 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.71 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.56 163.19 21.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.699 0.761 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.64 27.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.27 -48.39 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 1.062 HG13 HD11 ' A' ' 113' ' ' LEU . 85.4 t -63.38 -41.78 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -65.78 -33.43 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.6 m -70.57 -46.89 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.48 94.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.17 -51.77 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -56.48 -49.94 73.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 20.6 p -61.91 -38.48 88.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.622 ' SD ' HD11 ' A' ' 238' ' ' ILE . 5.1 tpt -62.31 -51.95 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.628 ' CE ' HG23 ' A' ' 163' ' ' ILE . 2.7 ttp -61.5 -38.62 87.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -49.04 79.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.3 mm -65.21 -48.49 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.6 mm -52.58 -45.93 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.525 HG23 ' NE1' ' A' ' 159' ' ' TRP . 32.1 mt -64.95 -51.33 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.2 -57.5 11.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -56.51 -59.21 11.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.5 -34.01 56.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.92 -23.7 44.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.108 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.1 mt -78.37 -32.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 6.8 t80 -48.38 -56.23 15.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.76 -23.65 30.57 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.697 2.264 . . . . 0.0 112.379 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.19 -45.24 83.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.01 -39.03 10.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -53.22 -48.59 68.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.923 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.07 -32.77 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.5 OUTLIER -67.23 -13.38 61.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -131.6 5.01 5.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 t80 -88.88 -53.48 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 32.3 mt -100.78 -41.1 7.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.975 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 31.4 ttp -116.44 164.6 14.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.36 -61.55 0.38 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.87 34.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.836 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.38 46.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 104.89 60.31 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 17.9 t -84.07 132.55 34.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 110.854 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.71 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.5 mp -52.78 -63.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -33.64 39.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.9 -54.47 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.4 t30 -61.12 -52.12 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 32' ' ' SER . 2.2 tm? -52.17 -58.46 6.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 221' ' ' LEU . 96.6 mt -54.2 -42.51 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.71 -52.56 63.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -37.92 83.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.1 tp -63.04 -45.0 94.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.75 -52.14 64.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.61 -32.05 73.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -66.18 -49.61 66.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 233' ' ' LEU . 53.7 t -73.33 -25.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -80.47 2.55 24.76 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-O 126.738 3.161 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.677 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 5.2 mmtm -131.59 -51.57 0.99 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.111 -3.493 . . . . 0.0 112.761 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.3 mm -65.33 -64.53 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.16 -1.837 . . . . 0.0 111.101 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.442 ' HB2' HG13 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -50.91 -36.0 35.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.9 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -51.56 -56.04 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.65 65.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.99 -47.36 85.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.8 mm -71.42 -50.77 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.622 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.5 mm -53.19 -40.92 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.648 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.9 t90 -74.71 -41.97 59.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -60.55 -42.54 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.02 -35.12 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.76 72.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' VAL . 60.7 t -79.76 -37.9 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -70.27 -37.8 74.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -77.04 -46.29 24.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.9 t -51.95 -62.3 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.92 93.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -151.39 158.84 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -107.57 160.52 26.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 111.116 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.588 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 54.0 Cg_endo -69.77 148.02 64.11 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 154.44 107.94 0.3 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.161 -0.799 . . . . 0.0 112.455 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.547 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.786 0.327 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.0 179.21 22.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.22 132.77 3.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.68 123.0 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 110.61 4.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp -99.02 170.13 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 170.7 12.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.18 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.64 -39.62 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -53.71 -62.36 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -48.05 80.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -52.79 -46.27 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.41 -51.44 16.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.5 t -52.11 -50.53 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 111.164 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 36' ' ' VAL . 17.9 t -66.18 -49.89 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -52.35 -49.13 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -63.79 -47.33 81.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.07 -38.2 78.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 32' ' ' SER . 98.7 t -68.79 -45.21 81.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 m -61.88 -51.59 67.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.92 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.087 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -59.18 -55.43 35.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD13 ' HE1' ' A' ' 77' ' ' MET . 5.0 tt -53.33 -39.72 64.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 45' ' ' VAL . 51.6 tp -61.45 -56.02 24.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -24.15 67.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.683 ' OG ' HD12 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -71.36 -51.85 21.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.3 t -69.58 -39.48 77.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 41' ' ' LEU . 82.0 t -65.05 -49.32 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.53 -45.06 76.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -64.54 -30.47 71.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -75.04 -51.78 12.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.83 -36.12 76.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.37 -9.26 59.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.42 -29.08 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.15 -11.66 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.17 24.6 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.801 ' HA ' HG22 ' A' ' 243' ' ' VAL . 7.9 p -112.51 156.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 148.65 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -55.56 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -20.7 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -88.58 -15.33 35.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -51.68 -50.38 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 64' ' ' VAL . 7.6 p -61.13 -50.34 73.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.41 ' OG ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.53 -35.53 72.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -68.71 -32.36 72.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -53.96 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 68' ' ' VAL . 14.8 m -64.5 -51.29 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.523 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.4 t -68.1 -38.16 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -36.38 68.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.79 -50.01 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -64.69 -48.45 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' VAL . 5.1 t -62.54 -33.56 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.03 -69.56 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 pt -45.4 -41.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -65.36 -49.41 69.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.734 ' CE2' HD11 ' A' ' 232' ' ' ILE . 23.5 t80 -52.77 -55.24 24.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -56.69 -46.15 81.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.56 -38.77 88.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -68.93 -68.53 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.435 ' HE1' HD13 ' A' ' 40' ' ' LEU . 3.2 ppp? -45.28 -42.9 10.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.7 t80 -65.03 -49.01 71.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.7 mmm -59.61 -48.99 79.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -56.21 22.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.26 -43.56 75.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.7 t -69.46 -27.67 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 111.081 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -69.93 -53.35 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -72.89 -26.05 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -50.08 -47.62 53.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.2 p -108.12 -39.06 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.93 -56.34 0.74 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.62 126.82 53.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.48 161.01 37.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 78.79 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.353 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 m -54.02 -25.66 22.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 96' ' ' ILE . 14.8 p -48.14 -32.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -69.56 -52.39 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -59.89 -45.03 93.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.437 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 35.8 t80 -60.34 -52.0 67.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.578 ' CD1' HG22 ' A' ' 92' ' ' VAL . 76.7 mt -63.55 -27.69 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.52 -68.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 109.275 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.635 ' CH2' H202 ' A' ' 301' ' ' RET . 11.1 t-105 -53.84 -32.78 54.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 1.0 OUTLIER -75.23 -32.76 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.953 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.1 tt -84.03 -14.9 49.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HB2' ' A' ' 72' ' ' ALA . 55.9 p -99.42 -32.69 11.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 98' ' ' TRP . 2.1 t -46.49 -59.41 5.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.0 Cg_endo -69.75 -23.33 30.95 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -71.63 -53.97 11.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.499 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.9 pp -71.93 -37.5 70.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 102' ' ' VAL . 21.9 mt -62.67 -51.38 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.04 -47.73 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -58.03 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HE1' HD22 ' A' ' 113' ' ' LEU . 19.6 t80 -51.21 -52.16 47.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.66 -30.49 71.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -66.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.41 HG21 ' OG ' ' A' ' 61' ' ' SER . 43.4 mm -58.56 -37.83 67.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 HG13 ' A' ' 182' ' ' VAL . 11.2 tp -65.12 -51.4 61.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -69.6 -16.58 63.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -54.14 -22.54 11.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -59.8 -30.06 68.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -120.1 -48.3 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 178.17 -73.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.2 m -155.17 157.21 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.37 123.6 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.0 -6.09 81.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.5 t -50.62 -28.95 9.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.95 -39.42 94.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -52.31 64.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -62.14 -34.05 75.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.05 -46.31 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.95 -58.18 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 133' ' ' VAL . 52.0 t -55.19 -50.09 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.45 94.68 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 t -59.85 -48.05 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -52.97 63.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' VAL . 47.4 t -52.31 -46.23 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -30.68 68.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -65.71 -50.17 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 154' ' ' ILE . 21.1 m -67.07 -39.12 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.739 ' HB2' H162 ' A' ' 301' ' ' RET . 2.9 t80 -68.31 -37.15 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.36 -51.9 19.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -64.35 -54.92 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 21.7 tpp -60.79 -43.08 98.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.79 -32.44 82.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.53 -28.53 8.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.35 -26.79 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.58 44.02 50.93 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 65.1 mt -84.97 -54.56 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -130.36 136.61 49.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -149.75 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.626 ' CB ' HD13 ' A' ' 209' ' ' LEU . . . -65.89 -45.65 81.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.08 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.618 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.03 -52.92 15.08 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.69 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.75 -9.86 27.16 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -60.73 -53.91 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -30.39 58.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 150' ' ' PRO . 39.9 mt -64.24 -66.48 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.645 HD13 HG21 ' A' ' 136' ' ' VAL . 24.3 mt -61.37 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.05 68.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.9 t -58.66 -49.59 76.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.26 -48.52 68.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.15 90.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -60.69 -56.42 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.25 -45.9 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.76 -41.29 99.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -57.85 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.2 mt -63.87 -37.95 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -52.94 -54.21 38.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -74.79 -48.71 23.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -51.36 -60.07 3.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -58.01 -20.29 37.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.17 17.96 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.36 -154.75 31.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 0.78 49.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.869 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.98 -70.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.449 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -24.11 45.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.7 m -77.18 -23.68 51.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 178' ' ' ALA . . . -57.46 -19.43 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 t -83.01 7.56 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.28 -65.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -119.85 -29.4 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 174' ' ' ALA . . . -61.27 -166.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.64 162.99 24.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.667 0.746 . . . . 0.0 110.879 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -16.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.97 37.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.705 HG13 HD11 ' A' ' 113' ' ' LEU . 87.3 t -65.91 -47.03 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.492 ' CG ' ' HB3' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -61.3 -38.29 86.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -66.82 -48.42 68.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.83 86.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -51.53 61.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.74 -41.03 73.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' ILE . 9.9 p -72.29 -32.23 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -64.74 -52.21 58.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.43 76.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -50.96 69.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 237' ' ' ILE . 24.3 pt -69.38 -33.46 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.536 HD11 ' HE1' ' A' ' 189' ' ' MET . 5.5 mm -61.26 -53.19 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 17.9 pt -67.33 -36.75 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.89 -60.97 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.72 97.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -61.63 -32.37 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.05 -27.52 35.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.3 mt -80.96 -31.03 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.8 t80 -48.36 -54.19 27.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.732 0.777 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.75 -21.91 32.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 0.0 112.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.4 t -70.19 -44.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.41 ' C ' HG21 ' A' ' 222' ' ' ILE . . . -82.5 -37.38 14.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.497 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.416 ' N ' HG21 ' A' ' 222' ' ' ILE . 71.6 t80 -57.95 -36.37 72.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.897 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 148' ' ' ALA . 13.9 t80 -63.39 -49.4 73.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 t -73.24 -13.93 61.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -96.79 -21.48 21.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -106.94 -51.26 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.626 HD13 ' CB ' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -99.54 39.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 8.8 ttt -65.48 91.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 51.74 31.36 30.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.8 t70 63.44 33.44 13.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.828 0.347 . . . . 0.0 110.815 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.95 21.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.449 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -68.84 125.07 18.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.64 160.54 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.845 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.19 -23.67 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.73 -62.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -58.01 -25.61 61.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.81 -58.81 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.02 -43.32 95.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -53.93 -58.49 7.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 221' ' ' LEU . 34.9 mm -59.47 -44.39 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.61 -47.81 78.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -66.73 -43.9 82.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 229' ' ' VAL . 4.4 tt -57.01 -49.64 75.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.92 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.2 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -56.43 -27.93 58.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.2 t80 -73.08 -46.91 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 225' ' ' LEU . 21.2 t -73.88 -25.43 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.88 2.26 31.28 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 126.686 3.136 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 3.5 mmtm -130.74 -58.3 1.03 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 117.109 -3.494 . . . . 0.0 112.71 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.734 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.4 mm -62.11 -64.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.08 174.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -38.21 50.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.57 -56.63 12.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.22 90.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.2 -44.17 96.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.312 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 192' ' ' ILE . 4.7 mm -67.65 -47.18 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.01 -40.9 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.63 ' O ' HG23 ' A' ' 243' ' ' VAL . 13.3 t90 -71.94 -41.08 68.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -62.95 -43.88 97.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.87 -32.5 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.21 62.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 54' ' ' VAL . 62.3 t -76.36 -33.22 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -75.88 -39.7 55.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.1 -42.84 55.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 t -52.05 -58.92 5.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.95 95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -76.9 -44.43 31.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . 63.48 160.43 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.9 Cg_endo -69.73 95.57 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.695 2.263 . . . . 0.0 112.39 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.75 93.13 2.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.196 -0.78 . . . . 0.0 112.531 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.739 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.9 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.838 0.351 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -134.93 173.26 21.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.3 -35.8 0.4 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.456 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.44 114.94 3.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.494 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 t0 57.78 82.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.06 167.02 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.38 -177.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.5 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -54.23 -36.23 63.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 61.4 m-20 -55.78 -69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.755 ' HB3' HD12 ' A' ' 217' ' ' LEU . 0.3 OUTLIER -60.5 -46.67 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.5 m -51.68 -45.78 63.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.62 -50.49 36.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' ASP . 80.1 t -54.36 -54.51 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.5 t -60.45 -49.97 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -52.44 -49.23 64.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -44.52 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -36.68 84.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 32' ' ' SER . 89.2 t -66.02 -51.51 59.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 m -62.83 -46.36 88.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.71 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.151 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.42 56.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 tt -51.58 -54.42 27.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -56.44 -54.22 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.72 62.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -66.18 -28.17 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -72.33 -50.15 29.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 49' ' ' VAL . 23.4 m -65.73 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -70.43 -51.69 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -63.41 -30.96 72.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -74.03 -51.25 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.8 t -68.32 -31.47 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.74 -4.88 53.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -55.78 -26.37 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.25 -10.67 22.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -95.49 24.6 5.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 62' ' ' LEU . 8.6 p -111.95 158.61 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.195 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -48.03 157.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.59 -55.9 11.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -61.4 -19.87 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 40.7 m95 -88.96 -6.81 56.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -50.81 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 64' ' ' VAL . 56.2 p -68.13 -39.07 82.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.737 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.57 -37.12 75.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.26 -33.7 76.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -54.89 8.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 112' ' ' ILE . 10.6 m -63.54 -53.53 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.536 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -66.09 -39.53 90.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.15 -32.7 69.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.79 -47.64 62.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.2 p -67.69 -45.32 84.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.476 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 m -69.51 -35.32 75.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.45 -45.97 65.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.59 -48.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.847 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.44 -41.91 97.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 25.2 t80 -59.94 -52.47 65.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -56.99 -50.27 73.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -56.59 -53.68 54.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.79 -53.21 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.97 -53.83 18.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.3 t80 -56.55 -43.46 79.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -51.95 67.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.498 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -53.56 -55.46 25.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.9 -46.33 60.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.0 t -67.51 -27.83 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.344 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -67.59 -54.83 16.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.512 ' CD1' ' HB1' ' A' ' 216' ' ' ALA . 11.2 tp -73.59 -24.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -46.77 -47.92 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 t -123.04 -39.11 2.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.158 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.55 -38.48 1.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.56 127.12 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p -138.61 160.25 64.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 97.59 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.7 2.266 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -69.58 -26.81 64.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.498 HG12 ' CD1' ' A' ' 96' ' ' ILE . 68.5 t -50.73 -46.65 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -38.31 90.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -64.08 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -36.41 70.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 92' ' ' VAL . 39.7 mt -63.73 -66.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 101' ' ' THR . 0.1 OUTLIER -54.51 -33.37 59.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.533 1.146 . . . . 0.0 109.305 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -55.95 -63.17 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' SD ' ' A' ' 134' ' ' MET . 0.3 OUTLIER -76.26 -10.47 59.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.918 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.87 -15.18 30.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.847 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.9 p -112.62 -36.24 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.495 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -46.67 -59.43 5.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.689 0.756 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.77 -18.68 36.82 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 68' ' ' VAL . 2.4 mm? -77.51 -53.92 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HA ' HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -66.1 -50.44 64.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 126' ' ' LYS . 35.5 mm -55.02 -56.08 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.0 t -58.54 -40.0 81.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -56.35 -65.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.691 ' CE2' HD12 ' A' ' 238' ' ' ILE . 43.9 t80 -50.0 -50.16 48.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 13.0 m-85 -60.1 -32.21 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.23 -62.22 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.737 HG21 ' CB ' ' A' ' 61' ' ' SER . 2.3 mp -50.77 -41.97 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 HG13 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -69.36 -41.4 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . . . -72.2 -15.68 61.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.36 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.086 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.4 -18.15 61.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.541 ' OG1' ' HB1' ' A' ' 174' ' ' ALA . 1.1 t -119.34 -49.38 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.179 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.63 -78.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.64 163.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 114' ' ' ALA . . . -104.05 118.09 35.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.29 -14.96 81.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.512 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.3 m -54.53 -23.99 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.868 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.41 -37.58 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -73.42 -42.04 62.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 129' ' ' VAL . 34.1 mttm -64.18 -50.32 68.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.88 -36.08 82.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.912 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -48.08 80.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.918 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.79 -58.91 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 133' ' ' VAL . 60.1 t -54.08 -52.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.79 -49.19 76.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.4 m -53.67 -45.87 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.62 -50.54 72.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 129' ' ' VAL . 62.8 t -51.36 -45.68 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.599 ' SD ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.6 -41.03 89.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -54.56 -53.18 57.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 154' ' ' ILE . 42.0 t -67.14 -50.87 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.738 ' CD1' H173 ' A' ' 301' ' ' RET . 16.4 t80 -51.93 -44.14 63.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.32 -52.47 8.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -53.5 -57.66 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.1 mmt -69.99 -32.56 70.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.57 78.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.43 -27.85 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -103.09 -28.16 12.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.48 20.75 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.472 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.116 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.459 ' HE3' ' HG3' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -115.49 122.35 45.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.4 -29.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.448 ' HB3' ' HG ' ' A' ' 209' ' ' LEU . . . -66.34 -42.97 87.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -70.22 -58.33 5.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.79 -6.26 18.18 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -65.14 -44.18 89.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.6 mp -58.95 -63.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.856 HD13 HG11 ' A' ' 136' ' ' VAL . 52.0 mt -58.36 -51.72 67.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -54.55 -49.07 62.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.465 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.537 ' O ' HG23 ' A' ' 160' ' ' VAL . 40.4 t -56.54 -51.1 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -49.34 65.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.53 83.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.573 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.6 t90 -67.42 -56.69 8.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 156' ' ' CYS . 25.7 t -53.82 -52.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -59.83 -44.67 93.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.542 ' O ' HD13 ' A' ' 166' ' ' LEU . 6.2 mmm -50.73 -56.59 11.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 194' ' ' ILE . 1.6 mp -62.29 -38.87 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -51.25 56.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.19 -52.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 162' ' ' MET . 8.7 mp -50.31 -59.09 4.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -57.04 -20.93 27.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -106.12 17.69 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -65.45 125.26 28.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.03 -0.55 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.847 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.54 -28.03 28.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -31.6 59.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.4 t -55.36 -25.82 37.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.541 ' HB1' ' OG1' ' A' ' 117' ' ' THR . . . -50.16 -33.24 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.1 m -117.08 -10.49 10.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 75.2 -58.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.8 t -98.16 -8.94 26.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.75 -166.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.08 161.76 52.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.636 0.731 . . . . 0.0 110.839 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -22.0 32.84 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.85 -43.16 47.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.651 HG13 HD12 ' A' ' 113' ' ' LEU . 17.9 t -70.73 -46.26 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.67 -36.51 84.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.706 ' O ' HG22 ' A' ' 188' ' ' THR . 32.2 t -71.16 -49.71 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.486 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -59.93 -37.88 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -50.61 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -53.58 -56.96 12.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 184' ' ' SER . 6.7 t -60.32 -41.98 94.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.463 ' HG3' HD11 ' A' ' 238' ' ' ILE . 0.4 OUTLIER -57.65 -51.51 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.443 ' HG2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.13 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -50.35 68.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -70.01 -39.5 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.17 -56.57 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 163' ' ' ILE . 54.4 mt -60.15 -48.46 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -49.83 -56.34 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.44 -59.72 10.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -54.44 -31.36 55.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.48 -22.89 43.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.104 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.4 mt -78.92 -32.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 151' ' ' ALA . 23.8 t80 -49.93 -54.5 31.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.682 0.753 . . . . 0.0 110.914 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.7 Cg_endo -69.77 -25.03 28.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.682 2.255 . . . . 0.0 112.384 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.6 t -71.51 -37.73 65.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.12 -28.88 39.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.41 -33.76 21.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.59 -28.03 12.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.7 p -47.83 -32.4 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.426 ' HA3' ' HE3' ' A' ' 210' ' ' MET . . . 136.58 44.03 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.466 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.752 ' CE1' HD12 ' A' ' 222' ' ' ILE . 0.8 OUTLIER -61.36 -19.77 62.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 148' ' ' ALA . 2.9 mt -92.59 -36.31 13.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.426 ' HE3' ' HA3' ' A' ' 207' ' ' GLY . 44.9 mtm -77.23 -172.86 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 67.72 62.49 4.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 13.1 t0 62.2 36.37 14.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.89 26.63 66.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.68 101.95 1.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.482 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.4 t -65.57 126.89 29.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.857 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB1' ' CD1' ' A' ' 84' ' ' ILE . . . -54.01 -42.09 68.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 28' ' ' TYR . 4.2 mm? -53.5 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.11 -26.98 65.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.682 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -62.67 -59.01 5.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -34.7 78.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.475 HD13 ' C ' ' A' ' 221' ' ' LEU . 2.9 tm? -62.36 -58.11 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.752 HD12 ' CE1' ' A' ' 208' ' ' TYR . 86.6 mt -58.82 -49.04 84.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.41 -54.54 45.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -60.84 -32.55 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 229' ' ' VAL . 26.0 tp -63.54 -49.25 74.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.72 -49.06 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -46.78 87.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -59.09 -44.18 91.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.826 HG13 HD13 ' A' ' 233' ' ' LEU . 99.1 t -72.91 -25.59 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -93.9 2.1 56.22 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.738 3.161 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -120.94 -60.36 1.66 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.095 -3.503 . . . . 0.0 112.751 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.8 mm -67.64 -64.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.177 174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.826 HD13 HG13 ' A' ' 229' ' ' VAL . 0.3 OUTLIER -54.09 -34.52 60.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -56.64 -56.56 19.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.42 -34.4 87.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -41.07 87.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.526 HD12 ' OG1' ' A' ' 188' ' ' THR . 1.1 mm -68.46 -50.1 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.691 HD12 ' CE2' ' A' ' 109' ' ' PHE . 39.6 mm -61.61 -37.73 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.604 ' O ' HG23 ' A' ' 243' ' ' VAL . 14.7 t90 -74.78 -41.96 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.67 -44.3 93.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.503 ' HB ' HG21 ' A' ' 188' ' ' THR . 8.1 p -70.59 -41.38 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.417 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.59 -39.08 91.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.774 HG22 ' HA ' ' A' ' 54' ' ' VAL . 87.8 t -78.45 -34.77 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -69.87 -40.92 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.14 -41.36 42.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 29.7 t -51.39 -46.68 62.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.71 92.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.823 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 110.03 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -115.36 160.48 34.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.584 0.707 . . . . 0.0 111.115 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.5 Cg_endo -69.8 -35.98 11.53 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -151.38 137.79 6.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.507 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.738 H173 ' CD1' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.819 0.342 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.45 -174.12 45.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.06 -173.25 13.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.85 -166.53 31.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.62 -70.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -151.86 148.57 27.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 168.43 15.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.096 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.9 t -52.03 -31.18 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -58.59 -63.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.563 ' CE2' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.98 -47.96 80.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -51.21 -47.71 62.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.13 -51.55 38.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 97.3 t -53.24 -56.19 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 111.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -48.78 78.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -52.05 -39.93 60.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -71.37 -40.0 70.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.67 -44.34 86.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG23 ' CE2' ' A' ' 228' ' ' PHE . 13.2 p -70.02 -35.83 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.5 m -71.03 -54.19 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.46 -44.9 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 228' ' ' PHE . . . -63.89 -50.27 69.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' CE2' ' A' ' 73' ' ' PHE . 2.1 tt -55.3 -42.36 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.4 tp -64.42 -56.1 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -38.15 74.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.516 ' OG ' HD12 ' A' ' 232' ' ' ILE . 3.2 t -67.56 -48.96 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -63.82 -46.55 84.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' LEU . 88.8 t -60.92 -46.61 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.26 -48.85 66.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -61.39 -28.85 69.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -75.66 -50.33 15.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.02 -33.19 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -79.23 -6.56 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -59.47 -27.76 66.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.62 -13.7 27.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.69 39.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.774 HG21 HD21 ' A' ' 62' ' ' LEU . 8.5 p -117.89 160.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 54' ' ' VAL . 26.0 t -48.87 143.11 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.22 57.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 -25.06 61.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -91.85 13.25 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -49.69 -50.26 44.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.3 p -76.84 -30.26 56.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -44.06 72.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.774 HD21 HG21 ' A' ' 54' ' ' VAL . 3.9 mm? -67.84 -28.94 67.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -53.34 20.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 21.8 m -70.69 -46.83 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.1 t -66.62 -39.0 88.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.06 -36.22 60.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.17 -49.83 58.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -65.67 -44.78 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' VAL . 96.4 m -67.62 -36.14 80.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.71 -41.57 74.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.461 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 mt -66.95 -50.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -65.11 -36.95 85.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.079 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CE2' HD12 ' A' ' 40' ' ' LEU . 57.9 t80 -60.53 -54.85 40.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -46.7 85.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -59.11 -63.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.17 -55.29 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -57.5 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.34 -40.46 82.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.4 mmt -59.91 -56.51 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -55.36 19.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -47.85 57.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 78' ' ' TYR . 94.4 t -64.08 -37.22 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -59.78 -48.12 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.6 tp -74.29 -25.93 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.52 -48.12 38.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -115.01 -39.36 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.164 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.64 -14.41 5.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -135.34 141.49 45.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.27 162.08 33.88 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.697 0.761 . . . . 0.0 110.826 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.32 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -66.78 -25.6 66.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -65.7 -53.19 44.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -62.31 -30.79 71.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -65.38 -56.44 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.91 -32.73 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.63 -61.99 2.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.147 . . . . 0.0 109.293 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 133' ' ' VAL . 5.2 t90 -61.02 -35.72 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 134' ' ' MET . 64.7 tp -73.91 -17.15 61.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 104' ' ' LEU . 1.2 tt -102.42 -16.5 16.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.66 HG23 HG22 ' A' ' 68' ' ' VAL . 6.0 m -100.41 -35.41 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 133' ' ' VAL . 2.4 t -55.51 -57.83 18.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.729 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.77 -20.97 34.07 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 68' ' ' VAL . 3.9 mp -78.56 -53.7 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 101' ' ' THR . 3.6 pp -62.48 -45.3 93.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 105' ' ' LEU . 10.6 tt -63.14 -42.16 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.47 ' N ' HG23 ' A' ' 106' ' ' ILE . 42.1 t -69.16 -41.34 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -54.44 46.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.34 -52.38 65.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.575 ' HA ' HD23 ' A' ' 113' ' ' LEU . 6.7 m-85 -57.38 -49.92 74.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.93 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 111' ' ' LEU . 1.9 tm? -57.9 -50.69 72.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 mt -50.77 -46.34 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -70.62 -28.2 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' VAL . . . -78.22 -19.01 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.04 -10.85 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.67 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -71.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.75 -75.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 7.1 p -48.21 141.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.25 98.45 5.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.02 77.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -48.02 -34.72 9.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mt -50.95 -53.23 34.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -65.13 -53.44 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -50.68 52.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -33.3 75.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.12 -51.39 61.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.75 -60.85 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.1 t -54.56 -45.17 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.25 -46.67 94.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 m -58.26 -57.1 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -51.22 -52.13 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 102' ' ' VAL . 68.8 t -53.13 -47.4 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.417 ' HB2' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -64.03 -44.98 90.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.0 -57.62 12.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 132' ' ' LEU . 43.9 t -53.2 -51.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.98 -36.65 79.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -55.96 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.942 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.1 mtt -53.13 -37.8 62.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.87 -30.16 58.08 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -40.26 -52.98 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -27.47 8.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.5 15.65 47.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 pt -98.19 -36.4 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.13 137.91 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.774 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 172.12 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.759 ' HB1' ' CE1' ' A' ' 204' ' ' TYR . . . -63.24 -40.69 98.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -71.01 -60.58 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.511 0.672 . . . . 0.0 110.932 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 147' ' ' ALA . 53.9 Cg_endo -69.75 -1.63 8.79 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.2 -50.49 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.64 -45.96 70.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.6 mp -61.11 -59.09 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.54 -47.09 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.96 -49.55 77.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.3 t -57.11 -51.47 69.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.892 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.26 -49.18 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.07 92.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.566 ' NE1' HG23 ' A' ' 194' ' ' ILE . 3.5 t90 -62.17 -56.38 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.6 t -57.09 -50.11 77.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -55.16 -44.54 75.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -59.18 -58.02 10.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.89 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.564 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -59.21 -33.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -61.02 -52.16 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.66 -31.57 63.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 162' ' ' MET . 6.4 mp -67.15 -52.27 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.416 ' CE3' ' HE1' ' A' ' 190' ' ' MET . 2.6 t-105 -57.6 -20.95 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.02 18.12 21.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.8 120.04 20.57 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -0.29 26.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.399 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.89 -27.25 28.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.523 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -72.27 -31.12 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 m -55.68 -26.08 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.09 -36.21 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.98 -15.04 10.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.35 -58.64 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.4 p -93.74 -12.78 28.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.6 -166.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.22 162.37 54.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.01 31.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.16 30.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 113' ' ' LEU . 89.2 t -68.68 -41.39 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -65.7 -36.96 85.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.516 ' C ' HG21 ' A' ' 241' ' ' VAL . 59.7 p -70.07 -49.45 50.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -60.72 -41.83 96.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.7 -51.1 64.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -53.91 -51.81 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 237' ' ' ILE . 1.4 m -61.66 -37.11 82.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.603 ' CG ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.96 -51.19 70.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.564 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -64.13 -35.6 81.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -50.94 70.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -33.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.84 -50.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.566 HG23 ' NE1' ' A' ' 159' ' ' TRP . 58.4 mt -64.27 -49.31 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.95 -58.58 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -57.26 -58.44 14.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -54.66 -30.98 56.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.02 -23.04 44.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA2' ' A' ' 196' ' ' GLY . 16.9 mt -80.01 -32.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.688 ' HE1' ' HB1' ' A' ' 151' ' ' ALA . 13.4 t80 -48.57 -54.01 30.57 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.76 -23.03 31.24 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.315 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 75.9 t -71.66 -36.5 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' THR . . . -82.98 -34.88 20.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.511 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.759 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -51.59 -40.21 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.9 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -64.4 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -50.51 -27.86 7.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 144.82 57.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.466 ' CD2' HD13 ' A' ' 219' ' ' LEU . 33.9 t80 -102.07 -20.87 14.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.937 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -98.26 -28.12 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.959 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -62.36 -178.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.23 -57.55 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.51 -39.76 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -22.75 75.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -131.78 93.88 0.29 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.16 160.36 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.38 -23.8 58.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.8 mt -55.24 -63.34 1.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -58.67 -33.56 70.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 208' ' ' TYR . 3.5 tp -59.63 -55.94 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.433 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.5 t30 -64.04 -36.87 85.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.535 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.4 tm? -63.49 -53.63 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 221' ' ' LEU . 19.8 mt -59.49 -48.09 88.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -57.09 12.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.52 -44.69 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -61.46 -39.83 92.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.46 27.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -29.31 69.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.676 ' CE2' HG23 ' A' ' 36' ' ' VAL . 44.3 t80 -71.64 -58.5 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 225' ' ' LEU . 9.1 p -62.44 -30.67 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -78.05 -25.33 47.7 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.679 3.133 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -76.9 -30.39 56.14 Favored 'General case' 0 N--CA 1.423 -1.79 0 O-C-N 117.114 -3.491 . . . . 0.0 112.778 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.516 HD12 ' OG ' ' A' ' 43' ' ' SER . 47.6 mm -86.95 -38.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.146 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.1 mt -55.78 -34.07 64.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -61.39 -57.54 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.68 -34.97 79.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.47 -39.41 85.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.762 0.315 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 188' ' ' THR . 5.0 mm -70.8 -50.03 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.603 HD11 ' CG ' ' A' ' 189' ' ' MET . 40.0 mm -62.16 -35.61 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.668 ' O ' HG23 ' A' ' 243' ' ' VAL . 37.7 t90 -77.59 -47.25 19.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -56.81 -42.66 79.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.4 p -74.35 -39.97 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.415 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.41 -39.72 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 54' ' ' VAL . 43.9 t -78.27 -38.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -42.46 99.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.03 -49.22 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.2 t -58.43 -33.37 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.31 -75.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -163.44 130.51 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -149.04 73.56 10.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.711 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 118.32 5.61 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 70.63 -149.54 46.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.121 -0.821 . . . . 0.0 112.482 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.507 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 102.94 1.58 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.494 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.49 -121.42 1.29 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.52 111.51 3.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -56.9 4.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -61.24 141.66 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 179.4 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -63.27 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -51.67 60.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -51.89 -50.52 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.56 -48.26 81.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.9 m -50.77 -47.55 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.01 32.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.1 t -53.55 -56.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -59.55 -45.8 90.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -51.92 -44.12 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -46.24 68.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -41.04 88.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 32' ' ' SER . 87.1 t -67.95 -49.3 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.8 m -60.2 -41.41 92.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.43 -52.17 55.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.071 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -55.17 29.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 tp -53.17 -46.48 68.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.98 -56.1 26.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.971 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.41 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.1 t -68.3 -29.29 68.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 m -72.34 -49.1 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 46' ' ' PHE . 20.0 m -65.15 -41.47 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -67.45 -50.5 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.2 -26.74 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -72.43 -50.06 29.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.41 -34.57 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.712 ' O ' HG13 ' A' ' 54' ' ' VAL . 81.6 mt-10 -80.14 -9.99 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -52.72 -29.0 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.99 -4.82 13.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.83 29.63 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 243' ' ' VAL . 12.6 m -114.34 -171.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.05 164.11 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.92 -54.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -25.66 64.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.465 ' CG ' ' HB1' ' A' ' 242' ' ' ALA . 61.7 m95 -83.51 -17.2 42.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.41 -49.68 53.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.94 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 64' ' ' VAL . 4.5 p -76.61 -43.91 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB2' HD13 ' A' ' 112' ' ' ILE . 5.0 t -53.03 -44.44 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -66.13 -31.61 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.6 m -73.85 -54.77 7.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 60' ' ' THR . 12.3 m -62.33 -50.39 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 64' ' ' VAL . 7.1 t -70.14 -40.46 74.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.8 -34.77 78.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.466 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.13 -49.63 55.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -62.74 -47.25 93.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.491 ' N ' HG13 ' A' ' 68' ' ' VAL . 51.8 p -62.96 -36.67 84.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.65 -66.66 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.473 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -47.46 -36.84 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -72.03 -49.41 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 232' ' ' ILE . 13.2 t80 -59.23 -49.48 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -62.07 -51.99 65.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -59.0 -43.41 91.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.82 -69.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -48.19 -35.96 12.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 82' ' ' VAL . 72.3 t80 -65.87 -75.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.5 mtt -53.55 -57.35 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.48 -56.79 16.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.06 -51.21 41.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.9 t -61.52 -52.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.403 ' O ' HG22 ' A' ' 86' ' ' THR . 1.1 m-90 -50.71 -55.44 16.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.73 -30.38 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.99 -21.23 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 83' ' ' TRP . 11.1 t -112.46 -21.5 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 63.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -139.49 149.97 44.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 p -115.15 79.97 6.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 0.0 110.924 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 73.07 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -70.06 -36.21 74.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 29.0 m -69.98 -43.9 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 25.7 m-85 -72.42 -32.57 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -78.26 -47.17 18.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.46 -37.09 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.82 -50.98 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.55 -36.17 73.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.289 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CE2' HG21 ' A' ' 102' ' ' VAL . 9.5 t-105 -75.39 -50.08 16.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.05 -11.06 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 tp -103.13 -34.02 9.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.42 HG21 ' CB ' ' A' ' 72' ' ' ALA . 91.4 m -85.36 -37.96 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 t -50.71 -53.31 48.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.625 0.726 . . . . 0.0 111.121 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.73 -25.1 29.09 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 68' ' ' VAL . 28.2 mt -75.84 -52.54 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.53 -41.15 93.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.676 ' N ' HD23 ' A' ' 105' ' ' LEU . 13.0 tt -66.78 -34.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.8 t -69.53 -53.48 18.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -58.25 -45.66 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.719 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 5.8 t80 -59.45 -49.78 76.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.481 ' HD1' ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -61.98 -33.58 74.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -61.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 61' ' ' SER . 5.6 tp -56.51 -39.91 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 186' ' ' TYR . 3.3 tt -64.39 -42.32 96.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -76.89 -18.51 58.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.44 -20.2 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.103 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 182' ' ' VAL . . . -101.45 -78.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -48.18 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' HG23 ' A' ' 117' ' ' THR . 1.1 m-20 174.89 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.1 p -168.23 131.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.481 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -110.34 102.49 11.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.25 -5.5 66.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -29.64 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.854 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 120' ' ' ALA . 1.8 pt? -61.75 -34.74 76.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -49.66 60.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.7 mttt -62.6 -50.36 71.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' HD12 ' A' ' 106' ' ' ILE . 6.5 mttt -61.53 -36.74 81.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -44.51 86.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -58.33 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 162' ' ' MET . 28.9 m -56.29 -38.77 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 -42.72 94.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.518 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.2 t -63.46 -45.05 92.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.62 -52.63 60.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 129' ' ' VAL . 75.3 t -54.21 -47.24 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.04 -58.0 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.806 HG13 HD23 ' A' ' 135' ' ' LEU . 19.0 m -68.75 -39.23 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.544 ' HB3' H163 ' A' ' 301' ' ' RET . 4.4 m-30 -56.48 -43.82 80.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.06 -50.11 8.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -55.06 31.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.792 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -65.23 -47.82 75.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.59 -33.13 62.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.16 -23.96 24.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.86 -27.27 9.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.66 49.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -37.3 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.506 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -170.7 137.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.792 ' HB2' ' HB3' ' A' ' 140' ' ' MET . . . 173.73 -27.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.124 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.9 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.582 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.7 t-105 -65.66 -55.49 23.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.55 0.691 . . . . 0.0 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.798 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.6 Cg_endo -69.75 -20.77 34.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.653 2.235 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.55 -29.06 6.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -69.58 -42.92 73.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 150' ' ' PRO . 5.1 mt -62.9 -67.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 136' ' ' VAL . 6.5 pt -51.65 -44.83 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.93 -48.89 77.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.1 m -61.21 -50.71 71.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.884 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -50.42 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.81 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.496 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.9 t90 -67.28 -57.5 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.496 HG23 ' CE3' ' A' ' 159' ' ' TRP . 91.0 t -61.7 -40.26 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -68.2 -45.33 73.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.968 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.633 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.1 tpt -53.88 -52.92 58.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.712 HG22 ' CE3' ' A' ' 167' ' ' TRP . 50.5 mt -63.6 -53.1 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -49.81 -33.31 16.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -53.68 8.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.5 pp -70.12 -11.13 60.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.712 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -62.81 -16.38 57.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.03 14.6 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.78 -158.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -66.16 -17.03 64.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.856 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.8 -21.16 67.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -74.03 -51.54 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -27.52 48.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.698 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -59.29 -20.2 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.075 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 14.0 m -53.14 -34.05 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.837 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.6 9.38 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -117.88 -21.28 8.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.698 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -111.92 -167.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.6 163.62 22.15 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 0.0 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -27.14 26.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.59 -45.26 31.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 116' ' ' ALA . 51.1 t -60.49 -47.72 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.29 -35.54 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -43.97 78.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.6 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.812 ' CD2' HD11 ' A' ' 113' ' ' LEU . 11.8 t80 -67.04 -46.82 73.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.973 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -49.3 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -64.92 -32.75 74.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.466 ' HE1' HG13 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -64.81 -52.58 56.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.0 ptm -63.52 -35.52 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.02 -48.21 79.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.566 HD12 HD12 ' A' ' 233' ' ' LEU . 31.2 mm -65.23 -54.45 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.14 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 234' ' ' PHE . 34.0 mm -50.71 -53.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.544 HD13 HD13 ' A' ' 163' ' ' ILE . 76.9 mt -56.84 -51.67 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -53.67 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.01 -62.72 5.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -53.62 -30.61 43.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -76.8 -26.3 54.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.07 -30.89 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.3 t80 -45.5 -56.19 10.29 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.674 0.75 . . . . 0.0 110.917 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.3 Cg_endo -69.7 -23.16 31.39 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.657 2.238 . . . . 0.0 112.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 198' ' ' ALA . 88.7 t -68.48 -45.2 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.95 -46.34 5.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.59 -48.57 71.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.918 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -49.95 -54.28 20.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.3 t -73.09 -14.21 61.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -92.41 -13.1 57.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.87 -51.04 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.936 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 29.0 mt -95.28 40.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -168.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -99.31 -37.68 3.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.59 47.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -165.05 25.09 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -96.45 98.09 2.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -179.23 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.01 65.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.88 -52.28 64.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.555 ' HA ' HD21 ' A' ' 221' ' ' LEU . 0.2 OUTLIER -51.54 -35.66 41.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.16 -44.63 59.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -55.47 -51.65 66.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 218' ' ' ASN . 1.2 pp -66.71 -48.87 67.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 221' ' ' LEU . 28.8 mt -54.38 -44.49 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -65.82 -52.98 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -56.85 -39.24 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.07 -49.15 71.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.23 -55.09 37.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -63.26 -32.66 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -60.91 -55.67 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 233' ' ' LEU . 21.5 t -72.09 -24.94 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -77.87 0.91 22.15 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 126.729 3.157 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -135.16 -63.75 0.67 Allowed 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 117.144 -3.473 . . . . 0.0 112.756 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.8 mm -51.0 -63.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.173 -1.831 . . . . 0.0 111.142 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -51.41 -34.23 33.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 193' ' ' ILE . 6.1 t80 -56.51 -56.74 17.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -64.72 -42.6 97.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.3 tt -52.53 -49.77 64.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.3 mm -69.28 -36.18 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.703 HD12 ' HA2' ' A' ' 235' ' ' GLY . 20.1 mt -52.9 -57.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.816 ' HB3' HD21 ' A' ' 62' ' ' LEU . 16.5 p-90 -74.02 -29.51 61.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -54.51 -55.99 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 242' ' ' ALA . 8.9 p -77.41 -42.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB1' ' CG ' ' A' ' 58' ' ' TRP . . . -57.35 -52.72 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 54' ' ' VAL . 97.2 t -67.84 -44.71 85.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -57.67 -44.82 86.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.11 -27.66 54.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.7 t -50.85 -34.45 27.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.5 t 51.7 30.43 6.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -146.07 175.59 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -142.63 160.36 54.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.594 0.711 . . . . 0.0 111.11 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.7 Cg_endo -69.76 154.45 67.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 112.14 41.57 1.06 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.509 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.544 H163 ' HB3' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.76 176.46 22.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.05 163.13 9.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.527 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -177.39 40.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.73 140.83 56.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -135.36 167.73 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.35 -177.21 3.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.18 -55.56 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.9 m -53.11 -42.87 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.72 -53.79 47.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' CG ' HD13 ' A' ' 217' ' ' LEU . 2.9 m-85 -62.04 -48.88 78.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 m -49.85 -48.96 50.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.47 -51.53 47.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.9 t -51.12 -56.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.8 t -57.05 -48.68 77.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -51.76 -42.18 62.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -39.74 78.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -65.24 -44.54 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 ' NH1' ' A' ' 80' ' ' ARG . 12.6 p -70.47 -33.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.0 m -69.72 -51.87 30.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.29 -48.36 80.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -60.4 -51.27 70.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 73' ' ' PHE . 2.3 tm? -55.69 -43.22 76.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.35 -57.9 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.82 62.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.5 p -68.83 -34.69 75.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.8 m -67.15 -52.74 37.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.6 m -62.09 -42.05 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.425 ' N ' HG23 ' A' ' 45' ' ' VAL . 12.2 t80 -68.22 -52.73 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.79 -31.7 68.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -77.62 -51.48 10.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 45' ' ' VAL . 77.0 t -62.01 -44.16 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.585 ' O ' HG13 ' A' ' 54' ' ' VAL . 23.5 tt0 -79.89 -4.58 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' ' CH2' ' A' ' 239' ' ' TRP . 1.2 tmt_? -55.29 -26.05 37.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.91 -3.31 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -106.02 42.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.958 HG11 HD21 ' A' ' 62' ' ' LEU . 9.5 m -112.47 -170.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -84.58 156.22 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.35 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -20.55 56.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -96.18 3.96 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.38 -51.85 50.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.6 p -78.47 -33.15 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -54.8 -42.94 72.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.958 HD21 HG11 ' A' ' 54' ' ' VAL . 7.0 mp -65.8 -29.0 69.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.5 m -71.23 -53.62 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 68' ' ' VAL . 16.9 m -70.64 -49.37 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.5 t -67.86 -37.97 82.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 -34.35 63.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.57 -50.06 48.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.1 p -67.61 -45.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.471 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.4 m -69.52 -34.3 74.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.67 -45.73 74.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.88 -48.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.32 -39.59 91.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.743 ' CE1' HD11 ' A' ' 232' ' ' ILE . 5.9 t80 -62.77 -54.62 36.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.05 -50.52 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -57.32 -49.61 75.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -45.85 91.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.9 ttp -53.57 -47.06 70.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.459 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -70.78 -30.72 67.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.8 mmt -66.84 -58.15 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.69 -49.61 75.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.2 t -66.9 -32.26 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 111.119 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -62.23 -51.0 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.02 -25.59 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.4 -48.79 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 t -121.84 -39.34 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.14 18.6 3.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 127.01 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.823 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.53 160.9 37.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 0.0 110.866 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 97.82 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.736 2.291 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.5 t -69.51 -25.38 64.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 96' ' ' ILE . 7.2 p -67.76 -37.05 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -70.14 -53.15 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.29 73.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -67.73 -55.92 11.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 92' ' ' VAL . 21.2 pt -65.55 -30.91 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -66.33 -48.07 71.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 102' ' ' VAL . 16.6 t90 -61.32 -41.47 97.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD13 ' HE2' ' A' ' 134' ' ' MET . 24.6 tp -76.81 -21.23 55.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.588 ' O ' HD13 ' A' ' 104' ' ' LEU . 7.8 tt -94.1 -11.41 30.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.965 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 72' ' ' ALA . 62.2 p -109.55 -38.93 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' ILE . 2.1 t -47.96 -58.47 7.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.23 36.42 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 100' ' ' LEU . 4.9 mp -78.24 -52.77 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HA ' HG11 ' A' ' 68' ' ' VAL . 1.1 pp -65.3 -51.81 58.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt -55.52 -39.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.431 ' N ' HG23 ' A' ' 106' ' ' ILE . 41.4 t -67.53 -50.49 58.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.37 -57.98 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -52.52 -52.25 55.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.68 -30.85 71.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.42 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.54 -35.65 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.615 HD21 HG13 ' A' ' 182' ' ' VAL . 3.4 tm? -70.48 -35.94 73.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.5 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -74.84 -21.65 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.2 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.74 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -64.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 176.47 -66.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.449 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 m -116.85 166.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -118.15 96.99 5.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 -11.51 84.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -25.34 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.98 -42.57 49.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.61 -43.32 59.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 166' ' ' LEU . 11.2 mttt -59.47 -51.7 68.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -66.09 -37.21 85.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.86 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.85 -58.2 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 162' ' ' MET . 93.9 t -51.84 -51.79 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.39 97.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.3 m -63.9 -40.36 96.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -55.69 12.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.08 -35.76 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.542 ' HE2' HD13 ' A' ' 99' ' ' LEU . 6.4 tmm? -70.75 -43.13 69.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -59.9 -52.84 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.601 ' N ' HD23 ' A' ' 135' ' ' LEU . 43.4 t -61.59 -50.95 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' HE2' H192 ' A' ' 301' ' ' RET . 3.4 m-85 -54.07 -38.89 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.17 -52.52 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -51.87 -57.71 8.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.9 mtt -71.56 -31.37 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -63.17 -28.49 72.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.54 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 141' ' ' GLY . 10.4 tt0 -34.54 -55.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.49 -30.97 6.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 -4.03 20.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 pt -108.92 3.51 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.518 ' HE3' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -107.1 132.48 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 46.72 47.66 14.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.6 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.081 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.603 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.0 t-105 -57.98 -54.23 57.66 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.729 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -17.34 37.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.96 -33.49 68.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -63.9 -36.65 84.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 150' ' ' PRO . 12.0 mt -62.27 -53.49 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.21 -48.91 13.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.08 -49.63 73.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.97 -49.4 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.88 -35.54 81.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.596 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.7 t90 -67.73 -57.31 6.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' CE3' ' A' ' 159' ' ' TRP . 76.5 t -55.73 -44.59 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.27 -47.07 85.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.791 ' HG3' HG22 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.45 -58.34 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.2 mp -64.82 -31.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -58.63 -49.39 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.31 -40.59 64.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 125' ' ' LYS . 7.5 tt -71.57 -13.91 61.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 -23.78 53.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.87 18.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.39 -162.25 0.26 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.488 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -22.93 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.913 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -65.86 -45.95 85.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.43 -60.0 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.97 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 p -65.36 -25.88 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -64.57 -14.31 57.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.107 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 32.0 t -56.85 -21.68 31.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -142.6 -40.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.6 p -71.28 -9.39 58.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.569 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -121.7 -166.0 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.075 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.11 164.31 22.01 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -27.68 26.25 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.323 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.49 -40.9 48.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.615 HG13 HD21 ' A' ' 113' ' ' LEU . 38.9 t -65.57 -45.88 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.89 -35.37 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 m -69.86 -45.59 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -66.81 -52.13 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.52 -41.23 84.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 p -64.03 -44.92 91.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.745 ' CE ' HD11 ' A' ' 193' ' ' ILE . 3.6 tpt -59.35 -52.8 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 ttp -61.3 -35.91 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.69 -40.38 92.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.757 HD11 ' CG2' ' A' ' 237' ' ' ILE . 10.9 mt -66.5 -53.68 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.745 HD11 ' CE ' ' A' ' 189' ' ' MET . 67.1 mt -56.1 -46.44 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.27 -48.7 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.87 -58.96 5.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.437 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.43 -57.68 18.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -53.27 -31.37 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.677 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.41 -29.15 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.437 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.2 mt -76.53 -31.09 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.6 t80 -47.38 -57.36 9.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.648 0.737 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.81 -20.87 34.03 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 0.0 112.38 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 198' ' ' ALA . 53.0 t -72.1 -44.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.7 -33.01 28.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.711 ' HA ' HD13 ' A' ' 222' ' ' ILE . 0.1 OUTLIER -52.02 -32.83 35.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 2.0 t80 -49.22 -30.9 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 203' ' ' GLY . 13.1 t -51.54 -28.53 13.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -144.34 14.69 2.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -68.48 -42.48 78.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.941 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.8 mt -127.18 11.95 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 60.2 mtm -129.63 -173.07 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.29 34.33 40.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.0 t70 62.04 43.82 8.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.35 -21.42 44.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.18 166.15 12.07 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -119.04 146.42 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.08 -40.29 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.545 HD13 ' CG ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -64.46 -51.83 61.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.432 ' N ' HD12 ' A' ' 217' ' ' LEU . 20.9 m-20 -60.19 -40.03 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 220' ' ' ASN . 3.3 tt -61.49 -56.97 14.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.564 ' N ' HD23 ' A' ' 219' ' ' LEU . 7.1 t-20 -57.47 -36.18 71.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.75 -58.93 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 204' ' ' TYR . 10.8 mt -54.02 -48.87 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.173 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.01 -37.76 88.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.78 -39.25 80.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.61 -52.8 55.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.61 -40.66 97.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 232' ' ' ILE . 42.4 t80 -57.74 -52.68 64.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.1 m -72.12 -24.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.28 0.64 13.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 126.696 3.141 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -134.32 -45.29 0.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 O-C-N 117.093 -3.504 . . . . 0.0 112.756 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.743 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.7 mp -75.65 -65.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.135 174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.06 -37.15 32.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 192' ' ' ILE . 1.9 t80 -54.07 -56.36 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 -35.15 86.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -49.09 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.757 ' CG2' HD11 ' A' ' 192' ' ' ILE . 1.3 mm -65.91 -45.89 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.32 -30.98 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.557 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.8 m0 -74.75 -42.82 57.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -42.4 95.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 242' ' ' ALA . 10.2 p -70.27 -40.14 77.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -71.74 -52.35 18.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 54' ' ' VAL . 71.6 t -57.48 -46.77 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -65.25 -50.77 64.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.88 -31.4 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.9 t -58.5 -48.54 80.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.5 t 62.13 63.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -130.32 43.11 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -146.09 71.79 13.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.594 0.711 . . . . 0.0 111.077 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -17.23 37.52 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.348 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -132.4 -46.12 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.515 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.518 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 mmm . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.63 -166.44 37.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.81 -132.06 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.77 78.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.38 94.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.48 168.32 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.13 -177.12 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.601 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -58.47 -72.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.13 -32.64 36.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.3 -62.15 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -58.18 -48.23 80.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.951 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -52.81 -45.9 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.77 -51.47 19.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 27' ' ' ASP . 89.0 t -52.7 -51.51 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.338 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 36' ' ' VAL . 26.0 t -64.76 -49.31 71.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -53.25 -47.63 68.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -47.48 80.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -40.6 88.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 32' ' ' SER . 86.0 t -67.99 -39.37 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.7 m -65.0 -53.01 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.71 85.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.75 -55.68 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' C ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.42 -33.45 69.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 45' ' ' VAL . 48.5 tp -68.92 -54.04 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.94 68.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' HD12 ' A' ' 232' ' ' ILE . 71.5 m -72.41 -52.31 16.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 t -66.21 -37.04 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 41' ' ' LEU . 60.3 t -66.7 -50.6 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.84 -43.85 78.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -64.51 -31.64 72.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.22 -52.09 13.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' VAL . 57.3 t -65.92 -39.64 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 54' ' ' VAL . 69.0 mt-10 -79.8 -7.54 58.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -55.64 -26.66 45.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -104.56 -9.36 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -96.15 30.72 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.826 HG11 HD22 ' A' ' 62' ' ' LEU . 4.6 m -110.09 -170.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -76.32 159.86 30.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.02 -55.21 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -21.82 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -88.5 -4.33 58.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -51.15 -49.68 60.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -42.99 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -52.46 -47.3 66.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG11 ' A' ' 54' ' ' VAL . 8.4 tp -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.5 m -70.56 -53.54 15.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' VAL . 26.3 m -72.03 -46.88 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.3 t -68.77 -39.28 80.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.77 -37.65 66.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.99 -48.08 66.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 101' ' ' THR . 72.9 t -64.74 -51.61 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.56 -48.79 64.68 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mt -64.71 -50.14 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.533 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -60.33 -36.87 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.782 ' CE2' HD11 ' A' ' 232' ' ' ILE . 18.7 t80 -60.84 -56.15 24.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.72 -45.92 77.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -57.77 -44.89 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.34 -54.77 41.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.872 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -50.2 30.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.551 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.19 -27.14 64.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.2 tpt -67.58 -58.67 4.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -36.79 81.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.82 -45.09 93.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.1 t -69.1 -36.2 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CZ3' HG23 ' A' ' 91' ' ' THR . 2.7 t-105 -65.51 -46.52 79.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -26.12 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -47.92 -48.03 32.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 p -115.37 -39.65 3.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -21.85 4.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.21 134.84 45.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.05 160.93 38.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.879 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.88 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.473 HG23 ' CZ3' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -58.27 -26.14 62.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 96' ' ' ILE . 41.2 t -49.44 -36.82 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -67.38 -51.77 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -62.57 -55.29 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -52.33 -49.15 64.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.63 HD12 HG12 ' A' ' 92' ' ' VAL . 64.6 mt -65.97 -35.05 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.96 -64.48 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.759 ' CH2' H202 ' A' ' 301' ' ' RET . 10.5 t-105 -51.83 -37.58 52.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.962 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tp -75.63 -27.41 58.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -87.67 -10.89 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.669 HG23 HG12 ' A' ' 68' ' ' VAL . 6.3 m -106.17 -25.55 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.699 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.3 t -56.05 -59.5 11.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.721 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.81 -39.68 6.13 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.319 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.95 -53.37 55.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD11 ' CE2' ' A' ' 234' ' ' PHE . 1.7 tm? -62.03 -48.72 79.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 110' ' ' TYR . 68.8 mt -61.82 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 123' ' ' LEU . 49.2 t -53.65 -53.48 51.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -53.49 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -49.7 -51.06 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.443 ' CE2' HG23 ' A' ' 106' ' ' ILE . 7.9 m-30 -58.89 -33.53 70.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.88 -66.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 61' ' ' SER . 48.7 mm -54.81 -36.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 113' ' ' LEU . 3.2 tm? -70.7 -33.37 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -77.04 -24.06 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.82 -23.01 16.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -84.3 -65.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.2 m -64.34 -74.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -170.76 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 5.6 m -153.12 131.26 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.85 99.91 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.98 -6.82 83.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.3 m -51.0 -25.64 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 0.4 OUTLIER -51.39 -45.35 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -48.76 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.2 mttt -58.42 -50.49 73.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.0 -36.63 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.492 ' C ' HD13 ' A' ' 127' ' ' LEU . 3.1 tm? -64.87 -46.87 79.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mt -65.4 -58.08 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.737 ' CG1' ' HB1' ' A' ' 158' ' ' ALA . 61.6 t -55.53 -51.16 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.73 -51.31 57.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.0 t -53.41 -47.48 69.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -52.23 66.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 129' ' ' VAL . 44.5 t -53.08 -45.46 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.699 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 mtt -68.4 -34.98 77.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -60.44 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.6 t -70.81 -52.72 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -53.58 -41.5 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.07 25.63 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.6 -55.92 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 mmt -65.44 -50.78 64.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.897 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.26 -31.2 59.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.23 -27.88 10.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 1.119 ' HB1' HD12 ' A' ' 145' ' ' ILE . . . -92.51 -27.52 17.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.91 11.71 55.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 1.119 HD12 ' HB1' ' A' ' 143' ' ' ALA . 5.2 mt -89.33 -54.81 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.148 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -136.86 141.39 42.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.02 -25.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -58.78 -36.64 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.499 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -68.92 -60.05 4.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.565 0.698 . . . . 0.0 110.916 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.757 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.345 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.7 -50.86 69.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -77.49 -30.14 52.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.9 mt -63.7 -62.86 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.78 -37.04 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.82 -43.61 91.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.0 t -63.55 -46.97 83.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.838 0.352 . . . . 0.0 110.834 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -49.84 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.737 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -65.98 -31.26 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.26 -55.96 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 159' ' ' TRP . 84.8 t -60.77 -43.56 95.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.16 -43.19 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -52.4 61.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.69 HG22 ' CE3' ' A' ' 167' ' ' TRP . 53.7 mt -63.93 -49.6 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -48.74 -38.67 22.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.02 -48.66 28.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.27 -10.69 59.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.69 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -71.24 -15.68 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.47 17.4 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -79.96 -165.53 31.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 4.9 mm-40 -84.93 -5.48 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -69.4 -55.26 10.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.463 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.29 -33.6 75.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.557 ' O ' HG22 ' A' ' 177' ' ' THR . 54.7 p -78.12 -25.25 47.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.643 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -52.64 -23.71 7.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 16.0 p -59.64 -18.71 43.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.73 -40.29 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 173' ' ' SER . 11.5 t -89.89 13.43 14.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.188 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.643 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -152.51 -166.39 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.2 163.56 31.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -25.96 28.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.02 -46.02 31.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.435 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.1 t -62.33 -47.82 91.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -36.61 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -68.21 -45.22 73.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.85 87.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -68.28 -49.45 60.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -37.31 78.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.499 HG21 HG21 ' A' ' 241' ' ' VAL . 3.1 p -72.03 -39.68 68.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -62.25 -52.96 61.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -66.22 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -60.18 -50.25 74.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -33.81 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 189' ' ' MET . 1.2 mp -64.69 -43.94 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 163' ' ' ILE . 80.7 mt -69.71 -51.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.66 -55.72 17.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -61.58 -57.34 18.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.521 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TRP . . . . . 0.451 ' CD1' H191 ' A' ' 301' ' ' RET . 25.6 m0 -53.12 -31.95 44.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.44 -28.21 52.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 14.2 mt -75.03 -30.42 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -44.74 -58.0 6.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.733 0.777 . . . . 0.0 110.949 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.72 -20.58 34.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 198' ' ' ALA . 93.1 t -71.52 -44.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.49 -34.59 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.62 -57.09 12.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.407 ' HA ' HD23 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -61.76 -30.93 71.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -50.84 -26.82 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.54 -42.55 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.776 ' CE2' HD21 ' A' ' 219' ' ' LEU . 0.2 OUTLIER -66.12 -22.33 66.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.393 . . . . 0.0 110.936 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.506 HD22 ' C ' ' A' ' 208' ' ' TYR . 4.5 mm? -120.24 39.81 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.947 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -169.54 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -97.18 17.34 59.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -132.6 -59.14 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 -16.57 1.07 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 74.71 164.85 12.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.7 t -121.87 174.64 6.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.67 81.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.082 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 25' ' ' ALA . 1.1 pp -56.17 -51.54 67.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 217' ' ' LEU . 1.9 t30 -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.776 HD21 ' CE2' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -62.01 -56.24 21.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -51.0 71.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -50.72 -58.48 5.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.53 ' N ' HD13 ' A' ' 221' ' ' LEU . 90.4 mt -53.72 -43.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.1 -48.05 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -36.82 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -49.58 76.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 200' ' ' TYR . . . -64.08 -51.0 66.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.69 -30.46 70.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.71 -46.18 59.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 34.2 m -71.73 -23.33 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.426 ' HB3' H203 ' A' ' 301' ' ' RET . 57.5 m-20 -95.09 2.94 55.26 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-O 126.697 3.141 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -60.18 1.48 Allowed 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 117.131 -3.481 . . . . 0.0 112.74 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.782 HD11 ' CE2' ' A' ' 73' ' ' PHE . 18.7 mm -66.47 -64.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.138 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.2 OUTLIER -48.59 -32.94 8.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 238' ' ' ILE . 14.1 t80 -58.36 -55.54 33.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.08 -34.43 88.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -42.65 87.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.9 mm -66.72 -47.61 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 234' ' ' PHE . 84.3 mt -65.91 -40.82 88.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 23.8 t90 -70.5 -39.33 74.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -68.72 -47.08 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 188' ' ' THR . 9.2 p -67.05 -33.01 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -76.94 -51.44 11.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 54' ' ' VAL . 72.2 t -62.88 -34.06 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -76.22 -54.57 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.78 -38.78 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 81.5 p -55.1 -35.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.7 t -52.02 114.71 1.39 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -160.85 -68.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 250' ' ' PRO . . . -179.26 -61.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 249' ' ' ALA . 54.3 Cg_endo -69.75 158.4 57.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -98.31 -70.89 1.0 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.459 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.495 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.759 H202 ' CH2' ' A' ' 98' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.91 -150.94 6.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.75 -19.24 66.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.48 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.7 41.66 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.16 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.77 -172.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -179.04 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -77.13 -71.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -30.54 45.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.52 -70.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.455 ' HB3' HD21 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -51.83 -43.03 63.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 84' ' ' ILE . 18.8 m -60.42 -40.95 92.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.16 -54.22 21.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.82 -40.8 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 74.0 m -64.58 -49.73 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -55.19 -44.71 75.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -46.91 82.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -39.78 91.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -64.44 -48.75 83.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -57.71 -50.06 74.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.05 71.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -57.99 -52.07 67.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.486 HD13 ' HG3' ' A' ' 77' ' ' MET . 1.3 tt -52.3 -47.3 66.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.57 -49.9 75.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.12 75.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.4 t -69.35 -37.49 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -46.01 71.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.5 m -66.69 -41.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.0 m-85 -69.08 -51.54 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -61.86 -33.41 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.45 -47.61 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' VAL . 86.3 t -70.44 -29.77 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -73.93 -10.77 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -56.11 -26.81 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -12.73 17.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -106.24 42.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.6 p -127.7 160.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 12.7 t -49.98 148.67 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 -48.73 65.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -58.88 -23.03 60.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CE2' ' HB2' ' A' ' 242' ' ' ALA . 45.1 m95 -88.02 7.36 31.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -49.64 -50.08 44.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -36.36 58.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' HG21 ' A' ' 112' ' ' ILE . 8.1 t -52.6 -42.38 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.596 HD21 HG21 ' A' ' 54' ' ' VAL . 4.3 mm? -68.29 -28.98 67.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.7 m -72.45 -52.21 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 17.2 m -67.19 -50.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' HG23 ' A' ' 64' ' ' VAL . 36.5 m -69.16 -36.7 77.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.95 -41.43 93.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 71' ' ' ILE . 31.7 mt -70.84 -47.43 59.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.664 HG12 HG23 ' A' ' 101' ' ' THR . 61.1 t -65.8 -55.36 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.494 HG23 ' HD2' ' A' ' 231' ' ' LYS . 9.7 m -68.37 -26.82 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.173 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.88 -51.45 24.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 67' ' ' LEU . 17.6 pt -64.2 -39.64 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.734 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -71.19 -37.95 72.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 232' ' ' ILE . 8.8 t80 -61.0 -57.93 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -47.56 85.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -55.14 -47.51 74.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -48.94 79.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -50.55 -51.34 48.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.0 t80 -58.71 -53.38 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.2 mmt -54.71 -47.52 73.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -53.1 -56.07 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.5 -33.78 73.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 78' ' ' TYR . 98.2 t -67.56 -47.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.157 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -61.71 -45.07 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 29' ' ' THR . 10.6 tp -73.63 -25.19 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -48.25 33.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.4 p -136.61 -39.81 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.57 -15.37 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 127.02 53.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.46 160.79 52.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.75 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 90.09 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -69.42 -32.55 71.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' PHE . 12.3 m -50.93 -45.87 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -69.54 -46.78 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -47.12 77.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -65.41 -39.89 92.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.81 -57.52 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -33.18 69.87 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.495 ' CZ3' H202 ' A' ' 301' ' ' RET . 25.1 t-105 -60.09 -58.75 7.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.06 -13.11 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.584 ' O ' HD22 ' A' ' 104' ' ' LEU . 6.3 tt -91.6 -16.6 26.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.734 HG21 ' CB ' ' A' ' 72' ' ' ALA . 25.5 m -110.76 -31.5 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -51.16 -59.51 7.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.613 0.721 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.6 Cg_endo -69.79 -35.5 12.44 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 100' ' ' LEU . 8.9 mp -64.91 -38.95 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -48.69 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mm -64.9 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.1 t -64.31 -55.33 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.83 -58.47 6.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.661 ' CE1' HD12 ' A' ' 238' ' ' ILE . 79.8 t80 -50.02 -54.56 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.541 ' HD2' ' HG ' ' A' ' 122' ' ' SER . 6.1 m-85 -61.16 -31.07 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.25 -67.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 61' ' ' SER . 46.3 mm -50.86 -40.72 20.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.802 HD12 HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -68.81 -35.36 76.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -77.73 -14.91 59.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.79 -23.28 11.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.78 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -122.09 -6.57 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.33 51.93 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 119' ' ' VAL . 3.1 p 179.8 112.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.76 97.71 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.32 -5.73 87.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.541 ' HG ' ' HD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -53.18 -23.44 8.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.89 -42.86 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -73.14 -37.41 66.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.67 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -65.95 -53.25 41.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -34.15 77.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -47.09 74.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.41 -59.81 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 125' ' ' LYS . 8.1 p -58.92 -33.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.1 -47.75 57.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.3 m -65.35 -38.6 90.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.383 . . . . 0.0 110.844 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -52.15 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 129' ' ' VAL . 77.9 t -56.88 -51.81 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.7 ptm -62.98 -33.67 75.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.98 -56.2 21.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.886 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 135' ' ' LEU . 71.7 t -60.62 -53.16 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.22 -37.12 71.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.5 -52.27 40.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -48.71 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.5 ttp -62.74 -34.38 77.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.81 -30.98 55.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.55 -48.0 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.77 -26.68 8.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 52.81 26.38 25.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.88 -37.38 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 111.129 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.838 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -131.06 -170.73 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.838 ' HB2' ' HE2' ' A' ' 146' ' ' MET . . . 77.14 -4.97 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.93 -43.14 62.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.2 t-105 -64.52 -55.62 28.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.73 -19.01 36.84 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -50.79 -42.36 57.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -58.54 -39.42 80.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.37 -64.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 151' ' ' ALA . 9.3 pt -51.69 -41.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.87 -50.03 32.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -56.82 -55.95 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 110.911 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 mt -54.72 -48.13 72.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.9 91.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.098 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.579 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.2 t90 -67.02 -56.87 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.48 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.2 t -52.96 -45.79 52.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.159 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -62.97 -45.08 94.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -58.47 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.579 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.4 mp -66.99 -32.04 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -55.82 -54.54 43.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -42.57 63.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.49 -15.49 62.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.442 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -57.38 -22.58 43.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.37 19.09 19.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.48 -163.41 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.21 -22.72 42.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 110.898 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.09 76.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.457 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -53.32 56.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -26.32 48.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -68.19 -11.62 59.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.47 -29.49 70.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -139.03 9.45 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -126.88 2.45 6.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.541 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -128.21 -165.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 164.1 17.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -22.87 31.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.313 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 245' ' ' GLU . . . -76.54 -42.45 42.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.802 HG13 HD12 ' A' ' 113' ' ' LEU . 54.3 t -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.64 78.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 188' ' ' THR . 41.7 t -70.36 -46.87 63.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 241' ' ' VAL . . . -62.89 -40.02 96.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -66.92 -52.07 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.27 -54.88 40.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.564 ' OG1' HG21 ' A' ' 241' ' ' VAL . 63.9 p -58.83 -40.76 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.421 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -56.15 -52.87 62.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.82 -32.68 74.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.33 -49.27 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -35.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.131 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 194' ' ' ILE . 1.3 mp -63.76 -48.18 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 159' ' ' TRP . 97.0 mt -69.12 -50.74 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -51.51 -55.26 19.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.402 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -60.21 -59.57 10.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -53.35 -31.34 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.44 -27.28 46.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.7 mt -75.0 -32.05 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.4 t80 -47.89 -57.72 9.49 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.8 -26.49 27.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.364 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 198' ' ' ALA . 52.3 t -70.85 -37.62 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.49 -40.78 12.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.48 -33.13 43.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -27.28 10.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 203' ' ' GLY . 14.1 t -49.8 -27.96 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.449 ' CZ ' HD12 ' A' ' 209' ' ' LEU . 2.8 p90 -57.65 -32.86 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.449 HD12 ' CZ ' ' A' ' 208' ' ' TYR . 13.5 mt -129.58 15.63 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 20.4 ttp -83.11 81.87 8.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.01 -15.17 40.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.19 15.65 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -178.9 42.45 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -49.56 163.54 0.6 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.78 146.81 44.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.36 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.075 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 25' ' ' ALA . 10.2 tp -53.0 -61.85 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.93 -37.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.01 -42.4 94.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.493 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.5 t-20 -64.58 -46.76 81.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 221' ' ' LEU . 3.4 tm? -60.27 -57.79 11.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 35.3 mm -53.11 -48.01 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.24 -36.38 83.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -70.28 -42.45 72.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -51.46 68.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.97 -52.24 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -58.71 -37.6 76.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 232' ' ' ILE . 39.2 t80 -64.34 -58.22 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.5 m -61.08 -25.62 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.68 1.23 20.52 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 126.69 3.138 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HD2' HG23 ' A' ' 69' ' ' THR . 21.3 mmtm -130.0 -60.28 1.03 Allowed 'General case' 0 N--CA 1.423 -1.793 0 O-C-N 117.116 -3.49 . . . . 0.0 112.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -60.97 -63.71 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.104 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.74 -40.54 69.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -52.78 -58.77 5.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.02 91.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.75 -48.96 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 241' ' ' VAL . 43.3 mm -65.7 -49.64 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 109' ' ' PHE . 45.9 mm -57.7 -52.43 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.654 ' O ' HG23 ' A' ' 243' ' ' VAL . 7.9 t90 -57.91 -43.47 86.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -55.46 -42.9 74.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 237' ' ' ILE . 14.6 t -63.86 -49.54 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' A' ' 58' ' ' TRP . . . -56.62 -51.34 69.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' VAL . 8.1 t -67.96 -31.69 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -60.74 -53.62 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 181' ' ' ALA . 0.9 OUTLIER -71.51 -35.72 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -43.43 65.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.0 t 59.7 -174.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -57.02 134.42 55.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -152.74 160.51 31.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.4 Cg_endo -69.81 166.3 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.85 160.05 29.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.106 -0.83 . . . . 0.0 112.453 -179.901 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.538 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.799 0.333 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.04 -131.62 1.46 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.5 172.34 23.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.77 43.83 5.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -176.87 43.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.92 166.85 17.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.75 178.35 8.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -70.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -54.95 -42.17 72.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 t0 -51.91 -57.0 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -47.9 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.549 ' OG1' HD11 ' A' ' 217' ' ' LEU . 23.9 m -51.13 -47.42 62.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.163 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.51 36.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 27' ' ' ASP . 92.2 t -52.98 -56.22 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.147 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t -58.6 -48.82 79.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -51.95 -39.7 59.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.48 -41.05 69.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.22 -44.31 92.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -36.09 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.9 m -69.67 -53.4 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.86 -46.54 89.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.8 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.62 HD13 ' HE2' ' A' ' 73' ' ' PHE . 4.6 tp -55.97 -47.54 77.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.18 -54.41 47.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.79 71.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 m -72.13 -41.51 67.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -41.19 94.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 49' ' ' VAL . 27.2 m -72.01 -37.89 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.02 -53.26 52.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.98 -47.95 75.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.21 -48.25 68.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 45' ' ' VAL . 95.6 t -74.14 -29.76 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.761 ' O ' HG13 ' A' ' 54' ' ' VAL . 45.8 mm-40 -79.9 -7.12 58.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -27.09 29.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -113.49 -4.04 13.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -94.73 8.99 40.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.6 m -104.27 -171.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -77.87 158.36 29.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.76 -55.19 28.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.49 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 73.6 m95 -87.77 -14.03 40.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -51.36 -49.73 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -36.1 69.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.746 ' HB2' HG21 ' A' ' 112' ' ' ILE . 2.2 p -56.92 -45.31 82.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.836 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.42 -27.14 66.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -71.0 -53.49 14.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 68' ' ' VAL . 23.2 m -72.02 -47.27 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.511 ' N ' HG23 ' A' ' 64' ' ' VAL . 11.4 p -68.77 -38.68 80.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.3 -33.82 58.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.89 -46.65 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -69.98 -44.07 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.454 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.3 m -70.54 -34.04 71.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.83 37.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -36.83 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.43 62.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.62 ' HE2' HD13 ' A' ' 40' ' ' LEU . 4.1 t80 -61.99 -48.81 78.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -64.36 -51.87 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -57.05 -52.68 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.64 -65.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -51.43 -32.88 28.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -61.07 -67.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.44 ' HA ' HG12 ' A' ' 82' ' ' VAL . 2.5 mmt -67.86 -59.58 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -50.91 -40.21 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.17 -57.62 4.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 79' ' ' MET . 4.8 p -53.77 -35.6 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . 0.8 OUTLIER -76.33 -58.5 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 88' ' ' ASP . 2.5 tp -56.83 -24.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -54.59 -27.16 37.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 83' ' ' TRP . 10.1 t -107.95 -21.6 12.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.77 -109.56 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 11.8 p-10 -123.53 142.5 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.25 161.99 38.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.69 0.757 . . . . 0.0 110.859 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 93' ' ' PHE . 54.3 Cg_endo -69.72 136.54 33.36 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 0.0 112.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -69.9 -29.96 67.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 93' ' ' PHE . 6.7 m -58.78 -45.75 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 92' ' ' VAL . 43.4 m-85 -69.93 -53.36 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -56.02 -47.96 76.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 18.8 t80 -57.26 -55.3 36.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.5 mt -62.35 -29.88 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -61.37 -61.61 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 109.24 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.46 -31.27 71.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.43 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 0.7 OUTLIER -72.21 -22.72 61.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.929 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 104' ' ' LEU . 4.2 tt -101.26 -18.82 15.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.803 HG22 HD23 ' A' ' 105' ' ' LEU . 35.8 m -94.79 -33.04 13.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -57.78 -56.76 31.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.602 0.715 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.81 -26.23 27.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.4 mm? -75.54 -54.0 7.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 101' ' ' THR . 3.3 pp -65.04 -39.47 93.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.4 mm -65.94 -43.9 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.0 t -61.76 -52.75 62.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.67 54.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.82 -45.84 64.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.97 -44.91 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -50.29 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 61' ' ' SER . 40.8 mm -59.93 -59.44 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.73 -22.09 44.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.22 -44.47 46.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.29 -17.97 33.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 182' ' ' VAL . . . -74.48 -39.07 62.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 -67.63 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' OD1' HG22 ' A' ' 119' ' ' VAL . 7.7 t-20 -161.43 -75.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.528 HG22 ' OD1' ' A' ' 118' ' ' ASN . 6.3 m -151.77 135.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB1' ' OH ' ' A' ' 186' ' ' TYR . . . -103.69 100.05 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.52 -8.51 59.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -52.17 -25.44 9.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 110' ' ' TYR . 1.7 pt? -63.52 -34.64 78.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -47.02 81.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -69.0 -44.76 72.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -64.41 -37.3 87.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.65 -47.66 62.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.49 -58.8 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 162' ' ' MET . 92.6 t -58.0 -51.57 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.36 -43.1 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.7 t -66.88 -36.6 82.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 136' ' ' VAL . 4.5 mt -64.08 -54.3 36.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -60.12 -39.68 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -67.06 -45.87 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 HD13 ' A' ' 154' ' ' ILE . 95.5 t -60.7 -49.63 83.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.616 ' HB2' H162 ' A' ' 301' ' ' RET . 22.5 t80 -66.69 -33.17 75.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.17 -52.07 15.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -65.22 -52.18 56.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 mmt -66.0 -44.6 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.66 -32.56 84.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -46.82 -52.69 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 145' ' ' ILE . . . -111.89 16.33 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.44 50.16 42.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.511 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 143' ' ' ALA . 2.6 mt -83.46 -18.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.96 132.1 54.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.87 -162.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.681 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -77.99 -25.64 48.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.641 ' CH2' HD11 ' A' ' 209' ' ' LEU . 3.3 m95 -66.42 -53.64 29.21 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.79 -12.35 32.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.35 -47.09 29.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.32 -34.38 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.3 mt -58.95 -57.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.77 HD13 HG11 ' A' ' 136' ' ' VAL . 60.6 mt -65.61 -47.74 85.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.436 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -57.21 -42.75 93.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.482 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.56 -50.93 63.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -55.87 -48.62 75.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.88 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.535 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -60.09 -55.72 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.5 t -57.16 -48.92 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.11 -41.65 97.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.78 ' HB2' HG11 ' A' ' 129' ' ' VAL . 1.7 tmt? -55.89 -59.28 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.535 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.7 mp -66.18 -31.67 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.39 -52.57 64.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -73.72 -34.58 64.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.23 -18.94 62.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.404 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -65.66 -35.22 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.21 18.85 14.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.68 -156.87 0.14 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.99 -12.85 61.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.2 15.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -77.16 -38.1 52.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.5 t -58.69 -53.45 58.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 178' ' ' ALA . . . -75.39 -11.15 59.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 t -52.98 -20.24 3.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.31 -58.47 4.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 12.92 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 174' ' ' ALA . . . -57.5 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.22 163.21 24.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -18.37 36.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.58 -47.76 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.509 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 17.3 t -62.27 -47.06 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -34.33 73.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB3' HG21 ' A' ' 241' ' ' VAL . 1.3 m -70.26 -45.18 66.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.6 95.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' OH ' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -67.88 -48.85 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.67 -56.19 24.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -59.08 -40.46 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -58.74 -52.36 66.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.1 ttp -61.02 -36.66 80.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -48.32 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.833 HG23 HD13 ' A' ' 233' ' ' LEU . 46.9 mm -64.15 -44.99 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.454 HG21 ' HE1' ' A' ' 162' ' ' MET . 69.3 mt -55.28 -46.88 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HG12 ' A' ' 163' ' ' ILE . 92.6 mt -64.41 -49.7 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.17 -57.14 10.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -59.37 -58.83 12.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -52.7 -31.48 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.26 -30.05 54.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.466 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.3 mt -74.31 -31.03 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -45.87 -58.53 6.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.4 Cg_endo -69.74 -21.38 33.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.312 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.9 t -70.83 -44.67 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.81 -30.78 28.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -53.16 -57.96 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -31.05 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -51.74 -27.21 11.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.155 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.99 -7.04 5.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 17.7 t80 -101.86 -14.65 17.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.641 HD11 ' CH2' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -126.71 33.4 4.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.913 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.84 -170.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.46 51.74 0.85 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.14 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.26 48.85 3.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.456 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -109.37 50.82 0.75 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.493 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 159.41 26.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.36 67.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.549 HD11 ' OG1' ' A' ' 29' ' ' THR . 0.2 OUTLIER -58.15 -62.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -51.96 -36.42 49.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.76 -52.09 65.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.84 -42.01 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.514 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.4 tm? -62.29 -55.46 27.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 221' ' ' LEU . 84.4 mt -60.46 -48.76 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.15 -57.89 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -40.54 74.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -50.4 71.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.22 -54.83 38.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.55 -35.95 82.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -61.79 -53.08 60.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 233' ' ' LEU . 8.6 p -71.9 -24.83 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -24.55 63.91 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 126.68 3.133 . . . . 0.0 110.83 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 1.6 mttm -112.91 -10.16 13.56 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 117.117 -3.489 . . . . 0.0 112.789 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.3 mm -91.97 -61.57 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.147 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.833 HD13 HG23 ' A' ' 192' ' ' ILE . 0.7 OUTLIER -50.52 -35.49 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -54.72 -57.59 10.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.56 -42.76 87.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HE1' ' A' ' 239' ' ' TRP . 12.4 tp -51.76 -50.98 59.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 241' ' ' VAL . 3.2 mm -68.54 -37.01 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.452 HG23 ' CZ3' ' A' ' 58' ' ' TRP . 4.0 mm -52.22 -57.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.502 ' HE1' HD12 ' A' ' 236' ' ' LEU . 16.0 p-90 -74.09 -29.39 61.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -53.74 -56.77 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.7 p -77.61 -43.62 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -55.87 -51.45 67.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.786 HG22 ' HA ' ' A' ' 54' ' ' VAL . 99.2 t -70.28 -41.93 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -54.06 -51.17 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -29.58 54.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.4 t -51.13 -30.84 17.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.48 -75.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -175.91 89.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -58.42 160.44 9.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.563 0.697 . . . . 0.0 111.128 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.6 Cg_endo -69.82 -47.89 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 172.17 -81.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.501 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.616 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.32 -166.25 12.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.05 173.39 21.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.49 162.54 36.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.483 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.12 118.54 4.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mt -140.85 164.63 29.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.24 164.01 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 217' ' ' LEU . . . -76.69 -65.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -52.46 -44.53 65.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -56.22 -61.58 2.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -51.94 -42.81 63.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.1 m -60.65 -41.29 94.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.58 -54.19 24.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.16 -40.24 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 76.9 p -64.8 -49.59 70.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -56.16 -44.26 79.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.56 -47.8 80.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.23 -40.82 91.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -63.47 -49.12 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 m -57.75 -47.08 83.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.33 78.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.13 -47.85 80.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.094 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.58 HD21 ' NE1' ' A' ' 74' ' ' TRP . 14.4 tp -60.78 -39.09 87.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.96 -56.83 15.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.52 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -69.7 -33.1 72.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.559 HG21 ' HH2' ' A' ' 74' ' ' TRP . 95.0 m -72.67 -45.68 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.3 p -65.37 -43.18 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -68.23 -49.11 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.859 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -63.71 -32.03 73.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -75.35 -52.3 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 45' ' ' VAL . 85.8 t -64.77 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.06 -0.62 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -74.04 -26.51 60.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.79 -19.3 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 22.52 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.123 HG21 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -94.75 174.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -53.63 150.44 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.86 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -79.17 -26.56 42.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HH2' ' HB1' ' A' ' 185' ' ' ALA . 59.4 m95 -87.13 -6.23 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -51.58 -50.46 60.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 64' ' ' VAL . 17.7 p -77.83 -35.68 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -59.43 -42.48 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.123 HD13 HG21 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -65.1 -30.21 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -55.65 5.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 68' ' ' VAL . 13.9 m -57.79 -51.8 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.534 ' N ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -70.77 -47.89 57.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.63 92.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.86 -47.18 60.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' VAL . 56.8 t -58.53 -56.43 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -63.55 -39.31 94.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.65 -68.95 1.46 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.442 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -50.12 -33.97 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 111.127 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 101' ' ' THR . . . -63.97 -52.43 59.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 40' ' ' LEU . 46.9 t80 -58.81 -48.77 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.58 ' NE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -62.1 -50.57 71.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -55.8 -60.88 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -54.2 -58.77 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.9 -33.35 36.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.3 m-85 -65.58 -69.15 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.71 -57.37 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -55.31 -52.22 64.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.471 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -59.57 -47.6 90.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.458 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 78' ' ' TYR . 27.1 t -61.37 -46.65 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -56.48 11.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 87' ' ' GLY . 6.8 tp -58.81 -26.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -21.65 47.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 p -114.2 -30.62 6.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 84' ' ' ILE . . . -164.46 -110.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -98.56 -176.08 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.769 0.319 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -115.78 155.68 47.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.679 0.752 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 121.51 8.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -69.69 -35.87 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 93' ' ' PHE . 7.3 p -66.99 -44.71 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.149 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.463 ' N ' HG13 ' A' ' 92' ' ' VAL . 4.7 m-85 -71.39 -44.27 65.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -64.45 -48.16 76.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -59.86 -52.78 63.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 92' ' ' VAL . 63.7 mt -65.96 -30.01 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 101' ' ' THR . 2.9 t70 -61.66 -57.44 11.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 109.297 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.428 ' HA ' ' HG1' ' A' ' 101' ' ' THR . 27.1 m0 -69.82 -30.67 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.878 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -75.12 -19.39 59.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -101.01 -31.73 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.538 HG21 ' HB1' ' A' ' 72' ' ' ALA . 55.8 p -79.83 -39.62 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.549 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -50.83 -56.61 18.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.79 -38.48 7.67 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.315 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.5 -51.99 67.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.4 tm? -67.11 -41.99 85.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.657 HG23 ' HA ' ' A' ' 123' ' ' LEU . 49.8 mt -59.93 -48.62 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.099 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.511 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.3 t -62.22 -57.53 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -52.07 -40.54 61.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -66.37 -50.18 64.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -35.38 65.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.58 -61.19 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.9 pt -55.68 -36.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 120' ' ' ALA . 1.4 tm? -71.78 -50.8 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.61 67.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.05 -11.11 60.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.119 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 182' ' ' VAL . . . -92.1 -29.67 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 -67.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -174.84 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 m -151.54 142.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 113' ' ' LEU . . . -126.37 108.14 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.81 -5.49 69.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -50.22 -27.98 6.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.903 0.382 . . . . 0.0 110.811 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -64.62 -41.0 96.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.625 ' N ' HD23 ' A' ' 123' ' ' LEU . 2.4 t80 -58.83 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.645 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -63.16 -48.31 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -60.28 -34.99 74.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 tp -68.33 -48.8 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.92 -56.73 18.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 133' ' ' VAL . 7.4 p -58.96 -43.1 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.445 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -58.04 -41.27 94.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.446 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 134' ' ' MET . 0.1 OUTLIER -71.07 -35.16 71.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -53.84 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 129' ' ' VAL . 26.5 m -58.16 -43.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.44 ' N ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -71.77 -28.99 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -66.11 -50.33 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.686 HG13 HD23 ' A' ' 135' ' ' LEU . 30.7 m -70.3 -41.22 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.774 ' HB2' H173 ' A' ' 301' ' ' RET . 35.4 t80 -61.92 -38.92 90.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 -50.5 9.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -63.24 -50.53 69.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.548 ' HB3' ' HE2' ' A' ' 146' ' ' MET . 14.1 mmt -65.49 -52.68 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.77 -32.61 74.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.72 -30.21 13.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 145' ' ' ILE . . . -112.53 -27.28 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.76 9.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 143' ' ' ALA . 1.3 pp -103.92 8.82 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.548 ' HE2' ' HB3' ' A' ' 140' ' ' MET . 0.1 OUTLIER -100.63 -169.29 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.32 107.59 18.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 208' ' ' TYR . . . -74.33 -22.55 59.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.3 t-105 -52.85 -57.8 14.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.59 0.71 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.0 Cg_endo -69.76 -19.24 36.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.329 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.22 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.26 -40.88 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mt -60.67 -41.59 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.8 mt -59.12 -57.17 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.636 ' HA3' H182 ' A' ' 301' ' ' RET . . . -66.27 -39.55 94.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 39.0 t -63.39 -57.36 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 153' ' ' ILE . 35.2 mt -53.52 -50.5 65.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.35 77.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.581 ' HE1' HG23 ' A' ' 194' ' ' ILE . 0.4 OUTLIER -64.53 -55.25 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG23 ' CE3' ' A' ' 159' ' ' TRP . 89.3 t -55.66 -51.61 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -35.59 75.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.6 mmt -61.62 -59.86 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.8 mp -58.39 -36.4 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.34 -36.37 82.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.05 -38.82 61.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -84.11 -11.14 57.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.483 ' CE3' HG22 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -56.33 -25.41 48.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.38 18.35 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.88 -130.39 1.51 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 0.5 OUTLIER -84.66 -12.69 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.933 0.397 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.01 -77.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -68.43 -25.03 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.885 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -70.89 -25.86 62.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 178' ' ' ALA . . . -65.19 -14.48 60.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.088 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 10.34 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -94.34 -76.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 t -120.14 -14.6 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 174' ' ' ALA . . . -61.19 -166.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.115 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.2 164.02 15.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 0.0 110.857 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.58 33.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.56 -44.48 34.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.067 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.967 HG22 ' HB1' ' A' ' 116' ' ' ALA . 16.9 t -62.52 -48.05 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLN . . . . . 0.431 ' HG2' ' HB3' ' A' ' 174' ' ' ALA . 6.3 tm0? -58.13 -36.99 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.2 m -68.2 -45.21 74.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.855 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.42 ' HB1' ' HH2' ' A' ' 58' ' ' TRP . . . -61.55 -39.43 91.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.68 -51.8 52.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -45.2 75.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.9 p -66.22 -38.24 87.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.827 ' HG2' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -59.2 -50.5 73.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.03 -34.48 76.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -59.54 -49.54 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 234' ' ' PHE . 22.0 pt -70.53 -36.72 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.413 HD11 ' HE2' ' A' ' 234' ' ' PHE . 13.6 mm -63.0 -48.77 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.581 HG23 ' HE1' ' A' ' 159' ' ' TRP . 55.7 mt -67.06 -51.91 49.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.1 -56.08 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.93 -58.48 14.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -54.21 -31.88 54.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.18 -24.64 43.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -78.93 -31.96 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.9 t80 -48.16 -55.42 18.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.71 -24.92 29.38 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.9 t -67.26 -43.18 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.634 ' O ' HG22 ' A' ' 206' ' ' THR . . . -84.07 -27.74 36.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -46.07 65.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.899 0.38 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.408 ' HB2' HD23 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -69.01 -31.39 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -53.68 -23.0 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -118.86 -26.35 2.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 148' ' ' ALA . 29.1 t80 -76.4 -50.56 13.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 205' ' ' PHE . 4.1 mm? -71.46 -23.59 61.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.2 tpp -75.8 -169.44 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.28 6.63 81.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -24.03 35.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.83 64.59 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 52.14 73.89 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 171.84 13.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -39.02 57.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.555 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 81.3 mt -61.39 -62.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -53.35 -42.51 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -53.64 54.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.4 ' HB2' HG12 ' A' ' 84' ' ' ILE . 2.4 t30 -58.18 -42.31 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.37 -58.82 6.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.629 HD12 ' HA3' ' A' ' 203' ' ' GLY . 47.4 mm -59.26 -47.92 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -58.07 -39.64 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 36' ' ' VAL . 1.8 t-20 -70.5 -46.24 64.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -51.27 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.59 -50.85 70.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.3 -28.08 69.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.66 -48.96 19.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.34 -23.15 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.444 ' HB3' H203 ' A' ' 301' ' ' RET . 5.4 m-20 -90.9 3.11 55.44 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-O 126.72 3.152 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -129.96 -64.88 0.85 Allowed 'General case' 0 N--CA 1.424 -1.769 0 O-C-N 117.128 -3.483 . . . . 0.0 112.782 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 73' ' ' PHE . 42.8 mm -55.86 -62.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.136 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -32.65 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.713 ' HA ' HD12 ' A' ' 192' ' ' ILE . 3.3 t80 -52.68 -55.77 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.81 -36.13 58.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -51.54 69.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.329 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 241' ' ' VAL . 1.1 mm -68.85 -49.6 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.827 HD11 ' HG2' ' A' ' 189' ' ' MET . 21.5 mm -56.87 -32.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.695 ' O ' HG23 ' A' ' 243' ' ' VAL . 20.1 t90 -76.01 -47.52 24.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -57.19 -40.84 78.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 237' ' ' ILE . 9.4 p -74.21 -40.47 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.98 -37.7 86.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 54' ' ' VAL . 43.7 t -78.54 -48.19 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -60.11 -37.56 80.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -76.95 -45.99 25.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 20.7 t -55.64 -72.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.5 t 58.39 44.45 18.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -158.42 94.67 1.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -87.54 160.39 47.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.521 0.677 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.578 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.6 Cg_endo -69.74 -43.93 2.38 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.677 2.251 . . . . 0.0 112.363 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 136.71 38.64 0.15 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.482 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.774 H173 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.778 0.323 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.88 81.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.05 -114.07 4.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.449 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.07 -149.15 38.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -86.9 131.24 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.49 124.51 51.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.55 175.53 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -52.2 -75.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -34.38 64.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -55.41 -64.11 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -59.66 -48.11 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 84' ' ' ILE . 96.6 m -51.58 -43.78 62.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.64 -50.47 30.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 27' ' ' ASP . 91.8 t -52.04 -51.14 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -64.74 -49.88 69.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -53.28 -47.04 69.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -48.02 75.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.59 -41.86 86.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 32' ' ' SER . 84.2 t -65.75 -43.94 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 m -60.67 -53.28 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.79 74.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.84 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 tp -53.03 -45.16 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 45' ' ' VAL . 18.7 tp -64.1 -54.12 38.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.84 73.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -70.38 -34.54 72.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.6 m -72.76 -49.29 31.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 41' ' ' LEU . 29.9 m -65.88 -39.53 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -69.46 -52.12 29.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.59 -31.79 72.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -74.62 -52.16 12.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.3 t -64.92 -38.81 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.72 -6.33 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -55.11 -26.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -99.99 -12.84 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 40.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.077 HG21 HD21 ' A' ' 62' ' ' LEU . 9.6 p -116.48 160.42 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.434 ' N ' HG22 ' A' ' 54' ' ' VAL . 1.6 t -47.79 152.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 -54.52 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -20.51 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.88 7.84 25.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -50.27 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -37.47 55.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.572 ' CB ' HD12 ' A' ' 112' ' ' ILE . 54.6 p -53.48 -37.08 62.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.077 HD21 HG21 ' A' ' 54' ' ' VAL . 2.9 mm? -65.03 -34.62 78.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -71.08 -47.69 56.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' A' ' 108' ' ' GLU . 17.7 t -70.21 -58.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -63.69 -41.42 98.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.58 91.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.879 HG22 HD12 ' A' ' 104' ' ' LEU . 5.0 t -59.25 -52.07 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -65.46 -26.45 67.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.3 -55.03 17.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.537 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 72' ' ' ALA . 12.1 tt -66.58 -42.47 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.108 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -61.7 -44.52 96.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 40' ' ' LEU . 20.3 t80 -60.87 -52.49 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -44.19 72.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.0 -54.75 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -41.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.5 ttp -59.85 -46.01 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t80 -70.07 -30.79 68.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -63.87 -59.81 4.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.574 HH11 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.48 -41.86 97.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.86 -49.03 73.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 78' ' ' TYR . 74.7 t -64.1 -43.69 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -52.78 -51.47 60.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.729 HG21 HG23 ' A' ' 29' ' ' THR . 30.4 mm -73.08 -26.37 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -49.01 -48.0 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.0 p -146.33 -40.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.52 57.09 0.13 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.34 127.03 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 p -113.26 75.1 2.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.739 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 93.17 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -51.22 -35.14 35.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.88 -43.8 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -68.09 -48.05 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -51.58 63.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -56.72 -55.55 32.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.96 -34.81 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -57.76 -68.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.326 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.3 m0 -57.48 -35.63 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -71.18 -18.27 62.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 104' ' ' LEU . 8.2 tt -100.29 -23.08 14.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 97' ' ' ASP . 21.9 p -91.72 -32.44 15.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.583 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.9 t -57.73 -55.52 44.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.662 0.744 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.77 -38.37 7.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 0.0 112.36 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.879 HD12 HG22 ' A' ' 68' ' ' VAL . 2.6 mm? -62.51 -52.91 61.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.527 ' HA ' HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -62.93 -40.98 99.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 123' ' ' LEU . 70.5 mt -67.05 -38.46 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.502 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.1 t -63.15 -62.53 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.716 ' HB3' HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -53.39 -49.09 67.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 113' ' ' LEU . 12.9 t80 -52.32 -50.36 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -39.64 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -51.47 69.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD12 ' CB ' ' A' ' 61' ' ' SER . 6.3 mm -58.51 -52.75 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -64.46 -21.97 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.36 -40.35 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.02 14.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -54.1 -54.69 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.625 HG21 ' HB3' ' A' ' 174' ' ' ALA . 0.2 OUTLIER -123.06 -53.8 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.15 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -164.96 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.547 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 11.3 m -143.51 150.25 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.3 122.69 36.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.71 -2.61 70.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.9 p -47.53 -31.28 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -61.13 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.897 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.64 ' N ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -53.96 -52.02 61.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -59.74 -48.64 80.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' C ' HD13 ' A' ' 106' ' ' ILE . 5.7 mmmm -61.1 -33.51 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.41 -48.16 68.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 132' ' ' LEU . 1.2 tt -61.22 -53.13 60.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 162' ' ' MET . 61.0 t -58.77 -48.01 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -39.31 97.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.528 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -65.82 -39.1 90.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 128' ' ' LEU . 1.2 mm? -66.49 -53.38 35.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.71 -36.08 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.562 ' HE2' HD23 ' A' ' 99' ' ' LEU . 11.4 tmm? -70.51 -39.83 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 66.8 t -64.69 -47.0 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -57.35 -42.3 81.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.36 21.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -56.12 -51.08 69.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.923 0.392 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -31.6 69.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.15 78.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -48.36 -33.08 8.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.94 -27.33 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.11 18.3 40.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.431 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 pt -93.69 -34.74 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.519 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -124.93 119.28 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . 172.73 -55.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.554 ' HB1' ' HE2' ' A' ' 204' ' ' TYR . . . -42.12 -34.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.726 ' O ' HD12 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -85.33 -64.82 0.22 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.568 0.699 . . . . 0.0 110.892 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.72 -54.74 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . -43.22 -38.49 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.41 -51.42 69.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 149' ' ' TRP . 2.9 mp -70.36 -40.1 77.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 77.8 mt -60.72 -50.96 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.408 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -63.87 -45.3 94.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 160' ' ' VAL . 47.3 t -55.81 -51.17 68.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 110.904 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.05 -49.75 76.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.14 71.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -64.75 -54.93 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 156' ' ' CYS . 32.0 t -53.05 -43.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.92 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.469 ' CE ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -54.76 -47.82 73.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.6 mp -65.17 -40.39 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.81 -50.62 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.99 -43.92 56.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.469 HD22 ' CE ' ' A' ' 162' ' ' MET . 34.9 tp -57.34 -40.45 78.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -57.73 -20.57 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.87 18.34 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -50.72 124.96 21.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -73.4 -3.97 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -57.38 -62.27 6.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -76.69 -25.09 53.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -72.85 -26.15 61.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.625 ' HB3' HG21 ' A' ' 117' ' ' THR . . . -54.2 -45.03 72.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.87 -15.3 61.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.01 -59.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 79.7 p -95.96 -8.17 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.82 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.81 162.07 54.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 0.0 110.871 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.85 10.06 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.68 -42.47 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.5 t -67.13 -41.72 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -66.11 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 188' ' ' THR . 1.2 t -72.53 -48.65 38.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.61 96.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 113' ' ' LEU . 45.5 t80 -65.53 -52.24 54.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -54.68 -50.32 68.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 184' ' ' SER . 75.5 p -60.66 -39.92 90.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.415 ' HE2' ' HB ' ' A' ' 238' ' ' ILE . 0.0 OUTLIER -58.05 -52.02 67.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.44 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -63.37 -35.76 81.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -49.1 78.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.11 -48.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -50.97 -48.16 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.542 HG23 ' NE1' ' A' ' 159' ' ' TRP . 73.9 mt -65.32 -44.85 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -59.32 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -63.25 -55.74 24.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.5 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TRP . . . . . 0.52 ' CD1' H191 ' A' ' 301' ' ' RET . 14.3 m0 -51.18 -33.8 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.763 0.316 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.42 -30.36 42.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.8 mt -67.74 -32.11 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.484 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -51.88 -60.55 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.74 . . . . 0.0 110.939 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.74 -24.51 29.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.671 2.247 . . . . 0.0 112.344 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 198' ' ' ALA . 29.8 t -75.23 -33.77 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.03 -36.62 17.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HE2' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.29 -32.74 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -67.14 -30.67 70.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 203' ' ' GLY . 32.3 p -47.79 -31.68 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.77 56.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -89.85 -23.4 21.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.447 HD12 ' CE3' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -119.33 -14.28 9.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -171.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 22.18 4.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.38 -38.35 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -145.4 60.35 0.49 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.99 24.5 5.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.61 175.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 0.0 110.867 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.81 -27.23 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 28' ' ' TYR . 13.1 mt -59.0 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -52.29 -34.79 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mp -62.18 -56.03 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 84' ' ' ILE . 1.9 t30 -58.23 -39.16 78.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.545 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.4 tm? -60.38 -51.46 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 221' ' ' LEU . 27.1 mt -59.65 -45.25 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -56.63 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -38.53 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.14 -51.31 68.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.26 36.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.66 -45.54 93.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.554 ' CD2' HD13 ' A' ' 232' ' ' ILE . 41.6 t80 -51.34 -54.86 22.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 40.6 t -70.6 -24.7 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -82.56 1.42 38.1 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.745 3.164 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.524 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 8.2 mmtm -130.28 -63.1 0.91 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.083 -3.51 . . . . 0.0 112.751 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.8 mp -56.48 -63.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.109 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.1 OUTLIER -55.92 -33.69 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.74 -53.82 52.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.86 -36.71 87.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.93 -40.19 83.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.41 -49.73 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.415 ' HB ' ' HE2' ' A' ' 189' ' ' MET . 11.8 tt -63.44 -33.88 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.607 ' O ' HG23 ' A' ' 243' ' ' VAL . 16.0 t90 -75.52 -42.88 51.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.96 -40.79 98.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.74 -37.89 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.64 -41.36 68.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 54' ' ' VAL . 86.4 t -73.39 -35.92 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -74.69 -35.7 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -76.75 -35.33 57.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 85.3 p -51.21 -49.16 61.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.9 t -164.72 -58.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -159.17 163.89 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -149.47 73.75 9.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.575 0.702 . . . . 0.0 111.132 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -41.79 4.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 142.32 -101.32 0.27 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.143 -0.81 . . . . 0.0 112.467 -179.888 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.523 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.815 0.341 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.24 124.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.442 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.7 -94.33 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.56 128.58 2.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.45 -59.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.94 156.16 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -178.25 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -61.69 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.32 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.8 m-20 -58.33 -74.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -47.23 84.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.1 m -52.37 -45.04 65.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.186 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.65 -51.91 33.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 27' ' ' ASP . 34.5 t -53.84 -55.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.59 ' CB ' HD23 ' A' ' 221' ' ' LEU . 99.1 p -58.52 -49.96 75.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.92 -39.33 58.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -70.14 -43.4 71.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -44.88 94.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.433 HG11 HH12 ' A' ' 80' ' ' ARG . 33.2 m -69.57 -34.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.087 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 41' ' ' LEU . 27.3 m -68.18 -54.3 18.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.71 88.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.94 -55.14 18.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.65 -32.76 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 37' ' ' THR . 4.1 mp -66.51 -57.75 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 t -70.2 -37.9 75.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.2 m -67.73 -46.39 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.85 -41.55 92.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.26 -51.09 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -62.87 -28.67 70.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -74.34 -49.18 23.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.09 -30.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.209 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.54 -6.03 56.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -59.88 -26.75 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -96.61 -9.8 28.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -108.38 42.34 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.9 p -120.74 159.25 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 54' ' ' VAL . 16.4 t -50.12 139.58 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.69 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -23.88 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -90.05 11.29 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -49.94 -50.06 47.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.76 -38.92 53.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.495 ' CA ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -53.16 -43.57 67.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.83 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -68.69 -53.72 20.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 26.0 m -70.98 -45.79 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 64' ' ' VAL . 6.6 t -66.7 -39.42 88.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.79 -34.71 59.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.73 -48.26 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.905 HG23 HD23 ' A' ' 104' ' ' LEU . 7.7 p -68.54 -44.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.46 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.7 m -69.0 -34.52 75.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.46 51.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.68 -46.79 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.95 -44.75 91.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -58.02 -56.34 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -49.98 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -56.73 -44.99 82.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -59.26 5.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.3 ttm -47.17 -41.76 18.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.542 ' O ' HG23 ' A' ' 82' ' ' VAL . 88.4 t80 -68.99 -40.41 78.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.01 -58.03 6.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -57.03 -42.82 81.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -63.37 -42.46 99.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 78' ' ' TYR . 47.1 t -69.56 -30.01 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -71.99 -41.83 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 220' ' ' ASN . 12.7 tt -76.62 -30.8 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -80.95 -49.79 10.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 m -79.17 -38.45 35.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -23.11 35.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -148.14 126.79 12.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.833 0.349 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 161.16 36.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.897 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 99.14 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.704 2.27 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.2 p -64.28 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 m -50.38 -35.13 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.23 -49.99 57.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -57.74 -45.74 85.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.79 -55.1 33.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.5 mt -61.28 -26.37 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.17 -67.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.107 . . . . 0.0 109.301 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.514 ' O ' HG23 ' A' ' 102' ' ' VAL . 13.0 t90 -51.86 -33.2 35.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.681 HD13 ' CE ' ' A' ' 134' ' ' MET . 9.6 tp -74.6 -38.55 62.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 100' ' ' LEU . 6.3 tt -84.22 -5.28 59.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.019 HG22 HD23 ' A' ' 105' ' ' LEU . 30.3 m -107.56 -39.43 5.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.52 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -44.61 -58.91 4.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.6 0.714 . . . . 0.0 111.159 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 127' ' ' LEU . 53.9 Cg_endo -69.74 -19.53 36.08 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.905 HD23 HG23 ' A' ' 68' ' ' VAL . 51.6 tp -75.67 -51.69 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.019 HD23 HG22 ' A' ' 101' ' ' THR . 1.7 pp -71.05 -35.88 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.1 -50.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.72 -47.63 80.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -61.52 -56.62 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 238' ' ' ILE . 59.6 t80 -51.47 -51.09 57.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -65.53 -35.09 79.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.0 -66.95 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.931 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.495 HG21 ' CA ' ' A' ' 61' ' ' SER . 49.7 mm -56.22 -45.25 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.07 HD11 HG13 ' A' ' 182' ' ' VAL . 7.3 tp -57.05 -44.69 83.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.67 -15.85 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.092 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -53.72 -23.37 11.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -22.73 62.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.674 ' OG1' ' HB1' ' A' ' 174' ' ' ALA . 1.6 t -128.17 -47.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' VAL . 2.9 m-20 -179.45 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.3 m -155.06 161.86 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.24 125.53 42.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.89 -11.02 84.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -50.56 -31.91 17.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.19 -38.64 83.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -45.31 93.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.9 mttm -62.15 -50.51 71.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HD2' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -64.65 -35.39 80.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 103' ' ' PRO . 3.9 tp -63.06 -48.51 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -57.59 8.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 133' ' ' VAL . 49.3 t -54.92 -46.86 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.53 99.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.1 t -62.88 -39.62 95.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -47.02 61.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 129' ' ' VAL . 97.8 t -56.73 -51.44 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.681 ' CE ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -68.3 -32.22 72.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -60.59 -48.93 79.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.632 ' N ' HD23 ' A' ' 135' ' ' LEU . 97.1 t -71.48 -40.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.756 ' HB2' H162 ' A' ' 301' ' ' RET . 7.8 t80 -63.32 -43.18 98.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.24 34.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.17 -56.0 13.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.21 -32.84 74.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.78 -29.65 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.448 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -55.31 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.34 -27.4 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.07 39.59 5.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tt -47.37 -33.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptm -108.58 -170.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.35 -174.4 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 208' ' ' TYR . . . -76.93 -20.34 56.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -61.41 -56.75 30.66 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.535 0.683 . . . . 0.0 110.89 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.859 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.73 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.16 32.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.61 -35.77 82.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 150' ' ' PRO . 49.3 mt -58.23 -51.7 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.22 -45.78 95.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.445 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -62.51 -41.0 99.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.499 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.5 m -63.9 -50.59 68.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -49.64 76.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.19 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.543 ' NE1' HG23 ' A' ' 194' ' ' ILE . 2.2 t90 -62.53 -55.98 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.9 t -56.25 -47.94 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.34 -40.14 89.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.585 ' HB2' HG11 ' A' ' 129' ' ' VAL . 10.7 ttm -60.95 -56.37 21.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.525 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -60.8 -32.33 51.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' TYR . . . . . 0.439 ' HD2' HG12 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -63.39 -50.89 68.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -73.87 -25.34 59.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' HD2' ' A' ' 126' ' ' LYS . 3.0 mm? -76.43 -43.33 40.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -57.54 -23.59 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.12 17.19 23.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.7 133.6 39.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -78.3 -0.35 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.32 -41.34 39.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -76.67 -26.28 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.9 m -56.46 -24.81 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.674 ' HB1' ' OG1' ' A' ' 117' ' ' THR . . . -47.93 -47.68 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.078 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 69.8 m -117.17 -1.49 11.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 74.94 -59.03 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.65 -10.89 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.187 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.86 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.076 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.26 162.99 20.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.866 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.16 22.84 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.344 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -46.77 28.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 1.07 HG13 HD11 ' A' ' 113' ' ' LEU . 96.3 t -65.84 -43.61 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -35.1 79.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.5 t -69.8 -47.28 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.59 97.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.047 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -65.88 -50.83 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -56.02 -55.49 32.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.633 HG22 HG23 ' A' ' 237' ' ' ILE . 2.5 m -58.88 -37.75 77.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.9 tpt -60.0 -48.74 80.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.525 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -66.19 -34.26 77.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -50.71 70.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.54 HG12 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.79 -35.2 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.126 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.93 -48.34 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 65.5 mt -64.85 -47.76 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.81 -59.16 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.41 -56.99 22.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -53.71 -32.11 50.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 202' ' ' VAL . . . -77.94 -26.31 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.106 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 18.4 mt -76.8 -28.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -42.7 -57.13 5.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.669 0.747 . . . . 0.0 110.954 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.6 Cg_endo -69.79 -82.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 198' ' ' ALA . 20.5 m -33.7 -42.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 202' ' ' VAL . . . -65.24 -57.79 10.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.745 ' OH ' HD22 ' A' ' 219' ' ' LEU . 6.6 t80 -57.01 -19.91 21.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.92 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -47.05 -26.98 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 t -49.53 -28.28 5.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.614 ' CZ ' HD12 ' A' ' 209' ' ' LEU . 0.9 OUTLIER -55.59 -27.24 48.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.614 HD12 ' CZ ' ' A' ' 208' ' ' TYR . 16.2 mt -127.43 -53.71 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.98 87.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -88.9 -15.55 59.27 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -52.48 -29.43 24.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -115.76 -17.78 6.32 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -104.59 77.34 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -179.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.78 -27.63 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 218' ' ' ASN . 0.9 OUTLIER -59.09 -51.97 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.421 ' O ' HG22 ' A' ' 222' ' ' ILE . 4.0 t-20 -61.39 -40.94 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.745 HD22 ' OH ' ' A' ' 204' ' ' TYR . 20.3 mt -59.52 -42.84 93.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.598 ' CB ' HD12 ' A' ' 84' ' ' ILE . 23.6 m120 -66.63 -47.17 73.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.59 HD23 ' CB ' ' A' ' 32' ' ' SER . 1.9 tm? -53.06 -58.75 5.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 204' ' ' TYR . 1.0 OUTLIER -57.14 -40.77 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.139 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.42 ' N ' HG23 ' A' ' 222' ' ' ILE . 30.9 t80 -62.61 -42.39 99.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -63.89 -46.2 85.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.03 17.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.11 -27.21 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.52 -54.92 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 225' ' ' LEU . 7.9 p -68.2 -23.55 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -69.75 -33.62 72.68 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 126.739 3.161 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.1 mmtm -103.58 -8.72 19.8 Favored 'General case' 0 N--CA 1.424 -1.773 0 O-C-N 117.11 -3.494 . . . . 0.0 112.747 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.3 -63.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.137 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 192' ' ' ILE . 7.5 tp -53.82 -31.09 47.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.54 -56.25 23.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.93 83.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 -39.39 85.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.633 HG23 HG22 ' A' ' 188' ' ' THR . 4.0 mm -70.25 -50.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.464 HD12 ' CE1' ' A' ' 109' ' ' PHE . 42.2 mm -62.44 -35.79 71.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 243' ' ' VAL . 29.5 t90 -76.84 -45.74 27.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.21 -42.11 85.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 237' ' ' ILE . 14.4 p -74.67 -38.23 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.9 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 54' ' ' VAL . 53.6 t -78.27 -40.79 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.9 -39.11 93.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.88 -48.65 17.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.2 t -59.78 -68.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.44 -75.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -107.26 158.19 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -104.43 160.37 26.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.122 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.8 Cg_endo -69.77 -18.27 37.07 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.88 45.27 5.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.487 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.756 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.9 mtp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.23 154.67 7.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.88 -143.17 8.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.23 176.08 46.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.539 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.81 124.11 27.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.31 158.69 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.96 178.39 8.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' THR . . . -57.77 -75.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -33.67 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.671 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -58.8 -56.51 21.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -47.71 83.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.936 HG22 HD11 ' A' ' 84' ' ' ILE . 30.5 p -51.04 -47.05 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.113 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.79 -50.87 32.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 27' ' ' ASP . 93.0 t -52.78 -55.67 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.8 t -60.83 -48.13 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -53.83 -41.56 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -47.24 68.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.08 -43.64 98.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' SER . 94.6 t -66.62 -41.41 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -62.63 -43.12 99.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.69 49.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.42 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 44' ' ' THR . 4.0 tt -53.14 -50.13 65.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.09 -55.73 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.75 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 232' ' ' ILE . 22.0 m -72.02 -44.51 63.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 40' ' ' LEU . 31.2 p -59.69 -47.28 86.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 46' ' ' PHE . 29.7 m -67.11 -42.83 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -55.95 -52.17 65.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.22 -47.76 82.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -74.95 -38.7 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 87.9 mt-10 -81.16 2.67 26.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.71 66.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -97.2 -3.05 41.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.31 23.73 13.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 62' ' ' LEU . 3.5 m -93.44 -170.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 153.7 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.59 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -21.68 55.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -88.93 10.43 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -51.01 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 p -77.88 -26.0 48.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -54.76 -43.27 72.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 54' ' ' VAL . 4.6 mp -74.7 -27.66 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -64.49 -53.68 44.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 44.7 t -71.53 -51.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 t -60.86 -35.48 76.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -42.27 63.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.66 -50.18 72.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -63.42 -43.48 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 68' ' ' VAL . 98.6 m -67.33 -36.66 81.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.82 -46.93 88.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.11 -48.42 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -58.64 -40.98 84.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -61.31 -53.31 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.86 -41.99 68.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -66.98 -59.66 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -42.02 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.06 -46.54 87.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t80 -61.87 -60.11 4.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -32.96 63.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -65.31 -33.57 87.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 78' ' ' TYR . 87.1 t -68.83 -38.47 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -71.6 -45.24 62.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.936 HD11 HG22 ' A' ' 29' ' ' THR . 10.1 tp -72.2 -26.01 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.59 -47.79 49.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -143.28 -39.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.69 36.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 31.7 m-20 -153.6 127.37 8.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.24 160.07 50.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.699 0.761 . . . . 0.0 110.822 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 101.44 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 m -69.3 -31.58 70.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.39 -51.19 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -51.72 57.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -48.63 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.69 -55.42 34.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.9 mt -55.49 -36.59 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -62.88 -52.79 61.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.297 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.666 ' CH2' H202 ' A' ' 301' ' ' RET . 8.3 t-105 -59.8 -43.19 94.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.97 -20.92 61.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.38 -17.43 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.784 HG21 ' HB2' ' A' ' 72' ' ' ALA . 71.8 p -96.77 -25.47 15.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 133' ' ' VAL . 2.6 t -57.15 -56.87 29.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.618 0.723 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.78 -27.61 26.17 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.91 -47.25 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' A' ' 234' ' ' PHE . 0.9 OUTLIER -65.57 -51.05 62.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.657 HG13 HG21 ' A' ' 129' ' ' VAL . 36.2 mm -58.49 -56.05 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.33 -34.56 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.18 -65.56 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.92 -52.29 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -56.91 -44.93 82.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.43 -59.49 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.5 mm -51.93 -42.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 HG12 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -67.9 -27.99 67.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.59 -25.97 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.57 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.96 -20.07 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -122.53 -73.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 117' ' ' THR . 2.0 m-20 170.1 -76.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.3 146.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.99 96.1 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.16 -3.48 89.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -48.8 -36.39 16.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -48.83 28.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -70.14 -50.02 44.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -51.68 -52.95 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.74 -47.55 74.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.71 -59.97 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.657 HG21 HG13 ' A' ' 106' ' ' ILE . 16.6 m -58.37 -33.65 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -67.41 -46.99 65.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.542 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -65.65 -49.36 68.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.835 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.69 -52.83 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 102' ' ' VAL . 53.5 t -59.78 -41.88 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -64.42 -44.89 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 136' ' ' VAL . 3.4 tt -60.45 -57.78 11.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.578 ' N ' HD23 ' A' ' 135' ' ' LEU . 86.3 t -53.14 -52.06 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.89 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.95 8.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -56.46 19.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -30.84 68.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -64.01 -30.29 77.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLY . 2.8 tt0 -35.7 -59.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 110.894 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.13 -30.47 4.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.89 -13.3 44.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.08 5.69 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.24 144.68 32.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.651 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 61.94 32.29 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.97 96.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -69.88 -58.52 5.31 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 110.925 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.5 Cg_endo -69.68 -5.12 15.39 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.329 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.02 -49.97 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.22 -45.76 79.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.7 mp -61.57 -43.37 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.2 mt -65.61 -55.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.71 98.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.94 -52.53 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 153' ' ' ILE . 2.9 mm? -53.61 -49.78 67.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HB1' ' HE2' ' A' ' 162' ' ' MET . . . -65.03 -34.21 77.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.456 ' HZ2' HG23 ' A' ' 194' ' ' ILE . 1.9 t90 -67.08 -54.69 19.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' CE3' ' A' ' 159' ' ' TRP . 99.3 t -57.95 -49.47 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -61.13 -43.06 99.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.489 ' HE2' ' HB1' ' A' ' 158' ' ' ALA . 15.9 mtm -55.44 -58.61 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 194' ' ' ILE . 85.1 mt -65.47 -31.9 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -58.93 -47.58 84.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -41.99 63.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.32 -16.73 63.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -56.53 -25.84 53.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.71 19.01 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -64.72 -153.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 75.8 mm-40 -69.53 -11.07 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.907 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -79.78 -40.61 14.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -56.92 -61.34 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.4 p -63.28 -25.26 68.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -59.09 -19.38 43.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 41.9 t -51.41 -30.07 18.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -39.28 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 p -71.52 -9.07 57.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.603 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -126.84 -166.63 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.12 163.08 24.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -20.08 35.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.357 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.51 -52.77 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.629 HG12 HD12 ' A' ' 113' ' ' LEU . 19.1 t -60.74 -48.82 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.173 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -58.28 -37.53 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -65.38 -47.15 77.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.12 88.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.22 -51.66 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -49.22 73.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.71 ' CG2' HD12 ' A' ' 237' ' ' ILE . 1.4 m -63.85 -32.38 73.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.681 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.1 OUTLIER -69.67 -35.34 75.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.45 ' HA ' HG22 ' A' ' 193' ' ' ILE . 5.1 ttp -74.96 -36.08 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -40.89 69.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 188' ' ' THR . 7.1 tp -71.09 -44.02 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 192' ' ' ILE . 16.1 tt -65.92 -37.92 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 163' ' ' ILE . 45.5 mt -69.1 -49.5 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -51.69 68.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.67 9.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.73 -34.6 59.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.34 -24.56 46.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.26 -32.28 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.557 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 2.8 t80 -48.44 -57.22 11.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.669 0.747 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.8 -25.35 28.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.651 2.234 . . . . 0.0 112.313 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.6 -40.57 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.115 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.95 -43.4 8.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.61 ' OH ' HD13 ' A' ' 219' ' ' LEU . 1.5 t80 -54.94 -31.2 60.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -49.99 -32.69 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 203' ' ' GLY . 11.4 t -51.33 -27.88 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -0.26 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.53 -50.33 10.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -113.76 24.69 11.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -169.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -94.15 19.07 55.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.13 -25.55 11.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.58 76.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 68.14 128.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 168.76 11.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 110.851 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.79 86.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.592 HD21 ' HB1' ' A' ' 25' ' ' ALA . 2.4 mt -60.95 -63.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -56.38 -42.03 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.61 HD13 ' OH ' ' A' ' 204' ' ' TYR . 9.8 tp -55.56 -49.28 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.42 -42.27 98.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.18 -58.0 10.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.404 HG21 ' CD2' ' A' ' 204' ' ' TYR . 37.3 mm -53.9 -46.98 64.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -60.46 -48.14 83.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.19 -38.99 93.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.9 OUTLIER -60.69 -51.38 69.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.06 -55.21 36.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.16 -40.7 77.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.655 ' CD2' HD13 ' A' ' 232' ' ' ILE . 27.0 t80 -62.98 -40.99 99.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 225' ' ' LEU . 88.2 t -71.98 -26.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -97.85 1.74 48.54 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 126.749 3.166 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.663 ' CE ' ' HB1' ' A' ' 72' ' ' ALA . 13.3 mmtm -116.48 -63.92 1.38 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.049 -3.532 . . . . 0.0 112.776 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.1 mp -66.81 -64.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.143 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -39.66 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.912 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -51.35 -58.83 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.24 93.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.28 -44.46 92.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.958 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.71 HD12 ' CG2' ' A' ' 188' ' ' THR . 0.8 OUTLIER -67.34 -47.89 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.681 HD11 ' SD ' ' A' ' 189' ' ' MET . 32.0 mm -54.85 -50.93 57.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.501 ' CZ3' HD12 ' A' ' 62' ' ' LEU . 4.4 m95 -72.15 -29.64 64.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.62 -54.23 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.5 p -76.14 -40.36 36.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.411 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -61.35 -53.44 56.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 54' ' ' VAL . 94.4 t -65.89 -47.51 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -58.69 -43.69 90.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.03 -41.3 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.5 p -50.83 -35.14 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.22 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -115.31 159.34 21.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -165.38 72.63 1.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.549 0.69 . . . . 0.0 111.079 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 90.99 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.358 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.92 -113.87 4.09 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.172 -0.793 . . . . 0.0 112.508 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.666 H202 ' CH2' ' A' ' 98' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 CA--C 1.526 0.041 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.37 -177.51 42.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.511 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.17 175.02 47.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.29 113.69 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.552 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 55.57 -175.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.23 111.53 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' C ' HD21 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -70.02 160.94 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -51.93 -42.22 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -58.19 -36.85 73.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.4 m-20 -61.36 -60.51 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.446 ' CD1' HD23 ' A' ' 217' ' ' LEU . 1.5 m-85 -61.15 -48.19 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -51.57 -47.31 63.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.81 -51.73 28.21 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 27' ' ' ASP . 96.2 t -54.67 -55.33 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -59.03 -48.61 80.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -52.32 -45.57 65.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.46 83.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.01 -39.25 91.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 97.6 t -65.51 -52.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -62.49 -45.73 91.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.79 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -61.46 -54.18 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' CZ ' ' A' ' 73' ' ' PHE . 3.0 tt -51.12 -52.83 39.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.542 ' N ' HD23 ' A' ' 40' ' ' LEU . 21.2 tp -55.29 -53.34 57.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.74 -40.62 66.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -69.2 -32.17 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -73.06 -46.81 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 46' ' ' PHE . 17.7 m -64.57 -42.89 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.24 -49.79 58.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 64.5 t80 -64.55 -27.63 69.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -74.42 -49.55 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.6 t -71.26 -38.27 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -79.58 -7.45 58.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -56.54 -26.85 56.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.41 -11.05 21.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.19 38.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 62' ' ' LEU . 5.2 p -113.24 162.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.411 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -48.32 149.21 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.61 -55.58 12.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -60.51 -22.99 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -88.78 8.75 27.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.73 -50.37 55.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -73.76 -34.49 64.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.207 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.787 ' HA ' HG21 ' A' ' 112' ' ' ILE . 19.8 m -50.73 -45.04 58.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.01 -30.12 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.539 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -70.83 -55.51 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.175 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 65' ' ' SER . 12.8 m -67.88 -51.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.112 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 64' ' ' VAL . 8.6 t -65.06 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.95 68.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' ILE . 4.0 mp -70.12 -47.63 60.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' THR . 6.6 p -65.24 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' VAL . 68.9 p -71.79 -33.12 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -49.25 54.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 7.1 tt -67.64 -43.39 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.699 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -65.09 -39.78 93.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.769 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 27.3 t80 -63.06 -57.78 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -53.74 -50.07 66.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.92 -47.38 74.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -44.13 97.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -51.02 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 82' ' ' VAL . 24.5 t80 -62.32 -48.75 78.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -57.32 12.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -51.58 -54.59 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -39.54 54.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.1 t -67.33 -43.85 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -57.06 -52.28 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.29 -25.67 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -48.37 40.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.6 p -139.0 -39.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.53 -6.78 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -122.56 127.14 49.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.82 160.35 41.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.676 0.75 . . . . 0.0 110.848 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 86.65 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -56.66 -33.35 66.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -61.55 -34.4 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -51.35 68.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -67.59 -34.68 77.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -55.09 32.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.93 -43.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -33.01 73.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -68.86 -50.29 51.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.42 -13.3 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 tt -95.82 -25.34 16.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.606 HG21 ' CB ' ' A' ' 72' ' ' ALA . 62.6 m -95.33 -35.8 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.531 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -50.12 -58.07 10.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.661 0.743 . . . . 0.0 111.178 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.8 -35.68 12.09 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.676 2.25 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 100' ' ' LEU . 9.9 mt -62.48 -43.38 98.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -46.14 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 102' ' ' VAL . 1.5 mp -63.62 -41.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 32.9 m -68.25 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.4 -52.37 22.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.609 ' CE1' HD23 ' A' ' 113' ' ' LEU . 54.5 t80 -57.88 -51.61 68.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' HB2' HD13 ' A' ' 123' ' ' LEU . 2.2 t80 -51.83 -36.67 48.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -62.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.787 HG21 ' HA ' ' A' ' 61' ' ' SER . 21.4 pt -52.89 -38.75 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' CE1' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -71.19 -51.43 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.83 -18.85 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.71 -23.68 30.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.16 86.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t 179.15 -48.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.28 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -87.68 167.77 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.422 ' HB1' ' HA3' ' A' ' 169' ' ' GLY . . . -62.98 111.22 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.14 -3.03 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 m -50.59 -20.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.491 ' HB2' HG23 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -47.3 -33.18 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -67.46 -44.66 78.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.63 ' O ' HG12 ' A' ' 129' ' ' VAL . 14.6 mptt -65.3 -45.33 84.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -37.53 87.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 128' ' ' LEU . 1.2 tt -68.16 -43.05 79.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 127' ' ' LEU . 1.2 mt -66.46 -56.35 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 133' ' ' VAL . 12.0 p -58.49 -39.59 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -65.2 -46.4 87.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.448 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -41.69 97.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.908 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.84 -52.41 63.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 129' ' ' VAL . 82.0 t -54.92 -46.01 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -27.14 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -67.8 -45.71 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 135' ' ' LEU . 11.0 m -73.27 -35.52 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.51 ' HE1' HD12 ' A' ' 154' ' ' ILE . 12.7 m-30 -70.42 -38.72 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.32 -43.68 19.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.529 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -67.63 -51.86 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.97 -35.46 74.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.27 -32.7 57.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.535 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.65 -32.1 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.0 -26.06 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.81 22.99 12.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 145' ' ' ILE . 11.0 mt -80.58 0.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -108.29 -170.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 150' ' ' PRO . . . -154.99 162.7 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 208' ' ' TYR . . . -71.77 -21.71 61.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.756 ' CZ3' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -70.49 -59.57 3.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.535 0.683 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.75 -14.05 35.58 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.55 -37.27 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.09 -37.81 88.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.3 mp -60.53 -53.15 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.51 HD12 ' HE1' ' A' ' 137' ' ' PHE . 88.4 mt -59.26 -50.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.33 -49.07 82.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.02 -50.0 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.47 -45.62 84.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.05 83.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.632 ' HE1' HD11 ' A' ' 163' ' ' ILE . 8.7 t90 -64.64 -55.24 21.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.23 -46.88 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -37.02 86.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.466 ' O ' HD12 ' A' ' 166' ' ' LEU . 10.7 mtp -59.43 -53.59 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.632 HD11 ' HE1' ' A' ' 159' ' ' TRP . 91.2 mt -63.99 -42.87 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -54.01 -44.4 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -74.65 -57.67 3.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 162' ' ' MET . 5.5 mt -51.5 -58.45 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.45 ' HE3' HG23 ' A' ' 163' ' ' ILE . 1.1 t-105 -57.12 -20.1 23.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.27 19.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 120' ' ' ALA . . . -59.63 -170.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.86 -3.67 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.93 20.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -64.81 -40.42 95.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -31.17 46.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 178' ' ' ALA . . . -71.85 -9.11 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.081 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 14.3 p -50.22 -25.04 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -50.21 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.91 11.37 39.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 174' ' ' ALA . . . -51.6 168.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.15 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 160.59 62.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -24.26 30.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.66 2.24 . . . . 0.0 112.356 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.2 52.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' A' ' 113' ' ' LEU . 60.2 t -66.86 -43.29 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -35.67 81.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 188' ' ' THR . 70.2 m -71.28 -47.5 56.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.585 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -60.39 -41.87 94.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.85 -52.79 39.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -52.46 -54.1 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 184' ' ' SER . 43.7 p -58.14 -45.63 87.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -44.41 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.519 ' HA ' HG22 ' A' ' 193' ' ' ILE . 17.5 ttp -72.43 -29.97 64.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -40.32 69.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -72.67 -44.45 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.16 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 190' ' ' MET . 6.5 tt -65.28 -40.99 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 193' ' ' ILE . 44.4 mt -69.13 -49.38 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -52.41 -58.15 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.29 -57.76 18.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TRP . . . . . 0.466 ' CZ2' HD11 ' A' ' 193' ' ' ILE . 34.3 m0 -54.28 -32.07 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.79 -23.87 44.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 196' ' ' GLY . 11.8 mt -77.12 -32.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.6 OUTLIER -48.85 -55.8 18.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 110.94 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.82 -21.7 32.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.246 . . . . 0.0 112.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 198' ' ' ALA . 50.2 t -71.07 -43.66 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.34 -40.93 10.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.482 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.67 -57.4 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.52 -32.56 72.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -52.16 -25.86 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.36 -7.54 5.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.445 ' CG ' ' HB2' ' A' ' 148' ' ' ALA . 4.3 t80 -78.6 -51.11 10.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.756 HD13 ' CZ3' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -114.97 38.69 3.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.906 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -167.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -51.76 -74.3 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -175.63 38.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -112.45 -1.09 26.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -57.87 99.28 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.95 173.03 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.55 70.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.9 mp -55.28 -63.31 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -54.21 -37.54 64.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -54.74 43.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -57.58 -48.76 78.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.3 tm? -58.94 -58.09 10.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 221' ' ' LEU . 45.5 mt -54.87 -46.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.1 -48.98 79.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -61.28 -41.05 96.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 tp -61.21 -48.8 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.51 -55.28 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.91 -27.02 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PHE . . . . . 0.429 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.9 t80 -66.72 -55.71 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.43 -25.53 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -68.96 -8.25 42.82 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.68 3.133 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.699 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 14.2 mmtm -129.85 -59.98 1.05 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 117.107 -3.496 . . . . 0.0 112.798 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 50.0 mm -51.26 -63.22 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.102 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.551 HD23 HG12 ' A' ' 237' ' ' ILE . 0.3 OUTLIER -54.82 -30.65 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -55.47 32.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.29 -37.09 93.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.42 -37.54 80.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.551 HG12 HD23 ' A' ' 233' ' ' LEU . 1.4 mm -69.43 -49.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.32 -35.58 74.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.0 t90 -75.95 -43.99 42.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.63 -42.2 92.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 185' ' ' ALA . 10.3 p -74.07 -38.28 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.49 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.8 t -75.36 -40.78 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -66.96 -36.11 81.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -76.83 -44.03 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.5 t -51.74 -45.27 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.2 t 63.42 179.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.82 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -64.51 138.48 58.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -170.61 160.45 5.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 111.104 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.4 Cg_endo -69.82 -174.63 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.61 -169.76 41.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.481 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.441 -179.907 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.471 H163 ' HB3' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.8 mtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.871 0.367 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.8 -132.28 6.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.26 68.99 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.47 89.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -147.39 -43.02 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.67 -176.18 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.82 -177.1 6.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.33 -72.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.75 -28.84 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.69 -73.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -43.76 63.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 84' ' ' ILE . 96.2 m -61.01 -39.28 89.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -52.92 22.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -39.02 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.2 t -67.63 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.33 -42.68 78.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -46.9 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.86 -41.95 96.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 32' ' ' SER . 92.5 t -67.06 -43.28 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -59.5 -49.2 78.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.09 92.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.68 -55.48 23.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD13 ' HZ ' ' A' ' 73' ' ' PHE . 1.3 pp -62.84 -31.94 73.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.92 -53.4 46.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -34.55 78.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.61 -39.55 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 40' ' ' LEU . 14.0 p -67.24 -43.52 81.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 49' ' ' VAL . 27.7 m -68.5 -38.51 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.15 -49.04 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.72 -30.29 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.87 -50.17 63.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 45' ' ' VAL . 12.4 p -73.75 -33.45 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.1 tp10 -79.65 -14.52 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -36.86 69.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.48 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.18 42.33 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 62' ' ' LEU . 14.2 m -114.51 -170.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.66 155.37 40.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.51 -50.93 65.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -24.73 62.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.439 ' HZ3' HG23 ' A' ' 238' ' ' ILE . 62.5 m95 -96.82 -4.33 40.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -51.57 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 112' ' ' ILE . 5.3 t -77.62 -35.02 53.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.594 ' CA ' HD13 ' A' ' 112' ' ' ILE . 1.3 p -50.73 -41.66 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 54' ' ' VAL . 12.5 mt -64.61 -33.16 75.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -68.65 -54.19 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.38 -57.01 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.53 89.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.57 -44.69 77.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.933 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.99 -55.25 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -33.1 75.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.23 -47.66 70.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.62 -46.9 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.22 -37.83 88.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -64.65 -54.04 38.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -45.49 80.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -59.7 -53.19 60.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -39.23 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -57.54 -55.2 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.658 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -59.31 -53.04 62.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.6 mmt -54.42 -47.89 72.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -55.34 -56.68 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -58.48 -34.0 73.75 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.511 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 78' ' ' TYR . 75.1 t -70.24 -33.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.34 . . . . 0.0 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -73.84 -40.7 63.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.553 HD13 ' CB ' ' A' ' 220' ' ' ASN . 9.7 tp -76.85 -26.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -87.52 -49.94 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 -39.67 26.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -12.72 56.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -152.97 130.16 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.29 162.01 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.706 0.765 . . . . 0.0 110.857 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 103.29 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -69.43 -26.67 64.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -42.21 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.172 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -48.38 67.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -57.67 -51.43 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.29 -50.62 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.08 -53.92 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 101' ' ' THR . 0.6 OUTLIER -57.67 -34.01 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.108 . . . . 0.0 109.336 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.6 -59.58 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.59 -11.37 60.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 100' ' ' LEU . 8.6 tt -91.85 -17.12 25.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.705 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.7 p -110.95 -39.39 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -43.79 -58.49 4.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.79 -21.12 33.81 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.311 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.2 mm? -75.71 -54.37 7.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -49.55 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.77 -58.59 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.3 t -59.33 -34.38 72.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.41 -63.33 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -50.47 -51.09 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -61.66 -40.01 93.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.8 tp -57.67 -66.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 60' ' ' THR . 0.6 OUTLIER -50.53 -34.56 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.158 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 182' ' ' VAL . 5.3 tp -70.58 -39.5 73.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.87 -14.82 59.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -17.07 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -24.64 60.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -119.26 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER 164.87 -78.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.13 134.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.89 97.46 4.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.26 -6.05 85.97 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -33.49 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.82 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -41.71 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.95 -37.47 64.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -64.95 -51.54 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -35.33 79.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.64 -49.79 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.17 -59.68 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 133' ' ' VAL . 58.8 t -52.65 -46.98 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.67 -49.61 76.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -53.73 -46.2 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.413 HD13 HD22 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -64.32 -42.04 96.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 129' ' ' VAL . 74.4 t -59.51 -55.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.96 68.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 136' ' ' VAL . 1.0 OUTLIER -64.77 -58.17 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 135' ' ' LEU . 42.7 t -66.6 -41.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' CA ' H162 ' A' ' 301' ' ' RET . 14.2 t80 -62.38 -38.66 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.07 -51.31 18.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.6 -56.91 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.89 -32.69 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.22 -29.51 72.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -38.12 -55.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.97 -31.47 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.32 -9.36 20.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 pt -107.44 8.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.116 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.66 ' CE ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -102.05 119.88 39.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' CE ' ' A' ' 146' ' ' MET . . . 44.38 53.94 6.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -73.55 -53.28 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.622 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.3 t90 -52.83 -53.25 56.7 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.555 0.693 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 147' ' ' ALA . 53.7 Cg_endo -69.7 -17.2 37.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.256 . . . . 0.0 112.379 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 148' ' ' ALA . . . -53.23 -34.69 58.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -29.33 69.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.62 -51.64 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.82 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.426 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -73.47 -46.9 23.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 36.1 t -61.71 -45.75 92.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.832 0.348 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.71 -49.58 74.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.77 -29.89 70.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.699 ' CE3' HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -67.3 -57.48 6.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.699 HG13 ' CE3' ' A' ' 159' ' ' TRP . 18.7 m -60.02 -41.79 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.25 -45.86 89.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.65 ' SD ' HG22 ' A' ' 129' ' ' VAL . 13.2 mmt -57.05 -54.9 41.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 194' ' ' ILE . 2.1 mp -64.56 -37.32 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.83 -36.97 86.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.56 -39.5 62.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -80.54 -14.51 58.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.93 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.18 -27.42 33.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.12 21.1 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -42.23 132.22 4.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -78.35 1.0 23.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.27 -40.05 29.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.09 -28.95 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.5 m -60.43 -24.87 65.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.4 -30.49 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.27 -13.7 16.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 75.02 -59.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 82.7 p -92.02 -11.66 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 48.12 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.34 163.15 47.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.644 0.735 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.35 27.79 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.244 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.75 -39.88 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 1.037 HG13 HD11 ' A' ' 113' ' ' LEU . 71.2 t -68.34 -43.99 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -67.44 -32.98 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.0 m -71.77 -49.11 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.94 99.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.1 -44.76 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -58.08 -56.79 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.1 m -58.19 -48.22 81.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -52.0 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -32.63 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -49.25 77.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 237' ' ' ILE . 2.4 mp -67.72 -47.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.55 -49.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.584 HD11 HG21 ' A' ' 163' ' ' ILE . 87.3 mt -65.37 -48.15 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -59.93 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.0 -54.61 33.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -53.23 -30.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.304 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -80.05 -28.95 39.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.51 -30.77 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 24.5 t80 -48.03 -54.37 25.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.686 0.755 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.76 -22.46 32.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 198' ' ' ALA . 80.7 t -69.27 -44.31 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.81 -32.35 27.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.482 ' HA ' HD13 ' A' ' 222' ' ' ILE . 60.2 t80 -58.36 -45.92 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.918 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.09 -53.87 24.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 t -72.47 -14.17 61.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -89.69 -19.75 46.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -111.44 -50.88 2.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.558 HD11 ' CD1' ' A' ' 149' ' ' TRP . 86.0 mt -93.87 39.94 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.52 -171.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -83.0 -18.06 65.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.79 -53.07 2.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.361 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 169.24 -27.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.61 137.75 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 96.0 p -121.91 178.62 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.48 -21.11 62.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -59.74 4.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.425 ' O ' HD12 ' A' ' 222' ' ' ILE . 14.0 m-20 -52.03 -37.91 55.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.35 -33.44 67.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.553 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.6 m120 -68.15 -48.82 64.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 221' ' ' LEU . 2.3 pp -68.53 -38.78 81.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 204' ' ' TYR . 40.4 mt -66.68 -47.14 84.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.422 HD21 HG21 ' A' ' 36' ' ' VAL . 39.4 t30 -63.85 -43.27 96.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.7 tp -62.47 -45.67 91.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -55.68 30.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.54 -37.56 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -62.14 -46.62 88.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 1.041 HG13 HD13 ' A' ' 233' ' ' LEU . 96.7 t -73.02 -25.15 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -92.14 2.35 56.64 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 126.704 3.145 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -124.07 -63.33 1.22 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.121 -3.487 . . . . 0.0 112.743 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 43.9 mm -61.59 -64.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.165 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 1.041 HD13 HG13 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -51.75 -36.65 48.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -57.83 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -66.76 -42.42 93.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.31 -49.54 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 241' ' ' VAL . 5.1 mm -69.07 -36.16 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.705 HD12 ' HA2' ' A' ' 235' ' ' GLY . 15.8 mt -52.39 -57.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.9 p-90 -73.67 -30.14 62.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.404 HD22 HD13 ' A' ' 237' ' ' ILE . 37.0 t30 -56.96 -52.19 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.4 p -75.08 -44.05 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.05 -55.68 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 54' ' ' VAL . 74.1 t -62.29 -43.42 98.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -46.92 74.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -74.21 -29.24 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.2 t -51.55 -33.24 31.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.47 -74.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -161.22 137.13 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -171.44 71.61 0.5 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.613 0.72 . . . . 0.0 111.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 101.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 173.46 -141.13 5.92 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.531 -179.887 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.532 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.34 84.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.92 -140.12 5.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.66 -160.83 47.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.01 -42.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 28' ' ' TYR . 16.7 mt -139.78 141.68 36.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.78 172.14 13.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -54.77 -65.47 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.73 -25.86 42.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -59.84 -68.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB2' HD22 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -63.7 -48.54 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.3 m -52.8 -44.34 66.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.27 -51.61 31.72 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 71.1 t -54.62 -55.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -59.45 -46.38 88.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -52.68 -43.74 65.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.21 -45.59 72.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -37.27 84.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 32' ' ' SER . 89.7 t -69.1 -52.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.9 m -61.73 -47.48 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.95 71.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -52.18 17.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 45' ' ' VAL . 5.5 tp -65.83 -42.37 90.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 45' ' ' VAL . . . -64.75 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.8 m -71.67 -36.18 70.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -74.81 -45.2 44.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 41' ' ' LEU . 12.3 p -67.28 -38.84 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -71.9 -49.63 36.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 45.6 t80 -63.6 -34.34 77.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -70.72 -52.24 22.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 45' ' ' VAL . 91.1 t -66.36 -35.63 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.631 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.4 tp10 -79.92 -22.38 42.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.642 ' O ' HG22 ' A' ' 54' ' ' VAL . 3.9 mtp180 -54.23 -44.66 71.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.97 -3.95 50.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -106.32 12.01 30.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 51' ' ' ARG . 8.4 m -94.35 -170.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.27 158.28 33.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -51.45 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.068 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -62.4 -34.29 76.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.466 ' CD1' ' HB1' ' A' ' 242' ' ' ALA . 95.6 m95 -83.7 -10.87 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -51.02 -50.58 58.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -77.29 -41.53 40.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.427 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -54.26 -46.95 72.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.747 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -70.79 -27.32 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.3 m -71.18 -53.61 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 68' ' ' VAL . 25.6 m -70.21 -45.5 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.0 t -69.56 -41.03 76.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.33 -33.4 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.46 -48.37 56.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.8 p -65.06 -47.78 86.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.51 ' N ' HG13 ' A' ' 68' ' ' VAL . 67.1 p -63.73 -38.11 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.02 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -48.03 -35.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 111.108 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -69.73 -49.41 53.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CE2' HD11 ' A' ' 232' ' ' ILE . 5.5 t80 -53.37 -46.53 69.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -67.73 -45.8 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -58.36 -45.22 88.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -72.94 -57.74 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -37.36 23.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.9 t80 -74.01 -55.4 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -57.84 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -66.55 -48.76 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.41 -48.74 53.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.9 t -66.37 -53.23 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -53.31 -55.93 20.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 88' ' ' ASP . 40.4 mm -61.33 -34.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -57.59 -22.02 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.4 m -99.41 -38.36 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.38 35.52 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.612 ' O ' HD13 ' A' ' 84' ' ' ILE . 2.3 m-20 -112.4 -177.42 3.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.6 t -147.77 75.39 11.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.653 0.74 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.05 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -38.58 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 19.7 m -62.98 -44.57 99.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 7.6 m-85 -73.01 -47.28 46.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -50.54 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.29 -55.96 27.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.97 -27.18 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -66.42 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.298 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.567 ' CE2' H202 ' A' ' 301' ' ' RET . 12.2 t-105 -60.53 -30.04 69.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -74.72 -30.55 61.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.58 -18.89 28.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.106 HG22 HD23 ' A' ' 105' ' ' LEU . 3.5 m -94.81 -39.62 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.643 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.1 t -43.55 -58.46 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.78 -18.91 36.66 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 68' ' ' VAL . 6.7 tp -77.21 -54.0 7.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.106 HD23 HG22 ' A' ' 101' ' ' THR . 1.0 OUTLIER -72.52 -47.38 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 mm -54.81 -46.79 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.443 ' HA ' HD13 ' A' ' 123' ' ' LEU . 48.6 t -69.07 -42.2 76.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -54.45 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -58.79 -50.97 71.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 6.6 m-85 -64.06 -28.54 69.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -66.84 -56.07 12.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.513 HD13 HD23 ' A' ' 111' ' ' LEU . 48.0 mm -65.03 -36.37 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 182' ' ' VAL . 9.5 tp -70.81 -55.27 8.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -71.39 -12.47 61.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 111' ' ' LEU . . . -51.7 -24.64 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -28.35 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -9.03 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 119' ' ' VAL . 36.4 t30 66.12 50.35 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -172.57 107.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.61 97.82 5.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.75 -35.89 27.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -49.85 -31.85 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 107' ' ' CYS . 8.1 tp -54.03 -50.72 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.53 85.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.02 -50.5 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.462 ' NZ ' HD13 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -65.82 -34.11 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 103' ' ' PRO . 2.1 tt -66.78 -47.97 70.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -58.87 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.9 -52.82 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.93 -42.59 86.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 m -63.55 -40.05 96.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -63.06 -56.15 19.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 154' ' ' ILE . 7.1 p -57.82 -35.64 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.643 ' CE ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -68.06 -40.51 82.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -65.49 -43.92 88.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.71 HG12 ' CE ' ' A' ' 140' ' ' MET . 60.2 t -64.88 -47.89 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.415 ' HD2' HG22 ' A' ' 133' ' ' VAL . 2.9 m-85 -62.42 -40.78 97.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.66 -49.4 64.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -52.99 62.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.71 ' CE ' HG12 ' A' ' 136' ' ' VAL . 20.4 ptp -59.15 -33.74 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.17 -31.7 57.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -29.88 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.871 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.4 -27.4 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 5.32 62.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.0 pp -63.89 -35.07 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.323 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.541 ' HB3' HD12 ' A' ' 145' ' ' ILE . 4.0 ptt? -135.15 133.91 39.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -160.59 -45.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -67.03 -46.3 74.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.628 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.73 -52.82 13.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.561 0.696 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.699 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.8 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.334 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -61.75 -52.41 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -77.44 -34.15 54.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 150' ' ' PRO . 36.2 mt -59.35 -65.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.672 HG22 HG23 ' A' ' 133' ' ' VAL . 28.1 mm -62.85 -44.6 99.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.59 86.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.8 t -60.43 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.63 -47.82 66.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.49 94.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -60.24 -55.37 34.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 156' ' ' CYS . 22.8 t -57.77 -50.11 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -39.49 87.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.564 ' SD ' HD22 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -57.98 -58.08 10.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.77 -38.92 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.59 -49.5 67.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.82 -54.68 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 190' ' ' MET . 6.1 mp -50.46 -59.82 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.79 -20.56 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.0 17.81 23.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -68.63 118.27 8.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.24 -0.74 26.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.877 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.05 -37.77 46.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.468 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.75 -27.89 69.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -55.16 -26.2 37.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.11 -39.3 55.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.25 -11.86 14.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.29 -58.65 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 t -100.06 -7.64 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.58 -166.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.04 161.78 51.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.7 0.762 . . . . 0.0 110.839 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -26.03 28.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -44.19 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.859 HG13 HD11 ' A' ' 113' ' ' LEU . 91.5 t -71.62 -42.46 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -66.21 -39.17 89.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.1 t -70.05 -49.38 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.78 97.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -65.46 -47.85 74.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.22 -44.39 83.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 237' ' ' ILE . 2.4 m -69.64 -35.11 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.472 ' HE3' ' N ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.73 -53.02 46.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.582 ' HB3' HD23 ' A' ' 166' ' ' LEU . 14.5 ptm -64.11 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.88 -47.76 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HG21 ' A' ' 237' ' ' ILE . 28.3 mm -65.65 -39.5 85.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.555 ' CG2' ' HE3' ' A' ' 162' ' ' MET . 42.2 mt -57.8 -57.58 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 pt -60.5 -38.68 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 199' ' ' ILE . 5.4 t80 -56.29 -59.47 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.56 -52.95 49.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -55.4 -36.73 66.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.796 0.331 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.6 -24.72 49.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 200' ' ' TYR . 19.6 mt -79.08 -26.97 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.54 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.5 t80 -32.7 -57.76 0.48 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.697 0.761 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.77 -65.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 57.3 t -36.51 -42.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -77.14 -57.86 3.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 222' ' ' ILE . 10.0 t80 -53.81 -21.68 7.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.858 0.361 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.58 -28.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 96.7 m -49.34 -29.45 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.14 18.02 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.605 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -57.28 -23.08 46.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.918 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.4 tp -129.36 -53.92 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.51 -175.14 3.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 125.89 38.12 0.48 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.2 68.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.61 25.62 70.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 55.51 82.56 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.518 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.9 p -72.58 135.55 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.71 57.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 25' ' ' ALA . 78.8 mt -55.99 -63.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -52.79 -31.48 38.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -57.39 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.483 HD13 ' C ' ' A' ' 221' ' ' LEU . 3.3 tm? -61.26 -58.63 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 204' ' ' TYR . 39.5 mm -60.21 -48.84 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -57.05 -49.14 76.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -60.34 -40.38 90.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.57 -48.9 78.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.45 -55.16 38.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.17 -27.54 69.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -67.44 -56.58 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.0 m -72.57 -25.02 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.92 -10.32 37.69 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-O 126.701 3.143 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -131.31 -56.24 1.02 Allowed 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 117.102 -3.499 . . . . 0.0 112.773 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.3 mm -53.8 -64.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.115 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -41.21 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.08 -57.3 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -62.65 -41.11 99.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.3 -48.96 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.7 mm -69.68 -36.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.752 HD12 ' HA2' ' A' ' 235' ' ' GLY . 39.4 mt -53.0 -58.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.747 ' HB3' HD21 ' A' ' 62' ' ' LEU . 15.9 p-90 -73.71 -29.63 62.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 237' ' ' ILE . 7.3 t-20 -54.87 -55.06 34.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.1 p -76.32 -44.8 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.474 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -56.58 -53.17 60.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 54' ' ' VAL . 85.1 t -67.47 -41.76 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -54.18 27.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 -34.73 69.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t -51.82 -68.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 t -174.66 96.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -53.88 172.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -123.75 160.49 51.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.615 0.721 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 54.4 Cg_endo -69.72 80.3 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.656 2.237 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 159.99 -58.64 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.489 -179.902 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.567 H202 ' CE2' ' A' ' 98' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mtm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.81 0.338 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.27 130.57 1.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.9 -73.52 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.69 46.51 2.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.495 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -175.02 77.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.54 -169.98 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.4 168.51 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -51.37 -60.35 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -52.56 -43.91 65.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.7 m-20 -54.53 -52.35 62.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.711 ' CD1' HD23 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -61.84 -47.57 84.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -51.22 -47.01 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.8 -50.58 34.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.505 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.3 t -53.58 -55.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.351 . . . . 0.0 111.117 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.2 t -61.12 -47.18 87.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -53.22 -45.25 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -46.21 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.04 -40.24 92.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 32' ' ' SER . 93.1 t -66.4 -48.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.9 p -61.11 -46.5 90.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.9 -51.87 67.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.93 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 73' ' ' PHE . 1.8 tt -55.68 -33.66 64.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 62.7 tp -68.44 -56.34 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.8 72.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -71.25 -43.11 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.5 m -65.2 -47.09 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 41' ' ' LEU . 7.2 p -67.25 -39.39 82.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.21 -49.81 63.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -67.18 -31.26 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.61 -48.91 58.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 45' ' ' VAL . 73.2 t -73.5 -37.25 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 tt0 -79.51 -10.57 59.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -27.78 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.02 -5.79 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -100.81 29.41 4.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 62' ' ' LEU . 17.6 m -108.58 -171.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.42 ' HG ' ' HD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -77.52 160.12 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.11 86.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -45.59 86.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 67.4 m95 -81.88 -1.64 48.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -50.94 -52.33 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.0 p -77.56 -35.33 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.161 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 112' ' ' ILE . 10.2 p -60.31 -31.85 70.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.12 -34.2 74.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -73.29 -56.39 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' THR . 6.0 m -59.74 -52.28 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 64' ' ' VAL . 9.4 p -69.2 -36.6 77.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.7 -34.6 78.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 63' ' ' THR . 6.0 mp -70.7 -47.29 60.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 104' ' ' LEU . 5.1 p -63.85 -44.69 98.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 p -71.65 -39.14 70.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.164 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.24 -45.22 95.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.451 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.64 -47.85 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.67 -44.59 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 16.1 t80 -58.38 -53.41 58.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -57.0 -47.39 80.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -60.15 -61.38 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.15 -54.32 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 -58.14 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -58.33 -38.04 76.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -57.1 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -53.46 44.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.39 -53.15 33.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 78' ' ' TYR . 78.3 t -62.02 -39.15 82.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.79 -51.95 64.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.054 HD11 ' HB1' ' A' ' 216' ' ' ALA . 9.6 tp -73.63 -25.83 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.1 -47.93 34.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 -38.78 4.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.14 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.42 126.53 52.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.7 162.22 32.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.613 0.721 . . . . 0.0 110.861 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 101.92 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.2 m -69.1 -26.02 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.7 t -48.04 -41.73 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 -44.82 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -67.2 -58.28 5.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.549 ' O ' HD23 ' A' ' 99' ' ' LEU . 8.4 mm -63.5 -62.53 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -53.66 -33.35 54.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.553 1.158 . . . . 0.0 109.277 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.423 ' HD1' HG23 ' A' ' 102' ' ' VAL . 4.5 t90 -58.13 -65.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -73.09 -9.88 59.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 99' ' ' LEU . 3.5 tt -91.42 -18.83 23.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.735 HG21 ' HB2' ' A' ' 72' ' ' ALA . 68.6 p -105.61 -39.05 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 4.0 t -44.28 -55.03 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.658 0.742 . . . . 0.0 111.128 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -23.25 31.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.252 . . . . 0.0 112.361 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 68' ' ' VAL . 20.2 mt -75.83 -54.63 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.682 HG21 ' CB ' ' A' ' 126' ' ' LYS . 35.4 mm -57.65 -37.81 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.63 -56.37 16.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -51.68 -46.62 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.42 -43.62 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.598 ' CD2' HD23 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -63.44 -32.61 74.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -56.81 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 61' ' ' SER . 5.5 tp -56.81 -40.3 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.135 HD12 HG13 ' A' ' 182' ' ' VAL . 3.2 mm? -70.82 -43.33 68.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -70.51 -18.58 62.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.38 -16.36 45.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 182' ' ' VAL . . . -92.3 -14.37 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -126.28 -74.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.451 ' H ' HG23 ' A' ' 117' ' ' THR . 0.4 OUTLIER 176.78 -33.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.454 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.6 p -170.68 145.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -115.65 145.43 42.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -5.04 82.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -39.09 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -51.5 -54.17 29.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.586 ' NZ ' HD22 ' A' ' 166' ' ' LEU . 20.6 ttpt -52.09 -50.1 62.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.682 ' CB ' HG21 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -66.28 -31.48 72.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.61 -49.7 74.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.61 -59.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.798 HG21 ' HG3' ' A' ' 162' ' ' MET . 50.6 t -53.77 -49.39 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.57 -48.71 83.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 m -53.43 -44.13 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.84 -48.12 72.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 129' ' ' VAL . 85.2 t -51.93 -54.41 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -64.8 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -56.11 -58.52 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.78 HG11 ' CD1' ' A' ' 154' ' ' ILE . 65.7 t -62.03 -51.72 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.571 ' HB2' H162 ' A' ' 301' ' ' RET . 54.4 t80 -51.96 -37.18 52.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.66 14.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -55.8 28.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 110.926 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -32.57 74.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.04 70.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.92 -32.86 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -28.58 7.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.53 26.37 10.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.2 pp -94.86 -34.9 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.096 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.739 ' HB3' HD12 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -146.74 142.45 27.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 171.73 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -57.72 -35.29 70.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -69.48 -61.46 3.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HA ' HD13 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.79 -6.72 19.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.271 . . . . 0.0 112.303 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.752 ' HB1' ' H42' ' A' ' 301' ' ' RET . . . -65.78 -48.73 70.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.55 -38.29 89.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.2 mp -65.03 -65.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.78 ' CD1' HG11 ' A' ' 136' ' ' VAL . 5.3 pt -57.58 -38.05 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -48.91 56.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.23 -44.02 92.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -50.47 72.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.89 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.565 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -62.94 -55.45 25.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CE3' ' A' ' 159' ' ' TRP . 82.5 t -58.41 -47.05 89.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.35 -46.17 89.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.798 ' HG3' HG21 ' A' ' 129' ' ' VAL . 9.3 tmm? -52.15 -58.66 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 194' ' ' ILE . 2.8 mp -68.09 -32.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -53.49 -54.52 36.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.19 -40.2 62.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.586 HD22 ' NZ ' ' A' ' 125' ' ' LYS . 28.2 tp -61.64 -24.94 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.439 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -58.9 -25.32 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.74 18.72 15.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -108.82 -13.45 18.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -85.25 -46.92 10.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -82.93 -41.66 8.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.58 -7.32 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.333 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -54.13 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.622 ' HB2' ' HB ' ' A' ' 117' ' ' THR . . . -97.22 -66.66 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 78.1 m -123.02 -65.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -173.33 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.9 t -112.04 -10.55 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.179 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.92 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.7 165.12 36.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.729 0.776 . . . . 0.0 110.827 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.57 16.4 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.3 54.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 1.135 HG13 HD12 ' A' ' 113' ' ' LEU . 96.7 t -70.42 -44.2 77.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.72 -39.94 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -68.18 -50.06 56.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -58.21 -39.99 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -45.1 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.68 -56.31 23.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' THR . . . . . 1.026 HG22 HD12 ' A' ' 237' ' ' ILE . 0.2 OUTLIER -58.67 -43.61 89.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -56.86 -47.42 80.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.494 ' SD ' HG23 ' A' ' 163' ' ' ILE . 35.7 ttp -65.42 -32.56 74.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.8 -51.27 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.63 -37.95 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.096 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.2 -46.17 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.595 HD11 HG12 ' A' ' 163' ' ' ILE . 87.2 mt -65.57 -49.58 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -51.23 -58.96 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.4 -58.52 13.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -52.77 -31.09 36.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.18 -24.11 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.26 -34.26 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 16.6 t80 -51.95 -55.57 29.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.663 0.744 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.72 -28.99 24.79 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.368 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 198' ' ' ALA . 38.9 t -72.5 -27.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 206' ' ' THR . . . -81.84 -46.75 6.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -37.32 45.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -48.81 -28.21 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.9 p -47.36 -30.54 3.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 134.08 49.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 26.5 t80 -63.25 -15.97 58.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.57 25.83 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.56 -25.31 49.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.508 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -98.93 18.81 16.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.361 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.02 51.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 92.6 107.56 1.72 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.519 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -60.69 125.2 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -51.09 -30.67 16.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.711 HD23 ' CD1' ' A' ' 28' ' ' TYR . 9.8 mp -61.82 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.29 -30.13 71.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.412 HD11 ' OH ' ' A' ' 208' ' ' TYR . 1.5 tt -60.6 -58.59 7.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -65.69 -37.32 86.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 221' ' ' LEU . 2.9 tm? -62.23 -55.87 24.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 48.1 mt -61.4 -47.64 92.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -59.8 -56.63 19.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -58.05 -49.03 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 229' ' ' VAL . 6.4 tp -59.39 -39.2 82.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -55.33 24.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.09 -28.12 69.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -70.97 -52.81 17.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 225' ' ' LEU . 17.7 m -72.06 -24.42 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -77.49 0.81 21.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-O 126.692 3.139 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.21 -59.63 0.87 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 117.122 -3.486 . . . . 0.0 112.75 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.1 mm -58.08 -64.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.148 174.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.445 HD12 HG13 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -52.13 -42.8 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.945 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.01 -58.45 6.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 -40.64 94.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -44.06 81.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 1.026 HD12 HG22 ' A' ' 188' ' ' THR . 0.9 OUTLIER -68.59 -48.18 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 27.5 mm -54.34 -50.09 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.448 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.9 m95 -72.02 -30.7 65.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -58.61 -53.74 54.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 185' ' ' ALA . 7.3 p -75.52 -42.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.21 -55.01 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.486 ' CG2' HG12 ' A' ' 54' ' ' VAL . 93.9 t -63.72 -48.31 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -35.44 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -71.6 -37.66 70.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.6 p -50.22 -40.8 48.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.93 -172.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.19 84.58 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -174.65 70.09 0.3 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.134 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 89.53 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 155.03 164.19 12.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.51 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.752 ' H42' ' HB1' ' A' ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.59 108.22 0.26 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.43 -48.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.515 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.06 78.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.491 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -174.59 63.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.86 170.19 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -177.11 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -73.88 -74.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m -51.97 -32.07 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -59.1 -58.44 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.836 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -48.33 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 m -49.87 -47.31 51.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.0 -50.54 39.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.0 t -51.33 -55.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 p -60.77 -48.31 82.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.2 -48.39 65.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -46.22 88.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.62 -38.19 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' SER . 85.5 t -65.94 -52.34 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 m -58.79 -54.24 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.66 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.57 69.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD13 ' HE2' ' A' ' 73' ' ' PHE . 7.8 tp -54.43 -42.43 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 45' ' ' VAL . 11.1 tp -67.36 -56.17 10.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.45 -39.14 64.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 m -69.89 -43.43 71.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -60.42 -49.06 79.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 49' ' ' VAL . 28.1 m -69.53 -36.1 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.14 -57.07 10.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 44.2 t80 -62.21 -45.88 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -54.14 -52.02 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 45' ' ' VAL . 88.6 t -70.9 -29.85 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -79.32 -6.21 56.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.7 -27.39 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.79 -10.67 47.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 31.87 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.4 p -120.82 154.02 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.1 142.06 2.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.83 74.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -23.86 61.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.624 ' HB3' HD23 ' A' ' 62' ' ' LEU . 26.2 m95 -88.6 6.56 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.953 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -53.57 -50.13 66.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -75.25 -33.53 61.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.5 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -63.92 -40.52 96.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 3.7 mm? -77.0 -26.75 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -70.93 -49.91 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 60' ' ' THR . 30.6 m -73.59 -45.17 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 9.2 t -70.47 -39.32 74.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.25 64.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.38 -51.06 60.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.857 0.361 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 105' ' ' LEU . 75.3 t -61.22 -51.9 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -63.66 -37.55 87.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.22 -37.05 93.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 mt -71.6 -45.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 101' ' ' THR . . . -60.72 -43.23 98.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 232' ' ' ILE . 43.6 t80 -64.97 -57.08 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -55.02 -51.89 64.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.22 -42.07 94.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -57.96 -71.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.3 ttp -52.26 -32.16 35.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -57.66 -68.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.913 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.455 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.2 mtt -74.81 -58.28 3.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -39.81 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -74.91 -57.51 4.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 79' ' ' MET . 5.8 p -53.72 -35.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 220' ' ' ASN . 8.3 tp -54.52 -26.89 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.29 -20.92 58.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -103.28 -38.24 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.19 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.71 -175.11 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.88 37.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.708 0.766 . . . . 0.0 110.847 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 84.44 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 t -60.07 -37.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.91 -52.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -51.05 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -34.38 74.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.11 -57.86 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -30.38 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 101' ' ' THR . 5.1 t70 -63.6 -66.83 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.311 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -31.6 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD22 ' SD ' ' A' ' 134' ' ' MET . 30.5 tp -77.23 -21.83 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HD23 ' A' ' 104' ' ' LEU . 3.9 tt -99.47 -16.38 18.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' ASP . 40.9 p -98.35 -32.6 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.499 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -57.55 -59.33 13.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.85 35.61 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.375 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.2 mm? -79.42 -51.98 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 101' ' ' THR . 3.7 pp -67.43 -40.82 85.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 126' ' ' LYS . 24.8 mm -66.66 -49.88 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.26 -40.83 97.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' OE2' HD13 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.14 -59.71 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -51.11 -50.84 58.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -64.41 -37.1 86.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -55.7 -63.87 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.5 HG21 ' N ' ' A' ' 61' ' ' SER . 48.7 mm -57.9 -44.69 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.749 HD21 HG13 ' A' ' 182' ' ' VAL . 2.8 tm? -55.92 -47.28 77.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.22 -15.68 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -55.37 -20.17 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.87 -26.63 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -123.48 -45.61 2.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.717 ' OD1' HG22 ' A' ' 119' ' ' VAL . 3.4 t-20 179.91 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.717 HG22 ' OD1' ' A' ' 118' ' ' ASN . 18.3 m -151.56 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -127.08 151.64 48.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.35 -2.47 73.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.21 -31.37 5.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.887 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.79 -40.52 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -49.93 25.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.588 ' CG ' HD13 ' A' ' 166' ' ' LEU . 3.9 mptt -58.22 -51.74 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.581 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -62.67 -35.68 80.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 tp -62.25 -47.03 86.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.62 -58.72 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 133' ' ' VAL . 6.0 m -55.31 -36.05 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.112 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.92 -45.57 72.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.5 t -63.01 -39.09 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.828 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -53.85 37.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 129' ' ' VAL . 59.6 t -56.68 -43.44 79.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -67.04 -36.4 82.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -61.4 -47.24 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.61 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.3 t -67.02 -48.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.466 ' HB2' H162 ' A' ' 301' ' ' RET . 8.9 t80 -58.32 -41.08 83.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.01 -51.67 8.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.13 -57.32 10.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.8 mmt -68.34 -46.13 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.81 55.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -45.57 -36.56 4.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.911 0.386 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.95 -27.45 8.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.084 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.09 27.37 5.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.488 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -104.71 -37.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.692 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -128.31 -168.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 79.28 0.42 2.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.114 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 208' ' ' TYR . . . -70.41 -42.61 71.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.555 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -70.11 -57.05 6.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.536 0.684 . . . . 0.0 110.93 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.77 -7.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.717 2.278 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.98 -48.0 81.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.49 -39.25 91.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 150' ' ' PRO . 7.6 mt -66.83 -58.93 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -35.25 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.06 -49.31 16.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.7 t -57.36 -50.63 72.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -50.11 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.58 94.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.592 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -61.55 -55.68 28.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' CE3' ' A' ' 159' ' ' TRP . 73.3 t -53.5 -48.07 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.66 -39.78 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.642 ' HG2' HG12 ' A' ' 129' ' ' VAL . 27.8 mtt -58.62 -58.22 9.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.3 mp -67.24 -30.88 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -58.26 -54.68 44.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -33.72 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' ' 125' ' ' LYS . 21.5 tp -74.63 -13.99 60.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.435 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -56.47 -21.22 24.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.85 21.62 14.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -38.4 137.71 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -72.31 -5.0 33.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.901 0.382 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.08 -41.42 37.92 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -77.69 -36.31 51.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 p -68.55 -25.14 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.28 -30.96 12.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 -8.78 13.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 75.06 -59.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 -8.52 30.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.73 -166.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.63 162.73 51.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.659 0.742 . . . . 0.0 110.854 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -30.83 21.52 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.5 -47.53 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.115 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.749 HG13 HD21 ' A' ' 113' ' ' LEU . 84.6 t -67.31 -44.6 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.01 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 t -66.62 -49.26 66.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.476 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.78 -42.2 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.29 -51.66 68.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.4 -54.71 43.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 31.9 m -55.33 -36.51 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.174 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.402 ' HE2' ' HA ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -63.71 -51.92 62.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.5 ttp -59.8 -37.53 79.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 -49.53 74.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -69.34 -53.45 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.2 mt -49.78 -50.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 91.3 mt -62.44 -49.79 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 199' ' ' ILE . 50.6 t80 -53.21 -48.86 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA2' HG12 ' A' ' 199' ' ' ILE . . . -62.06 -49.58 73.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.61 -28.43 69.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.84 -45.04 19.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 195' ' ' PHE . 21.0 pt -71.85 -29.46 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.7 t80 -45.59 -59.36 4.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.662 2.241 . . . . 0.0 112.343 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 198' ' ' ALA . 74.3 t -68.38 -43.88 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.67 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.99 -41.32 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.507 ' HA ' HG21 ' A' ' 222' ' ' ILE . 3.3 t80 -59.49 -24.57 63.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PHE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 70.6 t80 -54.47 -33.2 59.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 203' ' ' GLY . 6.2 t -66.26 -13.75 60.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.38 -4.79 6.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.594 ' CD1' ' HB1' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -64.99 -51.22 62.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.0 110.937 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.88 -54.49 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -168.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 166.05 42.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.7 31.44 7.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 110.879 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.16 23.55 9.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 68.13 84.4 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.35 122.15 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.832 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.33 70.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -59.8 -52.1 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -35.8 81.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.54 -58.63 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 84' ' ' ILE . 1.2 p-10 -63.74 -35.99 82.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.531 ' O ' HD22 ' A' ' 221' ' ' LEU . 1.3 tm? -63.07 -54.23 41.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 204' ' ' TYR . 23.3 mt -59.48 -48.13 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' TYR . . . . . 0.486 ' HD2' ' HH ' ' A' ' 204' ' ' TYR . 0.2 OUTLIER -62.14 -57.63 10.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -55.33 -39.86 70.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 229' ' ' VAL . 22.2 tp -62.83 -47.75 82.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.23 37.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.069 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -36.49 83.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.43 -40.8 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' LEU . 94.0 t -72.37 -42.66 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -72.78 -5.08 35.52 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 126.718 3.151 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -113.05 -27.07 8.18 Favored 'General case' 0 N--CA 1.424 -1.761 0 O-C-N 117.119 -3.488 . . . . 0.0 112.773 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 73' ' ' PHE . 31.8 mm -91.63 -63.44 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.14 174.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 233' ' ' LEU . 6.4 tp -49.08 -31.55 8.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.531 ' CZ ' HD11 ' A' ' 238' ' ' ILE . 71.6 t80 -57.52 -56.71 18.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.95 -39.76 89.16 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.97 -38.97 93.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.59 -47.43 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.531 HD11 ' CZ ' ' A' ' 234' ' ' PHE . 24.3 mt -55.48 -49.25 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 243' ' ' VAL . 3.4 t90 -69.85 -38.21 76.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -58.42 -53.85 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.7 p -65.15 -37.13 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.27 77.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 54' ' ' VAL . 98.9 t -81.27 -41.49 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -63.24 -39.57 94.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -77.52 -48.34 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.3 t -52.39 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.3 t 57.22 43.41 23.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -129.71 -176.59 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.81 ' HB3' ' HD3' ' A' ' 250' ' ' PRO . . . -179.08 -61.41 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 0.0 111.074 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 249' ' ' ALA . 53.4 Cg_endo -69.78 111.44 2.81 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 153.26 154.34 6.7 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.54 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.494 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.7 ttp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.853 0.359 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.61 -158.57 3.53 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -121.62 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.25 41.09 22.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.473 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.99 117.74 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.13 139.04 54.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.01 157.89 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -55.04 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -31.06 61.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -66.44 -68.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.779 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -49.71 -52.07 34.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 25' ' ' ALA . 5.6 t -61.82 -31.87 72.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.23 -55.51 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 32' ' ' SER . 15.4 m -57.0 -44.35 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 36' ' ' VAL . 35.0 t -64.37 -46.94 81.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.91 -40.14 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -47.5 69.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -43.98 97.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 32' ' ' SER . 93.2 t -63.2 -43.99 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.5 m -61.59 -42.66 99.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.13 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -51.9 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 232' ' ' ILE . 3.1 tm? -57.42 -39.03 75.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 tm? -61.19 -55.57 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.81 75.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -50.66 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.7 p -61.39 -40.4 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' LEU . 74.2 t -64.48 -48.05 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.92 -46.35 75.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 38.8 t80 -65.18 -28.72 69.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -74.66 -45.5 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' VAL . 61.1 t -73.55 -42.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.01 -4.01 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -26.38 62.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.03 -3.98 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.07 42.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.792 ' HA ' HG22 ' A' ' 243' ' ' VAL . 3.5 m -115.01 -170.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -66.27 152.94 43.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.62 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -27.81 64.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.471 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 58.3 m95 -91.69 1.6 57.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -51.11 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.473 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -77.56 -31.29 53.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 112' ' ' ILE . 5.4 p -55.29 -43.58 74.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 4.2 mm? -67.37 -29.67 69.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -54.82 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 65' ' ' SER . 15.5 m -62.91 -50.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 64' ' ' VAL . 1.1 p -70.12 -35.56 74.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.4 84.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.27 -47.92 59.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.54 -55.24 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 m -65.13 -37.52 87.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.29 99.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.478 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.51 -42.99 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 111.172 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.569 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -58.41 -47.89 82.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -63.98 -54.56 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -52.82 -51.19 61.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -63.92 -59.33 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -49.0 -62.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -38.31 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 82' ' ' VAL . 29.6 t80 -65.21 -70.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -59.67 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.478 HH21 HD11 ' A' ' 84' ' ' ILE . 2.1 tpm_? -53.47 -55.95 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.94 -54.6 27.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.0 t -56.59 -54.86 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.329 . . . . 0.0 111.156 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -54.18 -55.67 25.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HH21 ' A' ' 80' ' ' ARG . 41.6 mm -59.7 -26.52 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -21.28 50.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -38.33 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.08 31.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.52 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.77 -176.17 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 p -146.12 77.51 11.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.663 0.744 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 72.55 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.673 2.249 . . . . 0.0 112.328 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -69.87 -41.39 74.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 93' ' ' PHE . 4.7 m -54.56 -52.43 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.502 ' H ' HG23 ' A' ' 92' ' ' VAL . 34.5 m-85 -71.1 -44.61 65.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -55.46 -58.5 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -40.22 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 97' ' ' ASP . 21.6 mt -59.05 -63.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 101' ' ' THR . 18.6 t70 -59.02 -33.29 70.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.567 ' HE1' HG12 ' A' ' 133' ' ' VAL . 17.4 t-105 -60.58 -58.72 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.5 tm? -75.07 -11.99 60.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD23 ' O ' ' A' ' 100' ' ' LEU . 9.3 tt -90.96 -21.04 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.569 HG21 ' CB ' ' A' ' 72' ' ' ALA . 65.1 p -107.81 -34.36 6.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 t -47.57 -60.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.69 -30.46 22.54 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.27 . . . . 0.0 112.374 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 100' ' ' LEU . 3.1 mm? -64.88 -55.55 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.48 -43.01 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.36 -50.64 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 16.3 t -64.41 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -65.27 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.42 -50.21 60.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.48 -37.46 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.17 -66.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' N ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -50.75 -37.53 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.969 HD21 HG13 ' A' ' 182' ' ' VAL . 3.3 tm? -69.36 -39.82 77.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.43 -14.27 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.43 -14.67 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.02 -24.89 68.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -120.42 -70.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 117' ' ' THR . 2.1 m-20 165.24 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.46 138.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.02 96.94 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.99 85.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.0 p -48.78 -35.85 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.2 mp -49.48 -42.64 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -68.26 -53.68 22.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -52.09 64.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -36.14 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.31 -50.52 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.5 -60.13 2.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 89.9 t -56.58 -47.12 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.25 98.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.4 m -66.53 -55.26 16.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -53.81 43.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 129' ' ' VAL . 64.2 t -57.55 -45.09 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -61.92 -42.04 98.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 136' ' ' VAL . 2.1 tt -60.55 -57.82 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.627 ' CG1' HD12 ' A' ' 154' ' ' ILE . 48.5 t -52.67 -52.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -40.78 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.37 -51.46 52.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -60.44 -56.83 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -34.62 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.91 -29.19 59.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -39.79 -48.88 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' HG13 ' A' ' 145' ' ' ILE . . . -111.66 -28.95 7.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.78 17.02 33.29 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.403 HG13 ' HB1' ' A' ' 143' ' ' ALA . 12.9 mt -93.54 -55.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.123 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -111.45 138.35 48.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 174.07 -27.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.63 -31.64 48.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -74.54 -63.07 0.85 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.544 0.688 . . . . 0.0 110.881 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.71 -6.16 17.91 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.75 -49.63 74.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.95 -31.13 68.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mp -68.99 -61.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.627 HD12 ' CG1' ' A' ' 136' ' ' VAL . 1.3 pt -62.71 -38.96 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.194 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.43 93.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.489 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.94 -48.23 74.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -50.29 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.428 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.4 t90 -66.64 -57.89 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.428 HG23 ' CE3' ' A' ' 159' ' ' TRP . 59.8 t -61.36 -41.11 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.79 -47.09 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.23 -52.59 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.679 HG22 ' CE3' ' A' ' 167' ' ' TRP . 48.9 mt -63.13 -53.07 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -47.39 -35.59 8.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.96 -49.53 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -72.6 -16.39 61.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -116.69 18.42 14.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.53 13.34 6.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.61 -47.37 10.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -84.78 -41.45 7.68 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.33 -6.6 53.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -52.95 25.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 117' ' ' THR . . . -96.64 -66.68 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 7.6 m -123.21 -65.09 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -168.04 -38.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.74 1.16 17.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 48.34 -167.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -110.67 166.42 10.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.64 0.734 . . . . 0.0 110.849 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 179' ' ' SER . 53.9 Cg_endo -69.74 -36.79 10.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.79 -43.68 35.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.969 HG13 HD21 ' A' ' 113' ' ' LEU . 76.6 t -68.02 -46.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.01 -36.47 83.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 m -68.67 -47.24 67.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.54 -39.89 95.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -43.77 78.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.05 -49.35 78.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.6 m -65.16 -38.66 91.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -64.22 -42.31 96.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.9 ttp -71.7 -34.97 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -63.97 -50.89 66.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.72 HG21 ' CD1' ' A' ' 237' ' ' ILE . 2.2 pp -70.86 -38.33 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 8.1 mm -64.1 -47.56 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.517 HD13 HD13 ' A' ' 163' ' ' ILE . 62.3 mt -64.41 -52.95 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -52.34 -54.51 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.04 21.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -53.95 -36.32 62.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.67 -20.81 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.8 mt -82.01 -31.86 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -48.35 -54.09 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.666 0.746 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.2 Cg_endo -69.7 -20.86 34.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 198' ' ' ALA . 76.7 t -72.83 -43.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.57 -38.27 17.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.708 ' CD2' HG21 ' A' ' 222' ' ' ILE . 0.6 OUTLIER -52.39 -29.36 23.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -49.0 -30.75 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 203' ' ' GLY . 15.2 t -51.16 -24.64 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.1 22.24 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -46.39 -36.99 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.75 -37.48 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.4 ttp -60.12 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 67.22 40.93 92.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.464 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.52 26.35 12.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.832 0.348 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.78 24.42 9.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.443 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 109.75 102.32 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 135.72 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 0.0 110.879 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.65 -36.79 69.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 28' ' ' TYR . 17.0 mt -62.53 -63.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.39 -43.25 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -45.27 81.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -65.31 -44.66 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.98 -53.63 52.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.708 HG21 ' CD2' ' A' ' 204' ' ' TYR . 36.3 mm -57.15 -45.75 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -63.95 -54.64 31.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -56.37 -47.61 78.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -50.48 71.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.95 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -27.92 69.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -67.88 -56.43 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -24.95 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -80.4 2.78 23.63 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.68 3.133 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -131.18 -51.22 1.02 Allowed 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 117.158 -3.464 . . . . 0.0 112.753 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 40' ' ' LEU . 1.9 mp -63.83 -63.67 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.12 174.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 232' ' ' ILE . 5.9 tp -48.99 -36.55 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -56.1 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.39 -33.69 85.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.08 -41.32 86.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.72 ' CD1' HG21 ' A' ' 192' ' ' ILE . 19.6 mm -67.77 -50.01 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.524 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.7 mm -63.67 -36.52 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 24.8 t90 -74.1 -41.82 61.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -69.64 -40.98 76.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 185' ' ' ALA . 9.9 p -70.56 -36.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.21 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.5 t -66.3 -36.5 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -75.61 -50.6 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -58.54 -41.79 86.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -54.51 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.14 -179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -125.34 149.71 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -137.05 160.46 65.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.613 0.72 . . . . 0.0 111.094 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.5 Cg_endo -69.78 -35.17 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -139.12 93.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.459 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.45 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.513 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.4 174.9 21.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.3 24.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.471 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.78 170.86 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.517 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.05 -72.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -142.56 103.68 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.82 163.53 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 29' ' ' THR . . . -67.39 -65.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.43 -30.91 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.97 -67.83 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.688 ' CD2' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -52.43 -44.04 65.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.88 HG22 HD11 ' A' ' 84' ' ' ILE . 34.7 p -60.13 -38.73 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.15 -54.56 13.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -55.93 -41.43 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.633 ' O ' HG23 ' A' ' 36' ' ' VAL . 52.8 m -66.44 -48.43 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.02 -42.59 72.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -47.85 68.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 -42.62 96.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.698 HG12 HD22 ' A' ' 40' ' ' LEU . 91.8 t -63.91 -50.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -55.36 -43.39 75.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.33 -52.04 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -54.34 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.698 HD22 HG12 ' A' ' 36' ' ' VAL . 4.1 mp -51.16 -52.84 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -54.27 -48.64 70.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.48 -36.02 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.696 ' OG ' HD12 ' A' ' 232' ' ' ILE . 6.3 p -70.88 -34.93 72.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -70.78 -45.08 65.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.9 m -65.87 -42.83 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.74 -48.62 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -64.6 -29.87 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -74.95 -50.36 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 45' ' ' VAL . 94.0 t -65.73 -41.03 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -79.73 -6.22 56.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.486 ' CG ' HD22 ' A' ' 62' ' ' LEU . 12.0 ttt180 -57.4 -26.67 61.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -93.22 -10.71 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 243' ' ' VAL . 1.3 tpt180 -100.63 28.78 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.041 HG11 HD11 ' A' ' 62' ' ' LEU . 9.4 p -107.98 161.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.439 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -48.79 149.93 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.87 -55.88 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -23.86 59.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.744 ' CZ3' HD11 ' A' ' 238' ' ' ILE . 59.9 m95 -90.43 11.64 20.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -62.25 -50.46 71.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -34.26 73.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.179 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -43.2 62.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.041 HD11 HG11 ' A' ' 54' ' ' VAL . 2.6 mp -65.18 -29.53 70.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.4 m -70.14 -54.53 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 68' ' ' VAL . 12.6 m -69.62 -49.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.5 p -67.12 -36.87 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.67 -36.79 83.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.535 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tp -70.58 -49.97 42.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.4 p -66.08 -46.32 88.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.481 ' N ' HG13 ' A' ' 68' ' ' VAL . 52.3 m -71.51 -29.95 65.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.04 -52.01 30.58 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.497 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -68.69 -37.19 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -68.54 -42.09 78.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.75 -56.59 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.831 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -56.28 -50.21 72.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -60.78 -62.6 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -49.84 -51.27 41.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -53.69 27.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 4.7 m-85 -56.78 -46.21 81.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -57.12 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.44 -56.59 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.69 58.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.6 t -62.29 -28.12 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 111.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -70.29 -47.32 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.88 HD11 HG22 ' A' ' 29' ' ' THR . 1.6 tt -73.35 -24.96 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.32 -47.78 18.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.8 p -122.5 -39.23 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.21 -23.33 4.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -122.7 129.12 51.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.2 161.03 40.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 110.878 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 104.07 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -26.41 64.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 m -51.38 -41.29 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.093 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.83 -52.03 53.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -60.03 -37.72 80.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.08 -48.78 74.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.64 -50.25 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 3.9 t70 -62.85 -39.69 95.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.1 t-105 -61.03 -49.45 77.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.451 HD12 ' CG ' ' A' ' 134' ' ' MET . 1.0 OUTLIER -75.55 -16.53 60.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 tt -94.02 -14.74 25.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 72' ' ' ALA . 72.6 p -108.17 -29.48 8.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -54.88 -59.64 10.13 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.634 0.73 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.71 -35.55 12.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.315 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 100' ' ' LEU . 6.2 mt -65.4 -52.34 54.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 106' ' ' ILE . 1.5 tt -60.63 -50.57 73.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.574 ' N ' HD23 ' A' ' 105' ' ' LEU . 27.4 mm -57.69 -58.64 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.98 -33.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.97 -68.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -50.5 -50.72 52.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.35 -43.98 83.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.25 -66.71 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -31.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 113' ' ' LEU . 2.9 tm? -71.65 -42.09 67.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.2 -14.37 59.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.52 -17.31 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.41 -24.05 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -121.87 -69.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' THR . 1.7 m-20 165.77 -76.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -47.23 135.01 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.11 98.27 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.29 74.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -47.87 -33.5 7.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -48.26 -43.38 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.38 -53.26 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -52.91 -52.27 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -37.34 86.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.81 -50.85 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -59.76 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.5 t -53.03 -49.56 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.3 59.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 t -52.49 -57.21 10.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -53.04 44.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 129' ' ' VAL . 98.6 t -56.53 -44.56 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.451 ' CG ' HD12 ' A' ' 99' ' ' LEU . 14.8 mtt -64.25 -38.14 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.3 -58.72 7.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 154' ' ' ILE . 15.6 m -57.14 -43.0 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.62 -47.3 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.55 -52.23 47.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -58.71 -55.21 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.92 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' MET . . . . . 0.52 ' HE2' H173 ' A' ' 301' ' ' RET . 4.9 tmm? -58.37 -32.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.3 -30.18 59.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -41.61 -52.8 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.18 -28.48 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.73 16.95 48.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.5 pt -100.58 -37.27 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.63 139.82 47.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 170.4 -14.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -65.36 -38.84 91.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.579 ' CH2' HD21 ' A' ' 209' ' ' LEU . 1.7 m95 -69.12 -55.83 9.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.687 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.4 Cg_endo -69.76 -16.88 37.77 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.733 2.289 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -52.52 -53.21 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -77.7 -28.49 51.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 150' ' ' PRO . 46.0 mt -66.88 -64.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.073 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 136' ' ' VAL . 1.1 pt -63.29 -36.39 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.1 93.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.444 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.6 t -63.65 -46.77 84.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.71 -47.35 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.65 91.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 163' ' ' ILE . 11.0 t90 -61.06 -55.82 28.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 156' ' ' CYS . 43.5 t -58.88 -46.85 90.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.41 -43.28 99.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.698 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.9 mmm -57.35 -49.32 76.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.629 HD11 ' NE1' ' A' ' 159' ' ' TRP . 81.5 mt -63.59 -52.65 54.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -36.5 38.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.68 -58.76 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 162' ' ' MET . 0.5 OUTLIER -55.14 -55.77 27.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.433 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -56.14 -22.05 26.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.04 18.47 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -87.09 -155.23 27.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.473 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.35 -17.76 64.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.37 -31.23 34.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -49.59 73.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.9 t -77.95 -25.69 48.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -55.45 -23.55 26.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 18.6 p -52.25 -26.88 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -126.18 -33.47 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.1 p -89.65 12.7 16.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.605 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -145.68 -167.18 2.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.52 162.32 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.664 0.745 . . . . 0.0 110.898 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -28.57 25.19 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.304 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.32 -41.44 56.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 113' ' ' LEU . 98.6 t -63.8 -43.32 97.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.49 -32.59 72.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 t -69.8 -45.14 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.831 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -68.45 -40.8 80.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.537 ' CZ ' HD23 ' A' ' 166' ' ' LEU . 32.8 t80 -64.96 -51.39 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -61.86 -56.23 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.6 m -53.02 -44.18 67.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -59.9 -52.38 65.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.656 ' HG3' HD13 ' A' ' 166' ' ' LEU . 3.5 tmm? -54.78 -39.34 68.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.93 -52.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 194' ' ' ILE . 9.5 tt -52.7 -45.95 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 190' ' ' MET . 21.5 pt -69.58 -38.12 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' A' ' 199' ' ' ILE . 23.6 t80 -56.84 -58.32 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.97 -48.84 77.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.535 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -58.21 -33.11 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.03 -25.2 43.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.664 HD11 ' CE1' ' A' ' 195' ' ' PHE . 24.6 mt -80.34 -31.11 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.599 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -47.75 -54.5 22.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.693 0.758 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.72 -23.13 31.32 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.695 2.263 . . . . 0.0 112.386 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 198' ' ' ALA . 73.9 t -69.56 -44.32 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.91 -35.11 22.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.421 ' HB2' HG21 ' A' ' 222' ' ' ILE . 11.7 t80 -52.7 -29.44 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -48.76 -30.28 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 203' ' ' GLY . 8.9 t -50.5 -28.07 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.21 21.7 0.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.639 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 1.1 p90 -54.53 -26.06 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.579 HD21 ' CH2' ' A' ' 149' ' ' TRP . 1.0 OUTLIER -127.06 -46.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.925 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 3.4 mtm -51.6 121.66 6.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.88 43.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -63.23 -60.97 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.95 83.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.482 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.509 ' O ' HD23 ' A' ' 219' ' ' LEU . . . -93.67 39.08 3.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.3 m -61.34 -179.9 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.27 65.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -65.43 -51.77 57.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASN . . . . . 0.43 ' N ' HD12 ' A' ' 217' ' ' LEU . 2.0 t-20 -61.14 -41.56 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -60.15 -58.46 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -36.27 69.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -60.19 -57.92 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 200' ' ' TYR . 42.3 mm -55.51 -48.62 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.4 -51.54 69.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -60.04 -38.82 83.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -59.24 -51.22 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 200' ' ' TYR . . . -59.75 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.21 86.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.78 -39.31 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 225' ' ' LEU . 95.6 t -74.33 -24.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.44 ' CB ' H203 ' A' ' 301' ' ' RET . 24.6 m120 -96.11 2.51 53.27 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.671 3.129 . . . . 0.0 110.84 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.7 mmtm -121.51 -45.37 2.31 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 117.121 -3.487 . . . . 0.0 112.76 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.696 HD12 ' OG ' ' A' ' 43' ' ' SER . 46.5 mm -84.34 -65.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.08 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -36.22 44.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -55.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.29 -35.25 91.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -42.32 85.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 238' ' ' ILE . 1.1 mm -65.72 -50.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.744 HD11 ' CZ3' ' A' ' 58' ' ' TRP . 9.0 tp -62.84 -34.45 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' TRP . . . . . 0.709 ' O ' HG23 ' A' ' 243' ' ' VAL . 10.2 t90 -74.41 -44.27 52.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -60.32 -41.95 94.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 185' ' ' ALA . 13.6 p -72.67 -36.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.86 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 54' ' ' VAL . 61.4 t -74.8 -38.58 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -71.61 -35.83 70.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -76.85 -36.81 56.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.4 t -50.93 -54.88 20.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 m 72.23 -69.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.26 66.36 3.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 250' ' ' PRO . . . -68.31 -60.86 4.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.555 0.693 . . . . 0.0 111.082 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 249' ' ' ALA . 53.6 Cg_endo -69.76 134.58 28.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.379 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.35 140.46 9.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.536 -179.899 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.539 ' H7 ' H181 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 27' ' ' ASP . 16.2 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 175.6 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -55.73 -73.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -31.63 54.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -58.43 -71.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.564 ' HB2' HD23 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -58.39 -48.17 81.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -51.23 -42.88 61.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.96 -50.81 27.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 27' ' ' ASP . 57.7 t -51.17 -51.66 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 t -64.37 -48.74 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.34 -49.07 65.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -46.92 83.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -59.0 -38.76 79.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 32' ' ' SER . 84.1 t -68.09 -45.56 83.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 m -62.31 -50.54 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 tt -52.53 -52.53 54.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.8 -53.58 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -47.16 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -29.01 68.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.0 m -72.81 -48.87 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.8 m -65.66 -40.3 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.87 -51.34 41.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 48.8 t80 -63.37 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.05 -51.33 13.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 45' ' ' VAL . 90.0 t -67.62 -31.13 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -79.22 -7.06 57.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.38 -27.26 55.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.26 -12.54 27.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -102.39 36.69 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.672 ' HA ' HG22 ' A' ' 243' ' ' VAL . 8.2 p -120.03 158.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -47.8 147.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.27 -52.87 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.18 -21.82 60.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -87.73 6.97 32.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -51.33 -50.75 58.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -77.06 -36.17 56.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.153 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.509 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -54.92 -47.8 73.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -72.19 -27.5 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -67.77 -53.6 25.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 68' ' ' VAL . 29.8 m -71.73 -44.91 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 64' ' ' VAL . 4.2 t -66.32 -40.56 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -35.29 58.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.07 -49.19 65.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.7 p -68.48 -44.11 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.082 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.448 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.1 m -67.26 -35.26 79.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.95 -42.68 59.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 mt -68.48 -41.67 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -66.87 -43.63 83.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 232' ' ' ILE . 30.6 t80 -61.1 -51.95 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.56 -50.41 74.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -59.25 -61.43 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -51.5 -49.7 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -53.15 30.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 82' ' ' VAL . 18.8 t80 -58.72 -48.74 80.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.3 mmt -55.83 -54.84 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -51.41 -55.16 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.04 -45.87 56.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 78' ' ' TYR . 58.6 t -66.7 -35.68 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -59.75 -51.6 69.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.3 tp -74.51 -26.13 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -50.15 -48.61 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.9 p -111.43 -39.25 4.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 122.36 -13.66 8.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.46 127.03 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.7 161.28 35.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.643 0.735 . . . . 0.0 110.859 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 99.96 0.79 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.358 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 p -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -50.6 -33.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -71.57 -51.92 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -63.74 -33.55 75.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -53.79 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.57 -37.94 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 101' ' ' THR . 0.8 OUTLIER -63.25 -47.88 80.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 0.0 109.31 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.606 ' CD1' HG23 ' A' ' 102' ' ' VAL . 14.5 t90 -64.82 -41.67 95.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.8 tp -75.15 -16.58 60.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.551 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.4 tt -99.36 -16.8 18.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 72' ' ' ALA . 40.5 p -100.12 -29.17 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.606 HG23 ' CD1' ' A' ' 98' ' ' TRP . 2.2 t -60.0 -58.63 17.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.675 0.75 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.75 -24.82 29.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.71 2.273 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 100' ' ' LEU . 8.5 mt -76.51 -52.45 9.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.743 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.8 pp -64.08 -38.52 91.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.789 HD12 ' HD3' ' A' ' 126' ' ' LYS . 26.1 mm -70.55 -57.94 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.521 ' HB2' HD13 ' A' ' 123' ' ' LEU . 35.9 t -52.05 -49.83 62.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -55.48 33.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -51.11 -50.75 58.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.682 ' HB3' ' HB3' ' A' ' 120' ' ' ALA . 18.4 m-85 -68.53 -30.54 69.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -60.23 -63.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 61' ' ' SER . 39.4 mm -62.64 -37.53 79.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.062 HD11 HG13 ' A' ' 182' ' ' VAL . 4.9 tp -62.54 -50.45 71.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -76.97 -14.01 59.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.69 -23.62 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -27.65 68.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -117.81 -45.84 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -179.61 -78.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -154.74 157.34 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -106.8 124.29 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.31 -5.53 81.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -50.5 -28.15 7.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 107' ' ' CYS . 21.4 tp -51.82 -39.78 59.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -64.95 -52.68 55.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -49.94 74.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HD3' HD12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -64.32 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -48.32 76.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -58.58 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.856 HG11 ' HG3' ' A' ' 162' ' ' MET . 48.1 t -56.3 -51.95 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.63 74.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -45.35 91.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -60.47 -49.67 76.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 129' ' ' VAL . 39.6 t -54.8 -51.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.452 ' HE1' ' HA ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -62.53 -35.89 80.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -58.94 -51.01 71.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD12 ' A' ' 154' ' ' ILE . 80.7 t -64.62 -46.89 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -59.71 -39.51 84.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -51.99 8.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.56 -55.75 30.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.95 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.609 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 16.3 mmt -69.29 -47.9 63.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.63 -31.7 53.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -47.48 -46.77 27.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.6 -27.1 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.48 20.33 30.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.8 pt -75.52 -40.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.876 0.37 . . . . 0.0 111.157 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.64 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -156.39 132.52 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 146' ' ' MET . . . 165.11 -20.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.677 ' HB3' ' CE1' ' A' ' 208' ' ' TYR . . . -67.75 -43.0 80.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.638 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 4.9 t-105 -66.78 -54.82 19.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.532 0.682 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.71 -16.96 38.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.319 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.7 -33.17 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.4 -37.72 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.6 -65.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 136' ' ' VAL . 6.5 pt -50.68 -44.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.15 61.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.721 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.1 t -55.22 -50.5 69.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.15 -50.34 73.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.26 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.532 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.6 t90 -65.21 -55.14 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 156' ' ' CYS . 33.1 t -52.75 -50.15 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -39.88 94.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.856 ' HG3' HG11 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -54.84 -58.7 6.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.9 mp -68.49 -32.17 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -53.24 -55.91 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -76.65 -35.29 58.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 tp -60.52 -40.25 90.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -21.58 26.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -110.44 20.01 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.815 0.34 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.56 163.19 21.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.699 0.761 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.64 27.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.27 -48.39 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 1.062 HG13 HD11 ' A' ' 113' ' ' LEU . 85.4 t -63.38 -41.78 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -65.78 -33.43 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.6 m -70.57 -46.89 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.48 94.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.17 -51.77 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -56.48 -49.94 73.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 20.6 p -61.91 -38.48 88.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.622 ' SD ' HD11 ' A' ' 238' ' ' ILE . 5.1 tpt -62.31 -51.95 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.628 ' CE ' HG23 ' A' ' 163' ' ' ILE . 2.7 ttp -61.5 -38.62 87.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -49.04 79.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.3 mm -65.21 -48.49 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.6 mm -52.58 -45.93 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.525 HG23 ' NE1' ' A' ' 159' ' ' TRP . 32.1 mt -64.95 -51.33 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.2 -57.5 11.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -56.51 -59.21 11.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.5 -34.01 56.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.92 -23.7 44.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.108 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.1 mt -78.37 -32.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 6.8 t80 -48.38 -56.23 15.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.76 -23.65 30.57 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.697 2.264 . . . . 0.0 112.379 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.19 -45.24 83.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.01 -39.03 10.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -53.22 -48.59 68.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.923 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.07 -32.77 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.5 OUTLIER -67.23 -13.38 61.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -131.6 5.01 5.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.839 0.352 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.71 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.5 mp -52.78 -63.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -33.64 39.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.9 -54.47 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.4 t30 -61.12 -52.12 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 32' ' ' SER . 2.2 tm? -52.17 -58.46 6.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 221' ' ' LEU . 96.6 mt -54.2 -42.51 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.71 -52.56 63.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -37.92 83.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.1 tp -63.04 -45.0 94.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.75 -52.14 64.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.61 -32.05 73.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -66.18 -49.61 66.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 233' ' ' LEU . 53.7 t -73.33 -25.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -80.47 2.55 24.76 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-O 126.738 3.161 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.677 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 5.2 mmtm -131.59 -51.57 0.99 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.111 -3.493 . . . . 0.0 112.761 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.3 mm -65.33 -64.53 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.16 -1.837 . . . . 0.0 111.101 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.442 ' HB2' HG13 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -50.91 -36.0 35.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.9 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -51.56 -56.04 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.65 65.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.99 -47.36 85.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.8 mm -71.42 -50.77 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.622 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.5 mm -53.19 -40.92 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.648 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.9 t90 -74.71 -41.97 59.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -60.55 -42.54 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.02 -35.12 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.76 72.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' VAL . 60.7 t -79.76 -37.9 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -70.27 -37.8 74.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -77.04 -46.29 24.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.9 t -51.95 -62.3 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.795 0.331 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 170.7 12.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.18 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.64 -39.62 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -53.71 -62.36 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -48.05 80.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -52.79 -46.27 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.41 -51.44 16.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.5 t -52.11 -50.53 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 111.164 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 36' ' ' VAL . 17.9 t -66.18 -49.89 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -52.35 -49.13 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -63.79 -47.33 81.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.07 -38.2 78.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 32' ' ' SER . 98.7 t -68.79 -45.21 81.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 m -61.88 -51.59 67.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.92 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.087 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -59.18 -55.43 35.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD13 ' HE1' ' A' ' 77' ' ' MET . 5.0 tt -53.33 -39.72 64.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 45' ' ' VAL . 51.6 tp -61.45 -56.02 24.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -24.15 67.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.683 ' OG ' HD12 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -71.36 -51.85 21.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.3 t -69.58 -39.48 77.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 41' ' ' LEU . 82.0 t -65.05 -49.32 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.53 -45.06 76.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -64.54 -30.47 71.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -75.04 -51.78 12.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.83 -36.12 76.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.37 -9.26 59.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.42 -29.08 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.15 -11.66 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.17 24.6 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.801 ' HA ' HG22 ' A' ' 243' ' ' VAL . 7.9 p -112.51 156.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 148.65 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -55.56 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -20.7 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -88.58 -15.33 35.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -51.68 -50.38 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 64' ' ' VAL . 7.6 p -61.13 -50.34 73.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.41 ' OG ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.53 -35.53 72.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -68.71 -32.36 72.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -53.96 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 68' ' ' VAL . 14.8 m -64.5 -51.29 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.523 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.4 t -68.1 -38.16 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -36.38 68.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.79 -50.01 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -64.69 -48.45 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' VAL . 5.1 t -62.54 -33.56 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.03 -69.56 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 pt -45.4 -41.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -65.36 -49.41 69.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.734 ' CE2' HD11 ' A' ' 232' ' ' ILE . 23.5 t80 -52.77 -55.24 24.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -56.69 -46.15 81.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.56 -38.77 88.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -68.93 -68.53 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.435 ' HE1' HD13 ' A' ' 40' ' ' LEU . 3.2 ppp? -45.28 -42.9 10.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.7 t80 -65.03 -49.01 71.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.7 mmm -59.61 -48.99 79.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -56.21 22.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.26 -43.56 75.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.7 t -69.46 -27.67 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 111.081 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -69.93 -53.35 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -72.89 -26.05 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -50.08 -47.62 53.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.2 p -108.12 -39.06 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.93 -56.34 0.74 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.62 126.82 53.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.48 161.01 37.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 78.79 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.353 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 m -54.02 -25.66 22.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 96' ' ' ILE . 14.8 p -48.14 -32.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -69.56 -52.39 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -59.89 -45.03 93.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.437 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 35.8 t80 -60.34 -52.0 67.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.578 ' CD1' HG22 ' A' ' 92' ' ' VAL . 76.7 mt -63.55 -27.69 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.52 -68.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 109.275 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.599 ' O ' HG23 ' A' ' 102' ' ' VAL . 11.1 t-105 -53.84 -32.78 54.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 1.0 OUTLIER -75.23 -32.76 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.953 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.1 tt -84.03 -14.9 49.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HB2' ' A' ' 72' ' ' ALA . 55.9 p -99.42 -32.69 11.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 98' ' ' TRP . 2.1 t -46.49 -59.41 5.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.0 Cg_endo -69.75 -23.33 30.95 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -71.63 -53.97 11.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.499 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.9 pp -71.93 -37.5 70.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 102' ' ' VAL . 21.9 mt -62.67 -51.38 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.04 -47.73 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -58.03 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HE1' HD22 ' A' ' 113' ' ' LEU . 19.6 t80 -51.21 -52.16 47.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.66 -30.49 71.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -66.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.41 HG21 ' OG ' ' A' ' 61' ' ' SER . 43.4 mm -58.56 -37.83 67.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 HG13 ' A' ' 182' ' ' VAL . 11.2 tp -65.12 -51.4 61.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -69.6 -16.58 63.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -54.14 -22.54 11.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.556 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -59.8 -30.06 68.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -120.1 -48.3 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 178.17 -73.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.2 m -155.17 157.21 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.37 123.6 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.0 -6.09 81.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.5 t -50.62 -28.95 9.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.95 -39.42 94.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -52.31 64.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -62.14 -34.05 75.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.05 -46.31 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.95 -58.18 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 133' ' ' VAL . 52.0 t -55.19 -50.09 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.45 94.68 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 t -59.85 -48.05 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -52.97 63.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' VAL . 47.4 t -52.31 -46.23 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -30.68 68.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -65.71 -50.17 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 154' ' ' ILE . 21.1 m -67.07 -39.12 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -68.31 -37.15 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.36 -51.9 19.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -64.35 -54.92 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 21.7 tpp -60.79 -43.08 98.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.79 -32.44 82.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.53 -28.53 8.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.35 -26.79 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.58 44.02 50.93 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 65.1 mt -84.97 -54.56 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -130.36 136.61 49.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -149.75 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' A' ' 205' ' ' PHE . . . -65.89 -45.65 81.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.08 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.618 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.03 -52.92 15.08 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.69 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.75 -9.86 27.16 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -60.73 -53.91 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -30.39 58.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 150' ' ' PRO . 39.9 mt -64.24 -66.48 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.645 HD13 HG21 ' A' ' 136' ' ' VAL . 24.3 mt -61.37 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.05 68.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.9 t -58.66 -49.59 76.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.26 -48.52 68.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.15 90.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -60.69 -56.42 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.25 -45.9 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.76 -41.29 99.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -57.85 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.2 mt -63.87 -37.95 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -52.94 -54.21 38.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -74.79 -48.71 23.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -51.36 -60.07 3.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -58.01 -20.29 37.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.17 17.96 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.742 0.306 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.64 162.99 24.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.667 0.746 . . . . 0.0 110.879 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -16.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.97 37.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.705 HG13 HD11 ' A' ' 113' ' ' LEU . 87.3 t -65.91 -47.03 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.3 -38.29 86.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -66.82 -48.42 68.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.83 86.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -51.53 61.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.74 -41.03 73.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' ILE . 9.9 p -72.29 -32.23 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -64.74 -52.21 58.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.43 76.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -50.96 69.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 237' ' ' ILE . 24.3 pt -69.38 -33.46 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.536 HD11 ' HE1' ' A' ' 189' ' ' MET . 5.5 mm -61.26 -53.19 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 17.9 pt -67.33 -36.75 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.89 -60.97 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.72 97.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -61.63 -32.37 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.05 -27.52 35.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.3 mt -80.96 -31.03 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.8 t80 -48.36 -54.19 27.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.732 0.777 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.75 -21.91 32.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 0.0 112.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.4 t -70.19 -44.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.41 ' C ' HG21 ' A' ' 222' ' ' ILE . . . -82.5 -37.38 14.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.497 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.416 ' N ' HG21 ' A' ' 222' ' ' ILE . 71.6 t80 -57.95 -36.37 72.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.897 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 148' ' ' ALA . 13.9 t80 -63.39 -49.4 73.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 t -73.24 -13.93 61.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -96.79 -21.48 21.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 18.1 t80 . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 -179.826 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.888 0.375 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.19 -23.67 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.73 -62.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -25.61 61.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.81 -58.81 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.02 -43.32 95.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -53.93 -58.49 7.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 221' ' ' LEU . 34.9 mm -59.47 -44.39 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.61 -47.81 78.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.73 -43.9 82.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 229' ' ' VAL . 4.4 tt -57.01 -49.64 75.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.92 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.2 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -56.43 -27.93 58.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.2 t80 -73.08 -46.91 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 225' ' ' LEU . 21.2 t -73.88 -25.43 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.88 2.26 31.28 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 126.686 3.136 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 3.5 mmtm -130.74 -58.3 1.03 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 117.109 -3.494 . . . . 0.0 112.71 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.734 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.4 mm -62.11 -64.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.08 174.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -38.21 50.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.57 -56.63 12.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.22 90.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.2 -44.17 96.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.312 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 192' ' ' ILE . 4.7 mm -67.65 -47.18 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.01 -40.9 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.63 ' O ' HG23 ' A' ' 243' ' ' VAL . 13.3 t90 -71.94 -41.08 68.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -62.95 -43.88 97.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.87 -32.5 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.21 62.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 54' ' ' VAL . 62.3 t -76.36 -33.22 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -75.88 -39.7 55.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.1 -42.84 55.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 t -52.05 -58.92 5.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.38 -177.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.5 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -54.23 -36.23 63.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 61.4 m-20 -55.78 -69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.755 ' HB3' HD12 ' A' ' 217' ' ' LEU . 0.3 OUTLIER -60.5 -46.67 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.5 m -51.68 -45.78 63.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.62 -50.49 36.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' ASP . 80.1 t -54.36 -54.51 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.5 t -60.45 -49.97 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -52.44 -49.23 64.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -44.52 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -36.68 84.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 32' ' ' SER . 89.2 t -66.02 -51.51 59.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 m -62.83 -46.36 88.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.71 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.151 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.42 56.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 tt -51.58 -54.42 27.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -56.44 -54.22 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.72 62.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -66.18 -28.17 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -72.33 -50.15 29.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 49' ' ' VAL . 23.4 m -65.73 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -70.43 -51.69 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -63.41 -30.96 72.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -74.03 -51.25 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.8 t -68.32 -31.47 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.74 -4.88 53.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -55.78 -26.37 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.25 -10.67 22.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -95.49 24.6 5.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 62' ' ' LEU . 8.6 p -111.95 158.61 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.195 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -48.03 157.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.59 -55.9 11.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -61.4 -19.87 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 40.7 m95 -88.96 -6.81 56.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -50.81 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 64' ' ' VAL . 56.2 p -68.13 -39.07 82.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.737 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.57 -37.12 75.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.26 -33.7 76.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -54.89 8.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 112' ' ' ILE . 10.6 m -63.54 -53.53 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.536 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -66.09 -39.53 90.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.15 -32.7 69.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.79 -47.64 62.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.2 p -67.69 -45.32 84.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.476 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 m -69.51 -35.32 75.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.45 -45.97 65.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.59 -48.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.847 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.44 -41.91 97.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 25.2 t80 -59.94 -52.47 65.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -56.99 -50.27 73.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -56.59 -53.68 54.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.79 -53.21 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.97 -53.83 18.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.3 t80 -56.55 -43.46 79.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -51.95 67.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.498 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -53.56 -55.46 25.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.9 -46.33 60.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.0 t -67.51 -27.83 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.344 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -67.59 -54.83 16.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.512 ' CD1' ' HB1' ' A' ' 216' ' ' ALA . 11.2 tp -73.59 -24.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -46.77 -47.92 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 t -123.04 -39.11 2.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.158 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.55 -38.48 1.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.56 127.12 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p -138.61 160.25 64.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 97.59 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.7 2.266 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -69.58 -26.81 64.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.498 HG12 ' CD1' ' A' ' 96' ' ' ILE . 68.5 t -50.73 -46.65 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -38.31 90.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -64.08 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -36.41 70.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 92' ' ' VAL . 39.7 mt -63.73 -66.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 101' ' ' THR . 0.1 OUTLIER -54.51 -33.37 59.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.533 1.146 . . . . 0.0 109.305 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -55.95 -63.17 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' SD ' ' A' ' 134' ' ' MET . 0.3 OUTLIER -76.26 -10.47 59.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.918 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.87 -15.18 30.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.847 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.9 p -112.62 -36.24 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.495 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -46.67 -59.43 5.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.689 0.756 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.77 -18.68 36.82 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 68' ' ' VAL . 2.4 mm? -77.51 -53.92 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HA ' HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -66.1 -50.44 64.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 126' ' ' LYS . 35.5 mm -55.02 -56.08 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.0 t -58.54 -40.0 81.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -56.35 -65.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.691 ' CE2' HD12 ' A' ' 238' ' ' ILE . 43.9 t80 -50.0 -50.16 48.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 13.0 m-85 -60.1 -32.21 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.23 -62.22 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.737 HG21 ' CB ' ' A' ' 61' ' ' SER . 2.3 mp -50.77 -41.97 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 HG13 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -69.36 -41.4 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . . . -72.2 -15.68 61.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.36 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.086 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.4 -18.15 61.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.1 t -119.34 -49.38 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.179 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.63 -78.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.64 163.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 114' ' ' ALA . . . -104.05 118.09 35.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.29 -14.96 81.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.512 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.3 m -54.53 -23.99 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.868 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.41 -37.58 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -73.42 -42.04 62.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 129' ' ' VAL . 34.1 mttm -64.18 -50.32 68.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.88 -36.08 82.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.912 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -48.08 80.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.918 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.79 -58.91 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 133' ' ' VAL . 60.1 t -54.08 -52.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.79 -49.19 76.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.4 m -53.67 -45.87 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.62 -50.54 72.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 129' ' ' VAL . 62.8 t -51.36 -45.68 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.599 ' SD ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.6 -41.03 89.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -54.56 -53.18 57.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 154' ' ' ILE . 42.0 t -67.14 -50.87 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.93 -44.14 63.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.32 -52.47 8.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -53.5 -57.66 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.1 mmt -69.99 -32.56 70.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.57 78.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.43 -27.85 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -103.09 -28.16 12.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.48 20.75 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.472 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.116 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.459 ' HE3' ' HG3' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -115.49 122.35 45.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.4 -29.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.34 -42.97 87.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -70.22 -58.33 5.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.79 -6.26 18.18 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -65.14 -44.18 89.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.6 mp -58.95 -63.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.856 HD13 HG11 ' A' ' 136' ' ' VAL . 52.0 mt -58.36 -51.72 67.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -54.55 -49.07 62.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.465 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.537 ' O ' HG23 ' A' ' 160' ' ' VAL . 40.4 t -56.54 -51.1 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -49.34 65.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.53 83.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.573 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.6 t90 -67.42 -56.69 8.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 156' ' ' CYS . 25.7 t -53.82 -52.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -59.83 -44.67 93.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.542 ' O ' HD13 ' A' ' 166' ' ' LEU . 6.2 mmm -50.73 -56.59 11.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 194' ' ' ILE . 1.6 mp -62.29 -38.87 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -51.25 56.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.19 -52.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 162' ' ' MET . 8.7 mp -50.31 -59.09 4.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -57.04 -20.93 27.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -106.12 17.69 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.752 0.311 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.08 161.76 52.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.636 0.731 . . . . 0.0 110.839 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -22.0 32.84 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.85 -43.16 47.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.651 HG13 HD12 ' A' ' 113' ' ' LEU . 17.9 t -70.73 -46.26 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.67 -36.51 84.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.706 ' O ' HG22 ' A' ' 188' ' ' THR . 32.2 t -71.16 -49.71 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.486 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -59.93 -37.88 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -50.61 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -53.58 -56.96 12.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 184' ' ' SER . 6.7 t -60.32 -41.98 94.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.463 ' HG3' HD11 ' A' ' 238' ' ' ILE . 0.4 OUTLIER -57.65 -51.51 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.443 ' HG2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.13 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -50.35 68.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -70.01 -39.5 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.17 -56.57 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 163' ' ' ILE . 54.4 mt -60.15 -48.46 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -49.83 -56.34 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.44 -59.72 10.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -54.44 -31.36 55.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.48 -22.89 43.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.104 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.4 mt -78.92 -32.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 151' ' ' ALA . 23.8 t80 -49.93 -54.5 31.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.682 0.753 . . . . 0.0 110.914 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.7 Cg_endo -69.77 -25.03 28.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.682 2.255 . . . . 0.0 112.384 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.6 t -71.51 -37.73 65.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.12 -28.88 39.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.41 -33.76 21.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.59 -28.03 12.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.7 p -47.83 -32.4 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 136.58 44.03 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.752 ' CE1' HD12 ' A' ' 222' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.883 0.373 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB1' ' CD1' ' A' ' 84' ' ' ILE . . . -54.01 -42.09 68.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 28' ' ' TYR . 4.2 mm? -53.5 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.11 -26.98 65.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.682 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -62.67 -59.01 5.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -65.7 -34.7 78.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.475 ' C ' HD13 ' A' ' 221' ' ' LEU . 2.9 tm? -62.36 -58.11 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.752 HD12 ' CE1' ' A' ' 208' ' ' TYR . 86.6 mt -58.82 -49.04 84.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.41 -54.54 45.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -60.84 -32.55 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 229' ' ' VAL . 26.0 tp -63.54 -49.25 74.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.72 -49.06 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -46.78 87.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -59.09 -44.18 91.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.826 HG13 HD13 ' A' ' 233' ' ' LEU . 99.1 t -72.91 -25.59 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -93.9 2.1 56.22 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.738 3.161 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -120.94 -60.36 1.66 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.095 -3.503 . . . . 0.0 112.751 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.8 mm -67.64 -64.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.177 174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.826 HD13 HG13 ' A' ' 229' ' ' VAL . 0.3 OUTLIER -54.09 -34.52 60.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -56.64 -56.56 19.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.42 -34.4 87.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -41.07 87.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.526 HD12 ' OG1' ' A' ' 188' ' ' THR . 1.1 mm -68.46 -50.1 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.691 HD12 ' CE2' ' A' ' 109' ' ' PHE . 39.6 mm -61.61 -37.73 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.604 ' O ' HG23 ' A' ' 243' ' ' VAL . 14.7 t90 -74.78 -41.96 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.67 -44.3 93.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.503 ' HB ' HG21 ' A' ' 188' ' ' THR . 8.1 p -70.59 -41.38 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.417 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.59 -39.08 91.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.774 HG22 ' HA ' ' A' ' 54' ' ' VAL . 87.8 t -78.45 -34.77 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -69.87 -40.92 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.14 -41.36 42.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 29.7 t -51.39 -46.68 62.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.823 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' A' ' 27' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 168.43 15.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.096 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.9 t -52.03 -31.18 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -58.59 -63.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.563 ' CE2' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.98 -47.96 80.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -51.21 -47.71 62.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.13 -51.55 38.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 97.3 t -53.24 -56.19 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 111.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -48.78 78.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -52.05 -39.93 60.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -71.37 -40.0 70.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.67 -44.34 86.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG23 ' CE2' ' A' ' 228' ' ' PHE . 13.2 p -70.02 -35.83 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.5 m -71.03 -54.19 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.46 -44.9 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 228' ' ' PHE . . . -63.89 -50.27 69.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' CE2' ' A' ' 73' ' ' PHE . 2.1 tt -55.3 -42.36 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.4 tp -64.42 -56.1 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -38.15 74.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.516 ' OG ' HD12 ' A' ' 232' ' ' ILE . 3.2 t -67.56 -48.96 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -63.82 -46.55 84.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' LEU . 88.8 t -60.92 -46.61 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.26 -48.85 66.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -61.39 -28.85 69.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -75.66 -50.33 15.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.02 -33.19 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -79.23 -6.56 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -59.47 -27.76 66.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.62 -13.7 27.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.69 39.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.774 HG21 HD21 ' A' ' 62' ' ' LEU . 8.5 p -117.89 160.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 54' ' ' VAL . 26.0 t -48.87 143.11 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.22 57.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 -25.06 61.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -91.85 13.25 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -49.69 -50.26 44.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.3 p -76.84 -30.26 56.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -44.06 72.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.774 HD21 HG21 ' A' ' 54' ' ' VAL . 3.9 mm? -67.84 -28.94 67.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -53.34 20.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 21.8 m -70.69 -46.83 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.1 t -66.62 -39.0 88.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.06 -36.22 60.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.17 -49.83 58.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -65.67 -44.78 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' VAL . 96.4 m -67.62 -36.14 80.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.71 -41.57 74.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.461 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 mt -66.95 -50.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -65.11 -36.95 85.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.079 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CE2' HD12 ' A' ' 40' ' ' LEU . 57.9 t80 -60.53 -54.85 40.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -46.7 85.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -59.11 -63.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.17 -55.29 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -57.5 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.34 -40.46 82.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.4 mmt -59.91 -56.51 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -55.36 19.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -47.85 57.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 78' ' ' TYR . 94.4 t -64.08 -37.22 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -59.78 -48.12 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.6 tp -74.29 -25.93 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.52 -48.12 38.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -115.01 -39.36 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.164 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.64 -14.41 5.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -135.34 141.49 45.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.27 162.08 33.88 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.697 0.761 . . . . 0.0 110.826 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.32 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -66.78 -25.6 66.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -65.7 -53.19 44.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -62.31 -30.79 71.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -65.38 -56.44 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.91 -32.73 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.63 -61.99 2.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.147 . . . . 0.0 109.293 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 133' ' ' VAL . 5.2 t90 -61.02 -35.72 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 134' ' ' MET . 64.7 tp -73.91 -17.15 61.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.57 ' O ' HD22 ' A' ' 104' ' ' LEU . 1.2 tt -102.42 -16.5 16.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.66 HG23 HG22 ' A' ' 68' ' ' VAL . 6.0 m -100.41 -35.41 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 133' ' ' VAL . 2.4 t -55.51 -57.83 18.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.729 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.77 -20.97 34.07 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 68' ' ' VAL . 3.9 mp -78.56 -53.7 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 101' ' ' THR . 3.6 pp -62.48 -45.3 93.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 105' ' ' LEU . 10.6 tt -63.14 -42.16 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.47 ' N ' HG23 ' A' ' 106' ' ' ILE . 42.1 t -69.16 -41.34 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -54.44 46.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.34 -52.38 65.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.575 ' HA ' HD23 ' A' ' 113' ' ' LEU . 6.7 m-85 -57.38 -49.92 74.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.93 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 111' ' ' LEU . 1.9 tm? -57.9 -50.69 72.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 mt -50.77 -46.34 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -70.62 -28.2 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' VAL . . . -78.22 -19.01 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.04 -10.85 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.67 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -71.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.75 -75.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 7.1 p -48.21 141.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.25 98.45 5.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.02 77.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -48.02 -34.72 9.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mt -50.95 -53.23 34.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -65.13 -53.44 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -50.68 52.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -33.3 75.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.12 -51.39 61.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.75 -60.85 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.1 t -54.56 -45.17 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.25 -46.67 94.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 m -58.26 -57.1 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -51.22 -52.13 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 102' ' ' VAL . 68.8 t -53.13 -47.4 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.417 ' HB2' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -64.03 -44.98 90.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.0 -57.62 12.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 132' ' ' LEU . 43.9 t -53.2 -51.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.98 -36.65 79.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -55.96 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.942 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.1 mtt -53.13 -37.8 62.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.87 -30.16 58.08 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -40.26 -52.98 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -27.47 8.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.5 15.65 47.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 pt -98.19 -36.4 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.13 137.91 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.774 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 172.12 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.759 ' HB1' ' CE1' ' A' ' 204' ' ' TYR . . . -63.24 -40.69 98.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -71.01 -60.58 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.511 0.672 . . . . 0.0 110.932 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 147' ' ' ALA . 53.9 Cg_endo -69.75 -1.63 8.79 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.2 -50.49 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.64 -45.96 70.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.6 mp -61.11 -59.09 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.54 -47.09 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.96 -49.55 77.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.3 t -57.11 -51.47 69.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.892 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.26 -49.18 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.07 92.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.566 ' NE1' HG23 ' A' ' 194' ' ' ILE . 3.5 t90 -62.17 -56.38 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.6 t -57.09 -50.11 77.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -55.16 -44.54 75.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -59.18 -58.02 10.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.89 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.564 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -59.21 -33.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -61.02 -52.16 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.66 -31.57 63.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 162' ' ' MET . 6.4 mp -67.15 -52.27 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.416 ' CE3' ' HE1' ' A' ' 190' ' ' MET . 2.6 t-105 -57.6 -20.95 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.02 18.12 21.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.797 0.332 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.22 162.37 54.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.01 31.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.16 30.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 113' ' ' LEU . 89.2 t -68.68 -41.39 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -65.7 -36.96 85.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.516 ' C ' HG21 ' A' ' 241' ' ' VAL . 59.7 p -70.07 -49.45 50.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -60.72 -41.83 96.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.7 -51.1 64.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -53.91 -51.81 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 237' ' ' ILE . 1.4 m -61.66 -37.11 82.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.603 ' CG ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.96 -51.19 70.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.564 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -64.13 -35.6 81.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -50.94 70.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -33.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.84 -50.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.566 HG23 ' NE1' ' A' ' 159' ' ' TRP . 58.4 mt -64.27 -49.31 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.95 -58.58 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -57.26 -58.44 14.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -54.66 -30.98 56.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.02 -23.04 44.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA2' ' A' ' 196' ' ' GLY . 16.9 mt -80.01 -32.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.688 ' HE1' ' HB1' ' A' ' 151' ' ' ALA . 13.4 t80 -48.57 -54.01 30.57 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.76 -23.03 31.24 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.315 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 75.9 t -71.66 -36.5 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' THR . . . -82.98 -34.88 20.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.511 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.759 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -51.59 -40.21 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.9 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -64.4 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -50.51 -27.86 7.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 144.82 57.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.466 ' CD2' HD13 ' A' ' 219' ' ' LEU . 33.9 t80 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.937 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.38 -23.8 58.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.8 mt -55.24 -63.34 1.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -58.67 -33.56 70.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 208' ' ' TYR . 3.5 tp -59.63 -55.94 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.433 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.5 t30 -64.04 -36.87 85.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.4 tm? -63.49 -53.63 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 221' ' ' LEU . 19.8 mt -59.49 -48.09 88.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -57.09 12.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.52 -44.69 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -61.46 -39.83 92.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.46 27.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -29.31 69.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.676 ' CE2' HG23 ' A' ' 36' ' ' VAL . 44.3 t80 -71.64 -58.5 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 225' ' ' LEU . 9.1 p -62.44 -30.67 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -78.05 -25.33 47.7 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.679 3.133 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -76.9 -30.39 56.14 Favored 'General case' 0 N--CA 1.423 -1.79 0 O-C-N 117.114 -3.491 . . . . 0.0 112.778 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.516 HD12 ' OG ' ' A' ' 43' ' ' SER . 47.6 mm -86.95 -38.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.146 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.1 mt -55.78 -34.07 64.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -61.39 -57.54 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.68 -34.97 79.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.47 -39.41 85.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.762 0.315 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 188' ' ' THR . 5.0 mm -70.8 -50.03 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.603 HD11 ' CG ' ' A' ' 189' ' ' MET . 40.0 mm -62.16 -35.61 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.668 ' O ' HG23 ' A' ' 243' ' ' VAL . 37.7 t90 -77.59 -47.25 19.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -56.81 -42.66 79.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.4 p -74.35 -39.97 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.415 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.41 -39.72 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 54' ' ' VAL . 43.9 t -78.27 -38.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -42.46 99.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.03 -49.22 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.2 t -58.43 -33.37 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 179.4 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -63.27 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -51.67 60.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -51.89 -50.52 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.56 -48.26 81.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.9 m -50.77 -47.55 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.01 32.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.1 t -53.55 -56.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -59.55 -45.8 90.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -51.92 -44.12 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -46.24 68.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -41.04 88.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 32' ' ' SER . 87.1 t -67.95 -49.3 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.8 m -60.2 -41.41 92.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.43 -52.17 55.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.071 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -55.17 29.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 tp -53.17 -46.48 68.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.98 -56.1 26.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.971 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.41 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.1 t -68.3 -29.29 68.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 m -72.34 -49.1 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 46' ' ' PHE . 20.0 m -65.15 -41.47 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -67.45 -50.5 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.2 -26.74 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -72.43 -50.06 29.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.41 -34.57 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.712 ' O ' HG13 ' A' ' 54' ' ' VAL . 81.6 mt-10 -80.14 -9.99 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -52.72 -29.0 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.99 -4.82 13.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.83 29.63 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 243' ' ' VAL . 12.6 m -114.34 -171.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.05 164.11 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.92 -54.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -25.66 64.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.465 ' CG ' ' HB1' ' A' ' 242' ' ' ALA . 61.7 m95 -83.51 -17.2 42.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.41 -49.68 53.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.94 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 64' ' ' VAL . 4.5 p -76.61 -43.91 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB2' HD13 ' A' ' 112' ' ' ILE . 5.0 t -53.03 -44.44 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -66.13 -31.61 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.6 m -73.85 -54.77 7.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 60' ' ' THR . 12.3 m -62.33 -50.39 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 64' ' ' VAL . 7.1 t -70.14 -40.46 74.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.8 -34.77 78.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.466 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.13 -49.63 55.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -62.74 -47.25 93.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.491 ' N ' HG13 ' A' ' 68' ' ' VAL . 51.8 p -62.96 -36.67 84.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.65 -66.66 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.473 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -47.46 -36.84 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -72.03 -49.41 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 232' ' ' ILE . 13.2 t80 -59.23 -49.48 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -62.07 -51.99 65.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -59.0 -43.41 91.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.82 -69.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -48.19 -35.96 12.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 82' ' ' VAL . 72.3 t80 -65.87 -75.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.5 mtt -53.55 -57.35 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.48 -56.79 16.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.06 -51.21 41.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.9 t -61.52 -52.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.403 ' O ' HG22 ' A' ' 86' ' ' THR . 1.1 m-90 -50.71 -55.44 16.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.73 -30.38 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.99 -21.23 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 83' ' ' TRP . 11.1 t -112.46 -21.5 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 63.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -139.49 149.97 44.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 p -115.15 79.97 6.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 0.0 110.924 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 73.07 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -70.06 -36.21 74.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 29.0 m -69.98 -43.9 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 25.7 m-85 -72.42 -32.57 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -78.26 -47.17 18.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.46 -37.09 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.82 -50.98 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.55 -36.17 73.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.289 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CE2' HG21 ' A' ' 102' ' ' VAL . 9.5 t-105 -75.39 -50.08 16.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.05 -11.06 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 tp -103.13 -34.02 9.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.42 HG21 ' CB ' ' A' ' 72' ' ' ALA . 91.4 m -85.36 -37.96 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 t -50.71 -53.31 48.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.625 0.726 . . . . 0.0 111.121 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.73 -25.1 29.09 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 68' ' ' VAL . 28.2 mt -75.84 -52.54 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.53 -41.15 93.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.676 ' N ' HD23 ' A' ' 105' ' ' LEU . 13.0 tt -66.78 -34.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.8 t -69.53 -53.48 18.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -58.25 -45.66 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.719 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 5.8 t80 -59.45 -49.78 76.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.481 ' HD1' ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -61.98 -33.58 74.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -61.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 61' ' ' SER . 5.6 tp -56.51 -39.91 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 186' ' ' TYR . 3.3 tt -64.39 -42.32 96.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -76.89 -18.51 58.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.44 -20.2 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.103 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 182' ' ' VAL . . . -101.45 -78.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -48.18 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' HG23 ' A' ' 117' ' ' THR . 1.1 m-20 174.89 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.1 p -168.23 131.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.481 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -110.34 102.49 11.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.25 -5.5 66.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -29.64 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.854 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 120' ' ' ALA . 1.8 pt? -61.75 -34.74 76.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -49.66 60.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.7 mttt -62.6 -50.36 71.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' HD12 ' A' ' 106' ' ' ILE . 6.5 mttt -61.53 -36.74 81.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -44.51 86.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -58.33 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 162' ' ' MET . 28.9 m -56.29 -38.77 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 -42.72 94.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.518 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.2 t -63.46 -45.05 92.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.62 -52.63 60.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 129' ' ' VAL . 75.3 t -54.21 -47.24 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.04 -58.0 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.806 HG13 HD23 ' A' ' 135' ' ' LEU . 19.0 m -68.75 -39.23 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.407 ' HD1' HG23 ' A' ' 136' ' ' VAL . 4.4 m-30 -56.48 -43.82 80.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.06 -50.11 8.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -55.06 31.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.792 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -65.23 -47.82 75.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.59 -33.13 62.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.16 -23.96 24.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.86 -27.27 9.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.66 49.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -37.3 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.506 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -170.7 137.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.792 ' HB2' ' HB3' ' A' ' 140' ' ' MET . . . 173.73 -27.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.124 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.9 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.582 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.7 t-105 -65.66 -55.49 23.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.55 0.691 . . . . 0.0 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.798 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.6 Cg_endo -69.75 -20.77 34.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.653 2.235 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.55 -29.06 6.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -69.58 -42.92 73.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 150' ' ' PRO . 5.1 mt -62.9 -67.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 136' ' ' VAL . 6.5 pt -51.65 -44.83 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.93 -48.89 77.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.1 m -61.21 -50.71 71.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.884 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -50.42 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.81 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.496 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.9 t90 -67.28 -57.5 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.496 HG23 ' CE3' ' A' ' 159' ' ' TRP . 91.0 t -61.7 -40.26 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -68.2 -45.33 73.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.968 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.633 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.1 tpt -53.88 -52.92 58.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.712 HG22 ' CE3' ' A' ' 167' ' ' TRP . 50.5 mt -63.6 -53.1 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -49.81 -33.31 16.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -53.68 8.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.5 pp -70.12 -11.13 60.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.712 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -62.81 -16.38 57.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.03 14.6 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.502 -179.934 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.807 0.336 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.6 163.62 22.15 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 0.0 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -27.14 26.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.59 -45.26 31.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 116' ' ' ALA . 51.1 t -60.49 -47.72 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.29 -35.54 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -43.97 78.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.6 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.812 ' CD2' HD11 ' A' ' 113' ' ' LEU . 11.8 t80 -67.04 -46.82 73.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.973 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -49.3 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -64.92 -32.75 74.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.466 ' HE1' HG13 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -64.81 -52.58 56.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.0 ptm -63.52 -35.52 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.02 -48.21 79.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.566 HD12 HD12 ' A' ' 233' ' ' LEU . 31.2 mm -65.23 -54.45 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.14 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 234' ' ' PHE . 34.0 mm -50.71 -53.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.544 HD13 HD13 ' A' ' 163' ' ' ILE . 76.9 mt -56.84 -51.67 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -53.67 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.01 -62.72 5.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -53.62 -30.61 43.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -76.8 -26.3 54.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.07 -30.89 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.3 t80 -45.5 -56.19 10.29 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.674 0.75 . . . . 0.0 110.917 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.3 Cg_endo -69.7 -23.16 31.39 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.657 2.238 . . . . 0.0 112.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 198' ' ' ALA . 88.7 t -68.48 -45.2 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.95 -46.34 5.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.59 -48.57 71.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.918 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -49.95 -54.28 20.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.3 t -73.09 -14.21 61.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -92.41 -13.1 57.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 34.5 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.936 -179.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.01 65.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.88 -52.28 64.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.555 ' HA ' HD21 ' A' ' 221' ' ' LEU . 0.2 OUTLIER -51.54 -35.66 41.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.16 -44.63 59.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -55.47 -51.65 66.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 218' ' ' ASN . 1.2 pp -66.71 -48.87 67.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 221' ' ' LEU . 28.8 mt -54.38 -44.49 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -65.82 -52.98 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -56.85 -39.24 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.07 -49.15 71.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.23 -55.09 37.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -63.26 -32.66 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -60.91 -55.67 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 233' ' ' LEU . 21.5 t -72.09 -24.94 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -77.87 0.91 22.15 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 126.729 3.157 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -135.16 -63.75 0.67 Allowed 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 117.144 -3.473 . . . . 0.0 112.756 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.8 mm -51.0 -63.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.173 -1.831 . . . . 0.0 111.142 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -51.41 -34.23 33.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 193' ' ' ILE . 6.1 t80 -56.51 -56.74 17.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -64.72 -42.6 97.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.3 tt -52.53 -49.77 64.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.3 mm -69.28 -36.18 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.703 HD12 ' HA2' ' A' ' 235' ' ' GLY . 20.1 mt -52.9 -57.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.816 ' HB3' HD21 ' A' ' 62' ' ' LEU . 16.5 p-90 -74.02 -29.51 61.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -54.51 -55.99 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 242' ' ' ALA . 8.9 p -77.41 -42.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB1' ' CG ' ' A' ' 58' ' ' TRP . . . -57.35 -52.72 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 54' ' ' VAL . 97.2 t -67.84 -44.71 85.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -57.67 -44.82 86.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.11 -27.66 54.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.7 t -50.85 -34.45 27.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.816 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.847 0.356 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.35 -177.21 3.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.18 -55.56 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.9 m -53.11 -42.87 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.72 -53.79 47.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.545 ' CG ' HD13 ' A' ' 217' ' ' LEU . 2.9 m-85 -62.04 -48.88 78.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 m -49.85 -48.96 50.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.47 -51.53 47.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.9 t -51.12 -56.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.8 t -57.05 -48.68 77.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -51.76 -42.18 62.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -39.74 78.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -65.24 -44.54 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 ' NH1' ' A' ' 80' ' ' ARG . 12.6 p -70.47 -33.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.0 m -69.72 -51.87 30.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.29 -48.36 80.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -60.4 -51.27 70.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 73' ' ' PHE . 2.3 tm? -55.69 -43.22 76.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.35 -57.9 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.82 62.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.5 p -68.83 -34.69 75.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.8 m -67.15 -52.74 37.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.6 m -62.09 -42.05 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.425 ' N ' HG23 ' A' ' 45' ' ' VAL . 12.2 t80 -68.22 -52.73 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.79 -31.7 68.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -77.62 -51.48 10.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 45' ' ' VAL . 77.0 t -62.01 -44.16 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.585 ' O ' HG13 ' A' ' 54' ' ' VAL . 23.5 tt0 -79.89 -4.58 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' ' CH2' ' A' ' 239' ' ' TRP . 1.2 tmt_? -55.29 -26.05 37.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.91 -3.31 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -106.02 42.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.958 HG11 HD21 ' A' ' 62' ' ' LEU . 9.5 m -112.47 -170.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -84.58 156.22 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.35 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -20.55 56.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -96.18 3.96 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.38 -51.85 50.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.6 p -78.47 -33.15 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -54.8 -42.94 72.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.958 HD21 HG11 ' A' ' 54' ' ' VAL . 7.0 mp -65.8 -29.0 69.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.5 m -71.23 -53.62 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 68' ' ' VAL . 16.9 m -70.64 -49.37 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.5 t -67.86 -37.97 82.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 -34.35 63.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.57 -50.06 48.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.1 p -67.61 -45.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.471 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.4 m -69.52 -34.3 74.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.67 -45.73 74.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.88 -48.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.32 -39.59 91.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.743 ' CE1' HD11 ' A' ' 232' ' ' ILE . 5.9 t80 -62.77 -54.62 36.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.05 -50.52 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -57.32 -49.61 75.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -45.85 91.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.9 ttp -53.57 -47.06 70.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.459 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -70.78 -30.72 67.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.8 mmt -66.84 -58.15 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.422 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.69 -49.61 75.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.2 t -66.9 -32.26 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 111.119 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -62.23 -51.0 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.02 -25.59 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.4 -48.79 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 t -121.84 -39.34 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.14 18.6 3.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 127.01 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.823 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.53 160.9 37.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 0.0 110.866 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 97.82 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.736 2.291 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.5 t -69.51 -25.38 64.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 96' ' ' ILE . 7.2 p -67.76 -37.05 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -70.14 -53.15 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.29 73.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -67.73 -55.92 11.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 92' ' ' VAL . 21.2 pt -65.55 -30.91 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -66.33 -48.07 71.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 102' ' ' VAL . 16.6 t90 -61.32 -41.47 97.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD13 ' HE2' ' A' ' 134' ' ' MET . 24.6 tp -76.81 -21.23 55.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.588 ' O ' HD13 ' A' ' 104' ' ' LEU . 7.8 tt -94.1 -11.41 30.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.965 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 72' ' ' ALA . 62.2 p -109.55 -38.93 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' ILE . 2.1 t -47.96 -58.47 7.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.23 36.42 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 100' ' ' LEU . 4.9 mp -78.24 -52.77 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HA ' HG11 ' A' ' 68' ' ' VAL . 1.1 pp -65.3 -51.81 58.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt -55.52 -39.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.431 ' N ' HG23 ' A' ' 106' ' ' ILE . 41.4 t -67.53 -50.49 58.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.37 -57.98 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -52.52 -52.25 55.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.68 -30.85 71.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.42 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.54 -35.65 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.615 HD21 HG13 ' A' ' 182' ' ' VAL . 3.4 tm? -70.48 -35.94 73.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.5 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -74.84 -21.65 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.2 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.74 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -64.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 176.47 -66.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.449 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 m -116.85 166.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -118.15 96.99 5.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 -11.51 84.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -25.34 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.98 -42.57 49.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.61 -43.32 59.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 166' ' ' LEU . 11.2 mttt -59.47 -51.7 68.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -66.09 -37.21 85.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.86 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.85 -58.2 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 162' ' ' MET . 93.9 t -51.84 -51.79 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.39 97.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.3 m -63.9 -40.36 96.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -55.69 12.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.08 -35.76 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.542 ' HE2' HD13 ' A' ' 99' ' ' LEU . 6.4 tmm? -70.75 -43.13 69.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -59.9 -52.84 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.601 ' N ' HD23 ' A' ' 135' ' ' LEU . 43.4 t -61.59 -50.95 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -54.07 -38.89 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.17 -52.52 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -51.87 -57.71 8.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.9 mtt -71.56 -31.37 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -63.17 -28.49 72.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.54 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 141' ' ' GLY . 10.4 tt0 -34.54 -55.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.49 -30.97 6.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 -4.03 20.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 pt -108.92 3.51 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.518 ' HE3' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -107.1 132.48 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 46.72 47.66 14.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.6 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.081 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.603 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.0 t-105 -57.98 -54.23 57.66 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.729 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -17.34 37.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.96 -33.49 68.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -63.9 -36.65 84.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 150' ' ' PRO . 12.0 mt -62.27 -53.49 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.21 -48.91 13.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.08 -49.63 73.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.97 -49.4 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.88 -35.54 81.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.596 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.7 t90 -67.73 -57.31 6.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' CE3' ' A' ' 159' ' ' TRP . 76.5 t -55.73 -44.59 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.27 -47.07 85.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.791 ' HG3' HG22 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.45 -58.34 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.2 mp -64.82 -31.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -58.63 -49.39 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.31 -40.59 64.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 125' ' ' LYS . 7.5 tt -71.57 -13.91 61.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 -23.78 53.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.87 18.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.488 -179.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.807 0.337 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.11 164.31 22.01 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -27.68 26.25 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.323 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.49 -40.9 48.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.615 HG13 HD21 ' A' ' 113' ' ' LEU . 38.9 t -65.57 -45.88 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.89 -35.37 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 m -69.86 -45.59 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -66.81 -52.13 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.52 -41.23 84.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 p -64.03 -44.92 91.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.745 ' CE ' HD11 ' A' ' 193' ' ' ILE . 3.6 tpt -59.35 -52.8 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 ttp -61.3 -35.91 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.69 -40.38 92.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.757 HD11 ' CG2' ' A' ' 237' ' ' ILE . 10.9 mt -66.5 -53.68 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.745 HD11 ' CE ' ' A' ' 189' ' ' MET . 67.1 mt -56.1 -46.44 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.27 -48.7 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.87 -58.96 5.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.437 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.43 -57.68 18.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -53.27 -31.37 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.677 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.41 -29.15 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.437 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.2 mt -76.53 -31.09 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.6 t80 -47.38 -57.36 9.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.648 0.737 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.81 -20.87 34.03 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 0.0 112.38 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 198' ' ' ALA . 53.0 t -72.1 -44.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.7 -33.01 28.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.711 ' HA ' HD13 ' A' ' 222' ' ' ILE . 0.1 OUTLIER -52.02 -32.83 35.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 2.0 t80 -49.22 -30.9 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 203' ' ' GLY . 13.1 t -51.54 -28.53 13.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -144.34 14.69 2.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.941 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.08 -40.29 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.545 HD13 ' CG ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -64.46 -51.83 61.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.432 ' N ' HD12 ' A' ' 217' ' ' LEU . 20.9 m-20 -60.19 -40.03 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 220' ' ' ASN . 3.3 tt -61.49 -56.97 14.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.564 ' N ' HD23 ' A' ' 219' ' ' LEU . 7.1 t-20 -57.47 -36.18 71.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.75 -58.93 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 204' ' ' TYR . 10.8 mt -54.02 -48.87 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.173 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.01 -37.76 88.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.78 -39.25 80.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.61 -52.8 55.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.61 -40.66 97.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 232' ' ' ILE . 42.4 t80 -57.74 -52.68 64.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.1 m -72.12 -24.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.28 0.64 13.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 126.696 3.141 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -134.32 -45.29 0.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 O-C-N 117.093 -3.504 . . . . 0.0 112.756 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.743 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.7 mp -75.65 -65.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.135 174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.06 -37.15 32.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 192' ' ' ILE . 1.9 t80 -54.07 -56.36 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 -35.15 86.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -49.09 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.757 ' CG2' HD11 ' A' ' 192' ' ' ILE . 1.3 mm -65.91 -45.89 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.32 -30.98 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.557 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.8 m0 -74.75 -42.82 57.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -42.4 95.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 242' ' ' ALA . 10.2 p -70.27 -40.14 77.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -71.74 -52.35 18.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 54' ' ' VAL . 71.6 t -57.48 -46.77 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -65.25 -50.77 64.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.88 -31.4 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.9 t -58.5 -48.54 80.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.781 0.324 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.13 -177.12 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.601 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -58.47 -72.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.13 -32.64 36.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.3 -62.15 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -58.18 -48.23 80.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.951 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -52.81 -45.9 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.77 -51.47 19.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 27' ' ' ASP . 89.0 t -52.7 -51.51 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.338 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 36' ' ' VAL . 26.0 t -64.76 -49.31 71.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -53.25 -47.63 68.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -47.48 80.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -40.6 88.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 32' ' ' SER . 86.0 t -67.99 -39.37 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.7 m -65.0 -53.01 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.71 85.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.75 -55.68 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' C ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.42 -33.45 69.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 45' ' ' VAL . 48.5 tp -68.92 -54.04 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.94 68.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' HD12 ' A' ' 232' ' ' ILE . 71.5 m -72.41 -52.31 16.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 t -66.21 -37.04 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 41' ' ' LEU . 60.3 t -66.7 -50.6 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.84 -43.85 78.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -64.51 -31.64 72.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.22 -52.09 13.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' VAL . 57.3 t -65.92 -39.64 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 54' ' ' VAL . 69.0 mt-10 -79.8 -7.54 58.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -55.64 -26.66 45.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -104.56 -9.36 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -96.15 30.72 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.826 HG11 HD22 ' A' ' 62' ' ' LEU . 4.6 m -110.09 -170.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -76.32 159.86 30.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.02 -55.21 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -21.82 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -88.5 -4.33 58.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -51.15 -49.68 60.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -42.99 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -52.46 -47.3 66.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG11 ' A' ' 54' ' ' VAL . 8.4 tp -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.5 m -70.56 -53.54 15.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' VAL . 26.3 m -72.03 -46.88 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.3 t -68.77 -39.28 80.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.77 -37.65 66.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.99 -48.08 66.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 101' ' ' THR . 72.9 t -64.74 -51.61 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.56 -48.79 64.68 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mt -64.71 -50.14 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.533 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -60.33 -36.87 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.782 ' CE2' HD11 ' A' ' 232' ' ' ILE . 18.7 t80 -60.84 -56.15 24.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.72 -45.92 77.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -57.77 -44.89 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.34 -54.77 41.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.872 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -50.2 30.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.551 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.19 -27.14 64.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.2 tpt -67.58 -58.67 4.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -36.79 81.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.82 -45.09 93.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.1 t -69.1 -36.2 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CZ3' HG23 ' A' ' 91' ' ' THR . 2.7 t-105 -65.51 -46.52 79.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -26.12 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -47.92 -48.03 32.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 p -115.37 -39.65 3.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -21.85 4.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.21 134.84 45.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.05 160.93 38.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.879 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.88 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.473 HG23 ' CZ3' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -58.27 -26.14 62.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 96' ' ' ILE . 41.2 t -49.44 -36.82 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -67.38 -51.77 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -62.57 -55.29 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -52.33 -49.15 64.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.63 HD12 HG12 ' A' ' 92' ' ' VAL . 64.6 mt -65.97 -35.05 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.96 -64.48 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' VAL . 10.5 t-105 -51.83 -37.58 52.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.962 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tp -75.63 -27.41 58.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -87.67 -10.89 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.669 HG23 HG12 ' A' ' 68' ' ' VAL . 6.3 m -106.17 -25.55 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.699 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.3 t -56.05 -59.5 11.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.721 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.81 -39.68 6.13 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.319 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.95 -53.37 55.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.552 HD11 ' CE2' ' A' ' 234' ' ' PHE . 1.7 tm? -62.03 -48.72 79.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 110' ' ' TYR . 68.8 mt -61.82 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 123' ' ' LEU . 49.2 t -53.65 -53.48 51.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -53.49 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -49.7 -51.06 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.443 ' CE2' HG23 ' A' ' 106' ' ' ILE . 7.9 m-30 -58.89 -33.53 70.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.88 -66.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 61' ' ' SER . 48.7 mm -54.81 -36.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 113' ' ' LEU . 3.2 tm? -70.7 -33.37 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -77.04 -24.06 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.82 -23.01 16.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -84.3 -65.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.2 m -64.34 -74.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -170.76 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 5.6 m -153.12 131.26 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.85 99.91 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.98 -6.82 83.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.3 m -51.0 -25.64 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 0.4 OUTLIER -51.39 -45.35 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -48.76 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.2 mttt -58.42 -50.49 73.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.0 -36.63 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 127' ' ' LEU . 3.1 tm? -64.87 -46.87 79.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mt -65.4 -58.08 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.737 ' CG1' ' HB1' ' A' ' 158' ' ' ALA . 61.6 t -55.53 -51.16 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.73 -51.31 57.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.0 t -53.41 -47.48 69.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -52.23 66.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 129' ' ' VAL . 44.5 t -53.08 -45.46 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.699 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 mtt -68.4 -34.98 77.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -60.44 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.6 t -70.81 -52.72 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -53.58 -41.5 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.07 25.63 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.6 -55.92 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 mmt -65.44 -50.78 64.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.897 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.26 -31.2 59.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.23 -27.88 10.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 1.119 ' HB1' HD12 ' A' ' 145' ' ' ILE . . . -92.51 -27.52 17.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.91 11.71 55.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 1.119 HD12 ' HB1' ' A' ' 143' ' ' ALA . 5.2 mt -89.33 -54.81 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.148 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -136.86 141.39 42.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.02 -25.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -58.78 -36.64 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.499 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -68.92 -60.05 4.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.565 0.698 . . . . 0.0 110.916 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.757 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.345 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.7 -50.86 69.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -77.49 -30.14 52.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.9 mt -63.7 -62.86 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.78 -37.04 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.82 -43.61 91.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.0 t -63.55 -46.97 83.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.838 0.352 . . . . 0.0 110.834 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -49.84 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.737 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -65.98 -31.26 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.26 -55.96 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 159' ' ' TRP . 84.8 t -60.77 -43.56 95.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.16 -43.19 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -52.4 61.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.69 HG22 ' CE3' ' A' ' 167' ' ' TRP . 53.7 mt -63.93 -49.6 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -48.74 -38.67 22.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.02 -48.66 28.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.27 -10.69 59.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.69 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -71.24 -15.68 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.47 17.4 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.464 -179.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.822 0.344 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.2 163.56 31.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -25.96 28.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.02 -46.02 31.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.435 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.1 t -62.33 -47.82 91.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -36.61 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -68.21 -45.22 73.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.85 87.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -68.28 -49.45 60.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -37.31 78.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.499 HG21 HG21 ' A' ' 241' ' ' VAL . 3.1 p -72.03 -39.68 68.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -62.25 -52.96 61.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -66.22 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -60.18 -50.25 74.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -33.81 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 189' ' ' MET . 1.2 mp -64.69 -43.94 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 163' ' ' ILE . 80.7 mt -69.71 -51.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.66 -55.72 17.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -61.58 -57.34 18.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.521 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 25.6 m0 -53.12 -31.95 44.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.44 -28.21 52.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 14.2 mt -75.03 -30.42 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -44.74 -58.0 6.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.733 0.777 . . . . 0.0 110.949 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.72 -20.58 34.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 198' ' ' ALA . 93.1 t -71.52 -44.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.49 -34.59 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.62 -57.09 12.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 -30.93 71.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -50.84 -26.82 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.54 -42.55 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.776 ' CE2' HD21 ' A' ' 219' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.393 . . . . 0.0 110.936 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.67 81.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.082 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 25' ' ' ALA . 1.1 pp -56.17 -51.54 67.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 217' ' ' LEU . 1.9 t30 -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.776 HD21 ' CE2' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -62.01 -56.24 21.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -51.0 71.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -50.72 -58.48 5.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.53 ' N ' HD13 ' A' ' 221' ' ' LEU . 90.4 mt -53.72 -43.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.1 -48.05 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -36.82 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -49.58 76.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 200' ' ' TYR . . . -64.08 -51.0 66.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.69 -30.46 70.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.71 -46.18 59.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 34.2 m -71.73 -23.33 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -95.09 2.94 55.26 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-O 126.697 3.141 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -60.18 1.48 Allowed 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 117.131 -3.481 . . . . 0.0 112.74 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.782 HD11 ' CE2' ' A' ' 73' ' ' PHE . 18.7 mm -66.47 -64.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.138 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.2 OUTLIER -48.59 -32.94 8.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 238' ' ' ILE . 14.1 t80 -58.36 -55.54 33.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.08 -34.43 88.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -42.65 87.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.9 mm -66.72 -47.61 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 234' ' ' PHE . 84.3 mt -65.91 -40.82 88.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 23.8 t90 -70.5 -39.33 74.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -68.72 -47.08 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 188' ' ' THR . 9.2 p -67.05 -33.01 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -76.94 -51.44 11.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 54' ' ' VAL . 72.2 t -62.88 -34.06 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -76.22 -54.57 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.78 -38.78 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 81.5 p -55.1 -35.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -179.04 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -77.13 -71.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -30.54 45.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.52 -70.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.455 ' HB3' HD21 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -51.83 -43.03 63.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 84' ' ' ILE . 18.8 m -60.42 -40.95 92.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.16 -54.22 21.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.82 -40.8 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 74.0 m -64.58 -49.73 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -55.19 -44.71 75.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -46.91 82.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -39.78 91.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -64.44 -48.75 83.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -57.71 -50.06 74.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.05 71.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -57.99 -52.07 67.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.486 HD13 ' HG3' ' A' ' 77' ' ' MET . 1.3 tt -52.3 -47.3 66.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.57 -49.9 75.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.12 75.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.4 t -69.35 -37.49 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -46.01 71.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.5 m -66.69 -41.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.0 m-85 -69.08 -51.54 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -61.86 -33.41 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.45 -47.61 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' VAL . 86.3 t -70.44 -29.77 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -73.93 -10.77 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -56.11 -26.81 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -12.73 17.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -106.24 42.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.6 p -127.7 160.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 12.7 t -49.98 148.67 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 -48.73 65.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -58.88 -23.03 60.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CE2' ' HB2' ' A' ' 242' ' ' ALA . 45.1 m95 -88.02 7.36 31.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -49.64 -50.08 44.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -36.36 58.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' HG21 ' A' ' 112' ' ' ILE . 8.1 t -52.6 -42.38 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.596 HD21 HG21 ' A' ' 54' ' ' VAL . 4.3 mm? -68.29 -28.98 67.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.7 m -72.45 -52.21 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 17.2 m -67.19 -50.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' HG23 ' A' ' 64' ' ' VAL . 36.5 m -69.16 -36.7 77.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.95 -41.43 93.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 71' ' ' ILE . 31.7 mt -70.84 -47.43 59.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.664 HG12 HG23 ' A' ' 101' ' ' THR . 61.1 t -65.8 -55.36 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.494 HG23 ' HD2' ' A' ' 231' ' ' LYS . 9.7 m -68.37 -26.82 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.173 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.88 -51.45 24.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 67' ' ' LEU . 17.6 pt -64.2 -39.64 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.734 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -71.19 -37.95 72.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 232' ' ' ILE . 8.8 t80 -61.0 -57.93 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -47.56 85.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -55.14 -47.51 74.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -48.94 79.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -50.55 -51.34 48.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.0 t80 -58.71 -53.38 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.2 mmt -54.71 -47.52 73.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -53.1 -56.07 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.5 -33.78 73.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 78' ' ' TYR . 98.2 t -67.56 -47.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.157 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -61.71 -45.07 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 29' ' ' THR . 10.6 tp -73.63 -25.19 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -48.25 33.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.4 p -136.61 -39.81 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.57 -15.37 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 127.02 53.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.46 160.79 52.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.75 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 90.09 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -69.42 -32.55 71.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' PHE . 12.3 m -50.93 -45.87 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -69.54 -46.78 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -47.12 77.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -65.41 -39.89 92.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.81 -57.52 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -33.18 69.87 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.414 ' CE3' HG23 ' A' ' 102' ' ' VAL . 25.1 t-105 -60.09 -58.75 7.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.06 -13.11 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.584 ' O ' HD22 ' A' ' 104' ' ' LEU . 6.3 tt -91.6 -16.6 26.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.734 HG21 ' CB ' ' A' ' 72' ' ' ALA . 25.5 m -110.76 -31.5 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -51.16 -59.51 7.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.613 0.721 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.6 Cg_endo -69.79 -35.5 12.44 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 100' ' ' LEU . 8.9 mp -64.91 -38.95 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -48.69 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mm -64.9 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.1 t -64.31 -55.33 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.83 -58.47 6.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.661 ' CE1' HD12 ' A' ' 238' ' ' ILE . 79.8 t80 -50.02 -54.56 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.541 ' HD2' ' HG ' ' A' ' 122' ' ' SER . 6.1 m-85 -61.16 -31.07 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.25 -67.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 61' ' ' SER . 46.3 mm -50.86 -40.72 20.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.802 HD12 HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -68.81 -35.36 76.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -77.73 -14.91 59.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.79 -23.28 11.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.78 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -122.09 -6.57 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.33 51.93 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 119' ' ' VAL . 3.1 p 179.8 112.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.76 97.71 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.32 -5.73 87.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.541 ' HG ' ' HD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -53.18 -23.44 8.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.89 -42.86 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -73.14 -37.41 66.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.67 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -65.95 -53.25 41.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -34.15 77.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -47.09 74.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.41 -59.81 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 125' ' ' LYS . 8.1 p -58.92 -33.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.1 -47.75 57.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.3 m -65.35 -38.6 90.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.383 . . . . 0.0 110.844 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -52.15 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 129' ' ' VAL . 77.9 t -56.88 -51.81 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.7 ptm -62.98 -33.67 75.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.98 -56.2 21.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.886 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 135' ' ' LEU . 71.7 t -60.62 -53.16 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.22 -37.12 71.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.5 -52.27 40.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -48.71 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.5 ttp -62.74 -34.38 77.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.81 -30.98 55.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.55 -48.0 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.77 -26.68 8.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 52.81 26.38 25.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.88 -37.38 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 111.129 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.838 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -131.06 -170.73 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.838 ' HB2' ' HE2' ' A' ' 146' ' ' MET . . . 77.14 -4.97 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.93 -43.14 62.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.2 t-105 -64.52 -55.62 28.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.73 -19.01 36.84 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -50.79 -42.36 57.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -58.54 -39.42 80.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.37 -64.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 151' ' ' ALA . 9.3 pt -51.69 -41.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.87 -50.03 32.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -56.82 -55.95 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 110.911 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 mt -54.72 -48.13 72.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.9 91.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.098 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.579 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.2 t90 -67.02 -56.87 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.48 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.2 t -52.96 -45.79 52.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.159 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -62.97 -45.08 94.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -58.47 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.579 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.4 mp -66.99 -32.04 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -55.82 -54.54 43.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -42.57 63.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.49 -15.49 62.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.442 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -57.38 -22.58 43.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.37 19.09 19.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.795 0.331 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 164.1 17.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -22.87 31.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.313 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 245' ' ' GLU . . . -76.54 -42.45 42.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.802 HG13 HD12 ' A' ' 113' ' ' LEU . 54.3 t -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.64 78.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 188' ' ' THR . 41.7 t -70.36 -46.87 63.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 241' ' ' VAL . . . -62.89 -40.02 96.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -66.92 -52.07 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.27 -54.88 40.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.564 ' OG1' HG21 ' A' ' 241' ' ' VAL . 63.9 p -58.83 -40.76 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.421 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -56.15 -52.87 62.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.82 -32.68 74.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.33 -49.27 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -35.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.131 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 194' ' ' ILE . 1.3 mp -63.76 -48.18 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 159' ' ' TRP . 97.0 mt -69.12 -50.74 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -51.51 -55.26 19.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.402 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -60.21 -59.57 10.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -53.35 -31.34 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.44 -27.28 46.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.7 mt -75.0 -32.05 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.4 t80 -47.89 -57.72 9.49 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.8 -26.49 27.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.364 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 198' ' ' ALA . 52.3 t -70.85 -37.62 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.49 -40.78 12.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.48 -33.13 43.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -27.28 10.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 203' ' ' GLY . 14.1 t -49.8 -27.96 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 -179.809 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.36 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.075 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 25' ' ' ALA . 10.2 tp -53.0 -61.85 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.93 -37.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.01 -42.4 94.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.493 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.5 t-20 -64.58 -46.76 81.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 221' ' ' LEU . 3.4 tm? -60.27 -57.79 11.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 35.3 mm -53.11 -48.01 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.24 -36.38 83.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -70.28 -42.45 72.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -51.46 68.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.97 -52.24 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -58.71 -37.6 76.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 232' ' ' ILE . 39.2 t80 -64.34 -58.22 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.5 m -61.08 -25.62 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.68 1.23 20.52 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 126.69 3.138 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HD2' HG23 ' A' ' 69' ' ' THR . 21.3 mmtm -130.0 -60.28 1.03 Allowed 'General case' 0 N--CA 1.423 -1.793 0 O-C-N 117.116 -3.49 . . . . 0.0 112.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -60.97 -63.71 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.104 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.74 -40.54 69.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -52.78 -58.77 5.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.02 91.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.75 -48.96 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 241' ' ' VAL . 43.3 mm -65.7 -49.64 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 109' ' ' PHE . 45.9 mm -57.7 -52.43 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.654 ' O ' HG23 ' A' ' 243' ' ' VAL . 7.9 t90 -57.91 -43.47 86.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -55.46 -42.9 74.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 237' ' ' ILE . 14.6 t -63.86 -49.54 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' A' ' 58' ' ' TRP . . . -56.62 -51.34 69.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' VAL . 8.1 t -67.96 -31.69 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -60.74 -53.62 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 181' ' ' ALA . 0.9 OUTLIER -71.51 -35.72 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -43.43 65.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.345 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.75 178.35 8.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -70.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -54.95 -42.17 72.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 t0 -51.91 -57.0 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -47.9 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.549 ' OG1' HD11 ' A' ' 217' ' ' LEU . 23.9 m -51.13 -47.42 62.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.163 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.51 36.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 27' ' ' ASP . 92.2 t -52.98 -56.22 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.147 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t -58.6 -48.82 79.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -51.95 -39.7 59.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.48 -41.05 69.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.22 -44.31 92.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -36.09 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.9 m -69.67 -53.4 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.86 -46.54 89.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.8 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.62 HD13 ' HE2' ' A' ' 73' ' ' PHE . 4.6 tp -55.97 -47.54 77.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.18 -54.41 47.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.79 71.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 m -72.13 -41.51 67.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -41.19 94.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 49' ' ' VAL . 27.2 m -72.01 -37.89 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.02 -53.26 52.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.98 -47.95 75.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.21 -48.25 68.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 45' ' ' VAL . 95.6 t -74.14 -29.76 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.761 ' O ' HG13 ' A' ' 54' ' ' VAL . 45.8 mm-40 -79.9 -7.12 58.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -27.09 29.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -113.49 -4.04 13.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -94.73 8.99 40.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.6 m -104.27 -171.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -77.87 158.36 29.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.76 -55.19 28.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.49 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 73.6 m95 -87.77 -14.03 40.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -51.36 -49.73 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -36.1 69.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.746 ' HB2' HG21 ' A' ' 112' ' ' ILE . 2.2 p -56.92 -45.31 82.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.836 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.42 -27.14 66.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -71.0 -53.49 14.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 68' ' ' VAL . 23.2 m -72.02 -47.27 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.511 ' N ' HG23 ' A' ' 64' ' ' VAL . 11.4 p -68.77 -38.68 80.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.3 -33.82 58.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.89 -46.65 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -69.98 -44.07 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.454 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.3 m -70.54 -34.04 71.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.83 37.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -36.83 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.43 62.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.62 ' HE2' HD13 ' A' ' 40' ' ' LEU . 4.1 t80 -61.99 -48.81 78.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -64.36 -51.87 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -57.05 -52.68 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.64 -65.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -51.43 -32.88 28.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -61.07 -67.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.44 ' HA ' HG12 ' A' ' 82' ' ' VAL . 2.5 mmt -67.86 -59.58 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -50.91 -40.21 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.17 -57.62 4.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 79' ' ' MET . 4.8 p -53.77 -35.6 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . 0.8 OUTLIER -76.33 -58.5 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 88' ' ' ASP . 2.5 tp -56.83 -24.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -54.59 -27.16 37.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 83' ' ' TRP . 10.1 t -107.95 -21.6 12.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.77 -109.56 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 11.8 p-10 -123.53 142.5 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.25 161.99 38.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.69 0.757 . . . . 0.0 110.859 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 93' ' ' PHE . 54.3 Cg_endo -69.72 136.54 33.36 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 0.0 112.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -69.9 -29.96 67.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 93' ' ' PHE . 6.7 m -58.78 -45.75 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 92' ' ' VAL . 43.4 m-85 -69.93 -53.36 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -56.02 -47.96 76.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 18.8 t80 -57.26 -55.3 36.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.5 mt -62.35 -29.88 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -61.37 -61.61 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 109.24 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.46 -31.27 71.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.43 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 0.7 OUTLIER -72.21 -22.72 61.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.929 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 104' ' ' LEU . 4.2 tt -101.26 -18.82 15.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.803 HG22 HD23 ' A' ' 105' ' ' LEU . 35.8 m -94.79 -33.04 13.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -57.78 -56.76 31.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.602 0.715 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.81 -26.23 27.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.4 mm? -75.54 -54.0 7.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 101' ' ' THR . 3.3 pp -65.04 -39.47 93.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.4 mm -65.94 -43.9 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.0 t -61.76 -52.75 62.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.67 54.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.82 -45.84 64.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.97 -44.91 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -50.29 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 61' ' ' SER . 40.8 mm -59.93 -59.44 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.73 -22.09 44.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.22 -44.47 46.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.29 -17.97 33.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 182' ' ' VAL . . . -74.48 -39.07 62.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 -67.63 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' OD1' HG22 ' A' ' 119' ' ' VAL . 7.7 t-20 -161.43 -75.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.528 HG22 ' OD1' ' A' ' 118' ' ' ASN . 6.3 m -151.77 135.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB1' ' OH ' ' A' ' 186' ' ' TYR . . . -103.69 100.05 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.52 -8.51 59.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -52.17 -25.44 9.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 110' ' ' TYR . 1.7 pt? -63.52 -34.64 78.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -47.02 81.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -69.0 -44.76 72.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -64.41 -37.3 87.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.65 -47.66 62.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.49 -58.8 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 162' ' ' MET . 92.6 t -58.0 -51.57 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.36 -43.1 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.7 t -66.88 -36.6 82.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 136' ' ' VAL . 4.5 mt -64.08 -54.3 36.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -60.12 -39.68 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -67.06 -45.87 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 HD13 ' A' ' 154' ' ' ILE . 95.5 t -60.7 -49.63 83.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -66.69 -33.17 75.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.17 -52.07 15.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -65.22 -52.18 56.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 mmt -66.0 -44.6 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.66 -32.56 84.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -46.82 -52.69 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 145' ' ' ILE . . . -111.89 16.33 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.44 50.16 42.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.511 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 143' ' ' ALA . 2.6 mt -83.46 -18.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.96 132.1 54.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.87 -162.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.681 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -77.99 -25.64 48.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.614 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.3 m95 -66.42 -53.64 29.21 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.79 -12.35 32.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.35 -47.09 29.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.32 -34.38 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.3 mt -58.95 -57.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.77 HD13 HG11 ' A' ' 136' ' ' VAL . 60.6 mt -65.61 -47.74 85.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.21 -42.75 93.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.482 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.56 -50.93 63.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -55.87 -48.62 75.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.88 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.535 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -60.09 -55.72 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.5 t -57.16 -48.92 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.11 -41.65 97.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.78 ' HB2' HG11 ' A' ' 129' ' ' VAL . 1.7 tmt? -55.89 -59.28 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.535 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.7 mp -66.18 -31.67 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.39 -52.57 64.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -73.72 -34.58 64.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.23 -18.94 62.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.404 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -65.66 -35.22 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.21 18.85 14.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.796 0.331 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.22 163.21 24.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -18.37 36.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.58 -47.76 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.509 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 17.3 t -62.27 -47.06 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -34.33 73.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB3' HG21 ' A' ' 241' ' ' VAL . 1.3 m -70.26 -45.18 66.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.6 95.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.587 ' OH ' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -67.88 -48.85 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.67 -56.19 24.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -59.08 -40.46 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -58.74 -52.36 66.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.1 ttp -61.02 -36.66 80.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -48.32 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.833 HG23 HD13 ' A' ' 233' ' ' LEU . 46.9 mm -64.15 -44.99 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.454 HG21 ' HE1' ' A' ' 162' ' ' MET . 69.3 mt -55.28 -46.88 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HG12 ' A' ' 163' ' ' ILE . 92.6 mt -64.41 -49.7 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.17 -57.14 10.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -59.37 -58.83 12.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -52.7 -31.48 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.26 -30.05 54.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.466 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.3 mt -74.31 -31.03 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -45.87 -58.53 6.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.4 Cg_endo -69.74 -21.38 33.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.312 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.9 t -70.83 -44.67 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.81 -30.78 28.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -53.16 -57.96 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -31.05 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -51.74 -27.21 11.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.155 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.99 -7.04 5.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 17.7 t80 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.36 67.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.549 HD11 ' OG1' ' A' ' 29' ' ' THR . 0.2 OUTLIER -58.15 -62.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -51.96 -36.42 49.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.76 -52.09 65.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.84 -42.01 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.4 tm? -62.29 -55.46 27.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 221' ' ' LEU . 84.4 mt -60.46 -48.76 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.15 -57.89 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -40.54 74.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -50.4 71.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.22 -54.83 38.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.55 -35.95 82.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -61.79 -53.08 60.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 233' ' ' LEU . 8.6 p -71.9 -24.83 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -24.55 63.91 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 126.68 3.133 . . . . 0.0 110.83 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 1.6 mttm -112.91 -10.16 13.56 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 117.117 -3.489 . . . . 0.0 112.789 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.3 mm -91.97 -61.57 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.147 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.833 HD13 HG23 ' A' ' 192' ' ' ILE . 0.7 OUTLIER -50.52 -35.49 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -54.72 -57.59 10.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.56 -42.76 87.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HE1' ' A' ' 239' ' ' TRP . 12.4 tp -51.76 -50.98 59.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 241' ' ' VAL . 3.2 mm -68.54 -37.01 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.452 HG23 ' CZ3' ' A' ' 58' ' ' TRP . 4.0 mm -52.22 -57.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.502 ' HE1' HD12 ' A' ' 236' ' ' LEU . 16.0 p-90 -74.09 -29.39 61.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -53.74 -56.77 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.7 p -77.61 -43.62 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -55.87 -51.45 67.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.786 HG22 ' HA ' ' A' ' 54' ' ' VAL . 99.2 t -70.28 -41.93 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -54.06 -51.17 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -29.58 54.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.4 t -51.13 -30.84 17.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.822 0.344 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.24 164.01 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 217' ' ' LEU . . . -76.69 -65.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -52.46 -44.53 65.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -56.22 -61.58 2.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -51.94 -42.81 63.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.1 m -60.65 -41.29 94.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.58 -54.19 24.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.16 -40.24 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 76.9 p -64.8 -49.59 70.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -56.16 -44.26 79.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.56 -47.8 80.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.23 -40.82 91.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -63.47 -49.12 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 m -57.75 -47.08 83.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.33 78.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.13 -47.85 80.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.094 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.58 HD21 ' NE1' ' A' ' 74' ' ' TRP . 14.4 tp -60.78 -39.09 87.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.96 -56.83 15.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.52 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -69.7 -33.1 72.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.559 HG21 ' HH2' ' A' ' 74' ' ' TRP . 95.0 m -72.67 -45.68 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.3 p -65.37 -43.18 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -68.23 -49.11 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.859 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -63.71 -32.03 73.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -75.35 -52.3 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 45' ' ' VAL . 85.8 t -64.77 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.06 -0.62 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -74.04 -26.51 60.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.79 -19.3 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 22.52 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.123 HG21 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -94.75 174.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -53.63 150.44 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.86 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -79.17 -26.56 42.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HH2' ' HB1' ' A' ' 185' ' ' ALA . 59.4 m95 -87.13 -6.23 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -51.58 -50.46 60.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 64' ' ' VAL . 17.7 p -77.83 -35.68 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -59.43 -42.48 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.123 HD13 HG21 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -65.1 -30.21 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -55.65 5.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 68' ' ' VAL . 13.9 m -57.79 -51.8 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.534 ' N ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -70.77 -47.89 57.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.63 92.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.86 -47.18 60.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' VAL . 56.8 t -58.53 -56.43 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -63.55 -39.31 94.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.65 -68.95 1.46 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -50.12 -33.97 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 111.127 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 101' ' ' THR . . . -63.97 -52.43 59.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 40' ' ' LEU . 46.9 t80 -58.81 -48.77 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.58 ' NE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -62.1 -50.57 71.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -55.8 -60.88 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -54.2 -58.77 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.9 -33.35 36.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.3 m-85 -65.58 -69.15 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.71 -57.37 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -55.31 -52.22 64.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.471 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -59.57 -47.6 90.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.458 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 78' ' ' TYR . 27.1 t -61.37 -46.65 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -56.48 11.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 87' ' ' GLY . 6.8 tp -58.81 -26.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -21.65 47.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 p -114.2 -30.62 6.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 84' ' ' ILE . . . -164.46 -110.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -98.56 -176.08 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.769 0.319 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -115.78 155.68 47.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.679 0.752 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 121.51 8.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -69.69 -35.87 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 93' ' ' PHE . 7.3 p -66.99 -44.71 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.149 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.463 ' N ' HG13 ' A' ' 92' ' ' VAL . 4.7 m-85 -71.39 -44.27 65.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -64.45 -48.16 76.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -59.86 -52.78 63.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 92' ' ' VAL . 63.7 mt -65.96 -30.01 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 101' ' ' THR . 2.9 t70 -61.66 -57.44 11.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 109.297 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.428 ' HA ' ' HG1' ' A' ' 101' ' ' THR . 27.1 m0 -69.82 -30.67 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.878 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -75.12 -19.39 59.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -101.01 -31.73 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.538 HG21 ' HB1' ' A' ' 72' ' ' ALA . 55.8 p -79.83 -39.62 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.549 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -50.83 -56.61 18.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.79 -38.48 7.67 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.315 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.5 -51.99 67.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.473 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.4 tm? -67.11 -41.99 85.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.657 HG23 ' HA ' ' A' ' 123' ' ' LEU . 49.8 mt -59.93 -48.62 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.099 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.511 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.3 t -62.22 -57.53 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -52.07 -40.54 61.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -66.37 -50.18 64.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -35.38 65.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.58 -61.19 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.9 pt -55.68 -36.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 120' ' ' ALA . 1.4 tm? -71.78 -50.8 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.61 67.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.05 -11.11 60.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.119 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 182' ' ' VAL . . . -92.1 -29.67 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 -67.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -174.84 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 m -151.54 142.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 113' ' ' LEU . . . -126.37 108.14 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.81 -5.49 69.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -50.22 -27.98 6.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.903 0.382 . . . . 0.0 110.811 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -64.62 -41.0 96.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.625 ' N ' HD23 ' A' ' 123' ' ' LEU . 2.4 t80 -58.83 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.645 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -63.16 -48.31 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -60.28 -34.99 74.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 tp -68.33 -48.8 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.92 -56.73 18.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 133' ' ' VAL . 7.4 p -58.96 -43.1 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.445 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -58.04 -41.27 94.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.446 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 134' ' ' MET . 0.1 OUTLIER -71.07 -35.16 71.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -53.84 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 129' ' ' VAL . 26.5 m -58.16 -43.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.44 ' N ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -71.77 -28.99 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -66.11 -50.33 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.686 HG13 HD23 ' A' ' 135' ' ' LEU . 30.7 m -70.3 -41.22 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.422 ' N ' HG23 ' A' ' 136' ' ' VAL . 35.4 t80 -61.92 -38.92 90.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 -50.5 9.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -63.24 -50.53 69.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.548 ' HB3' ' HE2' ' A' ' 146' ' ' MET . 14.1 mmt -65.49 -52.68 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.77 -32.61 74.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.72 -30.21 13.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 145' ' ' ILE . . . -112.53 -27.28 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.76 9.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 143' ' ' ALA . 1.3 pp -103.92 8.82 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.548 ' HE2' ' HB3' ' A' ' 140' ' ' MET . 0.1 OUTLIER -100.63 -169.29 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.32 107.59 18.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 208' ' ' TYR . . . -74.33 -22.55 59.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.3 t-105 -52.85 -57.8 14.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.59 0.71 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.0 Cg_endo -69.76 -19.24 36.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.329 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.22 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.26 -40.88 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mt -60.67 -41.59 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.8 mt -59.12 -57.17 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.27 -39.55 94.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 39.0 t -63.39 -57.36 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 153' ' ' ILE . 35.2 mt -53.52 -50.5 65.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.35 77.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.581 ' HE1' HG23 ' A' ' 194' ' ' ILE . 0.4 OUTLIER -64.53 -55.25 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.494 HG23 ' CE3' ' A' ' 159' ' ' TRP . 89.3 t -55.66 -51.61 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -35.59 75.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.6 mmt -61.62 -59.86 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.8 mp -58.39 -36.4 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.34 -36.37 82.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.05 -38.82 61.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -84.11 -11.14 57.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.483 ' CE3' HG22 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -56.33 -25.41 48.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.38 18.35 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.79 0.329 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.2 164.02 15.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 0.0 110.857 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.58 33.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.56 -44.48 34.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.067 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.967 HG22 ' HB1' ' A' ' 116' ' ' ALA . 16.9 t -62.52 -48.05 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -58.13 -36.99 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.2 m -68.2 -45.21 74.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.855 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.42 ' HB1' ' HH2' ' A' ' 58' ' ' TRP . . . -61.55 -39.43 91.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.68 -51.8 52.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -45.2 75.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.9 p -66.22 -38.24 87.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.827 ' HG2' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -59.2 -50.5 73.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.03 -34.48 76.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -59.54 -49.54 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 234' ' ' PHE . 22.0 pt -70.53 -36.72 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.413 HD11 ' HE2' ' A' ' 234' ' ' PHE . 13.6 mm -63.0 -48.77 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.581 HG23 ' HE1' ' A' ' 159' ' ' TRP . 55.7 mt -67.06 -51.91 49.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.1 -56.08 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.93 -58.48 14.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -54.21 -31.88 54.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.18 -24.64 43.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -78.93 -31.96 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.9 t80 -48.16 -55.42 18.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.71 -24.92 29.38 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.9 t -67.26 -43.18 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.634 ' O ' HG22 ' A' ' 206' ' ' THR . . . -84.07 -27.74 36.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -46.07 65.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.899 0.38 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -31.39 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -53.68 -23.0 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -118.86 -26.35 2.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 148' ' ' ALA . 29.1 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -39.02 57.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.555 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 81.3 mt -61.39 -62.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -53.35 -42.51 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -53.64 54.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.4 ' HB2' HG12 ' A' ' 84' ' ' ILE . 2.4 t30 -58.18 -42.31 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.37 -58.82 6.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.629 HD12 ' HA3' ' A' ' 203' ' ' GLY . 47.4 mm -59.26 -47.92 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -58.07 -39.64 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 36' ' ' VAL . 1.8 t-20 -70.5 -46.24 64.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -51.27 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.59 -50.85 70.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.3 -28.08 69.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.66 -48.96 19.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.34 -23.15 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -90.9 3.11 55.44 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-O 126.72 3.152 . . . . 0.0 110.891 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -129.96 -64.88 0.85 Allowed 'General case' 0 N--CA 1.424 -1.769 0 O-C-N 117.128 -3.483 . . . . 0.0 112.782 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 73' ' ' PHE . 42.8 mm -55.86 -62.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.136 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -32.65 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.713 ' HA ' HD12 ' A' ' 192' ' ' ILE . 3.3 t80 -52.68 -55.77 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.81 -36.13 58.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -51.54 69.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.329 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 241' ' ' VAL . 1.1 mm -68.85 -49.6 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.827 HD11 ' HG2' ' A' ' 189' ' ' MET . 21.5 mm -56.87 -32.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.695 ' O ' HG23 ' A' ' 243' ' ' VAL . 20.1 t90 -76.01 -47.52 24.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -57.19 -40.84 78.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 237' ' ' ILE . 9.4 p -74.21 -40.47 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.98 -37.7 86.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 54' ' ' VAL . 43.7 t -78.54 -48.19 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -60.11 -37.56 80.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -76.95 -45.99 25.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 20.7 t -55.64 -72.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.5 t . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.841 0.353 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.55 175.53 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -52.2 -75.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -34.38 64.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -55.41 -64.11 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -59.66 -48.11 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 84' ' ' ILE . 96.6 m -51.58 -43.78 62.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.64 -50.47 30.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 27' ' ' ASP . 91.8 t -52.04 -51.14 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -64.74 -49.88 69.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -53.28 -47.04 69.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -48.02 75.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.59 -41.86 86.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 32' ' ' SER . 84.2 t -65.75 -43.94 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 m -60.67 -53.28 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.79 74.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.84 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 tp -53.03 -45.16 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 45' ' ' VAL . 18.7 tp -64.1 -54.12 38.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.84 73.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -70.38 -34.54 72.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.6 m -72.76 -49.29 31.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 41' ' ' LEU . 29.9 m -65.88 -39.53 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -69.46 -52.12 29.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.59 -31.79 72.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -74.62 -52.16 12.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.3 t -64.92 -38.81 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.72 -6.33 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -55.11 -26.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -99.99 -12.84 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 40.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.077 HG21 HD21 ' A' ' 62' ' ' LEU . 9.6 p -116.48 160.42 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.434 ' N ' HG22 ' A' ' 54' ' ' VAL . 1.6 t -47.79 152.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 -54.52 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -20.51 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.88 7.84 25.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -50.27 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -37.47 55.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.572 ' CB ' HD12 ' A' ' 112' ' ' ILE . 54.6 p -53.48 -37.08 62.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.077 HD21 HG21 ' A' ' 54' ' ' VAL . 2.9 mm? -65.03 -34.62 78.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -71.08 -47.69 56.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' A' ' 108' ' ' GLU . 17.7 t -70.21 -58.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -63.69 -41.42 98.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.58 91.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.879 HG22 HD12 ' A' ' 104' ' ' LEU . 5.0 t -59.25 -52.07 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -65.46 -26.45 67.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.3 -55.03 17.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.537 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 72' ' ' ALA . 12.1 tt -66.58 -42.47 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.108 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -61.7 -44.52 96.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 40' ' ' LEU . 20.3 t80 -60.87 -52.49 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -44.19 72.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.0 -54.75 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -41.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.5 ttp -59.85 -46.01 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t80 -70.07 -30.79 68.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -63.87 -59.81 4.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.574 HH11 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.48 -41.86 97.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.86 -49.03 73.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 78' ' ' TYR . 74.7 t -64.1 -43.69 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -52.78 -51.47 60.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.729 HG21 HG23 ' A' ' 29' ' ' THR . 30.4 mm -73.08 -26.37 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -49.01 -48.0 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.0 p -146.33 -40.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.52 57.09 0.13 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.34 127.03 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 p -113.26 75.1 2.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.739 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 93.17 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -51.22 -35.14 35.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.88 -43.8 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -68.09 -48.05 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -51.58 63.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -56.72 -55.55 32.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.96 -34.81 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -57.76 -68.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.326 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.3 m0 -57.48 -35.63 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -71.18 -18.27 62.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 104' ' ' LEU . 8.2 tt -100.29 -23.08 14.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 97' ' ' ASP . 21.9 p -91.72 -32.44 15.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.583 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.9 t -57.73 -55.52 44.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.662 0.744 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.77 -38.37 7.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 0.0 112.36 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.879 HD12 HG22 ' A' ' 68' ' ' VAL . 2.6 mm? -62.51 -52.91 61.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.527 ' HA ' HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -62.93 -40.98 99.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 123' ' ' LEU . 70.5 mt -67.05 -38.46 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.502 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.1 t -63.15 -62.53 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.716 ' HB3' HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -53.39 -49.09 67.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 113' ' ' LEU . 12.9 t80 -52.32 -50.36 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -39.64 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -51.47 69.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD12 ' CB ' ' A' ' 61' ' ' SER . 6.3 mm -58.51 -52.75 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -64.46 -21.97 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.36 -40.35 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.02 14.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -54.1 -54.69 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.06 -53.8 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.15 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -164.96 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.547 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 11.3 m -143.51 150.25 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.3 122.69 36.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.71 -2.61 70.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.9 p -47.53 -31.28 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -61.13 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.897 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.64 ' N ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -53.96 -52.02 61.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -59.74 -48.64 80.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.418 ' C ' HD13 ' A' ' 106' ' ' ILE . 5.7 mmmm -61.1 -33.51 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.41 -48.16 68.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 132' ' ' LEU . 1.2 tt -61.22 -53.13 60.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 162' ' ' MET . 61.0 t -58.77 -48.01 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -39.31 97.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.528 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -65.82 -39.1 90.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 128' ' ' LEU . 1.2 mm? -66.49 -53.38 35.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.71 -36.08 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.562 ' HE2' HD23 ' A' ' 99' ' ' LEU . 11.4 tmm? -70.51 -39.83 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 66.8 t -64.69 -47.0 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -57.35 -42.3 81.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.36 21.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -56.12 -51.08 69.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.923 0.392 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -31.6 69.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.15 78.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -48.36 -33.08 8.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.94 -27.33 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.11 18.3 40.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.431 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 pt -93.69 -34.74 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.519 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -124.93 119.28 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . 172.73 -55.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.554 ' HB1' ' HE2' ' A' ' 204' ' ' TYR . . . -42.12 -34.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.726 ' O ' HD12 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -85.33 -64.82 0.22 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.568 0.699 . . . . 0.0 110.892 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.72 -54.74 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . -43.22 -38.49 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.41 -51.42 69.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 149' ' ' TRP . 2.9 mp -70.36 -40.1 77.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 77.8 mt -60.72 -50.96 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -63.87 -45.3 94.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 160' ' ' VAL . 47.3 t -55.81 -51.17 68.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 110.904 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.05 -49.75 76.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.14 71.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -64.75 -54.93 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 156' ' ' CYS . 32.0 t -53.05 -43.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.92 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.469 ' CE ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -54.76 -47.82 73.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.6 mp -65.17 -40.39 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.81 -50.62 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.99 -43.92 56.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.469 HD22 ' CE ' ' A' ' 162' ' ' MET . 34.9 tp -57.34 -40.45 78.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -57.73 -20.57 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.87 18.34 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 -179.919 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.769 0.318 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.81 162.07 54.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 0.0 110.871 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.85 10.06 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.68 -42.47 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.5 t -67.13 -41.72 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -66.11 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 188' ' ' THR . 1.2 t -72.53 -48.65 38.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.61 96.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 113' ' ' LEU . 45.5 t80 -65.53 -52.24 54.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -54.68 -50.32 68.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 184' ' ' SER . 75.5 p -60.66 -39.92 90.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.415 ' HE2' ' HB ' ' A' ' 238' ' ' ILE . 0.0 OUTLIER -58.05 -52.02 67.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.44 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -63.37 -35.76 81.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -49.1 78.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.11 -48.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -50.97 -48.16 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.542 HG23 ' NE1' ' A' ' 159' ' ' TRP . 73.9 mt -65.32 -44.85 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -59.32 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -63.25 -55.74 24.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.5 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -51.18 -33.8 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.763 0.316 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.42 -30.36 42.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.8 mt -67.74 -32.11 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.484 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -51.88 -60.55 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.74 . . . . 0.0 110.939 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.74 -24.51 29.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.671 2.247 . . . . 0.0 112.344 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 198' ' ' ALA . 29.8 t -75.23 -33.77 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.03 -36.62 17.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HE2' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.29 -32.74 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -67.14 -30.67 70.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 203' ' ' GLY . 32.3 p -47.79 -31.68 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.77 56.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.3 t80 . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.775 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.857 0.361 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.81 -27.23 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 28' ' ' TYR . 13.1 mt -59.0 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -52.29 -34.79 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mp -62.18 -56.03 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 84' ' ' ILE . 1.9 t30 -58.23 -39.16 78.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.4 tm? -60.38 -51.46 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 221' ' ' LEU . 27.1 mt -59.65 -45.25 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -56.63 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -38.53 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.14 -51.31 68.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.26 36.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.66 -45.54 93.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.554 ' CD2' HD13 ' A' ' 232' ' ' ILE . 41.6 t80 -51.34 -54.86 22.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 40.6 t -70.6 -24.7 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -82.56 1.42 38.1 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.745 3.164 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.524 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 8.2 mmtm -130.28 -63.1 0.91 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.083 -3.51 . . . . 0.0 112.751 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.8 mp -56.48 -63.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.109 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.1 OUTLIER -55.92 -33.69 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.74 -53.82 52.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.86 -36.71 87.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.93 -40.19 83.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.41 -49.73 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.415 ' HB ' ' HE2' ' A' ' 189' ' ' MET . 11.8 tt -63.44 -33.88 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.607 ' O ' HG23 ' A' ' 243' ' ' VAL . 16.0 t90 -75.52 -42.88 51.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.96 -40.79 98.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.74 -37.89 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.64 -41.36 68.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 54' ' ' VAL . 86.4 t -73.39 -35.92 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -74.69 -35.7 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -76.75 -35.33 57.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 85.3 p -51.21 -49.16 61.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.9 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.871 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.77 0.319 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -178.25 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -61.69 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.32 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.8 m-20 -58.33 -74.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -47.23 84.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.1 m -52.37 -45.04 65.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.186 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.65 -51.91 33.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 27' ' ' ASP . 34.5 t -53.84 -55.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.59 ' CB ' HD23 ' A' ' 221' ' ' LEU . 99.1 p -58.52 -49.96 75.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.92 -39.33 58.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -70.14 -43.4 71.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -44.88 94.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.433 HG11 HH12 ' A' ' 80' ' ' ARG . 33.2 m -69.57 -34.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.087 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 41' ' ' LEU . 27.3 m -68.18 -54.3 18.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.71 88.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.94 -55.14 18.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.65 -32.76 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 37' ' ' THR . 4.1 mp -66.51 -57.75 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 t -70.2 -37.9 75.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.2 m -67.73 -46.39 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.85 -41.55 92.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.26 -51.09 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -62.87 -28.67 70.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -74.34 -49.18 23.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.09 -30.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.209 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.54 -6.03 56.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -59.88 -26.75 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -96.61 -9.8 28.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -108.38 42.34 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.9 p -120.74 159.25 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 54' ' ' VAL . 16.4 t -50.12 139.58 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.69 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -23.88 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -90.05 11.29 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -49.94 -50.06 47.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.76 -38.92 53.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.495 ' CA ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -53.16 -43.57 67.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.83 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -68.69 -53.72 20.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 26.0 m -70.98 -45.79 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 64' ' ' VAL . 6.6 t -66.7 -39.42 88.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.79 -34.71 59.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.73 -48.26 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.905 HG23 HD23 ' A' ' 104' ' ' LEU . 7.7 p -68.54 -44.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.46 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.7 m -69.0 -34.52 75.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.46 51.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.68 -46.79 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.95 -44.75 91.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -58.02 -56.34 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -49.98 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -56.73 -44.99 82.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -59.26 5.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.3 ttm -47.17 -41.76 18.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.542 ' O ' HG23 ' A' ' 82' ' ' VAL . 88.4 t80 -68.99 -40.41 78.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.01 -58.03 6.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -57.03 -42.82 81.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -63.37 -42.46 99.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 78' ' ' TYR . 47.1 t -69.56 -30.01 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -71.99 -41.83 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 220' ' ' ASN . 12.7 tt -76.62 -30.8 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -80.95 -49.79 10.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 m -79.17 -38.45 35.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -23.11 35.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -148.14 126.79 12.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.833 0.349 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 161.16 36.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.897 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 99.14 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.704 2.27 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.2 p -64.28 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 m -50.38 -35.13 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.23 -49.99 57.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -57.74 -45.74 85.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.79 -55.1 33.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.5 mt -61.28 -26.37 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.17 -67.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.107 . . . . 0.0 109.301 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.514 ' O ' HG23 ' A' ' 102' ' ' VAL . 13.0 t90 -51.86 -33.2 35.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.681 HD13 ' CE ' ' A' ' 134' ' ' MET . 9.6 tp -74.6 -38.55 62.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 100' ' ' LEU . 6.3 tt -84.22 -5.28 59.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.019 HG22 HD23 ' A' ' 105' ' ' LEU . 30.3 m -107.56 -39.43 5.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.52 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -44.61 -58.91 4.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.6 0.714 . . . . 0.0 111.159 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 127' ' ' LEU . 53.9 Cg_endo -69.74 -19.53 36.08 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.905 HD23 HG23 ' A' ' 68' ' ' VAL . 51.6 tp -75.67 -51.69 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.019 HD23 HG22 ' A' ' 101' ' ' THR . 1.7 pp -71.05 -35.88 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.1 -50.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.72 -47.63 80.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -61.52 -56.62 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 238' ' ' ILE . 59.6 t80 -51.47 -51.09 57.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -65.53 -35.09 79.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.0 -66.95 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.931 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.495 HG21 ' CA ' ' A' ' 61' ' ' SER . 49.7 mm -56.22 -45.25 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.07 HD11 HG13 ' A' ' 182' ' ' VAL . 7.3 tp -57.05 -44.69 83.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.67 -15.85 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.092 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -53.72 -23.37 11.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -22.73 62.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.6 t -128.17 -47.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' VAL . 2.9 m-20 -179.45 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.3 m -155.06 161.86 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.24 125.53 42.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.89 -11.02 84.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -50.56 -31.91 17.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.19 -38.64 83.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -45.31 93.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.9 mttm -62.15 -50.51 71.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HD2' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -64.65 -35.39 80.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 103' ' ' PRO . 3.9 tp -63.06 -48.51 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -57.59 8.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 133' ' ' VAL . 49.3 t -54.92 -46.86 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.53 99.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.1 t -62.88 -39.62 95.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -47.02 61.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 129' ' ' VAL . 97.8 t -56.73 -51.44 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.681 ' CE ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -68.3 -32.22 72.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -60.59 -48.93 79.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.632 ' N ' HD23 ' A' ' 135' ' ' LEU . 97.1 t -71.48 -40.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.32 -43.18 98.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.24 34.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.17 -56.0 13.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.21 -32.84 74.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.78 -29.65 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.448 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -55.31 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.34 -27.4 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.07 39.59 5.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tt -47.37 -33.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptm -108.58 -170.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.35 -174.4 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 208' ' ' TYR . . . -76.93 -20.34 56.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -61.41 -56.75 30.66 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.535 0.683 . . . . 0.0 110.89 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.859 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.73 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.16 32.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.61 -35.77 82.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 150' ' ' PRO . 49.3 mt -58.23 -51.7 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.22 -45.78 95.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.0 99.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.499 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.5 m -63.9 -50.59 68.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -49.64 76.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.19 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.543 ' NE1' HG23 ' A' ' 194' ' ' ILE . 2.2 t90 -62.53 -55.98 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.9 t -56.25 -47.94 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.34 -40.14 89.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.585 ' HB2' HG11 ' A' ' 129' ' ' VAL . 10.7 ttm -60.95 -56.37 21.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.525 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -60.8 -32.33 51.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . 0.439 ' HD2' HG12 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -63.39 -50.89 68.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -73.87 -25.34 59.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' HD2' ' A' ' 126' ' ' LYS . 3.0 mm? -76.43 -43.33 40.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -57.54 -23.59 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.12 17.19 23.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.489 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.828 0.347 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.26 162.99 20.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.866 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.16 22.84 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.344 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -46.77 28.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 1.07 HG13 HD11 ' A' ' 113' ' ' LEU . 96.3 t -65.84 -43.61 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -35.1 79.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.5 t -69.8 -47.28 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.59 97.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.047 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -65.88 -50.83 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -56.02 -55.49 32.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.633 HG22 HG23 ' A' ' 237' ' ' ILE . 2.5 m -58.88 -37.75 77.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.9 tpt -60.0 -48.74 80.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.525 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -66.19 -34.26 77.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -50.71 70.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.54 HG12 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.79 -35.2 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.126 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.93 -48.34 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 65.5 mt -64.85 -47.76 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.81 -59.16 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.41 -56.99 22.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -53.71 -32.11 50.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 202' ' ' VAL . . . -77.94 -26.31 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.106 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 18.4 mt -76.8 -28.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -42.7 -57.13 5.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.669 0.747 . . . . 0.0 110.954 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.6 Cg_endo -69.79 -82.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 198' ' ' ALA . 20.5 m -33.7 -42.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 202' ' ' VAL . . . -65.24 -57.79 10.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.745 ' OH ' HD22 ' A' ' 219' ' ' LEU . 6.6 t80 -57.01 -19.91 21.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.92 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -47.05 -26.98 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 t -49.53 -28.28 5.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.416 ' HB2' ' HB1' ' A' ' 148' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.78 -27.63 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 218' ' ' ASN . 0.9 OUTLIER -59.09 -51.97 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.421 ' O ' HG22 ' A' ' 222' ' ' ILE . 4.0 t-20 -61.39 -40.94 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.745 HD22 ' OH ' ' A' ' 204' ' ' TYR . 20.3 mt -59.52 -42.84 93.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.598 ' CB ' HD12 ' A' ' 84' ' ' ILE . 23.6 m120 -66.63 -47.17 73.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.59 HD23 ' CB ' ' A' ' 32' ' ' SER . 1.9 tm? -53.06 -58.75 5.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 204' ' ' TYR . 1.0 OUTLIER -57.14 -40.77 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.139 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.42 ' N ' HG23 ' A' ' 222' ' ' ILE . 30.9 t80 -62.61 -42.39 99.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -63.89 -46.2 85.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.03 17.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.11 -27.21 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.52 -54.92 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 225' ' ' LEU . 7.9 p -68.2 -23.55 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -69.75 -33.62 72.68 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 126.739 3.161 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.1 mmtm -103.58 -8.72 19.8 Favored 'General case' 0 N--CA 1.424 -1.773 0 O-C-N 117.11 -3.494 . . . . 0.0 112.747 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.3 -63.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.137 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 192' ' ' ILE . 7.5 tp -53.82 -31.09 47.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.54 -56.25 23.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.93 83.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 -39.39 85.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.633 HG23 HG22 ' A' ' 188' ' ' THR . 4.0 mm -70.25 -50.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.464 HD12 ' CE1' ' A' ' 109' ' ' PHE . 42.2 mm -62.44 -35.79 71.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 243' ' ' VAL . 29.5 t90 -76.84 -45.74 27.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.21 -42.11 85.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 237' ' ' ILE . 14.4 p -74.67 -38.23 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.9 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 54' ' ' VAL . 53.6 t -78.27 -40.79 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.9 -39.11 93.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.88 -48.65 17.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.2 t -59.78 -68.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.96 178.39 8.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' THR . . . -57.77 -75.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -33.67 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.671 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -58.8 -56.51 21.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -47.71 83.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.936 HG22 HD11 ' A' ' 84' ' ' ILE . 30.5 p -51.04 -47.05 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.113 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.79 -50.87 32.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 27' ' ' ASP . 93.0 t -52.78 -55.67 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.8 t -60.83 -48.13 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -53.83 -41.56 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -47.24 68.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.08 -43.64 98.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' SER . 94.6 t -66.62 -41.41 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -62.63 -43.12 99.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.69 49.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.42 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 44' ' ' THR . 4.0 tt -53.14 -50.13 65.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.09 -55.73 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.75 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 232' ' ' ILE . 22.0 m -72.02 -44.51 63.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 40' ' ' LEU . 31.2 p -59.69 -47.28 86.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 46' ' ' PHE . 29.7 m -67.11 -42.83 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.441 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -55.95 -52.17 65.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.22 -47.76 82.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -74.95 -38.7 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 87.9 mt-10 -81.16 2.67 26.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.71 66.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -97.2 -3.05 41.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.31 23.73 13.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 62' ' ' LEU . 3.5 m -93.44 -170.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 153.7 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.59 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -21.68 55.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -88.93 10.43 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -51.01 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 p -77.88 -26.0 48.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -54.76 -43.27 72.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 54' ' ' VAL . 4.6 mp -74.7 -27.66 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -64.49 -53.68 44.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 44.7 t -71.53 -51.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 t -60.86 -35.48 76.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -42.27 63.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.66 -50.18 72.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -63.42 -43.48 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 68' ' ' VAL . 98.6 m -67.33 -36.66 81.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.82 -46.93 88.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.11 -48.42 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -58.64 -40.98 84.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -61.31 -53.31 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.86 -41.99 68.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -66.98 -59.66 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -42.02 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.06 -46.54 87.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t80 -61.87 -60.11 4.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -32.96 63.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -65.31 -33.57 87.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 78' ' ' TYR . 87.1 t -68.83 -38.47 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -71.6 -45.24 62.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.936 HD11 HG22 ' A' ' 29' ' ' THR . 10.1 tp -72.2 -26.01 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.59 -47.79 49.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -143.28 -39.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.69 36.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 31.7 m-20 -153.6 127.37 8.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.24 160.07 50.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.699 0.761 . . . . 0.0 110.822 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 101.44 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 m -69.3 -31.58 70.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.39 -51.19 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -51.72 57.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -48.63 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.69 -55.42 34.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.9 mt -55.49 -36.59 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -62.88 -52.79 61.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.297 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.443 ' O ' HG23 ' A' ' 102' ' ' VAL . 8.3 t-105 -59.8 -43.19 94.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.97 -20.92 61.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.38 -17.43 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.784 HG21 ' HB2' ' A' ' 72' ' ' ALA . 71.8 p -96.77 -25.47 15.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 133' ' ' VAL . 2.6 t -57.15 -56.87 29.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.618 0.723 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.78 -27.61 26.17 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.91 -47.25 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' A' ' 234' ' ' PHE . 0.9 OUTLIER -65.57 -51.05 62.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.657 HG13 HG21 ' A' ' 129' ' ' VAL . 36.2 mm -58.49 -56.05 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.33 -34.56 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.18 -65.56 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.92 -52.29 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -56.91 -44.93 82.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.43 -59.49 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.5 mm -51.93 -42.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 HG12 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -67.9 -27.99 67.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.59 -25.97 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.57 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.96 -20.07 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -122.53 -73.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 117' ' ' THR . 2.0 m-20 170.1 -76.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.3 146.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.99 96.1 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.16 -3.48 89.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -48.8 -36.39 16.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -48.83 28.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -70.14 -50.02 44.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -51.68 -52.95 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.74 -47.55 74.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.71 -59.97 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.657 HG21 HG13 ' A' ' 106' ' ' ILE . 16.6 m -58.37 -33.65 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -67.41 -46.99 65.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.542 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -65.65 -49.36 68.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.835 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.69 -52.83 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 102' ' ' VAL . 53.5 t -59.78 -41.88 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -64.42 -44.89 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 136' ' ' VAL . 3.4 tt -60.45 -57.78 11.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.578 ' N ' HD23 ' A' ' 135' ' ' LEU . 86.3 t -53.14 -52.06 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.89 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.95 8.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -56.46 19.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -30.84 68.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -64.01 -30.29 77.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLY . 2.8 tt0 -35.7 -59.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 110.894 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.13 -30.47 4.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.89 -13.3 44.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.08 5.69 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.24 144.68 32.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.651 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 61.94 32.29 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.97 96.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -69.88 -58.52 5.31 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 110.925 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.5 Cg_endo -69.68 -5.12 15.39 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.329 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.02 -49.97 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.22 -45.76 79.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.7 mp -61.57 -43.37 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.2 mt -65.61 -55.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.71 98.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.94 -52.53 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 153' ' ' ILE . 2.9 mm? -53.61 -49.78 67.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HB1' ' HE2' ' A' ' 162' ' ' MET . . . -65.03 -34.21 77.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.456 ' HZ2' HG23 ' A' ' 194' ' ' ILE . 1.9 t90 -67.08 -54.69 19.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' CE3' ' A' ' 159' ' ' TRP . 99.3 t -57.95 -49.47 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -61.13 -43.06 99.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.489 ' HE2' ' HB1' ' A' ' 158' ' ' ALA . 15.9 mtm -55.44 -58.61 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 194' ' ' ILE . 85.1 mt -65.47 -31.9 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -58.93 -47.58 84.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -41.99 63.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.32 -16.73 63.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -56.53 -25.84 53.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.71 19.01 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.512 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.798 0.333 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.12 163.08 24.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -20.08 35.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.357 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.51 -52.77 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.629 HG12 HD12 ' A' ' 113' ' ' LEU . 19.1 t -60.74 -48.82 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.173 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -58.28 -37.53 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -65.38 -47.15 77.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.12 88.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.22 -51.66 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -49.22 73.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.71 ' CG2' HD12 ' A' ' 237' ' ' ILE . 1.4 m -63.85 -32.38 73.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.681 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.1 OUTLIER -69.67 -35.34 75.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.45 ' HA ' HG22 ' A' ' 193' ' ' ILE . 5.1 ttp -74.96 -36.08 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -40.89 69.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 188' ' ' THR . 7.1 tp -71.09 -44.02 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 192' ' ' ILE . 16.1 tt -65.92 -37.92 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 163' ' ' ILE . 45.5 mt -69.1 -49.5 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -51.69 68.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.67 9.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.73 -34.6 59.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.34 -24.56 46.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.26 -32.28 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.557 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 2.8 t80 -48.44 -57.22 11.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.669 0.747 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.8 -25.35 28.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.651 2.234 . . . . 0.0 112.313 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.6 -40.57 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.115 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.95 -43.4 8.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.61 ' OH ' HD13 ' A' ' 219' ' ' LEU . 1.5 t80 -54.94 -31.2 60.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -49.99 -32.69 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 203' ' ' GLY . 11.4 t -51.33 -27.88 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -0.26 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.899 0.381 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.79 86.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.592 HD21 ' HB1' ' A' ' 25' ' ' ALA . 2.4 mt -60.95 -63.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -56.38 -42.03 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.61 HD13 ' OH ' ' A' ' 204' ' ' TYR . 9.8 tp -55.56 -49.28 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.42 -42.27 98.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.18 -58.0 10.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.404 HG21 ' CD2' ' A' ' 204' ' ' TYR . 37.3 mm -53.9 -46.98 64.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -60.46 -48.14 83.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.19 -38.99 93.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.9 OUTLIER -60.69 -51.38 69.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.06 -55.21 36.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.16 -40.7 77.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.655 ' CD2' HD13 ' A' ' 232' ' ' ILE . 27.0 t80 -62.98 -40.99 99.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 225' ' ' LEU . 88.2 t -71.98 -26.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -97.85 1.74 48.54 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 126.749 3.166 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.663 ' CE ' ' HB1' ' A' ' 72' ' ' ALA . 13.3 mmtm -116.48 -63.92 1.38 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.049 -3.532 . . . . 0.0 112.776 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.1 mp -66.81 -64.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.143 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -39.66 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.912 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -51.35 -58.83 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.24 93.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.28 -44.46 92.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.958 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.71 HD12 ' CG2' ' A' ' 188' ' ' THR . 0.8 OUTLIER -67.34 -47.89 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.681 HD11 ' SD ' ' A' ' 189' ' ' MET . 32.0 mm -54.85 -50.93 57.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.501 ' CZ3' HD12 ' A' ' 62' ' ' LEU . 4.4 m95 -72.15 -29.64 64.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.62 -54.23 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.5 p -76.14 -40.36 36.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.411 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -61.35 -53.44 56.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 54' ' ' VAL . 94.4 t -65.89 -47.51 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -58.69 -43.69 90.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.03 -41.3 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.5 p -50.83 -35.14 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.798 0.332 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.488 ' C ' HD21 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -70.02 160.94 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -51.93 -42.22 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -58.19 -36.85 73.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.4 m-20 -61.36 -60.51 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.446 ' CD1' HD23 ' A' ' 217' ' ' LEU . 1.5 m-85 -61.15 -48.19 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -51.57 -47.31 63.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.81 -51.73 28.21 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 27' ' ' ASP . 96.2 t -54.67 -55.33 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -59.03 -48.61 80.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -52.32 -45.57 65.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.46 83.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.01 -39.25 91.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 97.6 t -65.51 -52.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -62.49 -45.73 91.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.79 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -61.46 -54.18 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' CZ ' ' A' ' 73' ' ' PHE . 3.0 tt -51.12 -52.83 39.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.542 ' N ' HD23 ' A' ' 40' ' ' LEU . 21.2 tp -55.29 -53.34 57.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.74 -40.62 66.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -69.2 -32.17 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -73.06 -46.81 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 46' ' ' PHE . 17.7 m -64.57 -42.89 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.24 -49.79 58.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 64.5 t80 -64.55 -27.63 69.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -74.42 -49.55 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.6 t -71.26 -38.27 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -79.58 -7.45 58.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -56.54 -26.85 56.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.41 -11.05 21.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.19 38.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 62' ' ' LEU . 5.2 p -113.24 162.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.411 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -48.32 149.21 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.61 -55.58 12.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -60.51 -22.99 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -88.78 8.75 27.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.73 -50.37 55.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -73.76 -34.49 64.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.207 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.787 ' HA ' HG21 ' A' ' 112' ' ' ILE . 19.8 m -50.73 -45.04 58.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.01 -30.12 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.539 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -70.83 -55.51 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.175 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 65' ' ' SER . 12.8 m -67.88 -51.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.112 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 64' ' ' VAL . 8.6 t -65.06 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.95 68.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' ILE . 4.0 mp -70.12 -47.63 60.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' THR . 6.6 p -65.24 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' VAL . 68.9 p -71.79 -33.12 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -49.25 54.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 7.1 tt -67.64 -43.39 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.699 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -65.09 -39.78 93.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.769 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 27.3 t80 -63.06 -57.78 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -53.74 -50.07 66.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.92 -47.38 74.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -44.13 97.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -51.02 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 82' ' ' VAL . 24.5 t80 -62.32 -48.75 78.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -57.32 12.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -51.58 -54.59 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -39.54 54.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.1 t -67.33 -43.85 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -57.06 -52.28 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.29 -25.67 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -48.37 40.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.6 p -139.0 -39.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.53 -6.78 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -122.56 127.14 49.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.82 160.35 41.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.676 0.75 . . . . 0.0 110.848 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 86.65 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -56.66 -33.35 66.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -61.55 -34.4 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -51.35 68.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -67.59 -34.68 77.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -55.09 32.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.93 -43.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -33.01 73.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -68.86 -50.29 51.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.42 -13.3 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 tt -95.82 -25.34 16.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.606 HG21 ' CB ' ' A' ' 72' ' ' ALA . 62.6 m -95.33 -35.8 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.531 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -50.12 -58.07 10.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.661 0.743 . . . . 0.0 111.178 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.8 -35.68 12.09 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.676 2.25 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 100' ' ' LEU . 9.9 mt -62.48 -43.38 98.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -46.14 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 102' ' ' VAL . 1.5 mp -63.62 -41.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 32.9 m -68.25 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.4 -52.37 22.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.609 ' CE1' HD23 ' A' ' 113' ' ' LEU . 54.5 t80 -57.88 -51.61 68.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.465 ' HB2' HD13 ' A' ' 123' ' ' LEU . 2.2 t80 -51.83 -36.67 48.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -62.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.787 HG21 ' HA ' ' A' ' 61' ' ' SER . 21.4 pt -52.89 -38.75 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' CE1' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -71.19 -51.43 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.83 -18.85 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.71 -23.68 30.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.16 86.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t 179.15 -48.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.28 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -87.68 167.77 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.422 ' HB1' ' HA3' ' A' ' 169' ' ' GLY . . . -62.98 111.22 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.14 -3.03 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 m -50.59 -20.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.491 ' HB2' HG23 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -47.3 -33.18 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -67.46 -44.66 78.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.63 ' O ' HG12 ' A' ' 129' ' ' VAL . 14.6 mptt -65.3 -45.33 84.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -37.53 87.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 128' ' ' LEU . 1.2 tt -68.16 -43.05 79.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 127' ' ' LEU . 1.2 mt -66.46 -56.35 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 133' ' ' VAL . 12.0 p -58.49 -39.59 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -65.2 -46.4 87.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.448 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -41.69 97.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.908 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.84 -52.41 63.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 129' ' ' VAL . 82.0 t -54.92 -46.01 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -27.14 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -67.8 -45.71 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 135' ' ' LEU . 11.0 m -73.27 -35.52 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.51 ' HE1' HD12 ' A' ' 154' ' ' ILE . 12.7 m-30 -70.42 -38.72 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.32 -43.68 19.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.529 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -67.63 -51.86 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.97 -35.46 74.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.27 -32.7 57.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.535 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.65 -32.1 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.0 -26.06 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.81 22.99 12.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 145' ' ' ILE . 11.0 mt -80.58 0.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -108.29 -170.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 150' ' ' PRO . . . -154.99 162.7 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 208' ' ' TYR . . . -71.77 -21.71 61.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.539 ' O ' HD12 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -70.49 -59.57 3.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.535 0.683 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.75 -14.05 35.58 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.55 -37.27 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.09 -37.81 88.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.3 mp -60.53 -53.15 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.51 HD12 ' HE1' ' A' ' 137' ' ' PHE . 88.4 mt -59.26 -50.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.33 -49.07 82.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.02 -50.0 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.47 -45.62 84.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.05 83.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.632 ' HE1' HD11 ' A' ' 163' ' ' ILE . 8.7 t90 -64.64 -55.24 21.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.23 -46.88 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -37.02 86.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.466 ' O ' HD12 ' A' ' 166' ' ' LEU . 10.7 mtp -59.43 -53.59 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.632 HD11 ' HE1' ' A' ' 159' ' ' TRP . 91.2 mt -63.99 -42.87 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -54.01 -44.4 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -74.65 -57.67 3.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 162' ' ' MET . 5.5 mt -51.5 -58.45 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.45 ' HE3' HG23 ' A' ' 163' ' ' ILE . 1.1 t-105 -57.12 -20.1 23.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.27 19.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 120' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.822 0.344 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 160.59 62.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -24.26 30.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.66 2.24 . . . . 0.0 112.356 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.2 52.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' A' ' 113' ' ' LEU . 60.2 t -66.86 -43.29 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -35.67 81.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 188' ' ' THR . 70.2 m -71.28 -47.5 56.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.585 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -60.39 -41.87 94.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.85 -52.79 39.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -52.46 -54.1 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 184' ' ' SER . 43.7 p -58.14 -45.63 87.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -44.41 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.519 ' HA ' HG22 ' A' ' 193' ' ' ILE . 17.5 ttp -72.43 -29.97 64.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -40.32 69.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -72.67 -44.45 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.16 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 190' ' ' MET . 6.5 tt -65.28 -40.99 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 193' ' ' ILE . 44.4 mt -69.13 -49.38 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -52.41 -58.15 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.29 -57.76 18.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . 0.466 ' CZ2' HD11 ' A' ' 193' ' ' ILE . 34.3 m0 -54.28 -32.07 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.79 -23.87 44.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 196' ' ' GLY . 11.8 mt -77.12 -32.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.6 OUTLIER -48.85 -55.8 18.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 110.94 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.82 -21.7 32.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.246 . . . . 0.0 112.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 198' ' ' ALA . 50.2 t -71.07 -43.66 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.34 -40.93 10.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.482 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.67 -57.4 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.52 -32.56 72.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -52.16 -25.86 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.36 -7.54 5.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.445 ' CG ' ' HB2' ' A' ' 148' ' ' ALA . 4.3 t80 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.55 70.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.9 mp -55.28 -63.31 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -54.21 -37.54 64.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -54.74 43.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -57.58 -48.76 78.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.3 tm? -58.94 -58.09 10.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 221' ' ' LEU . 45.5 mt -54.87 -46.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.1 -48.98 79.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.42 HD21 HG22 ' A' ' 36' ' ' VAL . 3.4 t30 -61.28 -41.05 96.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 tp -61.21 -48.8 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.51 -55.28 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.91 -27.02 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . 0.429 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.9 t80 -66.72 -55.71 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.43 -25.53 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -68.96 -8.25 42.82 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.68 3.133 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.699 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 14.2 mmtm -129.85 -59.98 1.05 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 117.107 -3.496 . . . . 0.0 112.798 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 50.0 mm -51.26 -63.22 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.102 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.551 HD23 HG12 ' A' ' 237' ' ' ILE . 0.3 OUTLIER -54.82 -30.65 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -55.47 32.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.29 -37.09 93.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.42 -37.54 80.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.551 HG12 HD23 ' A' ' 233' ' ' LEU . 1.4 mm -69.43 -49.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.32 -35.58 74.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.0 t90 -75.95 -43.99 42.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.63 -42.2 92.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 185' ' ' ALA . 10.3 p -74.07 -38.28 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.49 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.8 t -75.36 -40.78 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -66.96 -36.11 81.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -76.83 -44.03 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.5 t -51.74 -45.27 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.82 -179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.82 -177.1 6.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.33 -72.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.75 -28.84 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.69 -73.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -43.76 63.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 84' ' ' ILE . 96.2 m -61.01 -39.28 89.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -52.92 22.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -39.02 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.2 t -67.63 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.33 -42.68 78.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -46.9 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.86 -41.95 96.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 32' ' ' SER . 92.5 t -67.06 -43.28 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -59.5 -49.2 78.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.09 92.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.68 -55.48 23.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 HD13 ' HZ ' ' A' ' 73' ' ' PHE . 1.3 pp -62.84 -31.94 73.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.92 -53.4 46.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -34.55 78.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.61 -39.55 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 40' ' ' LEU . 14.0 p -67.24 -43.52 81.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 49' ' ' VAL . 27.7 m -68.5 -38.51 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.15 -49.04 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.72 -30.29 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.87 -50.17 63.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 45' ' ' VAL . 12.4 p -73.75 -33.45 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.1 tp10 -79.65 -14.52 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -36.86 69.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.48 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.18 42.33 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 62' ' ' LEU . 14.2 m -114.51 -170.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.66 155.37 40.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.51 -50.93 65.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -24.73 62.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.439 ' HZ3' HG23 ' A' ' 238' ' ' ILE . 62.5 m95 -96.82 -4.33 40.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -51.57 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 112' ' ' ILE . 5.3 t -77.62 -35.02 53.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.594 ' CA ' HD13 ' A' ' 112' ' ' ILE . 1.3 p -50.73 -41.66 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 54' ' ' VAL . 12.5 mt -64.61 -33.16 75.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -68.65 -54.19 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.38 -57.01 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.53 89.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.57 -44.69 77.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.933 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.99 -55.25 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -33.1 75.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.23 -47.66 70.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.62 -46.9 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.22 -37.83 88.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -64.65 -54.04 38.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -45.49 80.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -59.7 -53.19 60.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -39.23 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -57.54 -55.2 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.658 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -59.31 -53.04 62.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.6 mmt -54.42 -47.89 72.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -55.34 -56.68 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -58.48 -34.0 73.75 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.511 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 78' ' ' TYR . 75.1 t -70.24 -33.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.34 . . . . 0.0 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -73.84 -40.7 63.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.553 HD13 ' CB ' ' A' ' 220' ' ' ASN . 9.7 tp -76.85 -26.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -87.52 -49.94 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 -39.67 26.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -12.72 56.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -152.97 130.16 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.29 162.01 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.706 0.765 . . . . 0.0 110.857 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 103.29 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -69.43 -26.67 64.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -42.21 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.172 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -48.38 67.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -57.67 -51.43 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.29 -50.62 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.08 -53.92 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 101' ' ' THR . 0.6 OUTLIER -57.67 -34.01 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.108 . . . . 0.0 109.336 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.6 -59.58 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.59 -11.37 60.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 100' ' ' LEU . 8.6 tt -91.85 -17.12 25.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.705 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.7 p -110.95 -39.39 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -43.79 -58.49 4.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.79 -21.12 33.81 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.311 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.2 mm? -75.71 -54.37 7.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -49.55 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.77 -58.59 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.3 t -59.33 -34.38 72.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.41 -63.33 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -50.47 -51.09 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -61.66 -40.01 93.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.8 tp -57.67 -66.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 60' ' ' THR . 0.6 OUTLIER -50.53 -34.56 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.158 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 182' ' ' VAL . 5.3 tp -70.58 -39.5 73.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.87 -14.82 59.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -17.07 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -24.64 60.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -119.26 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER 164.87 -78.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.13 134.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.89 97.46 4.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.26 -6.05 85.97 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -33.49 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.82 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -41.71 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.95 -37.47 64.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -64.95 -51.54 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -35.33 79.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.64 -49.79 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.17 -59.68 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 133' ' ' VAL . 58.8 t -52.65 -46.98 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.67 -49.61 76.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -53.73 -46.2 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.413 HD13 HD22 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -64.32 -42.04 96.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 129' ' ' VAL . 74.4 t -59.51 -55.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.96 68.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 136' ' ' VAL . 1.0 OUTLIER -64.77 -58.17 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 135' ' ' LEU . 42.7 t -66.6 -41.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -62.38 -38.66 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.07 -51.31 18.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.6 -56.91 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.89 -32.69 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.22 -29.51 72.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -38.12 -55.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.97 -31.47 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.32 -9.36 20.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 pt -107.44 8.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.116 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.66 ' CE ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -102.05 119.88 39.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' CE ' ' A' ' 146' ' ' MET . . . 44.38 53.94 6.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -73.55 -53.28 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.622 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.3 t90 -52.83 -53.25 56.7 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.555 0.693 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 147' ' ' ALA . 53.7 Cg_endo -69.7 -17.2 37.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.256 . . . . 0.0 112.379 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 148' ' ' ALA . . . -53.23 -34.69 58.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -29.33 69.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.62 -51.64 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.82 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.47 -46.9 23.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 36.1 t -61.71 -45.75 92.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.832 0.348 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.71 -49.58 74.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.77 -29.89 70.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.699 ' CE3' HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -67.3 -57.48 6.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.699 HG13 ' CE3' ' A' ' 159' ' ' TRP . 18.7 m -60.02 -41.79 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.25 -45.86 89.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.65 ' SD ' HG22 ' A' ' 129' ' ' VAL . 13.2 mmt -57.05 -54.9 41.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 194' ' ' ILE . 2.1 mp -64.56 -37.32 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.83 -36.97 86.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.56 -39.5 62.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -80.54 -14.51 58.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.93 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.18 -27.42 33.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.12 21.1 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 -179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.835 0.35 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.34 163.15 47.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.644 0.735 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.35 27.79 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.244 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.75 -39.88 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 1.037 HG13 HD11 ' A' ' 113' ' ' LEU . 71.2 t -68.34 -43.99 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -67.44 -32.98 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.0 m -71.77 -49.11 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.94 99.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.1 -44.76 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -58.08 -56.79 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.1 m -58.19 -48.22 81.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -52.0 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -32.63 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -49.25 77.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 237' ' ' ILE . 2.4 mp -67.72 -47.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.55 -49.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.584 HD11 HG21 ' A' ' 163' ' ' ILE . 87.3 mt -65.37 -48.15 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -59.93 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.0 -54.61 33.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -53.23 -30.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.304 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -80.05 -28.95 39.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.51 -30.77 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 24.5 t80 -48.03 -54.37 25.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.686 0.755 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.76 -22.46 32.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 198' ' ' ALA . 80.7 t -69.27 -44.31 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.81 -32.35 27.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.482 ' HA ' HD13 ' A' ' 222' ' ' ILE . 60.2 t80 -58.36 -45.92 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.918 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.09 -53.87 24.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 t -72.47 -14.17 61.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -89.69 -19.75 46.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.902 -179.784 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 96.0 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.48 -21.11 62.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -59.74 4.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.425 ' O ' HD12 ' A' ' 222' ' ' ILE . 14.0 m-20 -52.03 -37.91 55.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.35 -33.44 67.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.553 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.6 m120 -68.15 -48.82 64.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 221' ' ' LEU . 2.3 pp -68.53 -38.78 81.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 204' ' ' TYR . 40.4 mt -66.68 -47.14 84.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.422 HD21 HG21 ' A' ' 36' ' ' VAL . 39.4 t30 -63.85 -43.27 96.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.7 tp -62.47 -45.67 91.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -55.68 30.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.54 -37.56 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -62.14 -46.62 88.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 1.041 HG13 HD13 ' A' ' 233' ' ' LEU . 96.7 t -73.02 -25.15 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -92.14 2.35 56.64 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 126.704 3.145 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -124.07 -63.33 1.22 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.121 -3.487 . . . . 0.0 112.743 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 43.9 mm -61.59 -64.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.165 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 1.041 HD13 HG13 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -51.75 -36.65 48.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -57.83 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -66.76 -42.42 93.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.31 -49.54 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 241' ' ' VAL . 5.1 mm -69.07 -36.16 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.705 HD12 ' HA2' ' A' ' 235' ' ' GLY . 15.8 mt -52.39 -57.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.9 p-90 -73.67 -30.14 62.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.404 HD22 HD13 ' A' ' 237' ' ' ILE . 37.0 t30 -56.96 -52.19 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.4 p -75.08 -44.05 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.05 -55.68 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 54' ' ' VAL . 74.1 t -62.29 -43.42 98.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -46.92 74.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -74.21 -29.24 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.2 t -51.55 -33.24 31.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 28' ' ' TYR . 16.7 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.795 0.331 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.78 172.14 13.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -54.77 -65.47 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.73 -25.86 42.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -59.84 -68.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB2' HD22 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -63.7 -48.54 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.3 m -52.8 -44.34 66.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.27 -51.61 31.72 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 71.1 t -54.62 -55.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -59.45 -46.38 88.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -52.68 -43.74 65.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.21 -45.59 72.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -37.27 84.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 32' ' ' SER . 89.7 t -69.1 -52.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.9 m -61.73 -47.48 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.95 71.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -52.18 17.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 45' ' ' VAL . 5.5 tp -65.83 -42.37 90.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 45' ' ' VAL . . . -64.75 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.8 m -71.67 -36.18 70.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -74.81 -45.2 44.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 41' ' ' LEU . 12.3 p -67.28 -38.84 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -71.9 -49.63 36.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 45.6 t80 -63.6 -34.34 77.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -70.72 -52.24 22.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 45' ' ' VAL . 91.1 t -66.36 -35.63 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.631 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.4 tp10 -79.92 -22.38 42.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.642 ' O ' HG22 ' A' ' 54' ' ' VAL . 3.9 mtp180 -54.23 -44.66 71.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.97 -3.95 50.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -106.32 12.01 30.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 51' ' ' ARG . 8.4 m -94.35 -170.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.27 158.28 33.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -51.45 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.068 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -62.4 -34.29 76.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.466 ' CD1' ' HB1' ' A' ' 242' ' ' ALA . 95.6 m95 -83.7 -10.87 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -51.02 -50.58 58.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -77.29 -41.53 40.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.427 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -54.26 -46.95 72.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.747 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -70.79 -27.32 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.3 m -71.18 -53.61 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 68' ' ' VAL . 25.6 m -70.21 -45.5 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.0 t -69.56 -41.03 76.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.33 -33.4 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.46 -48.37 56.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.8 p -65.06 -47.78 86.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.51 ' N ' HG13 ' A' ' 68' ' ' VAL . 67.1 p -63.73 -38.11 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.02 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -48.03 -35.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 111.108 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -69.73 -49.41 53.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CE2' HD11 ' A' ' 232' ' ' ILE . 5.5 t80 -53.37 -46.53 69.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -67.73 -45.8 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -58.36 -45.22 88.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -72.94 -57.74 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -37.36 23.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.9 t80 -74.01 -55.4 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -57.84 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -66.55 -48.76 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.41 -48.74 53.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.9 t -66.37 -53.23 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -53.31 -55.93 20.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 88' ' ' ASP . 40.4 mm -61.33 -34.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -57.59 -22.02 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.4 m -99.41 -38.36 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.38 35.52 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.612 ' O ' HD13 ' A' ' 84' ' ' ILE . 2.3 m-20 -112.4 -177.42 3.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.6 t -147.77 75.39 11.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.653 0.74 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.05 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -38.58 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 19.7 m -62.98 -44.57 99.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 7.6 m-85 -73.01 -47.28 46.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -50.54 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.29 -55.96 27.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.97 -27.18 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -66.42 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.298 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.477 ' O ' HG23 ' A' ' 102' ' ' VAL . 12.2 t-105 -60.53 -30.04 69.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -74.72 -30.55 61.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.58 -18.89 28.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.106 HG22 HD23 ' A' ' 105' ' ' LEU . 3.5 m -94.81 -39.62 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.643 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.1 t -43.55 -58.46 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.78 -18.91 36.66 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 68' ' ' VAL . 6.7 tp -77.21 -54.0 7.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.106 HD23 HG22 ' A' ' 101' ' ' THR . 1.0 OUTLIER -72.52 -47.38 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 mm -54.81 -46.79 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.443 ' HA ' HD13 ' A' ' 123' ' ' LEU . 48.6 t -69.07 -42.2 76.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -54.45 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -58.79 -50.97 71.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 6.6 m-85 -64.06 -28.54 69.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -66.84 -56.07 12.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.513 HD13 HD23 ' A' ' 111' ' ' LEU . 48.0 mm -65.03 -36.37 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 182' ' ' VAL . 9.5 tp -70.81 -55.27 8.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -71.39 -12.47 61.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 111' ' ' LEU . . . -51.7 -24.64 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -28.35 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -9.03 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 119' ' ' VAL . 36.4 t30 66.12 50.35 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -172.57 107.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.61 97.82 5.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.75 -35.89 27.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -49.85 -31.85 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 107' ' ' CYS . 8.1 tp -54.03 -50.72 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.53 85.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.02 -50.5 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' NZ ' HD13 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -65.82 -34.11 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 103' ' ' PRO . 2.1 tt -66.78 -47.97 70.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -58.87 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.9 -52.82 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.93 -42.59 86.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 m -63.55 -40.05 96.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -63.06 -56.15 19.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 154' ' ' ILE . 7.1 p -57.82 -35.64 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.643 ' CE ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -68.06 -40.51 82.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -65.49 -43.92 88.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.71 HG12 ' CE ' ' A' ' 140' ' ' MET . 60.2 t -64.88 -47.89 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . 0.415 ' HD2' HG22 ' A' ' 133' ' ' VAL . 2.9 m-85 -62.42 -40.78 97.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.66 -49.4 64.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -52.99 62.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . 0.71 ' CE ' HG12 ' A' ' 136' ' ' VAL . 20.4 ptp -59.15 -33.74 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.17 -31.7 57.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -29.88 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.871 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.4 -27.4 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 5.32 62.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.0 pp -63.89 -35.07 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.323 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.541 ' HB3' HD12 ' A' ' 145' ' ' ILE . 4.0 ptt? -135.15 133.91 39.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -160.59 -45.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -67.03 -46.3 74.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.628 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.73 -52.82 13.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.561 0.696 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.699 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.8 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.334 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -61.75 -52.41 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -77.44 -34.15 54.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 150' ' ' PRO . 36.2 mt -59.35 -65.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.672 HG22 HG23 ' A' ' 133' ' ' VAL . 28.1 mm -62.85 -44.6 99.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.59 86.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.8 t -60.43 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.63 -47.82 66.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.49 94.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -60.24 -55.37 34.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 156' ' ' CYS . 22.8 t -57.77 -50.11 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -39.49 87.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.564 ' SD ' HD22 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -57.98 -58.08 10.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.77 -38.92 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.59 -49.5 67.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.82 -54.68 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 190' ' ' MET . 6.1 mp -50.46 -59.82 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.79 -20.56 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.0 17.81 23.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.819 0.342 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.04 161.78 51.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.7 0.762 . . . . 0.0 110.839 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -26.03 28.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -44.19 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.859 HG13 HD11 ' A' ' 113' ' ' LEU . 91.5 t -71.62 -42.46 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -66.21 -39.17 89.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.1 t -70.05 -49.38 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.78 97.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -65.46 -47.85 74.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.22 -44.39 83.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 237' ' ' ILE . 2.4 m -69.64 -35.11 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.472 ' HE3' ' N ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.73 -53.02 46.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.582 ' HB3' HD23 ' A' ' 166' ' ' LEU . 14.5 ptm -64.11 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.88 -47.76 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HG21 ' A' ' 237' ' ' ILE . 28.3 mm -65.65 -39.5 85.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.555 ' CG2' ' HE3' ' A' ' 162' ' ' MET . 42.2 mt -57.8 -57.58 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 pt -60.5 -38.68 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 199' ' ' ILE . 5.4 t80 -56.29 -59.47 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.56 -52.95 49.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -55.4 -36.73 66.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.796 0.331 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.6 -24.72 49.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 200' ' ' TYR . 19.6 mt -79.08 -26.97 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.54 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.5 t80 -32.7 -57.76 0.48 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.697 0.761 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.77 -65.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 57.3 t -36.51 -42.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -77.14 -57.86 3.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 222' ' ' ILE . 10.0 t80 -53.81 -21.68 7.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.858 0.361 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.58 -28.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 96.7 m -49.34 -29.45 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.14 18.02 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.605 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.918 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.71 57.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 25' ' ' ALA . 78.8 mt -55.99 -63.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -52.79 -31.48 38.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -57.39 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.483 ' C ' HD13 ' A' ' 221' ' ' LEU . 3.3 tm? -61.26 -58.63 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 204' ' ' TYR . 39.5 mm -60.21 -48.84 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -57.05 -49.14 76.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -60.34 -40.38 90.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.57 -48.9 78.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.45 -55.16 38.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.17 -27.54 69.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -67.44 -56.58 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.0 m -72.57 -25.02 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.92 -10.32 37.69 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-O 126.701 3.143 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -131.31 -56.24 1.02 Allowed 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 117.102 -3.499 . . . . 0.0 112.773 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.3 mm -53.8 -64.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.115 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -41.21 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.08 -57.3 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -62.65 -41.11 99.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.3 -48.96 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.7 mm -69.68 -36.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.752 HD12 ' HA2' ' A' ' 235' ' ' GLY . 39.4 mt -53.0 -58.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.747 ' HB3' HD21 ' A' ' 62' ' ' LEU . 15.9 p-90 -73.71 -29.63 62.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 237' ' ' ILE . 7.3 t-20 -54.87 -55.06 34.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.1 p -76.32 -44.8 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.474 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -56.58 -53.17 60.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 54' ' ' VAL . 85.1 t -67.47 -41.76 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -54.18 27.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 -34.73 69.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t -51.82 -68.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 -179.834 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.816 0.341 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.4 168.51 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -51.37 -60.35 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -52.56 -43.91 65.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.7 m-20 -54.53 -52.35 62.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.711 ' CD1' HD23 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -61.84 -47.57 84.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -51.22 -47.01 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.8 -50.58 34.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.505 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.3 t -53.58 -55.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.351 . . . . 0.0 111.117 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.2 t -61.12 -47.18 87.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -53.22 -45.25 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -46.21 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.04 -40.24 92.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 32' ' ' SER . 93.1 t -66.4 -48.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.9 p -61.11 -46.5 90.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.9 -51.87 67.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.93 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 73' ' ' PHE . 1.8 tt -55.68 -33.66 64.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 62.7 tp -68.44 -56.34 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.8 72.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -71.25 -43.11 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.5 m -65.2 -47.09 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 41' ' ' LEU . 7.2 p -67.25 -39.39 82.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.21 -49.81 63.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -67.18 -31.26 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.61 -48.91 58.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 45' ' ' VAL . 73.2 t -73.5 -37.25 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 tt0 -79.51 -10.57 59.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -27.78 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.02 -5.79 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -100.81 29.41 4.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 62' ' ' LEU . 17.6 m -108.58 -171.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.42 ' HG ' ' HD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -77.52 160.12 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.11 86.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -45.59 86.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 67.4 m95 -81.88 -1.64 48.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -50.94 -52.33 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.0 p -77.56 -35.33 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.161 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 112' ' ' ILE . 10.2 p -60.31 -31.85 70.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.12 -34.2 74.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -73.29 -56.39 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' THR . 6.0 m -59.74 -52.28 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 64' ' ' VAL . 9.4 p -69.2 -36.6 77.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.7 -34.6 78.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 63' ' ' THR . 6.0 mp -70.7 -47.29 60.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 104' ' ' LEU . 5.1 p -63.85 -44.69 98.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 p -71.65 -39.14 70.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.164 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.24 -45.22 95.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.451 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.64 -47.85 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.67 -44.59 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 16.1 t80 -58.38 -53.41 58.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -57.0 -47.39 80.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -60.15 -61.38 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.15 -54.32 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 -58.14 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -58.33 -38.04 76.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -57.1 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -53.46 44.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.39 -53.15 33.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 78' ' ' TYR . 78.3 t -62.02 -39.15 82.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.79 -51.95 64.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.054 HD11 ' HB1' ' A' ' 216' ' ' ALA . 9.6 tp -73.63 -25.83 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.1 -47.93 34.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 -38.78 4.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.14 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.42 126.53 52.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.7 162.22 32.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.613 0.721 . . . . 0.0 110.861 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 101.92 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.2 m -69.1 -26.02 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.7 t -48.04 -41.73 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 -44.82 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -67.2 -58.28 5.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.549 ' O ' HD23 ' A' ' 99' ' ' LEU . 8.4 mm -63.5 -62.53 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -53.66 -33.35 54.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.553 1.158 . . . . 0.0 109.277 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.423 ' HD1' HG23 ' A' ' 102' ' ' VAL . 4.5 t90 -58.13 -65.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -73.09 -9.88 59.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 99' ' ' LEU . 3.5 tt -91.42 -18.83 23.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.735 HG21 ' HB2' ' A' ' 72' ' ' ALA . 68.6 p -105.61 -39.05 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 4.0 t -44.28 -55.03 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.658 0.742 . . . . 0.0 111.128 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -23.25 31.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.252 . . . . 0.0 112.361 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 68' ' ' VAL . 20.2 mt -75.83 -54.63 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.682 HG21 ' CB ' ' A' ' 126' ' ' LYS . 35.4 mm -57.65 -37.81 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.63 -56.37 16.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -51.68 -46.62 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.42 -43.62 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.598 ' CD2' HD23 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -63.44 -32.61 74.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -56.81 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 61' ' ' SER . 5.5 tp -56.81 -40.3 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.135 HD12 HG13 ' A' ' 182' ' ' VAL . 3.2 mm? -70.82 -43.33 68.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -70.51 -18.58 62.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.38 -16.36 45.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 182' ' ' VAL . . . -92.3 -14.37 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -126.28 -74.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.451 ' H ' HG23 ' A' ' 117' ' ' THR . 0.8 OUTLIER 176.78 -33.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.454 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.6 p -170.68 145.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -115.65 145.43 42.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -5.04 82.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -39.09 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -51.5 -54.17 29.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.586 ' NZ ' HD22 ' A' ' 166' ' ' LEU . 20.6 ttpt -52.09 -50.1 62.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.682 ' CB ' HG21 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -66.28 -31.48 72.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.61 -49.7 74.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.61 -59.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.798 HG21 ' HG3' ' A' ' 162' ' ' MET . 50.6 t -53.77 -49.39 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.57 -48.71 83.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 m -53.43 -44.13 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.84 -48.12 72.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 129' ' ' VAL . 85.2 t -51.93 -54.41 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -64.8 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -56.11 -58.52 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.78 HG11 ' CD1' ' A' ' 154' ' ' ILE . 65.7 t -62.03 -51.72 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -51.96 -37.18 52.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.66 14.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -55.8 28.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 110.926 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -32.57 74.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.04 70.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.92 -32.86 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -28.58 7.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.53 26.37 10.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.2 pp -94.86 -34.9 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.096 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.739 ' HB3' HD12 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -146.74 142.45 27.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 171.73 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -57.72 -35.29 70.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -69.48 -61.46 3.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HA ' HD13 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.79 -6.72 19.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.271 . . . . 0.0 112.303 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.548 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -65.78 -48.73 70.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.55 -38.29 89.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.2 mp -65.03 -65.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.78 ' CD1' HG11 ' A' ' 136' ' ' VAL . 5.3 pt -57.58 -38.05 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -48.91 56.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.23 -44.02 92.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -50.47 72.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.89 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.565 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -62.94 -55.45 25.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CE3' ' A' ' 159' ' ' TRP . 82.5 t -58.41 -47.05 89.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.35 -46.17 89.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.798 ' HG3' HG21 ' A' ' 129' ' ' VAL . 9.3 tmm? -52.15 -58.66 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 194' ' ' ILE . 2.8 mp -68.09 -32.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -53.49 -54.52 36.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.19 -40.2 62.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.586 HD22 ' NZ ' ' A' ' 125' ' ' LYS . 28.2 tp -61.64 -24.94 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.439 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -58.9 -25.32 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.74 18.72 15.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.494 -179.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.834 0.35 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.7 165.12 36.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.729 0.776 . . . . 0.0 110.827 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.57 16.4 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.3 54.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 1.135 HG13 HD12 ' A' ' 113' ' ' LEU . 96.7 t -70.42 -44.2 77.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.72 -39.94 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -68.18 -50.06 56.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -58.21 -39.99 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -45.1 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.68 -56.31 23.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 1.026 HG22 HD12 ' A' ' 237' ' ' ILE . 0.2 OUTLIER -58.67 -43.61 89.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -56.86 -47.42 80.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.494 ' SD ' HG23 ' A' ' 163' ' ' ILE . 35.7 ttp -65.42 -32.56 74.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.8 -51.27 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.63 -37.95 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.096 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.2 -46.17 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.595 HD11 HG12 ' A' ' 163' ' ' ILE . 87.2 mt -65.57 -49.58 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -51.23 -58.96 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.4 -58.52 13.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -52.77 -31.09 36.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.18 -24.11 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.26 -34.26 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 16.6 t80 -51.95 -55.57 29.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.663 0.744 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.72 -28.99 24.79 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.368 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 198' ' ' ALA . 38.9 t -72.5 -27.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 206' ' ' THR . . . -81.84 -46.75 6.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -37.32 45.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -48.81 -28.21 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.9 p -47.36 -30.54 3.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 134.08 49.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 26.5 t80 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.458 -0.072 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -51.09 -30.67 16.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.711 HD23 ' CD1' ' A' ' 28' ' ' TYR . 9.8 mp -61.82 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.29 -30.13 71.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . 0.412 HD11 ' OH ' ' A' ' 208' ' ' TYR . 1.5 tt -60.6 -58.59 7.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -65.69 -37.32 86.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 221' ' ' LEU . 2.9 tm? -62.23 -55.87 24.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 48.1 mt -61.4 -47.64 92.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -59.8 -56.63 19.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -49.03 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 229' ' ' VAL . 6.4 tp -59.39 -39.2 82.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -55.33 24.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.09 -28.12 69.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -70.97 -52.81 17.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 225' ' ' LEU . 17.7 m -72.06 -24.42 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -77.49 0.81 21.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-O 126.692 3.139 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.21 -59.63 0.87 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 117.122 -3.486 . . . . 0.0 112.75 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.1 mm -58.08 -64.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.148 174.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.445 HD12 HG13 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -52.13 -42.8 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.945 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.01 -58.45 6.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 -40.64 94.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -44.06 81.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 1.026 HD12 HG22 ' A' ' 188' ' ' THR . 0.9 OUTLIER -68.59 -48.18 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 27.5 mm -54.34 -50.09 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.448 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.9 m95 -72.02 -30.7 65.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -58.61 -53.74 54.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 185' ' ' ALA . 7.3 p -75.52 -42.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.21 -55.01 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.486 ' CG2' HG12 ' A' ' 54' ' ' VAL . 93.9 t -63.72 -48.31 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -35.44 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -71.6 -37.66 70.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.6 p -50.22 -40.8 48.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -177.11 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -73.88 -74.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m -51.97 -32.07 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -59.1 -58.44 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.836 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -48.33 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 m -49.87 -47.31 51.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.0 -50.54 39.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.0 t -51.33 -55.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 p -60.77 -48.31 82.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.2 -48.39 65.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -46.22 88.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.62 -38.19 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' SER . 85.5 t -65.94 -52.34 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 m -58.79 -54.24 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.66 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.57 69.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.588 HD13 ' HE2' ' A' ' 73' ' ' PHE . 7.8 tp -54.43 -42.43 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 45' ' ' VAL . 11.1 tp -67.36 -56.17 10.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.45 -39.14 64.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 m -69.89 -43.43 71.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -60.42 -49.06 79.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 49' ' ' VAL . 28.1 m -69.53 -36.1 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.14 -57.07 10.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 44.2 t80 -62.21 -45.88 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -54.14 -52.02 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 45' ' ' VAL . 88.6 t -70.9 -29.85 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -79.32 -6.21 56.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.7 -27.39 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.79 -10.67 47.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 31.87 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.4 p -120.82 154.02 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.1 142.06 2.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.83 74.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -23.86 61.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.624 ' HB3' HD23 ' A' ' 62' ' ' LEU . 26.2 m95 -88.6 6.56 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.953 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -53.57 -50.13 66.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -75.25 -33.53 61.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.5 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -63.92 -40.52 96.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 3.7 mm? -77.0 -26.75 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -70.93 -49.91 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 60' ' ' THR . 30.6 m -73.59 -45.17 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 9.2 t -70.47 -39.32 74.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.25 64.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.38 -51.06 60.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.857 0.361 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 105' ' ' LEU . 75.3 t -61.22 -51.9 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -63.66 -37.55 87.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.22 -37.05 93.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 mt -71.6 -45.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 101' ' ' THR . . . -60.72 -43.23 98.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 232' ' ' ILE . 43.6 t80 -64.97 -57.08 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -55.02 -51.89 64.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.22 -42.07 94.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -57.96 -71.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.3 ttp -52.26 -32.16 35.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -57.66 -68.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.913 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.455 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.2 mtt -74.81 -58.28 3.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -39.81 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -74.91 -57.51 4.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 79' ' ' MET . 5.8 p -53.72 -35.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 220' ' ' ASN . 8.3 tp -54.52 -26.89 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.29 -20.92 58.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -103.28 -38.24 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.19 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.71 -175.11 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.88 37.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.708 0.766 . . . . 0.0 110.847 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 84.44 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 t -60.07 -37.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.91 -52.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -51.05 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -34.38 74.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.11 -57.86 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -30.38 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 101' ' ' THR . 5.1 t70 -63.6 -66.83 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.311 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -31.6 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.474 HD22 ' SD ' ' A' ' 134' ' ' MET . 30.5 tp -77.23 -21.83 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HD23 ' A' ' 104' ' ' LEU . 3.9 tt -99.47 -16.38 18.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' ASP . 40.9 p -98.35 -32.6 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.499 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -57.55 -59.33 13.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.85 35.61 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.375 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.2 mm? -79.42 -51.98 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 101' ' ' THR . 3.7 pp -67.43 -40.82 85.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 126' ' ' LYS . 24.8 mm -66.66 -49.88 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.26 -40.83 97.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.425 ' OE2' HD13 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.14 -59.71 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -51.11 -50.84 58.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -64.41 -37.1 86.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -55.7 -63.87 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.5 HG21 ' N ' ' A' ' 61' ' ' SER . 48.7 mm -57.9 -44.69 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.749 HD21 HG13 ' A' ' 182' ' ' VAL . 2.8 tm? -55.92 -47.28 77.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.22 -15.68 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -55.37 -20.17 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.87 -26.63 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -123.48 -45.61 2.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.717 ' OD1' HG22 ' A' ' 119' ' ' VAL . 3.4 t-20 179.91 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.717 HG22 ' OD1' ' A' ' 118' ' ' ASN . 18.3 m -151.56 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -127.08 151.64 48.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.35 -2.47 73.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.21 -31.37 5.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.887 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.79 -40.52 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -49.93 25.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.588 ' CG ' HD13 ' A' ' 166' ' ' LEU . 3.9 mptt -58.22 -51.74 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.581 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -62.67 -35.68 80.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 tp -62.25 -47.03 86.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.62 -58.72 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 133' ' ' VAL . 6.0 m -55.31 -36.05 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.112 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.92 -45.57 72.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.5 t -63.01 -39.09 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.828 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -53.85 37.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 129' ' ' VAL . 59.6 t -56.68 -43.44 79.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -67.04 -36.4 82.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -61.4 -47.24 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.61 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.3 t -67.02 -48.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -58.32 -41.08 83.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.01 -51.67 8.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.13 -57.32 10.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.8 mmt -68.34 -46.13 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.81 55.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -45.57 -36.56 4.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.911 0.386 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.95 -27.45 8.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.084 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.09 27.37 5.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.488 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -104.71 -37.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.692 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -128.31 -168.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 79.28 0.42 2.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.114 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 208' ' ' TYR . . . -70.41 -42.61 71.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.555 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -70.11 -57.05 6.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.536 0.684 . . . . 0.0 110.93 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.77 -7.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.717 2.278 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.98 -48.0 81.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.49 -39.25 91.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 150' ' ' PRO . 7.6 mt -66.83 -58.93 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -35.25 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.06 -49.31 16.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.7 t -57.36 -50.63 72.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -50.11 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.58 94.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.592 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -61.55 -55.68 28.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' CE3' ' A' ' 159' ' ' TRP . 73.3 t -53.5 -48.07 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.66 -39.78 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.642 ' HG2' HG12 ' A' ' 129' ' ' VAL . 27.8 mtt -58.62 -58.22 9.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.3 mp -67.24 -30.88 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -58.26 -54.68 44.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -33.72 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' ' 125' ' ' LYS . 21.5 tp -74.63 -13.99 60.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.435 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -56.47 -21.22 24.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.85 21.62 14.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.791 0.329 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.63 162.73 51.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.659 0.742 . . . . 0.0 110.854 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -30.83 21.52 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.5 -47.53 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.115 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.749 HG13 HD21 ' A' ' 113' ' ' LEU . 84.6 t -67.31 -44.6 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.01 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 t -66.62 -49.26 66.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.476 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.78 -42.2 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.29 -51.66 68.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.4 -54.71 43.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 31.9 m -55.33 -36.51 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.174 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.402 ' HA ' ' HE2' ' A' ' 189' ' ' MET . 0.0 OUTLIER -63.71 -51.92 62.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.5 ttp -59.8 -37.53 79.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 -49.53 74.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -69.34 -53.45 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.2 mt -49.78 -50.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 91.3 mt -62.44 -49.79 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 199' ' ' ILE . 50.6 t80 -53.21 -48.86 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA2' HG12 ' A' ' 199' ' ' ILE . . . -62.06 -49.58 73.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.61 -28.43 69.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.84 -45.04 19.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 195' ' ' PHE . 21.0 pt -71.85 -29.46 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.7 t80 -45.59 -59.36 4.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.662 2.241 . . . . 0.0 112.343 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 198' ' ' ALA . 74.3 t -68.38 -43.88 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.67 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.99 -41.32 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.507 ' HA ' HG21 ' A' ' 222' ' ' ILE . 3.3 t80 -59.49 -24.57 63.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 70.6 t80 -54.47 -33.2 59.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 203' ' ' GLY . 6.2 t -66.26 -13.75 60.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.38 -4.79 6.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.594 ' CD1' ' HB1' ' A' ' 148' ' ' ALA . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.0 110.937 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.904 0.383 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.33 70.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -59.8 -52.1 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -35.8 81.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.54 -58.63 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 84' ' ' ILE . 1.2 p-10 -63.74 -35.99 82.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.531 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.3 tm? -63.07 -54.23 41.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 204' ' ' TYR . 23.3 mt -59.48 -48.13 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . 0.486 ' HD2' ' HH ' ' A' ' 204' ' ' TYR . 0.2 OUTLIER -62.14 -57.63 10.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -55.33 -39.86 70.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 229' ' ' VAL . 22.2 tp -62.83 -47.75 82.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.23 37.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.069 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -36.49 83.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.43 -40.8 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' LEU . 94.0 t -72.37 -42.66 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -72.78 -5.08 35.52 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 126.718 3.151 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -113.05 -27.07 8.18 Favored 'General case' 0 N--CA 1.424 -1.761 0 O-C-N 117.119 -3.488 . . . . 0.0 112.773 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 73' ' ' PHE . 31.8 mm -91.63 -63.44 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.14 174.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 233' ' ' LEU . 6.4 tp -49.08 -31.55 8.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.531 ' CZ ' HD11 ' A' ' 238' ' ' ILE . 71.6 t80 -57.52 -56.71 18.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.95 -39.76 89.16 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.97 -38.97 93.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.59 -47.43 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.531 HD11 ' CZ ' ' A' ' 234' ' ' PHE . 24.3 mt -55.48 -49.25 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 243' ' ' VAL . 3.4 t90 -69.85 -38.21 76.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -58.42 -53.85 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.7 p -65.15 -37.13 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.27 77.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 54' ' ' VAL . 98.9 t -81.27 -41.49 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -63.24 -39.57 94.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -77.52 -48.34 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.3 t -52.39 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 -179.842 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.822 0.344 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.01 157.89 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -55.04 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -31.06 61.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -66.44 -68.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.779 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -49.71 -52.07 34.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 25' ' ' ALA . 5.6 t -61.82 -31.87 72.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.23 -55.51 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 32' ' ' SER . 15.4 m -57.0 -44.35 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 36' ' ' VAL . 35.0 t -64.37 -46.94 81.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.91 -40.14 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -47.5 69.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -43.98 97.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 32' ' ' SER . 93.2 t -63.2 -43.99 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.5 m -61.59 -42.66 99.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.13 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -51.9 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 232' ' ' ILE . 3.1 tm? -57.42 -39.03 75.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 tm? -61.19 -55.57 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.81 75.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -50.66 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.7 p -61.39 -40.4 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' LEU . 74.2 t -64.48 -48.05 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.92 -46.35 75.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 38.8 t80 -65.18 -28.72 69.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -74.66 -45.5 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' VAL . 61.1 t -73.55 -42.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.01 -4.01 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -26.38 62.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.03 -3.98 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.07 42.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.792 ' HA ' HG22 ' A' ' 243' ' ' VAL . 3.5 m -115.01 -170.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -66.27 152.94 43.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.62 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -27.81 64.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.471 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 58.3 m95 -91.69 1.6 57.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -51.11 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.473 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -77.56 -31.29 53.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 112' ' ' ILE . 5.4 p -55.29 -43.58 74.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 4.2 mm? -67.37 -29.67 69.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -54.82 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 65' ' ' SER . 15.5 m -62.91 -50.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 64' ' ' VAL . 1.1 p -70.12 -35.56 74.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.4 84.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.27 -47.92 59.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.54 -55.24 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 m -65.13 -37.52 87.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.29 99.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.478 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.51 -42.99 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 111.172 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.569 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -58.41 -47.89 82.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -63.98 -54.56 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -52.82 -51.19 61.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -63.92 -59.33 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -49.0 -62.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -38.31 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 82' ' ' VAL . 29.6 t80 -65.21 -70.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -59.67 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.478 HH21 HD11 ' A' ' 84' ' ' ILE . 2.1 tpm_? -53.47 -55.95 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.94 -54.6 27.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.0 t -56.59 -54.86 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.329 . . . . 0.0 111.156 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -54.18 -55.67 25.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HH21 ' A' ' 80' ' ' ARG . 41.6 mm -59.7 -26.52 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -21.28 50.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -38.33 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.08 31.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.52 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.77 -176.17 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 p -146.12 77.51 11.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.663 0.744 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 72.55 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.673 2.249 . . . . 0.0 112.328 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -69.87 -41.39 74.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 93' ' ' PHE . 4.7 m -54.56 -52.43 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.502 ' H ' HG23 ' A' ' 92' ' ' VAL . 34.5 m-85 -71.1 -44.61 65.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -55.46 -58.5 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -40.22 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 97' ' ' ASP . 21.6 mt -59.05 -63.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 101' ' ' THR . 18.6 t70 -59.02 -33.29 70.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.567 ' HE1' HG12 ' A' ' 133' ' ' VAL . 17.4 t-105 -60.58 -58.72 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.5 tm? -75.07 -11.99 60.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 100' ' ' LEU . 9.3 tt -90.96 -21.04 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.569 HG21 ' CB ' ' A' ' 72' ' ' ALA . 65.1 p -107.81 -34.36 6.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 t -47.57 -60.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.69 -30.46 22.54 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.27 . . . . 0.0 112.374 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 100' ' ' LEU . 3.1 mm? -64.88 -55.55 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.48 -43.01 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.36 -50.64 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 16.3 t -64.41 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -65.27 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.42 -50.21 60.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.48 -37.46 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.17 -66.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' N ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -50.75 -37.53 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.969 HD21 HG13 ' A' ' 182' ' ' VAL . 3.3 tm? -69.36 -39.82 77.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.43 -14.27 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.43 -14.67 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.02 -24.89 68.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -120.42 -70.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 117' ' ' THR . 2.1 m-20 165.24 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.46 138.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.02 96.94 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.99 85.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.0 p -48.78 -35.85 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.2 mp -49.48 -42.64 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -68.26 -53.68 22.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -52.09 64.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -36.14 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.31 -50.52 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.5 -60.13 2.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 89.9 t -56.58 -47.12 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.25 98.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.4 m -66.53 -55.26 16.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -53.81 43.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 129' ' ' VAL . 64.2 t -57.55 -45.09 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -61.92 -42.04 98.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 136' ' ' VAL . 2.1 tt -60.55 -57.82 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.627 ' CG1' HD12 ' A' ' 154' ' ' ILE . 48.5 t -52.67 -52.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -40.78 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.37 -51.46 52.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -60.44 -56.83 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -34.62 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.91 -29.19 59.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -39.79 -48.88 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' HG13 ' A' ' 145' ' ' ILE . . . -111.66 -28.95 7.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.78 17.02 33.29 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.403 HG13 ' HB1' ' A' ' 143' ' ' ALA . 12.9 mt -93.54 -55.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.123 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -111.45 138.35 48.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 174.07 -27.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.63 -31.64 48.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -74.54 -63.07 0.85 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.544 0.688 . . . . 0.0 110.881 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.71 -6.16 17.91 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.75 -49.63 74.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.95 -31.13 68.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mp -68.99 -61.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.627 HD12 ' CG1' ' A' ' 136' ' ' VAL . 1.3 pt -62.71 -38.96 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.194 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.43 93.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.489 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.94 -48.23 74.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -50.29 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.428 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.4 t90 -66.64 -57.89 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.428 HG23 ' CE3' ' A' ' 159' ' ' TRP . 59.8 t -61.36 -41.11 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.79 -47.09 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.23 -52.59 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.679 HG22 ' CE3' ' A' ' 167' ' ' TRP . 48.9 mt -63.13 -53.07 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -47.39 -35.59 8.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.96 -49.53 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -72.6 -16.39 61.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -116.69 18.42 14.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.933 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.075 0 CA-C-O 120.856 0.36 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -110.67 166.42 10.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.64 0.734 . . . . 0.0 110.849 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 179' ' ' SER . 53.9 Cg_endo -69.74 -36.79 10.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.79 -43.68 35.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.969 HG13 HD21 ' A' ' 113' ' ' LEU . 76.6 t -68.02 -46.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.01 -36.47 83.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 m -68.67 -47.24 67.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.54 -39.89 95.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -43.77 78.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.05 -49.35 78.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.6 m -65.16 -38.66 91.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -64.22 -42.31 96.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.9 ttp -71.7 -34.97 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -63.97 -50.89 66.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.72 HG21 ' CD1' ' A' ' 237' ' ' ILE . 2.2 pp -70.86 -38.33 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 8.1 mm -64.1 -47.56 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.517 HD13 HD13 ' A' ' 163' ' ' ILE . 62.3 mt -64.41 -52.95 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -52.34 -54.51 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.04 21.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -53.95 -36.32 62.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.67 -20.81 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.8 mt -82.01 -31.86 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -48.35 -54.09 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.666 0.746 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.2 Cg_endo -69.7 -20.86 34.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 198' ' ' ALA . 76.7 t -72.83 -43.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.57 -38.27 17.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.708 ' CD2' HG21 ' A' ' 222' ' ' ILE . 0.6 OUTLIER -52.39 -29.36 23.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -49.0 -30.75 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 203' ' ' GLY . 15.2 t -51.16 -24.64 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.1 22.24 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.855 0.36 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.65 -36.79 69.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 28' ' ' TYR . 17.0 mt -62.53 -63.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.39 -43.25 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -45.27 81.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -65.31 -44.66 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.98 -53.63 52.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.708 HG21 ' CD2' ' A' ' 204' ' ' TYR . 36.3 mm -57.15 -45.75 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -63.95 -54.64 31.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.37 -47.61 78.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -50.48 71.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.95 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -27.92 69.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -67.88 -56.43 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -24.95 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -80.4 2.78 23.63 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.68 3.133 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -131.18 -51.22 1.02 Allowed 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 117.158 -3.464 . . . . 0.0 112.753 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 40' ' ' LEU . 1.9 mp -63.83 -63.67 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.12 174.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 232' ' ' ILE . 5.9 tp -48.99 -36.55 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -56.1 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.39 -33.69 85.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.08 -41.32 86.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.72 ' CD1' HG21 ' A' ' 192' ' ' ILE . 19.6 mm -67.77 -50.01 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.524 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.7 mm -63.67 -36.52 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 24.8 t90 -74.1 -41.82 61.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -69.64 -40.98 76.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 185' ' ' ALA . 9.9 p -70.56 -36.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.21 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.5 t -66.3 -36.5 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -75.61 -50.6 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -58.54 -41.79 86.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -54.51 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.819 0.342 . . . . 0.0 110.87 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.82 163.53 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 29' ' ' THR . . . -67.39 -65.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.43 -30.91 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.97 -67.83 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.688 ' CD2' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -52.43 -44.04 65.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.88 HG22 HD11 ' A' ' 84' ' ' ILE . 34.7 p -60.13 -38.73 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.15 -54.56 13.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -55.93 -41.43 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.633 ' O ' HG23 ' A' ' 36' ' ' VAL . 52.8 m -66.44 -48.43 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.02 -42.59 72.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -47.85 68.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 -42.62 96.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.698 HG12 HD22 ' A' ' 40' ' ' LEU . 91.8 t -63.91 -50.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -55.36 -43.39 75.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.33 -52.04 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -54.34 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.698 HD22 HG12 ' A' ' 36' ' ' VAL . 4.1 mp -51.16 -52.84 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -54.27 -48.64 70.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.48 -36.02 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.696 ' OG ' HD12 ' A' ' 232' ' ' ILE . 6.3 p -70.88 -34.93 72.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -70.78 -45.08 65.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.9 m -65.87 -42.83 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.74 -48.62 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -64.6 -29.87 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -74.95 -50.36 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 45' ' ' VAL . 94.0 t -65.73 -41.03 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -79.73 -6.22 56.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.486 ' CG ' HD22 ' A' ' 62' ' ' LEU . 12.0 ttt180 -57.4 -26.67 61.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -93.22 -10.71 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 243' ' ' VAL . 1.3 tpt180 -100.63 28.78 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.041 HG11 HD11 ' A' ' 62' ' ' LEU . 9.4 p -107.98 161.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.439 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -48.79 149.93 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.87 -55.88 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -23.86 59.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.744 ' CZ3' HD11 ' A' ' 238' ' ' ILE . 59.9 m95 -90.43 11.64 20.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -62.25 -50.46 71.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -34.26 73.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.179 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -43.2 62.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.041 HD11 HG11 ' A' ' 54' ' ' VAL . 2.6 mp -65.18 -29.53 70.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.4 m -70.14 -54.53 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 68' ' ' VAL . 12.6 m -69.62 -49.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.5 p -67.12 -36.87 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.67 -36.79 83.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.535 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tp -70.58 -49.97 42.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.4 p -66.08 -46.32 88.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.481 ' N ' HG13 ' A' ' 68' ' ' VAL . 52.3 m -71.51 -29.95 65.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.04 -52.01 30.58 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 71' ' ' ILE . 0.3 OUTLIER -68.69 -37.19 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -68.54 -42.09 78.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.75 -56.59 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.831 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -56.28 -50.21 72.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -60.78 -62.6 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -49.84 -51.27 41.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -53.69 27.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 4.7 m-85 -56.78 -46.21 81.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -57.12 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.44 -56.59 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.69 58.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.6 t -62.29 -28.12 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 111.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -70.29 -47.32 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.88 HD11 HG22 ' A' ' 29' ' ' THR . 1.6 tt -73.35 -24.96 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.32 -47.78 18.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.8 p -122.5 -39.23 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.21 -23.33 4.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -122.7 129.12 51.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.2 161.03 40.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 110.878 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 104.07 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -26.41 64.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 m -51.38 -41.29 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.093 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.83 -52.03 53.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -60.03 -37.72 80.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.08 -48.78 74.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.64 -50.25 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 3.9 t70 -62.85 -39.69 95.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.1 t-105 -61.03 -49.45 77.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.451 HD12 ' CG ' ' A' ' 134' ' ' MET . 1.0 OUTLIER -75.55 -16.53 60.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 tt -94.02 -14.74 25.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 72' ' ' ALA . 72.6 p -108.17 -29.48 8.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -54.88 -59.64 10.13 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.634 0.73 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.71 -35.55 12.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.315 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 100' ' ' LEU . 6.2 mt -65.4 -52.34 54.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 106' ' ' ILE . 1.5 tt -60.63 -50.57 73.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.574 ' N ' HD23 ' A' ' 105' ' ' LEU . 27.4 mm -57.69 -58.64 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.98 -33.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.97 -68.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -50.5 -50.72 52.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.35 -43.98 83.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.25 -66.71 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -31.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 113' ' ' LEU . 2.9 tm? -71.65 -42.09 67.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.2 -14.37 59.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.52 -17.31 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.41 -24.05 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -121.87 -69.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' THR . 1.7 m-20 165.77 -76.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -47.23 135.01 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.11 98.27 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.29 74.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -47.87 -33.5 7.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -48.26 -43.38 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.38 -53.26 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -52.91 -52.27 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -37.34 86.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.81 -50.85 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -59.76 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.5 t -53.03 -49.56 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.3 59.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 t -52.49 -57.21 10.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -53.04 44.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 129' ' ' VAL . 98.6 t -56.53 -44.56 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.451 ' CG ' HD12 ' A' ' 99' ' ' LEU . 14.8 mtt -64.25 -38.14 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.3 -58.72 7.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 154' ' ' ILE . 15.6 m -57.14 -43.0 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.62 -47.3 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.55 -52.23 47.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -58.71 -55.21 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.92 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -58.37 -32.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.3 -30.18 59.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -41.61 -52.8 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.18 -28.48 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.73 16.95 48.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.5 pt -100.58 -37.27 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.63 139.82 47.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 170.4 -14.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -65.36 -38.84 91.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.578 ' HB2' ' HD3' ' A' ' 150' ' ' PRO . 1.7 m95 -69.12 -55.83 9.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.687 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.4 Cg_endo -69.76 -16.88 37.77 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.733 2.289 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -52.52 -53.21 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -77.7 -28.49 51.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 150' ' ' PRO . 46.0 mt -66.88 -64.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.073 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 136' ' ' VAL . 1.1 pt -63.29 -36.39 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.1 93.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.444 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.6 t -63.65 -46.77 84.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.71 -47.35 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.65 91.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 163' ' ' ILE . 11.0 t90 -61.06 -55.82 28.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 156' ' ' CYS . 43.5 t -58.88 -46.85 90.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.41 -43.28 99.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.698 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.9 mmm -57.35 -49.32 76.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.629 HD11 ' NE1' ' A' ' 159' ' ' TRP . 81.5 mt -63.59 -52.65 54.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -36.5 38.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.68 -58.76 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 162' ' ' MET . 0.5 OUTLIER -55.14 -55.77 27.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.433 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -56.14 -22.05 26.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.04 18.47 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.473 -179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.786 0.327 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.52 162.32 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.664 0.745 . . . . 0.0 110.898 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -28.57 25.19 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.304 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.32 -41.44 56.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 113' ' ' LEU . 98.6 t -63.8 -43.32 97.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.49 -32.59 72.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 t -69.8 -45.14 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.831 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -68.45 -40.8 80.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.537 ' CZ ' HD23 ' A' ' 166' ' ' LEU . 32.8 t80 -64.96 -51.39 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -61.86 -56.23 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.6 m -53.02 -44.18 67.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -59.9 -52.38 65.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.656 ' HG3' HD13 ' A' ' 166' ' ' LEU . 3.5 tmm? -54.78 -39.34 68.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.93 -52.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 194' ' ' ILE . 9.5 tt -52.7 -45.95 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 190' ' ' MET . 21.5 pt -69.58 -38.12 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' A' ' 199' ' ' ILE . 23.6 t80 -56.84 -58.32 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.97 -48.84 77.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.535 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -58.21 -33.11 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.03 -25.2 43.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.664 HD11 ' CE1' ' A' ' 195' ' ' PHE . 24.6 mt -80.34 -31.11 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.599 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -47.75 -54.5 22.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.693 0.758 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.72 -23.13 31.32 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.695 2.263 . . . . 0.0 112.386 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 198' ' ' ALA . 73.9 t -69.56 -44.32 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.91 -35.11 22.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.421 ' HB2' HG21 ' A' ' 222' ' ' ILE . 11.7 t80 -52.7 -29.44 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -48.76 -30.28 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 203' ' ' GLY . 8.9 t -50.5 -28.07 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.21 21.7 0.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.639 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 1.1 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.27 65.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -65.43 -51.77 57.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . 0.43 ' N ' HD12 ' A' ' 217' ' ' LEU . 2.0 t-20 -61.14 -41.56 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -58.46 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -36.27 69.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -60.19 -57.92 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 200' ' ' TYR . 42.3 mm -55.51 -48.62 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.4 -51.54 69.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -60.04 -38.82 83.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -59.24 -51.22 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 200' ' ' TYR . . . -59.75 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.21 86.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.78 -39.31 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 225' ' ' LEU . 95.6 t -74.33 -24.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -96.11 2.51 53.27 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.671 3.129 . . . . 0.0 110.84 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.7 mmtm -121.51 -45.37 2.31 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 117.121 -3.487 . . . . 0.0 112.76 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.696 HD12 ' OG ' ' A' ' 43' ' ' SER . 46.5 mm -84.34 -65.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.08 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -36.22 44.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -55.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.29 -35.25 91.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -42.32 85.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 238' ' ' ILE . 1.1 mm -65.72 -50.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ILE . . . . . 0.744 HD11 ' CZ3' ' A' ' 58' ' ' TRP . 9.0 tp -62.84 -34.45 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' TRP . . . . . 0.709 ' O ' HG23 ' A' ' 243' ' ' VAL . 10.2 t90 -74.41 -44.27 52.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -60.32 -41.95 94.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 185' ' ' ALA . 13.6 p -72.67 -36.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.86 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 54' ' ' VAL . 61.4 t -74.8 -38.58 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -71.61 -35.83 70.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -76.85 -36.81 56.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.4 t -50.93 -54.88 20.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.817 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.99 146.56 10.24 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.448 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 141.05 -99.45 0.24 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.9 71.75 1.05 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -172.92 89.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.466 HD22 ' HB3' ' A' ' 27' ' ' ASP . 16.2 mt -145.7 150.7 36.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.932 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 175.6 2.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -55.73 -73.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.28 -31.63 54.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.834 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -58.43 -71.03 0.12 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.83 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.564 ' HB2' HD23 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -58.39 -48.17 81.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.5 m -51.23 -42.88 61.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.96 -50.81 27.02 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 27' ' ' ASP . 57.7 t -51.17 -51.66 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 0.0 111.167 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.674 ' O ' HG23 ' A' ' 36' ' ' VAL . 2.0 t -64.37 -48.74 74.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.854 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.34 -49.07 65.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -46.92 83.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -59.0 -38.76 79.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 32' ' ' SER . 84.1 t -68.09 -45.56 83.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 m -62.31 -50.54 71.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.105 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.1 -50.13 74.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 41' ' ' LEU . 1.6 tt -52.53 -52.53 54.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.888 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -58.8 -53.58 56.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.15 -47.16 65.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.082 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -29.01 68.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.0 m -72.81 -48.87 34.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.176 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 49' ' ' VAL . 22.8 m -65.66 -40.3 87.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -68.87 -51.34 41.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.861 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.41 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 48.8 t80 -63.37 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.896 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -75.05 -51.33 13.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.898 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 45' ' ' VAL . 90.0 t -67.62 -31.13 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -79.22 -7.06 57.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.6 ttt-85 -56.38 -27.26 55.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.26 -12.54 27.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -102.39 36.69 2.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.916 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.672 ' HA ' HG22 ' A' ' 243' ' ' VAL . 8.2 p -120.03 158.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.154 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.427 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -47.8 147.28 2.0 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.861 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.27 -52.87 35.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.107 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.18 -21.82 60.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 28.6 m95 -87.73 6.97 32.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -51.33 -50.75 58.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.861 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -77.06 -36.17 56.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.153 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.509 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -54.92 -47.8 73.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -72.19 -27.5 62.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 98.5 m -67.77 -53.6 25.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 68' ' ' VAL . 29.8 m -71.73 -44.91 68.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 64' ' ' VAL . 4.2 t -66.32 -40.56 90.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.867 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -35.29 58.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.07 -49.19 65.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.7 p -68.48 -44.11 83.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.082 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.448 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.1 m -67.26 -35.26 79.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.95 -42.68 59.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.473 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 32.0 mt -68.48 -41.67 83.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.857 0.36 . . . . 0.0 111.133 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -66.87 -43.63 83.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.815 ' CE2' HD11 ' A' ' 232' ' ' ILE . 30.6 t80 -61.1 -51.95 66.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.4 t90 -59.56 -50.41 74.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.884 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -59.25 -61.43 2.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.886 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -51.5 -49.7 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.927 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.26 -53.15 30.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.59 ' O ' HG23 ' A' ' 82' ' ' VAL . 18.8 t80 -58.72 -48.74 80.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 15.3 mmt -55.83 -54.84 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.844 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -51.41 -55.16 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.04 -45.87 56.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 78' ' ' TYR . 58.6 t -66.7 -35.68 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.801 0.334 . . . . 0.0 111.136 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 t-105 -59.75 -51.6 69.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.534 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.3 tp -74.51 -26.13 19.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -50.15 -48.61 53.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.9 p -111.43 -39.25 4.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.197 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 122.36 -13.66 8.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.515 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -137.46 127.03 25.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.7 161.28 35.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.643 0.735 . . . . 0.0 110.859 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 99.96 0.79 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.63 2.22 . . . . 0.0 112.358 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 p -65.24 -25.61 67.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.139 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.8 m -50.6 -33.28 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.123 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -71.57 -51.92 20.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.4 ttp180 -63.74 -33.55 75.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.95 -53.79 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 75.5 mt -66.57 -37.94 80.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 101' ' ' THR . 0.8 OUTLIER -63.25 -47.88 80.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.464 1.102 . . . . 0.0 109.31 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.606 ' CD1' HG23 ' A' ' 102' ' ' VAL . 14.5 t90 -64.82 -41.67 95.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.8 tp -75.15 -16.58 60.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.911 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.551 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.4 tt -99.36 -16.8 18.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.663 HG21 ' HB2' ' A' ' 72' ' ' ALA . 40.5 p -100.12 -29.17 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.123 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.606 HG23 ' CD1' ' A' ' 98' ' ' TRP . 2.2 t -60.0 -58.63 17.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.675 0.75 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.75 -24.82 29.29 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.71 2.273 . . . . 0.0 112.35 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 100' ' ' LEU . 8.5 mt -76.51 -52.45 9.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.743 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.8 pp -64.08 -38.52 91.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.789 HD12 ' HD3' ' A' ' 126' ' ' LYS . 26.1 mm -70.55 -57.94 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.521 ' HB2' HD13 ' A' ' 123' ' ' LEU . 35.9 t -52.05 -49.83 62.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.34 -55.48 33.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.931 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -51.11 -50.75 58.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.682 ' HB3' ' HB3' ' A' ' 120' ' ' ALA . 18.4 m-85 -68.53 -30.54 69.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 18.9 tp -60.23 -63.32 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 61' ' ' SER . 39.4 mm -62.64 -37.53 79.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.062 HD11 HG13 ' A' ' 182' ' ' VAL . 4.9 tp -62.54 -50.45 71.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -76.97 -14.01 59.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.074 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.69 -23.62 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.67 -27.65 68.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.5 t -117.81 -45.84 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.145 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -179.61 -78.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -154.74 157.34 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.865 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -106.8 124.29 49.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.31 -5.53 81.85 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.474 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.4 m -50.5 -28.15 7.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.38 . . . . 0.0 110.869 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.521 HD13 ' HB2' ' A' ' 107' ' ' CYS . 21.4 tp -51.82 -39.78 59.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.913 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -64.95 -52.68 55.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.0 -49.94 74.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.919 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.789 ' HD3' HD12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -64.32 -32.44 74.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.09 -48.32 76.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -58.58 5.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.856 HG11 ' HG3' ' A' ' 162' ' ' MET . 48.1 t -56.3 -51.95 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.37 -45.63 74.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -45.35 91.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -60.47 -49.67 76.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 129' ' ' VAL . 39.6 t -54.8 -51.68 49.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.107 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.452 ' HE1' ' HA ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -62.53 -35.89 80.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -58.94 -51.01 71.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.92 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.713 HG11 HD12 ' A' ' 154' ' ' ILE . 80.7 t -64.62 -46.89 91.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.185 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.547 ' HB2' H162 ' A' ' 301' ' ' RET . 76.1 t80 -59.71 -39.51 84.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.29 -51.99 8.08 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -57.56 -55.75 30.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.927 0.394 . . . . 0.0 110.95 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.609 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 16.3 mmt -69.29 -47.9 63.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -54.63 -31.7 53.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -47.48 -46.77 27.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -100.6 -27.1 13.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.098 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 56.48 20.33 30.03 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.8 pt -75.52 -40.06 41.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.876 0.37 . . . . 0.0 111.157 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.64 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -156.39 132.52 9.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 146' ' ' MET . . . 165.11 -20.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.094 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.677 ' HB3' ' CE1' ' A' ' 208' ' ' TYR . . . -67.75 -43.0 80.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.106 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.638 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 4.9 t-105 -66.78 -54.82 19.84 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.532 0.682 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 149' ' ' TRP . 54.0 Cg_endo -69.71 -16.96 38.03 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.319 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.7 -33.17 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.085 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.4 -37.72 88.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.6 -65.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.713 HD12 HG11 ' A' ' 136' ' ' VAL . 6.5 pt -50.68 -44.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.133 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.409 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -65.66 -49.15 61.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.5 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.721 ' O ' HG23 ' A' ' 160' ' ' VAL . 49.1 t -55.22 -50.5 69.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 0.0 110.913 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.15 -50.34 73.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.26 84.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.098 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.532 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.6 t90 -65.21 -55.14 20.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 156' ' ' CYS . 33.1 t -52.75 -50.15 43.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.087 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.11 -39.88 94.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.856 ' HG3' HG11 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -54.84 -58.7 6.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.628 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.9 mp -68.49 -32.17 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -53.24 -55.91 20.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -76.65 -35.29 58.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.5 tp -60.52 -40.25 90.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -21.58 26.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -110.44 20.01 18.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.109 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -47.96 164.88 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.489 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -83.19 1.15 42.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.921 0.391 . . . . 0.0 110.886 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.16 -58.61 7.72 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.497 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -76.85 -17.55 58.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.837 0.351 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.9 t -70.42 -23.78 62.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -45.56 -57.2 4.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.08 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.77 -57.45 2.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 176.53 -71.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.88 5.65 16.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.71 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.56 163.19 21.01 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.699 0.761 . . . . 0.0 110.82 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.64 27.53 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.27 -48.39 23.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.091 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 1.062 HG13 HD11 ' A' ' 113' ' ' LEU . 85.4 t -63.38 -41.78 93.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.152 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -65.78 -33.43 75.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.6 m -70.57 -46.89 62.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -65.01 -40.48 94.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.17 -51.77 54.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -56.48 -49.94 73.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.929 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 20.6 p -61.91 -38.48 88.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.622 ' SD ' HD11 ' A' ' 238' ' ' ILE . 5.1 tpt -62.31 -51.95 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.628 ' CE ' HG23 ' A' ' 163' ' ' ILE . 2.7 ttp -61.5 -38.62 87.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -49.04 79.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.3 mm -65.21 -48.49 83.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.6 mm -52.58 -45.93 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.525 HG23 ' NE1' ' A' ' 159' ' ' TRP . 32.1 mt -64.95 -51.33 68.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -56.2 -57.5 11.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -56.51 -59.21 11.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.505 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.5 -34.01 56.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.802 0.334 . . . . 0.0 110.921 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.681 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.92 -23.7 44.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.108 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.1 mt -78.37 -32.47 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.571 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 6.8 t80 -48.38 -56.23 15.31 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.627 0.727 . . . . 0.0 110.889 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.76 -23.65 30.57 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.697 2.264 . . . . 0.0 112.379 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.19 -45.24 83.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.01 -39.03 10.47 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -53.22 -48.59 68.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.956 0.408 . . . . 0.0 110.923 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -56.07 -32.77 64.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.915 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.5 OUTLIER -67.23 -13.38 61.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -131.6 5.01 5.51 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.677 ' CE1' ' HB3' ' A' ' 148' ' ' ALA . 2.6 t80 -88.88 -53.48 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.9 0.381 . . . . 0.0 110.915 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 32.3 mt -100.78 -41.1 7.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.975 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 31.4 ttp -116.44 164.6 14.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 153.36 -61.55 0.38 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.446 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 176.87 34.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.831 0.348 . . . . 0.0 110.836 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 104.6 -7.38 46.01 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 104.89 60.31 0.65 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 17.9 t -84.07 132.55 34.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.839 0.352 . . . . 0.0 110.854 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.71 64.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.5 mp -52.78 -63.08 1.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -33.64 39.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.9 -54.47 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.946 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.534 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.4 t30 -61.12 -52.12 66.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.887 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.611 HD23 ' HB2' ' A' ' 32' ' ' SER . 2.2 tm? -52.17 -58.46 6.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.406 ' N ' HD13 ' A' ' 221' ' ' LEU . 96.6 mt -54.2 -42.51 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.172 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -61.71 -52.56 63.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.86 -37.92 83.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.888 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.1 tp -63.04 -45.0 94.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.75 -52.14 64.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.062 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -64.61 -32.05 73.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -66.18 -49.61 66.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.442 HG13 ' HB2' ' A' ' 233' ' ' LEU . 53.7 t -73.33 -25.72 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.158 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -80.47 2.55 24.76 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-O 126.738 3.161 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.677 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 5.2 mmtm -131.59 -51.57 0.99 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.111 -3.493 . . . . 0.0 112.761 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.815 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.3 mm -65.33 -64.53 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.16 -1.837 . . . . 0.0 111.101 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.442 ' HB2' HG13 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -50.91 -36.0 35.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.9 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -51.56 -56.04 15.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -71.07 -32.65 65.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.487 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.99 -47.36 85.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.777 0.322 . . . . 0.0 110.858 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 5.8 mm -71.42 -50.77 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.12 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.622 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.5 mm -53.19 -40.92 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.648 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.9 t90 -74.71 -41.97 59.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.954 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -60.55 -42.54 96.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.02 -35.12 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.164 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.95 -37.76 72.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' VAL . 60.7 t -79.76 -37.9 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -70.27 -37.8 74.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -77.04 -46.29 24.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.9 t -51.95 -62.3 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.865 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 172.92 93.77 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.917 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -151.39 158.84 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.824 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -107.57 160.52 26.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.588 0.709 . . . . 0.0 111.116 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.588 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 54.0 Cg_endo -69.77 148.02 64.11 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.0 112.361 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 154.44 107.94 0.3 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.161 -0.799 . . . . 0.0 112.455 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.547 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.786 0.327 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.0 179.21 22.68 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.488 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.22 132.77 3.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.68 123.0 4.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -148.2 110.61 4.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.817 0.341 . . . . 0.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp -99.02 170.13 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 170.7 12.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.18 10.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.64 -39.62 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.646 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -53.71 -62.36 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -48.05 80.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.925 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -52.79 -46.27 67.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -71.41 -51.44 16.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.518 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.5 t -52.11 -50.53 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.38 . . . . 0.0 111.164 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 36' ' ' VAL . 17.9 t -66.18 -49.89 65.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -52.35 -49.13 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 22.2 t-105 -63.79 -47.33 81.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -59.07 -38.2 78.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 32' ' ' SER . 98.7 t -68.79 -45.21 81.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 56.4 m -61.88 -51.59 67.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -51.92 67.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.087 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.515 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -59.18 -55.43 35.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD13 ' HE1' ' A' ' 77' ' ' MET . 5.0 tt -53.33 -39.72 64.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.908 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 45' ' ' VAL . 51.6 tp -61.45 -56.02 24.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.99 -24.15 67.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.683 ' OG ' HD12 ' A' ' 232' ' ' ILE . 0.9 OUTLIER -71.36 -51.85 21.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.895 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.3 t -69.58 -39.48 77.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 41' ' ' LEU . 82.0 t -65.05 -49.32 80.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -67.53 -45.06 76.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -64.54 -30.47 71.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -75.04 -51.78 12.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.874 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.83 -36.12 76.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.134 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -79.37 -9.26 59.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -56.42 -29.08 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.824 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -93.15 -11.66 32.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.17 24.6 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.801 ' HA ' HG22 ' A' ' 243' ' ' VAL . 7.9 p -112.51 156.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 148.65 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.14 -55.56 31.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -20.7 59.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 42.9 m95 -88.58 -15.33 35.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -51.68 -50.38 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.859 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 64' ' ' VAL . 7.6 p -61.13 -50.34 73.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.178 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.41 ' OG ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.53 -35.53 72.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.871 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.722 HD22 HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -68.71 -32.36 72.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -53.96 10.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.118 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.67 ' O ' HG12 ' A' ' 68' ' ' VAL . 14.8 m -64.5 -51.29 69.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.523 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.4 t -68.1 -38.16 82.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -36.38 68.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.507 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 tp -68.79 -50.01 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 0.0 110.928 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -64.69 -48.45 84.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.141 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.512 ' N ' HG13 ' A' ' 68' ' ' VAL . 5.1 t -62.54 -33.56 75.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.03 -69.56 1.36 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.509 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.8 pt -45.4 -41.53 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.896 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -65.36 -49.41 69.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.099 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.734 ' CE2' HD11 ' A' ' 232' ' ' ILE . 23.5 t80 -52.77 -55.24 24.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -56.69 -46.15 81.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.862 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -61.56 -38.77 88.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -68.93 -68.53 0.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.435 ' HE1' HD13 ' A' ' 40' ' ' LEU . 3.2 ppp? -45.28 -42.9 10.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.607 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.7 t80 -65.03 -49.01 71.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.922 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 26.7 mmm -59.61 -48.99 79.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -56.21 22.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.26 -43.56 75.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.7 t -69.46 -27.67 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.794 0.331 . . . . 0.0 111.081 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -69.93 -53.35 18.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -72.89 -26.05 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.168 179.884 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -50.08 -47.62 53.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.2 p -108.12 -39.06 5.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.119 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.93 -56.34 0.74 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.62 126.82 53.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.48 161.01 37.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.694 0.759 . . . . 0.0 110.865 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 78.79 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.663 2.242 . . . . 0.0 112.353 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.0 m -54.02 -25.66 22.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.578 HG22 ' CD1' ' A' ' 96' ' ' ILE . 14.8 p -48.14 -32.86 3.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -69.56 -52.39 26.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -59.89 -45.03 93.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.437 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 35.8 t80 -60.34 -52.0 67.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.578 ' CD1' HG22 ' A' ' 92' ' ' VAL . 76.7 mt -63.55 -27.69 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.52 -68.17 0.4 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 109.275 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.635 ' CH2' H202 ' A' ' 301' ' ' RET . 11.1 t-105 -53.84 -32.78 54.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 1.0 OUTLIER -75.23 -32.76 61.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.953 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.1 tt -84.03 -14.9 49.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.896 HG21 ' HB2' ' A' ' 72' ' ' ALA . 55.9 p -99.42 -32.69 11.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 98' ' ' TRP . 2.1 t -46.49 -59.41 5.07 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.0 Cg_endo -69.75 -23.33 30.95 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.687 2.258 . . . . 0.0 112.351 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -71.63 -53.97 11.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.499 ' HA ' HG11 ' A' ' 68' ' ' VAL . 2.9 pp -71.93 -37.5 70.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 102' ' ' VAL . 21.9 mt -62.67 -51.38 72.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -66.04 -47.73 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.48 -58.03 10.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.942 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.409 ' HE1' HD22 ' A' ' 113' ' ' LEU . 19.6 t80 -51.21 -52.16 47.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.66 -30.49 71.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -66.48 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.926 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.41 HG21 ' OG ' ' A' ' 61' ' ' SER . 43.4 mm -58.56 -37.83 67.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD11 HG13 ' A' ' 182' ' ' VAL . 11.2 tp -65.12 -51.4 61.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -69.6 -16.58 63.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -54.14 -22.54 11.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -59.8 -30.06 68.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 t -120.1 -48.3 2.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.116 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 178.17 -73.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.2 m -155.17 157.21 4.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.37 123.6 38.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.068 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.0 -6.09 81.72 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.501 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.5 t -50.62 -28.95 9.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.0 110.826 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 pp -63.95 -39.42 94.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -52.31 64.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -50.09 75.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -62.14 -34.05 75.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 tp -68.05 -46.31 71.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.5 tp -62.95 -58.18 8.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 133' ' ' VAL . 52.0 t -55.19 -50.09 66.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.156 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.82 -43.45 94.68 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 t -59.85 -48.05 83.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 110.839 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.95 -52.97 63.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 129' ' ' VAL . 47.4 t -52.31 -46.23 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -30.68 68.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -65.71 -50.17 65.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.645 HG21 HD13 ' A' ' 154' ' ' ILE . 21.1 m -67.07 -39.12 82.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.128 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.739 ' HB2' H162 ' A' ' 301' ' ' RET . 2.9 t80 -68.31 -37.15 80.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.36 -51.9 19.7 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -64.35 -54.92 25.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 21.7 tpp -60.79 -43.08 98.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.79 -32.44 82.9 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -50.53 -28.53 8.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.827 0.346 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.35 -26.79 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.58 44.02 50.93 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 65.1 mt -84.97 -54.56 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -130.36 136.61 49.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.835 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -149.75 -47.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.626 ' CB ' HD13 ' A' ' 209' ' ' LEU . . . -65.89 -45.65 81.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.08 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.618 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.03 -52.92 15.08 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.583 0.706 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.69 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.75 -9.86 27.16 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -60.73 -53.91 51.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.114 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -30.39 58.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.832 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.69 HD12 ' HA ' ' A' ' 150' ' ' PRO . 39.9 mt -64.24 -66.48 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.645 HD13 HG21 ' A' ' 136' ' ' VAL . 24.3 mt -61.37 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.137 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -55.81 -49.05 68.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.499 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.9 t -58.66 -49.59 76.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -53.26 -48.52 68.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.15 90.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.083 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 8.7 t90 -60.69 -56.42 21.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.8 t -58.25 -45.9 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -62.76 -41.29 99.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.02 -57.85 10.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 48.2 mt -63.87 -37.95 81.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -52.94 -54.21 38.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -74.79 -48.71 23.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -51.36 -60.07 3.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.949 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -58.01 -20.29 37.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.864 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -98.17 17.96 17.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.087 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.36 -154.75 31.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.506 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -84.71 0.78 49.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.869 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.98 -70.0 0.92 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.449 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.58 -24.11 45.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 61.7 m -77.18 -23.68 51.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 178' ' ' ALA . . . -57.46 -19.43 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 2.1 t -83.01 7.56 15.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.92 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.28 -65.32 0.97 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -119.85 -29.4 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 174' ' ' ALA . . . -61.27 -166.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.64 162.99 24.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.667 0.746 . . . . 0.0 110.879 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -16.44 37.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.18 -45.97 37.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.054 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.705 HG13 HD11 ' A' ' 113' ' ' LEU . 87.3 t -65.91 -47.03 86.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.182 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.492 ' CG ' ' HB3' ' A' ' 174' ' ' ALA . 0.0 OUTLIER -61.3 -38.29 86.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.4 m -66.82 -48.42 68.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.83 86.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.112 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.96 -51.53 61.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.919 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -55.74 -41.03 73.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.874 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' ILE . 9.9 p -72.29 -32.23 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.135 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.536 ' HE1' HD11 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -64.74 -52.21 58.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.43 76.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -62.04 -50.96 69.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 237' ' ' ILE . 24.3 pt -69.38 -33.46 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.154 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.536 HD11 ' HE1' ' A' ' 189' ' ' MET . 5.5 mm -61.26 -53.19 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 17.9 pt -67.33 -36.75 77.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.1 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.89 -60.97 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -63.65 -43.72 97.49 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 14.4 m0 -61.63 -32.37 72.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.05 -27.52 35.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.047 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 22.3 mt -80.96 -31.03 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.8 t80 -48.36 -54.19 27.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.732 0.777 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.75 -21.91 32.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.655 2.237 . . . . 0.0 112.372 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.4 t -70.19 -44.59 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.16 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.41 ' C ' HG21 ' A' ' 222' ' ' ILE . . . -82.5 -37.38 14.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.497 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.416 ' N ' HG21 ' A' ' 222' ' ' ILE . 71.6 t80 -57.95 -36.37 72.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.897 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.472 ' CE2' ' HB1' ' A' ' 148' ' ' ALA . 13.9 t80 -63.39 -49.4 73.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 t -73.24 -13.93 61.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -96.79 -21.48 21.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -106.94 -51.26 2.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.87 0.367 . . . . 0.0 110.964 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.626 HD13 ' CB ' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -99.54 39.16 1.33 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 8.8 ttt -65.48 91.11 0.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 51.74 31.36 30.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 1.8 t70 63.44 33.44 13.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.828 0.347 . . . . 0.0 110.815 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.95 21.27 0.37 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.449 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -68.84 125.07 18.91 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.64 160.54 23.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.888 0.375 . . . . 0.0 110.845 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.19 -23.67 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.122 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.73 -62.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -58.01 -25.61 61.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.81 -58.81 5.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -64.02 -43.32 95.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.919 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.524 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -53.93 -58.49 7.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.524 ' N ' HD13 ' A' ' 221' ' ' LEU . 34.9 mm -59.47 -44.39 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.61 -47.81 78.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.73 -43.9 82.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.923 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 229' ' ' VAL . 4.4 tt -57.01 -49.64 75.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.92 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.18 -57.2 11.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -56.43 -27.93 58.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.515 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.2 t80 -73.08 -46.91 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 225' ' ' LEU . 21.2 t -73.88 -25.43 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.117 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.88 2.26 31.28 Favored 'General case' 0 C--O 1.208 -1.104 0 CA-C-O 126.686 3.136 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 3.5 mmtm -130.74 -58.3 1.03 Allowed 'General case' 0 N--CA 1.423 -1.799 0 O-C-N 117.109 -3.494 . . . . 0.0 112.71 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.734 HD11 ' CE2' ' A' ' 73' ' ' PHE . 45.4 mm -62.11 -64.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 113.195 -1.82 . . . . 0.0 111.08 174.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -38.21 50.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.57 -56.63 12.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.68 -35.22 90.78 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.503 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -63.2 -44.17 96.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.312 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.675 HG21 HG21 ' A' ' 192' ' ' ILE . 4.7 mm -67.65 -47.18 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.107 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 42.5 mm -63.01 -40.9 90.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.63 ' O ' HG23 ' A' ' 243' ' ' VAL . 13.3 t90 -71.94 -41.08 68.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -62.95 -43.88 97.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.87 -32.5 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.13 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -74.07 -41.21 62.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.801 HG22 ' HA ' ' A' ' 54' ' ' VAL . 62.3 t -76.36 -33.22 23.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -75.88 -39.7 55.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -75.1 -42.84 55.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 11.5 t -52.05 -58.92 5.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.95 95.26 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -76.9 -44.43 31.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . 63.48 160.43 0.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.581 0.705 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.9 Cg_endo -69.73 95.57 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.695 2.263 . . . . 0.0 112.39 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.75 93.13 2.27 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.487 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 CA-C-O 119.196 -0.78 . . . . 0.0 112.531 -179.929 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.739 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.9 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.838 0.351 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -134.93 173.26 21.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.3 -35.8 0.4 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.456 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.44 114.94 3.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.494 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.0 t0 57.78 82.13 0.13 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.841 0.353 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mp -140.06 167.02 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -68.38 -177.13 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.896 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.5 -61.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.046 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -54.23 -36.23 63.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.566 ' O ' HG23 ' A' ' 31' ' ' VAL . 61.4 m-20 -55.78 -69.2 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.755 ' HB3' HD12 ' A' ' 217' ' ' LEU . 0.3 OUTLIER -60.5 -46.67 89.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.5 m -51.68 -45.78 63.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.62 -50.49 36.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.458 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' ASP . 80.1 t -54.36 -54.51 21.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.072 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.5 t -60.45 -49.97 75.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -52.44 -49.23 64.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -61.31 -44.52 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -36.68 84.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 32' ' ' SER . 89.2 t -66.02 -51.51 59.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 m -62.83 -46.36 88.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.13 -51.71 65.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.151 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.4 -53.42 56.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 41' ' ' LEU . 2.2 tt -51.58 -54.42 27.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.892 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.599 ' N ' HD23 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -56.44 -54.22 48.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.934 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -49.72 62.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.123 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 m -66.18 -28.17 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.3 m -72.33 -50.15 29.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.521 ' O ' HG23 ' A' ' 49' ' ' VAL . 23.4 m -65.73 -38.18 81.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -70.43 -51.69 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -63.41 -30.96 72.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -74.03 -51.25 16.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.8 t -68.32 -31.47 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.096 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -79.74 -4.88 53.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -55.78 -26.37 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.25 -10.67 22.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -95.49 24.6 5.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.859 HG21 HD21 ' A' ' 62' ' ' LEU . 8.6 p -111.95 158.61 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.195 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -48.03 157.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.59 -55.9 11.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -61.4 -19.87 62.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.486 ' O ' HD23 ' A' ' 62' ' ' LEU . 40.7 m95 -88.96 -6.81 56.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.25 -50.81 61.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.432 ' O ' HG22 ' A' ' 64' ' ' VAL . 56.2 p -68.13 -39.07 82.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.737 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -58.57 -37.12 75.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.859 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.26 -33.7 76.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -54.89 8.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 112' ' ' ILE . 10.6 m -63.54 -53.53 44.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.536 ' H ' HG23 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -66.09 -39.53 90.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.15 -32.7 69.08 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.79 -47.64 62.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.867 0.365 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 105' ' ' LEU . 7.2 p -67.69 -45.32 84.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.476 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 m -69.51 -35.32 75.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.146 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.45 -45.97 65.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.6 mt -66.59 -48.38 80.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.349 . . . . 0.0 111.145 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.847 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.44 -41.91 97.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 25.2 t80 -59.94 -52.47 65.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.92 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -56.99 -50.27 73.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -56.59 -53.68 54.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -53.79 -53.21 55.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.97 -53.83 18.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 82' ' ' VAL . 7.3 t80 -56.55 -43.46 79.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -51.95 67.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.498 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -53.56 -55.46 25.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.9 -46.33 60.7 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.478 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.0 t -67.51 -27.83 39.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.344 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -67.59 -54.83 16.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.512 ' CD1' ' HB1' ' A' ' 216' ' ' ALA . 11.2 tp -73.59 -24.58 20.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -46.77 -47.92 20.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.0 t -123.04 -39.11 2.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.158 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.55 -38.48 1.82 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -110.56 127.12 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.6 p -138.61 160.25 64.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.65 0.738 . . . . 0.0 110.86 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 97.59 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.7 2.266 . . . . 0.0 112.353 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.0 t -69.58 -26.81 64.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.177 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.498 HG12 ' CD1' ' A' ' 96' ' ' ILE . 68.5 t -50.73 -46.65 28.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -38.31 90.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -64.08 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.902 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -36.41 70.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.498 ' CD1' HG12 ' A' ' 92' ' ' VAL . 39.7 mt -63.73 -66.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 101' ' ' THR . 0.1 OUTLIER -54.51 -33.37 59.78 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.533 1.146 . . . . 0.0 109.305 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 15.3 t-105 -55.95 -63.17 1.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.87 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.599 HD12 ' SD ' ' A' ' 134' ' ' MET . 0.3 OUTLIER -76.26 -10.47 59.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.918 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -90.87 -15.18 30.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.921 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.847 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.9 p -112.62 -36.24 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.495 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -46.67 -59.43 5.13 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.689 0.756 . . . . 0.0 111.136 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.77 -18.68 36.82 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 68' ' ' VAL . 2.4 mm? -77.51 -53.92 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HA ' HG11 ' A' ' 68' ' ' VAL . 0.8 OUTLIER -66.1 -50.44 64.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 126' ' ' LYS . 35.5 mm -55.02 -56.08 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 46.0 t -58.54 -40.0 81.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.661 ' O ' HD12 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -56.35 -65.69 0.56 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.691 ' CE2' HD12 ' A' ' 238' ' ' ILE . 43.9 t80 -50.0 -50.16 48.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 13.0 m-85 -60.1 -32.21 70.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.939 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mt -68.23 -62.22 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.9 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.737 HG21 ' CB ' ' A' ' 61' ' ' SER . 2.3 mp -50.77 -41.97 22.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.651 HD12 HG13 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -69.36 -41.4 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.91 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 120' ' ' ALA . . . -72.2 -15.68 61.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.108 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.1 -18.36 34.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.086 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.4 -18.15 61.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.541 ' OG1' ' HB1' ' A' ' 174' ' ' ALA . 1.1 t -119.34 -49.38 2.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.179 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 175.63 -78.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 m -134.64 163.3 37.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.132 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.563 ' HB2' ' CB ' ' A' ' 114' ' ' ALA . . . -104.05 118.09 35.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.061 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.29 -14.96 81.83 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.512 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.3 m -54.53 -23.99 18.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.93 0.395 . . . . 0.0 110.868 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 tt -50.41 -37.58 38.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.915 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -73.42 -42.04 62.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.488 ' O ' HG23 ' A' ' 129' ' ' VAL . 34.1 mttm -64.18 -50.32 68.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.86 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB3' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.88 -36.08 82.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.912 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.72 -48.08 80.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.918 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.79 -58.91 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 133' ' ' VAL . 60.1 t -54.08 -52.39 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -57.79 -49.19 76.5 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.483 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 18.4 m -53.67 -45.87 70.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 110.854 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.62 -50.54 72.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 129' ' ' VAL . 62.8 t -51.36 -45.68 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.098 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.599 ' SD ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -66.6 -41.03 89.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -54.56 -53.18 57.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.954 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 154' ' ' ILE . 42.0 t -67.14 -50.87 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.151 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.738 ' CD1' H173 ' A' ' 301' ' ' RET . 16.4 t80 -51.93 -44.14 63.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.876 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.32 -52.47 8.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.524 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -53.5 -57.66 9.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 15.1 mmt -69.99 -32.56 70.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.57 78.04 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.43 -27.85 4.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.891 0.377 . . . . 0.0 110.897 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -103.09 -28.16 12.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 55.48 20.75 24.71 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.472 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -38.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.116 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.459 ' HE3' ' HG3' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -115.49 122.35 45.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.4 -29.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.128 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.448 ' HB3' ' HG ' ' A' ' 209' ' ' LEU . . . -66.34 -42.97 87.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -70.22 -58.33 5.11 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.556 0.694 . . . . 0.0 110.956 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.79 -6.26 18.18 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 0.0 112.36 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -54.8 -50.79 67.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -65.14 -44.18 89.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.496 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.6 mp -58.95 -63.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.856 HD13 HG11 ' A' ' 136' ' ' VAL . 52.0 mt -58.36 -51.72 67.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.153 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -54.55 -49.07 62.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.465 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.537 ' O ' HG23 ' A' ' 160' ' ' VAL . 40.4 t -56.54 -51.1 69.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.87 0.367 . . . . 0.0 110.923 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.66 -49.34 65.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.63 -36.53 83.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.092 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.573 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.6 t90 -67.42 -56.69 8.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 156' ' ' CYS . 25.7 t -53.82 -52.0 39.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -59.83 -44.67 93.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.542 ' O ' HD13 ' A' ' 166' ' ' LEU . 6.2 mmm -50.73 -56.59 11.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.707 HD11 HG12 ' A' ' 194' ' ' ILE . 1.6 mp -62.29 -38.87 82.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.12 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -51.25 56.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.914 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -76.19 -52.08 10.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 162' ' ' MET . 8.7 mp -50.31 -59.09 4.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.459 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -57.04 -20.93 27.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.882 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -106.12 17.69 23.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -65.45 125.26 28.69 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.48 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.03 -0.55 28.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.867 0.365 . . . . 0.0 110.847 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.54 -28.03 28.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.472 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -31.6 59.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.793 0.33 . . . . 0.0 110.9 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.4 t -55.36 -25.82 37.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.837 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.541 ' HB1' ' OG1' ' A' ' 117' ' ' THR . . . -50.16 -33.24 18.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.1 m -117.08 -10.49 10.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 75.2 -58.66 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.8 t -98.16 -8.94 26.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.75 -166.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.151 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.08 161.76 52.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.636 0.731 . . . . 0.0 110.839 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -22.0 32.84 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.267 . . . . 0.0 112.36 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.85 -43.16 47.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.113 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.651 HG13 HD12 ' A' ' 113' ' ' LEU . 17.9 t -70.73 -46.26 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -63.67 -36.51 84.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.706 ' O ' HG22 ' A' ' 188' ' ' THR . 32.2 t -71.16 -49.71 41.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.858 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.486 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -59.93 -37.88 80.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -50.61 38.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 58.0 t-20 -53.58 -56.96 12.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.904 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 184' ' ' SER . 6.7 t -60.32 -41.98 94.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.463 ' HG3' HD11 ' A' ' 238' ' ' ILE . 0.4 OUTLIER -57.65 -51.51 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.443 ' HG2' HD11 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.13 -29.69 70.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.857 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -64.39 -50.35 68.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.78 HG13 HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -70.01 -39.5 77.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.082 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.2 mm -62.17 -56.57 16.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.132 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.707 HG12 HD11 ' A' ' 163' ' ' ILE . 54.4 mt -60.15 -48.46 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -49.83 -56.34 10.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.815 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.44 -59.72 10.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -54.44 -31.36 55.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.763 0.316 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.655 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.48 -22.89 43.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.104 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.4 mt -78.92 -32.22 15.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.127 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.611 ' HE2' ' HB1' ' A' ' 151' ' ' ALA . 23.8 t80 -49.93 -54.5 31.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.682 0.753 . . . . 0.0 110.914 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.7 Cg_endo -69.77 -25.03 28.99 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.682 2.255 . . . . 0.0 112.384 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.6 t -71.51 -37.73 65.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.474 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.12 -28.88 39.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.458 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -50.41 -33.76 21.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.59 -28.03 12.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.7 p -47.83 -32.4 6.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.141 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.426 ' HA3' ' HE3' ' A' ' 210' ' ' MET . . . 136.58 44.03 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.466 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.752 ' CE1' HD12 ' A' ' 222' ' ' ILE . 0.8 OUTLIER -61.36 -19.77 62.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.902 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' A' ' 148' ' ' ALA . 2.9 mt -92.59 -36.31 13.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.426 ' HE3' ' HA3' ' A' ' 207' ' ' GLY . 44.9 mtm -77.23 -172.86 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 67.72 62.49 4.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 13.1 t0 62.2 36.37 14.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.852 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.89 26.63 66.44 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.467 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 119.68 101.95 1.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.482 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 3.4 t -65.57 126.89 29.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.883 0.373 . . . . 0.0 110.857 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.512 ' HB1' ' CD1' ' A' ' 84' ' ' ILE . . . -54.01 -42.09 68.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.09 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.755 HD12 ' HB3' ' A' ' 28' ' ' TYR . 4.2 mm? -53.5 -63.01 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.931 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.11 -26.98 65.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.682 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -62.67 -59.01 5.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.932 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -65.7 -34.7 78.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.93 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.475 ' C ' HD13 ' A' ' 221' ' ' LEU . 2.9 tm? -62.36 -58.11 8.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.752 HD12 ' CE1' ' A' ' 208' ' ' TYR . 86.6 mt -58.82 -49.04 84.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.139 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.41 -54.54 45.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -60.84 -32.55 71.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 229' ' ' VAL . 26.0 tp -63.54 -49.25 74.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.72 -49.06 74.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.063 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.92 -46.78 87.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.868 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -59.09 -44.18 91.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.839 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.826 HG13 HD13 ' A' ' 233' ' ' LEU . 99.1 t -72.91 -25.59 22.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.115 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -93.9 2.1 56.22 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.738 3.161 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.9 mmtm -120.94 -60.36 1.66 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.095 -3.503 . . . . 0.0 112.751 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.8 mm -67.64 -64.75 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 113.193 -1.822 . . . . 0.0 111.177 174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.826 HD13 HG13 ' A' ' 229' ' ' VAL . 0.3 OUTLIER -54.09 -34.52 60.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -56.64 -56.56 19.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.929 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.42 -34.4 87.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -41.07 87.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.526 HD12 ' OG1' ' A' ' 188' ' ' THR . 1.1 mm -68.46 -50.1 59.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.125 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.691 HD12 ' CE2' ' A' ' 109' ' ' PHE . 39.6 mm -61.61 -37.73 78.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.144 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.604 ' O ' HG23 ' A' ' 243' ' ' VAL . 14.7 t90 -74.78 -41.96 59.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.877 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -59.67 -44.3 93.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.503 ' HB ' HG21 ' A' ' 188' ' ' THR . 8.1 p -70.59 -41.38 77.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.129 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.417 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.59 -39.08 91.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.13 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.774 HG22 ' HA ' ' A' ' 54' ' ' VAL . 87.8 t -78.45 -34.77 18.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -69.87 -40.92 75.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.14 -41.36 42.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 29.7 t -51.39 -46.68 62.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.71 92.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.823 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 110.03 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -115.36 160.48 34.19 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.584 0.707 . . . . 0.0 111.115 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.5 Cg_endo -69.8 -35.98 11.53 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.705 2.27 . . . . 0.0 112.338 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -151.38 137.79 6.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.488 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 CA-C-O 119.169 -0.795 . . . . 0.0 112.507 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.738 H173 ' CD1' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.819 0.342 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.45 -174.12 45.5 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.468 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.06 -173.25 13.31 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.85 -166.53 31.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.449 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -74.62 -70.13 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -151.86 148.57 27.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 168.43 15.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.16 -68.75 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.096 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.9 t -52.03 -31.18 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.84 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -58.59 -63.91 1.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.868 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.563 ' CE2' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -62.98 -47.96 80.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 28.7 m -51.21 -47.71 62.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.149 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.13 -51.55 38.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.488 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 97.3 t -53.24 -56.19 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.798 0.332 . . . . 0.0 111.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -48.78 78.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.863 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -52.05 -39.93 60.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -71.37 -40.0 70.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.91 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.67 -44.34 86.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.943 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG23 ' CE2' ' A' ' 228' ' ' PHE . 13.2 p -70.02 -35.83 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.188 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.5 m -71.03 -54.19 12.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.46 -44.9 95.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 228' ' ' PHE . . . -63.89 -50.27 69.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.466 HD12 ' CE2' ' A' ' 73' ' ' PHE . 2.1 tt -55.3 -42.36 73.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.608 ' O ' HG23 ' A' ' 45' ' ' VAL . 22.4 tp -64.42 -56.1 16.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.52 -38.15 74.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.516 ' OG ' HD12 ' A' ' 232' ' ' ILE . 3.2 t -67.56 -48.96 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.2 m -63.82 -46.55 84.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 41' ' ' LEU . 88.8 t -60.92 -46.61 96.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -67.26 -48.85 66.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -61.39 -28.85 69.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.859 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -75.66 -50.33 15.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.02 -33.19 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -79.23 -6.56 56.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -59.47 -27.76 66.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.62 -13.7 27.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.69 39.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.903 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.774 HG21 HD21 ' A' ' 62' ' ' LEU . 8.5 p -117.89 160.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.169 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.419 ' N ' HG22 ' A' ' 54' ' ' VAL . 26.0 t -48.87 143.11 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.95 -51.22 57.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.08 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.37 -25.06 61.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -91.85 13.25 18.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.926 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -49.69 -50.26 44.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.909 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.3 p -76.84 -30.26 56.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -54.48 -44.06 72.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.774 HD21 HG21 ' A' ' 54' ' ' VAL . 3.9 mm? -67.84 -28.94 67.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.27 -53.34 20.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.161 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 21.8 m -70.69 -46.83 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.496 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.1 t -66.62 -39.0 88.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.06 -36.22 60.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.4 mt -68.17 -49.83 58.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.816 0.341 . . . . 0.0 110.887 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.676 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.7 p -65.67 -44.78 93.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.47 ' N ' HG13 ' A' ' 68' ' ' VAL . 96.4 m -67.62 -36.14 80.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.156 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.71 -41.57 74.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.461 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.7 mt -66.95 -50.18 66.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 111.121 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -65.11 -36.95 85.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.079 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.466 ' CE2' HD12 ' A' ' 40' ' ' LEU . 57.9 t80 -60.53 -54.85 40.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.877 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.43 -46.7 85.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -59.11 -63.15 1.41 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.808 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -50.17 -55.29 15.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.46 -57.5 4.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.888 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.612 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -58.34 -40.46 82.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 7.4 mmt -59.91 -56.51 20.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.877 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.45 -55.36 19.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -47.85 57.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.495 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 78' ' ' TYR . 94.4 t -64.08 -37.22 79.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 111.169 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -59.78 -48.12 82.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 220' ' ' ASN . 9.6 tp -74.29 -25.93 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -48.52 -48.12 38.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.6 p -115.01 -39.36 3.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.164 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.64 -14.41 5.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.469 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -135.34 141.49 45.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.27 162.08 33.88 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.697 0.761 . . . . 0.0 110.826 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.32 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.684 2.256 . . . . 0.0 112.339 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -66.78 -25.6 66.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.6 p -54.35 -41.89 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -65.7 -53.19 44.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -62.31 -30.79 71.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.857 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -65.38 -56.44 12.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.86 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.4 mt -69.91 -32.73 52.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.63 -61.99 2.19 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.536 1.147 . . . . 0.0 109.293 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 133' ' ' VAL . 5.2 t90 -61.02 -35.72 77.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 134' ' ' MET . 64.7 tp -73.91 -17.15 61.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.936 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.57 ' O ' HD22 ' A' ' 104' ' ' LEU . 1.2 tt -102.42 -16.5 16.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.886 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.66 HG23 HG22 ' A' ' 68' ' ' VAL . 6.0 m -100.41 -35.41 9.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.696 HG21 HG11 ' A' ' 133' ' ' VAL . 2.4 t -55.51 -57.83 18.74 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.632 0.729 . . . . 0.0 111.142 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.77 -20.97 34.07 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.661 ' HB3' HG21 ' A' ' 68' ' ' VAL . 3.9 mp -78.56 -53.7 6.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.646 HD23 HG22 ' A' ' 101' ' ' THR . 3.6 pp -62.48 -45.3 93.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 105' ' ' LEU . 10.6 tt -63.14 -42.16 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.143 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.47 ' N ' HG23 ' A' ' 106' ' ' ILE . 42.1 t -69.16 -41.34 77.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -54.44 46.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -57.34 -52.38 65.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.575 ' HA ' HD23 ' A' ' 113' ' ' LEU . 6.7 m-85 -57.38 -49.92 74.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.93 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 111' ' ' LEU . 1.9 tm? -57.9 -50.69 72.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 mt -50.77 -46.34 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -70.62 -28.2 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 119' ' ' VAL . . . -78.22 -19.01 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.04 -10.85 33.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.36 -20.67 58.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 -71.74 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.139 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 170.75 -75.67 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.434 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 7.1 p -48.21 141.38 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.116 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -127.25 98.45 5.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -3.02 77.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.472 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -48.02 -34.72 9.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.891 0.377 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mt -50.95 -53.23 34.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -65.13 -53.44 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.51 -50.68 52.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -33.3 75.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.8 mt -65.12 -51.39 61.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mt -66.75 -60.85 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 133' ' ' VAL . 65.1 t -54.56 -45.17 71.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.25 -46.67 94.0 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.5 m -58.26 -57.1 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.906 0.384 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -51.22 -52.13 47.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 102' ' ' VAL . 68.8 t -53.13 -47.4 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.152 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.417 ' HB2' HD13 ' A' ' 99' ' ' LEU . 0.1 OUTLIER -64.03 -44.98 90.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.0 -57.62 12.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 132' ' ' LEU . 43.9 t -53.2 -51.13 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.98 -36.65 79.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -62.4 -52.42 49.34 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -55.96 18.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.942 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 41.1 mtt -53.13 -37.8 62.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.87 -30.16 58.08 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.471 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -40.26 -52.98 2.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.801 0.334 . . . . 0.0 110.845 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -27.47 8.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.5 15.65 47.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.499 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 pt -98.19 -36.4 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 0.0 111.152 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.13 137.91 49.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.851 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.774 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 172.12 -29.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.121 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.759 ' HB1' ' CE1' ' A' ' 204' ' ' TYR . . . -63.24 -40.69 98.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 149' ' ' TRP . 0.0 OUTLIER -71.01 -60.58 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.511 0.672 . . . . 0.0 110.932 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.484 ' HG2' ' HA ' ' A' ' 147' ' ' ALA . 53.9 Cg_endo -69.75 -1.63 8.79 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.726 2.284 . . . . 0.0 112.361 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.774 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.2 -50.49 71.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -68.64 -45.96 70.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.6 mp -61.11 -59.09 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.54 -47.09 94.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -59.96 -49.55 77.34 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.483 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.625 ' O ' HG23 ' A' ' 160' ' ' VAL . 50.3 t -57.11 -51.47 69.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.834 0.349 . . . . 0.0 110.892 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.1 mt -53.26 -49.18 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.07 92.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.095 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.566 ' NE1' HG23 ' A' ' 194' ' ' ILE . 3.5 t90 -62.17 -56.38 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.6 t -57.09 -50.11 77.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.12 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -55.16 -44.54 75.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.55 ' O ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -59.18 -58.02 10.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.89 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.564 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -59.21 -33.73 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -61.02 -52.16 66.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.66 -31.57 63.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 162' ' ' MET . 6.4 mp -67.15 -52.27 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.416 ' CE3' ' HE1' ' A' ' 190' ' ' MET . 2.6 t-105 -57.6 -20.95 36.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.02 18.12 21.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.8 120.04 20.57 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.456 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -0.29 26.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.937 0.399 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.89 -27.25 28.63 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.523 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 22.6 mttt -72.27 -31.12 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.3 m -55.68 -26.08 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.09 -36.21 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.104 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.3 m -116.98 -15.04 10.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.863 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.35 -58.64 0.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.4 p -93.74 -12.78 28.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.6 -166.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.073 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.22 162.37 54.58 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.659 0.742 . . . . 0.0 110.87 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -23.01 31.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.16 30.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 113' ' ' LEU . 89.2 t -68.68 -41.39 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -65.7 -36.96 85.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.516 ' C ' HG21 ' A' ' 241' ' ' VAL . 59.7 p -70.07 -49.45 50.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.588 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -60.72 -41.83 96.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -64.7 -51.1 64.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.926 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -53.91 -51.81 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 237' ' ' ILE . 1.4 m -61.66 -37.11 82.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.603 ' CG ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -60.96 -51.19 70.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.564 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -64.13 -35.6 81.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -50.94 70.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -33.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.4 mt -63.84 -50.3 78.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.566 HG23 ' NE1' ' A' ' 159' ' ' TRP . 58.4 mt -64.27 -49.31 81.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.95 -58.58 6.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.438 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -57.26 -58.44 14.56 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.516 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -54.66 -30.98 56.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 0.0 110.938 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.02 -23.04 44.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.075 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.438 HD12 ' HA2' ' A' ' 196' ' ' GLY . 16.9 mt -80.01 -32.38 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.688 ' HE1' ' HB1' ' A' ' 151' ' ' ALA . 13.4 t80 -48.57 -54.01 30.57 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.622 0.725 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.76 -23.03 31.24 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.651 2.234 . . . . 0.0 112.315 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 75.9 t -71.66 -36.5 59.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.167 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 206' ' ' THR . . . -82.98 -34.88 20.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.511 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.759 ' CE1' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -51.59 -40.21 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.976 0.417 . . . . 0.0 110.9 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -64.4 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -50.51 -27.86 7.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 144.82 57.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.487 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.466 ' CD2' HD13 ' A' ' 219' ' ' LEU . 33.9 t80 -102.07 -20.87 14.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.946 0.403 . . . . 0.0 110.937 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 148' ' ' ALA . 0.9 OUTLIER -98.26 -28.12 13.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.959 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -62.36 -178.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.23 -57.55 0.13 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -84.51 -39.76 18.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.856 0.36 . . . . 0.0 110.926 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.53 -22.75 75.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.538 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -131.78 93.88 0.29 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.535 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.16 160.36 24.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.374 . . . . 0.0 110.859 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.38 -23.8 58.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 64.8 mt -55.24 -63.34 1.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.894 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -58.67 -33.56 70.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 208' ' ' TYR . 3.5 tp -59.63 -55.94 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.433 ' HB2' HD13 ' A' ' 84' ' ' ILE . 3.5 t30 -64.04 -36.87 85.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.535 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.4 tm? -63.49 -53.63 49.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 221' ' ' LEU . 19.8 mt -59.49 -48.09 88.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -57.09 12.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -55.52 -44.69 76.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.543 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.6 OUTLIER -61.46 -39.83 92.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.46 -55.46 27.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -29.31 69.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.676 ' CE2' HG23 ' A' ' 36' ' ' VAL . 44.3 t80 -71.64 -58.5 3.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.895 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 225' ' ' LEU . 9.1 p -62.44 -30.67 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -78.05 -25.33 47.7 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.679 3.133 . . . . 0.0 110.823 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -76.9 -30.39 56.14 Favored 'General case' 0 N--CA 1.423 -1.79 0 O-C-N 117.114 -3.491 . . . . 0.0 112.778 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.516 HD12 ' OG ' ' A' ' 43' ' ' SER . 47.6 mm -86.95 -38.43 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.146 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 9.1 mt -55.78 -34.07 64.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -61.39 -57.54 11.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.867 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.68 -34.97 79.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.508 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 7.7 tt -67.47 -39.41 85.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.762 0.315 . . . . 0.0 110.933 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 188' ' ' THR . 5.0 mm -70.8 -50.03 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.603 HD11 ' CG ' ' A' ' 189' ' ' MET . 40.0 mm -62.16 -35.61 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.142 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.668 ' O ' HG23 ' A' ' 243' ' ' VAL . 37.7 t90 -77.59 -47.25 19.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.916 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -56.81 -42.66 79.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.921 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.588 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.4 p -74.35 -39.97 49.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.133 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.415 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.41 -39.72 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.724 HG22 ' HA ' ' A' ' 54' ' ' VAL . 43.9 t -78.27 -38.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.106 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -42.46 99.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -77.03 -49.22 15.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 15.2 t -58.43 -33.37 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.31 -75.65 0.07 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -163.44 130.51 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.86 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -149.04 73.56 10.17 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.592 0.711 . . . . 0.0 111.106 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 118.32 5.61 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.67 2.246 . . . . 0.0 112.345 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 70.63 -149.54 46.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.471 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 119.121 -0.821 . . . . 0.0 112.482 -179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.507 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.2 mtt . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.17 102.94 1.58 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.494 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 149.49 -121.42 1.29 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.498 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.52 111.51 3.09 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -56.9 4.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -61.24 141.66 57.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.02 179.4 6.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.844 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.56 -63.27 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.91 -51.67 60.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -51.89 -50.52 60.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.849 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -61.56 -48.26 81.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.9 m -50.77 -47.55 59.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.151 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -51.01 32.85 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.505 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 27' ' ' ASP . 90.1 t -53.55 -56.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 0.0 111.104 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 36' ' ' VAL . 1.0 OUTLIER -59.55 -45.8 90.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.84 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -51.92 -44.12 63.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.919 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -46.24 68.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.951 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -41.04 88.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 32' ' ' SER . 87.1 t -67.95 -49.3 69.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.8 m -60.2 -41.41 92.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.43 -52.17 55.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.071 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -55.17 29.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 12.2 tp -53.17 -46.48 68.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.98 -56.1 26.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.971 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.92 -46.41 64.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.1 t -68.3 -29.29 68.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.4 m -72.34 -49.1 36.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 46' ' ' PHE . 20.0 m -65.15 -41.47 91.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -67.45 -50.5 58.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -66.2 -26.74 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.874 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -72.43 -50.06 29.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.41 -34.57 36.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.712 ' O ' HG13 ' A' ' 54' ' ' VAL . 81.6 mt-10 -80.14 -9.99 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -52.72 -29.0 24.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -112.99 -4.82 13.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -95.83 29.63 2.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.866 ' HA ' HG22 ' A' ' 243' ' ' VAL . 12.6 m -114.34 -171.26 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.05 164.11 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.92 -54.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.124 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -25.66 64.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.897 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.465 ' CG ' ' HB1' ' A' ' 242' ' ' ALA . 61.7 m95 -83.51 -17.2 42.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.41 -49.68 53.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.94 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.59 ' O ' HG22 ' A' ' 64' ' ' VAL . 4.5 p -76.61 -43.91 36.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB2' HD13 ' A' ' 112' ' ' ILE . 5.0 t -53.03 -44.44 67.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -66.13 -31.61 72.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.6 m -73.85 -54.77 7.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 60' ' ' THR . 12.3 m -62.33 -50.39 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.499 ' N ' HG23 ' A' ' 64' ' ' VAL . 7.1 t -70.14 -40.46 74.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.8 -34.77 78.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.466 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tp -69.13 -49.63 55.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 64' ' ' VAL . 5.7 p -62.74 -47.25 93.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.154 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.491 ' N ' HG13 ' A' ' 68' ' ' VAL . 51.8 p -62.96 -36.67 84.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.65 -66.66 2.01 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.473 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -47.46 -36.84 4.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 0.0 111.125 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -72.03 -49.41 37.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CE2' HD11 ' A' ' 232' ' ' ILE . 13.2 t80 -59.23 -49.48 77.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -62.07 -51.99 65.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -59.0 -43.41 91.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.866 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -62.82 -69.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.7 tmm? -48.19 -35.96 12.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 82' ' ' VAL . 72.3 t80 -65.87 -75.37 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.5 mtt -53.55 -57.35 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.48 -56.79 16.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.833 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.06 -51.21 41.95 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.457 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.9 t -61.52 -52.15 64.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.819 0.343 . . . . 0.0 111.13 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.403 ' O ' HG22 ' A' ' 86' ' ' THR . 1.1 m-90 -50.71 -55.44 16.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.73 -30.38 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -62.99 -21.23 65.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 83' ' ' TRP . 11.1 t -112.46 -21.5 11.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.36 63.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -139.49 149.97 44.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.7 p -115.15 79.97 6.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 0.0 110.924 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 73.07 1.4 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 0.0 112.329 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -70.06 -36.21 74.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.107 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 29.0 m -69.98 -43.9 78.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 25.7 m-85 -72.42 -32.57 66.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -78.26 -47.17 18.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.46 -37.09 85.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.82 -50.98 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.164 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -58.55 -36.17 73.48 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.486 1.116 . . . . 0.0 109.289 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.478 ' CE2' HG21 ' A' ' 102' ' ' VAL . 9.5 t-105 -75.39 -50.08 16.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.925 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.05 -11.06 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.2 tp -103.13 -34.02 9.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.42 HG21 ' CB ' ' A' ' 72' ' ' ALA . 91.4 m -85.36 -37.96 19.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.198 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 3.3 t -50.71 -53.31 48.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.625 0.726 . . . . 0.0 111.121 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.73 -25.1 29.09 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 68' ' ' VAL . 28.2 mt -75.84 -52.54 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -65.53 -41.15 93.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.676 ' N ' HD23 ' A' ' 105' ' ' LEU . 13.0 tt -66.78 -34.1 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 40.8 t -69.53 -53.48 18.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.865 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -58.25 -45.66 87.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.719 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 5.8 t80 -59.45 -49.78 76.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.481 ' HD1' ' HB3' ' A' ' 120' ' ' ALA . 0.1 OUTLIER -61.98 -33.58 74.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -61.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 61' ' ' SER . 5.6 tp -56.51 -39.91 64.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.125 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.812 HD11 ' CD2' ' A' ' 186' ' ' TYR . 3.3 tt -64.39 -42.32 96.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -76.89 -18.51 58.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.44 -20.2 28.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.103 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 182' ' ' VAL . . . -101.45 -78.62 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.574 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -48.18 -76.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.132 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.574 ' H ' HG23 ' A' ' 117' ' ' THR . 1.1 m-20 174.89 -38.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.1 p -168.23 131.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.126 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.481 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -110.34 102.49 11.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.25 -5.5 66.74 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.449 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.79 -29.64 12.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.89 0.376 . . . . 0.0 110.854 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 120' ' ' ALA . 1.8 pt? -61.75 -34.74 76.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -67.96 -49.66 60.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 129' ' ' VAL . 1.7 mttt -62.6 -50.36 71.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.403 ' HB3' HD12 ' A' ' 106' ' ' ILE . 6.5 mttt -61.53 -36.74 81.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.4 tt -65.62 -44.51 86.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -58.33 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.633 HG11 ' HB2' ' A' ' 162' ' ' MET . 28.9 m -56.29 -38.77 56.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -66.18 -42.72 94.18 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.518 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.2 t -63.46 -45.05 92.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.62 -52.63 60.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.943 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 129' ' ' VAL . 75.3 t -54.21 -47.24 68.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.116 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -36.72 79.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 136' ' ' VAL . 0.2 OUTLIER -55.04 -58.0 9.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.806 HG13 HD23 ' A' ' 135' ' ' LEU . 19.0 m -68.75 -39.23 79.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.544 ' HB3' H163 ' A' ' 301' ' ' RET . 4.4 m-30 -56.48 -43.82 80.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.844 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -75.06 -50.11 8.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.26 -55.06 31.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.906 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.792 ' HB3' ' HB2' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -65.23 -47.82 75.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.86 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.59 -33.13 62.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.16 -23.96 24.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.882 0.372 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.86 -27.27 9.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 61.81 15.66 49.1 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.63 -37.3 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.809 0.338 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.506 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -170.7 137.14 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.792 ' HB2' ' HB3' ' A' ' 140' ' ' MET . . . 173.73 -27.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.124 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.9 84.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.582 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.7 t-105 -65.66 -55.49 23.31 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.55 0.691 . . . . 0.0 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.798 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.6 Cg_endo -69.75 -20.77 34.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.653 2.235 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.627 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -49.55 -29.06 6.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.089 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -69.58 -42.92 73.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 150' ' ' PRO . 5.1 mt -62.9 -67.05 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.496 HD12 HG21 ' A' ' 136' ' ' VAL . 6.5 pt -51.65 -44.83 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -62.93 -48.89 77.06 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 13.1 m -61.21 -50.71 71.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.884 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -50.42 64.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.92 -30.81 70.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.496 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.9 t90 -67.28 -57.5 6.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.496 HG23 ' CE3' ' A' ' 159' ' ' TRP . 91.0 t -61.7 -40.26 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -68.2 -45.33 73.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.968 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.633 ' HB2' HG11 ' A' ' 129' ' ' VAL . 8.1 tpt -53.88 -52.92 58.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.825 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.712 HG22 ' CE3' ' A' ' 167' ' ' TRP . 50.5 mt -63.6 -53.1 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.074 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -49.81 -33.31 16.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -53.68 8.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.908 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.5 pp -70.12 -11.13 60.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.712 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -62.81 -16.38 57.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.911 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.03 14.6 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.78 -158.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.502 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -66.16 -17.03 64.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 0.0 110.856 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.8 -21.16 67.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.493 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 45.4 tttt -74.03 -51.54 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.869 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.1 -27.52 48.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.698 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -59.29 -20.2 52.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.075 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 14.0 m -53.14 -34.05 55.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.837 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.6 9.38 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 23.2 m -117.88 -21.28 8.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.698 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -111.92 -167.11 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.083 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.6 163.62 22.15 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.665 0.745 . . . . 0.0 110.859 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -27.14 26.54 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.27 . . . . 0.0 112.327 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.59 -45.26 31.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.591 HG21 ' HB1' ' A' ' 116' ' ' ALA . 51.1 t -60.49 -47.72 91.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -59.29 -35.54 73.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -43.97 78.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.6 -38.15 90.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.812 ' CD2' HD11 ' A' ' 113' ' ' LEU . 11.8 t80 -67.04 -46.82 73.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.973 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -49.3 78.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 15.2 t -64.92 -32.75 74.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.16 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.466 ' HE1' HG13 ' A' ' 238' ' ' ILE . 0.9 OUTLIER -64.81 -52.58 56.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 26.0 ptm -63.52 -35.52 80.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.02 -48.21 79.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.566 HD12 HD12 ' A' ' 233' ' ' LEU . 31.2 mm -65.23 -54.45 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.14 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 234' ' ' PHE . 34.0 mm -50.71 -53.63 12.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.544 HD13 HD13 ' A' ' 163' ' ' ILE . 76.9 mt -56.84 -51.67 64.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -53.67 20.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.01 -62.72 5.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 32.9 m0 -53.62 -30.61 43.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.929 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.668 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -76.8 -26.3 54.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.07 -30.89 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.3 t80 -45.5 -56.19 10.29 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.674 0.75 . . . . 0.0 110.917 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.3 Cg_endo -69.7 -23.16 31.39 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.657 2.238 . . . . 0.0 112.389 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 198' ' ' ALA . 88.7 t -68.48 -45.2 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.132 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.95 -46.34 5.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.467 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.59 -48.57 71.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.912 0.387 . . . . 0.0 110.918 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -49.95 -54.28 20.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 12.3 t -73.09 -14.21 61.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -92.41 -13.1 57.68 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.503 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -113.87 -51.04 2.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.936 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 29.0 mt -95.28 40.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.923 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.04 -168.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -99.31 -37.68 3.99 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -178.59 47.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.812 0.339 . . . . 0.0 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -165.05 25.09 0.17 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -96.45 98.09 2.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.518 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -179.23 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 110.833 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.01 65.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.074 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.88 -52.28 64.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.926 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.555 ' HA ' HD21 ' A' ' 221' ' ' LEU . 0.2 OUTLIER -51.54 -35.66 41.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.846 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.16 -44.63 59.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.925 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -55.47 -51.65 66.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 218' ' ' ASN . 1.2 pp -66.71 -48.87 67.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 221' ' ' LEU . 28.8 mt -54.38 -44.49 66.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -65.82 -52.98 46.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -56.85 -39.24 73.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.07 -49.15 71.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.23 -55.09 37.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -63.26 -32.66 74.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -60.91 -55.67 30.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.4 HG13 ' HB2' ' A' ' 233' ' ' LEU . 21.5 t -72.09 -24.94 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 -77.87 0.91 22.15 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 126.729 3.157 . . . . 0.0 110.881 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.3 mmtm -135.16 -63.75 0.67 Allowed 'General case' 0 N--CA 1.423 -1.803 0 O-C-N 117.144 -3.473 . . . . 0.0 112.756 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.66 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.8 mm -51.0 -63.06 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 113.173 -1.831 . . . . 0.0 111.142 174.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.566 HD12 HD12 ' A' ' 192' ' ' ILE . 0.1 OUTLIER -51.41 -34.23 33.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.937 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 193' ' ' ILE . 6.1 t80 -56.51 -56.74 17.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.703 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -64.72 -42.6 97.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 5.3 tt -52.53 -49.77 64.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.457 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.3 mm -69.28 -36.18 71.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.139 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.703 HD12 ' HA2' ' A' ' 235' ' ' GLY . 20.1 mt -52.9 -57.74 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.119 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.816 ' HB3' HD21 ' A' ' 62' ' ' LEU . 16.5 p-90 -74.02 -29.51 61.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.935 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -54.51 -55.99 23.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 242' ' ' ALA . 8.9 p -77.41 -42.89 30.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.125 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HB1' ' CG ' ' A' ' 58' ' ' TRP . . . -57.35 -52.72 64.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.088 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 54' ' ' VAL . 97.2 t -67.84 -44.71 85.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -57.67 -44.82 86.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -77.11 -27.66 54.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 34.7 t -50.85 -34.45 27.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.5 t 51.7 30.43 6.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -146.07 175.59 10.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -142.63 160.36 54.03 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.594 0.711 . . . . 0.0 111.11 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.7 Cg_endo -69.76 154.45 67.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.693 2.262 . . . . 0.0 112.308 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 112.14 41.57 1.06 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 CA-C-O 119.131 -0.816 . . . . 0.0 112.509 -179.87 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.544 H163 ' HB3' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.807 0.337 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 107.76 176.46 22.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 137.05 163.13 9.62 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.527 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -177.39 40.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.501 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.73 140.83 56.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.883 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -135.36 167.73 20.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.35 -177.21 3.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.867 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.18 -55.56 32.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.9 m -53.11 -42.87 66.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -53.72 -53.79 47.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.545 ' CG ' HD13 ' A' ' 217' ' ' LEU . 2.9 m-85 -62.04 -48.88 78.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.7 m -49.85 -48.96 50.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -65.47 -51.53 47.62 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.498 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.9 t -51.12 -56.05 5.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.759 0.314 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.8 t -57.05 -48.68 77.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.847 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -51.76 -42.18 62.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.901 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -39.74 78.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.918 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -65.24 -44.54 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.923 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 ' NH1' ' A' ' 80' ' ' ARG . 12.6 p -70.47 -33.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.16 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 54.0 m -69.72 -51.87 30.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.167 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.29 -48.36 80.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.116 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -60.4 -51.27 70.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.075 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.556 HD23 ' HZ ' ' A' ' 73' ' ' PHE . 2.3 tm? -55.69 -43.22 76.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.35 -57.9 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.914 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.82 62.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.5 p -68.83 -34.69 75.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 72.8 m -67.15 -52.74 37.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.6 m -62.09 -42.05 93.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.178 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.425 ' N ' HG23 ' A' ' 45' ' ' VAL . 12.2 t80 -68.22 -52.73 30.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -58.79 -31.7 68.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -77.62 -51.48 10.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 45' ' ' VAL . 77.0 t -62.01 -44.16 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.112 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.585 ' O ' HG13 ' A' ' 54' ' ' VAL . 23.5 tt0 -79.89 -4.58 52.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' ' CH2' ' A' ' 239' ' ' TRP . 1.2 tmt_? -55.29 -26.05 37.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.91 -3.31 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.906 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -106.02 42.14 1.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.958 HG11 HD21 ' A' ' 62' ' ' LEU . 9.5 m -112.47 -170.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -84.58 156.22 21.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.35 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.117 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.65 -20.55 56.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -96.18 3.96 52.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.994 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.38 -51.85 50.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.6 p -78.47 -33.15 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.135 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -54.8 -42.94 72.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.958 HD21 HG11 ' A' ' 54' ' ' VAL . 7.0 mp -65.8 -29.0 69.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.5 m -71.23 -53.62 13.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 68' ' ' VAL . 16.9 m -70.64 -49.37 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.155 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 64' ' ' VAL . 3.5 t -67.86 -37.97 82.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.901 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 -34.35 63.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.461 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.57 -50.06 48.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.1 p -67.61 -45.37 85.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.471 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.4 m -69.52 -34.3 74.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.67 -45.73 74.02 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.462 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.4 mt -68.88 -48.39 70.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 111.145 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.627 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.32 -39.59 91.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.082 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.743 ' CE1' HD11 ' A' ' 232' ' ' ILE . 5.9 t80 -62.77 -54.62 36.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.2 t90 -54.05 -50.52 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -57.32 -49.61 75.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -45.85 91.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 40.9 ttp -53.57 -47.06 70.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.459 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -70.78 -30.72 67.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 8.8 mmt -66.84 -58.15 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.914 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.422 ' NH1' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -60.63 -44.49 96.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.69 -49.61 75.73 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.463 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.2 t -66.9 -32.26 57.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.354 . . . . 0.0 111.119 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -62.23 -51.0 69.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.8 tp -75.02 -25.59 18.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.13 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.4 -48.79 36.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.1 t -121.84 -39.34 2.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.186 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.14 18.6 3.09 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.474 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -153.25 127.01 8.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.81 0.338 . . . . 0.0 110.823 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.53 160.9 37.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.641 0.734 . . . . 0.0 110.866 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 97.82 0.65 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.736 2.291 . . . . 0.0 112.302 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.5 t -69.51 -25.38 64.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 96' ' ' ILE . 7.2 p -67.76 -37.05 77.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -70.14 -53.15 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -32.29 73.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -67.73 -55.92 11.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 92' ' ' VAL . 21.2 pt -65.55 -30.91 51.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.476 ' O ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -66.33 -48.07 71.45 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.495 ' CD1' HG23 ' A' ' 102' ' ' VAL . 16.6 t90 -61.32 -41.47 97.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD13 ' HE2' ' A' ' 134' ' ' MET . 24.6 tp -76.81 -21.23 55.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.932 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.588 ' O ' HD13 ' A' ' 104' ' ' LEU . 7.8 tt -94.1 -11.41 30.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.965 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.627 HG21 ' HB2' ' A' ' 72' ' ' ALA . 62.2 p -109.55 -38.93 5.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.158 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' ILE . 2.1 t -47.96 -58.47 7.77 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.582 0.706 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.23 36.42 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.677 2.251 . . . . 0.0 112.352 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 100' ' ' LEU . 4.9 mp -78.24 -52.77 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.54 ' HA ' HG11 ' A' ' 68' ' ' VAL . 1.1 pp -65.3 -51.81 58.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.922 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.698 HG21 ' HB2' ' A' ' 126' ' ' LYS . 6.0 tt -55.52 -39.87 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.131 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.431 ' N ' HG23 ' A' ' 106' ' ' ILE . 41.4 t -67.53 -50.49 58.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.0 mm-40 -55.37 -57.98 9.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.928 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -52.52 -52.25 55.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.68 -30.85 71.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.2 tp -62.42 -64.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.54 -35.65 38.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.116 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.615 HD21 HG13 ' A' ' 182' ' ' VAL . 3.4 tm? -70.48 -35.94 73.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.5 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -74.84 -21.65 59.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.109 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.55 -22.2 12.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.74 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.7 -64.71 1.02 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.157 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 176.47 -66.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.449 ' O ' ' HB1' ' A' ' 114' ' ' ALA . 4.4 m -116.85 166.74 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -118.15 96.99 5.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.079 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.18 -11.51 84.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.509 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.62 -25.34 6.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.98 -42.57 49.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.61 -43.32 59.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.849 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.534 ' HG2' HD12 ' A' ' 166' ' ' LEU . 11.2 mttt -59.47 -51.7 68.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.698 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -66.09 -37.21 85.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -58.86 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 32.7 tp -69.85 -58.2 4.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.791 HG22 ' HG3' ' A' ' 162' ' ' MET . 93.9 t -51.84 -51.79 26.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.39 97.55 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.3 m -63.9 -40.36 96.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.829 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -55.69 12.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.08 -35.76 42.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.542 ' HE2' HD13 ' A' ' 99' ' ' LEU . 6.4 tmm? -70.75 -43.13 69.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.5 OUTLIER -59.9 -52.84 63.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.94 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.601 ' N ' HD23 ' A' ' 135' ' ' LEU . 43.4 t -61.59 -50.95 78.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' HE2' H192 ' A' ' 301' ' ' RET . 3.4 m-85 -54.07 -38.89 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -73.17 -52.52 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -51.87 -57.71 8.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.9 mtt -71.56 -31.37 66.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.906 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -63.17 -28.49 72.27 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.54 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 141' ' ' GLY . 10.4 tt0 -34.54 -55.07 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.888 0.375 . . . . 0.0 110.888 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.49 -30.97 6.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.107 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 -4.03 20.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.514 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 pt -108.92 3.51 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.518 ' HE3' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -107.1 132.48 52.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 46.72 47.66 14.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.122 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -48.6 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.081 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.603 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.0 t-105 -57.98 -54.23 57.66 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.884 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.729 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -17.34 37.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.369 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.96 -33.49 68.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.096 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -63.9 -36.65 84.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.868 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 150' ' ' PRO . 12.0 mt -62.27 -53.49 46.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -34.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.126 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -74.21 -48.91 13.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.08 -49.63 73.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.78 0.324 . . . . 0.0 110.83 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.97 -49.4 77.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.88 -35.54 81.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.105 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.596 ' CD1' HD13 ' A' ' 163' ' ' ILE . 2.7 t90 -67.73 -57.31 6.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.934 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.51 HG23 ' CE3' ' A' ' 159' ' ' TRP . 76.5 t -55.73 -44.59 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -62.27 -47.07 85.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.791 ' HG3' HG22 ' A' ' 129' ' ' VAL . 0.7 OUTLIER -54.45 -58.34 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.596 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.2 mp -64.82 -31.38 53.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.111 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -58.63 -49.39 77.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.929 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.31 -40.59 64.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.534 HD12 ' HG2' ' A' ' 125' ' ' LYS . 7.5 tt -71.57 -13.91 61.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 -23.78 53.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.87 18.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.131 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.39 -162.25 0.26 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.488 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -22.93 66.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.913 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -65.86 -45.95 85.23 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.54 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.43 -60.0 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.828 0.346 . . . . 0.0 110.97 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.3 p -65.36 -25.88 67.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -64.57 -14.31 57.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.107 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 32.0 t -56.85 -21.68 31.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -142.6 -40.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 16.6 p -71.28 -9.39 58.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.071 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.569 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -121.7 -166.0 1.32 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.075 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.11 164.31 22.01 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.849 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -27.68 26.25 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.323 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.49 -40.9 48.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.08 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.615 HG13 HD21 ' A' ' 113' ' ' LEU . 38.9 t -65.57 -45.88 91.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.117 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -61.89 -35.37 78.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 70.1 m -69.86 -45.59 67.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.37 -39.63 95.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -66.81 -52.13 47.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -58.52 -41.23 84.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.899 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 8.0 p -64.03 -44.92 91.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.745 ' CE ' HD11 ' A' ' 193' ' ' ILE . 3.6 tpt -59.35 -52.8 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.0 ttp -61.3 -35.91 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.69 -40.38 92.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.757 HD11 ' CG2' ' A' ' 237' ' ' ILE . 10.9 mt -66.5 -53.68 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.1 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.745 HD11 ' CE ' ' A' ' 189' ' ' MET . 67.1 mt -56.1 -46.44 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 95.4 mt -65.27 -48.7 82.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -52.87 -58.96 5.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.437 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.43 -57.68 18.58 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.467 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -53.27 -31.37 43.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.731 0.3 . . . . 0.0 110.88 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.677 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.41 -29.15 47.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.437 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.2 mt -76.53 -31.09 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.6 t80 -47.38 -57.36 9.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.648 0.737 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.81 -20.87 34.03 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.657 2.238 . . . . 0.0 112.38 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 198' ' ' ALA . 53.0 t -72.1 -44.07 65.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.158 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.5 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.7 -33.01 28.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.475 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.711 ' HA ' HD13 ' A' ' 222' ' ' ILE . 0.1 OUTLIER -52.02 -32.83 35.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.904 0.383 . . . . 0.0 110.972 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.457 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 2.0 t80 -49.22 -30.9 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 203' ' ' GLY . 13.1 t -51.54 -28.53 13.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -144.34 14.69 2.07 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 205' ' ' PHE . 0.1 OUTLIER -68.48 -42.48 78.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.907 0.384 . . . . 0.0 110.941 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.8 mt -127.18 11.95 7.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.922 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 60.2 mtm -129.63 -173.07 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 52.29 34.33 40.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.527 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.0 t70 62.04 43.82 8.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.89 0.376 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 95.35 -21.42 44.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.515 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 127.18 166.15 12.07 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.493 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 16.5 t -119.04 146.42 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.843 0.354 . . . . 0.0 110.899 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.08 -40.29 70.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.545 HD13 ' CG ' ' A' ' 28' ' ' TYR . 1.0 OUTLIER -64.46 -51.83 61.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.432 ' N ' HD12 ' A' ' 217' ' ' LEU . 20.9 m-20 -60.19 -40.03 88.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 220' ' ' ASN . 3.3 tt -61.49 -56.97 14.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.564 ' N ' HD23 ' A' ' 219' ' ' LEU . 7.1 t-20 -57.47 -36.18 71.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.75 -58.93 6.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 204' ' ' TYR . 10.8 mt -54.02 -48.87 63.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.173 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -63.01 -37.76 88.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -68.78 -39.25 80.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.3 tp -64.61 -52.8 55.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.72 80.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.1 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.61 -40.66 97.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.66 ' CD2' HD13 ' A' ' 232' ' ' ILE . 42.4 t80 -57.74 -52.68 64.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 26.1 m -72.12 -24.52 22.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.128 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -74.28 0.64 13.59 Favored 'General case' 0 C--O 1.208 -1.119 0 CA-C-O 126.696 3.141 . . . . 0.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -134.32 -45.29 0.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 O-C-N 117.093 -3.504 . . . . 0.0 112.756 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.743 HD11 ' CE1' ' A' ' 73' ' ' PHE . 1.7 mp -75.65 -65.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.188 -1.824 . . . . 0.0 111.135 174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.06 -37.15 32.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.564 ' HA ' HG21 ' A' ' 192' ' ' ILE . 1.9 t80 -54.07 -56.36 18.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.5 -35.15 86.28 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.494 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -49.09 78.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.795 0.331 . . . . 0.0 110.879 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.757 ' CG2' HD11 ' A' ' 192' ' ' ILE . 1.3 mm -65.91 -45.89 89.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.112 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 34.6 mm -64.32 -30.98 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.557 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.8 m0 -74.75 -42.82 57.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.76 -42.4 95.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 242' ' ' ALA . 10.2 p -70.27 -40.14 77.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.406 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -71.74 -52.35 18.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.834 HG22 ' HA ' ' A' ' 54' ' ' VAL . 71.6 t -57.48 -46.77 85.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -65.25 -50.77 64.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.878 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.88 -31.4 66.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 1.9 t -58.5 -48.54 80.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.837 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 2.5 t 62.13 63.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.865 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -130.32 43.11 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -146.09 71.79 13.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.594 0.711 . . . . 0.0 111.077 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 -17.23 37.52 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.702 2.268 . . . . 0.0 112.348 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -132.4 -46.12 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.508 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 119.118 -0.823 . . . . 0.0 112.515 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.518 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 mmm . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.828 0.347 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.63 -166.44 37.32 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 175.81 -132.06 2.04 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.77 78.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 57.38 94.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.845 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.48 168.32 10.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.935 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.13 -177.12 5.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.818 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.601 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -58.47 -72.28 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.13 -32.64 36.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.652 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -61.3 -62.15 2.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.863 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.453 ' CD2' HD13 ' A' ' 217' ' ' LEU . 0.8 OUTLIER -58.18 -48.23 80.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.951 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -52.81 -45.9 67.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.77 -51.47 19.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 27' ' ' ASP . 89.0 t -52.7 -51.51 35.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.811 0.338 . . . . 0.0 111.128 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.653 ' O ' HG23 ' A' ' 36' ' ' VAL . 26.0 t -64.76 -49.31 71.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -53.25 -47.63 68.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -47.48 80.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.76 -40.6 88.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.895 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 32' ' ' SER . 86.0 t -67.99 -39.37 81.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.166 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.7 m -65.0 -53.01 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.164 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.71 85.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.75 -55.68 9.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' C ' HD12 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.42 -33.45 69.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 45' ' ' VAL . 48.5 tp -68.92 -54.04 17.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.93 -26.94 68.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.608 ' CB ' HD12 ' A' ' 232' ' ' ILE . 71.5 m -72.41 -52.31 16.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.7 t -66.21 -37.04 84.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.132 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 41' ' ' LEU . 60.3 t -66.7 -50.6 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -67.84 -43.85 78.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -64.51 -31.64 72.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.952 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.22 -52.09 13.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 45' ' ' VAL . 57.3 t -65.92 -39.64 85.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 54' ' ' VAL . 69.0 mt-10 -79.8 -7.54 58.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -55.64 -26.66 45.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -104.56 -9.36 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -96.15 30.72 2.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.826 HG11 HD22 ' A' ' 62' ' ' LEU . 4.6 m -110.09 -170.21 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -76.32 159.86 30.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.02 -55.21 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.117 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -21.82 62.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -88.5 -4.33 58.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -51.15 -49.68 60.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.89 -42.99 59.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.12 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -52.46 -47.3 66.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.818 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD22 HG11 ' A' ' 54' ' ' VAL . 8.4 tp -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.944 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.5 m -70.56 -53.54 15.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' VAL . 26.3 m -72.03 -46.88 57.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.131 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.504 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.3 t -68.77 -39.28 80.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.77 -37.65 66.49 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -67.99 -48.08 66.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.929 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.669 HG12 HG23 ' A' ' 101' ' ' THR . 72.9 t -64.74 -51.61 65.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -65.73 -34.01 77.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.56 -48.79 64.68 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.455 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mt -64.71 -50.14 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 0.0 111.126 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.533 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -60.33 -36.87 78.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.782 ' CE2' HD11 ' A' ' 232' ' ' ILE . 18.7 t80 -60.84 -56.15 24.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 4.9 t-105 -55.72 -45.92 77.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -57.77 -44.89 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.34 -54.77 41.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.872 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -50.2 30.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.551 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -70.19 -27.14 64.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.2 tpt -67.58 -58.67 4.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.843 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -36.79 81.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.914 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -64.82 -45.09 93.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.1 t -69.1 -36.2 72.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CZ3' HG23 ' A' ' 91' ' ' THR . 2.7 t-105 -65.51 -46.52 79.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.98 -26.12 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -47.92 -48.03 32.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.9 p -115.37 -39.65 3.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.29 -21.85 4.27 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.21 134.84 45.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.0 110.928 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.05 160.93 38.72 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.602 0.715 . . . . 0.0 110.879 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 96.88 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.269 . . . . 0.0 112.333 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.473 HG23 ' CZ3' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -58.27 -26.14 62.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 96' ' ' ILE . 41.2 t -49.44 -36.82 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -67.38 -51.77 48.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -62.57 -55.29 28.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.842 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -52.33 -49.15 64.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.63 HD12 HG12 ' A' ' 92' ' ' VAL . 64.6 mt -65.97 -35.05 74.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.96 -64.48 0.85 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.495 1.122 . . . . 0.0 109.311 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.759 ' CH2' H202 ' A' ' 301' ' ' RET . 10.5 t-105 -51.83 -37.58 52.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.962 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.8 tp -75.63 -27.41 58.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -87.67 -10.89 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.861 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.669 HG23 HG12 ' A' ' 68' ' ' VAL . 6.3 m -106.17 -25.55 11.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.167 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.699 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.3 t -56.05 -59.5 11.56 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.613 0.721 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.81 -39.68 6.13 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.319 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.95 -53.37 55.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.552 HD11 ' CE2' ' A' ' 234' ' ' PHE . 1.7 tm? -62.03 -48.72 79.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.443 HG23 ' CE2' ' A' ' 110' ' ' TYR . 68.8 mt -61.82 -57.94 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 123' ' ' LEU . 49.2 t -53.65 -53.48 51.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -53.49 -66.12 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -49.7 -51.06 41.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.443 ' CE2' HG23 ' A' ' 106' ' ' ILE . 7.9 m-30 -58.89 -33.53 70.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.952 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mt -64.88 -66.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.932 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.554 HG21 ' CB ' ' A' ' 61' ' ' SER . 48.7 mm -54.81 -36.5 37.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 113' ' ' LEU . 3.2 tm? -70.7 -33.37 70.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -77.04 -24.06 52.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.82 -23.01 16.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.435 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -84.3 -65.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.107 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 98.2 m -64.34 -74.18 0.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -170.76 -75.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 5.6 m -153.12 131.26 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -102.85 99.91 9.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.98 -6.82 83.33 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.518 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.3 m -51.0 -25.64 4.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 0.4 OUTLIER -51.39 -45.35 62.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.59 -48.76 76.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 129' ' ' VAL . 11.2 mttt -58.42 -50.49 73.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.0 -36.63 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 127' ' ' LEU . 3.1 tm? -64.87 -46.87 79.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mt -65.4 -58.08 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.737 ' CG1' ' HB1' ' A' ' 158' ' ' ALA . 61.6 t -55.53 -51.16 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -56.73 -51.31 57.61 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.0 t -53.41 -47.48 69.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -52.23 66.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.948 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 129' ' ' VAL . 44.5 t -53.08 -45.46 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.699 ' CE ' HG21 ' A' ' 102' ' ' VAL . 2.6 mtt -68.4 -34.98 77.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -60.44 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.6 t -70.81 -52.72 25.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -53.58 -41.5 66.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.43 -48.07 25.63 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.487 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -57.6 -55.92 28.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 110.93 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.7 mmt -65.44 -50.78 64.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.897 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -56.26 -31.2 59.18 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.485 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -51.23 -27.88 10.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.821 0.343 . . . . 0.0 110.867 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 1.119 ' HB1' HD12 ' A' ' 145' ' ' ILE . . . -92.51 -27.52 17.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 65.91 11.71 55.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.446 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 1.119 HD12 ' HB1' ' A' ' 143' ' ' ALA . 5.2 mt -89.33 -54.81 7.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.0 111.148 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.455 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -136.86 141.39 42.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.531 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 176.02 -25.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -58.78 -36.64 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.499 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -68.92 -60.05 4.78 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.565 0.698 . . . . 0.0 110.916 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.757 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.73 -8.66 24.18 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.709 2.272 . . . . 0.0 112.345 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.7 -50.86 69.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -77.49 -30.14 52.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.757 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.9 mt -63.7 -62.86 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.3 pt -63.78 -37.04 78.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.82 -43.61 91.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 43.0 t -63.55 -46.97 83.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.838 0.352 . . . . 0.0 110.834 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -49.84 76.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.737 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -65.98 -31.26 72.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.512 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -66.26 -55.96 13.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.512 HG23 ' CE3' ' A' ' 159' ' ' TRP . 84.8 t -60.77 -43.56 95.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -66.16 -43.19 87.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -52.4 61.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.69 HG22 ' CE3' ' A' ' 167' ' ' TRP . 53.7 mt -63.93 -49.6 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.178 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -48.74 -38.67 22.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.02 -48.66 28.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.27 -10.69 59.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.69 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -71.24 -15.68 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.47 17.4 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -79.96 -165.53 31.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.464 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 4.9 mm-40 -84.93 -5.48 59.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.872 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -69.4 -55.26 10.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.463 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -67.29 -33.6 75.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 110.94 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.557 ' O ' HG22 ' A' ' 177' ' ' THR . 54.7 p -78.12 -25.25 47.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.643 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -52.64 -23.71 7.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.07 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 16.0 p -59.64 -18.71 43.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.73 -40.29 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 173' ' ' SER . 11.5 t -89.89 13.43 14.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.188 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.643 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -152.51 -166.39 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.2 163.56 31.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -25.96 28.02 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.666 2.244 . . . . 0.0 112.382 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.02 -46.02 31.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.435 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.1 t -62.33 -47.82 91.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -36.61 74.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.3 t -68.21 -45.22 73.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.85 87.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.088 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -68.28 -49.45 60.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.909 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.78 -37.31 78.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.499 HG21 HG21 ' A' ' 241' ' ' VAL . 3.1 p -72.03 -39.68 68.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.419 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -62.25 -52.96 61.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.879 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -66.22 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -60.18 -50.25 74.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.26 -33.81 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.419 HD13 ' O ' ' A' ' 189' ' ' MET . 1.2 mp -64.69 -43.94 96.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.143 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 163' ' ' ILE . 80.7 mt -69.71 -51.25 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.66 -55.72 17.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -61.58 -57.34 18.34 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.521 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . 0.451 ' CD1' H191 ' A' ' 301' ' ' RET . 25.6 m0 -53.12 -31.95 44.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.805 0.336 . . . . 0.0 110.969 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.44 -28.21 52.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 14.2 mt -75.03 -30.42 23.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.119 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -44.74 -58.0 6.02 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.733 0.777 . . . . 0.0 110.949 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.8 Cg_endo -69.72 -20.58 34.85 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.374 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 198' ' ' ALA . 93.1 t -71.52 -44.29 70.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.49 -34.59 19.34 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -54.62 -57.09 12.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.969 0.414 . . . . 0.0 110.898 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.407 ' HA ' HD23 ' A' ' 209' ' ' LEU . 0.3 OUTLIER -61.76 -30.93 71.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.874 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -50.84 -26.82 6.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.54 -42.55 0.49 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.451 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.776 ' CE2' HD21 ' A' ' 219' ' ' LEU . 0.2 OUTLIER -66.12 -22.33 66.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.924 0.393 . . . . 0.0 110.936 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.506 HD22 ' C ' ' A' ' 208' ' ' TYR . 4.5 mm? -120.24 39.81 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.947 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -86.85 -169.54 2.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.875 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -97.18 17.34 59.34 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.46 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -132.6 -59.14 0.91 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.854 0.359 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 149.85 -16.57 1.07 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 74.71 164.85 12.37 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.477 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 26.7 t -121.87 174.64 6.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 0.0 110.847 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.97 -37.67 81.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.082 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 25' ' ' ALA . 1.1 pp -56.17 -51.54 67.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.924 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.447 ' N ' HD12 ' A' ' 217' ' ' LEU . 1.9 t30 -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.776 HD21 ' CE2' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -62.01 -56.24 21.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.934 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.39 -51.0 71.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.53 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.4 tm? -50.72 -58.48 5.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.53 ' N ' HD13 ' A' ' 221' ' ' LEU . 90.4 mt -53.72 -43.67 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -61.1 -48.05 83.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.906 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -36.82 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -49.58 76.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.466 ' HB1' ' CD2' ' A' ' 200' ' ' TYR . . . -64.08 -51.0 66.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.69 -30.46 70.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.71 -46.18 59.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 34.2 m -71.73 -23.33 22.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.149 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.426 ' HB3' H203 ' A' ' 301' ' ' RET . 57.5 m-20 -95.09 2.94 55.26 Favored 'General case' 0 C--O 1.207 -1.16 0 CA-C-O 126.697 3.141 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 -60.18 1.48 Allowed 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 117.131 -3.481 . . . . 0.0 112.74 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.782 HD11 ' CE2' ' A' ' 73' ' ' PHE . 18.7 mm -66.47 -64.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.22 -1.809 . . . . 0.0 111.138 174.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.2 OUTLIER -48.59 -32.94 8.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 238' ' ' ILE . 14.1 t80 -58.36 -55.54 33.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.08 -34.43 88.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -42.65 87.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.799 0.333 . . . . 0.0 110.884 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 11.9 mm -66.72 -47.61 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 234' ' ' PHE . 84.3 mt -65.91 -40.82 88.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.464 ' O ' HG23 ' A' ' 243' ' ' VAL . 23.8 t90 -70.5 -39.33 74.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -68.72 -47.08 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 188' ' ' THR . 9.2 p -67.05 -33.01 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -76.94 -51.44 11.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.117 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.641 HG22 ' HA ' ' A' ' 54' ' ' VAL . 72.2 t -62.88 -34.06 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -76.22 -54.57 6.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -56.78 -38.78 72.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.901 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 81.5 p -55.1 -35.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.884 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 11.7 t -52.02 114.71 1.39 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -160.85 -68.33 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 250' ' ' PRO . . . -179.26 -61.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 0.0 111.116 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 249' ' ' ALA . 54.3 Cg_endo -69.75 158.4 57.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.659 2.24 . . . . 0.0 112.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -98.31 -70.89 1.0 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.459 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 CA-C-O 119.128 -0.818 . . . . 0.0 112.495 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.759 H202 ' CH2' ' A' ' 98' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.843 0.354 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -167.91 -150.94 6.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.75 -19.24 66.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.48 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.7 41.66 3.08 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.494 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -176.16 -73.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.902 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 53.77 -172.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.941 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.43 -179.04 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -77.13 -71.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -30.54 45.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -63.52 -70.42 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.455 ' HB3' HD21 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -51.83 -43.03 63.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.539 HG23 HG12 ' A' ' 84' ' ' ILE . 18.8 m -60.42 -40.95 92.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.162 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.16 -54.22 21.93 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -56.82 -40.8 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.875 0.369 . . . . 0.0 111.12 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 74.0 m -64.58 -49.73 70.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -55.19 -44.71 75.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -46.91 82.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.06 -39.78 91.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.935 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -64.44 -48.75 83.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.122 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 16.2 m -57.71 -50.06 74.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.16 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.77 -51.05 71.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.508 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -57.99 -52.07 67.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.136 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.486 HD13 ' HG3' ' A' ' 77' ' ' MET . 1.3 tt -52.3 -47.3 66.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' N ' HD23 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -58.57 -49.9 75.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.58 -37.12 75.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.096 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.4 t -69.35 -37.49 77.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -46.01 71.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 49' ' ' VAL . 24.5 m -66.69 -41.02 87.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.4 ' N ' HG23 ' A' ' 45' ' ' VAL . 4.0 m-85 -69.08 -51.54 37.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -61.86 -33.41 74.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.45 -47.61 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 45' ' ' VAL . 86.3 t -70.44 -29.77 40.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -73.93 -10.77 59.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -56.11 -26.81 51.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.92 -12.73 17.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -106.24 42.01 1.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.657 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.6 p -127.7 160.73 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 54' ' ' VAL . 12.7 t -49.98 148.67 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.828 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.84 -48.73 65.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.08 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpt -58.88 -23.03 60.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CE2' ' HB2' ' A' ' 242' ' ' ALA . 45.1 m95 -88.02 7.36 31.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt -49.64 -50.08 44.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.9 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -36.36 58.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.616 ' HB2' HG21 ' A' ' 112' ' ' ILE . 8.1 t -52.6 -42.38 64.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.596 HD21 HG21 ' A' ' 54' ' ' VAL . 4.3 mm? -68.29 -28.98 67.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.913 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 92.7 m -72.45 -52.21 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.134 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 68' ' ' VAL . 17.2 m -67.19 -50.24 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.087 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.537 ' N ' HG23 ' A' ' 64' ' ' VAL . 36.5 m -69.16 -36.7 77.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.95 -41.43 93.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' O ' HG23 ' A' ' 71' ' ' ILE . 31.7 mt -70.84 -47.43 59.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.82 0.343 . . . . 0.0 110.887 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.664 HG12 HG23 ' A' ' 101' ' ' THR . 61.1 t -65.8 -55.36 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.156 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.494 HG23 ' HD2' ' A' ' 231' ' ' LYS . 9.7 m -68.37 -26.82 65.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.173 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -69.88 -51.45 24.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 67' ' ' LEU . 17.6 pt -64.2 -39.64 86.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.841 0.353 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.734 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -71.19 -37.95 72.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.154 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.718 ' CE1' HD11 ' A' ' 232' ' ' ILE . 8.8 t80 -61.0 -57.93 10.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.56 -47.56 85.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -55.14 -47.51 74.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.9 -48.94 79.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.943 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.486 ' HG3' HD13 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -50.55 -51.34 48.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.888 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.698 ' O ' HG23 ' A' ' 82' ' ' VAL . 6.0 t80 -58.71 -53.38 59.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.2 mmt -54.71 -47.52 73.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -53.1 -56.07 19.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.818 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.5 -33.78 73.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 78' ' ' TYR . 98.2 t -67.56 -47.11 81.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.814 0.34 . . . . 0.0 111.157 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -61.71 -45.07 95.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.539 HG12 HG23 ' A' ' 29' ' ' THR . 10.6 tp -73.63 -25.19 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.124 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.1 -48.25 33.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.4 p -136.61 -39.81 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.57 -15.37 2.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -117.06 127.02 53.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.811 0.339 . . . . 0.0 110.87 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.46 160.79 52.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.674 0.75 . . . . 0.0 110.906 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 90.09 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.712 2.275 . . . . 0.0 112.323 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.8 t -69.42 -32.55 71.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.184 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' PHE . 12.3 m -50.93 -45.87 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 0.1 OUTLIER -69.54 -46.78 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -47.12 77.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -65.41 -39.89 92.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.957 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.81 -57.52 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -33.18 69.87 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.495 1.122 . . . . 0.0 109.306 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.495 ' CZ3' H202 ' A' ' 301' ' ' RET . 25.1 t-105 -60.09 -58.75 7.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 pp -75.06 -13.11 60.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.584 ' O ' HD22 ' A' ' 104' ' ' LEU . 6.3 tt -91.6 -16.6 26.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.734 HG21 ' CB ' ' A' ' 72' ' ' ALA . 25.5 m -110.76 -31.5 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -51.16 -59.51 7.55 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.613 0.721 . . . . 0.0 111.123 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.6 Cg_endo -69.79 -35.5 12.44 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.663 2.242 . . . . 0.0 112.313 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.584 HD22 ' O ' ' A' ' 100' ' ' LEU . 8.9 mp -64.91 -38.95 92.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.06 -48.69 42.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.942 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 38.4 mm -64.9 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.1 t -64.31 -55.33 22.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.83 -58.47 6.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.661 ' CE1' HD12 ' A' ' 238' ' ' ILE . 79.8 t80 -50.02 -54.56 19.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.541 ' HD2' ' HG ' ' A' ' 122' ' ' SER . 6.1 m-85 -61.16 -31.07 70.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 tp -64.25 -67.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.93 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.616 HG21 ' HB2' ' A' ' 61' ' ' SER . 46.3 mm -50.86 -40.72 20.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.802 HD12 HG13 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -68.81 -35.36 76.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.641 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -77.73 -14.91 59.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.79 -23.28 11.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.143 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.78 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.122 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.3 t -122.09 -6.57 8.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.161 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.33 51.93 1.99 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 119' ' ' VAL . 3.1 p 179.8 112.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.76 97.71 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.32 -5.73 87.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.489 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.541 ' HG ' ' HD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -53.18 -23.44 8.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.821 -179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.89 -42.86 27.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -73.14 -37.41 66.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.67 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -65.95 -53.25 41.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.5 -34.15 77.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.21 -47.09 74.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.953 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.41 -59.81 2.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.942 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.67 HG12 ' O ' ' A' ' 125' ' ' LYS . 8.1 p -58.92 -33.02 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.176 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.1 -47.75 57.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.504 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.3 m -65.35 -38.6 90.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.383 . . . . 0.0 110.844 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -52.15 51.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 129' ' ' VAL . 77.9 t -56.88 -51.81 63.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 5.7 ptm -62.98 -33.67 75.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.8 OUTLIER -61.98 -56.2 21.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.886 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.592 ' N ' HD23 ' A' ' 135' ' ' LEU . 71.7 t -60.62 -53.16 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.22 -37.12 71.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -65.5 -52.27 40.98 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -66.0 -48.71 70.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.888 0.375 . . . . 0.0 110.905 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 6.5 ttp -62.74 -34.38 77.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.846 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.81 -30.98 55.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.55 -48.0 10.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 110.888 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.77 -26.68 8.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.072 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 52.81 26.38 25.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.88 -37.38 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.803 0.335 . . . . 0.0 111.129 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.838 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.4 OUTLIER -131.06 -170.73 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.838 ' HB2' ' HE2' ' A' ' 146' ' ' MET . . . 77.14 -4.97 2.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.083 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.93 -43.14 62.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.13 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.2 t-105 -64.52 -55.62 28.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.9 Cg_endo -69.73 -19.01 36.84 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.333 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -50.79 -42.36 57.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.102 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -58.54 -39.42 80.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 3.7 mp -69.37 -64.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.109 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 151' ' ' ALA . 9.3 pt -51.69 -41.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.138 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.87 -50.03 32.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -56.82 -55.95 27.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 110.911 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 34.9 mt -54.72 -48.13 72.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.927 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.21 -39.9 91.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.098 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.579 ' CD1' HD13 ' A' ' 163' ' ' ILE . 1.2 t90 -67.02 -56.87 8.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.48 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.2 t -52.96 -45.79 52.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.159 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -62.97 -45.08 94.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.941 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -58.47 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.579 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.4 mp -66.99 -32.04 56.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -55.82 -54.54 43.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -42.57 63.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.3 tp -65.49 -15.49 62.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.442 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -57.38 -22.58 43.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.37 19.09 19.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.055 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.48 -163.41 0.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.497 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.21 -22.72 42.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.92 0.39 . . . . 0.0 110.898 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -62.85 -30.09 76.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.457 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -53.32 56.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -26.32 48.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -68.19 -11.62 59.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.086 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 41.4 t -62.47 -29.49 70.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -139.03 9.45 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.4 m -126.88 2.45 6.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.541 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -128.21 -165.92 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.088 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.45 164.1 17.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.654 0.74 . . . . 0.0 110.893 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -22.87 31.26 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.682 2.255 . . . . 0.0 112.313 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' A' ' 245' ' ' GLU . . . -76.54 -42.45 42.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.134 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.802 HG13 HD12 ' A' ' 113' ' ' LEU . 54.3 t -66.18 -46.3 87.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -34.64 78.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 188' ' ' THR . 41.7 t -70.36 -46.87 63.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.504 ' N ' HG11 ' A' ' 241' ' ' VAL . . . -62.89 -40.02 96.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.109 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -66.92 -52.07 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -56.27 -54.88 40.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.564 ' OG1' HG21 ' A' ' 241' ' ' VAL . 63.9 p -58.83 -40.76 85.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.421 ' O ' HD13 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -56.15 -52.87 62.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.889 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.82 -32.68 74.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -60.33 -49.27 78.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.962 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -35.82 51.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.131 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 194' ' ' ILE . 1.3 mp -63.76 -48.18 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.561 HG23 ' HE1' ' A' ' 159' ' ' TRP . 97.0 mt -69.12 -50.74 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -51.51 -55.26 19.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.402 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -60.21 -59.57 10.13 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.538 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -53.35 -31.34 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.761 0.315 . . . . 0.0 110.923 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.44 -27.28 46.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.402 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.7 mt -75.0 -32.05 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.4 t80 -47.89 -57.72 9.49 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.8 -26.49 27.32 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.364 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 198' ' ' ALA . 52.3 t -70.85 -37.62 69.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.49 -40.78 12.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.514 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.48 -33.13 43.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.93 0.395 . . . . 0.0 110.908 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -27.28 10.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 203' ' ' GLY . 14.1 t -49.8 -27.96 5.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.105 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -159.56 23.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.523 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.449 ' CZ ' HD12 ' A' ' 209' ' ' LEU . 2.8 p90 -57.65 -32.86 67.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.939 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.449 HD12 ' CZ ' ' A' ' 208' ' ' TYR . 13.5 mt -129.58 15.63 5.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 20.4 ttp -83.11 81.87 8.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 107.01 -15.17 40.31 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.499 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.19 15.65 9.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.825 0.345 . . . . 0.0 110.85 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -178.9 42.45 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -49.56 163.54 0.6 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.78 146.81 44.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.866 0.365 . . . . 0.0 110.875 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.01 -20.36 62.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.075 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.549 HD22 ' HA ' ' A' ' 25' ' ' ALA . 10.2 tp -53.0 -61.85 2.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.93 -37.08 60.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.01 -42.4 94.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.905 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.493 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.5 t-20 -64.58 -46.76 81.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 221' ' ' LEU . 3.4 tm? -60.27 -57.79 11.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 35.3 mm -53.11 -48.01 54.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -63.24 -36.38 83.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -70.28 -42.45 72.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.4 -51.46 68.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -62.97 -52.24 63.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -58.71 -37.6 76.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 232' ' ' ILE . 39.2 t80 -64.34 -58.22 7.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.881 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.5 m -61.08 -25.62 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.68 1.23 20.52 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 126.69 3.138 . . . . 0.0 110.867 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.494 ' HD2' HG23 ' A' ' 69' ' ' THR . 21.3 mmtm -130.0 -60.28 1.03 Allowed 'General case' 0 N--CA 1.423 -1.793 0 O-C-N 117.116 -3.49 . . . . 0.0 112.754 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.718 HD11 ' CE1' ' A' ' 73' ' ' PHE . 3.8 mp -60.97 -63.71 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 113.096 -1.865 . . . . 0.0 111.104 174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 4.2 tp -54.74 -40.54 69.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -52.78 -58.77 5.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.54 -35.02 91.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.497 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.75 -48.96 79.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.781 0.324 . . . . 0.0 110.902 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.739 ' O ' HG23 ' A' ' 241' ' ' VAL . 43.3 mm -65.7 -49.64 76.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.661 HD12 ' CE1' ' A' ' 109' ' ' PHE . 45.9 mm -57.7 -52.43 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.144 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.654 ' O ' HG23 ' A' ' 243' ' ' VAL . 7.9 t90 -57.91 -43.47 86.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -55.46 -42.9 74.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 237' ' ' ILE . 14.6 t -63.86 -49.54 81.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' A' ' 58' ' ' TRP . . . -56.62 -51.34 69.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' VAL . 8.1 t -67.96 -31.69 53.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.14 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 12.5 mmtp -60.74 -53.62 55.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.884 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 181' ' ' ALA . 0.9 OUTLIER -71.51 -35.72 70.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -43.43 65.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.856 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.0 t 59.7 -174.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.898 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -57.02 134.42 55.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -152.74 160.51 31.0 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 111.074 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.4 Cg_endo -69.81 166.3 28.14 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.347 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.85 160.05 29.63 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.509 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 CA-C-O 119.106 -0.83 . . . . 0.0 112.453 -179.901 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.538 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.799 0.333 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.04 -131.62 1.46 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.5 172.34 23.89 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.77 43.83 5.63 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.538 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -176.87 43.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.894 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.92 166.85 17.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.75 178.35 8.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -70.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -54.95 -42.17 72.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.663 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.7 t0 -51.91 -57.0 10.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.33 -47.9 82.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.954 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.549 ' OG1' HD11 ' A' ' 217' ' ' LEU . 23.9 m -51.13 -47.42 62.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.163 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.5 -51.51 36.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 27' ' ' ASP . 92.2 t -52.98 -56.22 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.147 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t -58.6 -48.82 79.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -51.95 -39.7 59.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -71.48 -41.05 69.81 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 mt -64.22 -44.31 92.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.9 p -70.9 -36.09 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 47.9 m -69.67 -53.4 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.09 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.86 -46.54 89.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.063 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.36 -49.8 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.122 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.62 HD13 ' HE2' ' A' ' 73' ' ' PHE . 4.6 tp -55.97 -47.54 77.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.1 tp -58.18 -54.41 47.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.55 -33.79 71.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 m -72.13 -41.51 67.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -41.19 94.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.484 ' O ' HG23 ' A' ' 49' ' ' VAL . 27.2 m -72.01 -37.89 62.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.094 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -64.02 -53.26 52.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -64.98 -47.95 75.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.21 -48.25 68.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 45' ' ' VAL . 95.6 t -74.14 -29.76 25.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.761 ' O ' HG13 ' A' ' 54' ' ' VAL . 45.8 mm-40 -79.9 -7.12 58.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.855 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.0 -27.09 29.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -113.49 -4.04 13.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -94.73 8.99 40.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.6 m -104.27 -171.62 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -77.87 158.36 29.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.84 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.76 -55.19 28.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.101 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.75 -25.49 63.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.452 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 73.6 m95 -87.77 -14.03 40.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -51.36 -49.73 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -36.1 69.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.746 ' HB2' HG21 ' A' ' 112' ' ' ILE . 2.2 p -56.92 -45.31 82.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.836 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.42 -27.14 66.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.909 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.2 m -71.0 -53.49 14.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.074 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 68' ' ' VAL . 23.2 m -72.02 -47.27 55.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.511 ' N ' HG23 ' A' ' 64' ' ' VAL . 11.4 p -68.77 -38.68 80.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.848 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.3 -33.82 58.51 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.507 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.89 -46.65 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.922 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.665 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -69.98 -44.07 78.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.454 ' N ' HG13 ' A' ' 68' ' ' VAL . 97.3 m -70.54 -34.04 71.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -74.61 -40.83 37.29 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.74 -36.83 66.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.78 0.324 . . . . 0.0 111.075 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.92 -43.43 62.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.62 ' HE2' HD13 ' A' ' 40' ' ' LEU . 4.1 t80 -61.99 -48.81 78.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -64.36 -51.87 61.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -57.05 -52.68 64.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.862 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.64 -65.64 0.56 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.943 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -51.43 -32.88 28.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.917 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -61.07 -67.86 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.44 ' HA ' HG12 ' A' ' 82' ' ' VAL . 2.5 mmt -67.86 -59.58 3.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.912 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -50.91 -40.21 56.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.17 -57.62 4.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 79' ' ' MET . 4.8 p -53.77 -35.6 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.831 0.348 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.601 ' O ' HG22 ' A' ' 86' ' ' THR . 0.8 OUTLIER -76.33 -58.5 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.771 HD12 ' HA ' ' A' ' 88' ' ' ASP . 2.5 tp -56.83 -24.45 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.123 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -54.59 -27.16 37.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 83' ' ' TRP . 10.1 t -107.95 -21.6 12.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.122 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.77 -109.56 0.25 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.771 ' HA ' HD12 ' A' ' 84' ' ' ILE . 11.8 p-10 -123.53 142.5 50.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.783 0.325 . . . . 0.0 110.874 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.25 161.99 38.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.69 0.757 . . . . 0.0 110.859 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 93' ' ' PHE . 54.3 Cg_endo -69.72 136.54 33.36 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.721 2.281 . . . . 0.0 112.358 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.6 t -69.9 -29.96 67.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 93' ' ' PHE . 6.7 m -58.78 -45.75 91.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.068 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.407 ' N ' HG23 ' A' ' 92' ' ' VAL . 43.4 m-85 -69.93 -53.36 18.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 ttp85 -56.02 -47.96 76.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CZ ' HD13 ' A' ' 99' ' ' LEU . 18.8 t80 -57.26 -55.3 36.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 54.5 mt -62.35 -29.88 47.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.133 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -61.37 -61.61 2.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.491 1.119 . . . . 0.0 109.24 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.46 -31.27 71.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.43 HD13 ' CZ ' ' A' ' 95' ' ' TYR . 0.7 OUTLIER -72.21 -22.72 61.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.929 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 104' ' ' LEU . 4.2 tt -101.26 -18.82 15.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.803 HG22 HD23 ' A' ' 105' ' ' LEU . 35.8 m -94.79 -33.04 13.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.547 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.3 t -57.78 -56.76 31.17 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.602 0.715 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.81 -26.23 27.56 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.4 mm? -75.54 -54.0 7.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.803 HD23 HG22 ' A' ' 101' ' ' THR . 3.3 pp -65.04 -39.47 93.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 123' ' ' LEU . 17.4 mm -65.94 -43.9 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.0 t -61.76 -52.75 62.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.18 -53.67 54.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -51.82 -45.84 64.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.798 ' CD2' HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -59.97 -44.91 94.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.931 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.35 -50.29 70.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 61' ' ' SER . 40.8 mm -59.93 -59.44 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.168 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.73 -22.09 44.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.919 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.22 -44.47 46.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.094 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.29 -17.97 33.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 182' ' ' VAL . . . -74.48 -39.07 62.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.119 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.0 -67.63 0.94 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.092 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' OD1' HG22 ' A' ' 119' ' ' VAL . 7.7 t-20 -161.43 -75.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.528 HG22 ' OD1' ' A' ' 118' ' ' ASN . 6.3 m -151.77 135.07 7.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.13 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.587 ' HB1' ' OH ' ' A' ' 186' ' ' TYR . . . -103.69 100.05 9.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -69.52 -8.51 59.95 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 p -52.17 -25.44 9.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.884 0.374 . . . . 0.0 110.812 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.798 HD13 ' CD2' ' A' ' 110' ' ' TYR . 1.7 pt? -63.52 -34.64 78.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -47.02 81.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -69.0 -44.76 72.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -64.41 -37.3 87.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.934 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.65 -47.66 62.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.49 -58.8 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.78 HG11 ' HB2' ' A' ' 162' ' ' MET . 92.6 t -58.0 -51.57 69.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -54.36 -43.1 75.99 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 17.7 t -66.88 -36.6 82.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.0 110.873 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 136' ' ' VAL . 4.5 mt -64.08 -54.3 36.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 p -60.12 -39.68 81.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.27 93.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -67.06 -45.87 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.77 HG11 HD13 ' A' ' 154' ' ' ILE . 95.5 t -60.7 -49.63 83.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.616 ' HB2' H162 ' A' ' 301' ' ' RET . 22.5 t80 -66.69 -33.17 75.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.17 -52.07 15.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.447 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -65.22 -52.18 56.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 4.9 mmt -66.0 -44.6 84.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -63.66 -32.56 84.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -46.82 -52.69 13.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' HD11 ' A' ' 145' ' ' ILE . . . -111.89 16.33 20.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 51.44 50.16 42.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.511 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.467 HD11 ' HB3' ' A' ' 143' ' ' ALA . 2.6 mt -83.46 -18.04 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.844 0.354 . . . . 0.0 111.15 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -108.96 132.1 54.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -83.87 -162.97 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.681 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -77.99 -25.64 48.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.101 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.641 ' CH2' HD11 ' A' ' 209' ' ' LEU . 3.3 m95 -66.42 -53.64 29.21 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.563 0.697 . . . . 0.0 110.9 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 53.7 Cg_endo -69.79 -12.35 32.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.636 2.224 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.35 -47.09 29.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.111 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.32 -34.38 61.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' A' ' 150' ' ' PRO . 41.3 mt -58.95 -57.71 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.77 HD13 HG11 ' A' ' 136' ' ' VAL . 60.6 mt -65.61 -47.74 85.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.436 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -57.21 -42.75 93.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.482 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 36.4 t -65.56 -50.93 63.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.813 0.34 . . . . 0.0 110.876 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -55.87 -48.62 75.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.46 -39.88 95.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.126 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.535 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -60.09 -55.72 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.483 HG23 ' CE3' ' A' ' 159' ' ' TRP . 95.5 t -57.16 -48.92 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.137 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.11 -41.65 97.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.918 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.78 ' HB2' HG11 ' A' ' 129' ' ' VAL . 1.7 tmt? -55.89 -59.28 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.535 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.7 mp -66.18 -31.67 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.155 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -56.39 -52.57 64.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -73.72 -34.58 64.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.1 tt -71.23 -18.94 62.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.404 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.7 OUTLIER -65.66 -35.22 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -97.21 18.85 14.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.68 -156.87 0.14 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.506 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.99 -12.85 61.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.2 15.25 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.447 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -77.16 -38.1 52.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 2.5 t -58.69 -53.45 58.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 178' ' ' ALA . . . -75.39 -11.15 59.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.123 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 11.9 t -52.98 -20.24 3.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.31 -58.47 4.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.8 12.92 7.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 174' ' ' ALA . . . -57.5 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.22 163.21 24.26 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.697 0.76 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -18.37 36.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.58 -47.76 21.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.509 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 17.3 t -62.27 -47.06 94.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.118 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.95 -34.33 73.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.462 ' HB3' HG21 ' A' ' 241' ' ' VAL . 1.3 m -70.26 -45.18 66.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.13 -39.6 95.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.141 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' OH ' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -67.88 -48.85 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.943 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.67 -56.19 24.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.4 m -59.08 -40.46 85.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.1 tpt -58.74 -52.36 66.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 47.1 ttp -61.02 -36.66 80.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -60.54 -48.32 82.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.833 HG23 HD13 ' A' ' 233' ' ' LEU . 46.9 mm -64.15 -44.99 97.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.454 HG21 ' HE1' ' A' ' 162' ' ' MET . 69.3 mt -55.28 -46.88 78.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.52 HD11 HG12 ' A' ' 163' ' ' ILE . 92.6 mt -64.41 -49.7 79.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.17 -57.14 10.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -59.37 -58.83 12.31 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -52.7 -31.48 37.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.745 0.307 . . . . 0.0 110.907 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.676 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -77.26 -30.05 54.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.466 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.3 mt -74.31 -31.03 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -45.87 -58.53 6.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 0.0 110.928 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.4 Cg_endo -69.74 -21.38 33.65 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.312 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 198' ' ' ALA . 71.9 t -70.83 -44.67 75.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 206' ' ' THR . . . -83.81 -30.78 28.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -53.16 -57.96 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.914 0.388 . . . . 0.0 110.917 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -31.05 72.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -51.74 -27.21 11.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.155 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.99 -7.04 5.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.681 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 17.7 t80 -101.86 -14.65 17.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.926 0.393 . . . . 0.0 110.956 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.641 HD11 ' CH2' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -126.71 33.4 4.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.913 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.84 -170.06 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.827 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -130.46 51.74 0.85 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.519 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.14 -35.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -88.26 48.85 3.66 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.456 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -109.37 50.82 0.75 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.493 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 159.41 26.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.23 -26.36 67.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.549 HD11 ' OG1' ' A' ' 29' ' ' THR . 0.2 OUTLIER -58.15 -62.35 1.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.948 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -51.96 -36.42 49.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.76 -52.09 65.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -59.84 -42.01 92.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.4 tm? -62.29 -55.46 27.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 221' ' ' LEU . 84.4 mt -60.46 -48.76 87.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.065 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -60.15 -57.89 10.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -40.54 74.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.58 -50.4 71.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.22 -54.83 38.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.078 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.55 -35.95 82.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -61.79 -53.08 60.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 233' ' ' LEU . 8.6 p -71.9 -24.83 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -24.55 63.91 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-O 126.68 3.133 . . . . 0.0 110.83 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 73' ' ' PHE . 1.6 mttm -112.91 -10.16 13.56 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 117.117 -3.489 . . . . 0.0 112.789 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.3 mm -91.97 -61.57 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.147 174.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.833 HD13 HG23 ' A' ' 192' ' ' ILE . 0.7 OUTLIER -50.52 -35.49 29.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.906 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -54.72 -57.59 10.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.56 -42.76 87.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.495 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.502 HD12 ' HE1' ' A' ' 239' ' ' TRP . 12.4 tp -51.76 -50.98 59.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 241' ' ' VAL . 3.2 mm -68.54 -37.01 77.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.452 HG23 ' CZ3' ' A' ' 58' ' ' TRP . 4.0 mm -52.22 -57.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.185 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.502 ' HE1' HD12 ' A' ' 236' ' ' LEU . 16.0 p-90 -74.09 -29.39 61.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.908 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -53.74 -56.77 14.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.7 p -77.61 -43.62 29.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.106 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.47 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -55.87 -51.45 67.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.133 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.786 HG22 ' HA ' ' A' ' 54' ' ' VAL . 99.2 t -70.28 -41.93 78.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.118 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -54.06 -51.17 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.26 -29.58 54.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.916 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.4 t -51.13 -30.84 17.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.837 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.48 -75.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -175.91 89.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -58.42 160.44 9.72 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.563 0.697 . . . . 0.0 111.128 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.6 Cg_endo -69.82 -47.89 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 172.17 -81.19 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.502 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.501 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.616 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.829 0.347 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.32 -166.25 12.68 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.462 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.05 173.39 21.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.507 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.49 162.54 36.27 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.483 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -54.12 118.54 4.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mt -140.85 164.63 29.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.24 164.01 25.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 217' ' ' LEU . . . -76.69 -65.44 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.121 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -52.46 -44.53 65.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -56.22 -61.58 2.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -51.94 -42.81 63.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 26.1 m -60.65 -41.29 94.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -66.58 -54.19 24.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.472 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.9 m -57.16 -40.24 72.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.804 0.335 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 76.9 p -64.8 -49.59 70.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -56.16 -44.26 79.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -63.56 -47.8 80.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp -60.23 -40.82 91.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.951 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 87.2 t -63.47 -49.12 83.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 39.8 m -57.75 -47.08 83.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.33 78.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.13 -47.85 80.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.094 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.58 HD21 ' NE1' ' A' ' 74' ' ' TRP . 14.4 tp -60.78 -39.09 87.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.5 tp -61.96 -56.83 15.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.93 -37.52 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.148 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -69.7 -33.1 72.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.849 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.559 HG21 ' HH2' ' A' ' 74' ' ' TRP . 95.0 m -72.67 -45.68 57.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.165 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.3 p -65.37 -43.18 94.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' N ' HG13 ' A' ' 45' ' ' VAL . 1.6 m-85 -68.23 -49.11 62.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.859 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -63.71 -32.03 73.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.864 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -75.35 -52.3 11.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 45' ' ' VAL . 85.8 t -64.77 -36.58 77.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.06 -0.62 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.418 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -74.04 -26.51 60.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.89 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.79 -19.3 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.38 22.52 10.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.123 HG21 HD13 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -94.75 174.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.155 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -53.63 150.44 7.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 -179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.28 -41.86 97.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -79.17 -26.56 42.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HH2' ' HB1' ' A' ' 185' ' ' ALA . 59.4 m95 -87.13 -6.23 58.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -51.58 -50.46 60.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 64' ' ' VAL . 17.7 p -77.83 -35.68 50.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 p -59.43 -42.48 91.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.123 HD13 HG21 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -65.1 -30.21 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.5 -55.65 5.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.121 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 68' ' ' VAL . 13.9 m -57.79 -51.8 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.534 ' N ' HG23 ' A' ' 64' ' ' VAL . 0.1 OUTLIER -70.77 -47.89 57.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.63 92.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.86 -47.18 60.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 64' ' ' VAL . 56.8 t -58.53 -56.43 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -63.55 -39.31 94.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.209 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.65 -68.95 1.46 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -50.12 -33.97 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 0.0 111.127 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.538 ' HB1' HG21 ' A' ' 101' ' ' THR . . . -63.97 -52.43 59.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 40' ' ' LEU . 46.9 t80 -58.81 -48.77 80.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.911 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.58 ' NE1' HD21 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -62.1 -50.57 71.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.939 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -55.8 -60.88 2.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -54.2 -58.77 6.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.9 -33.35 36.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.448 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.3 m-85 -65.58 -69.15 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.915 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.2 mmt -59.71 -57.37 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.471 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -55.31 -52.22 64.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.846 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.471 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -59.57 -47.6 90.12 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.458 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 78' ' ' TYR . 27.1 t -61.37 -46.65 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -65.94 -56.48 11.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 87' ' ' GLY . 6.8 tp -58.81 -26.81 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.15 -21.65 47.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.834 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 p -114.2 -30.62 6.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.178 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 84' ' ' ILE . . . -164.46 -110.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -98.56 -176.08 3.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.769 0.319 . . . . 0.0 110.876 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 m -115.78 155.68 47.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.679 0.752 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 121.51 8.21 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.353 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -69.69 -35.87 75.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.162 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 93' ' ' PHE . 7.3 p -66.99 -44.71 88.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.149 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.463 ' N ' HG13 ' A' ' 92' ' ' VAL . 4.7 m-85 -71.39 -44.27 65.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -64.45 -48.16 76.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -59.86 -52.78 63.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 92' ' ' VAL . 63.7 mt -65.96 -30.01 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 101' ' ' THR . 2.9 t70 -61.66 -57.44 11.98 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 109.297 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.428 ' HA ' ' HG1' ' A' ' 101' ' ' THR . 27.1 m0 -69.82 -30.67 68.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.878 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -75.12 -19.39 59.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 tt -101.01 -31.73 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.538 HG21 ' HB1' ' A' ' 72' ' ' ALA . 55.8 p -79.83 -39.62 30.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.549 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.4 t -50.83 -56.61 18.1 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.568 0.699 . . . . 0.0 111.113 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.79 -38.48 7.67 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.677 2.251 . . . . 0.0 112.315 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.7 mt -58.5 -51.99 67.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.473 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.4 tm? -67.11 -41.99 85.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.935 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.657 HG23 ' HA ' ' A' ' 123' ' ' LEU . 49.8 mt -59.93 -48.62 87.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.099 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.511 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.3 t -62.22 -57.53 11.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.904 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -52.07 -40.54 61.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -66.37 -50.18 64.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -35.38 65.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.8 tp -71.58 -61.19 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.9 pt -55.68 -36.35 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.108 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 120' ' ' ALA . 1.4 tm? -71.78 -50.8 26.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.924 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.61 67.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.05 -11.11 60.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.119 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.967 ' HB1' HG22 ' A' ' 182' ' ' VAL . . . -92.1 -29.67 16.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.85 -67.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -174.84 -61.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.911 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 m -151.54 142.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.112 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 113' ' ' LEU . . . -126.37 108.14 10.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.81 -5.49 69.61 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.479 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -50.22 -27.98 6.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.903 0.382 . . . . 0.0 110.811 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.657 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -64.62 -41.0 96.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.625 ' N ' HD23 ' A' ' 123' ' ' LEU . 2.4 t80 -58.83 -52.27 66.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.645 ' O ' HG12 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -63.16 -48.31 78.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.905 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 13.2 mmtm -60.28 -34.99 74.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.1 tp -68.33 -48.8 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.92 -56.73 18.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.676 ' O ' HG22 ' A' ' 133' ' ' VAL . 7.4 p -58.96 -43.1 87.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.445 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -58.04 -41.27 94.4 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.446 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 134' ' ' MET . 0.1 OUTLIER -71.07 -35.16 71.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -53.84 12.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 129' ' ' VAL . 26.5 m -58.16 -43.74 86.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.44 ' N ' HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -71.77 -28.99 64.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.686 HD23 HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -66.11 -50.33 64.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.686 HG13 HD23 ' A' ' 135' ' ' LEU . 30.7 m -70.3 -41.22 78.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.774 ' HB2' H173 ' A' ' 301' ' ' RET . 35.4 t80 -61.92 -38.92 90.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.57 -50.5 9.45 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.471 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -63.24 -50.53 69.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.915 0.388 . . . . 0.0 110.932 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.548 ' HB3' ' HE2' ' A' ' 146' ' ' MET . 14.1 mmt -65.49 -52.68 51.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -59.77 -32.61 74.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.476 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -50.72 -30.21 13.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.827 0.346 . . . . 0.0 110.874 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 145' ' ' ILE . . . -112.53 -27.28 8.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.5 25.76 9.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.496 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 143' ' ' ALA . 1.3 pp -103.92 8.82 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.126 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.548 ' HE2' ' HB3' ' A' ' 140' ' ' MET . 0.1 OUTLIER -100.63 -169.29 1.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -102.32 107.59 18.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 208' ' ' TYR . . . -74.33 -22.55 59.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.079 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 4.3 t-105 -52.85 -57.8 14.66 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.59 0.71 . . . . 0.0 110.946 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.0 Cg_endo -69.76 -19.24 36.37 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.662 2.241 . . . . 0.0 112.329 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -59.04 -31.22 68.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -57.26 -40.88 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mt -60.67 -41.59 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 38.8 mt -59.12 -57.17 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.636 ' HA3' H182 ' A' ' 301' ' ' RET . . . -66.27 -39.55 94.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.438 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 39.0 t -63.39 -57.36 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.858 0.361 . . . . 0.0 110.867 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.445 HD12 HG22 ' A' ' 153' ' ' ILE . 35.2 mt -53.52 -50.5 65.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.917 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.35 77.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.581 ' HE1' HG23 ' A' ' 194' ' ' ILE . 0.4 OUTLIER -64.53 -55.25 21.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.939 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.494 HG23 ' CE3' ' A' ' 159' ' ' TRP . 89.3 t -55.66 -51.61 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.183 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.14 -35.59 75.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.927 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 1.6 mmt -61.62 -59.86 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.8 mp -58.39 -36.4 58.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -66.34 -36.37 82.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -75.05 -38.82 61.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.88 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -84.11 -11.14 57.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.483 ' CE3' HG22 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -56.33 -25.41 48.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -94.38 18.35 11.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.88 -130.39 1.51 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 0.5 OUTLIER -84.66 -12.69 53.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.933 0.397 . . . . 0.0 110.909 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -56.01 -77.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -68.43 -25.03 64.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.795 0.331 . . . . 0.0 110.885 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 32.3 t -70.89 -25.86 62.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 178' ' ' ALA . . . -65.19 -14.48 60.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.088 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.75 10.34 31.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -94.34 -76.79 0.47 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.881 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.4 t -120.14 -14.6 8.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.508 ' HB3' ' O ' ' A' ' 174' ' ' ALA . . . -61.19 -166.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.115 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.2 164.02 15.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 0.0 110.857 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -21.58 33.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.56 -44.48 34.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.067 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.967 HG22 ' HB1' ' A' ' 116' ' ' ALA . 16.9 t -62.52 -48.05 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.144 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . 0.431 ' HG2' ' HB3' ' A' ' 174' ' ' ALA . 6.3 tm0? -58.13 -36.99 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.2 m -68.2 -45.21 74.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.855 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.42 ' HB1' ' HH2' ' A' ' 58' ' ' TRP . . . -61.55 -39.43 91.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.68 -51.8 52.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.16 -45.2 75.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.909 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.9 p -66.22 -38.24 87.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.827 ' HG2' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -59.2 -50.5 73.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 21.4 ptm -68.03 -34.48 76.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -59.54 -49.54 77.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.713 HD12 ' HA ' ' A' ' 234' ' ' PHE . 22.0 pt -70.53 -36.72 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.413 HD11 ' HE2' ' A' ' 234' ' ' PHE . 13.6 mm -63.0 -48.77 86.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.115 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.581 HG23 ' HE1' ' A' ' 159' ' ' TRP . 55.7 mt -67.06 -51.91 49.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -53.1 -56.08 19.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.847 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.93 -58.48 14.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.506 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 17.6 m0 -54.21 -31.88 54.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.782 0.325 . . . . 0.0 110.88 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.679 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.18 -24.64 43.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 13.5 mt -78.93 -31.96 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.164 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 12.9 t80 -48.16 -55.42 18.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.654 0.74 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.71 -24.92 29.38 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.662 2.241 . . . . 0.0 112.363 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 198' ' ' ALA . 55.9 t -67.26 -43.18 88.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.634 ' O ' HG22 ' A' ' 206' ' ' THR . . . -84.07 -27.74 36.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.504 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -46.07 65.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.899 0.38 . . . . 0.0 110.925 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.408 ' HB2' HD23 ' A' ' 209' ' ' LEU . 0.2 OUTLIER -69.01 -31.39 70.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.916 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.6 OUTLIER -53.68 -23.0 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.159 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -118.86 -26.35 2.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.519 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 148' ' ' ALA . 29.1 t80 -76.4 -50.56 13.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.895 0.379 . . . . 0.0 110.92 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 205' ' ' PHE . 4.1 mm? -71.46 -23.59 61.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.2 tpp -75.8 -169.44 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -86.28 6.63 81.3 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -24.03 35.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.83 64.59 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.476 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 52.14 73.89 0.35 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 171.84 13.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.82 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -39.02 57.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.133 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.555 ' CD1' ' HB1' ' A' ' 25' ' ' ALA . 81.3 mt -61.39 -62.98 1.44 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -53.35 -42.51 66.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -53.64 54.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.4 ' HB2' HG12 ' A' ' 84' ' ' ILE . 2.4 t30 -58.18 -42.31 85.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -59.37 -58.82 6.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.629 HD12 ' HA3' ' A' ' 203' ' ' GLY . 47.4 mm -59.26 -47.92 88.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.141 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -58.07 -39.64 79.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.471 ' OD1' HG21 ' A' ' 36' ' ' VAL . 1.8 t-20 -70.5 -46.24 64.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.899 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -51.27 70.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.947 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.59 -50.85 70.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.092 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.3 -28.08 69.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.66 -48.96 19.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 97.7 t -72.34 -23.15 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.444 ' HB3' H203 ' A' ' 301' ' ' RET . 5.4 m-20 -90.9 3.11 55.44 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-O 126.72 3.152 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.7 mmtm -129.96 -64.88 0.85 Allowed 'General case' 0 N--CA 1.424 -1.769 0 O-C-N 117.128 -3.483 . . . . 0.0 112.782 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.455 HD11 ' CD2' ' A' ' 73' ' ' PHE . 42.8 mm -55.86 -62.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 113.193 -1.821 . . . . 0.0 111.136 174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -32.65 10.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.866 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.713 ' HA ' HD12 ' A' ' 192' ' ' ILE . 3.3 t80 -52.68 -55.77 20.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -72.81 -36.13 58.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -51.54 69.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.329 . . . . 0.0 110.906 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.408 ' O ' HG12 ' A' ' 241' ' ' VAL . 1.1 mm -68.85 -49.6 62.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.127 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.827 HD11 ' HG2' ' A' ' 189' ' ' MET . 21.5 mm -56.87 -32.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.695 ' O ' HG23 ' A' ' 243' ' ' VAL . 20.1 t90 -76.01 -47.52 24.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -57.19 -40.84 78.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 237' ' ' ILE . 9.4 p -74.21 -40.47 50.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.134 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -65.98 -37.7 86.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 54' ' ' VAL . 43.7 t -78.54 -48.19 22.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -60.11 -37.56 80.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -76.95 -45.99 25.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 20.7 t -55.64 -72.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 7.5 t 58.39 44.45 18.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -158.42 94.67 1.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -87.54 160.39 47.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.521 0.677 . . . . 0.0 111.15 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.578 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.6 Cg_endo -69.74 -43.93 2.38 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.677 2.251 . . . . 0.0 112.363 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 136.71 38.64 0.15 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 CA-C-O 119.12 -0.822 . . . . 0.0 112.482 -179.915 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.774 H173 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.778 0.323 . . . . 0.0 110.929 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.88 81.54 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.484 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 72.05 -114.07 4.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.449 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.07 -149.15 38.89 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.505 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -86.9 131.24 34.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.867 0.365 . . . . 0.0 110.844 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.49 124.51 51.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.55 175.53 6.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.568 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -52.2 -75.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -34.38 64.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -55.41 -64.11 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.871 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.683 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -59.66 -48.11 82.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 84' ' ' ILE . 96.6 m -51.58 -43.78 62.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.166 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.64 -50.47 30.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.463 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 27' ' ' ASP . 91.8 t -52.04 -51.14 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -64.74 -49.88 69.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.869 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -53.28 -47.04 69.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -48.02 75.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.59 -41.86 86.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.932 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 32' ' ' SER . 84.2 t -65.75 -43.94 93.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.093 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 m -60.67 -53.28 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.15 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.23 -49.79 74.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.15 -48.84 79.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.632 HD13 ' CZ ' ' A' ' 73' ' ' PHE . 1.7 tp -53.03 -45.16 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 45' ' ' VAL . 18.7 tp -64.1 -54.12 38.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.31 -39.84 73.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -70.38 -34.54 72.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.6 m -72.76 -49.29 31.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 41' ' ' LEU . 29.9 m -65.88 -39.53 84.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -69.46 -52.12 29.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -62.59 -31.79 72.67 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -74.62 -52.16 12.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.839 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.3 t -64.92 -38.81 83.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.158 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -79.72 -6.33 57.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.885 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.5 ttt85 -55.11 -26.55 38.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -99.99 -12.84 19.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.15 40.26 1.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.852 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.077 HG21 HD21 ' A' ' 62' ' ' LEU . 9.6 p -116.48 160.42 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.106 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.434 ' N ' HG22 ' A' ' 54' ' ' VAL . 1.6 t -47.79 152.35 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.6 -54.52 16.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -20.51 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -86.88 7.84 25.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 -50.27 60.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.91 -37.47 55.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.572 ' CB ' HD12 ' A' ' 112' ' ' ILE . 54.6 p -53.48 -37.08 62.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.83 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.077 HD21 HG21 ' A' ' 54' ' ' VAL . 2.9 mm? -65.03 -34.62 78.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.92 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.1 m -71.08 -47.69 56.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.716 HG12 ' HB3' ' A' ' 108' ' ' GLU . 17.7 t -70.21 -58.03 6.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.13 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -63.69 -41.42 98.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.97 -46.58 91.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.448 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.0 tp -59.79 -47.39 85.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.897 0.379 . . . . 0.0 110.922 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.879 HG22 HD12 ' A' ' 104' ' ' LEU . 5.0 t -59.25 -52.07 65.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 76.4 p -65.46 -26.45 67.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.3 -55.03 17.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.537 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 72' ' ' ALA . 12.1 tt -66.58 -42.47 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 0.0 111.108 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -61.7 -44.52 96.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.632 ' CZ ' HD13 ' A' ' 40' ' ' LEU . 20.3 t80 -60.87 -52.49 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -44.19 72.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -59.0 -54.75 43.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.801 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -41.28 67.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.5 ttp -59.85 -46.01 90.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.594 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.4 t80 -70.07 -30.79 68.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.906 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -63.87 -59.81 4.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.868 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.574 HH11 HG11 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.48 -41.86 97.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -56.86 -49.03 73.89 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.495 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 78' ' ' TYR . 74.7 t -64.1 -43.69 97.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.803 0.335 . . . . 0.0 111.099 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -52.78 -51.47 60.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.729 HG21 HG23 ' A' ' 29' ' ' THR . 30.4 mm -73.08 -26.37 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.095 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -49.01 -48.0 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 59.0 p -146.33 -40.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.143 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.52 57.09 0.13 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.482 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.34 127.03 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.843 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.5 p -113.26 75.1 2.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.739 . . . . 0.0 110.885 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 93.17 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 73.4 p -51.22 -35.14 35.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 90.3 t -64.88 -43.8 96.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.142 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -68.09 -48.05 66.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.96 -51.58 63.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -56.72 -55.55 32.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 34.6 mm -61.96 -34.81 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.152 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 101' ' ' THR . 0.9 OUTLIER -57.76 -68.42 0.24 Allowed 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.326 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.419 ' O ' HG23 ' A' ' 102' ' ' VAL . 25.3 m0 -57.48 -35.63 70.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.912 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.694 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.9 tm? -71.18 -18.27 62.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' O ' HD23 ' A' ' 104' ' ' LEU . 8.2 tt -100.29 -23.08 14.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 97' ' ' ASP . 21.9 p -91.72 -32.44 15.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.135 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.583 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.9 t -57.73 -55.52 44.02 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.662 0.744 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.77 -38.37 7.88 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.692 2.261 . . . . 0.0 112.36 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.879 HD12 HG22 ' A' ' 68' ' ' VAL . 2.6 mm? -62.51 -52.91 61.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.527 ' HA ' HG11 ' A' ' 68' ' ' VAL . 3.0 tm? -62.93 -40.98 99.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.491 HG23 ' HA ' ' A' ' 123' ' ' LEU . 70.5 mt -67.05 -38.46 81.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.502 ' HA ' HD12 ' A' ' 123' ' ' LEU . 35.1 t -63.15 -62.53 1.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.871 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.716 ' HB3' HG12 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -53.39 -49.09 67.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 113' ' ' LEU . 12.9 t80 -52.32 -50.36 62.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -39.64 80.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.93 -51.47 69.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD12 ' CB ' ' A' ' 61' ' ' SER . 6.3 mm -58.51 -52.75 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.501 HD21 ' HB2' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -64.46 -21.97 66.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -75.36 -40.35 58.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.091 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.01 -22.02 14.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.092 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.486 ' CB ' HG21 ' A' ' 182' ' ' VAL . . . -54.1 -54.69 35.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.093 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.625 HG21 ' HB3' ' A' ' 174' ' ' ALA . 0.2 OUTLIER -123.06 -53.8 1.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.15 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -164.96 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.547 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 11.3 m -143.51 150.25 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.181 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -126.3 122.69 36.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.71 -2.61 70.45 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.504 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.9 p -47.53 -31.28 4.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 124' ' ' PHE . 0.0 OUTLIER -61.13 -43.89 98.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.897 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.64 ' N ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -53.96 -52.02 61.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -59.74 -48.64 80.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.418 ' C ' HD13 ' A' ' 106' ' ' ILE . 5.7 mmmm -61.1 -33.51 73.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.41 -48.16 68.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 132' ' ' LEU . 1.2 tt -61.22 -53.13 60.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 162' ' ' MET . 61.0 t -58.77 -48.01 87.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.173 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -39.31 97.19 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.528 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 35.1 t -65.82 -39.1 90.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.932 0.396 . . . . 0.0 110.894 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 128' ' ' LEU . 1.2 mm? -66.49 -53.38 35.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 28.1 m -59.71 -36.08 63.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.562 ' HE2' HD23 ' A' ' 99' ' ' LEU . 11.4 tmm? -70.51 -39.83 73.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -63.37 -50.48 69.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.624 ' N ' HD23 ' A' ' 135' ' ' LEU . 66.8 t -64.69 -47.0 90.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -57.35 -42.3 81.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.36 21.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -56.12 -51.08 69.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.923 0.392 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.7 -31.6 69.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.15 78.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.492 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -48.36 -33.08 8.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 110.917 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.94 -27.33 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 59.11 18.3 40.9 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.431 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 pt -93.69 -34.74 5.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.876 0.37 . . . . 0.0 111.131 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.519 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -124.93 119.28 28.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.844 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.604 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . 172.73 -55.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.554 ' HB1' ' HE2' ' A' ' 204' ' ' TYR . . . -42.12 -34.39 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.106 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.726 ' O ' HD12 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -85.33 -64.82 0.22 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.568 0.699 . . . . 0.0 110.892 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.72 -54.74 0.21 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.681 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . -43.22 -38.49 2.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.41 -51.42 69.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.726 HD12 ' O ' ' A' ' 149' ' ' TRP . 2.9 mp -70.36 -40.1 77.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.138 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 77.8 mt -60.72 -50.96 78.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.408 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -63.87 -45.3 94.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.458 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.57 ' O ' HG23 ' A' ' 160' ' ' VAL . 47.3 t -55.81 -51.17 68.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.859 0.361 . . . . 0.0 110.904 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.05 -49.75 76.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.968 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.39 -38.14 71.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.109 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.542 ' NE1' HG23 ' A' ' 194' ' ' ILE . 0.9 OUTLIER -64.75 -54.93 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.921 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 156' ' ' CYS . 32.0 t -53.05 -43.93 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.146 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.92 84.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.469 ' CE ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -54.76 -47.82 73.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 159' ' ' TRP . 1.6 mp -65.17 -40.39 88.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.81 -50.62 70.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.892 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.99 -43.92 56.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.469 HD22 ' CE ' ' A' ' 162' ' ' MET . 34.9 tp -57.34 -40.45 78.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 9.6 t-105 -57.73 -20.57 35.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -107.87 18.34 21.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.093 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -50.72 124.96 21.66 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.459 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -73.4 -3.97 30.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -57.38 -62.27 6.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -76.69 -25.09 53.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.76 0.314 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.6 t -72.85 -26.15 61.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.625 ' HB3' HG21 ' A' ' 117' ' ' THR . . . -54.2 -45.03 72.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.132 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 1.9 t -64.87 -15.3 61.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.01 -59.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.835 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 79.7 p -95.96 -8.17 34.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.82 -166.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.81 162.07 54.79 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 0.0 110.871 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -36.85 10.06 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.337 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.68 -42.47 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.134 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 116' ' ' ALA . 48.5 t -67.13 -41.72 87.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -66.11 -33.19 75.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.903 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 188' ' ' THR . 1.2 t -72.53 -48.65 38.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.45 -43.61 96.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.501 ' HB2' HD21 ' A' ' 113' ' ' LEU . 45.5 t80 -65.53 -52.24 54.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -54.68 -50.32 68.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 184' ' ' SER . 75.5 p -60.66 -39.92 90.17 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.415 ' HE2' ' HB ' ' A' ' 238' ' ' ILE . 0.0 OUTLIER -58.05 -52.02 67.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.44 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -63.37 -35.76 81.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -49.1 78.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.6 mp -65.11 -48.61 83.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -50.97 -48.16 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.082 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.542 HG23 ' NE1' ' A' ' 159' ' ' TRP . 73.9 mt -65.32 -44.85 94.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -50.43 -59.32 4.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.547 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -63.25 -55.74 24.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.5 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . 0.52 ' CD1' H191 ' A' ' 301' ' ' RET . 14.3 m0 -51.18 -33.8 28.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.763 0.316 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.533 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.42 -30.36 42.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.547 HD12 ' HA2' ' A' ' 196' ' ' GLY . 12.8 mt -67.74 -32.11 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.484 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -51.88 -60.55 5.83 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.655 0.74 . . . . 0.0 110.939 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.74 -24.51 29.66 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.671 2.247 . . . . 0.0 112.344 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 198' ' ' ALA . 29.8 t -75.23 -33.77 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.103 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 206' ' ' THR . . . -82.03 -36.62 17.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.554 ' HE2' ' HB1' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -52.29 -32.74 38.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.429 . . . . 0.0 110.958 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -67.14 -30.67 70.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 203' ' ' GLY . 32.3 p -47.79 -31.68 5.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.127 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.77 56.23 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.495 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -89.85 -23.4 21.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.905 0.383 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.447 HD12 ' CE3' ' A' ' 149' ' ' TRP . 0.7 OUTLIER -119.33 -14.28 9.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -171.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 22.18 4.31 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.509 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.38 -38.35 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -145.4 60.35 0.49 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.45 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -127.99 24.5 5.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.51 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.61 175.3 1.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.857 0.361 . . . . 0.0 110.867 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.81 -27.23 68.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.683 HD22 ' HB3' ' A' ' 28' ' ' TYR . 13.1 mt -59.0 -63.19 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -52.29 -34.79 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.3 mp -62.18 -56.03 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.619 ' HB3' HD11 ' A' ' 84' ' ' ILE . 1.9 t30 -58.23 -39.16 78.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.929 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.545 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.4 tm? -60.38 -51.46 69.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.412 ' N ' HD13 ' A' ' 221' ' ' LEU . 27.1 mt -59.65 -45.25 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -64.18 -56.63 13.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.84 -38.53 75.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 11.0 tp -62.14 -51.31 68.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -56.56 -55.26 36.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.088 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.66 -45.54 93.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.554 ' CD2' HD13 ' A' ' 232' ' ' ILE . 41.6 t80 -51.34 -54.86 22.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 233' ' ' LEU . 40.6 t -70.6 -24.7 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -82.56 1.42 38.1 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.745 3.164 . . . . 0.0 110.901 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.524 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 8.2 mmtm -130.28 -63.1 0.91 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.083 -3.51 . . . . 0.0 112.751 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.554 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.8 mp -56.48 -63.45 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 113.169 -1.832 . . . . 0.0 111.109 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 229' ' ' VAL . 0.1 OUTLIER -55.92 -33.69 64.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.74 -53.82 52.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.86 -36.71 87.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.93 -40.19 83.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 1.6 mm -69.41 -49.73 57.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.415 ' HB ' ' HE2' ' A' ' 189' ' ' MET . 11.8 tt -63.44 -33.88 63.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.084 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.607 ' O ' HG23 ' A' ' 243' ' ' VAL . 16.0 t90 -75.52 -42.88 51.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -62.96 -40.79 98.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . . . . . . . . . 13.8 p -72.74 -37.89 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -71.64 -41.36 68.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.096 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.73 HG22 ' HA ' ' A' ' 54' ' ' VAL . 86.4 t -73.39 -35.92 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -74.69 -35.7 62.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -76.75 -35.33 57.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.891 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 85.3 p -51.21 -49.16 61.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 17.9 t -164.72 -58.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -159.17 163.89 35.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -149.47 73.75 9.79 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.575 0.702 . . . . 0.0 111.132 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -41.79 4.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 142.32 -101.32 0.27 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.143 -0.81 . . . . 0.0 112.467 -179.888 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.523 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.815 0.341 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.24 124.73 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.442 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.7 -94.33 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.56 128.58 2.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.45 -59.35 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.94 156.16 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.945 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.69 -178.25 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.876 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.83 -61.69 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -32.32 51.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 31' ' ' VAL . 2.8 m-20 -58.33 -74.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -47.23 84.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 94.1 m -52.37 -45.04 65.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.186 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -67.65 -51.91 33.1 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.517 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 27' ' ' ASP . 34.5 t -53.84 -55.11 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.59 ' CB ' HD23 ' A' ' 221' ' ' LEU . 99.1 p -58.52 -49.96 75.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -51.92 -39.33 58.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -70.14 -43.4 71.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -44.88 94.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.433 HG11 HH12 ' A' ' 80' ' ' ARG . 33.2 m -69.57 -34.82 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.087 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.556 ' O ' HD13 ' A' ' 41' ' ' LEU . 27.3 m -68.18 -54.3 18.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.152 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.71 88.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.94 -55.14 18.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.126 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -59.65 -32.76 70.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 37' ' ' THR . 4.1 mp -66.51 -57.75 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.5 71.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.094 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 t -70.2 -37.9 75.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.2 m -67.73 -46.39 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.85 -41.55 92.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.125 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -69.26 -51.09 41.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -62.87 -28.67 70.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.936 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -74.34 -49.18 23.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.888 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 p -71.09 -30.28 40.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.209 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -79.54 -6.03 56.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.858 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -59.88 -26.75 66.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.873 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -96.61 -9.8 28.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -108.38 42.34 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.749 ' HA ' HG22 ' A' ' 243' ' ' VAL . 9.9 p -120.74 159.25 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.176 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 54' ' ' VAL . 16.4 t -50.12 139.58 14.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.69 67.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -23.88 59.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -90.05 11.29 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -49.94 -50.06 47.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.76 -38.92 53.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.131 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.495 ' CA ' HG21 ' A' ' 112' ' ' ILE . 0.1 OUTLIER -53.16 -43.57 67.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.866 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.07 -27.83 64.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.966 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 m -68.69 -53.72 20.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.676 ' O ' HG12 ' A' ' 68' ' ' VAL . 26.0 m -70.98 -45.79 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.157 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.487 ' N ' HG23 ' A' ' 64' ' ' VAL . 6.6 t -66.7 -39.42 88.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.79 -34.71 59.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.484 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.73 -48.26 64.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.791 0.329 . . . . 0.0 110.883 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.905 HG23 HD23 ' A' ' 104' ' ' LEU . 7.7 p -68.54 -44.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.46 ' N ' HG13 ' A' ' 68' ' ' VAL . 86.7 m -69.0 -34.52 75.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.46 51.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.503 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 35.5 mt -65.68 -46.79 88.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.136 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.738 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.95 -44.75 91.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -58.02 -56.34 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -49.98 71.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -56.73 -44.99 82.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.876 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.7 -59.26 5.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 2.3 ttm -47.17 -41.76 18.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.542 ' O ' HG23 ' A' ' 82' ' ' VAL . 88.4 t80 -68.99 -40.41 78.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.909 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.01 -58.03 6.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.517 ' HE ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -57.03 -42.82 81.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' N ' ' HE ' ' A' ' 80' ' ' ARG . . . -63.37 -42.46 99.13 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 78' ' ' TYR . 47.1 t -69.56 -30.01 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.071 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -71.99 -41.83 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.598 HD12 ' CB ' ' A' ' 220' ' ' ASN . 12.7 tt -76.62 -30.8 19.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -80.95 -49.79 10.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 m -79.17 -38.45 35.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.191 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -23.11 35.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -148.14 126.79 12.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.833 0.349 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.59 161.16 36.63 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.627 0.727 . . . . 0.0 110.897 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 99.14 0.72 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.704 2.27 . . . . 0.0 112.303 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.2 p -64.28 -26.41 68.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.173 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 m -50.38 -35.13 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -68.23 -49.99 57.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.8 ttm-85 -57.74 -45.74 85.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -61.79 -55.1 33.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.5 mt -61.28 -26.37 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.17 -67.34 0.5 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.472 1.107 . . . . 0.0 109.301 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.514 ' O ' HG23 ' A' ' 102' ' ' VAL . 13.0 t90 -51.86 -33.2 35.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.681 HD13 ' CE ' ' A' ' 134' ' ' MET . 9.6 tp -74.6 -38.55 62.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.887 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 100' ' ' LEU . 6.3 tt -84.22 -5.28 59.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.019 HG22 HD23 ' A' ' 105' ' ' LEU . 30.3 m -107.56 -39.43 5.62 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.163 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.52 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -44.61 -58.91 4.58 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.6 0.714 . . . . 0.0 111.159 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 127' ' ' LEU . 53.9 Cg_endo -69.74 -19.53 36.08 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.905 HD23 HG23 ' A' ' 68' ' ' VAL . 51.6 tp -75.67 -51.69 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.019 HD23 HG22 ' A' ' 101' ' ' THR . 1.7 pp -71.05 -35.88 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.961 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.1 -50.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.122 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.9 t -63.72 -47.63 80.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -61.52 -56.62 18.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.464 ' CE1' HD12 ' A' ' 238' ' ' ILE . 59.6 t80 -51.47 -51.09 57.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -65.53 -35.09 79.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.0 -66.95 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.931 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.495 HG21 ' CA ' ' A' ' 61' ' ' SER . 49.7 mm -56.22 -45.25 81.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.122 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.07 HD11 HG13 ' A' ' 182' ' ' VAL . 7.3 tp -57.05 -44.69 83.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.67 -15.85 58.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.092 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -53.72 -23.37 11.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.094 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.83 -22.73 62.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.115 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.674 ' OG1' ' HB1' ' A' ' 174' ' ' ALA . 1.6 t -128.17 -47.65 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.168 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.415 ' O ' HG13 ' A' ' 119' ' ' VAL . 2.9 m-20 -179.45 -76.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 118' ' ' ASN . 3.3 m -155.06 161.86 2.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.65 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -126.24 125.53 42.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.89 -11.02 84.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.4 m -50.56 -31.91 17.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.89 0.376 . . . . 0.0 110.855 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 pp -60.19 -38.64 83.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -45.31 93.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.481 ' O ' HG23 ' A' ' 129' ' ' VAL . 5.9 mttm -62.15 -50.51 71.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.589 ' HD2' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -64.65 -35.39 80.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.913 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 103' ' ' PRO . 3.9 tp -63.06 -48.51 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.81 -57.59 8.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 133' ' ' VAL . 49.3 t -54.92 -46.86 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.14 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.53 99.59 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.1 t -62.88 -39.62 95.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.884 0.374 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -47.02 61.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.874 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 129' ' ' VAL . 97.8 t -56.73 -51.44 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.681 ' CE ' HD13 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -68.3 -32.22 72.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.87 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.632 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.2 OUTLIER -60.59 -48.93 79.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.896 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.632 ' N ' HD23 ' A' ' 135' ' ' LEU . 97.1 t -71.48 -40.59 72.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.155 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.756 ' HB2' H162 ' A' ' 301' ' ' RET . 7.8 t80 -63.32 -43.18 98.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.24 34.12 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.17 -56.0 13.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 110.908 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 19.1 mmt -67.21 -32.84 74.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.78 -29.65 59.0 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.448 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -40.79 -55.31 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.372 . . . . 0.0 110.897 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -114.34 -27.4 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.089 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.07 39.59 5.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.474 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tt -47.37 -33.74 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 4.0 ptm -108.58 -170.39 1.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -113.35 -174.4 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 208' ' ' TYR . . . -76.93 -20.34 56.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.552 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -61.41 -56.75 30.66 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.535 0.683 . . . . 0.0 110.89 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.859 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.73 -7.36 20.86 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.71 -46.16 32.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.067 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.61 -35.77 82.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.859 HD12 ' HA ' ' A' ' 150' ' ' PRO . 49.3 mt -58.23 -51.7 67.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.09 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 69.5 mt -64.22 -45.78 95.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.149 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.445 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -62.51 -41.0 99.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.499 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.661 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.5 m -63.9 -50.59 68.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.881 0.372 . . . . 0.0 110.904 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.15 -49.64 76.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.19 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.121 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.543 ' NE1' HG23 ' A' ' 194' ' ' ILE . 2.2 t90 -62.53 -55.98 22.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 156' ' ' CYS . 21.9 t -56.25 -47.94 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -60.34 -40.14 89.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.585 ' HB2' HG11 ' A' ' 129' ' ' VAL . 10.7 ttm -60.95 -56.37 21.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.525 HG23 ' CE ' ' A' ' 190' ' ' MET . 1.7 mp -60.8 -32.33 51.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.105 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . 0.439 ' HD2' HG12 ' A' ' 160' ' ' VAL . 0.2 OUTLIER -63.39 -50.89 68.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -73.87 -25.34 59.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.875 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' HD2' ' A' ' 126' ' ' LYS . 3.0 mm? -76.43 -43.33 40.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.964 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -57.54 -23.59 51.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.12 17.19 23.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.7 133.6 39.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.489 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -78.3 -0.35 28.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.902 0.382 . . . . 0.0 110.877 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.32 -41.34 39.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -76.67 -26.28 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.878 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.9 m -56.46 -24.81 48.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.674 ' HB1' ' OG1' ' A' ' 117' ' ' THR . . . -47.93 -47.68 32.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.078 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 69.8 m -117.17 -1.49 11.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 74.94 -59.03 0.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.65 -10.89 33.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.187 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.86 -166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.076 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.26 162.99 20.4 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.866 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.16 22.84 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.674 2.25 . . . . 0.0 112.344 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -46.77 28.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 1.07 HG13 HD11 ' A' ' 113' ' ' LEU . 96.3 t -65.84 -43.61 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.125 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.43 -35.1 79.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 14.5 t -69.8 -47.28 63.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.888 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.59 97.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.047 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -65.88 -50.83 63.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.908 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -56.02 -55.49 32.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.633 HG22 HG23 ' A' ' 237' ' ' ILE . 2.5 m -58.88 -37.75 77.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.9 tpt -60.0 -48.74 80.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.525 ' CE ' HG23 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -66.19 -34.26 77.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.48 -50.71 70.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.54 HG12 HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.79 -35.2 74.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.126 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.7 mt -62.93 -48.34 88.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.113 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 65.5 mt -64.85 -47.76 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.81 -59.16 4.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.41 -56.99 22.19 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -53.71 -32.11 50.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.77 0.319 . . . . 0.0 110.896 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 202' ' ' VAL . . . -77.94 -26.31 48.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.106 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 196' ' ' GLY . 18.4 mt -76.8 -28.93 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.135 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.556 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.2 OUTLIER -42.7 -57.13 5.12 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.669 0.747 . . . . 0.0 110.954 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.6 Cg_endo -69.79 -82.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.642 2.228 . . . . 0.0 112.34 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 198' ' ' ALA . 20.5 m -33.7 -42.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 202' ' ' VAL . . . -65.24 -57.79 10.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.472 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.745 ' OH ' HD22 ' A' ' 219' ' ' LEU . 6.6 t80 -57.01 -19.91 21.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.894 0.378 . . . . 0.0 110.92 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -47.05 -26.98 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 3.6 t -49.53 -28.28 5.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.17 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.471 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.614 ' CZ ' HD12 ' A' ' 209' ' ' LEU . 0.9 OUTLIER -55.59 -27.24 48.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.925 0.393 . . . . 0.0 110.925 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.614 HD12 ' CZ ' ' A' ' 208' ' ' TYR . 16.2 mt -127.43 -53.71 1.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -67.98 87.64 0.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -88.9 -15.55 59.27 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.513 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -52.48 -29.43 24.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.892 0.377 . . . . 0.0 110.884 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -115.76 -17.78 6.32 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.461 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -104.59 77.34 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.457 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -179.32 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.866 0.365 . . . . 0.0 110.845 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.78 -27.63 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 218' ' ' ASN . 0.9 OUTLIER -59.09 -51.97 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.951 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.421 ' O ' HG22 ' A' ' 222' ' ' ILE . 4.0 t-20 -61.39 -40.94 96.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.745 HD22 ' OH ' ' A' ' 204' ' ' TYR . 20.3 mt -59.52 -42.84 93.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.89 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.598 ' CB ' HD12 ' A' ' 84' ' ' ILE . 23.6 m120 -66.63 -47.17 73.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.59 HD23 ' CB ' ' A' ' 32' ' ' SER . 1.9 tm? -53.06 -58.75 5.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.936 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 204' ' ' TYR . 1.0 OUTLIER -57.14 -40.77 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.139 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.42 ' N ' HG23 ' A' ' 222' ' ' ILE . 30.9 t80 -62.61 -42.39 99.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -63.89 -46.2 85.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 229' ' ' VAL . 0.2 OUTLIER -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.03 17.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.11 -27.21 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.52 -54.92 6.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 225' ' ' LEU . 7.9 p -68.2 -23.55 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 -69.75 -33.62 72.68 Favored 'General case' 0 C--O 1.207 -1.162 0 CA-C-O 126.739 3.161 . . . . 0.0 110.918 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.506 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.1 mmtm -103.58 -8.72 19.8 Favored 'General case' 0 N--CA 1.424 -1.773 0 O-C-N 117.11 -3.494 . . . . 0.0 112.747 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.9 mm -92.3 -63.5 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 113.174 -1.83 . . . . 0.0 111.137 174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 192' ' ' ILE . 7.5 tp -53.82 -31.09 47.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -60.54 -56.25 23.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -68.34 -35.93 83.36 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.6 tp -67.38 -39.39 85.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.633 HG23 HG22 ' A' ' 188' ' ' THR . 4.0 mm -70.25 -50.11 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.464 HD12 ' CE1' ' A' ' 109' ' ' PHE . 42.2 mm -62.44 -35.79 71.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.644 ' O ' HG23 ' A' ' 243' ' ' VAL . 29.5 t90 -76.84 -45.74 27.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.872 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -58.21 -42.11 85.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 237' ' ' ILE . 14.4 p -74.67 -38.23 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.8 -38.9 83.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.749 HG22 ' HA ' ' A' ' 54' ' ' VAL . 53.6 t -78.27 -40.79 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.164 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -64.9 -39.11 93.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.88 -48.65 17.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.914 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 30.2 t -59.78 -68.07 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.44 -75.61 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -107.26 158.19 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.572 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -104.43 160.37 26.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.617 0.723 . . . . 0.0 111.122 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.572 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.8 Cg_endo -69.77 -18.27 37.07 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.702 2.268 . . . . 0.0 112.36 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.88 45.27 5.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.472 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 CA-C-O 119.145 -0.808 . . . . 0.0 112.487 -179.88 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.756 H162 ' HB2' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.9 mtp . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.23 154.67 7.43 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 159.88 -143.17 8.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.461 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.23 176.08 46.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.539 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.81 124.11 27.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -116.31 158.69 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.96 178.39 8.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' THR . . . -57.77 -75.0 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.087 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.01 -33.67 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.671 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -58.8 -56.51 21.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.864 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.93 -47.71 83.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.936 HG22 HD11 ' A' ' 84' ' ' ILE . 30.5 p -51.04 -47.05 61.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.113 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.79 -50.87 32.97 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.522 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 27' ' ' ASP . 93.0 t -52.78 -55.67 10.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.132 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.518 ' O ' HG23 ' A' ' 36' ' ' VAL . 32.8 t -60.83 -48.13 83.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -53.83 -41.56 67.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -47.24 68.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.903 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 mp -61.08 -43.64 98.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' SER . 94.6 t -66.62 -41.41 88.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.14 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.3 m -62.63 -43.12 99.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.69 49.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.68 -55.42 30.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.146 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.767 ' O ' HG23 ' A' ' 44' ' ' THR . 4.0 tt -53.14 -50.13 65.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 24.1 tp -54.09 -55.73 24.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.75 60.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.081 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.453 ' HB3' HG23 ' A' ' 232' ' ' ILE . 22.0 m -72.02 -44.51 63.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.833 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 40' ' ' LEU . 31.2 p -59.69 -47.28 86.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.14 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 46' ' ' PHE . 29.7 m -67.11 -42.83 88.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.441 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.4 m-85 -55.95 -52.17 65.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.34 -37.46 80.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -62.22 -47.76 82.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.7 t -74.95 -38.7 43.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 87.9 mt-10 -81.16 2.67 26.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.86 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -23.71 66.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -97.2 -3.05 41.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 243' ' ' VAL . 0.0 OUTLIER -110.31 23.73 13.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 62' ' ' LEU . 3.5 m -93.44 -170.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.144 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 153.7 41.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.46 -55.59 9.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.091 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -21.68 55.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 34.6 m95 -88.93 10.43 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -51.01 26.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.915 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.6 p -77.88 -26.0 48.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.154 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.4 t -54.76 -43.27 72.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.857 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 54' ' ' VAL . 4.6 mp -74.7 -27.66 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.927 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.3 m -64.49 -53.68 44.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 68' ' ' VAL . 44.7 t -71.53 -51.8 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.153 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.9 t -60.86 -35.48 76.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.55 -42.27 63.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.485 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 tp -62.66 -50.18 72.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.869 0.366 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 64' ' ' VAL . 7.6 p -63.42 -43.48 98.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.444 ' N ' HG13 ' A' ' 68' ' ' VAL . 98.6 m -67.33 -36.66 81.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.136 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -64.82 -46.93 88.13 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.7 mt -67.11 -48.42 78.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 0.0 111.137 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.784 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -58.64 -40.98 84.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.683 ' CE1' HD21 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -61.31 -53.31 58.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.86 -41.99 68.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 m170 -66.98 -59.66 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.892 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.23 -42.02 63.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -63.06 -46.54 87.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.898 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.63 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 t80 -61.87 -60.11 4.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.967 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -32.96 63.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -55.98 20.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.452 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -65.31 -33.57 87.08 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.508 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 78' ' ' TYR . 87.1 t -68.83 -38.47 78.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.801 0.334 . . . . 0.0 111.151 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -71.6 -45.24 62.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.936 HD11 HG22 ' A' ' 29' ' ' THR . 10.1 tp -72.2 -26.01 24.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.088 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.59 -47.79 49.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -143.28 -39.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 134.69 36.18 0.23 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 31.7 m-20 -153.6 127.37 8.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.847 0.356 . . . . 0.0 110.864 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.24 160.07 50.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.699 0.761 . . . . 0.0 110.822 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 101.44 0.91 Allowed 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.685 2.257 . . . . 0.0 112.337 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.0 m -69.3 -31.58 70.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.14 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.39 -51.19 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.71 -51.72 57.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -48.63 69.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -59.69 -55.42 34.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.957 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.9 mt -55.49 -36.59 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -62.88 -52.79 61.72 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.464 1.103 . . . . 0.0 109.297 179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.666 ' CH2' H202 ' A' ' 301' ' ' RET . 8.3 t-105 -59.8 -43.19 94.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.938 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.97 -20.92 61.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.885 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.38 -17.43 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.784 HG21 ' HB2' ' A' ' 72' ' ' ALA . 71.8 p -96.77 -25.47 15.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.685 HG21 HG11 ' A' ' 133' ' ' VAL . 2.6 t -57.15 -56.87 29.11 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.618 0.723 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.8 Cg_endo -69.78 -27.61 26.17 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.1 mt -72.91 -47.25 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' A' ' 234' ' ' PHE . 0.9 OUTLIER -65.57 -51.05 62.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.657 HG13 HG21 ' A' ' 129' ' ' VAL . 36.2 mm -58.49 -56.05 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 50.0 t -58.33 -34.56 70.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.18 -65.56 0.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.92 -52.29 43.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -56.91 -44.93 82.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.945 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 14.1 tp -53.43 -59.49 4.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.911 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 15.5 mm -51.93 -42.29 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.629 HD12 HG12 ' A' ' 182' ' ' VAL . 0.1 OUTLIER -67.9 -27.99 67.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.59 -25.97 50.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.09 -12.57 27.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.107 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.96 -20.07 46.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 118' ' ' ASN . 0.2 OUTLIER -122.53 -73.64 0.64 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.115 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.408 ' H ' HG23 ' A' ' 117' ' ' THR . 2.0 m-20 170.1 -76.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.3 146.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.175 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -125.99 96.1 4.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.067 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.16 -3.48 89.63 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.508 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.5 p -48.8 -36.39 16.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.61 -48.83 28.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.94 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -70.14 -50.02 44.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.636 ' O ' HG22 ' A' ' 129' ' ' VAL . 0.4 OUTLIER -51.68 -52.95 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.6 pttt -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.918 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 62.3 tp -65.74 -47.55 74.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.0 tp -67.71 -59.97 2.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.657 HG21 HG13 ' A' ' 106' ' ' ILE . 16.6 m -58.37 -33.65 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.115 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.495 ' HA2' HG11 ' A' ' 102' ' ' VAL . . . -67.41 -46.99 65.6 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.542 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.7 t -65.65 -49.36 68.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.835 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -56.69 -52.83 63.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 102' ' ' VAL . 53.5 t -59.78 -41.88 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.107 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -64.42 -44.89 89.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 136' ' ' VAL . 3.4 tt -60.45 -57.78 11.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.578 ' N ' HD23 ' A' ' 135' ' ' LEU . 86.3 t -53.14 -52.06 33.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.89 -34.68 71.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -72.12 -53.95 8.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.532 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.77 -56.46 19.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.862 0.363 . . . . 0.0 110.927 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -30.84 68.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 142' ' ' GLU . . . -64.01 -30.29 77.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.502 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 141' ' ' GLY . 2.8 tt0 -35.7 -59.94 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 110.894 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -120.13 -30.47 4.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 82.89 -13.3 44.28 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.0 pt -109.08 5.69 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.24 144.68 32.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.846 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.651 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 61.94 32.29 17.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.094 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.97 96.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.066 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -69.88 -58.52 5.31 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.573 0.701 . . . . 0.0 110.925 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 149' ' ' TRP . 54.5 Cg_endo -69.68 -5.12 15.39 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.728 2.285 . . . . 0.0 112.329 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.02 -49.97 73.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.072 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.22 -45.76 79.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 153' ' ' ILE . 4.7 mp -61.57 -43.37 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.104 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 60.2 mt -65.61 -55.44 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.096 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.72 -43.71 98.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 40.8 t -58.94 -52.53 65.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.879 0.371 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 153' ' ' ILE . 2.9 mm? -53.61 -49.78 67.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.925 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.489 ' HB1' ' HE2' ' A' ' 162' ' ' MET . . . -65.03 -34.21 77.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.456 ' HZ2' HG23 ' A' ' 194' ' ' ILE . 1.9 t90 -67.08 -54.69 19.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.92 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.432 HG23 ' CE3' ' A' ' 159' ' ' TRP . 99.3 t -57.95 -49.47 81.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -61.13 -43.06 99.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.489 ' HE2' ' HB1' ' A' ' 158' ' ' ALA . 15.9 mtm -55.44 -58.61 7.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 194' ' ' ILE . 85.1 mt -65.47 -31.9 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -58.93 -47.58 84.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.23 -41.99 63.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.32 -16.73 63.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -56.53 -25.84 53.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -103.71 19.01 20.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -64.72 -153.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.512 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.576 ' O ' ' HB2' ' A' ' 174' ' ' ALA . 75.8 mm-40 -69.53 -11.07 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 110.907 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -79.78 -40.61 14.36 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.5 tptp -56.92 -61.34 2.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.342 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.4 p -63.28 -25.26 68.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -59.09 -19.38 43.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 41.9 t -51.41 -30.07 18.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.8 -39.28 0.88 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.893 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 24.7 p -71.52 -9.07 57.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.603 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -126.84 -166.63 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.12 163.08 24.6 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.645 0.736 . . . . 0.0 110.871 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -20.08 35.55 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.658 2.239 . . . . 0.0 112.357 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.51 -52.77 9.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.629 HG12 HD12 ' A' ' 113' ' ' LEU . 19.1 t -60.74 -48.82 87.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.173 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -58.28 -37.53 75.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 21.3 t -65.38 -47.15 77.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.12 88.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.135 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -64.22 -51.66 62.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -55.64 -49.22 73.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.71 ' CG2' HD12 ' A' ' 237' ' ' ILE . 1.4 m -63.85 -32.38 73.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.092 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.681 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.1 OUTLIER -69.67 -35.34 75.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.45 ' HA ' HG22 ' A' ' 193' ' ' ILE . 5.1 ttp -74.96 -36.08 62.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -40.89 69.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 188' ' ' THR . 7.1 tp -71.09 -44.02 75.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.475 ' N ' HG23 ' A' ' 192' ' ' ILE . 16.1 tt -65.92 -37.92 80.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 163' ' ' ILE . 45.5 mt -69.1 -49.5 61.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.102 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.89 -51.69 68.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.48 -59.67 9.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 26.0 m0 -53.73 -34.6 59.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.765 0.317 . . . . 0.0 110.926 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.34 -24.56 46.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.9 mm -76.26 -32.28 22.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.094 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.557 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 2.8 t80 -48.44 -57.22 11.34 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.669 0.747 . . . . 0.0 110.904 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.8 -25.35 28.49 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.651 2.234 . . . . 0.0 112.313 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 198' ' ' ALA . 40.9 t -68.6 -40.57 82.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.115 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.95 -43.4 8.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.61 ' OH ' HD13 ' A' ' 219' ' ' LEU . 1.5 t80 -54.94 -31.2 60.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.948 0.404 . . . . 0.0 110.935 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -49.99 -32.69 15.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.518 HG22 ' O ' ' A' ' 203' ' ' GLY . 11.4 t -51.33 -27.88 10.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.109 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -0.26 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.53 -50.33 10.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.872 0.368 . . . . 0.0 110.951 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -113.76 24.69 11.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.06 -169.5 1.83 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.9 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -94.15 19.07 55.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -106.13 -25.55 11.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 71.1 18.58 76.6 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 68.14 128.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.0 168.76 11.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.899 0.381 . . . . 0.0 110.851 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.17 -40.79 86.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.106 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.592 HD21 ' HB1' ' A' ' 25' ' ' ALA . 2.4 mt -60.95 -63.27 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -56.38 -42.03 77.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.61 HD13 ' OH ' ' A' ' 204' ' ' TYR . 9.8 tp -55.56 -49.28 73.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -63.42 -42.27 98.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.18 -58.0 10.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.404 HG21 ' CD2' ' A' ' 204' ' ' TYR . 37.3 mm -53.9 -46.98 64.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -60.46 -48.14 83.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -63.19 -38.99 93.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.9 OUTLIER -60.69 -51.38 69.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.06 -55.21 36.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -57.16 -40.7 77.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.655 ' CD2' HD13 ' A' ' 232' ' ' ILE . 27.0 t80 -62.98 -40.99 99.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 225' ' ' LEU . 88.2 t -71.98 -26.5 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -97.85 1.74 48.54 Favored 'General case' 0 C--O 1.207 -1.144 0 CA-C-O 126.749 3.166 . . . . 0.0 110.88 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.663 ' CE ' ' HB1' ' A' ' 72' ' ' ALA . 13.3 mmtm -116.48 -63.92 1.38 Allowed 'General case' 0 N--CA 1.423 -1.794 0 O-C-N 117.049 -3.532 . . . . 0.0 112.776 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.655 HD13 ' CD2' ' A' ' 228' ' ' PHE . 3.1 mp -66.81 -64.07 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.143 174.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -39.66 58.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.912 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.449 ' CD2' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -51.35 -58.83 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -63.57 -36.24 93.1 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 9.6 tp -59.28 -44.46 92.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.958 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.71 HD12 ' CG2' ' A' ' 188' ' ' THR . 0.8 OUTLIER -67.34 -47.89 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.097 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.681 HD11 ' SD ' ' A' ' 189' ' ' MET . 32.0 mm -54.85 -50.93 57.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.147 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.501 ' CZ3' HD12 ' A' ' 62' ' ' LEU . 4.4 m95 -72.15 -29.64 64.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -58.62 -54.23 49.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 242' ' ' ALA . 7.5 p -76.14 -40.36 36.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.115 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.411 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -61.35 -53.44 56.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.698 HG22 ' HA ' ' A' ' 54' ' ' VAL . 94.4 t -65.89 -47.51 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 34.3 tttt -58.69 -43.69 90.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.03 -41.3 97.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 6.5 p -50.83 -35.14 30.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.22 -75.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -115.31 159.34 21.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.877 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -165.38 72.63 1.38 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.549 0.69 . . . . 0.0 111.079 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 90.99 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.668 2.246 . . . . 0.0 112.358 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 87.92 -113.87 4.09 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 CA-C-O 119.172 -0.793 . . . . 0.0 112.508 -179.936 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.666 H202 ' CH2' ' A' ' 98' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 CA--C 1.526 0.041 0 CA-C-O 120.796 0.331 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.37 -177.51 42.39 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.511 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -178.17 175.02 47.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.29 113.69 0.35 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.552 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 55.57 -175.92 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.3 mt -103.23 111.53 23.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' C ' HD21 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -70.02 160.94 31.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.852 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -51.93 -42.22 62.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.2 t -58.19 -36.85 73.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 31' ' ' VAL . 30.4 m-20 -61.36 -60.51 3.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.446 ' CD1' HD23 ' A' ' 217' ' ' LEU . 1.5 m-85 -61.15 -48.19 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 86.5 m -51.57 -47.31 63.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.81 -51.73 28.21 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 27' ' ' ASP . 96.2 t -54.67 -55.33 16.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -59.03 -48.61 80.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -52.32 -45.57 65.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -45.46 83.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.01 -39.25 91.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 32' ' ' SER . 97.6 t -65.51 -52.63 48.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 m -62.49 -45.73 91.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.28 -51.79 64.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 228' ' ' PHE . . . -61.46 -54.18 46.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' CZ ' ' A' ' 73' ' ' PHE . 3.0 tt -51.12 -52.83 39.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.542 ' N ' HD23 ' A' ' 40' ' ' LEU . 21.2 tp -55.29 -53.34 57.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.74 -40.62 66.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.131 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -69.2 -32.17 71.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.2 m -73.06 -46.81 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.128 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 46' ' ' PHE . 17.7 m -64.57 -42.89 96.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.159 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.24 -49.79 58.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.456 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 64.5 t80 -64.55 -27.63 69.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -74.42 -49.55 22.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 45' ' ' VAL . 87.6 t -71.26 -38.27 69.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -79.58 -7.45 58.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -56.54 -26.85 56.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -99.41 -11.05 21.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -101.19 38.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.871 HG21 HD21 ' A' ' 62' ' ' LEU . 5.2 p -113.24 162.67 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.411 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -48.32 149.21 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.61 -55.58 12.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.079 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -60.51 -22.99 64.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -88.78 8.75 27.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -50.73 -50.37 55.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -73.76 -34.49 64.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.207 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.787 ' HA ' HG21 ' A' ' 112' ' ' ILE . 19.8 m -50.73 -45.04 58.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.871 HD21 HG21 ' A' ' 54' ' ' VAL . 3.7 mm? -65.01 -30.12 71.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.539 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -70.83 -55.51 8.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.175 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 65' ' ' SER . 12.8 m -67.88 -51.63 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.112 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.518 ' N ' HG23 ' A' ' 64' ' ' VAL . 8.6 t -65.06 -37.56 87.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.4 -33.95 68.35 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.566 ' O ' HG22 ' A' ' 71' ' ' ILE . 4.0 mp -70.12 -47.63 60.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 69' ' ' THR . 6.6 p -65.24 -45.15 94.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.468 ' N ' HG13 ' A' ' 68' ' ' VAL . 68.9 p -71.79 -33.12 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.145 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.11 -49.25 54.78 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 67' ' ' LEU . 7.1 tt -67.64 -43.39 86.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.699 ' HB1' ' HE3' ' A' ' 231' ' ' LYS . . . -65.09 -39.78 93.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.076 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.769 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 27.3 t80 -63.06 -57.78 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 13.5 t90 -53.74 -50.07 66.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.92 -47.38 74.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -44.13 97.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -51.02 65.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 82' ' ' VAL . 24.5 t80 -62.32 -48.75 78.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -57.32 12.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -51.58 -54.59 26.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.67 -39.54 54.53 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 78' ' ' TYR . 90.1 t -67.33 -43.85 87.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 0.0 111.155 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.4 t-105 -57.06 -52.28 65.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.934 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.48 HD13 ' O ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -73.29 -25.67 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.74 -48.37 40.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.6 p -139.0 -39.91 0.48 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.53 -6.78 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.511 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -122.56 127.14 49.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.838 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.82 160.35 41.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.676 0.75 . . . . 0.0 110.848 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 86.65 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.7 t -56.66 -33.35 66.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.172 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -61.55 -34.4 61.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -51.35 68.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.886 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -67.59 -34.68 77.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.891 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -55.09 32.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.5 mt -63.93 -43.59 97.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.0 -33.01 73.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 1.151 . . . . 0.0 109.329 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -68.86 -50.29 51.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.5 tt -75.42 -13.3 60.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.46 ' O ' HD12 ' A' ' 104' ' ' LEU . 5.3 tt -95.82 -25.34 16.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.606 HG21 ' CB ' ' A' ' 72' ' ' ALA . 62.6 m -95.33 -35.8 11.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.11 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.531 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -50.12 -58.07 10.74 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.661 0.743 . . . . 0.0 111.178 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 54.1 Cg_endo -69.8 -35.68 12.09 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.676 2.25 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 100' ' ' LEU . 9.9 mt -62.48 -43.38 98.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.62 -46.14 59.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 102' ' ' VAL . 1.5 mp -63.62 -41.34 92.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 32.9 m -68.25 -63.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.4 -52.37 22.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.609 ' CE1' HD23 ' A' ' 113' ' ' LEU . 54.5 t80 -57.88 -51.61 68.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.903 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' HB2' HD13 ' A' ' 123' ' ' LEU . 2.2 t80 -51.83 -36.67 48.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.897 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -62.83 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.787 HG21 ' HA ' ' A' ' 61' ' ' SER . 21.4 pt -52.89 -38.75 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 ' CE1' ' A' ' 109' ' ' PHE . 0.1 OUTLIER -71.19 -51.43 24.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.926 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.83 -18.85 63.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.71 -23.68 30.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.16 86.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.7 t 179.15 -48.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.28 103.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.6 ' CG2' HD12 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -87.68 167.77 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.111 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.422 ' HB1' ' HA3' ' A' ' 169' ' ' GLY . . . -62.98 111.22 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -65.14 -3.03 10.09 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 m -50.59 -20.85 1.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.491 ' HB2' HG23 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -47.3 -33.18 5.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -67.46 -44.66 78.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.853 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.63 ' O ' HG12 ' A' ' 129' ' ' VAL . 14.6 mptt -65.3 -45.33 84.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -37.53 87.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.908 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 128' ' ' LEU . 1.2 tt -68.16 -43.05 79.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 127' ' ' LEU . 1.2 mt -66.46 -56.35 11.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 133' ' ' VAL . 12.0 p -58.49 -39.59 75.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.137 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.403 ' N ' HG13 ' A' ' 129' ' ' VAL . . . -65.2 -46.4 87.71 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.448 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.48 -41.69 97.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.908 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 tt -62.84 -52.41 63.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.91 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 129' ' ' VAL . 82.0 t -54.92 -46.01 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -27.14 64.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -67.8 -45.71 74.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 135' ' ' LEU . 11.0 m -73.27 -35.52 47.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.51 ' HE1' HD12 ' A' ' 154' ' ' ILE . 12.7 m-30 -70.42 -38.72 74.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -76.32 -43.68 19.65 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.529 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -67.63 -51.86 45.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -69.97 -35.46 74.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.27 -32.7 57.83 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.535 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -51.65 -32.1 28.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.868 0.366 . . . . 0.0 110.888 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.0 -26.06 9.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.81 22.99 12.37 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.474 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 145' ' ' ILE . 11.0 mt -80.58 0.31 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 111.092 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -108.29 -170.06 1.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' A' ' 150' ' ' PRO . . . -154.99 162.7 41.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB2' ' CG ' ' A' ' 208' ' ' TYR . . . -71.77 -21.71 61.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.097 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.756 ' CZ3' HD13 ' A' ' 209' ' ' LEU . 0.0 OUTLIER -70.49 -59.57 3.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.535 0.683 . . . . 0.0 110.908 -179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.64 ' HA ' HD13 ' A' ' 153' ' ' ILE . 54.1 Cg_endo -69.75 -14.05 35.58 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 0.0 112.349 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.55 -37.27 56.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.101 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.09 -37.81 88.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.857 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.64 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.3 mp -60.53 -53.15 52.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.51 HD12 ' HE1' ' A' ' 137' ' ' PHE . 88.4 mt -59.26 -50.83 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -60.33 -49.07 82.66 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.474 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.02 -50.0 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 0.0 110.883 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.9 mt -57.47 -45.62 84.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.05 83.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.632 ' HE1' HD11 ' A' ' 163' ' ' ILE . 8.7 t90 -64.64 -55.24 21.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.884 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.23 -46.88 78.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -37.02 86.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.466 ' O ' HD12 ' A' ' 166' ' ' LEU . 10.7 mtp -59.43 -53.59 56.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.632 HD11 ' HE1' ' A' ' 159' ' ' TRP . 91.2 mt -63.99 -42.87 97.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.197 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -54.01 -44.4 70.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -74.65 -57.67 3.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 162' ' ' MET . 5.5 mt -51.5 -58.45 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.45 ' HE3' HG23 ' A' ' 163' ' ' ILE . 1.1 t-105 -57.12 -20.1 23.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.942 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.27 19.93 17.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.144 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.422 ' HA3' ' HB1' ' A' ' 120' ' ' ALA . . . -59.63 -170.1 0.39 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.513 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.86 -3.67 42.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.05 -26.93 20.92 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 pttp -64.81 -40.42 95.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.766 0.317 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.69 -31.17 46.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 178' ' ' ALA . . . -71.85 -9.11 57.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.081 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 14.3 p -50.22 -25.04 3.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -50.21 -74.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.91 11.37 39.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.533 ' HB2' ' O ' ' A' ' 174' ' ' ALA . . . -51.6 168.26 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.15 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 160.59 62.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 0.0 110.874 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -24.26 30.03 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.66 2.24 . . . . 0.0 112.356 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.28 -43.2 52.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' A' ' 113' ' ' LEU . 60.2 t -66.86 -43.29 89.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.17 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.01 -35.67 81.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 188' ' ' THR . 70.2 m -71.28 -47.5 56.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.852 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.585 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -60.39 -41.87 94.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -66.85 -52.79 39.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -52.46 -54.1 36.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.861 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 184' ' ' SER . 43.7 p -58.14 -45.63 87.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -44.41 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.519 ' HA ' HG22 ' A' ' 193' ' ' ILE . 17.5 ttp -72.43 -29.97 64.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 -40.32 69.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.921 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 193' ' ' ILE . 0.0 OUTLIER -72.67 -44.45 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.16 179.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 190' ' ' MET . 6.5 tt -65.28 -40.99 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.09 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.456 ' N ' HG23 ' A' ' 193' ' ' ILE . 44.4 mt -69.13 -49.38 62.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -52.41 -58.15 7.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.559 ' HA2' HD12 ' A' ' 199' ' ' ILE . . . -58.29 -57.76 18.12 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.477 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . 0.466 ' CZ2' HD11 ' A' ' 193' ' ' ILE . 34.3 m0 -54.28 -32.07 55.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.69 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.79 -23.87 44.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.559 HD12 ' HA2' ' A' ' 196' ' ' GLY . 11.8 mt -77.12 -32.33 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 0.6 OUTLIER -48.85 -55.8 18.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.709 0.766 . . . . 0.0 110.94 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.82 -21.7 32.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.668 2.246 . . . . 0.0 112.323 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 198' ' ' ALA . 50.2 t -71.07 -43.66 75.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.138 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.34 -40.93 10.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.482 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -52.67 -57.4 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.916 0.389 . . . . 0.0 110.919 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -61.52 -32.56 72.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 203' ' ' GLY . 0.4 OUTLIER -52.16 -25.86 10.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 -179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.36 -7.54 5.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.517 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.445 ' CG ' ' HB2' ' A' ' 148' ' ' ALA . 4.3 t80 -78.6 -51.11 10.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.928 0.394 . . . . 0.0 110.945 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.756 HD13 ' CZ3' ' A' ' 149' ' ' TRP . 0.2 OUTLIER -114.97 38.69 3.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.906 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -167.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -51.76 -74.3 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -175.63 38.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.873 0.368 . . . . 0.0 110.86 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -112.45 -1.09 26.29 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.477 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -57.87 99.28 0.1 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.49 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.95 173.03 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.884 0.373 . . . . 0.0 110.862 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.46 -29.55 70.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.107 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 25' ' ' ALA . 10.9 mp -55.28 -63.31 1.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -54.21 -37.54 64.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.1 -54.74 43.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -57.58 -48.76 78.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 222' ' ' ILE . 1.3 tm? -58.94 -58.09 10.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.941 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.537 ' N ' HD13 ' A' ' 221' ' ' LEU . 45.5 mt -54.87 -46.52 75.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.13 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -61.1 -48.98 79.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.926 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.42 HD21 HG22 ' A' ' 36' ' ' VAL . 3.4 t30 -61.28 -41.05 96.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 21.1 tp -61.21 -48.8 79.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.51 -55.28 36.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.91 -27.02 69.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . 0.429 ' CZ ' ' HB1' ' A' ' 39' ' ' ALA . 35.9 t80 -66.72 -55.71 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 28.3 m -72.43 -25.53 23.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -68.96 -8.25 42.82 Favored 'General case' 0 C--O 1.208 -1.113 0 CA-C-O 126.68 3.133 . . . . 0.0 110.894 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.699 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 14.2 mmtm -129.85 -59.98 1.05 Allowed 'General case' 0 N--CA 1.423 -1.801 0 O-C-N 117.107 -3.496 . . . . 0.0 112.798 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.769 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 50.0 mm -51.26 -63.22 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.178 -1.828 . . . . 0.0 111.102 174.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.551 HD23 HG12 ' A' ' 237' ' ' ILE . 0.3 OUTLIER -54.82 -30.65 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -55.47 32.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -65.29 -37.09 93.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.42 -37.54 80.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.551 HG12 HD23 ' A' ' 233' ' ' LEU . 1.4 mm -69.43 -49.71 57.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.087 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 77.3 mt -64.32 -35.58 74.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.684 ' O ' HG23 ' A' ' 243' ' ' VAL . 17.0 t90 -75.95 -43.99 42.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.894 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.63 -42.2 92.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 185' ' ' ALA . 10.3 p -74.07 -38.28 48.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.49 83.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.103 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.8 t -75.36 -40.78 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -66.96 -36.11 81.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -76.83 -44.03 34.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.847 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 12.5 t -51.74 -45.27 63.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.2 t 63.42 179.64 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.82 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -64.51 138.48 58.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.858 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -170.61 160.45 5.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.709 . . . . 0.0 111.104 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.574 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.4 Cg_endo -69.82 -174.63 0.96 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.61 -169.76 41.19 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.481 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.195 -0.781 . . . . 0.0 112.441 -179.907 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.471 H163 ' HB3' ' A' ' 137' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.8 mtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.871 0.367 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.8 -132.28 6.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.514 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 177.26 68.99 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.515 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 53.47 89.8 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.448 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -147.39 -43.02 0.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.85 0.357 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.67 -176.18 3.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -82.82 -177.1 6.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.33 -72.67 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.088 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.75 -28.84 36.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -63.69 -73.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.858 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -51.89 -43.76 63.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.445 HG23 HG12 ' A' ' 84' ' ' ILE . 96.2 m -61.01 -39.28 89.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.125 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.65 -52.92 22.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.481 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.7 p -58.29 -39.02 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.788 0.328 . . . . 0.0 111.108 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.639 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.2 t -67.63 -49.57 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.892 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.33 -42.68 78.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.855 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -67.34 -46.9 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.86 -41.95 96.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 32' ' ' SER . 92.5 t -67.06 -43.28 88.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.0 m -59.5 -49.2 78.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.184 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.09 92.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.107 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.68 -55.48 23.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.065 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 HD13 ' HZ ' ' A' ' 73' ' ' PHE . 1.3 pp -62.84 -31.94 73.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.0 tp -64.92 -53.4 46.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.73 -34.55 78.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.61 -39.55 70.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 40' ' ' LEU . 14.0 p -67.24 -43.52 81.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.153 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 49' ' ' VAL . 27.7 m -68.5 -38.51 79.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -65.15 -49.04 71.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -70.72 -30.29 66.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -66.87 -50.17 63.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.909 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 45' ' ' VAL . 12.4 p -73.75 -33.45 37.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' VAL . 1.1 tp10 -79.65 -14.52 58.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -36.86 69.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -85.48 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.18 42.33 2.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 62' ' ' LEU . 14.2 m -114.51 -170.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.121 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.66 155.37 40.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.51 -50.93 65.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.128 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -24.73 62.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.439 ' HZ3' HG23 ' A' ' 238' ' ' ILE . 62.5 m95 -96.82 -4.33 40.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -51.57 40.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.607 HG23 ' CD1' ' A' ' 112' ' ' ILE . 5.3 t -77.62 -35.02 53.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.594 ' CA ' HD13 ' A' ' 112' ' ' ILE . 1.3 p -50.73 -41.66 56.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 -179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.95 HD11 HG11 ' A' ' 54' ' ' VAL . 12.5 mt -64.61 -33.16 75.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -68.65 -54.19 17.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.0 t -69.38 -57.01 9.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -61.22 -41.83 97.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.53 89.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.57 -44.69 77.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.933 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -66.99 -55.25 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.0 m -64.96 -33.1 75.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.23 -47.66 70.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.2 mt -66.62 -46.9 84.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.368 . . . . 0.0 111.149 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -63.22 -37.83 88.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.133 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.8 ' CZ ' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -64.65 -54.04 38.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -45.49 80.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -59.7 -53.19 60.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -39.23 90.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -57.54 -55.2 37.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.658 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -59.31 -53.04 62.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 13.6 mmt -54.42 -47.89 72.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -55.34 -56.68 17.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.798 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -58.48 -34.0 73.75 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.511 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 78' ' ' TYR . 75.1 t -70.24 -33.9 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.815 0.34 . . . . 0.0 111.077 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -73.84 -40.7 63.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.553 HD13 ' CB ' ' A' ' 220' ' ' ASN . 9.7 tp -76.85 -26.35 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.154 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -87.52 -49.94 6.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.6 m -80.76 -39.67 26.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.113 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 102.4 -12.72 56.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -152.97 130.16 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.761 0.315 . . . . 0.0 110.895 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.29 162.01 34.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.706 0.765 . . . . 0.0 110.857 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 103.29 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.0 t -69.43 -26.67 64.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.8 m -50.23 -42.21 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.172 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.58 -48.38 67.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -57.67 -51.43 69.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.918 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -57.29 -50.62 72.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 59.7 mt -58.08 -53.92 39.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 101' ' ' THR . 0.6 OUTLIER -57.67 -34.01 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.472 1.108 . . . . 0.0 109.336 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -58.6 -59.58 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.886 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.59 -11.37 60.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.945 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 100' ' ' LEU . 8.6 tt -91.85 -17.12 25.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.919 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.705 HG21 ' HB2' ' A' ' 72' ' ' ALA . 81.7 p -110.95 -39.39 4.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.145 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.521 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -43.79 -58.49 4.54 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.664 0.745 . . . . 0.0 111.163 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.9 Cg_endo -69.79 -21.12 33.81 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.738 2.292 . . . . 0.0 112.311 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 101' ' ' THR . 2.2 mm? -75.71 -54.37 7.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.91 -49.55 70.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.77 -58.59 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.098 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.3 t -59.33 -34.38 72.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.41 -63.33 1.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -50.47 -51.09 50.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.887 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -61.66 -40.01 93.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.921 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.8 tp -57.67 -66.3 0.49 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.607 ' CD1' HG23 ' A' ' 60' ' ' THR . 0.6 OUTLIER -50.53 -34.56 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.158 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.037 HD11 HG13 ' A' ' 182' ' ' VAL . 5.3 tp -70.58 -39.5 73.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.87 -14.82 59.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.142 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.78 -17.07 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.49 -24.64 60.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -119.26 -68.94 0.88 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' THR . 0.3 OUTLIER 164.87 -78.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.13 134.74 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.89 97.46 4.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.26 -6.05 85.97 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.44 -33.49 21.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.903 0.382 . . . . 0.0 110.82 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.56 -41.71 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -73.95 -37.47 64.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.489 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -64.95 -51.54 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -35.33 79.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.929 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 12.2 mt -62.64 -49.79 73.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 10.2 mt -69.17 -59.68 2.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 133' ' ' VAL . 58.8 t -52.65 -46.98 50.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.67 -49.61 76.74 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -53.73 -46.2 70.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.919 0.39 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.413 HD13 HD22 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -64.32 -42.04 96.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.914 -179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 129' ' ' VAL . 74.4 t -59.51 -55.97 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.142 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.07 -27.96 68.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.852 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.585 HD23 ' N ' ' A' ' 136' ' ' VAL . 1.0 OUTLIER -64.77 -58.17 6.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.585 ' N ' HD23 ' A' ' 135' ' ' LEU . 42.7 t -66.6 -41.51 88.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.118 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.474 ' CA ' H162 ' A' ' 301' ' ' RET . 14.2 t80 -62.38 -38.66 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -71.07 -51.31 18.89 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -58.6 -56.91 16.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -66.89 -32.69 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.22 -29.51 72.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.483 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -38.12 -55.9 1.23 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -115.97 -31.47 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 76.32 -9.36 20.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.503 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.4 pt -107.44 8.85 9.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.818 0.342 . . . . 0.0 111.116 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.66 ' CE ' ' HB3' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -102.05 119.88 39.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' CE ' ' A' ' 146' ' ' MET . . . 44.38 53.94 6.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.079 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 151' ' ' ALA . . . -73.55 -53.28 10.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.088 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.622 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 5.3 t90 -52.83 -53.25 56.7 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.555 0.693 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.629 ' HG2' ' HB1' ' A' ' 147' ' ' ALA . 53.7 Cg_endo -69.7 -17.2 37.97 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.256 . . . . 0.0 112.379 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 148' ' ' ALA . . . -53.23 -34.69 58.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.61 -29.33 69.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.913 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 35.8 mt -65.62 -51.64 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.098 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -35.82 76.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.426 ' HA3' ' H41' ' A' ' 301' ' ' RET . . . -73.47 -46.9 23.87 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.487 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.427 ' O ' HG22 ' A' ' 160' ' ' VAL . 36.1 t -61.71 -45.75 92.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.832 0.348 . . . . 0.0 110.875 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.71 -49.58 74.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.77 -29.89 70.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.699 ' CE3' HG13 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -67.3 -57.48 6.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.699 HG13 ' CE3' ' A' ' 159' ' ' TRP . 18.7 m -60.02 -41.79 87.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -63.25 -45.86 89.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.65 ' SD ' HG22 ' A' ' 129' ' ' VAL . 13.2 mmt -57.05 -54.9 41.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.584 HG21 HD11 ' A' ' 194' ' ' ILE . 2.1 mp -64.56 -37.32 79.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.108 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.83 -36.97 86.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -74.56 -39.5 62.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.867 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.681 ' O ' HD12 ' A' ' 166' ' ' LEU . 0.3 OUTLIER -80.54 -14.51 58.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.93 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -54.18 -27.42 33.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -108.12 21.1 17.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -42.23 132.22 4.46 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -78.35 1.0 23.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 110.86 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -49.27 -40.05 29.15 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -77.09 -28.95 54.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.5 m -60.43 -24.87 65.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.89 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.4 -30.49 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.128 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 81.5 m -104.27 -13.7 16.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 75.02 -59.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 82.7 p -92.02 -11.66 35.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 48.12 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.34 163.15 47.61 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.644 0.735 . . . . 0.0 110.883 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -26.35 27.79 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.667 2.244 . . . . 0.0 112.349 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.75 -39.88 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.079 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 1.037 HG13 HD11 ' A' ' 113' ' ' LEU . 71.2 t -68.34 -43.99 83.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.144 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -67.44 -32.98 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.0 m -71.77 -49.11 41.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.908 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.94 99.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.106 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.1 -44.76 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -58.08 -56.79 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 1.1 m -58.19 -48.22 81.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.183 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.75 -52.0 51.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.4 -32.63 74.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -49.25 77.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.497 HD13 HG21 ' A' ' 237' ' ' ILE . 2.4 mp -67.72 -47.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.8 mt -51.55 -49.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.584 HD11 HG21 ' A' ' 163' ' ' ILE . 87.3 mt -65.37 -48.15 84.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.131 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.78 -59.93 3.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.0 -54.61 33.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 16.4 m0 -53.23 -30.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.737 0.304 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -80.05 -28.95 39.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 15.9 mt -80.51 -30.77 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.608 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 24.5 t80 -48.03 -54.37 25.1 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.686 0.755 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.76 -22.46 32.06 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 198' ' ' ALA . 80.7 t -69.27 -44.31 80.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.095 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -82.81 -32.35 27.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.456 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.482 ' HA ' HD13 ' A' ' 222' ' ' ILE . 60.2 t80 -58.36 -45.92 87.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.918 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.09 -53.87 24.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 6.8 t -72.47 -14.17 61.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.191 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -89.69 -19.75 46.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -111.44 -50.88 2.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.902 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.558 HD11 ' CD1' ' A' ' 149' ' ' TRP . 86.0 mt -93.87 39.94 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.52 -171.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.898 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -83.0 -18.06 65.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.5 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.79 -53.07 2.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.361 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 169.24 -27.68 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 81.61 137.75 2.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.462 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 96.0 p -121.91 178.62 4.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.889 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.48 -21.11 62.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -59.74 4.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.425 ' O ' HD12 ' A' ' 222' ' ' ILE . 14.0 m-20 -52.03 -37.91 55.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 6.5 mp -72.35 -33.44 67.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.553 ' CB ' HD13 ' A' ' 84' ' ' ILE . 1.6 m120 -68.15 -48.82 64.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 221' ' ' LEU . 2.3 pp -68.53 -38.78 81.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 204' ' ' TYR . 40.4 mt -66.68 -47.14 84.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.171 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.422 HD21 HG21 ' A' ' 36' ' ' VAL . 39.4 t30 -63.85 -43.27 96.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 229' ' ' VAL . 2.7 tp -62.47 -45.67 91.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -60.12 -55.68 30.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -61.54 -37.56 84.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -62.14 -46.62 88.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 1.041 HG13 HD13 ' A' ' 233' ' ' LEU . 96.7 t -73.02 -25.15 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.137 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -92.14 2.35 56.64 Favored 'General case' 0 C--O 1.207 -1.173 0 CA-C-O 126.704 3.145 . . . . 0.0 110.849 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -124.07 -63.33 1.22 Allowed 'General case' 0 N--CA 1.423 -1.797 0 O-C-N 117.121 -3.487 . . . . 0.0 112.743 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 73' ' ' PHE . 43.9 mm -61.59 -64.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.165 174.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 1.041 HD13 HG13 ' A' ' 229' ' ' VAL . 0.1 OUTLIER -51.75 -36.65 48.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.01 -57.83 7.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.705 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -66.76 -42.42 93.14 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.483 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tp -53.31 -49.54 66.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.749 0.309 . . . . 0.0 110.887 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 241' ' ' VAL . 5.1 mm -69.07 -36.16 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.705 HD12 ' HA2' ' A' ' 235' ' ' GLY . 15.8 mt -52.39 -57.59 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . . . . . . . . . 16.9 p-90 -73.67 -30.14 62.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.909 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.404 HD22 HD13 ' A' ' 237' ' ' ILE . 37.0 t30 -56.96 -52.19 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.934 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.4 p -75.08 -44.05 44.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.119 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.464 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.05 -55.68 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.085 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 54' ' ' VAL . 74.1 t -62.29 -43.42 98.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.173 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.64 -46.92 74.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.903 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -74.21 -29.24 61.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 23.2 t -51.55 -33.24 31.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.838 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.47 -74.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -161.22 137.13 8.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -171.44 71.61 0.5 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.613 0.72 . . . . 0.0 111.133 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 101.24 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 173.46 -141.13 5.92 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.464 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 CA-C-O 119.102 -0.832 . . . . 0.0 112.531 -179.887 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.532 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.8 ttt . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.781 0.324 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.34 84.83 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.48 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.92 -140.12 5.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 78.66 -160.83 47.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.444 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.01 -42.67 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.503 HD12 ' CE2' ' A' ' 28' ' ' TYR . 16.7 mt -139.78 141.68 36.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.78 172.14 13.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HA ' HD21 ' A' ' 217' ' ' LEU . . . -54.77 -65.47 0.57 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.73 -25.86 42.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.656 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -59.84 -68.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.868 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.609 ' HB2' HD22 ' A' ' 217' ' ' LEU . 0.6 OUTLIER -63.7 -48.54 76.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 95.3 m -52.8 -44.34 66.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.27 -51.61 31.72 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.495 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 27' ' ' ASP . 71.1 t -54.62 -55.46 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.846 0.355 . . . . 0.0 111.132 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.67 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -59.45 -46.38 88.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.836 -179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -52.68 -43.74 65.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -68.21 -45.59 72.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.97 -37.27 84.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 32' ' ' SER . 89.7 t -69.1 -52.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 26.9 m -61.73 -47.48 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.1 -50.95 71.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.14 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -52.18 17.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 45' ' ' VAL . 5.5 tp -65.83 -42.37 90.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.888 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 45' ' ' VAL . . . -64.75 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.8 m -71.67 -36.18 70.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -74.81 -45.2 44.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.139 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 41' ' ' LEU . 12.3 p -67.28 -38.84 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -71.9 -49.63 36.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.859 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.688 ' CZ ' HD23 ' A' ' 62' ' ' LEU . 45.6 t80 -63.6 -34.34 77.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.891 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -70.72 -52.24 22.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.847 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 45' ' ' VAL . 91.1 t -66.36 -35.63 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.631 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.4 tp10 -79.92 -22.38 42.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.642 ' O ' HG22 ' A' ' 54' ' ' VAL . 3.9 mtp180 -54.23 -44.66 71.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -79.97 -3.95 50.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -106.32 12.01 30.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.842 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 51' ' ' ARG . 8.4 m -94.35 -170.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.154 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.27 158.28 33.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.25 -51.45 63.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.068 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -62.4 -34.29 76.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.466 ' CD1' ' HB1' ' A' ' 242' ' ' ALA . 95.6 m95 -83.7 -10.87 57.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.8 ttpt -51.02 -50.58 58.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -77.29 -41.53 40.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.427 ' CB ' HG21 ' A' ' 112' ' ' ILE . 0.3 OUTLIER -54.26 -46.95 72.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.875 -179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.747 HD21 ' HB3' ' A' ' 239' ' ' TRP . 0.0 OUTLIER -70.79 -27.32 63.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.938 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.3 m -71.18 -53.61 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.635 ' O ' HG12 ' A' ' 68' ' ' VAL . 25.6 m -70.21 -45.5 75.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' VAL . 13.0 t -69.56 -41.03 76.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.33 -33.4 64.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.46 -48.37 56.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.353 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.635 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.8 p -65.06 -47.78 86.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.51 ' N ' HG13 ' A' ' 68' ' ' VAL . 67.1 p -63.73 -38.11 89.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.63 -67.02 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.514 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -48.03 -35.94 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.358 . . . . 0.0 111.108 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -69.73 -49.41 53.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.119 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.52 ' CE2' HD11 ' A' ' 232' ' ' ILE . 5.5 t80 -53.37 -46.53 69.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -67.73 -45.8 73.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -58.36 -45.22 88.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.879 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -72.94 -57.74 3.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.979 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -37.36 23.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.849 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.488 ' O ' HG23 ' A' ' 82' ' ' VAL . 56.9 t80 -74.01 -55.4 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.885 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -57.84 9.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.917 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.525 ' NH2' HD11 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -66.55 -48.76 68.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.841 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.41 -48.74 53.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 78' ' ' TYR . 70.9 t -66.37 -53.23 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.802 0.334 . . . . 0.0 111.155 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -53.31 -55.93 20.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.612 HD13 ' O ' ' A' ' 88' ' ' ASP . 40.4 mm -61.33 -34.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -57.59 -22.02 42.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.4 m -99.41 -38.36 8.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.38 35.52 0.46 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.486 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.612 ' O ' HD13 ' A' ' 84' ' ' ILE . 2.3 m-20 -112.4 -177.42 3.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.834 0.349 . . . . 0.0 110.869 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.6 t -147.77 75.39 11.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.653 0.74 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.05 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.363 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.46 -38.58 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 93' ' ' PHE . 19.7 m -62.98 -44.57 99.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.057 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.455 ' N ' HG23 ' A' ' 92' ' ' VAL . 7.6 m-85 -73.01 -47.28 46.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.02 -50.54 72.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.83 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -60.29 -55.96 27.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.97 -27.18 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -66.42 0.55 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.515 1.134 . . . . 0.0 109.298 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.567 ' CE2' H202 ' A' ' 301' ' ' RET . 12.2 t-105 -60.53 -30.04 69.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.89 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -74.72 -30.55 61.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.0 tt -87.58 -18.89 28.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.106 HG22 HD23 ' A' ' 105' ' ' LEU . 3.5 m -94.81 -39.62 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.152 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.643 HG21 ' CE ' ' A' ' 134' ' ' MET . 2.1 t -43.55 -58.46 4.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.615 0.722 . . . . 0.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.78 -18.91 36.66 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.354 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 68' ' ' VAL . 6.7 tp -77.21 -54.0 7.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.106 HD23 HG22 ' A' ' 101' ' ' THR . 1.0 OUTLIER -72.52 -47.38 48.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.93 179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 25.5 mm -54.81 -46.79 75.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.18 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.443 ' HA ' HD13 ' A' ' 123' ' ' LEU . 48.6 t -69.07 -42.2 76.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -54.45 45.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.859 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -58.79 -50.97 71.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.85 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 6.6 m-85 -64.06 -28.54 69.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.962 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' A' ' 115' ' ' ALA . 0.5 OUTLIER -66.84 -56.07 12.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.898 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.513 HD13 HD23 ' A' ' 111' ' ' LEU . 48.0 mm -65.03 -36.37 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.141 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.859 HD11 HG13 ' A' ' 182' ' ' VAL . 9.5 tp -70.81 -55.27 8.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 120' ' ' ALA . . . -71.39 -12.47 61.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.52 ' HB2' ' O ' ' A' ' 111' ' ' LEU . . . -51.7 -24.64 6.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.9 -28.35 68.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.077 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -9.03 8.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.633 ' O ' HG13 ' A' ' 119' ' ' VAL . 36.4 t30 66.12 50.35 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -172.57 107.21 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . . . -119.61 97.82 5.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.75 -35.89 27.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -49.85 -31.85 12.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 107' ' ' CYS . 8.1 tp -54.03 -50.72 66.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.881 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.4 -46.53 85.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -56.02 -50.5 70.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.462 ' NZ ' HD13 ' A' ' 193' ' ' ILE . 0.9 OUTLIER -65.82 -34.11 77.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' A' ' 103' ' ' PRO . 2.1 tt -66.78 -47.97 70.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.28 -58.87 4.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 76.7 t -57.9 -52.82 53.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.123 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -55.93 -42.59 86.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.478 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 8.6 m -63.55 -40.05 96.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.86 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.6 mt -63.06 -56.15 19.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.672 HG23 HG22 ' A' ' 154' ' ' ILE . 7.1 p -57.82 -35.64 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.147 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.643 ' CE ' HG21 ' A' ' 102' ' ' VAL . 0.4 OUTLIER -68.06 -40.51 82.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -65.49 -43.92 88.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.71 HG12 ' CE ' ' A' ' 140' ' ' MET . 60.2 t -64.88 -47.89 86.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.415 ' HD2' HG22 ' A' ' 133' ' ' VAL . 2.9 m-85 -62.42 -40.78 97.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.66 -49.4 64.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.491 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -60.48 -52.99 62.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.906 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.71 ' CE ' HG12 ' A' ' 136' ' ' VAL . 20.4 ptp -59.15 -33.74 71.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.17 -31.7 57.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.47 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.59 -29.88 7.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.878 0.371 . . . . 0.0 110.871 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -107.4 -27.4 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.111 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.24 5.32 62.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.489 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.0 pp -63.89 -35.07 72.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.777 0.323 . . . . 0.0 111.13 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.541 ' HB3' HD12 ' A' ' 145' ' ' ILE . 4.0 ptt? -135.15 133.91 39.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.9 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . -160.59 -45.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.605 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -67.03 -46.3 74.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.628 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 3.4 m95 -69.73 -52.82 13.11 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.561 0.696 . . . . 0.0 110.913 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.699 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.8 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.655 2.237 . . . . 0.0 112.334 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -61.75 -52.41 64.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -77.44 -34.15 54.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 150' ' ' PRO . 36.2 mt -59.35 -65.51 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.177 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.672 HG22 HG23 ' A' ' 133' ' ' VAL . 28.1 mm -62.85 -44.6 99.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -57.18 -47.59 86.47 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.515 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.416 ' O ' HG23 ' A' ' 160' ' ' VAL . 41.8 t -60.43 -50.47 73.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.8 0.333 . . . . 0.0 110.867 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.63 -47.82 66.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.49 94.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.121 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -60.24 -55.37 34.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 156' ' ' CYS . 22.8 t -57.77 -50.11 78.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -39.49 87.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.564 ' SD ' HD22 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -57.98 -58.08 10.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.91 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 20.5 mt -62.77 -38.92 82.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -53.59 -49.5 67.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -74.82 -54.68 6.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.885 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.582 HD23 ' HB3' ' A' ' 190' ' ' MET . 6.1 mp -50.46 -59.82 3.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -57.79 -20.56 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -105.0 17.81 23.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -68.63 118.27 8.95 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.481 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.24 -0.74 26.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 110.877 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.05 -37.77 46.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.468 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.75 -27.89 69.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.777 0.323 . . . . 0.0 110.88 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.3 m -55.16 -26.2 37.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.11 -39.3 55.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.099 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.25 -11.86 14.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.29 -58.65 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.874 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 t -100.06 -7.64 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.103 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.58 -166.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.04 161.78 51.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.7 0.762 . . . . 0.0 110.839 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -26.03 28.17 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.699 2.266 . . . . 0.0 112.348 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.91 -44.19 41.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.139 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.859 HG13 HD11 ' A' ' 113' ' ' LEU . 91.5 t -71.62 -42.46 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -66.21 -39.17 89.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.1 t -70.05 -49.38 51.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.848 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.78 97.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -65.46 -47.85 74.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.22 -44.39 83.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 237' ' ' ILE . 2.4 m -69.64 -35.11 74.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.472 ' HE3' ' N ' ' A' ' 189' ' ' MET . 0.0 OUTLIER -65.73 -53.02 46.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.909 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.582 ' HB3' HD23 ' A' ' 166' ' ' LEU . 14.5 ptm -64.11 -37.85 88.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -61.88 -47.76 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HG21 ' A' ' 237' ' ' ILE . 28.3 mm -65.65 -39.5 85.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.116 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.555 ' CG2' ' HE3' ' A' ' 162' ' ' MET . 42.2 mt -57.8 -57.58 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 15.6 pt -60.5 -38.68 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.155 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.463 ' CD2' HD11 ' A' ' 199' ' ' ILE . 5.4 t80 -56.29 -59.47 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -58.56 -52.95 49.9 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.483 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -55.4 -36.73 66.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.796 0.331 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.6 -24.72 49.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.066 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.468 ' O ' ' C ' ' A' ' 200' ' ' TYR . 19.6 mt -79.08 -26.97 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.54 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.5 t80 -32.7 -57.76 0.48 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.697 0.761 . . . . 0.0 110.943 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.77 -65.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.688 2.259 . . . . 0.0 112.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' A' ' 201' ' ' PRO . 57.3 t -36.51 -42.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.189 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -77.14 -57.86 3.56 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 222' ' ' ILE . 10.0 t80 -53.81 -21.68 7.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.858 0.361 . . . . 0.0 110.886 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -46.58 -28.97 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 96.7 m -49.34 -29.45 6.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.14 18.02 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.431 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.605 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 0.3 OUTLIER -57.28 -23.08 46.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.918 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 1.4 tp -129.36 -53.92 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -92.51 -175.14 3.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 125.89 38.12 0.48 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.453 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.2 68.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.61 25.62 70.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.486 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 55.51 82.56 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.518 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 2.9 p -72.58 135.55 45.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.861 0.362 . . . . 0.0 110.88 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.75 -28.71 57.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 25' ' ' ALA . 78.8 mt -55.99 -63.21 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -52.79 -31.48 38.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -57.39 10.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -58.55 -40.0 81.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.483 ' C ' HD13 ' A' ' 221' ' ' LEU . 3.3 tm? -61.26 -58.63 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 204' ' ' TYR . 39.5 mm -60.21 -48.84 86.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.105 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -57.05 -49.14 76.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -60.34 -40.38 90.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.57 -48.9 78.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -59.45 -55.16 38.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.056 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -62.17 -27.54 69.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.83 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -67.44 -56.58 9.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.0 m -72.57 -25.02 22.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -65.92 -10.32 37.69 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-O 126.701 3.143 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -131.31 -56.24 1.02 Allowed 'General case' 0 N--CA 1.424 -1.762 0 O-C-N 117.102 -3.499 . . . . 0.0 112.773 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 73' ' ' PHE . 44.3 mm -53.8 -64.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.115 174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.63 -41.21 61.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.932 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -51.08 -57.3 9.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.752 ' HA2' HD12 ' A' ' 238' ' ' ILE . . . -62.65 -41.11 99.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.479 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 2.5 tt -52.3 -48.96 65.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.756 0.312 . . . . 0.0 110.905 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.511 ' O ' HG12 ' A' ' 241' ' ' VAL . 4.7 mm -69.68 -36.62 71.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.752 HD12 ' HA2' ' A' ' 235' ' ' GLY . 39.4 mt -53.0 -58.07 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.092 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.747 ' HB3' HD21 ' A' ' 62' ' ' LEU . 15.9 p-90 -73.71 -29.63 62.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.912 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 237' ' ' ILE . 7.3 t-20 -54.87 -55.06 34.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.872 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 237' ' ' ILE . 7.1 p -76.32 -44.8 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.474 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -56.58 -53.17 60.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.064 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.615 HG22 ' HA ' ' A' ' 54' ' ' VAL . 85.1 t -67.47 -41.76 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 -54.18 27.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.93 -34.73 69.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 7.9 t -51.82 -68.83 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.892 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.5 t -174.66 96.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.868 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -53.88 172.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.599 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -123.75 160.49 51.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.615 0.721 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.599 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 54.4 Cg_endo -69.72 80.3 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.656 2.237 . . . . 0.0 112.411 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 159.99 -58.64 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.497 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.489 -179.902 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.567 H202 ' CE2' ' A' ' 98' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.4 mtm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.81 0.338 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 161.27 130.57 1.13 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.474 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.9 -73.52 0.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.494 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.69 46.51 2.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.495 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -175.02 77.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -144.54 -169.98 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.4 168.51 18.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.865 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -51.37 -60.35 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -52.56 -43.91 65.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.82 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.7 m-20 -54.53 -52.35 62.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.711 ' CD1' HD23 ' A' ' 217' ' ' LEU . 0.2 OUTLIER -61.84 -47.57 84.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.3 m -51.22 -47.01 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.142 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.8 -50.58 34.84 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.505 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.3 t -53.58 -55.22 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.836 0.351 . . . . 0.0 111.117 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.2 t -61.12 -47.18 87.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.861 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -53.22 -45.25 68.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.05 -46.21 78.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 mt -61.04 -40.24 92.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.943 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 32' ' ' SER . 93.1 t -66.4 -48.15 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.134 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.9 p -61.11 -46.5 90.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.156 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.9 -51.87 67.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.081 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.92 -54.93 35.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.701 HD12 ' CE2' ' A' ' 73' ' ' PHE . 1.8 tt -55.68 -33.66 64.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.873 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HG12 ' A' ' 45' ' ' VAL . 62.7 tp -68.44 -56.34 8.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.873 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -32.8 72.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.8 t -71.25 -43.11 67.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 92.5 m -65.2 -47.09 78.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 41' ' ' LEU . 7.2 p -67.25 -39.39 82.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.151 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -67.21 -49.81 63.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -67.18 -31.26 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -69.61 -48.91 58.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 45' ' ' VAL . 73.2 t -73.5 -37.25 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.681 ' O ' HG13 ' A' ' 54' ' ' VAL . 2.5 tt0 -79.51 -10.57 59.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.42 -27.78 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.894 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.02 -5.79 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -100.81 29.41 4.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.703 HG11 HD21 ' A' ' 62' ' ' LEU . 17.6 m -108.58 -171.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.148 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.42 ' HG ' ' HD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -77.52 160.12 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.11 86.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.125 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -45.59 86.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.42 ' HD1' ' HG ' ' A' ' 55' ' ' SER . 67.4 m95 -81.88 -1.64 48.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.955 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -50.94 -52.33 43.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.871 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 64' ' ' VAL . 18.0 p -77.56 -35.33 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.161 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.448 ' HB3' HD13 ' A' ' 112' ' ' ILE . 10.2 p -60.31 -31.85 70.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.703 HD21 HG11 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -69.12 -34.2 74.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.56 ' O ' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -73.29 -56.39 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.152 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' THR . 6.0 m -59.74 -52.28 62.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.494 ' H ' HG23 ' A' ' 64' ' ' VAL . 9.4 p -69.2 -36.6 77.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.891 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.7 -34.6 78.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.447 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 63' ' ' THR . 6.0 mp -70.7 -47.29 60.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 104' ' ' LEU . 5.1 p -63.85 -44.69 98.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.435 ' N ' HG13 ' A' ' 68' ' ' VAL . 70.0 p -71.65 -39.14 70.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.164 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.24 -45.22 95.7 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.451 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 48.7 mt -69.64 -47.85 68.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 0.0 111.105 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.735 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -61.67 -44.59 96.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.789 ' CE2' HD11 ' A' ' 232' ' ' ILE . 16.1 t80 -58.38 -53.41 58.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -57.0 -47.39 80.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -60.15 -61.38 2.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -50.15 -54.32 21.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.949 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.22 -58.14 4.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -58.33 -38.04 76.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 -179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -57.1 13.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -53.46 44.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.892 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.39 -53.15 33.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 78' ' ' TYR . 78.3 t -62.02 -39.15 82.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.093 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -54.79 -51.95 64.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.054 HD11 ' HB1' ' A' ' 216' ' ' ALA . 9.6 tp -73.63 -25.83 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.1 -47.93 34.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.895 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.52 -38.78 4.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.14 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.538 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.42 126.53 52.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.7 162.22 32.5 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.613 0.721 . . . . 0.0 110.861 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 101.92 0.96 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.696 2.264 . . . . 0.0 112.374 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 58.2 m -69.1 -26.02 64.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.198 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 81.7 t -48.04 -41.73 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.132 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.73 -44.82 88.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.6 mtm180 -67.2 -58.28 5.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -51.65 -41.04 61.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.549 ' O ' HD23 ' A' ' 99' ' ' LEU . 8.4 mm -63.5 -62.53 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' HG23 ' A' ' 101' ' ' THR . 0.0 OUTLIER -53.66 -33.35 54.99 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.553 1.158 . . . . 0.0 109.277 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.423 ' HD1' HG23 ' A' ' 102' ' ' VAL . 4.5 t90 -58.13 -65.04 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -73.09 -9.88 59.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' N ' HD23 ' A' ' 99' ' ' LEU . 3.5 tt -91.42 -18.83 23.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.735 HG21 ' HB2' ' A' ' 72' ' ' ALA . 68.6 p -105.61 -39.05 6.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.59 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 4.0 t -44.28 -55.03 10.55 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.658 0.742 . . . . 0.0 111.128 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.75 -23.25 31.07 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.677 2.252 . . . . 0.0 112.361 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.463 ' HB3' HG21 ' A' ' 68' ' ' VAL . 20.2 mt -75.83 -54.63 6.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.89 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.682 HG21 ' CB ' ' A' ' 126' ' ' LYS . 35.4 mm -57.65 -37.81 61.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.6 t -63.63 -56.37 16.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -51.68 -46.62 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.887 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -62.42 -43.62 98.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.598 ' CD2' HD23 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -63.44 -32.61 74.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -56.81 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.448 HD13 ' HB3' ' A' ' 61' ' ' SER . 5.5 tp -56.81 -40.3 70.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.098 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.135 HD12 HG13 ' A' ' 182' ' ' VAL . 3.2 mm? -70.82 -43.33 68.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 119' ' ' VAL . . . -70.51 -18.58 62.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.38 -16.36 45.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 182' ' ' VAL . . . -92.3 -14.37 28.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.079 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 174' ' ' ALA . 0.1 OUTLIER -126.28 -74.89 0.59 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.149 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.451 ' H ' HG23 ' A' ' 117' ' ' THR . 0.8 OUTLIER 176.78 -33.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.883 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.454 ' HA ' ' HB1' ' A' ' 114' ' ' ALA . 4.6 p -170.68 145.06 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.534 ' HB3' ' HD1' ' A' ' 110' ' ' TYR . . . -115.65 145.43 42.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.54 -5.04 82.1 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.469 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -39.09 23.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 110.825 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.598 HD23 ' CD2' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -51.5 -54.17 29.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.928 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.68 -47.85 84.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.586 ' NZ ' HD22 ' A' ' 166' ' ' LEU . 20.6 ttpt -52.09 -50.1 62.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.682 ' CB ' HG21 ' A' ' 106' ' ' ILE . 0.8 OUTLIER -66.28 -31.48 72.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 tt -62.61 -49.7 74.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mt -71.61 -59.64 2.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.952 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.798 HG21 ' HG3' ' A' ' 162' ' ' MET . 50.6 t -53.77 -49.39 58.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.111 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -61.57 -48.71 83.05 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 7.7 m -53.43 -44.13 68.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.872 0.367 . . . . 0.0 110.83 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.84 -48.12 72.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.728 HG23 ' O ' ' A' ' 129' ' ' VAL . 85.2 t -51.93 -54.41 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 4.4 ptt? -64.8 -38.14 89.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.9 OUTLIER -56.11 -58.52 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.931 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.78 HG11 ' CD1' ' A' ' 154' ' ' ILE . 65.7 t -62.03 -51.72 69.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.571 ' HB2' H162 ' A' ' 301' ' ' RET . 54.4 t80 -51.96 -37.18 52.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -70.72 -52.66 14.43 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -55.8 28.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.909 0.385 . . . . 0.0 110.926 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -32.57 74.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.62 -32.04 70.89 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.457 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -47.92 -32.86 6.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.72 -28.58 7.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 50.53 26.37 10.07 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.739 HD12 ' HB3' ' A' ' 146' ' ' MET . 2.2 pp -94.86 -34.9 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 111.096 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.739 ' HB3' HD12 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -146.74 142.45 27.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 171.73 -26.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.06 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 208' ' ' TYR . . . -57.72 -35.29 70.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.142 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.477 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -69.48 -61.46 3.18 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.574 0.702 . . . . 0.0 110.891 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.575 ' HA ' HD13 ' A' ' 153' ' ' ILE . 53.3 Cg_endo -69.79 -6.72 19.29 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.271 . . . . 0.0 112.303 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.752 ' HB1' ' H42' ' A' ' 301' ' ' RET . . . -65.78 -48.73 70.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -62.55 -38.29 89.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.575 HD13 ' HA ' ' A' ' 150' ' ' PRO . 4.2 mp -65.03 -65.86 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.78 ' CD1' HG11 ' A' ' 136' ' ' VAL . 5.3 pt -57.58 -38.05 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.27 -48.91 56.03 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.502 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.1 t -59.23 -44.02 92.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.75 -50.47 72.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.82 -36.89 84.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.139 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.565 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.0 OUTLIER -62.94 -55.45 25.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.967 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.565 HG23 ' CE3' ' A' ' 159' ' ' TRP . 82.5 t -58.41 -47.05 89.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.1 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -62.35 -46.17 89.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.798 ' HG3' HG21 ' A' ' 129' ' ' VAL . 9.3 tmm? -52.15 -58.66 5.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.595 HG12 HD11 ' A' ' 194' ' ' ILE . 2.8 mp -68.09 -32.05 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -53.49 -54.52 36.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -74.19 -40.2 62.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.586 HD22 ' NZ ' ' A' ' 125' ' ' LYS . 28.2 tp -61.64 -24.94 67.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.439 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -58.9 -25.32 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.928 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -115.74 18.72 15.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.07 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -108.82 -13.45 18.27 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.494 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -85.25 -46.92 10.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 110.888 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -82.93 -41.66 8.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.504 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -77.58 -7.32 56.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.333 . . . . 0.0 110.875 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.33 -54.13 23.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.622 ' HB2' ' HB ' ' A' ' 117' ' ' THR . . . -97.22 -66.66 0.89 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.087 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 78.1 m -123.02 -65.06 1.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -173.33 -36.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.9 t -112.04 -10.55 13.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.179 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.92 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.7 165.12 36.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.729 0.776 . . . . 0.0 110.827 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.57 16.4 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.3 54.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 1.135 HG13 HD12 ' A' ' 113' ' ' LEU . 96.7 t -70.42 -44.2 77.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -62.72 -39.94 95.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.96 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.9 t -68.18 -50.06 56.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.469 ' HA ' HG11 ' A' ' 241' ' ' VAL . . . -58.21 -39.99 80.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.097 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -45.1 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.896 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.68 -56.31 23.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 1.026 HG22 HD12 ' A' ' 237' ' ' ILE . 0.2 OUTLIER -58.67 -43.61 89.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -56.86 -47.42 80.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.828 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.494 ' SD ' HG23 ' A' ' 163' ' ' ILE . 35.7 ttp -65.42 -32.56 74.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -62.8 -51.27 67.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.445 HG13 HD12 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -66.63 -37.95 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.096 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 15.8 mm -60.2 -46.17 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.16 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.595 HD11 HG12 ' A' ' 163' ' ' ILE . 87.2 mt -65.57 -49.58 77.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.135 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -51.23 -58.96 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -60.4 -58.52 13.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.467 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -52.77 -31.09 36.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -81.18 -24.11 37.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.097 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 3.4 mm -74.26 -34.26 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 16.6 t80 -51.95 -55.57 29.43 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.663 0.744 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.1 Cg_endo -69.72 -28.99 24.79 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.711 2.274 . . . . 0.0 112.368 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 198' ' ' ALA . 38.9 t -72.5 -27.91 27.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.102 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 206' ' ' THR . . . -81.84 -46.75 6.57 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.509 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.09 -37.32 45.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -48.81 -28.21 3.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 203' ' ' GLY . 40.9 p -47.36 -30.54 3.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.147 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 134.08 49.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.474 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' ALA . 26.5 t80 -63.25 -15.97 58.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.932 0.396 . . . . 0.0 110.918 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.57 25.83 10.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -173.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.56 -25.31 49.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.508 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -98.93 18.81 16.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.859 0.361 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.91 41.02 51.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.483 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 92.6 107.56 1.72 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.519 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.0 m -60.69 125.2 22.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 1.054 ' HB1' HD11 ' A' ' 84' ' ' ILE . . . -51.09 -30.67 16.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.108 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.711 HD23 ' CD1' ' A' ' 28' ' ' TYR . 9.8 mp -61.82 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -63.29 -30.13 71.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.412 HD11 ' OH ' ' A' ' 208' ' ' TYR . 1.5 tt -60.6 -58.59 7.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -65.69 -37.32 86.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.913 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.488 ' C ' HD13 ' A' ' 221' ' ' LEU . 2.9 tm? -62.23 -55.87 24.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 48.1 mt -61.4 -47.64 92.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.114 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -59.8 -56.63 19.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -49.03 78.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 229' ' ' VAL . 6.4 tp -59.39 -39.2 82.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -63.54 -55.33 24.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -65.09 -28.12 69.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -70.97 -52.81 17.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 225' ' ' LEU . 17.7 m -72.06 -24.42 22.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.113 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -77.49 0.81 21.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-O 126.692 3.139 . . . . 0.0 110.84 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -133.21 -59.63 0.87 Allowed 'General case' 0 N--CA 1.423 -1.824 0 O-C-N 117.122 -3.486 . . . . 0.0 112.75 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.789 HD11 ' CE2' ' A' ' 73' ' ' PHE . 48.1 mm -58.08 -64.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.148 174.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.445 HD12 HG13 ' A' ' 192' ' ' ILE . 0.2 OUTLIER -52.13 -42.8 63.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.945 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -52.01 -58.45 6.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -58.58 -40.64 94.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.67 -44.06 81.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.858 0.361 . . . . 0.0 110.976 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 1.026 HD12 HG22 ' A' ' 188' ' ' THR . 0.9 OUTLIER -68.59 -48.18 73.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.149 179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 27.5 mm -54.34 -50.09 59.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.448 ' O ' HG23 ' A' ' 243' ' ' VAL . 4.9 m95 -72.02 -30.7 65.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -58.61 -53.74 54.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.469 HG11 ' HA ' ' A' ' 185' ' ' ALA . 7.3 p -75.52 -42.55 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 241' ' ' VAL . . . -60.21 -55.01 38.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.486 ' CG2' HG12 ' A' ' 54' ' ' VAL . 93.9 t -63.72 -48.31 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.141 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -35.44 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -71.6 -37.66 70.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.6 p -50.22 -40.8 48.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.93 -172.87 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.826 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.19 84.58 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -174.65 70.09 0.3 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.582 0.706 . . . . 0.0 111.134 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 89.53 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.648 2.232 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 155.03 164.19 12.78 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.464 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 CA-C-O 119.15 -0.806 . . . . 0.0 112.51 -179.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.752 ' H42' ' HB1' ' A' ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.041 0 CA-C-O 120.78 0.324 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.59 108.22 0.26 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.482 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.43 -48.16 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.515 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.06 78.99 0.11 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.491 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -174.59 63.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.362 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.86 170.19 20.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -177.11 2.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.863 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.624 ' HA ' HD22 ' A' ' 217' ' ' LEU . . . -73.88 -74.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.115 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m -51.97 -32.07 31.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.889 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.691 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -59.1 -58.44 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.836 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -48.33 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.7 m -49.87 -47.31 51.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.0 -50.54 39.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.49 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 27' ' ' ASP . 98.0 t -51.33 -55.77 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 0.0 111.169 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.701 ' O ' HG23 ' A' ' 36' ' ' VAL . 80.8 p -60.77 -48.31 82.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.2 -48.39 65.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 -46.22 88.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 26.4 tp -60.62 -38.19 83.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 32' ' ' SER . 85.5 t -65.94 -52.34 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 m -58.79 -54.24 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.35 -47.66 75.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.118 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.91 -51.57 69.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.588 HD13 ' HE2' ' A' ' 73' ' ' PHE . 7.8 tp -54.43 -42.43 70.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 45' ' ' VAL . 11.1 tp -67.36 -56.17 10.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.927 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.45 -39.14 64.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.0 m -69.89 -43.43 71.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 97.0 m -60.42 -49.06 79.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.153 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 49' ' ' VAL . 28.1 m -69.53 -36.1 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -64.14 -57.07 10.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.642 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 44.2 t80 -62.21 -45.88 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -54.14 -52.02 62.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 45' ' ' VAL . 88.6 t -70.9 -29.85 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -79.32 -6.21 56.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.599 ' O ' HG12 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -61.7 -27.39 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.79 -10.67 47.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.863 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.49 31.87 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.691 ' HA ' HG22 ' A' ' 243' ' ' VAL . 14.4 p -120.82 154.02 24.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.1 142.06 2.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.83 74.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -23.86 61.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.835 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.624 ' HB3' HD23 ' A' ' 62' ' ' LEU . 26.2 m95 -88.6 6.56 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.953 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -53.57 -50.13 66.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -75.25 -33.53 61.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.5 ' N ' HG21 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -63.92 -40.52 96.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.866 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.642 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 3.7 mm? -77.0 -26.75 54.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.6 m -70.93 -49.91 40.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.14 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 60' ' ' THR . 30.6 m -73.59 -45.17 51.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 9.2 t -70.47 -39.32 74.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.17 -43.25 64.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 39.7 mt -66.38 -51.06 60.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.857 0.361 . . . . 0.0 110.899 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.4 HG11 ' N ' ' A' ' 105' ' ' LEU . 75.3 t -61.22 -51.9 67.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.106 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 94.8 m -63.66 -37.55 87.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.146 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.22 -37.05 93.58 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 27.4 mt -71.6 -45.89 65.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.885 0.374 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB2' ' HB ' ' A' ' 101' ' ' THR . . . -60.72 -43.23 98.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.098 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.732 ' CE2' HD11 ' A' ' 232' ' ' ILE . 43.6 t80 -64.97 -57.08 9.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -55.02 -51.89 64.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -60.22 -42.07 94.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.876 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -57.96 -71.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 1.3 ttp -52.26 -32.16 35.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -57.66 -68.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.913 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.455 ' HA ' HG12 ' A' ' 82' ' ' VAL . 21.2 mtt -74.81 -58.28 3.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -39.81 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.891 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 84' ' ' ILE . . . -74.91 -57.51 4.41 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' A' ' 79' ' ' MET . 5.8 p -53.72 -35.55 27.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 0.0 111.172 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.66 -58.75 3.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 220' ' ' ASN . 8.3 tp -54.52 -26.89 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.29 -20.92 58.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.3 p -103.28 -38.24 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.155 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.19 -86.9 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.453 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -81.71 -175.11 5.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 110.872 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.99 161.88 37.88 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.708 0.766 . . . . 0.0 110.847 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 84.44 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.66 2.24 . . . . 0.0 112.364 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 t -60.07 -37.61 80.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.162 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -69.91 -52.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.22 -51.05 69.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -34.38 74.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -63.11 -57.86 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.6 mt -68.5 -30.38 47.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.127 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.678 ' O ' HG23 ' A' ' 101' ' ' THR . 5.1 t70 -63.6 -66.83 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 1.127 . . . . 0.0 109.311 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.37 -31.6 63.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.919 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD22 ' SD ' ' A' ' 134' ' ' MET . 30.5 tp -77.23 -21.83 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.446 ' O ' HD23 ' A' ' 104' ' ' LEU . 3.9 tt -99.47 -16.38 18.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.678 HG23 ' O ' ' A' ' 97' ' ' ASP . 40.9 p -98.35 -32.6 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.499 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.1 t -57.55 -59.33 13.27 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.619 0.723 . . . . 0.0 111.114 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.76 -19.85 35.61 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.704 2.269 . . . . 0.0 112.375 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 100' ' ' LEU . 2.2 mm? -79.42 -51.98 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.94 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 101' ' ' THR . 3.7 pp -67.43 -40.82 85.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 126' ' ' LYS . 24.8 mm -66.66 -49.88 70.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.26 -40.83 97.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' OE2' HD13 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.14 -59.71 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -51.11 -50.84 58.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -64.41 -37.1 86.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.918 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.0 mt -55.7 -63.87 1.03 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.937 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.5 HG21 ' N ' ' A' ' 61' ' ' SER . 48.7 mm -57.9 -44.69 87.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.194 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.749 HD21 HG13 ' A' ' 182' ' ' VAL . 2.8 tm? -55.92 -47.28 77.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 120' ' ' ALA . . . -77.22 -15.68 59.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.129 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 112' ' ' ILE . . . -55.37 -20.17 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.87 -26.63 15.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.088 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.2 t -123.48 -45.61 2.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.717 ' OD1' HG22 ' A' ' 119' ' ' VAL . 3.4 t-20 179.91 -76.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.717 HG22 ' OD1' ' A' ' 118' ' ' ASN . 18.3 m -151.56 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.156 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . . . -127.08 151.64 48.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.059 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.35 -2.47 73.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.482 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.21 -31.37 5.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.887 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -55.79 -40.52 72.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.05 -49.93 25.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.588 ' CG ' HD13 ' A' ' 166' ' ' LEU . 3.9 mptt -58.22 -51.74 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.581 ' HB2' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -62.67 -35.68 80.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.912 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 tp -62.25 -47.03 86.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.932 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.62 -58.72 4.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 133' ' ' VAL . 6.0 m -55.31 -36.05 38.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.112 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -67.92 -45.57 72.73 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.472 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 43.5 t -63.01 -39.09 93.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.861 0.362 . . . . 0.0 110.828 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -53.85 37.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 129' ' ' VAL . 59.6 t -56.68 -43.44 79.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.169 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.474 ' SD ' HD22 ' A' ' 99' ' ' LEU . 0.2 OUTLIER -67.04 -36.4 82.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.86 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 136' ' ' VAL . 0.1 OUTLIER -61.4 -47.24 86.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.868 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.61 ' N ' HD23 ' A' ' 135' ' ' LEU . 45.3 t -67.02 -48.77 78.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.466 ' HB2' H162 ' A' ' 301' ' ' RET . 8.9 t80 -58.32 -41.08 83.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -74.01 -51.67 8.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.53 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -53.13 -57.32 10.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 0.0 110.899 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 12.8 mmt -68.34 -46.13 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -55.13 -30.81 55.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.549 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -45.57 -36.56 4.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.911 0.386 . . . . 0.0 110.879 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -111.95 -27.45 8.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.084 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 48.09 27.37 5.16 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.488 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.6 tp -104.71 -37.08 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.856 0.36 . . . . 0.0 111.15 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.692 ' HE2' ' HB2' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -128.31 -168.73 1.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.779 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 79.28 0.42 2.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.114 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.594 ' HB1' ' CD1' ' A' ' 208' ' ' TYR . . . -70.41 -42.61 71.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.555 ' N ' ' HD2' ' A' ' 150' ' ' PRO . 0.1 OUTLIER -70.11 -57.05 6.46 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.536 0.684 . . . . 0.0 110.93 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.883 ' HA ' HD12 ' A' ' 153' ' ' ILE . 53.7 Cg_endo -69.77 -7.3 20.71 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.717 2.278 . . . . 0.0 112.338 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.779 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -57.98 -48.0 81.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.49 -39.25 91.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 150' ' ' PRO . 7.6 mt -66.83 -58.93 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -35.25 68.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.06 -49.31 16.78 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.475 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 35.7 t -57.36 -50.63 72.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.829 0.347 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -50.11 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -61.43 -40.58 94.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.592 ' CD1' HD13 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -61.55 -55.68 28.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.539 HG23 ' CE3' ' A' ' 159' ' ' TRP . 73.3 t -53.5 -48.07 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.66 -39.78 92.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.642 ' HG2' HG12 ' A' ' 129' ' ' VAL . 27.8 mtt -58.62 -58.22 9.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 159' ' ' TRP . 2.3 mp -67.24 -30.88 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -58.26 -54.68 44.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.954 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.74 -33.72 62.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.902 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.588 HD13 ' CG ' ' A' ' 125' ' ' LYS . 21.5 tp -74.63 -13.99 60.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.435 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.6 OUTLIER -56.47 -21.22 24.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -101.85 21.62 14.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -38.4 137.71 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.497 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -72.31 -5.0 33.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.901 0.382 . . . . 0.0 110.872 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -50.08 -41.42 37.92 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.51 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -77.69 -36.31 51.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.807 0.337 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 1.1 p -68.55 -25.14 64.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.28 -30.96 12.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 -8.78 13.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 75.06 -59.34 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.871 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 -8.52 30.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.157 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 47.73 -166.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.63 162.73 51.44 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.659 0.742 . . . . 0.0 110.854 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -30.83 21.52 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.676 2.251 . . . . 0.0 112.321 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.5 -47.53 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.115 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.749 HG13 HD21 ' A' ' 113' ' ' LEU . 84.6 t -67.31 -44.6 87.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.01 -38.03 89.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.8 t -66.62 -49.26 66.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.476 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.78 -42.2 99.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.29 -51.66 68.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.923 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -57.4 -54.71 43.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 31.9 m -55.33 -36.51 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.174 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.402 ' HA ' ' HE2' ' A' ' 189' ' ' MET . 0.0 OUTLIER -63.71 -51.92 62.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 2.5 ttp -59.8 -37.53 79.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.04 -49.53 74.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.919 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -69.34 -53.45 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.14 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.2 mt -49.78 -50.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.543 HG23 ' NE1' ' A' ' 159' ' ' TRP . 91.3 mt -62.44 -49.79 82.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.644 ' O ' HG23 ' A' ' 199' ' ' ILE . 50.6 t80 -53.21 -48.86 67.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.422 ' HA2' HG12 ' A' ' 199' ' ' ILE . . . -62.06 -49.58 73.74 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.475 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -62.61 -28.43 69.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.808 0.337 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.84 -45.04 19.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 195' ' ' PHE . 21.0 pt -71.85 -29.46 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 1.7 t80 -45.59 -59.36 4.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.9 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.662 2.241 . . . . 0.0 112.343 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 198' ' ' ALA . 74.3 t -68.38 -43.88 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.142 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.67 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.99 -41.32 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.507 ' HA ' HG21 ' A' ' 222' ' ' ILE . 3.3 t80 -59.49 -24.57 63.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.951 0.405 . . . . 0.0 110.899 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 70.6 t80 -54.47 -33.2 59.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.67 HG22 ' O ' ' A' ' 203' ' ' GLY . 6.2 t -66.26 -13.75 60.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -125.38 -4.79 6.85 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.594 ' CD1' ' HB1' ' A' ' 148' ' ' ALA . 0.2 OUTLIER -64.99 -51.22 62.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.917 0.389 . . . . 0.0 110.937 -179.824 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.88 -54.49 2.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.965 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.17 -168.59 1.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 166.05 42.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 51.7 31.44 7.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 110.879 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 102.16 23.55 9.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.488 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 68.13 84.4 0.12 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.35 122.15 45.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.832 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.13 -29.33 70.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -59.8 -52.1 66.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.69 -35.8 81.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.54 -58.63 7.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.441 ' HB2' HG23 ' A' ' 84' ' ' ILE . 1.2 p-10 -63.74 -35.99 82.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.531 HD22 ' O ' ' A' ' 221' ' ' LEU . 1.3 tm? -63.07 -54.23 41.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.936 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 204' ' ' TYR . 23.3 mt -59.48 -48.13 88.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.155 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . 0.486 ' HD2' ' HH ' ' A' ' 204' ' ' TYR . 0.2 OUTLIER -62.14 -57.63 10.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -55.33 -39.86 70.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 229' ' ' VAL . 22.2 tp -62.83 -47.75 82.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.28 -55.23 37.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.069 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.18 -36.49 83.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -61.43 -40.8 95.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.836 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 225' ' ' LEU . 94.0 t -72.37 -42.66 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.133 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -72.78 -5.08 35.52 Favored 'General case' 0 C--O 1.207 -1.14 0 CA-C-O 126.718 3.151 . . . . 0.0 110.896 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -113.05 -27.07 8.18 Favored 'General case' 0 N--CA 1.424 -1.761 0 O-C-N 117.119 -3.488 . . . . 0.0 112.773 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 73' ' ' PHE . 31.8 mm -91.63 -63.44 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.14 174.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.413 ' HA ' HD12 ' A' ' 233' ' ' LEU . 6.4 tp -49.08 -31.55 8.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.531 ' CZ ' HD11 ' A' ' 238' ' ' ILE . 71.6 t80 -57.52 -56.71 18.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -67.95 -39.76 89.16 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.8 tp -62.97 -38.97 93.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . . . . . . . . . 2.7 mm -70.59 -47.43 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.531 HD11 ' CZ ' ' A' ' 234' ' ' PHE . 24.3 mt -55.48 -49.25 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.669 ' O ' HG23 ' A' ' 243' ' ' VAL . 3.4 t90 -69.85 -38.21 76.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.934 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -58.42 -53.85 53.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 185' ' ' ALA . 14.7 p -65.15 -37.13 79.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.27 77.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.691 HG22 ' HA ' ' A' ' 54' ' ' VAL . 98.9 t -81.27 -41.49 19.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.116 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -63.24 -39.57 94.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -77.52 -48.34 17.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 10.3 t -52.39 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 8.3 t 57.22 43.41 23.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -129.71 -176.59 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.81 ' HB3' ' HD3' ' A' ' 250' ' ' PRO . . . -179.08 -61.41 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.602 0.715 . . . . 0.0 111.074 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.81 ' HD3' ' HB3' ' A' ' 249' ' ' ALA . 53.4 Cg_endo -69.78 111.44 2.81 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.689 2.259 . . . . 0.0 112.352 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 153.26 154.34 6.7 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 CA-C-O 119.187 -0.785 . . . . 0.0 112.54 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.494 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.7 ttp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.853 0.359 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 52.61 -158.57 3.53 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.483 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.46 -121.62 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.25 41.09 22.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.473 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.99 117.74 1.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 0.0 110.866 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 mp -125.13 139.04 54.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -63.01 157.89 20.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.623 ' HA ' HD11 ' A' ' 217' ' ' LEU . . . -55.04 -61.72 2.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -31.06 61.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.834 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -66.44 -68.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.779 ' HB3' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -49.71 -52.07 34.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 25' ' ' ALA . 5.6 t -61.82 -31.87 72.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.134 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -70.23 -55.51 8.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 32' ' ' SER . 15.4 m -57.0 -44.35 82.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.148 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 36' ' ' VAL . 35.0 t -64.37 -46.94 81.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -56.91 -40.14 75.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.52 -47.5 69.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -43.98 97.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 32' ' ' SER . 93.2 t -63.2 -43.99 99.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.162 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.5 m -61.59 -42.66 99.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.13 64.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.45 -51.9 67.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 232' ' ' ILE . 3.1 tm? -57.42 -39.03 75.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.939 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.595 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.5 tm? -61.19 -55.57 30.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.948 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.81 75.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.103 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.24 -50.66 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.7 p -61.39 -40.4 94.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 41' ' ' LEU . 74.2 t -64.48 -48.05 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -66.92 -46.35 75.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 62' ' ' LEU . 38.8 t80 -65.18 -28.72 69.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -74.66 -45.5 44.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 45' ' ' VAL . 61.1 t -73.55 -42.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.147 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -80.01 -4.01 50.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -26.38 62.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -102.03 -3.98 26.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.07 42.57 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.792 ' HA ' HG22 ' A' ' 243' ' ' VAL . 3.5 m -115.01 -170.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.154 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.1 t -66.27 152.94 43.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.833 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.09 -44.62 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -27.81 64.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.471 ' CZ3' HG23 ' A' ' 238' ' ' ILE . 58.3 m95 -91.69 1.6 57.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.964 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.29 -51.11 47.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.473 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -77.56 -31.29 53.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.13 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 112' ' ' ILE . 5.4 p -55.29 -43.58 74.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.865 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.606 HD12 ' CZ ' ' A' ' 47' ' ' PHE . 4.2 mm? -67.37 -29.67 69.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.21 -54.82 7.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.197 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.515 HG23 ' N ' ' A' ' 65' ' ' SER . 15.5 m -62.91 -50.1 80.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.515 ' N ' HG23 ' A' ' 64' ' ' VAL . 1.1 p -70.12 -35.56 74.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.868 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.4 84.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.531 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.27 -47.92 59.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.0 t -62.54 -55.24 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.2 m -65.13 -37.52 87.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.42 -43.29 99.26 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.478 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.51 -42.99 72.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.83 0.348 . . . . 0.0 111.172 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.569 ' CB ' HG21 ' A' ' 101' ' ' THR . . . -58.41 -47.89 82.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.064 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -63.98 -54.56 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.893 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -52.82 -51.19 61.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -63.92 -59.33 4.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -49.0 -62.93 1.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.906 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.61 -38.31 54.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.536 ' O ' HG23 ' A' ' 82' ' ' VAL . 29.6 t80 -65.21 -70.77 0.21 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.922 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -59.67 4.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.886 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.478 HH21 HD11 ' A' ' 84' ' ' ILE . 2.1 tpm_? -53.47 -55.95 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -52.94 -54.6 27.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 78' ' ' TYR . 69.0 t -56.59 -54.86 23.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.792 0.329 . . . . 0.0 111.156 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -54.18 -55.67 25.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.478 HD11 HH21 ' A' ' 80' ' ' ARG . 41.6 mm -59.7 -26.52 35.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -21.28 50.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.28 -38.33 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 127.08 31.32 0.75 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.52 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -98.77 -176.17 3.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.827 0.346 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.1 p -146.12 77.51 11.88 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.663 0.744 . . . . 0.0 110.86 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 72.55 1.44 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.673 2.249 . . . . 0.0 112.328 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 t -69.87 -41.39 74.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.093 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 93' ' ' PHE . 4.7 m -54.56 -52.43 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.124 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.502 ' H ' HG23 ' A' ' 92' ' ' VAL . 34.5 m-85 -71.1 -44.61 65.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -55.46 -58.5 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.82 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.19 -40.22 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 97' ' ' ASP . 21.6 mt -59.05 -63.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.15 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.504 ' O ' HG23 ' A' ' 101' ' ' THR . 18.6 t70 -59.02 -33.29 70.57 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.567 ' HE1' HG12 ' A' ' 133' ' ' VAL . 17.4 t-105 -60.58 -58.72 7.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.997 -1.002 . . . . 0.0 110.899 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 99' ' ' LEU . 2.5 tm? -75.07 -11.99 60.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.527 ' O ' HD23 ' A' ' 100' ' ' LEU . 9.3 tt -90.96 -21.04 21.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.919 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.569 HG21 ' CB ' ' A' ' 72' ' ' ALA . 65.1 p -107.81 -34.36 6.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.134 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 103' ' ' PRO . 2.3 t -47.57 -60.12 4.61 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.642 0.734 . . . . 0.0 111.147 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 102' ' ' VAL . 53.7 Cg_endo -69.69 -30.46 22.54 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.704 2.27 . . . . 0.0 112.374 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 100' ' ' LEU . 3.1 mm? -64.88 -55.55 18.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 pp -65.48 -43.01 91.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 21.4 mm -62.36 -50.64 79.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.107 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 16.3 t -64.41 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -65.27 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -51.42 -50.21 60.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.48 -37.46 81.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.17 -66.47 0.53 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.956 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' N ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -50.75 -37.53 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.132 179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.969 HD21 HG13 ' A' ' 182' ' ' VAL . 3.3 tm? -69.36 -39.82 77.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.43 -14.27 59.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.43 -14.67 13.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.02 -24.89 68.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.115 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -120.42 -70.16 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.152 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 117' ' ' THR . 2.1 m-20 165.24 -77.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 p -48.46 138.7 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.141 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.02 96.94 4.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.99 85.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.49 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.0 p -48.78 -35.85 15.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.921 0.391 . . . . 0.0 110.873 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.2 mp -49.48 -42.64 43.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.906 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -68.26 -53.68 22.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.15 -52.09 64.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 -36.14 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.9 tp -67.31 -50.52 59.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.5 -60.13 2.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 133' ' ' VAL . 89.9 t -56.58 -47.12 82.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.25 98.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.4 m -66.53 -55.26 16.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -53.81 43.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.933 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 129' ' ' VAL . 64.2 t -57.55 -45.09 86.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.135 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -61.92 -42.04 98.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 136' ' ' VAL . 2.1 tt -60.55 -57.82 11.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.627 ' CG1' HD12 ' A' ' 154' ' ' ILE . 48.5 t -52.67 -52.93 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.134 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -40.78 68.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -64.37 -51.46 52.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.52 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -60.44 -56.83 16.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.92 0.39 . . . . 0.0 110.937 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.31 -34.62 68.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.874 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.91 -29.19 59.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -39.79 -48.88 2.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.863 0.363 . . . . 0.0 110.885 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.403 ' HB1' HG13 ' A' ' 145' ' ' ILE . . . -111.66 -28.95 7.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 58.78 17.02 33.29 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.403 HG13 ' HB1' ' A' ' 143' ' ' ALA . 12.9 mt -93.54 -55.1 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.123 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.496 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -111.45 138.35 48.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.9 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 174.07 -27.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -53.63 -31.64 48.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.094 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.506 ' CB ' ' CD ' ' A' ' 150' ' ' PRO . 0.0 OUTLIER -74.54 -63.07 0.85 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.544 0.688 . . . . 0.0 110.881 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.506 ' CD ' ' CB ' ' A' ' 149' ' ' TRP . 53.6 Cg_endo -69.71 -6.16 17.91 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.716 2.277 . . . . 0.0 112.342 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -62.75 -49.63 74.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -69.95 -31.13 68.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' A' ' 150' ' ' PRO . 3.4 mp -68.99 -61.81 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.627 HD12 ' CG1' ' A' ' 136' ' ' VAL . 1.3 pt -62.71 -38.96 83.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.194 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.84 -43.43 93.92 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.489 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 41.9 t -64.94 -48.23 74.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.897 0.379 . . . . 0.0 110.863 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.26 -50.29 71.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -67.42 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.428 ' CE3' HG23 ' A' ' 160' ' ' VAL . 1.4 t90 -66.64 -57.89 6.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.428 HG23 ' CE3' ' A' ' 159' ' ' TRP . 59.8 t -61.36 -41.11 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -66.79 -47.09 73.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -52.23 -52.59 51.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.887 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.679 HG22 ' CE3' ' A' ' 167' ' ' TRP . 48.9 mt -63.13 -53.07 50.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.17 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -47.39 -35.59 8.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -74.96 -49.53 19.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.38 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.933 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.679 ' CE3' HG22 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -72.6 -16.39 61.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -116.69 18.42 14.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.53 13.34 6.94 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -84.61 -47.37 10.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.874 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -84.78 -41.45 7.68 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.496 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.8 mtpp -77.33 -6.6 53.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.805 0.336 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -52.95 25.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 117' ' ' THR . . . -96.64 -66.68 0.89 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.093 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 7.6 m -123.21 -65.09 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -168.04 -38.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.74 1.16 17.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.188 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . 48.34 -167.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 180' ' ' PRO . 0.1 OUTLIER -110.67 166.42 10.79 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.64 0.734 . . . . 0.0 110.849 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 179' ' ' SER . 53.9 Cg_endo -69.74 -36.79 10.21 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.702 2.268 . . . . 0.0 112.364 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -76.79 -43.68 35.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.087 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.969 HG13 HD21 ' A' ' 113' ' ' LEU . 76.6 t -68.02 -46.08 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -63.01 -36.47 83.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.0 m -68.67 -47.24 67.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.575 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -62.54 -39.89 95.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -43.77 78.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.96 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -60.05 -49.35 78.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 2.6 m -65.16 -38.66 91.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 238' ' ' ILE . 0.0 OUTLIER -64.22 -42.31 96.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 3.9 ttp -71.7 -34.97 70.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -63.97 -50.89 66.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.72 HG21 ' CD1' ' A' ' 237' ' ' ILE . 2.2 pp -70.86 -38.33 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 8.1 mm -64.1 -47.56 89.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.094 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.517 HD13 HD13 ' A' ' 163' ' ' ILE . 62.3 mt -64.41 -52.95 48.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -52.34 -54.51 30.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.04 21.87 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -53.95 -36.32 62.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 110.889 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.667 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -78.67 -20.81 49.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 14.8 mt -82.01 -31.86 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.158 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.616 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -48.35 -54.09 28.84 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.666 0.746 . . . . 0.0 110.899 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 54.2 Cg_endo -69.7 -20.86 34.56 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.681 2.254 . . . . 0.0 112.328 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 198' ' ' ALA . 76.7 t -72.83 -43.88 59.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.425 ' O ' HG22 ' A' ' 206' ' ' THR . . . -80.57 -38.27 17.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.516 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.708 ' CD2' HG21 ' A' ' 222' ' ' ILE . 0.6 OUTLIER -52.39 -29.36 23.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.937 0.399 . . . . 0.0 110.936 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -49.0 -30.75 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 203' ' ' GLY . 15.2 t -51.16 -24.64 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.184 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -156.1 22.24 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -46.39 -36.99 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.895 0.379 . . . . 0.0 110.915 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.75 -37.48 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.882 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 1.4 ttp -60.12 -171.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 67.22 40.93 92.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.464 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 57.52 26.35 12.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.832 0.348 . . . . 0.0 110.857 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 100.78 24.42 9.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.443 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 109.75 102.32 2.72 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.502 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.25 135.72 44.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 0.0 110.879 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.65 -36.79 69.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.111 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 28' ' ' TYR . 17.0 mt -62.53 -63.32 1.26 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -57.39 -43.25 83.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.57 -45.27 81.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -65.31 -44.66 87.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.98 -53.63 52.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.708 HG21 ' CD2' ' A' ' 204' ' ' TYR . 36.3 mm -57.15 -45.75 84.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -63.95 -54.64 31.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.37 -47.61 78.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -50.48 71.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.68 -54.95 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -27.92 69.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -67.88 -56.43 9.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 35.4 m -70.48 -24.95 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -80.4 2.78 23.63 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-O 126.68 3.133 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -131.18 -51.22 1.02 Allowed 'General case' 0 N--CA 1.423 -1.789 0 O-C-N 117.158 -3.464 . . . . 0.0 112.753 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.516 HD11 HD23 ' A' ' 40' ' ' LEU . 1.9 mp -63.83 -63.67 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 113.198 -1.819 . . . . 0.0 111.12 174.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.402 ' N ' HG22 ' A' ' 232' ' ' ILE . 5.9 tp -48.99 -36.55 17.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -56.1 -56.72 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -66.39 -33.69 85.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.08 -41.32 86.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.796 0.331 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.72 ' CD1' HG21 ' A' ' 192' ' ' ILE . 19.6 mm -67.77 -50.01 64.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.524 HD11 ' SD ' ' A' ' 189' ' ' MET . 24.7 mm -63.67 -36.52 76.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.141 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 243' ' ' VAL . 24.8 t90 -74.1 -41.82 61.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.962 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -69.64 -40.98 76.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.889 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 185' ' ' ALA . 9.9 p -70.56 -36.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.21 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.138 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.792 HG22 ' HA ' ' A' ' 54' ' ' VAL . 47.5 t -66.3 -36.5 77.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.113 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -75.61 -50.6 15.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -58.54 -41.79 86.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 18.5 t -52.67 -54.51 32.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.14 -179.3 4.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.841 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -125.34 149.71 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 250' ' ' PRO . . . -137.05 160.46 65.97 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.613 0.72 . . . . 0.0 111.094 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 249' ' ' ALA . 53.5 Cg_endo -69.78 -35.17 13.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.324 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -139.12 93.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.459 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 CA-C-O 119.14 -0.811 . . . . 0.0 112.45 -179.957 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.513 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.1 mmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.816 0.341 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.4 174.9 21.03 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.494 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -145.26 175.3 24.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.471 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.78 170.86 18.17 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.517 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.05 -72.1 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.782 0.325 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -142.56 103.68 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.82 163.53 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 29' ' ' THR . . . -67.39 -65.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.43 -30.91 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.839 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.97 -67.83 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.688 ' CD2' HD13 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -52.43 -44.04 65.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 -179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.88 HG22 HD11 ' A' ' 84' ' ' ILE . 34.7 p -60.13 -38.73 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -69.15 -54.56 13.18 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.481 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -55.93 -41.43 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.633 ' O ' HG23 ' A' ' 36' ' ' VAL . 52.8 m -66.44 -48.43 70.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -55.02 -42.59 72.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -47.85 68.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.34 -42.62 96.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.923 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.698 HG12 HD22 ' A' ' 40' ' ' LEU . 91.8 t -63.91 -50.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.098 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.6 m -55.36 -43.39 75.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.142 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.33 -52.04 63.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.93 -54.34 47.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.085 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.698 HD22 HG12 ' A' ' 36' ' ' VAL . 4.1 mp -51.16 -52.84 40.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.5 tp -54.27 -48.64 70.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.938 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.48 -36.02 73.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.097 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.696 ' OG ' HD12 ' A' ' 232' ' ' ILE . 6.3 p -70.88 -34.93 72.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.2 m -70.78 -45.08 65.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.152 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' VAL . 17.9 m -65.87 -42.83 92.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' N ' HG23 ' A' ' 45' ' ' VAL . 1.5 m-85 -68.74 -48.62 63.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.85 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -64.6 -29.87 70.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -74.95 -50.36 16.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.848 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 45' ' ' VAL . 94.0 t -65.73 -41.03 89.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.162 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -79.73 -6.22 56.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.88 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.486 ' CG ' HD22 ' A' ' 62' ' ' LEU . 12.0 ttt180 -57.4 -26.67 61.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.909 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -93.22 -10.71 34.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 243' ' ' VAL . 1.3 tpt180 -100.63 28.78 4.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.041 HG11 HD11 ' A' ' 62' ' ' LEU . 9.4 p -107.98 161.11 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.439 ' N ' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -48.79 149.93 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.87 -55.88 9.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.083 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.58 -23.86 59.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.744 ' CZ3' HD11 ' A' ' 238' ' ' ILE . 59.9 m95 -90.43 11.64 20.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.937 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -62.25 -50.46 71.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.27 -34.26 73.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.179 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.53 -43.2 62.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.041 HD11 HG11 ' A' ' 54' ' ' VAL . 2.6 mp -65.18 -29.53 70.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.4 m -70.14 -54.53 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.157 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.662 ' O ' HG12 ' A' ' 68' ' ' VAL . 12.6 m -69.62 -49.29 60.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.482 ' N ' HG23 ' A' ' 64' ' ' VAL . 2.5 p -67.12 -36.87 82.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.857 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.67 -36.79 83.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.535 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 tp -70.58 -49.97 42.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.839 0.352 . . . . 0.0 110.906 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 64' ' ' VAL . 6.4 p -66.08 -46.32 88.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.481 ' N ' HG13 ' A' ' 68' ' ' VAL . 52.3 m -71.51 -29.95 65.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.04 -52.01 30.58 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.497 HD13 ' O ' ' A' ' 71' ' ' ILE . 0.3 OUTLIER -68.69 -37.19 77.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.1 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HB2' HG21 ' A' ' 101' ' ' THR . . . -68.54 -42.09 78.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.119 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.75 -56.59 16.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.831 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 16.9 t90 -56.28 -50.21 72.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.92 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -60.78 -62.6 1.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -49.84 -51.27 41.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -53.69 27.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.845 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.592 ' O ' HG23 ' A' ' 82' ' ' VAL . 4.7 m-85 -56.78 -46.21 81.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -57.12 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -50.44 -56.59 10.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.869 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -48.69 58.92 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 78' ' ' TYR . 93.6 t -62.29 -28.12 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.818 0.342 . . . . 0.0 111.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -70.29 -47.32 61.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.88 HD11 HG22 ' A' ' 29' ' ' THR . 1.6 tt -73.35 -24.96 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -46.32 -47.78 18.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.8 p -122.5 -39.23 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.108 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.21 -23.33 4.63 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.473 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -122.7 129.12 51.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.79 0.329 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.2 161.03 40.87 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.641 0.734 . . . . 0.0 110.878 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 104.07 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.713 2.275 . . . . 0.0 112.345 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -26.41 64.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.0 m -51.38 -41.29 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.093 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -65.83 -52.03 53.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -60.03 -37.72 80.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.08 -48.78 74.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.909 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.64 -50.25 80.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.114 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 101' ' ' THR . 3.9 t70 -62.85 -39.69 95.15 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.483 1.114 . . . . 0.0 109.311 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TRP . . . . . 0.403 ' O ' HG23 ' A' ' 102' ' ' VAL . 18.1 t-105 -61.03 -49.45 77.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.917 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.451 HD12 ' CG ' ' A' ' 134' ' ' MET . 1.0 OUTLIER -75.55 -16.53 60.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.908 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.613 ' O ' HD12 ' A' ' 104' ' ' LEU . 2.7 tt -94.02 -14.74 25.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.607 HG21 ' HB2' ' A' ' 72' ' ' ALA . 72.6 p -108.17 -29.48 8.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 2.2 t -54.88 -59.64 10.13 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.634 0.73 . . . . 0.0 111.075 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 102' ' ' VAL . 53.5 Cg_endo -69.71 -35.55 12.57 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.715 2.277 . . . . 0.0 112.315 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 100' ' ' LEU . 6.2 mt -65.4 -52.34 54.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 106' ' ' ILE . 1.5 tt -60.63 -50.57 73.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.946 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.574 ' N ' HD23 ' A' ' 105' ' ' LEU . 27.4 mm -57.69 -58.64 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.111 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 42.2 t -58.98 -33.2 70.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.97 -68.22 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -50.5 -50.72 52.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.873 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -57.35 -43.98 83.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 mt -56.25 -66.71 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.76 -31.73 10.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 113' ' ' LEU . 2.9 tm? -71.65 -42.09 67.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.2 -14.37 59.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.52 -17.31 5.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.111 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.41 -24.05 64.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.094 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -121.87 -69.17 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.149 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.416 ' CB ' ' O ' ' A' ' 117' ' ' THR . 1.7 m-20 165.77 -76.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.2 p -47.23 135.01 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -128.11 98.27 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.6 -2.29 74.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -47.87 -33.5 7.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 mt -48.26 -43.38 32.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -71.38 -53.26 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 129' ' ' VAL . 0.0 OUTLIER -52.91 -52.27 58.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -37.34 86.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.81 -50.85 67.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -59.76 2.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.66 ' O ' HG23 ' A' ' 133' ' ' VAL . 67.5 t -53.03 -49.56 49.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.127 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -59.48 -51.3 59.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.516 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 16.1 t -52.49 -57.21 10.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.859 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.8 -53.04 44.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.957 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 129' ' ' VAL . 98.6 t -56.53 -44.56 80.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.111 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.451 ' CG ' HD12 ' A' ' 99' ' ' LEU . 14.8 mtt -64.25 -38.14 89.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.887 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.8 tt -61.3 -58.72 7.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 154' ' ' ILE . 15.6 m -57.14 -43.0 80.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -56.62 -47.3 79.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.55 -52.23 47.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -58.71 -55.21 37.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 110.92 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' MET . . . . . 0.52 ' HE2' H173 ' A' ' 301' ' ' RET . 4.9 tmm? -58.37 -32.52 68.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -75.3 -30.18 59.07 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -41.61 -52.8 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.892 0.377 . . . . 0.0 110.886 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -112.18 -28.48 7.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.057 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 60.73 16.95 48.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.5 pt -100.58 -37.27 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.793 0.33 . . . . 0.0 111.117 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.559 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -112.63 139.82 47.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 151' ' ' ALA . . . 170.4 -14.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.079 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 208' ' ' TYR . . . -65.36 -38.84 91.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.104 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.579 ' CH2' HD21 ' A' ' 209' ' ' LEU . 1.7 m95 -69.12 -55.83 9.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.687 . . . . 0.0 110.882 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.71 ' HA ' HD12 ' A' ' 153' ' ' ILE . 54.4 Cg_endo -69.76 -16.88 37.77 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.733 2.289 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 147' ' ' ALA . . . -52.52 -53.21 49.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -77.7 -28.49 51.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 150' ' ' PRO . 46.0 mt -66.88 -64.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.073 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 136' ' ' VAL . 1.1 pt -63.29 -36.39 75.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.132 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.1 93.27 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.444 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.451 ' O ' HG23 ' A' ' 160' ' ' VAL . 43.6 t -63.65 -46.77 84.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.847 0.356 . . . . 0.0 110.903 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -59.71 -47.35 86.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.65 91.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.108 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . 0.629 ' NE1' HD11 ' A' ' 163' ' ' ILE . 11.0 t90 -61.06 -55.82 28.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 156' ' ' CYS . 43.5 t -58.88 -46.85 90.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.41 -43.28 99.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.698 ' O ' HD12 ' A' ' 166' ' ' LEU . 1.9 mmm -57.35 -49.32 76.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.883 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.629 HD11 ' NE1' ' A' ' 159' ' ' TRP . 81.5 mt -63.59 -52.65 54.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.125 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -36.5 38.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -74.68 -58.76 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.853 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.698 HD12 ' O ' ' A' ' 162' ' ' MET . 0.5 OUTLIER -55.14 -55.77 27.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.433 ' HE3' HG23 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -56.14 -22.05 26.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -111.04 18.47 19.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.089 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -87.09 -155.23 27.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.473 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.35 -17.76 64.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 0.0 110.941 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -52.37 -31.23 34.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -49.59 73.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 12.9 t -77.95 -25.69 48.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' A' ' 178' ' ' ALA . . . -55.45 -23.55 26.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.153 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 18.6 p -52.25 -26.88 12.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -126.18 -33.47 2.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.1 p -89.65 12.7 16.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.605 ' HB3' ' HB1' ' A' ' 174' ' ' ALA . . . -145.68 -167.18 2.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.119 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.52 162.32 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.664 0.745 . . . . 0.0 110.898 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -28.57 25.19 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.304 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -75.32 -41.44 56.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.046 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 113' ' ' LEU . 98.6 t -63.8 -43.32 97.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.131 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.49 -32.59 72.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 3.7 t -69.8 -45.14 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.831 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.59 ' HA ' HG21 ' A' ' 241' ' ' VAL . . . -68.45 -40.8 80.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.091 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.537 ' CZ ' HD23 ' A' ' 166' ' ' LEU . 32.8 t80 -64.96 -51.39 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.947 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -61.86 -56.23 21.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.856 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.6 m -53.02 -44.18 67.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -59.9 -52.38 65.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.879 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.656 ' HG3' HD13 ' A' ' 166' ' ' LEU . 3.5 tmm? -54.78 -39.34 68.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mm -72.93 -52.79 20.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.12 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 194' ' ' ILE . 9.5 tt -52.7 -45.95 49.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.118 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 190' ' ' MET . 21.5 pt -69.58 -38.12 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.139 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' PHE . . . . . 0.664 ' CE1' HD11 ' A' ' 199' ' ' ILE . 23.6 t80 -56.84 -58.32 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.897 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.97 -48.84 77.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.535 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -58.21 -33.11 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.795 0.331 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.68 ' O ' HG23 ' A' ' 202' ' ' VAL . . . -79.03 -25.2 43.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.15 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.664 HD11 ' CE1' ' A' ' 195' ' ' PHE . 24.6 mt -80.34 -31.11 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.138 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.599 ' N ' ' HD2' ' A' ' 201' ' ' PRO . 13.8 t80 -47.75 -54.5 22.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.693 0.758 . . . . 0.0 110.904 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 200' ' ' TYR . 53.5 Cg_endo -69.72 -23.13 31.32 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.695 2.263 . . . . 0.0 112.386 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 198' ' ' ALA . 73.9 t -69.56 -44.32 79.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.127 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.561 ' O ' HG22 ' A' ' 206' ' ' THR . . . -81.91 -35.11 22.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.472 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.421 ' HB2' HG21 ' A' ' 222' ' ' ILE . 11.7 t80 -52.7 -29.44 26.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -48.76 -30.28 5.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 203' ' ' GLY . 8.9 t -50.5 -28.07 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -153.21 21.7 0.76 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.639 ' CD2' ' HB1' ' A' ' 148' ' ' ALA . 1.1 p90 -54.53 -26.06 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.579 HD21 ' CH2' ' A' ' 149' ' ' TRP . 1.0 OUTLIER -127.06 -46.55 1.52 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.925 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 3.4 mtm -51.6 121.66 6.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -72.41 -43.88 43.95 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -63.23 -60.97 2.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.15 -32.95 83.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.482 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.509 ' O ' HD23 ' A' ' 219' ' ' LEU . . . -93.67 39.08 3.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.5 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 50.3 m -61.34 -179.9 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.23 -33.27 65.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.106 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 218' ' ' ASN . 1.0 OUTLIER -65.43 -51.77 57.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . 0.43 ' N ' HD12 ' A' ' 217' ' ' LEU . 2.0 t-20 -61.14 -41.56 96.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 214' ' ' GLY . 1.0 OUTLIER -60.15 -58.46 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -36.27 69.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -60.19 -57.92 10.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.935 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.495 HG22 ' CE2' ' A' ' 200' ' ' TYR . 42.3 mm -55.51 -48.62 77.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.4 -51.54 69.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -60.04 -38.82 83.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 229' ' ' VAL . 0.8 OUTLIER -59.24 -51.22 70.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.429 ' HB2' ' HD2' ' A' ' 200' ' ' TYR . . . -59.75 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.084 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -45.21 86.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.909 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.78 -39.31 88.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 225' ' ' LEU . 95.6 t -74.33 -24.8 19.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.098 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.44 ' CB ' H203 ' A' ' 301' ' ' RET . 24.6 m120 -96.11 2.51 53.27 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-O 126.671 3.129 . . . . 0.0 110.84 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.582 ' HE3' ' HB1' ' A' ' 72' ' ' ALA . 6.7 mmtm -121.51 -45.37 2.31 Favored 'General case' 0 N--CA 1.423 -1.798 0 O-C-N 117.121 -3.487 . . . . 0.0 112.76 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.696 HD12 ' OG ' ' A' ' 43' ' ' SER . 46.5 mm -84.34 -65.46 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.08 174.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.58 -36.22 44.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -55.93 25.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -64.29 -35.25 91.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.0 -42.32 85.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.735 0.302 . . . . 0.0 110.887 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 238' ' ' ILE . 1.1 mm -65.72 -50.72 69.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.744 HD11 ' CZ3' ' A' ' 58' ' ' TRP . 9.0 tp -62.84 -34.45 66.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.118 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' TRP . . . . . 0.709 ' O ' HG23 ' A' ' 243' ' ' VAL . 10.2 t90 -74.41 -44.27 52.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -60.32 -41.95 94.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' VAL . . . . . 0.59 HG21 ' HA ' ' A' ' 185' ' ' ALA . 13.6 p -72.67 -36.39 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -70.98 -39.86 72.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.108 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.782 HG22 ' HA ' ' A' ' 54' ' ' VAL . 61.4 t -74.8 -38.58 44.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.134 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -71.61 -35.83 70.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.921 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 -76.85 -36.81 56.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 25.4 t -50.93 -54.88 20.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.865 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 1.4 m 72.23 -69.43 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.26 66.36 3.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.89 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 250' ' ' PRO . . . -68.31 -60.86 4.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.555 0.693 . . . . 0.0 111.082 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 249' ' ' ALA . 53.6 Cg_endo -69.76 134.58 28.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.379 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.35 140.46 9.58 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 CA-C-O 119.156 -0.802 . . . . 0.0 112.536 -179.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.539 H181 ' H7 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_